role,name,affiliation,address,trial_id,processed_name,first_name,gender,gender_probability,gender_sample_count,Rank,NCT Number,Title,Status,Study Results,Conditions,Interventions,First Posted,Locations,URL
Principal Investigator,"Pierre BOURDILLON, MD",Fondation A. de Rothschild,,NCT04427254,pierre bourdillon,pierre,male,0.99,91174,2,NCT04427254,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,Not yet recruiting,No Results Available,COVID19,"Drug: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies","June 11, 2020","Fondation A de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04427254
Principal Investigator,"Pierre CROISILLE, PhD",CHU SAINT-ETIENNE,,NCT04377685,pierre croisille,pierre,male,0.99,91174,3,NCT04377685,Prediction of Clinical Course in COVID19 Patients,Recruiting,No Results Available,COVID 19,Other: CT-Scan,"May 6, 2020","Chu Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04377685
Principal Investigator,"Pierre Asfar, MD, PhD","CHU Angers, service de médecine intensive réanimation",,NCT04337190,pierre asfar,pierre,male,0.99,91174,296,NCT04337190,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome,Biological: blood sampling,"April 7, 2020","University Hospital Angers, Angers, France",https://ClinicalTrials.gov/show/NCT04337190
Principal Investigator,"Pierre HAUSFATER, MD",GH Pitié Salpêtrière - Charles Foix,,NCT04352348,pierre hausfater,pierre,male,0.99,91174,364,NCT04352348,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Recruiting,No Results Available,COVID-19,Other: blood samples,"April 20, 2020","GH Pitié-Salpêtrière / Service d'Accueil des Urgences, Paris, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04352348
Principal Investigator,"Pierre PATOZ, PharmD",CH Tourcoing,,NCT04337996,pierre patoz,pierre,male,0.99,91174,535,NCT04337996,Dynamic Evaluation of COVID-19 Diagnostic Tests,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: COVID-19 diagnostic test,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04337996
Principal Investigator,"Barthelemy LAFONDESMURS, MD",CH Tourcoing,,NCT04337996,barthelemy lafondesmurs,barthelemy,male,0.86,450,535,NCT04337996,Dynamic Evaluation of COVID-19 Diagnostic Tests,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: COVID-19 diagnostic test,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04337996
Principal Investigator,"Pierre PATOZ, PharmD",CH Tourcoing,,NCT04429724,pierre patoz,pierre,male,0.99,91174,568,NCT04429724,Health Professional Exposure Assessment to Covid-19,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: Diagnostic test Covid-19,"June 12, 2020",,https://ClinicalTrials.gov/show/NCT04429724
Principal Investigator,SIVERY,CH Wattrelos,,NCT04429724,sivery,sivery,female,0.5,2,568,NCT04429724,Health Professional Exposure Assessment to Covid-19,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: Diagnostic test Covid-19,"June 12, 2020",,https://ClinicalTrials.gov/show/NCT04429724
Principal Investigator,Pierre Corbeau,CHU Nimes,,NCT04351711,pierre corbeau,pierre,male,0.99,91174,889,NCT04351711,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Not yet recruiting,No Results Available,SARS-CoV-2|Covid-19,Other: Immunological profiling,"April 17, 2020","CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04351711
Study Director,"Pierre Fumoleau, PhD",Institut Curie,,NCT04369066,pierre fumoleau,pierre,male,0.99,91174,1404,NCT04369066,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie",Recruiting,No Results Available,Volunteers From the Institute Curie Staff Who Are Not Showing Active SARS-CoV-2 Infection,Diagnostic Test: Blood samples (collection of 5 mL of blood in a dry tube)|Diagnostic Test: Nasopharyngeal swabs,"April 30, 2020","Institut Curie, Paris, France",https://ClinicalTrials.gov/show/NCT04369066
Principal Investigator,Nuriye Kupeli,"Marie Curie Palliative Care Research Department, UCL",,NCT04386668,nuriye kupeli,nuriye,female,0.97,1069,4,NCT04386668,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,Not yet recruiting,No Results Available,COVID19,Other: Let It Out (LIO)-C|Other: Neutral writing control,"May 13, 2020",,https://ClinicalTrials.gov/show/NCT04386668
Principal Investigator,"M.Sc. Mahmoud Elkazzaz, M.Sc.in Biochemistry",Damitta University,,NCT04396067,mahmoud elkazzaz,mahmoud,male,0.98,21229,5,NCT04396067,Combination With Inhibitor of Neutrophil Elastase (All-trans Retinoic Acid ) and Isotretinoin May Enhances Neutralizing Antibodies in COVID -19 Infected Patients Better Than COVID-19 Inactivated Vaccines,Not yet recruiting,No Results Available,COVID -19,Drug: Aerosolized 13 cis retinoic acid|Drug: Aerosolized All trans retinoic acid|Other: Placebo,"May 20, 2020",,https://ClinicalTrials.gov/show/NCT04396067
Principal Investigator,"M.Sc. Mahmoud Elkazzaz, M.Sc.Biochemistry","Faculty of Science, Damietta University",,NCT04353180,mahmoud elkazzaz,mahmoud,male,0.98,21229,94,NCT04353180,Assessment the Activity Value of 13- Cis-Retinoic Acid (Isotretinoin) in the Treatment of COVID-19 (Randomized),Not yet recruiting,No Results Available,COVID19,Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|Drug: Standard treatment,"April 20, 2020","Faculty of Medicine, Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt|Faculty of Medicine, Kafr El-sheikh University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04353180
Study Chair,"Dr.Tamer Hydara, Lecturer of Internal Medicine","Faculty of Medicine, Kafr Elshiekh University",,NCT04353180,tamer hydara,tamer,male,0.97,15379,94,NCT04353180,Assessment the Activity Value of 13- Cis-Retinoic Acid (Isotretinoin) in the Treatment of COVID-19 (Randomized),Not yet recruiting,No Results Available,COVID19,Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|Drug: Standard treatment,"April 20, 2020","Faculty of Medicine, Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt|Faculty of Medicine, Kafr El-sheikh University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04353180
Principal Investigator,"M.Sc. Mahmoud Elkazzaz, M.Sc.Biochemistry",General Organization of Export and Import control system,,NCT04382950,mahmoud elkazzaz,mahmoud,male,0.98,21229,112,NCT04382950,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Not yet recruiting,No Results Available,COVID,Combination Product: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid,"May 11, 2020",,https://ClinicalTrials.gov/show/NCT04382950
Principal Investigator,"M.Sc. Mahmoud Elkazzaz, M.Sc.Biochemistry",General Organization of Export and Import control system,,NCT04375046,mahmoud elkazzaz,mahmoud,male,0.98,21229,188,NCT04375046,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Not yet recruiting,No Results Available,COVID-19,Drug: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2),"May 5, 2020",,https://ClinicalTrials.gov/show/NCT04375046
Study Chair,"M.Sc. Mahmoud Elkazzaz, M.Sc.in Biochemistry",Damitta University,,NCT04371822,mahmoud elkazzaz,mahmoud,male,0.98,21229,615,NCT04371822,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Not yet recruiting,No Results Available,COVID-19,Drug: SnPP Protoporphyrin plus Sunlight exposure|Drug: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.|Other: placebo,"May 1, 2020","Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt",https://ClinicalTrials.gov/show/NCT04371822
Study Chair,"Mahmoud Tantawy, MD",Misr University for Science and Technology,,NCT04323345,mahmoud tantawy,mahmoud,male,0.98,21229,1388,NCT04323345,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Recruiting,No Results Available,COVID-19,Dietary Supplement: Natural Honey|Other: Standard Care,"March 26, 2020","Mahmoud Tantawy, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04323345
Principal Investigator,"Mahmoud El-Bendary, M.D",Mansoura University,,NCT04390269,mahmoud el-bendary,mahmoud,male,0.98,21229,1882,NCT04390269,Immunogenetics Predictors With COVID-19,Not yet recruiting,No Results Available,Genetic Predisposition to Disease,,"May 15, 2020","Mansoura Faculty of Medicine, Mansoura, Dakahlyia, Egypt",https://ClinicalTrials.gov/show/NCT04390269
Principal Investigator,"Mahmoud Alalfy, PhD","Algezeera hospitaland National Research Centre ,Egypt",,NCT04393415,mahmoud alalfy,mahmoud,male,0.98,21229,2026,NCT04393415,Using PRP and Cord Blood in Treatment of Covid -19,Not yet recruiting,No Results Available,Virus,Combination Product: stem cells,"May 19, 2020","Aljazeera( Al Gazeera) hospital, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04393415
Principal Investigator,"Mahmoud Alalfy, PhD","Algezeera hospitaland National Research Centre ,Egypt",,NCT04427813,mahmoud alalfy,mahmoud,male,0.98,21229,2040,NCT04427813,Sexual Health and Problems During the Covid -19 Infection,Not yet recruiting,No Results Available,Sexual Behavior,Behavioral: questionaire to husband and wife,"June 11, 2020","Algazeerah, Giza, Egypt",https://ClinicalTrials.gov/show/NCT04427813
Principal Investigator,"Regan N Theiler, MD, PhD",Mayo Clinic,,NCT04379284,regan n theiler,regan,male,0.76,443,6,NCT04379284,Risks of COVID19 in the Pregnant Population,Not yet recruiting,No Results Available,COVID19,Other: Biospecimen collection,"May 7, 2020","Mayo Clinic in Rochester, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04379284
Principal Investigator,"Anca Askanase, MD, MPH",Columbia University,,NCT04349371,anca askanase,anca,female,0.96,9304,7,NCT04349371,Saved From COVID-19,Recruiting,No Results Available,COVID,Drug: Chloroquine|Drug: Placebo oral tablet,"April 16, 2020","Columbia University Irving Medical Center/NYP, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04349371
Principal Investigator,"Tamer A Elhadidy, MD",assistant professor,,NCT04388436,tamer a elhadidy,tamer,male,0.97,15379,10,NCT04388436,Post Covid-19 Cardiopulmonary and Immunological Changes,"Active, not recruiting",No Results Available,COVID,,"May 14, 2020","Mansoura faculty of medicine, Mansoura, Dakahlia, Egypt",https://ClinicalTrials.gov/show/NCT04388436
Principal Investigator,"Sherief Abd-Elsalam, ass. prof.",Tanta University Faculty of medicine,,NCT04345419,sherief abd-elsalam,sherief,male,0.98,150,12,NCT04345419,A Real-life Experience on Treatment of Patients With COVID 19,Recruiting,No Results Available,COVID,Drug: Chloroquine|Drug: Favipiravir|Drug: Nitazoxanide|Drug: Ivermectin|Drug: Niclosamide|Drug: Other drugs,"April 14, 2020","Tanta university hospital, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04345419
Study Director,"Eslam Saber, ass. lect",Tanta University Faculty of medicine,,NCT04345419,eslam saber,eslam,male,0.97,2682,12,NCT04345419,A Real-life Experience on Treatment of Patients With COVID 19,Recruiting,No Results Available,COVID,Drug: Chloroquine|Drug: Favipiravir|Drug: Nitazoxanide|Drug: Ivermectin|Drug: Niclosamide|Drug: Other drugs,"April 14, 2020","Tanta university hospital, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04345419
Study Chair,"Mai Khalaf, ass. lect.",Tanta University Faculty of medicine,,NCT04345419,mai khalaf,mai,female,0.84,7369,12,NCT04345419,A Real-life Experience on Treatment of Patients With COVID 19,Recruiting,No Results Available,COVID,Drug: Chloroquine|Drug: Favipiravir|Drug: Nitazoxanide|Drug: Ivermectin|Drug: Niclosamide|Drug: Other drugs,"April 14, 2020","Tanta university hospital, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04345419
Principal Investigator,"sherief Abd-Elsalam, Ass. Prof.",ass. Prof. Tropical Medicine,,NCT04403555,sherief abd-elsalam,sherief,male,0.98,150,65,NCT04403555,Ivermectin and Doxycycine in COVID-19 Treatment,Not yet recruiting,No Results Available,COVID,Drug: Ivermectin|Drug: Doxycycline|Drug: Chloroquine,"May 27, 2020","Sherief Abd-Elsalam, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04403555
Principal Investigator,"sherief Abd-Elsalam, Ass. Prof.",Tanta University - Faculty of Medicine,,NCT04351295,sherief abd-elsalam,sherief,male,0.98,150,71,NCT04351295,Efficacy of Faviprevir in COVID-19 Treatment,Not yet recruiting,No Results Available,COVID,Drug: Favipiravir|Drug: Placebos,"April 17, 2020","Tanta University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04351295
Principal Investigator,"Sherief Abd-Elsalam, ass. prof.",Tanta University Faculty of medicine,,NCT04345406,sherief abd-elsalam,sherief,male,0.98,150,74,NCT04345406,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Not yet recruiting,No Results Available,COVID,Drug: ACEIs|Drug: Conventional treatment,"April 14, 2020","Tanta University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04345406
Principal Investigator,"sherief Abd-Elsalam, Ass. Prof.",Tanta University - Faculty of Medicine,,NCT04351347,sherief abd-elsalam,sherief,male,0.98,150,83,NCT04351347,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Recruiting,No Results Available,COVID,Drug: Ivermectin|Drug: Nitazoxanide with ivermectin|Drug: Ivermectin wth chloroquine,"April 17, 2020","Tanta University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04351347
Principal Investigator,"sherief Abd-Elsalam, Ass. Prof.",ass. Prof. Tropical Medicine,,NCT04447534,sherief abd-elsalam,sherief,male,0.98,150,86,NCT04447534,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,Recruiting,No Results Available,COVID,Drug: Chloroquine|Drug: zinc,"June 25, 2020","Tanta university hospital, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04447534
Principal Investigator,"sherief Abd-Elsalam, Ass. Prof.",ass. Prof. Tropical Medicine,,NCT04382846,sherief abd-elsalam,sherief,male,0.98,150,439,NCT04382846,Novel Regimens in COVID-19 Treatment,Not yet recruiting,No Results Available,COVID|Corona Virus Infection,Drug: Nitazoxanide|Drug: Ivermectin|Drug: Chloroquine|Drug: Azithromycin,"May 11, 2020",,https://ClinicalTrials.gov/show/NCT04382846
Principal Investigator,"sherief Abd-Elsalam, Ass. Prof.",Tanta University - Faculty of Medicine,,NCT04353336,sherief abd-elsalam,sherief,male,0.98,150,1128,NCT04353336,Efficacay of Chloroquine in COVID-19 Treatment,Recruiting,No Results Available,COVID-19|Coronavirus Infection,Drug: Chloroquine,"April 20, 2020","Tanta University, Tanta, Egypt",https://ClinicalTrials.gov/show/NCT04353336
Principal Investigator,Vishwesh Kulkarni,University of Warwick,,NCT04354753,vishwesh kulkarni,vishwesh,male,1.0,24,14,NCT04354753,AiM COVID for Covid 19 Tracking and Prediction,Completed,No Results Available,COVID 19,Other: No Intervention,"April 21, 2020","Aarogyam (UK), Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04354753
Principal Investigator,"Federica Picariello, PhD",King's College London,,NCT04408157,federica picariello,federica,female,0.99,56361,15,NCT04408157,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Not yet recruiting,No Results Available,COVID,Behavioral: Self-management booklet (SWitCh: Stay well during COVID-19),"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04408157
Study Chair,"Federica Marelli-Berg, PhD",Queen Mary University of London,,NCT04340921,federica marelli-berg,federica,female,0.99,56361,1255,NCT04340921,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Recruiting,No Results Available,Cardiovascular Disease Acute|Cardiomyopathies|COVID,Biological: COVID-19 exposure,"April 10, 2020","Barts Health Nhs Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04340921
Principal Investigator,"Sam (Saidi) Mohiddin, MD",Barts & The London NHS Trust,,NCT04340921,sam (saidi) mohiddin,sam,male,0.81,96261,1255,NCT04340921,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Recruiting,No Results Available,Cardiovascular Disease Acute|Cardiomyopathies|COVID,Biological: COVID-19 exposure,"April 10, 2020","Barts Health Nhs Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04340921
Principal Investigator,"Michael Farkouh, MD, MSc",Peter Munk Cardiac Centre; University Health Network; University of Toronto,,NCT04404218,michael farkouh,michael,male,0.99,245870,16,NCT04404218,The Açaí Berry COVID-19 Anti-Inflammation Trial,Not yet recruiting,No Results Available,COVID,Dietary Supplement: Açaí palm berry extract - natural product|Other: Placebo,"May 27, 2020",,https://ClinicalTrials.gov/show/NCT04404218
Principal Investigator,"Ana Andreazza, PhD",Department of Pharmacology & Toxicology; University of Toronto,,NCT04404218,ana andreazza,ana,female,0.98,273767,16,NCT04404218,The Açaí Berry COVID-19 Anti-Inflammation Trial,Not yet recruiting,No Results Available,COVID,Dietary Supplement: Açaí palm berry extract - natural product|Other: Placebo,"May 27, 2020",,https://ClinicalTrials.gov/show/NCT04404218
Principal Investigator,"Michael F Holick, PhD,MD",Boston University,,NCT04386850,michael f holick,michael,male,0.99,245870,87,NCT04386850,Oral 25-hydroxyvitamin D3 and COVID-19,Recruiting,No Results Available,COVID 19,Drug: Oral 25-Hydroxyvitamin D3,"May 13, 2020","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04386850
Study Chair,"Mohamadali Sahraian, MD",Tehran University of Medical Sciences,,NCT04386850,mohamadali sahraian,mohamadali,male,0.93,28,87,NCT04386850,Oral 25-hydroxyvitamin D3 and COVID-19,Recruiting,No Results Available,COVID 19,Drug: Oral 25-Hydroxyvitamin D3,"May 13, 2020","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04386850
Principal Investigator,"zhila Maghbooli, PhD",Tehran University of Medical Sciences,,NCT04386850,zhila maghbooli,zhila,female,0.92,49,87,NCT04386850,Oral 25-hydroxyvitamin D3 and COVID-19,Recruiting,No Results Available,COVID 19,Drug: Oral 25-Hydroxyvitamin D3,"May 13, 2020","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04386850
Principal Investigator,"Arash Shirvani, MD, PhD",Boston University,,NCT04386850,arash shirvani,arash,male,0.98,6033,87,NCT04386850,Oral 25-hydroxyvitamin D3 and COVID-19,Recruiting,No Results Available,COVID 19,Drug: Oral 25-Hydroxyvitamin D3,"May 13, 2020","Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04386850
Principal Investigator,"Michael Joyner, MD",Mayo Clinic,,NCT04338360,michael joyner,michael,male,0.99,245870,124,NCT04338360,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,Available,No Results Available,COVID19,Biological: COVID-19 convalescent plasma,"April 8, 2020","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States|Mayo Clinic Health System in Austin, Austin, Minnesota, United States|Mayo Clinic Health System in Cannon Falls, Cannon Falls, Minnesota, United States|Mayo Clinic Health System in Lake City, Lake City, Minnesota, United States|Mayo Clinic Health System in Mankato, Mankato, Minnesota, United States|Mayo Clinic Health System in Owatonna, Owatonna, Minnesota, United States|Mayo Clinic Health System in Red Wing, Red Wing, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Mayo Clinic Health System - Eau Claire, Eau Claire, Wisconsin, United States|Mayo Clinic Health System - Franciscan Healthcare, La Crosse, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04338360
Study Director,"Michael D Hill, MD",University of Calgary,,NCT04329611,michael d hill,michael,male,0.99,245870,181,NCT04329611,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Suspended,No Results Available,COVID-19,Drug: Hydroxychloroquine,"April 1, 2020","University of Calgary/Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04329611
Principal Investigator,"Luanne Metz, MD",University of Calgary,,NCT04329611,luanne metz,luanne,female,0.97,101,181,NCT04329611,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Suspended,No Results Available,COVID-19,Drug: Hydroxychloroquine,"April 1, 2020","University of Calgary/Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04329611
Principal Investigator,"Michael S. Avidan, MBBCh",Washington Univeristy School of Medicine,,NCT04333732,michael s. avidan,michael,male,0.99,245870,277,NCT04333732,CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Not yet recruiting,No Results Available,COVID 19,Drug: Low-dose chloroquine|Drug: Mid-dose chloroquine|Drug: High-dose chloroquine|Drug: Placebo,"April 3, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States|Population Health Resarch Institute, Hamilton, Ontario, Canada|University of Toronto, Toronto, Ontario, Canada|St James's Hospital, Dublin, Leinster, Ireland|Universitas Academic Hospital, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Johannesburg, Gauteng, South Africa|Steve Biko Academic Hospital, Pretoria, Gauteng, South Africa|Tygerberg Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT04333732
Principal Investigator,"Ramani Moonesinghe, MD","University College, London",,NCT04333732,ramani moonesinghe,ramani,female,0.5,96,277,NCT04333732,CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Not yet recruiting,No Results Available,COVID 19,Drug: Low-dose chloroquine|Drug: Mid-dose chloroquine|Drug: High-dose chloroquine|Drug: Placebo,"April 3, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States|Population Health Resarch Institute, Hamilton, Ontario, Canada|University of Toronto, Toronto, Ontario, Canada|St James's Hospital, Dublin, Leinster, Ireland|Universitas Academic Hospital, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Johannesburg, Gauteng, South Africa|Steve Biko Academic Hospital, Pretoria, Gauteng, South Africa|Tygerberg Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT04333732
Principal Investigator,"Helen Rees, MD",Wits University,,NCT04333732,helen rees,helen,female,0.98,32058,277,NCT04333732,CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION,Not yet recruiting,No Results Available,COVID 19,Drug: Low-dose chloroquine|Drug: Mid-dose chloroquine|Drug: High-dose chloroquine|Drug: Placebo,"April 3, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States|Population Health Resarch Institute, Hamilton, Ontario, Canada|University of Toronto, Toronto, Ontario, Canada|St James's Hospital, Dublin, Leinster, Ireland|Universitas Academic Hospital, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Johannesburg, Gauteng, South Africa|Steve Biko Academic Hospital, Pretoria, Gauteng, South Africa|Tygerberg Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia",https://ClinicalTrials.gov/show/NCT04333732
Principal Investigator,"Michael C Sneller, M.D.",National Institute of Allergy and Infectious Diseases (NIAID),,NCT04411147,michael c sneller,michael,male,0.99,245870,429,NCT04411147,A Longitudinal Study of COVID-19 Sequelae and Immunity,Recruiting,No Results Available,COVID-19,,"June 2, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04411147
Principal Investigator,"Michael J Borrie, MB ChB",Lawson Health Research Institute,,NCT04397328,michael j borrie,michael,male,0.99,245870,457,NCT04397328,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo,"May 21, 2020",,https://ClinicalTrials.gov/show/NCT04397328
Principal Investigator,"Michael Runyon, MD, MPH",Atrium Health,,NCT04361123,michael runyon,michael,male,0.99,245870,514,NCT04361123,Atrium COVID-19 Syndromic and Serologic Surveillance,Enrolling by invitation,No Results Available,Coronavirus|COVID,Other: daily syndromic surveillance|Diagnostic Test: monthly serologic IgM/G test,"April 24, 2020","Atrium Health, Charlotte, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04361123
Principal Investigator,"Michael Millis, MD",University of Chicago,,NCT04361214,michael millis,michael,male,0.99,245870,552,NCT04361214,Leflunomide in Mild COVID-19 Patients,Recruiting,No Results Available,COVID-19,Drug: Leflunomide,"April 24, 2020","University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04361214
Principal Investigator,"Michael Gordon, MD",HonorHealth Research Institute,,NCT04339426,michael gordon,michael,male,0.99,245870,678,NCT04339426,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Recruiting,No Results Available,Covid19,Drug: Atovaquone/Azithromycin,"April 9, 2020","HonorHealth, Scottsdale, Arizona, United States",https://ClinicalTrials.gov/show/NCT04339426
Principal Investigator,"Michael Fralick, MD, PhD",Sinai Health System,,NCT04383613,michael fralick,michael,male,0.99,245870,794,NCT04383613,Prone Positioning for Patients on General Medical Wards With COVID19,Recruiting,No Results Available,Covid-19|ARDS,Other: Prone positioning,"May 12, 2020","William Osler Health System, Brampton, Ontario, Canada|William Osler Health System, Etobicoke, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04383613
Principal Investigator,"Fahad Razak, MD, MSc",St. Michael's Hospital (Unity Health Toronto),,NCT04383613,fahad razak,fahad,male,0.98,12501,794,NCT04383613,Prone Positioning for Patients on General Medical Wards With COVID19,Recruiting,No Results Available,Covid-19|ARDS,Other: Prone positioning,"May 12, 2020","William Osler Health System, Brampton, Ontario, Canada|William Osler Health System, Etobicoke, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04383613
Principal Investigator,"Amol Verma, MD, MPhil",St. Michael's Hospital (Unity Health Toronto),,NCT04383613,amol verma,amol,male,0.9,816,794,NCT04383613,Prone Positioning for Patients on General Medical Wards With COVID19,Recruiting,No Results Available,Covid-19|ARDS,Other: Prone positioning,"May 12, 2020","William Osler Health System, Brampton, Ontario, Canada|William Osler Health System, Etobicoke, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04383613
Principal Investigator,"Michael Belmont, MD",NYU Langone Health,,NCT04354870,michael belmont,michael,male,0.99,245870,856,NCT04354870,COVID-19 PrEP HCW HCQ Study,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine (HCQ),"April 21, 2020","NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04354870
Principal Investigator,"Michael Businelle, PhD",The University of Oklahoma Health Sciences Center,,NCT04397614,michael businelle,michael,male,0.99,245870,914,NCT04397614,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,Not yet recruiting,No Results Available,Sars-CoV2|Covid-19,Other: mHealth Assessments,"May 21, 2020","Stephenson Cancer Center, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04397614
Principal Investigator,"Katherine Moxley, MD",The University of Oklahoma Health Sciences Center,,NCT04397614,katherine moxley,katherine,female,0.98,8451,914,NCT04397614,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,Not yet recruiting,No Results Available,Sars-CoV2|Covid-19,Other: mHealth Assessments,"May 21, 2020","Stephenson Cancer Center, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04397614
Principal Investigator,"Michael Yin, MD, MS",Associate Professor of Medicine,,NCT04448145,michael yin,michael,male,0.99,245870,1322,NCT04448145,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,Recruiting,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV 2,,"June 25, 2020","Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04448145
Study Director,"Michael Mack, MD",Baylor Research Institute,,NCT04371393,michael mack,michael,male,0.99,245870,1350,NCT04371393,MSCs in COVID-19 ARDS,Recruiting,No Results Available,Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID,Biological: Remestemcel-L|Drug: Placebo,"May 1, 2020","University of Southern California, Los Angeles, California, United States|Emory University, Atlanta, Georgia, United States|Lutheran Hospital, Fort Wayne, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Mount Sinai Health, New York, New York, United States|Northwell Health, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Baylor, Smith & White, Plano, Texas, United States|University of Virginia, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04371393
Study Director,"Peter Smith, MD",Duke University,,NCT04371393,peter smith,peter,male,0.99,165452,1350,NCT04371393,MSCs in COVID-19 ARDS,Recruiting,No Results Available,Mesenchymal Stromal Cells|Remestemcel-L|Acute Respiratory Distress Syndrome|COVID,Biological: Remestemcel-L|Drug: Placebo,"May 1, 2020","University of Southern California, Los Angeles, California, United States|Emory University, Atlanta, Georgia, United States|Lutheran Hospital, Fort Wayne, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Mount Sinai Health, New York, New York, United States|Northwell Health, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Baylor, Smith & White, Plano, Texas, United States|University of Virginia, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04371393
Study Director,"Michael J Dawson, MD","Leading BioSciences, Inc",,NCT04390217,michael j dawson,michael,male,0.99,245870,1428,NCT04390217,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19|Coronavirus Disease 2019|Covid19|COVID-19 Pneumonia,Drug: LB1148|Drug: Placebo,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04390217
Principal Investigator,"Michael De Brucker, MD PHD",UZ Brussels,,NCT04391829,michael de brucker,michael,male,0.99,245870,1498,NCT04391829,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Not yet recruiting,No Results Available,COVID-19|Sars-CoV2|Corona Virus Infection|Semen,Diagnostic Test: Ejaculated semen sample,"May 18, 2020",,https://ClinicalTrials.gov/show/NCT04391829
Principal Investigator,"Michael S. Gordon, M.D.",HonorHealth Research Institute,,NCT04415073,michael s. gordon,michael,male,0.99,245870,1645,NCT04415073,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,Recruiting,No Results Available,Coronavirus|COVID|ARDS|Cytokine Storm|Cytokine Release Syndrome,Drug: SNDX-6352|Drug: Placebo,"June 4, 2020","HonorHealth, Scottsdale, Arizona, United States|Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04415073
Principal Investigator,"Michael Puskarich, MD, MS",University of Minnesota,,NCT04312009,michael puskarich,michael,male,0.99,245870,1772,NCT04312009,Losartan for Patients With COVID-19 Requiring Hospitalization,Recruiting,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Losartan|Other: Placebo,"March 17, 2020","University of Florida Gainesviile, Gainesville, Florida, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04312009
Principal Investigator,"Christopher Tignanelli, MD",University of Minnesota,,NCT04312009,christopher tignanelli,christopher,male,0.99,53539,1772,NCT04312009,Losartan for Patients With COVID-19 Requiring Hospitalization,Recruiting,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Losartan|Other: Placebo,"March 17, 2020","University of Florida Gainesviile, Gainesville, Florida, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04312009
Principal Investigator,"Michael Puskarich, MD, MS",University of Minnesota,,NCT04311177,michael puskarich,michael,male,0.99,245870,1775,NCT04311177,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Recruiting,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Losartan|Other: Placebo,"March 17, 2020","Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Health System, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04311177
Principal Investigator,"Christopher Tignanelli, MD",University of Minnesota,,NCT04311177,christopher tignanelli,christopher,male,0.99,53539,1775,NCT04311177,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Recruiting,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Losartan|Other: Placebo,"March 17, 2020","Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Health System, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04311177
Principal Investigator,"Michael Osthoff, PD Dr. med.","University Hospital Basel, Division of Internal Medicine",,NCT04414631,michael osthoff,michael,male,0.99,245870,1987,NCT04414631,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Not yet recruiting,No Results Available,Coronavirus Infections,Drug: Conestat alfa,"June 4, 2020","University Hospital Basel, Division of Internal Medicine, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04414631
Principal Investigator,"Michael Hettchen, MSc","Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg",,NCT04420806,michael hettchen,michael,male,0.99,245870,2055,NCT04420806,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,"Active, not recruiting",No Results Available,Exercise|Detraining|Muscle Weakness|Muscle Atrophy,Other: HIT-exercise|Other: Sham intervention,"June 9, 2020","Institute of Medical Physics, Friedrich-Alexanden University Erlangen-Nürnberg, Erlangen, Germany",https://ClinicalTrials.gov/show/NCT04420806
Principal Investigator,"Michael P Grocott, MD",University Hospital Southampton NHS Foundation Trust,,NCT04362059,michael p grocott,michael,male,0.99,245870,2092,NCT04362059,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Not yet recruiting,No Results Available,Respiratory Infections,Device: COVSurf Drug Delivery System|Other: Standard of Care,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04362059
Principal Investigator,"Michael McGillion, PhD","McMaster University, Population Health Research Institute",,NCT04344665,michael mcgillion,michael,male,0.99,245870,2232,NCT04344665,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Not yet recruiting,No Results Available,Surgery|Perioperative Complication|COVID,Other: Virtual Care and Remote Automated Monitoring,"April 14, 2020",,https://ClinicalTrials.gov/show/NCT04344665
Principal Investigator,"PJ Devereaux, PhD","McMaster University, Population Health Research Institute",,NCT04344665,pj devereaux,pj,male,0.86,1195,2232,NCT04344665,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Not yet recruiting,No Results Available,Surgery|Perioperative Complication|COVID,Other: Virtual Care and Remote Automated Monitoring,"April 14, 2020",,https://ClinicalTrials.gov/show/NCT04344665
Principal Investigator,"Michael Joyner, MD",Mayo Clinic,,NCT04325672,michael joyner,michael,male,0.99,245870,2256,NCT04325672,Convalescent Plasma to Limit Coronavirus Associated Complications,Withdrawn,No Results Available,Coronavirus,Biological: Convalescent Plasma,"March 27, 2020",,https://ClinicalTrials.gov/show/NCT04325672
Study Director,"Michael J Telch, PhD",The University of Texas at Austin,,NCT04414826,michael j telch,michael,male,0.99,245870,2333,NCT04414826,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,Recruiting,No Results Available,Loneliness,Behavioral: Mindfulness Alone (MO) Intervention|Behavioral: Mindfulness + Compassion Intervention (MC),"June 4, 2020","Laboratory for the Study of Anxiety Disorders, University of Texas at Austin, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04414826
Principal Investigator,"Mikael Rubin, MA",The University of Texas at Austin,,NCT04414826,mikael rubin,mikael,male,0.99,16160,2333,NCT04414826,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,Recruiting,No Results Available,Loneliness,Behavioral: Mindfulness Alone (MO) Intervention|Behavioral: Mindfulness + Compassion Intervention (MC),"June 4, 2020","Laboratory for the Study of Anxiety Disorders, University of Texas at Austin, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04414826
Principal Investigator,"Ana Freitas, PhD",HeartGenetics SA,,NCT04370808,ana freitas,ana,female,0.98,273767,398,NCT04370808,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"May 1, 2020","Cardiovascular Center at Universidade de Lisboa, Lisbon, Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Lisbon, Lisboa, Portugal|Centro Hospitalar de São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04370808
Principal Investigator,"Fausto J Pinto, PhD",Faculty of Medicine of Universidade de Lisboa,,NCT04370808,fausto j pinto,fausto,male,0.99,6403,398,NCT04370808,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"May 1, 2020","Cardiovascular Center at Universidade de Lisboa, Lisbon, Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Lisbon, Lisboa, Portugal|Centro Hospitalar de São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04370808
Principal Investigator,"Tiago Guimarães, PhD",Faculty of Medicine of the University of Porto,,NCT04370808,tiago guimarães,tiago,male,0.99,27078,398,NCT04370808,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"May 1, 2020","Cardiovascular Center at Universidade de Lisboa, Lisbon, Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Lisbon, Lisboa, Portugal|Centro Hospitalar de São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04370808
Principal Investigator,"Christoph Schmaderer, M.D.","Department of Nephrology, TUM Medical School, Klinikum rechts der Isar",,NCT04347460,christoph schmaderer,christoph,male,1.0,17656,17,NCT04347460,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Recruiting,No Results Available,COVID,,"April 15, 2020","Department of nephrology, Klinikum rechts der Isar, München, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04347460
Principal Investigator,"Christoph U. Correll, MD",Northwell Health,,NCT04383470,christoph u. correll,christoph,male,1.0,17656,1924,NCT04383470,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Recruiting,No Results Available,Mental Health Wellness 1|Pandemic,,"May 12, 2020","Aristotle University of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04383470
Principal Investigator,"Marco Solmi, MD",University of Padova,,NCT04383470,marco solmi,marco,male,0.99,357670,1924,NCT04383470,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Recruiting,No Results Available,Mental Health Wellness 1|Pandemic,,"May 12, 2020","Aristotle University of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04383470
Study Director,"Agorastos Agorastos, MD",Aristotle University Of Thessaloniki,,NCT04383470,agorastos agorastos,agorastos,male,1.0,3,1924,NCT04383470,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Recruiting,No Results Available,Mental Health Wellness 1|Pandemic,,"May 12, 2020","Aristotle University of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04383470
Study Director,"Andres Estradè, MSc",Universidad Católica del Uruguay,,NCT04383470,andres estradè,andres,male,0.98,46013,1924,NCT04383470,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Recruiting,No Results Available,Mental Health Wellness 1|Pandemic,,"May 12, 2020","Aristotle University of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04383470
Study Chair,"Luis Madero, MD","Hospital Infantil Universitario Niño Jesús, Oncohematology Department",,NCT04366271,luis madero,luis,male,0.99,176693,18,NCT04366271,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,Recruiting,No Results Available,COVID,Biological: Mesenchymal cells|Drug: Standard of care,"April 28, 2020","Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Cruces, Barakaldo, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Infantil Universitario Niño Jesus, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Complejo Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04366271
Study Chair,"Luis Montiel-López, MD, MSc","CMN ""20 de Noviembre""",,NCT04443270,luis montiel-lópez,luis,male,0.99,176693,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Carlos A Delgado-Quintana, MD","CMN ""20 de Noviembre""",,NCT04443270,carlos a delgado-quintana,carlos,male,0.99,236888,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Paul Mondragón-Terán, PhD","CMN ""20 de Noviembre""",,NCT04443270,paul mondragón-terán,paul,male,0.99,148099,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Juan A Pineda-Juárez, PhD","CMN ""20 de Noviembre""",,NCT04443270,juan a pineda-juárez,juan,male,0.98,274814,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Juan A Suárez-Cuenca, MD, PhD","CMN ""20 de Noviembre""",,NCT04443270,juan a suárez-cuenca,juan,male,0.98,274814,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Ricardo P Vázquez-Alvarado, MD","CMN ""20 de Noviembre""",,NCT04443270,ricardo p vázquez-alvarado,ricardo,male,0.99,75750,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Principal Investigator,"Sandra Muñoz-López, MD, MSc","CMN ""20 de Noviembre""",,NCT04443270,sandra muñoz-lópez,sandra,female,0.98,266121,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Director,"Sandra Muñoz-López, MD, MSc","CMN ""20 de Noviembre""",,NCT04443270,sandra muñoz-lópez,sandra,female,0.98,266121,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Maricela Escarela-Serrano, MD","CMN ""20 de Noviembre""",,NCT04443270,maricela escarela-serrano,maricela,female,0.98,721,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Fedra Irazoque-Palazuelos, MD","CMN ""20 de Noviembre""",,NCT04443270,fedra irazoque-palazuelos,fedra,female,0.98,272,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Alberto H De la Vega-Bravo, MD","CMN ""20 de Noviembre""",,NCT04443270,alberto h de la vega-bravo,alberto,male,0.99,124347,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Eduardo Soei-Sarmiento, BsC","CMN ""20 de Noviembre""",,NCT04443270,eduardo soei-sarmiento,eduardo,male,0.99,43964,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Maribel Santosbeña-Lagunes, MD","CMN ""20 de Noviembre""",,NCT04443270,maribel santosbeña-lagunes,maribel,female,0.99,12908,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Joel Vargas-Hernández, MD","CMN ""20 de Noviembre""",,NCT04443270,joel vargas-hernández,joel,male,0.98,42048,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Alejandro Alanis-Vega, MD","CMN ""20 de Noviembre""",,NCT04443270,alejandro alanis-vega,alejandro,male,0.99,56977,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Mireya Rodríguez-Martínez, MD","CMN ""20 de Noviembre""",,NCT04443270,mireya rodríguez-martínez,mireya,female,0.98,1985,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"María C Méndez-Vidrio, MD","CMN ""20 de Noviembre""",,NCT04443270,maría c méndez-vidrio,maría,female,0.99,232436,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Study Chair,"Fidel Cerda-Tellez, MD","CMN ""20 de Noviembre""",,NCT04443270,fidel cerda-tellez,fidel,male,0.93,3581,403,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Chloroquine phosphate,"June 23, 2020","Centro Médico Nacional ""20 de Noviembre"", Mexico City, Benito Juárez, Mexico",https://ClinicalTrials.gov/show/NCT04443270
Principal Investigator,"Luis P Maskin, MD",Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,,NCT04395105,luis p maskin,luis,male,0.99,176693,1173,NCT04395105,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|Covid-19",Drug: Dexamethasone,"May 20, 2020","CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Caba, Argentina",https://ClinicalTrials.gov/show/NCT04395105
Principal Investigator,"Pablo O Rodriguez, MD",Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,,NCT04395105,pablo o rodriguez,pablo,male,0.99,76709,1173,NCT04395105,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|Covid-19",Drug: Dexamethasone,"May 20, 2020","CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Caba, Argentina",https://ClinicalTrials.gov/show/NCT04395105
Principal Investigator,"Luis Ortega Paz, MD, PhD",Hospital Clínic of Barcelona,,NCT04359927,luis ortega paz,luis,male,0.99,176693,1393,NCT04359927,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Recruiting,No Results Available,Sars-CoV2|Covid19|Cardiovascular Diseases|Cardiovascular Risk Factor,,"April 24, 2020","Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain",https://ClinicalTrials.gov/show/NCT04359927
Study Director,"Salvatore Brugaletta, MD, PhD",Hospital Clínic of Barcelona,,NCT04359927,salvatore brugaletta,salvatore,male,0.99,66507,1393,NCT04359927,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Recruiting,No Results Available,Sars-CoV2|Covid19|Cardiovascular Diseases|Cardiovascular Risk Factor,,"April 24, 2020","Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain",https://ClinicalTrials.gov/show/NCT04359927
Study Chair,"Manel Sabaté, MD, PhD",Hospital Clínic of Barcelona,,NCT04359927,manel sabaté,manel,male,0.61,10628,1393,NCT04359927,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Recruiting,No Results Available,Sars-CoV2|Covid19|Cardiovascular Diseases|Cardiovascular Risk Factor,,"April 24, 2020","Hospital Clínic of Barcelona, Barcelona, Catalonia, Spain",https://ClinicalTrials.gov/show/NCT04359927
Principal Investigator,"Luis M Villela, MD",ISSSTESON,,NCT04356482,luis m villela,luis,male,0.99,176693,1533,NCT04356482,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Convalescence|Plasma|Doses,Biological: convalescent plasma,"April 22, 2020","Hospital Del Issste Regional En Guadalajara Jalisco, Guadalajara, Jalisco, Mexico|Secretaria de Salud Del Estado de Sonora, Hospital General Del Estado, Hermosillo, Sonora, Mexico|Hospital Central Norte Pemex, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04356482
Principal Investigator,"Sandeep Budhiraja, MRCP, FACP",Max Healthcare,,NCT04373824,sandeep budhiraja,sandeep,male,0.98,4494,19,NCT04373824,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Recruiting,No Results Available,COVID,Drug: Ivermectin,"May 4, 2020","Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04373824
Principal Investigator,"Sandeep Budhiraja, MRCP, FACP",Max Healthcare,,NCT04367064,sandeep budhiraja,sandeep,male,0.98,4494,105,NCT04367064,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),Recruiting,No Results Available,COVID,,"April 29, 2020","Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04367064
Principal Investigator,"Faiq I Gorial, Professor",University of Baghdad,,NCT04343092,faiq i gorial,faiq,male,0.99,301,20,NCT04343092,Efficacy of Ivermectin as Add on Therapy in COVID19 Patients,Completed,No Results Available,COVID 19,Drug: Ivermectin (IVM),"April 13, 2020","General Directorate of Medical City, Bagdad, Baghdad, Iraq",https://ClinicalTrials.gov/show/NCT04343092
Study Chair,Jawad I. Rasheed,Arab Board for Health Specialiazation in Iraq,,NCT04343092,jawad i. rasheed,jawad,male,0.97,9921,20,NCT04343092,Efficacy of Ivermectin as Add on Therapy in COVID19 Patients,Completed,No Results Available,COVID 19,Drug: Ivermectin (IVM),"April 13, 2020","General Directorate of Medical City, Bagdad, Baghdad, Iraq",https://ClinicalTrials.gov/show/NCT04343092
Principal Investigator,"Jawad Kirmani, MD",Hackensack Meridian Health Corporation,,NCT04345653,jawad kirmani,jawad,male,0.97,9921,241,NCT04345653,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,"Active, not recruiting",No Results Available,COVID19,Drug: Hydroxychloroquine Sulfate (HCQ),"April 14, 2020","Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04345653
Principal Investigator,"Timothy J Ness, MD PhD",University of Alabama at Birmingham,,NCT04338126,timothy j ness,timothy,male,0.99,13105,21,NCT04338126,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,Not yet recruiting,No Results Available,COVID19,Drug: Tranexamic acid|Drug: Placebo oral tablet,"April 8, 2020","University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04338126
Principal Investigator,"Timothy J Ness, MD PhD",University of Alabama at Birmingham,,NCT04338074,timothy j ness,timothy,male,0.99,13105,197,NCT04338074,TXA and Corona Virus 2019 (COVID19) in Outpatients,Recruiting,No Results Available,COVID-19,Drug: Tranexamic acid tablets|Drug: Placebo oral tablet,"April 8, 2020","University of Alabama at Birmingham, Birmingham, Alabama, United States",https://ClinicalTrials.gov/show/NCT04338074
Principal Investigator,"Ahmed Samir, MD",Department of Radio-diagnosis.,,NCT04433039,ahmed samir,ahmed,male,0.98,139051,22,NCT04433039,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,Completed,No Results Available,COVID,,"June 16, 2020","Faculty of Medicine, University of Alexandria, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04433039
Principal Investigator,"Ahmed Samir, MD",Department of Radio-diagnosis.,,NCT04382469,ahmed samir,ahmed,male,0.98,139051,151,NCT04382469,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,Completed,No Results Available,COVID,,"May 11, 2020","Faculty of Medicine, University of Alexandria, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04382469
Principal Investigator,Ahmed Rezk,Cairo University,,NCT04354805,ahmed rezk,ahmed,male,0.98,139051,598,NCT04354805,Administration of Chlorpromazine as a Treatment for COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Chlorpromazine,"April 21, 2020","Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04354805
Study Director,"Ahmed M Abdul Ghani, MD",Lecture of Internal Medicine Hepatology & gastroenterology Unit,,NCT04447144,ahmed m abdul ghani,ahmed,male,0.98,139051,1335,NCT04447144,"Nutritional Habits, and COVID-19 Outcome",Recruiting,No Results Available,Covid19|Chronic Inflammation|Non-Communicable Chronic Diseases,,"June 25, 2020","Faculty of Medicine Cairo University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04447144
Study Director,"Ahmed M Elsheikh, MD,MBA,CMQOE",Security Forces Program Hospital,,NCT04433286,ahmed m elsheikh,ahmed,male,0.98,139051,1956,NCT04433286,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Not yet recruiting,No Results Available,Physical Stress|Career Burnout|Satisfaction,Other: Questionnaire,"June 16, 2020","Faculty of Medicine Mansoura University, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433286
Principal Investigator,"Mostafa Shalaby, MD, MSc, PhD",Mansoura Faculty of Medicine,,NCT04433286,mostafa shalaby,mostafa,male,0.98,14950,1956,NCT04433286,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Not yet recruiting,No Results Available,Physical Stress|Career Burnout|Satisfaction,Other: Questionnaire,"June 16, 2020","Faculty of Medicine Mansoura University, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433286
Study Chair,"Hosam Hamed, MD, MSc, PhD",Mansoura Faculty of Medicine,,NCT04433286,hosam hamed,hosam,male,0.97,2153,1956,NCT04433286,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Not yet recruiting,No Results Available,Physical Stress|Career Burnout|Satisfaction,Other: Questionnaire,"June 16, 2020","Faculty of Medicine Mansoura University, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433286
Principal Investigator,Ahmed Abogamal,Al-Azhar Faculty of medicine- Cairo,,NCT04422522,ahmed abogamal,ahmed,male,0.98,139051,2021,NCT04422522,Fibromyalgia During the COVID-19 Pandemic,"Active, not recruiting",No Results Available,"Fibromyalgia, Primary",,"June 9, 2020","Al-Azhar Faculty of medicine, Rheumatology Department, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04422522
Study Director,"Ahmed M Elsheikh, MD,MBA,CMQOE",Mansoura University,,NCT04433312,ahmed m elsheikh,ahmed,male,0.98,139051,2095,NCT04433312,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Not yet recruiting,No Results Available,"Satisfaction, Patient|Quality of Life",Other: Questionnaire,"June 16, 2020","Mansoura Faculty of Medicine, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433312
Principal Investigator,"Mostafa Shalaby, MD, MSc, PhD",Mansoura University,,NCT04433312,mostafa shalaby,mostafa,male,0.98,14950,2095,NCT04433312,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Not yet recruiting,No Results Available,"Satisfaction, Patient|Quality of Life",Other: Questionnaire,"June 16, 2020","Mansoura Faculty of Medicine, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433312
Study Chair,"Hosam Hamed, MD, MSc, PhD",Mansoura University,,NCT04433312,hosam hamed,hosam,male,0.97,2153,2095,NCT04433312,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Not yet recruiting,No Results Available,"Satisfaction, Patient|Quality of Life",Other: Questionnaire,"June 16, 2020","Mansoura Faculty of Medicine, Mansoura, Egypt",https://ClinicalTrials.gov/show/NCT04433312
Principal Investigator,"Ahmed S Abdulamir, PhD",Alkarkh health directorate,,NCT04441424,ahmed s abdulamir,ahmed,male,0.98,139051,2139,NCT04441424,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,Completed,No Results Available,IMMUNOTHERAPY,Biological: Convalescent plasma|Drug: Hydroxychloroquin with Azithromycin,"June 22, 2020","Akarkh Healt hdirectorate, Baghdad, Iraq",https://ClinicalTrials.gov/show/NCT04441424
Principal Investigator,"Ahmed M Mukhtar, M.D",Cairo University,,NCT04354792,ahmed m mukhtar,ahmed,male,0.98,139051,2206,NCT04354792,Asymptomatic COVID-19 Infection Among Healthcare Workers,Completed,No Results Available,Immunologic Activity Alteration,Diagnostic Test: Serum SARs COV 2 IGg screening in health care workers,"April 21, 2020","Cairo University Hospital, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04354792
Principal Investigator,"Rejko Krüger, Dr",Luxembourg Institute of Health,,NCT04379297,rejko krüger,rejko,male,1.0,1,25,NCT04379297,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),"Active, not recruiting",No Results Available,COVID19,,"May 7, 2020","Luxembourg Institute of Health, Strassen, Luxembourg",https://ClinicalTrials.gov/show/NCT04379297
Principal Investigator,DAVID OWEN,"National Health Service, United Kingdom",,NCT04419610,david owen,david,male,0.99,501011,27,NCT04419610,RAS and Coagulopathy in COVID19,Not yet recruiting,No Results Available,COVID,Biological: TRV027|Other: sodium chloride 0.9%,"June 5, 2020",,https://ClinicalTrials.gov/show/NCT04419610
Principal Investigator,Katrina Pollock,"National Health Service, United Kingdom",,NCT04419610,katrina pollock,katrina,female,0.98,6088,27,NCT04419610,RAS and Coagulopathy in COVID19,Not yet recruiting,No Results Available,COVID,Biological: TRV027|Other: sodium chloride 0.9%,"June 5, 2020",,https://ClinicalTrials.gov/show/NCT04419610
Principal Investigator,"David Siu, MD FRCP",HKU,,NCT04343794,david siu,david,male,0.99,501011,129,NCT04343794,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Recruiting,No Results Available,COVID19,Device: BIOVITALS,"April 13, 2020","The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04343794
Principal Investigator,"David Feltl, Prof.","General University Hospital, Prague",,NCT04401085,david feltl,david,male,0.99,501011,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Principal Investigator,"Martin Repko, Prof.","Masaryk University, Faculty of Medicine",,NCT04401085,martin repko,martin,male,0.98,180687,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Study Director,"Roman Chlíbek, Prof.",University of Defence in Brno,,NCT04401085,roman chlíbek,roman,male,0.98,54731,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Study Chair,"Roman Prymula, Prof.","Ministry of Health, Czech Republic",,NCT04401085,roman prymula,roman,male,0.98,54731,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Study Director,"Rastislav Maďar, Assoc. Prof.","University of Ostrava, Faculy of Medicine",,NCT04401085,rastislav maďar,rastislav,male,0.99,1040,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Study Director,"Ladislav Dušek, Prof.",Institute of Health Information and Statistics of the Czech Republic,,NCT04401085,ladislav dušek,ladislav,male,0.99,9627,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Study Chair,"Jarmila Rážová, M.D.; Ph.D.","Ministry of Health, Czech Republic",,NCT04401085,jarmila rážová,jarmila,female,1.0,6722,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Principal Investigator,"Aleksi Šedo, Prof.","Charles University, First Faculty of Medicine",,NCT04401085,aleksi šedo,aleksi,male,0.98,1352,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Principal Investigator,"Jaroslav Štěrba, Prof.",Brno University Hospital,,NCT04401085,jaroslav štěrba,jaroslav,male,0.99,20096,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Principal Investigator,"Dalibor Valík, Prof.",Masaryk Memorial Cancer Institute,,NCT04401085,dalibor valík,dalibor,male,0.99,4838,227,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,Completed,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"May 26, 2020","Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia",https://ClinicalTrials.gov/show/NCT04401085
Principal Investigator,"David DELARBRE, MD",French Army Health Service,,NCT04366232,david delarbre,david,male,0.99,501011,267,NCT04366232,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Not yet recruiting,No Results Available,Covid-19,Drug: Anakinra alone (stages 2b/3)|Drug: Anakinra and Ruxolitinib (overcome stage 3)|Other: Standard of care,"April 28, 2020","AP-HM, Hôpital de la Conception, Marseille, Bouches-du-Rhône, France|Hôpital Sainte-Musse, Toulon, VAR, France|Sainte Anne Teaching Military Hospital, Toulon, Var, France",https://ClinicalTrials.gov/show/NCT04366232
Principal Investigator,"David J. Cohen, MD",Columbia University,,NCT04381052,david j. cohen,david,male,0.99,501011,273,NCT04381052,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Drug: Clazakizumab|Other: Placebo,"May 8, 2020","Columbia University Medical Center / New York Presbyerian Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04381052
Study Chair,"David Marsolais, PhD",CRIUCPQ-UL,,NCT04405102,david marsolais,david,male,0.99,501011,345,NCT04405102,COVID-19 Ozanimod Intervention Study,Not yet recruiting,No Results Available,COVID-19,Drug: Ozanimod|Other: Standard of care,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04405102
Principal Investigator,"François Lellouche, MD",IUCPQ-UL,,NCT04405102,françois lellouche,françois,male,1.0,7,345,NCT04405102,COVID-19 Ozanimod Intervention Study,Not yet recruiting,No Results Available,COVID-19,Drug: Ozanimod|Other: Standard of care,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04405102
Study Chair,"Nathalie Châteauvert, B. pharm",CRIUCPQ-UL,,NCT04405102,nathalie châteauvert,nathalie,female,0.98,94304,345,NCT04405102,COVID-19 Ozanimod Intervention Study,Not yet recruiting,No Results Available,COVID-19,Drug: Ozanimod|Other: Standard of care,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04405102
Principal Investigator,"David Bennett, MD",Azienda Ospedaliera Universitaria Senese,,NCT04433000,david bennett,david,male,0.99,501011,422,NCT04433000,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,Recruiting,No Results Available,Covid-19 Pneumonia,Diagnostic Test: Butterfly,"June 16, 2020","Azienda Ospedaliera Universitaria Senese, Siena, Si, Italy",https://ClinicalTrials.gov/show/NCT04433000
Principal Investigator,"David J Lowe, MBChB",NHS Greater Glasgow and Clyde,,NCT04397380,david j lowe,david,male,0.99,501011,460,NCT04397380,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,Not yet recruiting,No Results Available,Pyrexia|COVID,Device: Thermography|Device: Tympanic Temperature,"May 21, 2020","Queen Elizabeth University Hospital, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04397380
Principal Investigator,"David KLATZMANN, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04379466,david klatzmann,david,male,0.99,501011,502,NCT04379466,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,Not yet recruiting,No Results Available,COVID-19,,"May 7, 2020",,https://ClinicalTrials.gov/show/NCT04379466
Principal Investigator,"David Hager, MD PhD",Johns Hopkins University,,NCT04353206,david hager,david,male,0.99,501011,518,NCT04353206,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,Recruiting,No Results Available,Covid-19|Sars-CoV2,Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,"April 20, 2020","8700 Beverly Blvd., Los Angeles, California, United States|Johns Hopkins University, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04353206
Principal Investigator,"Noah Merin, MD PhD",Cedars-Sinai Medical Center,,NCT04353206,noah merin,noah,male,0.88,3939,518,NCT04353206,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,Recruiting,No Results Available,Covid-19|Sars-CoV2,Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,"April 20, 2020","8700 Beverly Blvd., Los Angeles, California, United States|Johns Hopkins University, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04353206
Principal Investigator,"David A Tuveson, MD PhD",Cold Spring Harbor Laboratory,,NCT04389567,david a tuveson,david,male,0.99,501011,550,NCT04389567,Famotidine Outpatient COVID-19 Treatment Study,Completed,No Results Available,COVID-19,Drug: Famotidine,"May 15, 2020","Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States",https://ClinicalTrials.gov/show/NCT04389567
Study Director,"David Chalvet, MD",Numa Health International,,NCT04371471,david chalvet,david,male,0.99,501011,796,NCT04371471,Covid-19 Pandemic Triage Score,Completed,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: STC-19 score,"May 1, 2020","Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle, France",https://ClinicalTrials.gov/show/NCT04371471
Study Director,"Kamyar M. Hedayat, MD",Numa Health International,,NCT04371471,kamyar m. hedayat,kamyar,male,0.99,366,796,NCT04371471,Covid-19 Pandemic Triage Score,Completed,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: STC-19 score,"May 1, 2020","Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle, France",https://ClinicalTrials.gov/show/NCT04371471
Study Director,"Jean-Claude Lapraz, MD",Numa Health International,,NCT04371471,jean-claude lapraz,jean-claude,male,0.99,9062,796,NCT04371471,Covid-19 Pandemic Triage Score,Completed,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: STC-19 score,"May 1, 2020","Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle, France",https://ClinicalTrials.gov/show/NCT04371471
Principal Investigator,"Serge Bénéteaud, MD",Groupe Hospitalier de la Rochelle Ré Aunis,,NCT04371471,serge bénéteaud,serge,male,0.99,33691,796,NCT04371471,Covid-19 Pandemic Triage Score,Completed,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: STC-19 score,"May 1, 2020","Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle, France",https://ClinicalTrials.gov/show/NCT04371471
Study Director,David Gisi,Kantonsspital Winterthur KSW,,NCT04375709,david gisi,david,male,0.99,501011,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Giuseppe Mungo, MSc",Kantonsspital Winterthur KSW,,NCT04375709,giuseppe mungo,giuseppe,male,0.99,163742,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Principal Investigator,"Martina Betschart, PhD",Kantonsspital Winterthur KSW,,NCT04375709,martina betschart,martina,female,0.99,101262,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Spencer Rezek, MSc Cand.",Kantonsspital Winterthur KSW,,NCT04375709,spencer rezek,spencer,male,0.96,2141,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Ines Unger, MSc Cand.",Kantonsspital Winterthur KSW,,NCT04375709,ines unger,ines,female,0.98,25430,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Natalie Ott, MSc Cand.",Kantonsspital Winterthur KSW,,NCT04375709,natalie ott,natalie,female,0.98,22384,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Swantje Beyer, MD",Kantonsspital Winterthur KSW,,NCT04375709,swantje beyer,swantje,female,0.94,324,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Markus Hofer, MD",Kantonsspital Winterthur KSW,,NCT04375709,markus hofer,markus,male,1.0,47703,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Chair,"Karrer Urs, PD MD",Kantonsspital Winterthur KSW,,NCT04375709,karrer urs,karrer,female,0.5,4,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Study Director,"Cornel Sieber, Prof. MD",Kantonsspital Winterthur KSW,,NCT04375709,cornel sieber,cornel,male,0.98,2614,822,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Recruiting,No Results Available,Covid-19 (New Coronavirus) Infection,Other: Physical exercise|Behavioral: Education sessions,"May 5, 2020","Kantonsspital Winterthur, Winterthur, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04375709
Principal Investigator,"David J Sullivan, MD",The Johns Hopkins University,,NCT04373460,david j sullivan,david,male,0.99,501011,1003,NCT04373460,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,Recruiting,No Results Available,SARS-CoV 2,Biological: SARS-CoV-2 convalescent plasma|Biological: Plasma from a volunteer donor,"May 4, 2020","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|JHSPH Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|MedStar Washington Hospital Center, Hyattsville, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04373460
Principal Investigator,"David Bernal, Ph MD",Hospital Universitario de Fuenlabrada,,NCT04346147,david bernal,david,male,0.99,501011,1009,NCT04346147,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Hidroxicloroquine|Drug: Lopinavir/ritonavir|Drug: Imatinib tablets|Drug: Baricitinib Oral Tablet,"April 15, 2020","Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04346147
Principal Investigator,"David CHARIER, MD",CHU SAINT-ETIENNE,,NCT04374045,david charier,david,male,0.99,501011,1024,NCT04374045,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,Recruiting,No Results Available,SARS-CoV 2,Other: ECG-Holter,"May 5, 2020","CHU Hopital nord, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04374045
Principal Investigator,"David Kozono, MD, PhD",Brigham and Women's Hospital,,NCT04393948,david kozono,david,male,0.99,501011,1069,NCT04393948,Lung Irradiation for COVID-19 Pneumonia,Recruiting,No Results Available,SARS-CoV 2,Radiation: Phase 1|Radiation: Phase 2,"May 19, 2020","Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04393948
Principal Investigator,"David SEGUY, MD,PhD","University Hospital, Lille",,NCT04351490,david seguy,david,male,0.99,501011,1116,NCT04351490,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Not yet recruiting,No Results Available,SARS-CoV 2,Dietary Supplement: Zinc gluconate|Dietary Supplement: 25-OH cholecalciferol,"April 17, 2020",,https://ClinicalTrials.gov/show/NCT04351490
Principal Investigator,"David J Pinato, MD",Clinical Senior Lecturer and Consultant in Medical Oncology,,NCT04393974,david j pinato,david,male,0.99,501011,1264,NCT04393974,COVID-19 and Cancer Patients,Recruiting,No Results Available,Cancer|Sars-CoV2,,"May 19, 2020","Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04393974
Principal Investigator,"David Dayya, DO, PhD, MPH",Phelps Hospital - Northwell Health,,NCT04407260,david dayya,david,male,0.99,501011,1337,NCT04407260,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19.",Completed,No Results Available,COVID -19|Respiratory Failure|Hypoxia,Device: Oxygen Hood,"May 29, 2020","Phelps Hospital, Sleepy Hollow, New York, United States",https://ClinicalTrials.gov/show/NCT04407260
Principal Investigator,"Owen J O'Neill, MD, MPH, FUHM",Phelps Hospital - Northwell Health,,NCT04407260,owen j o'neill,owen,male,0.98,4067,1337,NCT04407260,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19.",Completed,No Results Available,COVID -19|Respiratory Failure|Hypoxia,Device: Oxygen Hood,"May 29, 2020","Phelps Hospital, Sleepy Hollow, New York, United States",https://ClinicalTrials.gov/show/NCT04407260
Principal Investigator,"David Ho, M.D,",Columbia University Irving Medical Center,,NCT04342195,david ho,david,male,0.99,501011,1438,NCT04342195,Acquiring Convalescent Specimens for COVID-19 Antibodies,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Corona Virus Infection,Procedure: Blood draw,"April 10, 2020","Columbia University Irving Medical Center/NYP, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04342195
Principal Investigator,"David A Morrow, MD, MPH",TIMI Study Group,,NCT04409834,david a morrow,david,male,0.99,501011,1472,NCT04409834,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Not yet recruiting,No Results Available,COVID-19|Venous Thromboembolism|Arterial Thrombosis,Drug: Unfractionated Heparin IV|Drug: Enoxaparin 1 mg/kg|Drug: Clopidogrel|Drug: Unfractionated heparin SC|Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409834
Study Chair,"Marc S Sabatine, MD, MPH",TIMI Study Group,,NCT04409834,marc s sabatine,marc,male,0.99,116213,1472,NCT04409834,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Not yet recruiting,No Results Available,COVID-19|Venous Thromboembolism|Arterial Thrombosis,Drug: Unfractionated Heparin IV|Drug: Enoxaparin 1 mg/kg|Drug: Clopidogrel|Drug: Unfractionated heparin SC|Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409834
Principal Investigator,"David L Paterson, PhD",The University of Queensland,,NCT04377165,david l paterson,david,male,0.99,501011,1486,NCT04377165,Innovative Tool to Limit Spread of SARS-CoV-2 in Residential Aged Care Facilities,Not yet recruiting,No Results Available,COVID|Influenza|Gastroenteritis,Behavioral: Gamification|Behavioral: Newsfeed function,"May 6, 2020",,https://ClinicalTrials.gov/show/NCT04377165
Principal Investigator,"David Saadoun, MD, PhD",Pitié-Salpêtrière Hospital,,NCT04397237,david saadoun,david,male,0.99,501011,1704,NCT04397237,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,Not yet recruiting,No Results Available,COVID-19|Systemic Lupus Erythematosus|Sjogren's Syndrome|Axial Spondyloarthritis|Rheumatoid Arthritis|Giant Cell Arteritis,,"May 21, 2020",,https://ClinicalTrials.gov/show/NCT04397237
Principal Investigator,"David B Peden, MD","University of North Carolina, Chapel Hill",,NCT04367740,david b peden,david,male,0.99,501011,1782,NCT04367740,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",Enrolling by invitation,No Results Available,Asymptomatic Condition|Infection Viral|Coronavirus Infections|Severe Acute Respiratory Syndrome Coronavirus 2|Coronaviridae Infections|RNA Virus Infections|Virus Diseases|Communicable Disease,Diagnostic Test: To assess for development of IgG antibodies against SARS-CoV2,"April 29, 2020","Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04367740
Principal Investigator,"David E Leaf, MD, MMSc",Brigham and Women's Hospital,,NCT04343898,david e leaf,david,male,0.99,501011,2060,NCT04343898,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Recruiting,No Results Available,Coronavirus Infection,Other: No intervention,"April 13, 2020","Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04343898
Study Director,"Shruti Gupta, MD, MPH",Brigham and Women's Hospital,,NCT04343898,shruti gupta,shruti,female,0.97,444,2060,NCT04343898,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Recruiting,No Results Available,Coronavirus Infection,Other: No intervention,"April 13, 2020","Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04343898
Principal Investigator,"David Boulware, MD, MPH",University of Minnesota,,NCT04308668,david boulware,david,male,0.99,501011,2329,NCT04308668,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Completed,No Results Available,Corona Virus Infection|Acute Respiratory Distress Syndrome|SARS-CoV Infection|Coronavirus|Coronavirus Infections,Drug: Hydroxychloroquine|Other: Placebo,"March 16, 2020","Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Research Institute of the McGill University Heath Centre, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04308668
Principal Investigator,"Mohammed Ali Arif, FRCP",Shaheed Zulfiqar Ali Bhutto Medical University,,NCT04359537,mohammed ali arif,mohammed,male,0.98,51883,28,NCT04359537,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine Sulfate 200 MG|Other: Placebo,"April 24, 2020","Shaheed Zulfiaqar Ali Bhutto Medical University, Islamabad, Federal Capital, Pakistan",https://ClinicalTrials.gov/show/NCT04359537
Study Director,"Rauf Niazi, FRCP",Shaheed Zulfiqar Ali Bhutto Medical University /PIMS,,NCT04359537,rauf niazi,rauf,male,0.98,1554,28,NCT04359537,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine Sulfate 200 MG|Other: Placebo,"April 24, 2020","Shaheed Zulfiaqar Ali Bhutto Medical University, Islamabad, Federal Capital, Pakistan",https://ClinicalTrials.gov/show/NCT04359537
Principal Investigator,Dr Mohammed Kamran,Future Genetics Limited,,NCT04399733,mohammed kamran,mohammed,male,0.98,51883,342,NCT04399733,EMPOWER - BAME vs COVID,Not yet recruiting,No Results Available,"COVID-19, SARS-CoV 2 Infection|Health Disparities",,"May 22, 2020","Future Genetics Limited, Birmingham, West Midlands, United Kingdom",https://ClinicalTrials.gov/show/NCT04399733
Principal Investigator,"Mohammed K Elbadrawy, PhD",Chest department Mansoura University Hospital,,NCT04374591,mohammed k elbadrawy,mohammed,male,0.98,51883,809,NCT04374591,Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series,"Active, not recruiting",No Results Available,Pneumonia|Covid19,Drug: Sodium Bicarbonate,"May 5, 2020","Gomhoria Street, Mansoura, Outside U.S./Canada, Egypt",https://ClinicalTrials.gov/show/NCT04374591
Principal Investigator,mohammed m othman,MOH,,NCT04385836,mohammed m othman,mohammed,male,0.98,51883,2254,NCT04385836,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Recruiting,No Results Available,Coronavirus,Drug: alpha one antitrypsin inhalation,"May 13, 2020","Ministry of Health, Mecca, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04385836
Principal Investigator,Mervat Eissa,Cairo University,,NCT04407299,mervat eissa,mervat,female,0.98,206,30,NCT04407299,COVID-19 Impact on Rheumatic Patients,Completed,No Results Available,COVID,Behavioral: self-administered structured questionnaire,"May 29, 2020","Kasr Alainy Hospital, Cairo, Non-US/Non-Canadian, Egypt",https://ClinicalTrials.gov/show/NCT04407299
Study Chair,"Mustafa KM Nimeiri, MD","Al Neelain University, Faculty of Medicine",,NCT04381871,mustafa km nimeiri,mustafa,male,0.97,168672,31,NCT04381871,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Not yet recruiting,No Results Available,COVID 19,Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin,"May 11, 2020","Omdurman Teaching Hospital, Khartoum, Omdurman, Sudan|Jabra Hospital,, Khartoum, Sudan",https://ClinicalTrials.gov/show/NCT04381871
Study Director,"Moawia M Mukhtar, PhD","University of Khartom , Institute of Endemic Diseases",,NCT04381871,moawia m mukhtar,moawia,male,0.99,81,31,NCT04381871,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Not yet recruiting,No Results Available,COVID 19,Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin,"May 11, 2020","Omdurman Teaching Hospital, Khartoum, Omdurman, Sudan|Jabra Hospital,, Khartoum, Sudan",https://ClinicalTrials.gov/show/NCT04381871
Principal Investigator,"Mustafa Cetin, Prof",TC Erciyes University,,NCT04389385,mustafa cetin,mustafa,male,0.97,168672,1915,NCT04389385,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),"Active, not recruiting",No Results Available,Corona Virus Infection|Pneumonia,Biological: COVID-19 Specific T Cell derived exosomes (CSTC-Exo),"May 15, 2020","GENKOK, Kayseri, Melikgazi, Turkey",https://ClinicalTrials.gov/show/NCT04389385
Principal Investigator,"Mustafa Sevinc, MD",Sisli Hamidiye Etfal Training and Research Hospital,,NCT04444557,mustafa sevinc,mustafa,male,0.97,168672,2037,NCT04444557,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,Completed,No Results Available,Depression|Hemodialysis,Other: Beck Depression Inventory (BDI),"June 23, 2020","Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04444557
Principal Investigator,"Umar Farooq, PhD",Khyber Medical University Peshawer,,NCT04328272,umar farooq,umar,male,0.98,4010,32,NCT04328272,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Not yet recruiting,No Results Available,COVID19,Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 500Mg Oral Tablet|Dietary Supplement: Glucose tablets,"March 31, 2020","Ayub Teaching Institution, Abbottābād, K.p.k, Pakistan",https://ClinicalTrials.gov/show/NCT04328272
Principal Investigator,"Anne Drewry, MD",Washington Univeristy School of Medicine,,NCT04426344,anne drewry,anne,female,0.97,78727,33,NCT04426344,Core Warming of COVID-19 Patients,Not yet recruiting,No Results Available,COVID 19,Device: ensoETM device,"June 11, 2020","Barnes-Jewish Hospital, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04426344
Study Chair,Anne Greenough,King's College London,,NCT04363489,anne greenough,anne,female,0.97,78727,329,NCT04363489,The CEDiD Study (COVID-19 Early Diagnosis in Doctors),Not yet recruiting,No Results Available,Covid19,Device: Wearable Medical Device (Empatica E4),"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363489
Study Director,Dina Radenkovic,King's College London,,NCT04363489,dina radenkovic,dina,female,0.97,20572,329,NCT04363489,The CEDiD Study (COVID-19 Early Diagnosis in Doctors),Not yet recruiting,No Results Available,Covid19,Device: Wearable Medical Device (Empatica E4),"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363489
Study Director,Alexander Zargaran,King's College London,,NCT04363489,alexander zargaran,alexander,male,0.99,66065,329,NCT04363489,The CEDiD Study (COVID-19 Early Diagnosis in Doctors),Not yet recruiting,No Results Available,Covid19,Device: Wearable Medical Device (Empatica E4),"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363489
Principal Investigator,"Anne F Ambrose, MD",Albert Einstein College of Medicine,,NCT04406532,anne f ambrose,anne,female,0.97,78727,516,NCT04406532,Home-Based Covid-19 Rehabilitation Program,Not yet recruiting,No Results Available,Covid-19,Behavioral: PT-Pal|Behavioral: Self-guided exercises,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04406532
Principal Investigator,"Joe Verghese, MBBS",Albert Einstein College of Medicine,,NCT04406532,joe verghese,joe,male,0.95,58829,516,NCT04406532,Home-Based Covid-19 Rehabilitation Program,Not yet recruiting,No Results Available,Covid-19,Behavioral: PT-Pal|Behavioral: Self-guided exercises,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04406532
Principal Investigator,"Anne BERA, MD","University Hospital, Lille",,NCT04353011,anne bera,anne,female,0.97,78727,1176,NCT04353011,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Completed,No Results Available,Sars-CoV2|Chronic Pain,Other: questionnaire assesment,"April 20, 2020","Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04353011
Principal Investigator,"Anne Margarita Dyrhol Riise, MD, Professor",Oslo University Hospital,,NCT04321616,anne margarita dyrhol riise,anne,female,0.97,78727,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Principal Investigator,"Andreas Barratt-Due, MD, PhD",Oslo University Hospital,,NCT04321616,andreas barratt-due,andreas,male,0.99,71365,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Study Chair,"Paul Aukrust, MD, Professor",Oslo University Hospital,,NCT04321616,paul aukrust,paul,male,0.99,148099,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Principal Investigator,"Inge Christoffer Olsen, PhD",NorCRIN,,NCT04321616,inge christoffer olsen,inge,female,0.94,7763,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Principal Investigator,"Trine Kåsine, MD",Oslo University Hospital,,NCT04321616,trine kåsine,trine,female,0.97,1262,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Principal Investigator,"Katerina Nezvalova-Henriksen, Pharm D, PhD",Oslo Hospital Pharmacies,,NCT04321616,katerina nezvalova-henriksen,katerina,female,0.99,22022,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Principal Investigator,"Marius Trøseid, MD, PhD",Oslo University Hospital,,NCT04321616,marius trøseid,marius,male,0.99,30101,1252,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,Recruiting,No Results Available,SARS-CoV Infection|COVID 19|Acute Respiratory Distress Syndrome ARDS,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,"March 25, 2020","Andreas Barratt-Due, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04321616
Principal Investigator,"Anne Marie Rosendahl Madsen, MD","Bandim Health Project, University of Southern Denmark",,NCT04373291,anne marie rosendahl madsen,anne,female,0.97,78727,1724,NCT04373291,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,Not yet recruiting,No Results Available,COVID-19|Non-specific Effects of Vaccines|Morbidity|Absenteeism|Heterologous Immunity,Biological: BCG-Denmark|Biological: Saline,"May 4, 2020",,https://ClinicalTrials.gov/show/NCT04373291
Study Chair,"Christine Stabell Benn, Professor","Bandim Health Project, University of Southern Denmark",,NCT04373291,christine stabell benn,christine,female,0.99,91004,1724,NCT04373291,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,Not yet recruiting,No Results Available,COVID-19|Non-specific Effects of Vaccines|Morbidity|Absenteeism|Heterologous Immunity,Biological: BCG-Denmark|Biological: Saline,"May 4, 2020",,https://ClinicalTrials.gov/show/NCT04373291
Principal Investigator,"Frederik Schaltz-Buchholzer, MD","Bandim Health Project, University of Southern Denmark",,NCT04373291,frederik schaltz-buchholzer,frederik,male,0.99,4045,1724,NCT04373291,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,Not yet recruiting,No Results Available,COVID-19|Non-specific Effects of Vaccines|Morbidity|Absenteeism|Heterologous Immunity,Biological: BCG-Denmark|Biological: Saline,"May 4, 2020",,https://ClinicalTrials.gov/show/NCT04373291
Principal Investigator,"Veronika Müller, MD, PhD",Semmelweis University,,NCT04345679,veronika müller,veronika,female,0.99,47316,34,NCT04345679,Anti COVID-19 Convalescent Plasma Therapy,Not yet recruiting,No Results Available,COVID 19,Biological: anti-SARS-CoV-2 convalescent plasma,"April 14, 2020",,https://ClinicalTrials.gov/show/NCT04345679
Principal Investigator,"Jean-Marc Naccache, MD",Groupe Hospitalier Paris Saint Joseph,,NCT04365582,jean-marc naccache,jean-marc,male,0.99,8788,35,NCT04365582,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Recruiting,No Results Available,COVID,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Lopinavir 200Mg/Ritonavir 50Mg Tab,"April 28, 2020","Hôpital Privé d'Antony, Antony, France|Hôpital Avicenne, Bobigny, France|Centre Hospitalier Intercommunal de Créteil, Créteil, France|Groupe Hospitalier Paris Saint-Joseph, Paris, France|Institut Mutualiste Montsouris, Paris, France",https://ClinicalTrials.gov/show/NCT04365582
Principal Investigator,"Jean-Marc TRELUYER, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04442087,jean-marc treluyer,jean-marc,male,0.99,8788,1399,NCT04442087,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,Not yet recruiting,No Results Available,SARS-CoV2,Biological: Serology SARS-CoV2|Behavioral: Data collection,"June 22, 2020","Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04442087
Study Director,"Solen KERNEIS, MD",Assistance Publique - Hôpitaux de Paris,,NCT04442087,solen kerneis,solen,female,0.87,315,1399,NCT04442087,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,Not yet recruiting,No Results Available,SARS-CoV2,Biological: Serology SARS-CoV2|Behavioral: Data collection,"June 22, 2020","Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04442087
Study Director,"Flore ROZENBERG, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04442087,flore rozenberg,flore,female,0.95,4029,1399,NCT04442087,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,Not yet recruiting,No Results Available,SARS-CoV2,Biological: Serology SARS-CoV2|Behavioral: Data collection,"June 22, 2020","Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04442087
Principal Investigator,"Sharon Nachman, MD",Stony Brook University Hospital,,NCT04359329,sharon nachman,sharon,female,0.98,33532,39,NCT04359329,Estrogen Patch for COVID-19 Symptoms,Recruiting,No Results Available,COVID,Drug: Estradiol patch,"April 24, 2020","Stony Brook University Hospital, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04359329
Principal Investigator,"Sharon Yeatts, PhD",Medical University of South Carolina,,NCT04355767,sharon yeatts,sharon,female,0.98,33532,563,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Biological: Saline,"April 21, 2020","Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04355767
Principal Investigator,"Robert Silbergleit, MD",University of Michigan,,NCT04355767,robert silbergleit,robert,male,0.99,177418,563,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Biological: Saline,"April 21, 2020","Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04355767
Principal Investigator,"Clifton W Callaway, MD, PhD",University of Pittsburgh,,NCT04355767,clifton w callaway,clifton,male,0.99,493,563,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Biological: Saline,"April 21, 2020","Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04355767
Principal Investigator,"Valerie Durkalski-Mauldin, PhD",Medical University of South Carolina,,NCT04355767,valerie durkalski-mauldin,valerie,female,0.98,38121,563,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Biological: Saline,"April 21, 2020","Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04355767
Principal Investigator,"Frederick Korley, MD, PhD",University of Michigan,,NCT04355767,frederick korley,frederick,male,0.99,5190,563,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Biological: Saline,"April 21, 2020","Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04355767
Principal Investigator,"William Barsan, MD",University of Michigan,,NCT04355767,william barsan,william,male,0.99,64097,563,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Biological: Saline,"April 21, 2020","Stanford University, Stanford, California, United States|University of Michigan, Ann Arbor, Michigan, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States",https://ClinicalTrials.gov/show/NCT04355767
Study Director,"Maha A Mohamed, professor",Assiut univeristy,,NCT04383548,maha a mohamed,maha,female,0.93,6250,42,NCT04383548,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,Not yet recruiting,No Results Available,COVID19,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,"May 12, 2020",,https://ClinicalTrials.gov/show/NCT04383548
Principal Investigator,"Magdy El Ekiaby, Doctor","Sabrawishy hospital,Dokki,Giza,Egypt",,NCT04383548,magdy el ekiaby,magdy,male,0.95,1676,42,NCT04383548,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,Not yet recruiting,No Results Available,COVID19,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,"May 12, 2020",,https://ClinicalTrials.gov/show/NCT04383548
Principal Investigator,"Azza M Ez-Eldin, professor",Assiut univeristy,,NCT04383548,azza m ez-eldin,azza,female,0.73,1126,42,NCT04383548,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,Not yet recruiting,No Results Available,COVID19,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,"May 12, 2020",,https://ClinicalTrials.gov/show/NCT04383548
Principal Investigator,"Alia M Hussein, professor",Assiut univeristy,,NCT04383548,alia m hussein,alia,female,0.89,2758,42,NCT04383548,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,Not yet recruiting,No Results Available,COVID19,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,"May 12, 2020",,https://ClinicalTrials.gov/show/NCT04383548
Principal Investigator,Maha Moussa,Fayoum University,,NCT04401371,maha moussa,maha,female,0.93,6250,2089,NCT04401371,Distance Learning for Dental Student During COVID-19 Pandemic,Completed,No Results Available,Distance Education Learning Environment,,"May 26, 2020","Faculty of Dentistry, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04401371
Study Director,"Walter Manucha, PhD","IMBECU, Univ Nac de Cuyo, Mendoza, Argentina",,NCT04411446,walter manucha,walter,male,0.99,30023,44,NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Not yet recruiting,No Results Available,COVID,Drug: Vitamin D|Drug: Placebo,"June 2, 2020","Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04411446
Principal Investigator,"Carlos Tajer, MD",Hospital de Alta Complejidad El Cruce - Universidad Nacional Arturo Jauretche,,NCT04411446,carlos tajer,carlos,male,0.99,236888,44,NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Not yet recruiting,No Results Available,COVID,Drug: Vitamin D|Drug: Placebo,"June 2, 2020","Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04411446
Principal Investigator,"Laura Antonietti, MD",Hospital de Alta Complejidad El Cruce - Universidad Nacional Arturo Jauretche,,NCT04411446,laura antonietti,laura,female,0.98,288403,44,NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Not yet recruiting,No Results Available,COVID,Drug: Vitamin D|Drug: Placebo,"June 2, 2020","Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04411446
Principal Investigator,"Felipe Inserra, MD",Universidad Maimónides - Hospital Universitario Austral,,NCT04411446,felipe inserra,felipe,male,0.98,18670,44,NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Not yet recruiting,No Results Available,COVID,Drug: Vitamin D|Drug: Placebo,"June 2, 2020","Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04411446
Principal Investigator,"Javier Mariani, MD",Hospital de Alta Complejidad El Cruce - Universidad Nacional Arturo Jauretche,,NCT04411446,javier mariani,javier,male,0.99,106497,44,NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Not yet recruiting,No Results Available,COVID,Drug: Vitamin D|Drug: Placebo,"June 2, 2020","Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04411446
Principal Investigator,"Walter K Kraft, MD",Thomas Jefferson University,,NCT04371640,walter k kraft,walter,male,0.99,30023,873,NCT04371640,Sirolimus in COVID-19 Phase 1,Recruiting,No Results Available,SARS-CoV-2|Covid-19,Drug: Sirolimus 1 MG/ML|Drug: Placebo,"May 1, 2020","Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04371640
Principal Investigator,"Walter W Chatham, MD",University of Alabama at Birmingham,,NCT04362111,walter w chatham,walter,male,0.99,30023,1170,NCT04362111,Early Identification and Treatment of Cytokine Storm Syndrome in Covid-19,Not yet recruiting,No Results Available,Cytokine Storm|COVID-19,Drug: Anakinra|Drug: Normal saline,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04362111
Principal Investigator,"Walter P Maksymowych, MD",University of Alberta,,NCT04347798,walter p maksymowych,walter,male,0.99,30023,1615,NCT04347798,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Enrolling by invitation,No Results Available,Covid-19 Infection|Rheumatoid Arthritis|Psoriatic Arthritis|Hydroxychloroquine,Other: Hydroxychloroquine/Chloroquine,"April 15, 2020","University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04347798
Principal Investigator,"Stephanie O Keeling, MD",University of Alberta,,NCT04347798,stephanie o keeling,stephanie,female,0.98,68107,1615,NCT04347798,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Enrolling by invitation,No Results Available,Covid-19 Infection|Rheumatoid Arthritis|Psoriatic Arthritis|Hydroxychloroquine,Other: Hydroxychloroquine/Chloroquine,"April 15, 2020","University of Alberta, Edmonton, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04347798
Principal Investigator,"Carlos Ferrer Albiach, MD",Hospital Provincial de Castellon,,NCT04414293,carlos ferrer albiach,carlos,male,0.99,236888,210,NCT04414293,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Not yet recruiting,No Results Available,"COVID|Pneumonia, Viral",Radiation: Lung Low Dose Radiation,"June 4, 2020","Hospital Provincial de Castellon, Castellón De La Plana, Castellon, Spain",https://ClinicalTrials.gov/show/NCT04414293
Principal Investigator,"Carlos Simon, MD,PhD",Igenomix,,NCT04389658,carlos simon,carlos,male,0.99,236888,271,NCT04389658,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),Recruiting,No Results Available,COVID-19,,"May 15, 2020","Igenomix, Paterna, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04389658
Principal Investigator,"Xavier Santamaria, MD,PhD",Igenomix,,NCT04389658,xavier santamaria,xavier,male,0.99,36056,271,NCT04389658,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),Recruiting,No Results Available,COVID-19,,"May 15, 2020","Igenomix, Paterna, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04389658
Study Director,"Carlos Escobar-Soto, MD, PhD",Trustem,,NCT04429763,carlos escobar-soto,carlos,male,0.99,236888,657,NCT04429763,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Biological: Umbilical cord derived mesenchymal stem cells|Biological: Placebo,"June 12, 2020",,https://ClinicalTrials.gov/show/NCT04429763
Study Chair,"Guillermo Sánchez-Vanegas, MD, PhD",Fundación Universitaria de Ciencias de la Salud,,NCT04429763,guillermo sánchez-vanegas,guillermo,male,0.99,15173,657,NCT04429763,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Biological: Umbilical cord derived mesenchymal stem cells|Biological: Placebo,"June 12, 2020",,https://ClinicalTrials.gov/show/NCT04429763
Principal Investigator,"Carlos J Chaccour, MD PhD",Clinica Universidad de Navarra and Barcelona Institute of Global Health,,NCT04390022,carlos j chaccour,carlos,male,0.99,236888,1305,NCT04390022,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,Recruiting,No Results Available,Covid-19|Coronavirus Infection|SARS-CoV-2 Infection,Drug: Ivermectin|Drug: Placebo,"May 15, 2020","Clinica Universidad de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04390022
Study Director,"Carlos Wambier, MD",Brown University,,NCT04368897,carlos wambier,carlos,male,0.99,236888,1628,NCT04368897,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Recruiting,No Results Available,SARS-CoV 2|COVID|COVID-19|Androgenetic Alopecia|Androgen Receptor Abnormal|Androgen Deficiency,Diagnostic Test: CAG length <24|Diagnostic Test: CAG length >=24,"April 30, 2020","Hospital Universitario Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04368897
Principal Investigator,"Sabina Herrera, MD",Hospital Universitario Ramon y Cajal,,NCT04368897,sabina herrera,sabina,female,0.98,19547,1628,NCT04368897,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Recruiting,No Results Available,SARS-CoV 2|COVID|COVID-19|Androgenetic Alopecia|Androgen Receptor Abnormal|Androgen Deficiency,Diagnostic Test: CAG length <24|Diagnostic Test: CAG length >=24,"April 30, 2020","Hospital Universitario Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04368897
Principal Investigator,Carlos Ferrando,Medical Research and Clinical Consulting,,NCT04368975,carlos ferrando,carlos,male,0.99,236888,1973,NCT04368975,ARDS Caused by COVID-19,Recruiting,No Results Available,Acute Respiratory Failure With Hypoxia,,"April 30, 2020","Ricard Mellado, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04368975
Study Chair,"Laura RICHERT, Dr","University Hospital, Bordeaux",,NCT04356495,laura richert,laura,female,0.98,288403,1427,NCT04356495,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Recruiting,No Results Available,Corona Virus Infection|Sars-CoV2,Dietary Supplement: Vitamins|Drug: Hydroxychloroquine|Drug: Imatinib|Drug: Favipiravir|Drug: Telmisartan,"April 22, 2020","Bordeaux university Hospital, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04356495
Study Director,"Xavier ANGLARET, Dr",Inserm 1219,,NCT04356495,xavier anglaret,xavier,male,0.99,36056,1427,NCT04356495,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Recruiting,No Results Available,Corona Virus Infection|Sars-CoV2,Dietary Supplement: Vitamins|Drug: Hydroxychloroquine|Drug: Imatinib|Drug: Favipiravir|Drug: Telmisartan,"April 22, 2020","Bordeaux university Hospital, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04356495
Principal Investigator,"Denis MALVY, Pr","University Hospital, Bordeaux",,NCT04356495,denis malvy,denis,male,0.96,57303,1427,NCT04356495,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Recruiting,No Results Available,Corona Virus Infection|Sars-CoV2,Dietary Supplement: Vitamins|Drug: Hydroxychloroquine|Drug: Imatinib|Drug: Favipiravir|Drug: Telmisartan,"April 22, 2020","Bordeaux university Hospital, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04356495
Principal Investigator,"Felipe García, MD",Hospital Clínic de Barcelona,,NCT04329650,felipe garcía,felipe,male,0.98,18670,400,NCT04329650,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Recruiting,No Results Available,COVID-19,Drug: Siltuximab|Drug: Methylprednisolone,"April 1, 2020","Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitari Mútua de Terrassa, Terrassa, Spain",https://ClinicalTrials.gov/show/NCT04329650
Study Director,"Felipe Jurado-Camacho, MD. MSc",National Institute of Respiratory Diseases - México,,NCT04318015,felipe jurado-camacho,felipe,male,0.98,18670,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Principal Investigator,"Jorge Rojas-Serrano, MD, PhD.",National Institute of Respiratory Diseases - México,,NCT04318015,jorge rojas-serrano,jorge,male,0.99,118451,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Study Chair,"Carmen Hernandez Cárdenas, MD, MSc",National Institute of Respiratory Diseases - México,,NCT04318015,carmen hernandez cárdenas,carmen,female,0.98,103801,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Study Chair,"Ireri Thirion-Romero, MD, MSc",National Institute of Respiratory Diseases - México,,NCT04318015,ireri thirion-romero,ireri,female,0.6,15,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Study Chair,"Sebastian Rodríguez-Llamazares, MD, MPH",National Institute of Respiratory Diseases - México,,NCT04318015,sebastian rodríguez-llamazares,sebastian,male,0.99,81792,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Study Director,"Rogelio Perez-Padilla, MD",National Institute of Respiratory Diseases - México,,NCT04318015,rogelio perez-padilla,rogelio,male,0.99,2159,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Study Chair,"Cristobal Guadarrama-Pérez, MD",National Institute of Respiratory Diseases - México,,NCT04318015,cristobal guadarrama-pérez,cristobal,male,0.98,4849,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Study Chair,"Alejandra Ramírez-Venegas, MD, MSc",National Institute of Respiratory Diseases - México,,NCT04318015,alejandra ramírez-venegas,alejandra,female,0.98,16369,1196,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 23, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04318015
Principal Investigator,"Felipe Teran, MD",University of Pennsylvania,,NCT04379544,felipe teran,felipe,male,0.98,18670,1947,NCT04379544,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,Recruiting,No Results Available,Coronavirus|Respiratory Failure,Other: Observation only,"May 7, 2020","University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04379544
Study Chair,Javier Cortés,"IOB Institute of Oncology, Vall d´Hebron Institute of Oncology (VHIO)",,NCT04335305,javier cortés,javier,male,0.99,106497,1144,NCT04335305,Checkpoint Blockade in COVID-19 Pandemic,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral",Drug: Tocilizumab|Biological: Pembrolizumab (MK-3475),"April 6, 2020","Hospital Quirónsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Ruber Juan Bravo, Madrid, Spain|Hospital Ruber Internacional, Madrid, Spain|Hospital Arnau de Vilanova-Lliria, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04335305
Study Chair,"Javier Hortal, MD PhD",Hospital Universitario Gregorio Marañon,,NCT04422535,javier hortal,javier,male,0.99,106497,2078,NCT04422535,Effects on the Qt Interval of COVID-19 Coronavirus Infection,Recruiting,No Results Available,Coronavirus Infection|Intensive Care Patients,,"June 9, 2020","Servicio de Anestesia, Hospital General Universitario Gregorio Marañon, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04422535
Principal Investigator,Marco von Strauss und Torney,Clarunis University Centre for Gastrointestinal and Liver Diseases,,NCT04444687,marco von strauss und torney,marco,male,0.99,357670,47,NCT04444687,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,Not yet recruiting,No Results Available,COVID,Diagnostic Test: Test for SARS-CoV-2,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444687
Principal Investigator,"Marco Alessandro Minetto, MD, PhD","University of Turin, Italy",,NCT04382729,marco alessandro minetto,marco,male,0.99,357670,371,NCT04382729,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Recruiting,No Results Available,COVID-19 Pneumonia,Other: Neuromuscular Electrical Stimulation|Other: Physical Therapy Exercise,"May 11, 2020","San Luigi Gonzaga Hospital, Orbassano, TO, Italy",https://ClinicalTrials.gov/show/NCT04382729
Principal Investigator,"Marco Marietta, MD",Azienda Ospedaliero-Universitaria di Modena,,NCT04408235,marco marietta,marco,male,0.99,357670,1104,NCT04408235,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Not yet recruiting,No Results Available,"COVID|Pneumonia, Viral|Coagulation Disorder",Drug: Enoxaparin,"May 29, 2020","Azienda Ospedaliero-Universitaria, Modena, Italy",https://ClinicalTrials.gov/show/NCT04408235
Principal Investigator,"Marco Ranucci, MD",IRCCS Policlinico San Donato,,NCT04441502,marco ranucci,marco,male,0.99,357670,1182,NCT04441502,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,Recruiting,No Results Available,Covid19|Interstitial Pneumonia,,"June 22, 2020","IRCCS Policlinico San Donato, San Donato Milanese, MI, Italy",https://ClinicalTrials.gov/show/NCT04441502
Principal Investigator,"Marco Contoli, MD",Pulmonology Unit,,NCT04343053,marco contoli,marco,male,0.99,357670,1529,NCT04343053,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Other: SARS-Cov-2 infection,"April 13, 2020","Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy",https://ClinicalTrials.gov/show/NCT04343053
Principal Investigator,"Savino Spadaro, MD",Intensive care unit,,NCT04343053,savino spadaro,savino,male,0.98,1254,1529,NCT04343053,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Other: SARS-Cov-2 infection,"April 13, 2020","Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy",https://ClinicalTrials.gov/show/NCT04343053
Principal Investigator,"Gianluca Campo, MD",Cardiology Unit,,NCT04343053,gianluca campo,gianluca,male,0.99,41833,1529,NCT04343053,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Other: SARS-Cov-2 infection,"April 13, 2020","Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy",https://ClinicalTrials.gov/show/NCT04343053
Principal Investigator,"Marco Confalonieri, MD",University of Trieste,,NCT04323592,marco confalonieri,marco,male,0.99,357670,1914,NCT04323592,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Completed,Has Results,"Severe Acute Respiratory Syndrome (SARS) Pneumonia|Coronavirus Infections|ARDS, Human",Drug: Methylprednisolone|Other: standard care,"March 26, 2020","Marco Confalonieri, Trieste, TS, Italy",https://ClinicalTrials.gov/show/NCT04323592
Study Director,"Regina Grossmann, Dr med",Head of Clinical Trials Center University Hospital Zurich,,NCT04414657,regina grossmann,regina,female,0.98,18851,49,NCT04414657,USZ BioResource COVID,Recruiting,No Results Available,COVID19,Other: blood sampling for biobank,"June 4, 2020","University Hospital Zurich, Clinical Trials Center, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04414657
Study Director,"Arnaud Bourdin, MD PhD","University Hospital, Montpellier",,NCT04422574,arnaud bourdin,arnaud,male,0.99,39701,52,NCT04422574,COVID 19 Serology in Pulmonologists,Completed,No Results Available,Covid 19,,"June 9, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04422574
Principal Investigator,"Arnaud Leroy, MD","University Hospital, Lille",,NCT04405362,arnaud leroy,arnaud,male,0.99,39701,1294,NCT04405362,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,Not yet recruiting,No Results Available,SARS-CoV 2|Traumatic Stress Disorder,,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04405362
Study Chair,"Anselm Gitt, MD",Stiftung IHF and Klinikum der Stadt Ludwigshafen,,NCT04335188,anselm gitt,anselm,male,0.99,242,53,NCT04335188,COVID-19 Registry Rhineland-Palatinate (Germany),Recruiting,No Results Available,COVID,Other: Prospective oberservational registry,"April 6, 2020","Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie, Ludwigshafen, RLP, Germany",https://ClinicalTrials.gov/show/NCT04335188
Principal Investigator,"Raymond Chung, MD",Massachusetts General Hospital,,NCT04343976,raymond chung,raymond,male,0.99,21679,56,NCT04343976,Pegylated Interferon Lambda Treatment for COVID-19,Enrolling by invitation,No Results Available,COVID-19|COVID,Drug: Pegylated interferon lambda,"April 14, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04343976
Study Director,"Karamat Hu Bukhari, FCPS MED",Combined Military Hospital Lahore,,NCT04392713,karamat hu bukhari,karamat,male,0.94,32,57,NCT04392713,Efficacy of Ivermectin in COVID-19,Recruiting,No Results Available,COVID,Drug: Ivermectin 6 MG Oral Tablet (2 tablets),"May 19, 2020","Combined Military Hospital Lahore, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04392713
Principal Investigator,Jean-Michel CONSTANTIN,Assistance Publique - Hôpitaux de Paris,,NCT04357444,jean-michel constantin,jean-michel,male,0.99,6577,59,NCT04357444,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Not yet recruiting,No Results Available,COVID 19,Drug: 1: ILT101|Drug: 2: Placebo Comparator,"April 22, 2020","Service Anesthésie Réanimation - Groupe Hospitalier Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04357444
Study Director,"Dr Shiv Kumar Sarin, DM",Institute of Liver & Biliary Sciences,,NCT04352491,shiv kumar sarin,shiv,male,0.91,795,60,NCT04352491,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Completed,No Results Available,COVID 19,Other: No intervention,"April 20, 2020","Institute of Liver and Biliary Sciences, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04352491
Study Director,"Dr Shiv Kumar Sarin, DM",Institute of Liver & Biliary Sciences,,NCT04345640,shiv kumar sarin,shiv,male,0.91,795,2107,NCT04345640,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Recruiting,No Results Available,Liver Cirrhoses,Other: no intervention,"April 14, 2020","Institute of Liver and Biliary Sciences, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04345640
Principal Investigator,"Didier BESSIS, PhD",University Hospitals of Montpellier,,NCT04361786,didier bessis,didier,male,0.99,42959,67,NCT04361786,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,Recruiting,No Results Available,COVID 19,,"April 24, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04361786
Principal Investigator,Didier Guillemot,Raymond Poincaré Hospital,,NCT04339881,didier guillemot,didier,male,0.99,42959,1464,NCT04339881,NOsocomial Dissemination Risk of SARS-Cov2,Not yet recruiting,No Results Available,Sars-CoV2,,"April 9, 2020",,https://ClinicalTrials.gov/show/NCT04339881
Principal Investigator,Marianne Martinello,"Kirby Institute, UNSW Sydney",,NCT04383652,marianne martinello,marianne,female,0.99,37801,68,NCT04383652,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Recruiting,No Results Available,COVID,Other: Biological sample and clinical data collection,"May 12, 2020","NSW Health Pathology, Randwick, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Sydney Children's Hospital, Randwick, New South Wales, Australia|Blacktown Hospital, Blacktown, Australia|Royal Prince Alfred Hospital, Camperdown, Australia|St Vincent's Hospital, Darlinghurst, Australia|Northern Beaches Hospital, Frenchs Forest, Australia|Royal North Shore Hospital, Saint Leonards, Australia|Westmead Hospital, Westmead, Australia",https://ClinicalTrials.gov/show/NCT04383652
Principal Investigator,Rowena Bull,"School of Medical Sciences, UNSW Sydney",,NCT04383652,rowena bull,rowena,female,0.99,2929,68,NCT04383652,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Recruiting,No Results Available,COVID,Other: Biological sample and clinical data collection,"May 12, 2020","NSW Health Pathology, Randwick, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Sydney Children's Hospital, Randwick, New South Wales, Australia|Blacktown Hospital, Blacktown, Australia|Royal Prince Alfred Hospital, Camperdown, Australia|St Vincent's Hospital, Darlinghurst, Australia|Northern Beaches Hospital, Frenchs Forest, Australia|Royal North Shore Hospital, Saint Leonards, Australia|Westmead Hospital, Westmead, Australia",https://ClinicalTrials.gov/show/NCT04383652
Principal Investigator,"Jonathan Leff, MD",Montefiore Medical Center,,NCT04425720,jonathan leff,jonathan,male,0.99,87986,70,NCT04425720,Use of Remote Monitoring for COVID-19 Patient,Not yet recruiting,No Results Available,COVID,Device: LifeSignals Biosensor 1AX*|Other: Standard of Care,"June 11, 2020","Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04425720
Principal Investigator,"Jonathan Gerber, MD",UMASS MEDICAL SCHOOL,,NCT04445207,jonathan gerber,jonathan,male,0.99,87986,630,NCT04445207,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,Available,No Results Available,COVID|Sars-CoV2|Corona Virus Infection,Biological: Convalescent Plasma,"June 24, 2020","UMass Medical School, Worcester, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04445207
Principal Investigator,"Jonathan Chelly, MD",Centre Hospitalier Intercommunal Toulon La Seyne sur Mer,,NCT04373759,jonathan chelly,jonathan,male,0.99,87986,804,NCT04373759,Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,Recruiting,No Results Available,Sars-CoV2|Covid-19,Other: Cardiopulmonary resuscitation|Other: Modified Rankin score,"May 4, 2020","CHU Felix Guyon, Saint-Denis, La Reunion, France|CHU Amiens Picardie, Amiens, France|CH Angoulème, Angoulême, France|CH Argenteuil, Argenteuil, France|CH Bethune, Beuvry, France|CHU Ambroise Paré AP-HP, Boulogne-Billancourt, France|CH Brive, Brive-la-Gaillarde, France|CHU Caen, Caen, France|Hôpital Privé St Martin, Caen, France|CH Cahors, Cahors, France|CHU Antoine Béclère AP-HP, Clamart, France|CH Louis Mourier AP-HP, Colombes, France|CHU Henri Mondor AP-HP, Créteil, France|CHU Dijon, Dijon, France|CH de la Dracénie, Draguignan, France|CHI Frejus St Raphael, Fréjus, France|Grand Hôpital de l'Est Francilien, Jossigny, France|CH La Rochelle, La Rochelle, France|CHU Grenoble-Alpes, La Tronche, France|CH Versailles, Le Chesnay, France|CHU Kremlin Bicêtre, Le Kremlin-Bicêtre, France|CH Lens, Lens, France|CHRU Roger Salengro, Lille, France|CH Sambre Avesnois, Maubeuge, France|CHU Meaux, Meaux, France|Groupe Hospitalier Sud Ile de France, Melun, France|CHU Montpellier, Montpellier, France|CHR Orléans, Orléans, France|CHU Lariboisière AP-HP, Paris, France|CHU Saint Louis AP-HP, Paris, France|CHU St Antoine, Paris, France|Groupe Hospitalier Saint Joseph, Paris, France|CHU Necker Enfants Malades, Paris, France|Groupe Hospitalier Diaconesse Croix Saint-Simon, Paris, France|Hôpital Privé Claude Galien, Quincy-sous-Sénart, France|CHU Rouen, Rouen, France|Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, France|Hôpital Nord Franche Comté, Trévenans, France|Institut Gustave Roussy, Villejuif, France|CH Etampes, Étampes, France|CHU Martinique - Fort de France, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04373759
Principal Investigator,"Jonathan Spicer, MD, PhD",McGill University Health Centre/Research Institute of the McGill University Health Centre,,NCT04409925,jonathan spicer,jonathan,male,0.99,87986,829,NCT04409925,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Not yet recruiting,No Results Available,COVID-19 Infection,Drug: rhDNase I,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409925
Study Chair,"Jonathan C Javitt, MD, MPH","NeuroRx, Inc.",,NCT04311697,jonathan c javitt,jonathan,male,0.99,87986,1557,NCT04311697,Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,Recruiting,No Results Available,Critical COVID-19 With Respiratory Failure|Acute Respiratory Distress Syndrome (ARDS)|Corona Virus Infection|Acute Lung Injury,Drug: Aviptadil by intravenous infusion + standard of care|Drug: Normal Saline Infusion + standard of care,"March 17, 2020","University of California - Irvine, Irvine, California, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|Robert I Grossman School of Medicine / NYU Langone Medical Center, New York, New York, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Rambam Health Care Campus, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04311697
Study Chair,"Jonathan C Javitt, MD, MPH",NeuroRx,,NCT04360096,jonathan c javitt,jonathan,male,0.99,87986,1649,NCT04360096,Inhaled Aviptadil for the Treatment of Non-Acute Lung Injury in COVID-19,Not yet recruiting,No Results Available,SARS-CoV 2|COVID|ARDS|ALI|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Dyspnea,Drug: Aviptadil (VIP)|Drug: Placebo,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04360096
Study Chair,"Jonathan Montomoli, MD, PhD",RISC-19-ICU board,,NCT04357275,jonathan montomoli,jonathan,male,0.99,87986,1679,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,"April 22, 2020","University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
Study Chair,"Philippe Guerci, MD",RISC-19-ICU board,,NCT04357275,philippe guerci,philippe,male,0.99,82618,1679,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,"April 22, 2020","University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
Study Chair,"Pedro D Wendel Garcia, MSc",RISC-19-ICU board,,NCT04357275,pedro d wendel garcia,pedro,male,0.99,165413,1679,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,"April 22, 2020","University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
Principal Investigator,"Matthias P Hilty, MD",RISC-19-ICU board,,NCT04357275,matthias p hilty,matthias,male,1.0,26402,1679,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,"April 22, 2020","University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
Study Chair,"Reto A Schüpbach, MD",RISC-19-ICU board,,NCT04357275,reto a schüpbach,reto,male,0.99,1853,1679,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,"April 22, 2020","University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
Study Chair,"Theirry Fumeaux, MD",RISC-19-ICU board,,NCT04357275,theirry fumeaux,theirry,male,0.96,27,1679,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Recruiting,No Results Available,Critical Illness|ARDS|Inflammatory Response|COVID-19|Circulatory Shock,Other: ICU treatment,"April 22, 2020","University Hospital of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04357275
Principal Investigator,JORGE CARRIEL,"Hospital Clínico San Carlos, Madrid",,NCT04362969,jorge carriel,jorge,male,0.99,118451,73,NCT04362969,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",Not yet recruiting,No Results Available,COVID,,"April 27, 2020","GastroMuñoz, Guayaquil, Guayas, Ecuador",https://ClinicalTrials.gov/show/NCT04362969
Principal Investigator,"Lubov Barabanova, MD","Clinic ""Scandinavia""",,NCT04406038,lubov barabanova,lubov,female,0.98,752,75,NCT04406038,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",Recruiting,No Results Available,COVID19,,"May 28, 2020","Clinic ""Scandinavia"", Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04406038
Principal Investigator,"Colin Berry, MBChB/PhD",University of Glasgow / NHS Greater Glasgow & Clyde,,NCT04403607,colin berry,colin,male,0.98,13002,76,NCT04403607,Cardiac Imaging in SARS-CoV-2 (COVID-19),Recruiting,No Results Available,COVID,,"May 27, 2020","Royal Alexandra Hospital, Paisley, Renfrewshire, United Kingdom|Royal Infirmary, Glasgow, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom",https://ClinicalTrials.gov/show/NCT04403607
Study Director,"Colin Broom, MD","Pulmotect, Inc.",,NCT04313023,colin broom,colin,male,0.98,13002,768,NCT04313023,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Recruiting,No Results Available,COVID-19,Drug: PUL-042 Inhalation Solution|Drug: Placebo,"March 18, 2020","University of California Irvine, Orange, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Willis-Knighton Physcian Network, Bossier City, Louisiana, United States|Englewood Health, Englewood, New Jersey, United States|Ascension St. John, Tulsa, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04313023
Study Director,"Colin Broom, MD","Pulmotect, Inc.",,NCT04312997,colin broom,colin,male,0.98,13002,774,NCT04312997,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Recruiting,No Results Available,COVID-19,Drug: PUL-042 Inhalation Solution|Drug: Placebo,"March 18, 2020","University of California Irvine, Orange, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|St. Elizabeth Healthcare, Edgewood, Kentucky, United States|Ascension St. John, Tulsa, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04312997
Principal Investigator,"Gian Paolo Rossi, Prof.","University of Padova, Italy",,NCT04352400,gian paolo rossi,gian,male,0.98,10303,77,NCT04352400,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Not yet recruiting,No Results Available,COVID19,Drug: Nafamostat Mesilate|Drug: Placebo,"April 20, 2020",,https://ClinicalTrials.gov/show/NCT04352400
Principal Investigator,"Westyn Branch-Elliman, MD",VA Boston Healthcare System,,NCT04359901,westyn branch-elliman,westyn,female,1.0,1,78,NCT04359901,Sarilumab for Patients With Moderate COVID-19 Disease,Recruiting,No Results Available,COVID,Biological: SARILUMAB,"April 24, 2020","VA Boston Healthcare System, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04359901
Principal Investigator,"Kent Holland, MD",Northside Hospital,,NCT04408040,kent holland,kent,male,0.98,5262,82,NCT04408040,Use of Convalescent Plasma for COVID-19,Not yet recruiting,No Results Available,COVID,Biological: Convalescent Plasma,"May 29, 2020","Northside Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04408040
Principal Investigator,"Kasper Iversen, Prof.",Herlev-Gentofte Hospital,,NCT04346186,kasper iversen,kasper,male,0.98,2906,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Henning Bundgaard, Prof.","Rigshospitalet, Denmark",,NCT04346186,henning bundgaard,henning,male,0.99,3049,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Henrik Ullum, Prof.","Rigshospitalet, Denmark",,NCT04346186,henrik ullum,henrik,male,0.99,10710,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Thomas Benfield, Prof.",Hvidovre University Hospital,,NCT04346186,thomas benfield,thomas,male,0.99,176440,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Susanne Dam Poulsen, Prof.","Rigshospitalet, Denmark",,NCT04346186,susanne dam poulsen,susanne,female,0.98,22012,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Jørgen Rungby, Prof.",Bispebjerg Hospital,,NCT04346186,jørgen rungby,jørgen,male,1.0,188,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Fredrik Folke, Associate prof.",Akutberedskabet,,NCT04346186,fredrik folke,fredrik,male,0.99,9106,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,Thea Kølsen Fischer,Nordsjællands Hospital,,NCT04346186,thea kølsen fischer,thea,female,0.97,2778,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Ove Andersen, Prof.",Hvidovre University Hospital,,NCT04346186,ove andersen,ove,male,0.98,989,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,Ida Hageman,"Mental Health Services in the Capital Region, Denmark",,NCT04346186,ida hageman,ida,female,0.97,11672,84,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Not yet recruiting,No Results Available,COVID,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"April 15, 2020","Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne, Denmark",https://ClinicalTrials.gov/show/NCT04346186
Principal Investigator,"Kasper Karmark Iversen, Prof., DMSc",Herlev Hospital,,NCT04337541,kasper karmark iversen,kasper,male,0.98,2906,580,NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Recruiting,No Results Available,COVID-19,Other: Surgical facial mask,"April 7, 2020","Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04337541
Principal Investigator,"Henrik Ullum, Prof., DMSc","Rigshospitalet, Denmark",,NCT04337541,henrik ullum,henrik,male,0.99,10710,580,NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Recruiting,No Results Available,COVID-19,Other: Surgical facial mask,"April 7, 2020","Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04337541
Principal Investigator,"Thomas Benfield, Prof., DMSc",Hvidovre University Hospital,,NCT04337541,thomas benfield,thomas,male,0.99,176440,580,NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Recruiting,No Results Available,COVID-19,Other: Surgical facial mask,"April 7, 2020","Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04337541
Principal Investigator,"Christian Torp-Pedersen, Prof., DMSc",Nordsjællands Hospital,,NCT04337541,christian torp-pedersen,christian,male,0.99,156233,580,NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Recruiting,No Results Available,COVID-19,Other: Surgical facial mask,"April 7, 2020","Rigshospitalet, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04337541
Principal Investigator,"Henning Bundgaard, Prof. Dr. med.","The Capital Region's Unit of Inherited Cardiac Diseases Faculty of Health and Medical Sciences University of Copenhagen Rigshospitalet, University of Copenhagen",,NCT04335136,henning bundgaard,henning,male,0.99,3049,703,NCT04335136,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Recruiting,No Results Available,COVID-19,Drug: RhACE2 APN01|Drug: Physiological saline solution,"April 6, 2020","Medizinische Universität Innsbruck, Innsbruck, Austria|Kaiser Franz Josef Spital, 4. Medizinische Abteilung mit Infektions- und Tropenmedizin, Wien, Austria|Medizinische Universität Wien, Wien, Austria|The National University Hospital, Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Klinikum rechts der Isar, Technische Universität München, München, Germany",https://ClinicalTrials.gov/show/NCT04335136
Principal Investigator,"Henning Bliddal, DMSc",The Parker Institute,,NCT04373798,henning bliddal,henning,male,0.99,3049,2066,NCT04373798,C-reactive Protein Levels Among Individuals With COVID-19,Recruiting,No Results Available,Coronavirus Infection,Diagnostic Test: C-reactive protein,"May 4, 2020","The Parker Institute, Frederiksberg Hospital, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04373798
Principal Investigator,"Henrik Bergquist, Assoc Prof","Sahlgrenska University Hospital, Sweden",,NCT04412356,henrik bergquist,henrik,male,0.99,10710,1611,NCT04412356,Timing of Tracheotomy in Covid-19 Patients,Recruiting,No Results Available,Covid-19|ARDS|Tracheostomy Complication|Respiratory Insufficiency|Corona Virus Infection,Procedure: Tracheotomy,"June 2, 2020","Sahlgrenska University Hospital, Gothenburg, Sweden",https://ClinicalTrials.gov/show/NCT04412356
Principal Investigator,"Thomas FLAMENT, Dr",University Hospital of Tours,,NCT04338100,thomas flament,thomas,male,0.99,176440,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Thomas DELOMAS, Dr",Hospital of Saint-Lô,,NCT04338100,thomas delomas,thomas,male,0.99,176440,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Philippe LE CONTE, Pr",University Hospital of Nantes,,NCT04338100,philippe le conte,philippe,male,0.99,82618,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Louis SOULAT, Pr",University Hospital of Rennes,,NCT04338100,louis soulat,louis,male,0.97,26805,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Nicolas MARJANOVIC, Dr",University Hospital of Poitiers,,NCT04338100,nicolas marjanovic,nicolas,male,0.99,116713,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Francis COUTURAUD, Dr",University Hospital of Brest,,NCT04338100,francis couturaud,francis,male,0.94,38777,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Laure BAUDIN, Dr",Hospital of Cholet,,NCT04338100,laure baudin,laure,female,0.97,22451,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Karim TAZAROURTE, Pr",Hospices Civils de Lyon (University Hospital of Lyon),,NCT04338100,karim tazarourte,karim,male,0.98,92804,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Luc-Marie JOLY, Pr","University Hospital, Rouen",,NCT04338100,luc-marie joly,luc-marie,male,1.0,4,327,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Not yet recruiting,No Results Available,COVID|Coronavirus Infection,Procedure: Follow-up at 14 days,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338100
Principal Investigator,"Thomas Hiemstra, PhD",Cambridge University Hospitals NHS Foundation Trust,,NCT04389359,thomas hiemstra,thomas,male,0.99,176440,496,NCT04389359,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate 200 MG,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04389359
Principal Investigator,"Thomas Waterfield, BMBCh","Queen's University, Belfast",,NCT04347408,thomas waterfield,thomas,male,0.99,176440,986,NCT04347408,Seroprevalence of SARS-Cov-2 Antibodies in Children,Recruiting,No Results Available,COVID|Corona Virus Infection,Diagnostic Test: Covid-19 Antibody testing (IgG and IgM),"April 15, 2020","Royal Belfast Hospital for Sick Children, Belfast, United Kingdom|University Hospital of Wales, Cardiff, United Kingdom|Royal Hospital for Children, Glasgow, United Kingdom|Public Health England, London, United Kingdom|Public Health England, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04347408
Principal Investigator,"Thomas E. Coyle, MD",TriHealth Inc.,,NCT04392232,thomas e. coyle,thomas,male,0.99,176440,1123,NCT04392232,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,Recruiting,No Results Available,Coronavirus|COVID-19|Convalescent Plasma,Drug: Convalescent Plasma,"May 18, 2020","Good Samaritan Hospital, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04392232
Principal Investigator,"Thomas Marron, MD",Icahn School of Medicine at Mount Sinai,,NCT04388709,thomas marron,thomas,male,0.99,176440,1210,NCT04388709,Interferon Lambda Therapy for COVID-19,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Peginterferon Lambda-1A,"May 14, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04388709
Study Director,"Thomas E Serena, MD","SerenaGroup, Inc.",,NCT04386265,thomas e serena,thomas,male,0.99,176440,1242,NCT04386265,Compassionate Use of Hyperbaric Oxygen Therapy,Enrolling by invitation,No Results Available,COVID-19,,"May 13, 2020","White River Wound Healing Center, Batesville, Arkansas, United States|Community Hospital, Monterey, California, United States|Innovative Healing Systems, Tampa, Florida, United States|Decatur Memorial Hospital, Decatur, Indiana, United States|Providence Medical Wound Care Center, Kansas City, Kansas, United States|West Jefferson Medical Center, Marrero, Louisiana, United States|The Wound Treatment Center, Opelousas, Louisiana, United States|Christus Shreveport Bossier Hyperbaric & Wound Care Center, Shreveport, Louisiana, United States|Ascension Providence Rochester Hospital Wound Care Center, Rochester, Michigan, United States|CHI, Chattanooga, Tennessee, United States|Klinika Baromedical, Poznan, Wielkopolskie, Poland",https://ClinicalTrials.gov/show/NCT04386265
Principal Investigator,"Thomas J Reiter, MD",Medical University of Vienna,,NCT04347694,thomas j reiter,thomas,male,0.99,176440,1348,NCT04347694,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,Recruiting,No Results Available,SARS-CoV 2|Immunization; Infection,,"April 15, 2020","Medical University of Vienna, Division for Nephrology and Dialysis, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04347694
Principal Investigator,Thomas Treibel,Barts Heart Center,,NCT04318314,thomas treibel,thomas,male,0.99,176440,1886,NCT04318314,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Recruiting,No Results Available,Health Care Worker Patient Transmission|Coronavirus|Coronavirus Infections|Immunological Abnormality,Diagnostic Test: COPAN swabbing and blood sample collection,"March 23, 2020","Barts Heart Center, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04318314
Principal Investigator,James C Moon,BHC & UCL,,NCT04318314,james c moon,james,male,0.99,117309,1886,NCT04318314,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Recruiting,No Results Available,Health Care Worker Patient Transmission|Coronavirus|Coronavirus Infections|Immunological Abnormality,Diagnostic Test: COPAN swabbing and blood sample collection,"March 23, 2020","Barts Heart Center, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04318314
Study Director,Charlotte Manisty,BHC & UCL,,NCT04318314,charlotte manisty,charlotte,female,0.97,37761,1886,NCT04318314,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Recruiting,No Results Available,Health Care Worker Patient Transmission|Coronavirus|Coronavirus Infections|Immunological Abnormality,Diagnostic Test: COPAN swabbing and blood sample collection,"March 23, 2020","Barts Heart Center, London, United Kingdom|Royal Free London NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04318314
Principal Investigator,"Thomas Berger, Prof. Dr.",University of Bern,,NCT04380909,thomas berger,thomas,male,0.99,176440,2133,NCT04380909,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Recruiting,No Results Available,"Psychological Distress|Adjustment, Psychological|Coronavirus",Behavioral: Internet-based self-help|Behavioral: Internet-based self-help after 3 weeks,"May 8, 2020","Universität Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04380909
Study Director,"Hansjörg Znoj, Prof. Dr.",University of Bern,,NCT04380909,hansjörg znoj,hansjörg,male,1.0,8,2133,NCT04380909,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Recruiting,No Results Available,"Psychological Distress|Adjustment, Psychological|Coronavirus",Behavioral: Internet-based self-help|Behavioral: Internet-based self-help after 3 weeks,"May 8, 2020","Universität Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04380909
Principal Investigator,"Thomas Pilgrim, MD","University of Bern, Switzerland",,NCT04333875,thomas pilgrim,thomas,male,0.99,176440,2318,NCT04333875,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,"Active, not recruiting",No Results Available,Aortic Valve Stenosis,Device: TAVR or SAVR,"April 3, 2020","Department of Cardiology, Bern University Hospital, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04333875
Principal Investigator,"Susanne Arnold, MD",University of Kentucky,,NCT04374019,susanne arnold,susanne,female,0.98,22012,230,NCT04374019,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Recruiting,No Results Available,COVID|Sars-CoV2,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine and Azithromycin|Drug: Hydroxychloroquine and Ivermectin|Drug: Camostat Mesilate,"May 5, 2020","University of Kentucky Markey Cancer Center, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04374019
Study Chair,"Susanne G Dudman, Professor",University of Oslo,,NCT04381819,susanne g dudman,susanne,female,0.98,22012,2152,NCT04381819,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Recruiting,No Results Available,SARS Virus|Severe Acute Respiratory Syndrome,Diagnostic Test: SARS-CoV-2 PCR,"May 11, 2020","Vestre Viken Drammen Hospital, Drammen, Viken, Norway|Haukeland University Hospital, Bergen, Norway|Østfold Hospital Trust, Fredrikstad, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|University Hospital North Norway, Tromsø, Norway|St Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04381819
Study Director,"Fredrik G Müller, Professor",University of Oslo,,NCT04381819,fredrik g müller,fredrik,male,0.99,9106,2152,NCT04381819,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Recruiting,No Results Available,SARS Virus|Severe Acute Respiratory Syndrome,Diagnostic Test: SARS-CoV-2 PCR,"May 11, 2020","Vestre Viken Drammen Hospital, Drammen, Viken, Norway|Haukeland University Hospital, Bergen, Norway|Østfold Hospital Trust, Fredrikstad, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|University Hospital North Norway, Tromsø, Norway|St Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04381819
Principal Investigator,"Jan C Holter, PhD",Oslo University Hospital,,NCT04381819,jan c holter,jan,male,0.95,142869,2152,NCT04381819,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Recruiting,No Results Available,SARS Virus|Severe Acute Respiratory Syndrome,Diagnostic Test: SARS-CoV-2 PCR,"May 11, 2020","Vestre Viken Drammen Hospital, Drammen, Viken, Norway|Haukeland University Hospital, Bergen, Norway|Østfold Hospital Trust, Fredrikstad, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|University Hospital North Norway, Tromsø, Norway|St Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04381819
Principal Investigator,"Susanne Benseler, MD PhD",University of Calgary,,NCT04423042,susanne benseler,susanne,female,0.98,22012,2241,NCT04423042,Tocilizumab in Coronavirus-19 Positive Patients,Not yet recruiting,No Results Available,Covid19|COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Coronavirus|Inflammation,Biological: Tocilizumab,"June 9, 2020",,https://ClinicalTrials.gov/show/NCT04423042
Principal Investigator,"Thea K Fischer, professor",Nordsjællands Hospital,,NCT04431310,thea k fischer,thea,female,0.97,2778,1457,NCT04431310,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,Recruiting,No Results Available,"Covid-19|Health Personnel|Personnel, Hospital",Other: Serial seroconversion measurements in hospital employees during the COVID-19 pandemic,"June 16, 2020","Nordsjællands Hospital, Hillerød, Capital Region, Denmark|Nykøbing Falster County Hospital, Nykøbing Falster, Southern Region, Denmark",https://ClinicalTrials.gov/show/NCT04431310
Principal Investigator,"Arash Naeim, MD, PhD","University of California, Los Angeles",,NCT04359602,arash naeim,arash,male,0.98,6033,844,NCT04359602,COVID-19 Recovered Volunteer Research Participant Pool Registry,Recruiting,No Results Available,Recovered From COVID-19,,"April 24, 2020","Ronald Reagan UCLA Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04359602
Principal Investigator,"Jonpaul Sze Tsing Zee, MBChB",Hong Kong Sanatorium & Hospital,,NCT04416061,jonpaul sze tsing zee,jonpaul,male,1.0,31,90,NCT04416061,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,"Active, not recruiting",No Results Available,COVID,Diagnostic Test: COVID 19 Diagnostic Test,"June 4, 2020","Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04416061
Principal Investigator,"Beatriz H Aristizabal, PhD",Unidad de Investigación Genética Molecular,,NCT04420260,beatriz h aristizabal,beatriz,female,0.99,27836,91,NCT04420260,Primary Prevention of Infection by COVID-19 in Health Providers,Not yet recruiting,No Results Available,COVID,Dietary Supplement: Group A: oropharygeal spray and immunostimulant|Dietary Supplement: Group B: Placebo oropharyngeal spray + Active principle immunostimulant|Dietary Supplement: Group C:Active principle oropharyngeal spray + Placebo taken PO|Dietary Supplement: Group D:Placebo oropharyngeal spray + Placebo taken PO,"June 9, 2020",,https://ClinicalTrials.gov/show/NCT04420260
Principal Investigator,"Yvonne (Bonnie) A Maldonado, MD",Stanford University,,NCT04346628,yvonne (bonnie) a maldonado,yvonne,female,0.98,29756,95,NCT04346628,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,Not yet recruiting,No Results Available,COVID,Drug: Favipiravir|Drug: Placebo|Other: Standard of care treatment,"April 15, 2020","Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04346628
Study Director,Emilie Garrido-Pradalie,Assistance Publique Hôpitaux de Marseille,,NCT04371367,emilie garrido-pradalie,emilie,female,0.98,72741,97,NCT04371367,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Recruiting,No Results Available,COVID,Biological: avdoralimab|Other: Placebo,"May 1, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04371367
Study Director,Emilie EGP GARRIDO-PRADALIE,Assistance Publique Hôpitaux de Marseille,,NCT04369820,emilie egp garrido-pradalie,emilie,female,0.98,72741,288,NCT04369820,C5a Receptor Expression - COVID-19 (C5-COV),Recruiting,No Results Available,COVID-19,Other: draw blood,"April 30, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04369820
Principal Investigator,"Emilie SBIDIAN, Pr",Assistance Publique - Hôpitaux de Paris,,NCT04356417,emilie sbidian,emilie,female,0.98,72741,996,NCT04356417,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Not yet recruiting,No Results Available,"AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection",Other: - Synthetic anti-malarial drugs,"April 22, 2020","Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04356417
Principal Investigator,"Emilie Carretier, MD",Assistance Publique - Hôpitaux de Paris,,NCT04363671,emilie carretier,emilie,female,0.98,72741,1229,NCT04363671,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),Not yet recruiting,No Results Available,Remote Consultation|Covid-19,,"April 27, 2020","Maison de Solenn, Cochin Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04363671
Study Director,Emilie Garrido-Pradalie,ASSISTANCE PUBLIQUE HÔPITAUX de MARSEILLE,,NCT04337008,emilie garrido-pradalie,emilie,female,0.98,72741,1327,NCT04337008,Renin Angiotensin System - CoronaVirus,Recruiting,No Results Available,COVID 19,Other: blood draw,"April 7, 2020","ASSISTANCE PUBLIQUE HÖPITAUX de MARSEILLE, Marseille, France",https://ClinicalTrials.gov/show/NCT04337008
Principal Investigator,Emilie Bérard,"Service d'Epidémiologie, CHU de Toulouse UMR 1027, INSERM",,NCT04397835,emilie bérard,emilie,female,0.98,72741,1617,NCT04397835,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,Recruiting,No Results Available,COVID-19|Anxiety|Depression|Stress,,"May 21, 2020","CHU de Toulouse, Toulouse, Occitanie, France",https://ClinicalTrials.gov/show/NCT04397835
Principal Investigator,"Emilie Olie, MD PhD","University Hospital, Montpellier",,NCT04417374,emilie olie,emilie,female,0.98,72741,1651,NCT04417374,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19","Active, not recruiting",No Results Available,COVID 19|Disease Outbreak|Mental Disorders,Other: Description of groups caracteristics,"June 4, 2020","University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04417374
Principal Investigator,"Emilie Olie, MD PhD","University Hospital, Montpellier",,NCT04374643,emilie olie,emilie,female,0.98,72741,1777,NCT04374643,Descriptive Study of the PSYchological Impact of CONFinement Measures in Subjects With Mood Disorders,Recruiting,No Results Available,"Depression, Unipolar|COVID 19",Other: Questionnaire to study the psychological impact of confinement,"May 5, 2020","University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04374643
Principal Investigator,"Emilie Belley-Cote, MD PhD",Population Health Research Institute,,NCT04324463,emilie belley-cote,emilie,female,0.98,72741,1958,NCT04324463,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Recruiting,No Results Available,Coronavirus|Severe Acute Respiratory Syndrome,Drug: Cholchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban,"March 27, 2020","Hamilton Health Sciences, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04324463
Principal Investigator,"John Eikelboom, MBBS MSc",Population Health Research Institute,,NCT04324463,john eikelboom,john,male,0.99,218952,1958,NCT04324463,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Recruiting,No Results Available,Coronavirus|Severe Acute Respiratory Syndrome,Drug: Cholchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban,"March 27, 2020","Hamilton Health Sciences, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04324463
Principal Investigator,"Richard Whitlock, MD PhD",Population Health Research Institute,,NCT04324463,richard whitlock,richard,male,0.99,101928,1958,NCT04324463,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Recruiting,No Results Available,Coronavirus|Severe Acute Respiratory Syndrome,Drug: Cholchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban,"March 27, 2020","Hamilton Health Sciences, Hamilton, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04324463
Principal Investigator,"Elliott Bennett-Guerrero, MD",Stony Brook Hospital,,NCT04344535,elliott bennett-guerrero,elliott,male,0.98,926,98,NCT04344535,Convalescent Plasma vs. Standard Plasma for COVID-19,Enrolling by invitation,No Results Available,COVID,Biological: Convalescent Plasma|Biological: Standard Donor Plasma,"April 14, 2020","Stony Brook University Hospital, Stony Brook, New York, United States",https://ClinicalTrials.gov/show/NCT04344535
Principal Investigator,"Andreas Baranyi, Prof.",Medical University of Graz,,NCT04359121,andreas baranyi,andreas,male,0.99,71365,99,NCT04359121,COVID-19 and the Developement of Phobic Fears of Disease,Recruiting,No Results Available,COVID19,Other: Questionnaires for specific phobia,"April 24, 2020","Medical University of Graz, Graz, Styria, Austria",https://ClinicalTrials.gov/show/NCT04359121
Principal Investigator,"Andreas Neubauer, Prof Dr.",Universitätsklinikum Giessen und Marburg (UKGM),,NCT04359290,andreas neubauer,andreas,male,0.99,71365,412,NCT04359290,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Not yet recruiting,No Results Available,"ARDS, Human|COVID",Drug: Ruxolitinib administration,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359290
Principal Investigator,"Co-PI: Andreas M. Zeiher, Prof. Dr.","Johann Wolfgang Goethe-University, Frankfurt am Main, Germany",,NCT04416048,andreas m. zeiher,andreas,male,0.99,71365,489,NCT04416048,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Rivaroxaban|Other: Standard Of Care (SOC),"June 4, 2020","Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Cardiology and Pneumology Clinic Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Bayern, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Cardiology, Pneumology and Intensive Care Clinic, München Klinik Neuperlach, München, Bayern, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic and Polyclinic Internal Medicine Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany|Cardiology and Pneumology Clinic Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Clinic for Vascular Medicine, Städtisches Krankenhaus Dresden, Dresden, Sachsen, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Cardiology, Pneumology and Intensive Care Clinic Helios Klinikum Pirna, Dresden, Pirna, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Internal Medicine II, Cardiology, Sana Klinikum, Lichtenberg. Berlin, Berlin, Germany|Medical Clinic II. St. Joseph Hospital Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine, Hospital Bethel Berlin in Lichterfelde, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Intensive Care and Cardiology, Hospital Havelhöhe, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04416048
Principal Investigator,"Ulf Landmesser, Prof. Dr.","Charite University, Berlin, Germany",,NCT04416048,ulf landmesser,ulf,male,0.98,3044,489,NCT04416048,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Rivaroxaban|Other: Standard Of Care (SOC),"June 4, 2020","Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Cardiology and Pneumology Clinic Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Bayern, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Cardiology, Pneumology and Intensive Care Clinic, München Klinik Neuperlach, München, Bayern, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic and Polyclinic Internal Medicine Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany|Cardiology and Pneumology Clinic Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Clinic for Vascular Medicine, Städtisches Krankenhaus Dresden, Dresden, Sachsen, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Cardiology, Pneumology and Intensive Care Clinic Helios Klinikum Pirna, Dresden, Pirna, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Internal Medicine II, Cardiology, Sana Klinikum, Lichtenberg. Berlin, Berlin, Germany|Medical Clinic II. St. Joseph Hospital Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine, Hospital Bethel Berlin in Lichterfelde, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Intensive Care and Cardiology, Hospital Havelhöhe, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04416048
Principal Investigator,"Co-PI: Steffen Massberg, Prof. Dr.",Ludwig-Maximilians - University of Munich,,NCT04416048,steffen massberg,steffen,male,1.0,12961,489,NCT04416048,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Rivaroxaban|Other: Standard Of Care (SOC),"June 4, 2020","Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Cardiology and Pneumology Clinic Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Bayern, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Cardiology, Pneumology and Intensive Care Clinic, München Klinik Neuperlach, München, Bayern, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic and Polyclinic Internal Medicine Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany|Cardiology and Pneumology Clinic Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Clinic for Vascular Medicine, Städtisches Krankenhaus Dresden, Dresden, Sachsen, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Cardiology, Pneumology and Intensive Care Clinic Helios Klinikum Pirna, Dresden, Pirna, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Internal Medicine II, Cardiology, Sana Klinikum, Lichtenberg. Berlin, Berlin, Germany|Medical Clinic II. St. Joseph Hospital Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine, Hospital Bethel Berlin in Lichterfelde, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Intensive Care and Cardiology, Hospital Havelhöhe, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04416048
Principal Investigator,"Co-PI: Ursula Rauch-Kröhnert, Prof. Dr.","Charité University, Berlin, Germany",,NCT04416048,ursula rauch-kröhnert,ursula,female,0.98,7051,489,NCT04416048,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Rivaroxaban|Other: Standard Of Care (SOC),"June 4, 2020","Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Cardiology and Pneumology Clinic Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Bayern, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Cardiology, Pneumology and Intensive Care Clinic, München Klinik Neuperlach, München, Bayern, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic and Polyclinic Internal Medicine Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany|Cardiology and Pneumology Clinic Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Clinic for Vascular Medicine, Städtisches Krankenhaus Dresden, Dresden, Sachsen, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Cardiology, Pneumology and Intensive Care Clinic Helios Klinikum Pirna, Dresden, Pirna, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Internal Medicine II, Cardiology, Sana Klinikum, Lichtenberg. Berlin, Berlin, Germany|Medical Clinic II. St. Joseph Hospital Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine, Hospital Bethel Berlin in Lichterfelde, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Intensive Care and Cardiology, Hospital Havelhöhe, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04416048
Principal Investigator,"Andreas Hochhaus, Prof. Dr.",University Hospital Jena,,NCT04338958,andreas hochhaus,andreas,male,0.99,71365,609,NCT04338958,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Recruiting,No Results Available,Covid-19,Drug: Ruxolitinib,"April 8, 2020","Universitätsmedizin Göttingen - Klinik für Hämatologie und Onkologie, Göttingen, Germany|University Hospital Jena, Jena, Germany|Klinikum der Landeshauptstadt Stuttgart gKöR, Stuttgart, Germany|Universitätsklinikum Ulm, Ulm, Germany|Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany",https://ClinicalTrials.gov/show/NCT04338958
Study Director,"Andreas G Niethammer, MD PhD","Sorrento Therapeutics, Inc.",,NCT04440007,andreas g niethammer,andreas,male,0.99,71365,762,NCT04440007,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With SOC Versus SOC in Subjects With COVID-19,Not yet recruiting,No Results Available,Covid-19,Drug: Abivertinib|Other: Standard of Care,"June 19, 2020",,https://ClinicalTrials.gov/show/NCT04440007
Principal Investigator,"Andreas Buser, Prof. Dr. med.","Blutspendezentrum SRK beider Basel, Universitätsspital Basel",,NCT04389944,andreas buser,andreas,male,0.99,71365,939,NCT04389944,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,Recruiting,No Results Available,Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection),Other: convalescent plasma application to SARS-CoV-2 infected patients,"May 15, 2020","Blutspendezentrum SRK beider Basel, University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04389944
Study Director,"Andreas Ströhle, Prof.Dr.",Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy,,NCT04331106,andreas ströhle,andreas,male,0.99,71365,949,NCT04331106,Survey of the Anxiety Associated With the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety Related to the COVID-19 Pandemic,Diagnostic Test: Online Questionnaire,"April 2, 2020","Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04331106
Principal Investigator,"Antonia Bendau, M.Sc.Psych.",Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy,,NCT04331106,antonia bendau,antonia,female,0.98,18904,949,NCT04331106,Survey of the Anxiety Associated With the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety Related to the COVID-19 Pandemic,Diagnostic Test: Online Questionnaire,"April 2, 2020","Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04331106
Study Chair,"Andreas R Luft, Prof",University of Zurich,,NCT04373109,andreas r luft,andreas,male,0.99,71365,1579,NCT04373109,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Recruiting,No Results Available,Stroke|Rehabilitation|COVID-19|Cohort Studies,Behavioral: Observation,"May 4, 2020","University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04373109
Principal Investigator,"Andreas Flammer, PD Dr. med","University Hospital Zurich, Zurich, Switzerland",,NCT04390555,andreas flammer,andreas,male,0.99,71365,1949,NCT04390555,The Global PCHF-COVICAV Registry,Recruiting,No Results Available,COVID-19|Cardiovascular Diseases|Cardiovascular Risk Factor|Heart Failure,,"May 15, 2020","Zurich Heart Center, Unispital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04390555
Study Director,"Frank Ruschitzka, Prof. Dr. med","University Hospital Zurich, Zurich, Switzerland",,NCT04390555,frank ruschitzka,frank,male,0.99,82391,1949,NCT04390555,The Global PCHF-COVICAV Registry,Recruiting,No Results Available,COVID-19|Cardiovascular Diseases|Cardiovascular Risk Factor|Heart Failure,,"May 15, 2020","Zurich Heart Center, Unispital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04390555
Principal Investigator,"Mateusz Sokolski, MD, PhD","Wroclaw Medical University, Wroclaw, Poland",,NCT04390555,mateusz sokolski,mateusz,male,1.0,62053,1949,NCT04390555,The Global PCHF-COVICAV Registry,Recruiting,No Results Available,COVID-19|Cardiovascular Diseases|Cardiovascular Risk Factor|Heart Failure,,"May 15, 2020","Zurich Heart Center, Unispital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04390555
Principal Investigator,"Nada Alachkar, MD",Johns Hopkins University,,NCT04363502,nada alachkar,nada,female,0.93,19335,100,NCT04363502,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Recruiting,No Results Available,COVID,Drug: Clazakizumab|Drug: Placebo,"April 27, 2020","Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04363502
Principal Investigator,Dina Mounir Elkady,Lecturer at cairo ubiversity,,NCT04391881,dina mounir elkady,dina,female,0.97,20572,102,NCT04391881,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,Not yet recruiting,No Results Available,Oral Health and COVID 19,,"May 18, 2020",,https://ClinicalTrials.gov/show/NCT04391881
Study Chair,"Francesco Franceschi, MD PhD","Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma",,NCT04371562,francesco franceschi,francesco,male,0.99,196032,103,NCT04371562,Predicting Death and ICU Admission in COVID-19 Patients in ED,Completed,No Results Available,COVID,,"May 1, 2020","Marcello Covino, Roma, RM, Italy",https://ClinicalTrials.gov/show/NCT04371562
Principal Investigator,"Francesco Perrone, MD, PhD","Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale",,NCT04317092,francesco perrone,francesco,male,0.99,196032,367,NCT04317092,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Tocilizumab Injection,"March 20, 2020","Azienda Ospedaliera ""SS. Antonio e Biagio e C. Arrigo"" (Dipartimento Internistico SSD Reumatologia), Alessandria, Italy|Ospedale di Busto Arsizio ASST Valle Olona (U.O.C. Malattie Infettive), Busto Arsizio, Italy|A.O.U. Policlinico V. Emanuele (U.O. di Malattie infettive, U.O. di Anestesia e Rianimazione, U.O. di Medicina d'Urgenza), Catania, Italy|AOE Cannizzaro di Catania (U.O. di Malattie Infettive, U.O. di Anestesia e Rianimazione, U.O., Catania, Italy|Ospedale Annunziata Azienda Ospedaliera di Cosenza (U.O.C. Malattie Infettive), Cosenza, Italy|ASST OVEST MILANESE presidi Legnano - Magenta, Magenta, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione I), Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione II), Modena, Italy|A.O.U. di Modena (Dipartimento Medicine Specialistiche - Struttura Complessa Malattie Infettive), Modena, Italy|Dipartimento Medicine Specialistiche - Struttura Complessa Malattie dell'Apparato Respiratorio, Modena, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Oncologia), Naples, Italy|National Cancer Institute, Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Anestesia Rianimazione e terapia intensiva), Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Malattie Infettive ad indirizzo respiratorio), Naples, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore di Pesaro (UOC Pronto Soccorso e Medicina d'Urgenza), Pesaro, Italy|Denominazione: UOC di Medicina e Chirurgia d'Accettazione e d'Urgenza dell'Ospedale Santa Maria delle Grazie di Pozzuoli, Pozzuoli, Italy|Ospedale Santa Maria delle Croci, AUSL della Romagna (U.O. Anestesia e Rianimazione), Ravenna, Italy|Grande Ospedale Metropolitano, Reggio Calabria, Reggio Calabria, Italy|Ospedale Infermi, AUSL della Romagna (U.O. Malattie Infettive), Rimini, Italy|Policlinico Gemelli (U.O.C. Dipartimento Scienze di Laboratorio e Infettivologiche), Rome, Italy|ASST Sette Laghi (Dipartimento di Medicina Interna), Varese, Italy|ASST Sette Laghi (Dipartimento Emergenze ed Urgenze), Varese, Italy|ASST Sette Laghi (U.O.C. Anestesia e Rianimazione Neurochirurgica e Generale), Varese, Italy|ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali), Varese, Italy|A.O.U. Integrata di Verona (Dip. Malattie Infettive), Verona, Italy|Ospedale Magalini (U.O. Malattie Infettive), Villafranca Di Verona, Italy",https://ClinicalTrials.gov/show/NCT04317092
Principal Investigator,Francesco Menichetti,"Azienda Ospedaliero, Universitaria Pisana",,NCT04393727,francesco menichetti,francesco,male,0.99,196032,793,NCT04393727,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,Recruiting,No Results Available,COVID|SARS-CoV 2,Biological: CONVALESCENT PLASMA,"May 19, 2020","Azienda Ospedaliero Universitaria Pisana, Pisa, Italy",https://ClinicalTrials.gov/show/NCT04393727
Principal Investigator,"Francesco Menichetti, MD","Azienda Ospedaliero, Universitaria Pisana",,NCT04393051,francesco menichetti,francesco,male,0.99,196032,1261,NCT04393051,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Not yet recruiting,No Results Available,Covid-19|SARS-CoV 2|SARS Pneumonia,Drug: Baricitinib Oral Tablet,"May 19, 2020","Azienda Ospedaliero Universitaria Pisana, Pisa, Italy",https://ClinicalTrials.gov/show/NCT04393051
Principal Investigator,"Francesco Passamonti, MD","Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy",,NCT04352556,francesco passamonti,francesco,male,0.99,196032,1328,NCT04352556,COVID19-hematological Malignancies: the Italian Hematology Alliance,Recruiting,No Results Available,SARS-CoV-2 Infection|Hematological Malignancies,,"April 20, 2020","SC Ematologia Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|UOC Ematologia, Ospedali Riuniti, Ancona, Italy|UOC Ematologia e Terapia Cellulare, Ospedale Mazzoni, Ascoli Piceno, Italy|SC Oncologia Medica, CRO, Aviano, Italy|SC Ematologia, Policlinico Bari, Bari, Italy|UOC Ematologia, I.R.C.C.S Istituto Tumori Giovanni Paolo II, Bari, Italy|SSD Ematologia, Ospedale degli Infermi, Biella, Italy|UOC Ematologia, Azienda Ospedaliero-Universitaria Policlinico S.Orsola-Malpighi,, Bologna, Italy|Ematologia e Centro Trapianto Midollo Osseo, Ospedale di Bolzano, Bolzano, Italy|UO Ematologia e CTMO, ASST Spedali Civili, Brescia, Italy|UO Ematologia e CTMO, ASST Spedali Civili, Brescia, Italy|UOC Onco-Ematologia ASST Valle Olona, Busto Arsizio, Italy|SC Ematologia e CTMO AZIENDA OSPEDALIERA ""G. BROTZU"" - OSPEDALE ONCOLOGICO BUSINCO, Cagliari, Italy|UOC Ematologia, AOU Policlinico Vittorio Emanuele, Catania, Italy|Ematologia, Ospedale Valduce, Como, Italy|UOC Ematologia, Azienda Ospedaliera di Cosenza, Cosenza, Italy|UO Ematologia e CTMO, ASST Cremona, Cremona, Italy|SC Ematologia Ospedale S. Croce, Cuneo, Italy|UOC, Ematologia Azienda Ospedaliero Universitaria Arcispedale S. Anna, Ferrara, Italy|S.O.D. Ematologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|UOC Ematologia, Policlinico Ospedali Riuniti, Foggia, Italy|IRST-IRCC di Meldola, Forlì, Italy|UO Ematologia, Ospedale Policlinico S.Martino IRCCS, Genova, Italy|UO Ematologia, Ospedale Policlinico San Martino, Genova, Italy|UOC di Ematologia e Trapianto di Cellule Staminali, P.O. Vito Fazzi, Lecce, Italy|UOC di Ematologia, Ospedale di Legnano, Legnano, Italy|UO Dipartimento di Ematologia, USL 6, Livorno, Italy|UOC Oncologia ASST Lodi, Lodi, Italy|UOC Ematologia Azienda Ospedaliera Universitaria ""G.Martino"", Messina, Italy|UO Ematologia, Ospedale dell'Angelo di Mestre, Mestre, Italy|Ematologia, IEO, Milano, Italy|SC Ematologia, Istituto Nazionale dei Tumori, Milano, Italy|SC Ematologia, Ospedale Niguarda, Milano, Italy|UO Ematologia, IRCCS Ospedale San Raffaele, Milano, Italy|UO Servizio di Ematologia e Medicina Trasfusionale, Ospedale Luigi Sacco, Milano, Italy|UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|UO Ematologia Policlinico di Modena, Modena, Italy|UOC Ematologia, Ospedale S. Gerardo, Monza, Italy|SC Ematologia Istituto Nazionale Tumori - IRCCS ""Fondazione G. Pascale"",, Napoli, Italy|UOC Ematologia e Trapianti di Midollo, AOU Federico II, Napoli, Italy|UOC Ematologia, Ospedale Antonio Cardarelli, Napoli, Italy|UOC Ematologia, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy|Ospedale san Luigi Gonzaga, Orbassano, Italy|Ematologia Azienda Ospedaliera di Padova, Padova, Italy|UO Ematologia, Policlinico Paolo Giaccone, Palermo, Italy|UOC Ematologia e CTMO, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy|SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|SC Ematologia e Trapianto di Midollo Osseo, Azienda Ospedaliera di Perugia, Perugia, Italy|UO Ematologia e CTMO, Azienda Ospedaliera Ospedali Riuniti, Pesaro, Italy|UOC di Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy|UO Ematologia e CTMO, Presidio Ospedaliero di Piacenza, Piacenza, Italy|UO Ematologia, AOU Pisana- Santa Chiara, Pisa, Italy|UO Ematologia dell'Ospedale Santa Maria delle Croci, Ravenna, Italy|UOC Ematologia, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy|SC Ematologia, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|UO Ematologia, Ospedale Infermi, Rimini, Italy|AOU Azienda Ospedaliera Universitaria Sant'Andrea, Roma, Italy|IFO - Ematologia e Trapianto Cellule -Istituto Nazionale del Cancro di Regina Elena, Roma, Italy|SC Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|UO Ematologia e Trapianti di Cellule Staminali, A.O. S. Camillo-Forlanini, Roma, Italy|UO Ematologia, Policlinico Tor Vergata, Roma, Italy|UOC Ematologia e trapianto di cellule staminali, Policlinico Universitario Campus Bio-Medico, Roma, Italy|UOC Ematologia Policlinico Umberto I, Roma, Italy|UOC Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|UOC Ematologia- Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy|UO Ematologia, Istituto Clinico Humanitas, Rozzano, Italy|UOC Ematologia e centro trapianti cellule staminali emopoietiche, AOU San Giovanni Di Dio e Ruggi D'aragona, Salerno, Italy|Ematologia ASL Imperiese, Sanremo, Italy|Medicina Interna ed Ematologia, Asl 1, Savona, Italy|UOC Ematologia, Policlinico Santa Maria alle Scotte, Siena, Italy|UOC Ematologia e Trapianto Midollo Osseo, Ospedale S. G. Moscati, Taranto, Italy|SCDU Ematologia e terapie cellulari, Ospedale Mauriziano Umberto I, Torino, Italy|UO Ematologia, Ospedale Universitario Molinette San Giovanni Battista, Torino, Italy|UO Ematologia, Ospedale Universitario Molinette San Giovanni Battista, Torino, Italy|UO Ematologia, Ospedale Civili Ca' Foncello, Treviso, Italy|SC Ematologia, Azienda sanitaria universitaria Giuliano Isontina, Trieste, Italy|Clinica Ematologia, Azienda Ospedaliera-Universitaria Santa Maria della Misericordia, Udine, Italy|UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione Macchi, Varese, Italy|UOC Ematologia, Azienda Ospedaliera Integrata di Verona, Verona, Italy|UOC Ematologia, Azienda Ospedaliera Integrata di Verona, Verona, Italy|UOC Ematologia, Ospedale San Bortolo, Vicenza, Italy",https://ClinicalTrials.gov/show/NCT04352556
Principal Investigator,"Francesco Pugliese, MD, PhD",University of Rome Sapienza - Policlinico Umberto I Rome (Italy),,NCT04366089,francesco pugliese,francesco,male,0.99,196032,1395,NCT04366089,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Recruiting,No Results Available,"COVID|SARS-CoV 2|Pneumonia, Viral|Coronavirus Infection","Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care|Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine","April 28, 2020","Francesco Pugliese, Rome, RM, Italy",https://ClinicalTrials.gov/show/NCT04366089
Principal Investigator,"Francesco Sanguedolce, MD, PhD",Fundacio Puigvert,,NCT04409899,francesco sanguedolce,francesco,male,0.99,196032,1523,NCT04409899,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,Recruiting,No Results Available,COVID-19|Urologic Diseases|Surgery--Complications|Epidemic Disease,Diagnostic Test: Blood tests,"June 1, 2020","Fundacio Puigvert, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04409899
Principal Investigator,"Karin Ried, PhD","National Institute of Integrative Medicine, Australia",,NCT04395768,karin ried,karin,female,0.97,25914,107,NCT04395768,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,Not yet recruiting,No Results Available,COVID19,Dietary Supplement: Vitamin C|Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Zinc Citrate|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin B12,"May 20, 2020",,https://ClinicalTrials.gov/show/NCT04395768
Principal Investigator,"Benoit PILMIS, MD",Groupe Hospitalier Paris Saint Joseph,,NCT04365530,benoit pilmis,benoit,male,0.99,27836,109,NCT04365530,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,Recruiting,No Results Available,COVID,,"April 28, 2020","Hôpital Marie Lannelongue, Le Plessis-Robinson, France|AURA Paris Plaisance, Paris, France|Fondation Sainte-Marie, Paris, France|Groupe Hospitalier Paris Saint-Joseph, Paris, France|Hôpital Bellan, Paris, France",https://ClinicalTrials.gov/show/NCT04365530
Principal Investigator,"Dean J Kereiakes, MD",The Christ Hospital,,NCT04355897,dean j kereiakes,dean,male,0.98,13192,111,NCT04355897,CoVID-19 Plasma in Treatment of COVID-19 Patients,Recruiting,No Results Available,COVID 19,Biological: Convalescent COVID 19 Plasma,"April 21, 2020","The Christ Hospital, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04355897
Study Director,"Hélène Gros, MD",Robert Ballanger,,NCT04366206,hélène gros,hélène,female,0.98,13222,114,NCT04366206,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Recruiting,No Results Available,COVID|SARS-CoV 2,,"April 28, 2020","Centre Hospitalier Intercommunal Robert Ballanger, Aulnay-sous-Bois, France|Groupe Hospitalier Pitie Salpetriere, Paris, France",https://ClinicalTrials.gov/show/NCT04366206
Principal Investigator,Hélène Salvator,Pneumology unit,,NCT04379154,hélène salvator,hélène,female,0.98,13222,947,NCT04379154,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19),Recruiting,No Results Available,COVID-19,Device: Volatile Organic Compounds analysis,"May 7, 2020","Hôpital Foch, Suresnes, France",https://ClinicalTrials.gov/show/NCT04379154
Study Director,"Hélène Donnadieu-Rigole, MD PhD","University Hospital, Montpellier",,NCT04343339,hélène donnadieu-rigole,hélène,female,0.98,13222,1080,NCT04343339,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Recruiting,No Results Available,"Addiction, Substance|COVID-19",,"April 13, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04343339
Principal Investigator,"Frédéric COUTANT, MD",Hospices Civils de Lyon,,NCT04354766,frédéric coutant,frédéric,male,1.0,91,115,NCT04354766,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,Recruiting,No Results Available,COVID,Other: Blood sample,"April 21, 2020","Hôpital de la Croix-Rousse, Lyon, France",https://ClinicalTrials.gov/show/NCT04354766
Principal Investigator,"Frédéric ADNET, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04325633,frédéric adnet,frédéric,male,1.0,91,347,NCT04325633,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Drug: 1: Naproxen|Drug: 2: Standard of care,"March 27, 2020",,https://ClinicalTrials.gov/show/NCT04325633
Principal Investigator,Frédéric BLANC,"University Hospital, Strasbourg, France",,NCT04359953,frédéric blanc,frédéric,male,1.0,91,443,NCT04359953,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Not yet recruiting,No Results Available,COVID-19 Infection,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Telmisartan,"April 24, 2020","CHU de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04359953
Principal Investigator,"Frédéric Balen, MD",University Hospital of Toulouse,,NCT04371328,frédéric balen,frédéric,male,1.0,91,1587,NCT04371328,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,"Active, not recruiting",No Results Available,Emergencies,Other: RECOP unit patient,"May 1, 2020","University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04371328
Principal Investigator,"Kristin Newby, MD",Duke University,,NCT04424004,kristin newby,kristin,female,0.93,6934,116,NCT04424004,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,Not yet recruiting,No Results Available,COVID 19,Other: COVID-19 PCR and serology testing,"June 9, 2020",,https://ClinicalTrials.gov/show/NCT04424004
Principal Investigator,"Massimo Galli, Professor",University of Milan,,NCT04386239,massimo galli,massimo,male,0.99,69361,118,NCT04386239,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Not yet recruiting,No Results Available,COVID19,Drug: Sarilumab Prefilled Syringe,"May 13, 2020",,https://ClinicalTrials.gov/show/NCT04386239
Study Director,"Massimo Costantini, Ph.D.",Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia,,NCT04346355,massimo costantini,massimo,male,0.99,69361,843,NCT04346355,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Terminated,No Results Available,COVID-19 Pneumonia,Drug: Tocilizumab,"April 15, 2020","Ospedale di Guastalla, Guastalla, RE, Italy|Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy|Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|ASST Cremona, Cremona, Italy|Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy|Azienda Ospedaliero Universitaria Ferrara, Ferrara, Italy|Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|Ospedale Evangelico Internazionale di Genova, Genova, Italy|Azienda Sociosanitaria ASL 1 ,Imperia, Imperia, Italy|Azienda Sociosanitaria ASL 5 La Spezia, La Spezia, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|IRCCS Istituto Auxologico Italiano Milano, Milano, Italy|Azienda Ospedaliero-Universitaria ""Maggiore della Carità"" di Novara, Novara, Italy|Ospedali Riuniti Padova Sud - ULSS 6 Euganea, Padova, Italy|Azienda Ospedaliero-Universitaria Parma, Parma, Italy|Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|AO Ordine Mauriziano di Torino, Torino, Italy|ASST Bergamo Ovest -Treviglio, Treviglio, Italy|AULSS 2 Marca Trevigiana, Treviso, Italy|AULSS2 Marca Trevigiana - Ospedale Vittorio Veneto, Treviso, Italy|AULSS 3 Serenissima Ospedale ""Dell'Angelo"", Venezia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|IRCCS Sacro Cuore Don Calabria, Verona, Italy",https://ClinicalTrials.gov/show/NCT04346355
Study Director,"Carlo Salvarani, M.D.",Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia,,NCT04346355,carlo salvarani,carlo,male,0.99,55640,843,NCT04346355,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Terminated,No Results Available,COVID-19 Pneumonia,Drug: Tocilizumab,"April 15, 2020","Ospedale di Guastalla, Guastalla, RE, Italy|Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy|Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|ASST Cremona, Cremona, Italy|Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy|Azienda Ospedaliero Universitaria Ferrara, Ferrara, Italy|Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|Ospedale Evangelico Internazionale di Genova, Genova, Italy|Azienda Sociosanitaria ASL 1 ,Imperia, Imperia, Italy|Azienda Sociosanitaria ASL 5 La Spezia, La Spezia, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|IRCCS Istituto Auxologico Italiano Milano, Milano, Italy|Azienda Ospedaliero-Universitaria ""Maggiore della Carità"" di Novara, Novara, Italy|Ospedali Riuniti Padova Sud - ULSS 6 Euganea, Padova, Italy|Azienda Ospedaliero-Universitaria Parma, Parma, Italy|Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|AO Ordine Mauriziano di Torino, Torino, Italy|ASST Bergamo Ovest -Treviglio, Treviglio, Italy|AULSS 2 Marca Trevigiana, Treviso, Italy|AULSS2 Marca Trevigiana - Ospedale Vittorio Veneto, Treviso, Italy|AULSS 3 Serenissima Ospedale ""Dell'Angelo"", Venezia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|IRCCS Sacro Cuore Don Calabria, Verona, Italy",https://ClinicalTrials.gov/show/NCT04346355
Principal Investigator,"MASSIMO VOLPE, MD","Univerity of Rome ""La Sapienza""",,NCT04331574,massimo volpe,massimo,male,0.99,69361,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Study Chair,"Guido Iaccarino, MD",Federico II University,,NCT04331574,guido iaccarino,guido,male,0.99,15568,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Study Director,"Guido Grassi, MD","Inversity of Milan, BICOCCA",,NCT04331574,guido grassi,guido,male,0.99,15568,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Principal Investigator,Leonardo Sechi,University of Udine,,NCT04331574,leonardo sechi,leonardo,male,0.99,31322,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Principal Investigator,"MariaLorenza Muiesan, MD",Università degli Studi di Brescia,,NCT04331574,marialorenza muiesan,marialorenza,female,1.0,5,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Principal Investigator,"Claudio Borghi, MD",University of Bologna,,NCT04331574,claudio borghi,claudio,male,0.99,67759,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Principal Investigator,"Claudio Ferri, MD",University of L'Aquila,,NCT04331574,claudio ferri,claudio,male,0.99,67759,1323,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,Recruiting,No Results Available,COVID-19|Hypertension|Cardiovascular Diseases,,"April 2, 2020","Spedali Civili di Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04331574
Principal Investigator,"Olga Sanchez Pernaute, MD, PhD",FUNDACION JIMENEZ DIAZ,,NCT04392531,olga sanchez pernaute,olga,female,0.98,80307,119,NCT04392531,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,Recruiting,No Results Available,COVID19 Infection,Drug: Cyclosporine|Drug: Standard treatment,"May 19, 2020","Complejo Hospitalario Universitario La Coruña, La Coruña, Galicia, Spain|Hospital Quiron La Coruña, La Coruña, Galicia, Spain|Hospital Rey Juan Carlos, Mostoles, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital General de Villalba, Villalba, Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Clinica Universitaria de Navarra, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04392531
Principal Investigator,"Ericka L Fink, MD",University of Pittsburgh,,NCT04379089,ericka l fink,ericka,female,0.98,1522,123,NCT04379089,Neurologic Manifestations of COVID 19 in Children,Recruiting,No Results Available,COVID|Neurologic Manifestations,Other: Observational study only,"May 7, 2020","UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04379089
Principal Investigator,"Kyle Kimura, MD",Vanderbilt University Medical Center,,NCT04347538,kyle kimura,kyle,male,0.98,12606,125,NCT04347538,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Recruiting,No Results Available,COVID 19,Other: Saline Nasal Irrigation|Other: Saline with Baby Shampoo Nasal Irrigation,"April 15, 2020","Vanderblt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04347538
Study Director,"Justin H. Turner, MD, PhD",Vanderbilt University Medical Center,,NCT04347538,justin h. turner,justin,male,0.98,29577,125,NCT04347538,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Recruiting,No Results Available,COVID 19,Other: Saline Nasal Irrigation|Other: Saline with Baby Shampoo Nasal Irrigation,"April 15, 2020","Vanderblt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04347538
Principal Investigator,"Justin L Grodin, MD, MPH",UT Southwestern Medical Center at Dallas,,NCT04435457,justin l grodin,justin,male,0.98,29577,1578,NCT04435457,Cardiovascular Implications of COVID-19,Not yet recruiting,No Results Available,SARS-CoV 2|SARS Pneumonia|COVID-19|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere|Cardiac Complication,,"June 17, 2020",,https://ClinicalTrials.gov/show/NCT04435457
Principal Investigator,"Frances Hall Hall, FRCP (UK), D.Phil",Cambridge University Hospitals NHS Foundation Trust,,NCT04390464,frances hall hall,frances,female,0.88,3173,127,NCT04390464,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Recruiting,No Results Available,COVID19,Drug: Ravulizumab|Drug: Baricitinib|Other: Standard of care,"May 15, 2020","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04390464
Principal Investigator,"Domingo A Pascual Figal, MD",HCUVA,,NCT04350320,domingo a pascual figal,domingo,male,0.98,5937,128,NCT04350320,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Recruiting,No Results Available,COVID19,Drug: Colchicine Tablets|Drug: Standard therapy for COVID-19 according to the stablished hospital protocols.,"April 17, 2020","Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain",https://ClinicalTrials.gov/show/NCT04350320
Principal Investigator,"Nasser Al Ansari, FRCPath",Hamad Medical Corporation (HMC),,NCT04437693,nasser al ansari,nasser,male,0.98,8884,131,NCT04437693,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Not yet recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine,"June 18, 2020",,https://ClinicalTrials.gov/show/NCT04437693
Principal Investigator,"Nasser Malekpour Alamdari, MD",Shahid Beheshti University of Medical Sciences,,NCT04359615,nasser malekpour alamdari,nasser,male,0.98,8884,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Study Chair,"Mohammad Fathi, MD",Shahid Beheshti University of Medical Sciences,,NCT04359615,mohammad fathi,mohammad,male,0.98,31501,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Study Director,"Sasan Tavana, MD",Shahid Beheshti University of Medical Sciences,,NCT04359615,sasan tavana,sasan,male,0.97,986,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Principal Investigator,"Mehran Lack, MD",Shahid Beheshti University of Medical Sciences,,NCT04359615,mehran lack,mehran,male,0.98,2033,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Principal Investigator,"Nader Markazi, MD",Shahid Beheshti University of Medical Sciences,,NCT04359615,nader markazi,nader,male,0.98,6855,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Principal Investigator,"Sanaz Zargar Balaye Jam, MD",Shahid Beheshti University of Medical Sciences,,NCT04359615,sanaz zargar balaye jam,sanaz,female,0.97,1269,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Principal Investigator,"Seyed Sina Naghibi Irvani, MD, MPH, MBA",Shahid Beheshti University of Medical Sciences,,NCT04359615,seyed sina naghibi irvani,seyed,male,0.98,521,428,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Favipiravir|Drug: Hydroxychloroquine,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359615
Principal Investigator,"Nasser Malekpour Alamdari, MD",Shahid Beheshti University of Medical Sciences,,NCT04359316,nasser malekpour alamdari,nasser,male,0.98,8884,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Study Chair,"Mohammad Fathi, MD",Shahid Beheshti University of Medical Sciences,,NCT04359316,mohammad fathi,mohammad,male,0.98,31501,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Study Director,"Sasan Tavana, MD",Shahid Beheshti University of Medical Sciences,,NCT04359316,sasan tavana,sasan,male,0.97,986,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Principal Investigator,"Mehran Lack, MD",Shahid Beheshti University of Medical Sciences,,NCT04359316,mehran lack,mehran,male,0.98,2033,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Principal Investigator,"Nader Markazi, MD",Shahid Beheshti University of Medical Sciences,,NCT04359316,nader markazi,nader,male,0.98,6855,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Principal Investigator,"Sanaz Zargar Balaye Jam, MD",Shahid Beheshti University of Medical Sciences,,NCT04359316,sanaz zargar balaye jam,sanaz,female,0.97,1269,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Principal Investigator,"Seyed Sina Naghibi Irvani, MD, MPH, MBA",Shahid Beheshti University of Medical Sciences,,NCT04359316,seyed sina naghibi irvani,seyed,male,0.98,521,434,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 24, 2020","Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04359316
Principal Investigator,"Amy Mathers, MD",University of Virginia,,NCT04368260,amy mathers,amy,female,0.97,31233,132,NCT04368260,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Recruiting,No Results Available,COVID19,Device: Control swab|Device: Prototype swab,"April 29, 2020","University of Virginia, Charlottesville, Virginia, United States",https://ClinicalTrials.gov/show/NCT04368260
Principal Investigator,"Lars Wik, MD",Oslo University Hospital,,NCT04335097,lars wik,lars,male,0.99,22753,133,NCT04335097,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Recruiting,No Results Available,COVID 19,Device: Biosensors,"April 6, 2020","Lillestrom legevakt, Lillestrom, Norway",https://ClinicalTrials.gov/show/NCT04335097
Principal Investigator,"Lars Petter Bjørnsen, MD, PhD",NTNU/St. Olav's Hospital,,NCT04422691,lars petter bjørnsen,lars,male,0.99,22753,1449,NCT04422691,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,Not yet recruiting,No Results Available,"COVID-19|Pneumonia, Viral|Pulmonary Infection",Diagnostic Test: Lung ultrasound,"June 9, 2020","Haukeland universitetssykehus, Bergen, Norway|Nordland Hospital, Bodø, Norway|Drammen sykehus, Drammen, Norway|Sørlandet sykehus, Kristiansand, Kristiansand, Norway|Akershus University Hospital, Oslo, Norway|Ullevål University Hospital, Oslo, Norway|Sykehuset Telemark HF, Skien, Norway|Stavanger Universitetssjukehus, Stavanger, Norway|St Olavs Hospital, Trondheim, Norway",https://ClinicalTrials.gov/show/NCT04422691
Study Chair,"Lars Østergaard, Professor",Head of Department,,NCT04321096,lars østergaard,lars,male,0.99,22753,1699,NCT04321096,The Impact of Camostat Mesilate on COVID-19 Infection,Recruiting,No Results Available,Corona Virus Infection,Drug: Camostat Mesilate|Drug: Placebo oral tablet,"March 25, 2020","Department of Infectious Diseases, Aalborg, Denmark|Department for Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark|Herning Regional Hospital, Herning, Denmark|Northzealands hospital - Hillerød, Hillerød, Denmark|Horsens Regional Hospital, Horsens, Denmark|Bispebjerg hospital, København, Denmark|Dept. of Infectious Diseases, Odense University Hospital, Odense, Denmark|Randers Regional Hospital, Randers, Denmark|Silkeborg Hospital, Silkeborg, Denmark",https://ClinicalTrials.gov/show/NCT04321096
Principal Investigator,"Lars Erik Kristensen, PhD",The Parker Institute,,NCT04322773,lars erik kristensen,lars,male,0.99,22753,2229,NCT04322773,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Recruiting,No Results Available,Corona Virus Disease,Drug: RoActemra iv|Drug: RoActemra sc|Drug: Kevzara sc|Other: Standard medical care,"March 26, 2020","Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark|Hillerød Hospital, Hillerød, Denmark",https://ClinicalTrials.gov/show/NCT04322773
Principal Investigator,"Pascal FASCIA, MD",Hospices Civils de Lyon,,NCT04441710,pascal fascia,pascal,male,0.99,84147,136,NCT04441710,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,Not yet recruiting,No Results Available,COVID,Other: Questionnaire,"June 22, 2020","CHU de Grenoble - Hôpital Nord, La Tronche, France|Hôpital de la Croix Rousse, Lyon, France|Hôpital Henry Gabrielle, Saint-Genis-Laval, France|CHU de Saint Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04441710
Study Director,"François GUEYFFIER, MD",Hospices Civils de Lyon,,NCT04441710,françois gueyffier,françois,male,1.0,7,136,NCT04441710,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,Not yet recruiting,No Results Available,COVID,Other: Questionnaire,"June 22, 2020","CHU de Grenoble - Hôpital Nord, La Tronche, France|Hôpital de la Croix Rousse, Lyon, France|Hôpital Henry Gabrielle, Saint-Genis-Laval, France|CHU de Saint Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04441710
Study Director,"Pascal AMEDRO, MD-PhD",UH MONTPELLIER,,NCT04336384,pascal amedro,pascal,male,0.99,84147,958,NCT04336384,Impact of Covid-19 in Congenital Heart Disease,Recruiting,No Results Available,Congenital Heart Disease|Covid-19,,"April 7, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04336384
Principal Investigator,"François BELONCLE, MCU PH","CHU Angers, Médecine intensive réanimation",,NCT04350710,françois beloncle,françois,male,1.0,7,872,NCT04350710,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID,Other: PEEP trial,"April 17, 2020","CHU, Angers, France",https://ClinicalTrials.gov/show/NCT04350710
Principal Investigator,"François Lamontagne, MD, FRCPC, MSc",Université de Sherbrooke and CIUSSS de l'Estrie - CHUS,,NCT04401150,françois lamontagne,françois,male,1.0,7,1068,NCT04401150,Lessening Organ Dysfunction With VITamin C - COVID-19,Not yet recruiting,No Results Available,Vitamin C|COVID-19|Hospitalized Patients,Drug: Vitamin C|Drug: Control,"May 26, 2020","Research Centre of the CHUS, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04401150
Principal Investigator,"Neill K Adhikari, MDCM, FRCPC, MSc","Sunnybrook Health Sciences Centre, University of Toronto",,NCT04401150,neill k adhikari,neill,male,0.97,262,1068,NCT04401150,Lessening Organ Dysfunction With VITamin C - COVID-19,Not yet recruiting,No Results Available,Vitamin C|COVID-19|Hospitalized Patients,Drug: Vitamin C|Drug: Control,"May 26, 2020","Research Centre of the CHUS, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04401150
Principal Investigator,"François Dubos, MD,PhD","University Hospital, Lille",,NCT04336761,françois dubos,françois,male,1.0,7,1236,NCT04336761,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Recruiting,No Results Available,Coronavirus|COVID|Infection Viral,Diagnostic Test: nasopharyngeal swab,"April 7, 2020","CH Louis MOURIER, Colombes, France|Hôpital Jeanne de Flandres, CHU, Lille, France|Hôpital Mère Enfant CHU, Nantes, France|Hôpitaux Pédiatriques de Nice CHU-Lenval, Nice, France|Hôpital des enfants - CHU, Toulouse, France|CHU de Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04336761
Study Director,Anya Loncaric,Bausch Health,,NCT04356677,anya loncaric,anya,female,0.97,4118,139,NCT04356677,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Not yet recruiting,No Results Available,COVID19,Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole,"April 22, 2020",,https://ClinicalTrials.gov/show/NCT04356677
Study Chair,"Jean-Jacques Garaud, MD",INOTREM SA,,NCT04429334,jean-jacques garaud,jean-jacques,male,0.99,3778,141,NCT04429334,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",Not yet recruiting,No Results Available,COVID19,Drug: nangibotide|Drug: placebo,"June 12, 2020","Réanimation Médicale, Hôpital Central, Nancy, France",https://ClinicalTrials.gov/show/NCT04429334
Principal Investigator,"Jean-Jacques KILADJIAN, Pr",FIM,,NCT04416438,jean-jacques kiladjian,jean-jacques,male,0.99,3778,1222,NCT04416438,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,Not yet recruiting,No Results Available,Myeloproliferative Neoplasm|COVID-19 Infection,,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04416438
Principal Investigator,"Laurence LEGROS, Dr",FIM,,NCT04416438,laurence legros,laurence,female,0.96,53900,1222,NCT04416438,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,Not yet recruiting,No Results Available,Myeloproliferative Neoplasm|COVID-19 Infection,,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04416438
Principal Investigator,"Sangeeta Pathak, MBBS,Diploma","Max Super Speciality Hospital, Saket (DDF)",,NCT04374487,sangeeta pathak,sangeeta,female,0.99,273,142,NCT04374487,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",Not yet recruiting,No Results Available,COVID 19,Drug: Convalescent Plasma|Other: Standard Care Therapy,"May 5, 2020","Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04374487
Principal Investigator,"Sangeeta Joshi, MD",Duke University,,NCT04343690,sangeeta joshi,sangeeta,female,0.99,273,549,NCT04343690,COPING With COVID-19( CWC-19),Not yet recruiting,No Results Available,COVID-19,Behavioral: Crisis management coaching,"April 13, 2020","Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04343690
Principal Investigator,"Patty Lee, MD",Duke University,,NCT04343690,patty lee,patty,female,0.96,10123,549,NCT04343690,COPING With COVID-19( CWC-19),Not yet recruiting,No Results Available,COVID-19,Behavioral: Crisis management coaching,"April 13, 2020","Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04343690
Principal Investigator,"Philippe Gaudard, MD","University Hospital, Montpellier",,NCT04355715,philippe gaudard,philippe,male,0.99,82618,143,NCT04355715,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,"Active, not recruiting",No Results Available,COVID 19|SARS-Cov-2,,"April 21, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04355715
Principal Investigator,"Philippe Jouvet, MD PhD MBA",St. Justine's Hospital,,NCT04361435,philippe jouvet,philippe,male,0.99,82618,1137,NCT04361435,Lung Recruitment Device for COVID-19,Not yet recruiting,No Results Available,COVID-19|Physiotherapy,Procedure: Chest physiotherapy using a non-invasive oscillating device,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04361435
Principal Investigator,Philippe CASSIER,Centre Leon Berard,,NCT04333914,philippe cassier,philippe,male,0.99,82618,1424,NCT04333914,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Suspended,No Results Available,SARS-CoV-2 (COVID-19) Infection|Advanced or Metastatic Hematological or Solid Tumor,Drug: Chloroquine analog (GNS651)|Drug: Nivolumab|Drug: Tocilizumab|Other: Standard of care|Drug: Avdoralimab|Drug: Monalizumab,"April 3, 2020","Centre Léon Bérard, Lyon, Rhône, France|CHU Clermont Ferrand, Clermont Ferrand, France|Centre Oscar Lambret, Lille, France|AP-HP Hôpital Saint Antoine, Paris, France|AP-HP La Pitié Salpétrière, Paris, France|Hôpital Saint-Joseph, Paris, France|AP-HP Tenon, Paris, France|AP-HP Hôpital Bichat Claude Bernard, Paris, France|GH Diaconesses Croix Saint Simon, Paris, France|Gustave Roussy, Villejuif, France",https://ClinicalTrials.gov/show/NCT04333914
Principal Investigator,Philippe Rousselot,CH Versailles,,NCT04357613,philippe rousselot,philippe,male,0.99,82618,2036,NCT04357613,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Not yet recruiting,No Results Available,SARS Virus,Drug: Experimental drug,"April 22, 2020","CHU Bordeaux, Bordeaux, France|CH de Versailles, Le Chesnay, France",https://ClinicalTrials.gov/show/NCT04357613
Principal Investigator,"Philippe VANHEMS, MD, PhD","Service Hygiène, Epidémiologie et Prévention",,NCT04290780,philippe vanhems,philippe,male,0.99,82618,2209,NCT04290780,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Recruiting,No Results Available,Infection Viral,Other: nosocomial infection/hospital acquired infection,"March 2, 2020","Service Hygiène, Epidémiologie et Prévention, Lyon, France|Service Hygiène, Epidémiologie et Prévention, Lyon, France",https://ClinicalTrials.gov/show/NCT04290780
Principal Investigator,Samia Girgis,Vice Director of ASU Hospital,,NCT04443712,samia girgis,samia,female,0.98,13449,146,NCT04443712,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),Recruiting,No Results Available,Coronavirus Disease 2019 (COVID19),,"June 23, 2020","Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04443712
Principal Investigator,"Latha Dulipsingh, MD",Saint Francis Hospital and Medical Centerr/Trinity Health Of New England,,NCT04343261,latha dulipsingh,latha,female,0.97,150,148,NCT04343261,Convalescent Plasma in the Treatment of COVID 19,Enrolling by invitation,No Results Available,SARS-CoV-2|COVID|Coronavirus,Biological: Convalescent Plasma,"April 13, 2020","Trinity Health Of New England, Hartford, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04343261
Principal Investigator,"Antoine Vieillard-Baron, MD, PhD",Hospital Ambroise Paré Paris,,NCT04414410,antoine vieillard-baron,antoine,male,0.99,38236,149,NCT04414410,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,Enrolling by invitation,No Results Available,COVID|Sars-CoV2,,"June 4, 2020","University Hospital Ambroise Pare, Boulogne-Billancourt, Hauts De Seine, France",https://ClinicalTrials.gov/show/NCT04414410
Study Chair,"Antoine KIMMOUN, MD-PhD",CHRU de NANCY,,NCT04376879,antoine kimmoun,antoine,male,0.99,38236,207,NCT04376879,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Recruiting,No Results Available,COVID-19,Other: Data monitoring for 48h within the first 12 hours of admission for COVID-19,"May 6, 2020","Louis Mourier hospital (AP-HP), Colombes, France|Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04376879
Study Chair,"Jean Damien RICARD, MD-PhD","AP-HP, Louis Mourier Hospital",,NCT04376879,jean damien ricard,jean,male,0.95,196185,207,NCT04376879,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Recruiting,No Results Available,COVID-19,Other: Data monitoring for 48h within the first 12 hours of admission for COVID-19,"May 6, 2020","Louis Mourier hospital (AP-HP), Colombes, France|Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04376879
Study Chair,"Julie JOSSE, PhD",Ecole Polytechnique & INRIA,,NCT04376879,julie josse,julie,female,0.98,116926,207,NCT04376879,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Recruiting,No Results Available,COVID-19,Other: Data monitoring for 48h within the first 12 hours of admission for COVID-19,"May 6, 2020","Louis Mourier hospital (AP-HP), Colombes, France|Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04376879
Study Chair,"Patrick ROSSIGNOL, MD-PhD",CHRU de NANCY,,NCT04376879,patrick rossignol,patrick,male,0.99,153288,207,NCT04376879,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Recruiting,No Results Available,COVID-19,Other: Data monitoring for 48h within the first 12 hours of admission for COVID-19,"May 6, 2020","Louis Mourier hospital (AP-HP), Colombes, France|Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04376879
Principal Investigator,"Antoine MONSEL, MD, PhD",Hôpital Pitié-Salpêtrière - Assitance Publique - Hôpitaux de Paris,,NCT04333368,antoine monsel,antoine,male,0.99,38236,1581,NCT04333368,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Severe Acute Respiratory Distress Syndrome,Biological: Umbilical cord Wharton's jelly-derived human|Other: NaCl 0.9%,"April 3, 2020","Hôpital Pitié-Salpêtrière - APHP, Paris, France|Hôpital Européen Georges Pompidou - APHP, Paris, France",https://ClinicalTrials.gov/show/NCT04333368
Principal Investigator,"Giuseppe Curigliano, MD",European IO,,NCT04434417,giuseppe curigliano,giuseppe,male,0.99,163742,150,NCT04434417,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,Recruiting,No Results Available,COVID,Device: 2019-nCoV IgG/IgM Rapid Test Cassette,"June 16, 2020","Papa Giovanni XXIII Hospital, Bergamo, Italy|Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy|Azienda Ospedaliera Niguarda Cà Granda, Milano, Italy|European IO, Division of Early Drug Development for Innovative Therapies, Milan, Italy",https://ClinicalTrials.gov/show/NCT04434417
Principal Investigator,"Antonio Marra, MD",European IO,,NCT04434417,antonio marra,antonio,male,0.99,328654,150,NCT04434417,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,Recruiting,No Results Available,COVID,Device: 2019-nCoV IgG/IgM Rapid Test Cassette,"June 16, 2020","Papa Giovanni XXIII Hospital, Bergamo, Italy|Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy|Azienda Ospedaliera Niguarda Cà Granda, Milano, Italy|European IO, Division of Early Drug Development for Innovative Therapies, Milan, Italy",https://ClinicalTrials.gov/show/NCT04434417
Principal Investigator,"Giuseppe Foti, Prof.",ASST Monza-University Milano Bicocca,,NCT04365959,giuseppe foti,giuseppe,male,0.99,163742,833,NCT04365959,The Prone Position in Covid-19 Affected Patients,"Active, not recruiting",No Results Available,Sars-CoV2,Procedure: Prone position,"April 28, 2020","ASST Monza, Monza, MB, Italy",https://ClinicalTrials.gov/show/NCT04365959
Principal Investigator,"Giuseppe GRITTI, MD",ASST PAPA GIOVANNI XXIII,,NCT04322188,giuseppe gritti,giuseppe,male,0.99,163742,1230,NCT04322188,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Completed,No Results Available,Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection,,"March 26, 2020","ASST - Papa Giovanni XXIII, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04322188
Principal Investigator,"Giuseppe Ietto, M.D.",Università degli Studi dell'Insubria,,NCT04375176,giuseppe ietto,giuseppe,male,0.99,163742,1324,NCT04375176,Monocytes and NK Cells Activity in Covid-19 Patients,Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Immunomodulation,Diagnostic Test: Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2,"May 5, 2020","ATS Insubria, Varese, Italy",https://ClinicalTrials.gov/show/NCT04375176
Principal Investigator,"Lorenzo Mortara, Professor",Università degli Studi dell'Insubria,,NCT04375176,lorenzo mortara,lorenzo,male,0.99,55168,1324,NCT04375176,Monocytes and NK Cells Activity in Covid-19 Patients,Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Immunomodulation,Diagnostic Test: Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2,"May 5, 2020","ATS Insubria, Varese, Italy",https://ClinicalTrials.gov/show/NCT04375176
Study Chair,"Giulio Carcano, Professor",Università degli Studi dell'Insubria,,NCT04375176,giulio carcano,giulio,male,0.99,19697,1324,NCT04375176,Monocytes and NK Cells Activity in Covid-19 Patients,Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome Coronavirus 2|Immunomodulation,Diagnostic Test: Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2,"May 5, 2020","ATS Insubria, Varese, Italy",https://ClinicalTrials.gov/show/NCT04375176
Principal Investigator,"Antonio Ramos, MD, PhD",Hospital Universitario Puerta de Hierro Majadahonda,,NCT04345523,antonio ramos,antonio,male,0.99,328654,261,NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,Recruiting,No Results Available,COVID-19,Other: Blood and derivatives.|Drug: Standard of Care,"April 14, 2020","Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04345523
Study Chair,"Cristina Avendaño Solá, MD, PhD",Hospital Universitario Puerta de Hierro Majadahonda,,NCT04345523,cristina avendaño solá,cristina,female,0.99,140931,261,NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,Recruiting,No Results Available,COVID-19,Other: Blood and derivatives.|Drug: Standard of Care,"April 14, 2020","Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04345523
Principal Investigator,"José Luis Bueno, MD",Hospital Universitario Puerta de Hierro Majadahonda,,NCT04345523,josé luis bueno,josé,male,0.97,2086,261,NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,Recruiting,No Results Available,COVID-19,Other: Blood and derivatives.|Drug: Standard of Care,"April 14, 2020","Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04345523
Study Chair,"Rafael Duarte Palomino, MD, PhD",Hospital Universitario Puerta de Hierro Majadahonda,,NCT04345523,rafael duarte palomino,rafael,male,0.99,45829,261,NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,Recruiting,No Results Available,COVID-19,Other: Blood and derivatives.|Drug: Standard of Care,"April 14, 2020","Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04345523
Principal Investigator,"Inmaculada Casas Flecha, PharmD, PhD","Centro Nacional de Microbiología, Instituto de Salud Carlos III",,NCT04345523,inmaculada casas flecha,inmaculada,female,0.99,4672,261,NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,Recruiting,No Results Available,COVID-19,Other: Blood and derivatives.|Drug: Standard of Care,"April 14, 2020","Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04345523
Study Director,"Antonio Cubillo, MD",Director,,NCT04420299,antonio cubillo,antonio,male,0.99,328654,331,NCT04420299,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Recruiting,No Results Available,Covid-19,Drug: Bemiparin,"June 9, 2020","Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04420299
Study Director,Antonio Esquinas,Hospital General Universitario Morales Meseguer,,NCT04342104,antonio esquinas,antonio,male,0.99,328654,1038,NCT04342104,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Recruiting,No Results Available,Respiratory Failure|Covid-19,Other: Monitoring for aggravation|Other: Evaluate HACOR score effectivity in this patients,"April 10, 2020","Hospital General Universitario Morales Meseguer, Murcia, Spain",https://ClinicalTrials.gov/show/NCT04342104
Principal Investigator,Miguel Guia,Hospital General Universitario Morales Meseguer,,NCT04342104,miguel guia,miguel,male,0.99,158479,1038,NCT04342104,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Recruiting,No Results Available,Respiratory Failure|Covid-19,Other: Monitoring for aggravation|Other: Evaluate HACOR score effectivity in this patients,"April 10, 2020","Hospital General Universitario Morales Meseguer, Murcia, Spain",https://ClinicalTrials.gov/show/NCT04342104
Principal Investigator,"Antonio Ciardo, Dr.",University Hospital Heidelberg,,NCT04381273,antonio ciardo,antonio,male,0.99,328654,1139,NCT04381273,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,Recruiting,No Results Available,Covid-19|Periodontal Diseases,Other: No intervention,"May 8, 2020","University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04381273
Study Chair,Antonio J Carcas,Hospital Universitario La Paz,,NCT04353128,antonio j carcas,antonio,male,0.99,328654,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,"Pedro de la Oliva, MD, PhD",Hospital Universitario La Paz,,NCT04353128,pedro de la oliva,pedro,male,0.99,165413,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,José R Arribas,Hospital Universitario La Paz,,NCT04353128,josé r arribas,josé,male,0.97,2086,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,Juan González,Hospital Universitario La Paz,,NCT04353128,juan gonzález,juan,male,0.98,274814,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,"Miguel Rodriguez-Rubio, MD",Hospital Universitario La Paz,,NCT04353128,miguel rodriguez-rubio,miguel,male,0.99,158479,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,"Alberto M Borobia, MD, PhD",Hospital Universitario La Paz,,NCT04353128,alberto m borobia,alberto,male,0.99,124347,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,María J Rosales,Hospital Universitario La Paz,,NCT04353128,maría j rosales,maría,female,0.99,232436,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,Irene García García,Hospital Universitario La Paz,,NCT04353128,irene garcía garcía,irene,female,0.99,50462,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Study Chair,Amelia Rodríguez Mariblanca,Hospital Universitario La Paz,,NCT04353128,amelia rodríguez mariblanca,amelia,female,0.98,9165,1589,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Recruiting,No Results Available,Covid19|SARS-CoV 2|Coronavirus Infection,Drug: Melatonin 2mg|Drug: Placebo oral tablet,"April 20, 2020","Hospital Universitario La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04353128
Principal Investigator,"Antonio José Ojeda Niño, MD",Pain unit physician,,NCT04394169,antonio josé ojeda niño,antonio,male,0.99,328654,1783,NCT04394169,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Not yet recruiting,No Results Available,Post ICU Syndrome|Chronic Pain|Covid-19,Behavioral: Intervention program,"May 19, 2020",,https://ClinicalTrials.gov/show/NCT04394169
Principal Investigator,Antonio Secchi,IRCCS San Raffaele,,NCT04377776,antonio secchi,antonio,male,0.99,328654,1938,NCT04377776,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",Completed,No Results Available,Kidney Transplant|Pancreas Tranplant|Pancreatic Islet Transplantation,Other: Practice details,"May 6, 2020","IRCCS San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04377776
Study Chair,"Antonio Lanzone, PhD","Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome IT",,NCT04353141,antonio lanzone,antonio,male,0.99,328654,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Study Chair,"Giovanni Scambia, PhD","Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome IT",,NCT04353141,giovanni scambia,giovanni,male,0.99,104824,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Study Chair,"Antonia Testa, PhD","Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome IT",,NCT04353141,antonia testa,antonia,female,0.98,18904,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Study Chair,"Tom Bourne, PhD","Queen Charlotte's & Chelsea Hospital, Imperial College London, London, UK",,NCT04353141,tom bourne,tom,male,0.99,126230,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Study Chair,"Jan Deprest, PhD",KU Leuven,,NCT04353141,jan deprest,jan,male,0.95,142869,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Study Chair,"Dirk Timmerman, PhD","KU Leuven, Leuven BE",,NCT04353141,dirk timmerman,dirk,male,0.99,23736,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Study Chair,"Francesca Moro, MD","Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome IT",,NCT04353141,francesca moro,francesca,female,0.99,106743,2261,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,Recruiting,No Results Available,"COVID|Pregnancy Complications, Infectious|Pregnancy Related|Pregnancy, High Risk|Pregnancy Disease|Pneumonia|Pneumonia, Viral|Diagnoses Disease",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,"April 20, 2020","University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04353141
Principal Investigator,"Martine MAUGET FAYSSE, MD",Fondation A. de Rothschild,,NCT04387292,martine mauget faysse,martine,female,0.98,39487,154,NCT04387292,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Recruiting,No Results Available,COVID19|Ophthalmopathy,Procedure: Ophthalmologic exam,"May 13, 2020","Fondation A de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04387292
Principal Investigator,"Martine Dr LOUET, PhD","AP-HP, Hôpital la Pitié Salpêtrière, Paris",,NCT04418375,martine dr louet,martine,female,0.98,39487,425,NCT04418375,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),Not yet recruiting,No Results Available,COVID-19,,"June 5, 2020",,https://ClinicalTrials.gov/show/NCT04418375
Principal Investigator,"Nathalie Dr DEMORY, PhD","AP-HP, Hôpital Européen Georges Pompidou, Paris",,NCT04418375,nathalie dr demory,nathalie,female,0.98,94304,425,NCT04418375,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),Not yet recruiting,No Results Available,COVID-19,,"June 5, 2020",,https://ClinicalTrials.gov/show/NCT04418375
Principal Investigator,"Solen Dr KERNEIS, PhD","AP-HP, Hôpital Cochin, Paris",,NCT04418375,solen dr kerneis,solen,female,0.87,315,425,NCT04418375,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),Not yet recruiting,No Results Available,COVID-19,,"June 5, 2020",,https://ClinicalTrials.gov/show/NCT04418375
Principal Investigator,"Martine MAUGET FAYSSE, MD",Fondation Adolphe de Rothschild,,NCT04395859,martine mauget faysse,martine,female,0.98,39487,1787,NCT04395859,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,Recruiting,No Results Available,Age Related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion,Procedure: Questionnaire|Other: Data collection up to 1 year,"May 20, 2020","Centre Pôle Vision du val d'Ouest, Ecully, France|Fondation Adolphe de Rothschild, Paris, France|Hôpital Lariboisière, Paris, France|Centre ophtalmologique Maison Rouge, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04395859
Principal Investigator,"Martine LAVILLE, MD",Centre Intégré de l'obésité de Lyon / HCL,,NCT04431284,martine laville,martine,female,0.98,39487,1996,NCT04431284,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,Not yet recruiting,No Results Available,Feeding and Eating Disorders,Other: Questionnaires,"June 16, 2020","Centre Intégré de l'obésité de Lyon / HCL, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04431284
Principal Investigator,"Emmanuel DISSE, MD",Centre Intégré de l'obésité de Lyon / HCL,,NCT04431284,emmanuel disse,emmanuel,male,0.99,45589,1996,NCT04431284,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,Not yet recruiting,No Results Available,Feeding and Eating Disorders,Other: Questionnaires,"June 16, 2020","Centre Intégré de l'obésité de Lyon / HCL, Pierre-Bénite, France",https://ClinicalTrials.gov/show/NCT04431284
Principal Investigator,"Arjun Chandna, MD",Mahidol Oxford Tropical Medicine Research Unit,,NCT04441372,arjun chandna,arjun,male,0.99,1611,155,NCT04441372,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 (COVID-19) Respiratory Infection,Not yet recruiting,No Results Available,Sars-CoV2|COVID,,"June 22, 2020","International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04441372
Principal Investigator,"Sakib Burza, PhD","Medecins Sans Frontieres, Spain",,NCT04441372,sakib burza,sakib,male,0.97,185,155,NCT04441372,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 (COVID-19) Respiratory Infection,Not yet recruiting,No Results Available,Sars-CoV2|COVID,,"June 22, 2020","International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04441372
Principal Investigator,"Hollis R O'Neal, Jr., MD, MSc","Pulmonary & Critical Care LSUHSC, Baton Rouge",,NCT04372472,hollis r o'neal,hollis,male,0.8,65,156,NCT04372472,SQuISH-COVID: A Pilot Study,"Active, not recruiting",No Results Available,Sepsis|COVID-19,,"May 4, 2020","Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04372472
Principal Investigator,"Ory Wiesel, MD",Maimonides Medical Center,,NCT04409886,ory wiesel,ory,male,0.52,599,158,NCT04409886,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,Not yet recruiting,No Results Available,"COVID, Coronavirus",Device: Hyperbaric Chamber,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409886
Principal Investigator,"Olivier EPAULARD, MD-PhD","University Hospital, Grenoble",,NCT04380662,olivier epaulard,olivier,male,0.99,76702,159,NCT04380662,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,Not yet recruiting,No Results Available,Covid19,Other: Risk factors,"May 8, 2020","Grenoble University Hospital, Grenoble, France",https://ClinicalTrials.gov/show/NCT04380662
Principal Investigator,"Olivier Ziegler, PU-PH",CHRU of Nancy,,NCT04425213,olivier ziegler,olivier,male,0.99,76702,1437,NCT04425213,Obesity and Mortality of Critically Ill Patients With COVID-19,Completed,No Results Available,COVID|Severe Acute Respiratory Syndrome|Obesity|Comorbidities and Coexisting Conditions,,"June 11, 2020","Centre hospitalo-universitaire régional de Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04425213
Principal Investigator,"Philip A Chan, MD","Warren Alpert Medical School and School of Public Health, Brown University",,NCT04435522,philip a chan,philip,male,0.99,21882,161,NCT04435522,Maraviroc in SARS-CoV-2,Not yet recruiting,No Results Available,COVID,Drug: Maraviroc,"June 17, 2020","Rhode Isand Hospital, Providence, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04435522
Principal Investigator,"John W Sanders, MD, MPH&TM",Wake Forest University Health Sciences,,NCT04342884,john w sanders,john,male,0.99,218952,163,NCT04342884,COVID-19 Community Research Partnership,Recruiting,No Results Available,Coronavirus|COVID,,"April 13, 2020","Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04342884
Principal Investigator,"John DiPersio, M.D., Ph.D.",Washington University School of Medicine,,NCT04372602,john dipersio,john,male,0.99,218952,170,NCT04372602,Duvelisib to Combat COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Duvelisib|Procedure: Peripheral blood draw,"May 4, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04372602
Principal Investigator,"John P Corcoran, BMBCh MRCP",University Hospitals Plymouth NHS Trust,,NCT04351802,john p corcoran,john,male,0.99,218952,206,NCT04351802,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: Lung ultrasound,"April 17, 2020",,https://ClinicalTrials.gov/show/NCT04351802
Study Chair,"John E Fiadjoe, MD",Children's Hospital of Philadelphia,,NCT04449042,john e fiadjoe,john,male,0.99,218952,225,NCT04449042,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,Recruiting,No Results Available,Airway Management|COVID19,Procedure: airway management during sedation or general anesthesia,"June 26, 2020","Boston Children's Hopsital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04449042
Principal Investigator,"John D Beckham, MD","University of Colorado Denver, Anschutz Medical Campus",,NCT04372368,john d beckham,john,male,0.99,218952,374,NCT04372368,Convalescent Plasma for the Treatment of Patients With COVID-19,Available,No Results Available,COVID-19|SARS-CoV 2,Biological: COVID-19 Convalescent Plasma,"May 4, 2020","Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|UCHealth Memorial Hospital North, Colorado Springs, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States",https://ClinicalTrials.gov/show/NCT04372368
Principal Investigator,"John DiPersio, M.D., Ph.D.",Washington University School of Medicine,,NCT04354714,john dipersio,john,male,0.99,218952,512,NCT04354714,Ruxolitinib to Combat COVID-19,Withdrawn,No Results Available,COVID-19,Drug: Ruxolitinib|Procedure: Peripheral blood draw,"April 21, 2020",,https://ClinicalTrials.gov/show/NCT04354714
Principal Investigator,"John Roll, PhD",Washington State University,,NCT04382625,john roll,john,male,0.99,218952,519,NCT04382625,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Not yet recruiting,No Results Available,SARS-CoV-2 Pneumonia|COVID-19,Drug: Hydroxychloroquine,"May 11, 2020","Kootenai Health, Coeur d'Alene, Idaho, United States",https://ClinicalTrials.gov/show/NCT04382625
Principal Investigator,"Sean Cook, D.O.",Kootenai Health,,NCT04382625,sean cook,sean,male,0.99,25765,519,NCT04382625,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Not yet recruiting,No Results Available,SARS-CoV-2 Pneumonia|COVID-19,Drug: Hydroxychloroquine,"May 11, 2020","Kootenai Health, Coeur d'Alene, Idaho, United States",https://ClinicalTrials.gov/show/NCT04382625
Principal Investigator,"Jeanette Berg, MD, PhD",Kootenai Health,,NCT04382625,jeanette berg,jeanette,female,0.98,8016,519,NCT04382625,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Not yet recruiting,No Results Available,SARS-CoV-2 Pneumonia|COVID-19,Drug: Hydroxychloroquine,"May 11, 2020","Kootenai Health, Coeur d'Alene, Idaho, United States",https://ClinicalTrials.gov/show/NCT04382625
Principal Investigator,"Sterling McPherson, PhD",Washington State University,,NCT04382625,sterling mcpherson,sterling,male,0.93,274,519,NCT04382625,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Not yet recruiting,No Results Available,SARS-CoV-2 Pneumonia|COVID-19,Drug: Hydroxychloroquine,"May 11, 2020","Kootenai Health, Coeur d'Alene, Idaho, United States",https://ClinicalTrials.gov/show/NCT04382625
Principal Investigator,"John Mark Sloan, MD",Boston Medical Center,,NCT04356690,john mark sloan,john,male,0.99,218952,618,NCT04356690,Etoposide in Patients With COVID-19 Infection,Recruiting,No Results Available,COVID-19,Drug: Etoposide,"April 22, 2020","Boston Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04356690
Principal Investigator,John Radford,The University of Manchester,,NCT04397705,john radford,john,male,0.99,218952,1217,NCT04397705,Remote Monitoring of Cancer Patients With Suspected Covid-19,Not yet recruiting,No Results Available,COVID|Oncology|Haematological Malignancy,Device: Patient Status Engine,"May 21, 2020","The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04397705
Principal Investigator,"John H Stone, MD",Massachusetts General Hospital,,NCT04356937,john h stone,john,male,0.99,218952,1244,NCT04356937,Efficacy of Tocilizumab on Patients With COVID-19,Recruiting,No Results Available,SARS-CoV 2,Drug: Tocilizumab|Drug: Placebos,"April 22, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04356937
Principal Investigator,"John William McEvoy, MBBCh MHS","National University of Ireland, Galway, Ireland",,NCT04330300,john william mcevoy,john,male,0.99,218952,1543,NCT04330300,Coronavirus (COVID-19) ACEi/ARB Investigation,Recruiting,No Results Available,Hypertension|COVID-19,Drug: Thiazide or Thiazide-like diuretics|Drug: Calcium Channel Blockers|Drug: ACE inhibitor|Drug: Angiotensin receptor blocker,"April 1, 2020","University Hospital Galway, Galway, Ireland",https://ClinicalTrials.gov/show/NCT04330300
Principal Investigator,"John Gunstad, PhD",Kent State University,,NCT04398277,john gunstad,john,male,0.99,218952,1688,NCT04398277,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Recruiting,No Results Available,Psychological Stress,Behavioral: Daily Coping Toolkit,"May 21, 2020","Akron Children's Hospital, Akron, Ohio, United States|Summa Health Systems, Akron, Ohio, United States|Kent State University, Kent, Ohio, United States",https://ClinicalTrials.gov/show/NCT04398277
Principal Investigator,"Doug Delahanty, PhD",Kent State University,,NCT04398277,doug delahanty,doug,male,0.99,4055,1688,NCT04398277,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Recruiting,No Results Available,Psychological Stress,Behavioral: Daily Coping Toolkit,"May 21, 2020","Akron Children's Hospital, Akron, Ohio, United States|Summa Health Systems, Akron, Ohio, United States|Kent State University, Kent, Ohio, United States",https://ClinicalTrials.gov/show/NCT04398277
Principal Investigator,"John M Søfteland, MD, PhD","Transplant Institute, Sahlgrenska University",,NCT04407221,john m søfteland,john,male,0.99,218952,1742,NCT04407221,COVID-19 Research in Organ Transplant Recipients,Not yet recruiting,No Results Available,Transplant Recipients,,"May 29, 2020","The Transplant Institute, Gothenburg, Vastra Gotaland, Sweden",https://ClinicalTrials.gov/show/NCT04407221
Study Chair,"Mihai Oltean, MD, PhD","Transplant Institute, Sahlgrenska University",,NCT04407221,mihai oltean,mihai,male,0.96,16701,1742,NCT04407221,COVID-19 Research in Organ Transplant Recipients,Not yet recruiting,No Results Available,Transplant Recipients,,"May 29, 2020","The Transplant Institute, Gothenburg, Vastra Gotaland, Sweden",https://ClinicalTrials.gov/show/NCT04407221
Study Director,"Vanda Friman, MD, PhD","Department of Infectious diseases, Gothenburg University",,NCT04407221,vanda friman,vanda,female,0.98,4582,1742,NCT04407221,COVID-19 Research in Organ Transplant Recipients,Not yet recruiting,No Results Available,Transplant Recipients,,"May 29, 2020","The Transplant Institute, Gothenburg, Vastra Gotaland, Sweden",https://ClinicalTrials.gov/show/NCT04407221
Study Director,"John Steiner, MD, MPH",KP Institute for Health Research,,NCT04351880,john steiner,john,male,0.99,218952,2328,NCT04351880,Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge,Recruiting,No Results Available,Heart Failure|Copd|Liver Failure|Covid19|Diabetes Mellitus|Cancer|End Stage Renal Disease,Other: Medically Tailored Meals,"April 17, 2020","St Joseph's Hospital, Denver, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States",https://ClinicalTrials.gov/show/NCT04351880
Principal Investigator,"Rebecca S Boxer, MD, MS",KP Institute for Health Research,,NCT04351880,rebecca s boxer,rebecca,female,0.98,36835,2328,NCT04351880,Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge,Recruiting,No Results Available,Heart Failure|Copd|Liver Failure|Covid19|Diabetes Mellitus|Cancer|End Stage Renal Disease,Other: Medically Tailored Meals,"April 17, 2020","St Joseph's Hospital, Denver, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States",https://ClinicalTrials.gov/show/NCT04351880
Principal Investigator,"Alex C Spyropoulos, MD",Northwell Health,,NCT04401293,alex c spyropoulos,alex,male,0.9,411319,165,NCT04401293,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,Recruiting,No Results Available,Sars-CoV2|COVID,Drug: Enoxaparin|Drug: Prophylactic/Intermediate Dose Enoxaparin,"May 26, 2020","Beth Israel Newark, Newark, New Jersey, United States|Southside Hospital, Bay Shore, New York, United States|Huntington Hospital, Huntington, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States|Staten Island University Hospital, Staten Island, New York, United States",https://ClinicalTrials.gov/show/NCT04401293
Study Chair,"Julia Barbado, MD, PhD","University Hospital Río Hortega, Valladolid, Spain",,NCT04361942,julia barbado,julia,female,0.97,106666,167,NCT04361942,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Recruiting,No Results Available,COVID-19 Pneumonia,Biological: Mesenchymal Stromal Cells|Other: Placebo,"April 24, 2020","Hospital Universitario Rio Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04361942
Study Director,"Rosa Conde, MD, PhD","University Hospital Río Hortega, Valladolid, Spain",,NCT04361942,rosa conde,rosa,female,0.98,77424,167,NCT04361942,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Recruiting,No Results Available,COVID-19 Pneumonia,Biological: Mesenchymal Stromal Cells|Other: Placebo,"April 24, 2020","Hospital Universitario Rio Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04361942
Principal Investigator,"Margarita González-Vallinas, PhD",University of Valladolid,,NCT04361942,margarita gonzález-vallinas,margarita,female,0.98,12994,167,NCT04361942,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Recruiting,No Results Available,COVID-19 Pneumonia,Biological: Mesenchymal Stromal Cells|Other: Placebo,"April 24, 2020","Hospital Universitario Rio Hortega, Valladolid, Spain",https://ClinicalTrials.gov/show/NCT04361942
Principal Investigator,"Julia Ferencz, MD",ClarData,,NCT04344171,julia ferencz,julia,female,0.97,106666,326,NCT04344171,CovidDB: The Covid-19 Inpatient Database,Recruiting,No Results Available,COVID-19,,"April 14, 2020","RoMed - Klinikum Bad Aibling, Bad Aibling, Germany|DONAUISAR Klinikum Deggendorf, Deggendorf, Germany|DONAUISAR Klinikum Dingolfing, Dingolfing, Germany|RoMed - Klinikum Prien am Chiemsee, Prien, Germany|RoMed - Klinikum Rosenheim, Rosenheim, Germany|Universitätsklinikum Ulm, Ulm, Germany|RoMed - Klinikum Wasserburg Am Inn, Wasserburg Am Inn, Germany|Klinikum Altmühlfranken, Weißenburg, Germany|Timiş County Emergency Clinical Hospital, Timisoara, Romania",https://ClinicalTrials.gov/show/NCT04344171
Principal Investigator,"Hans-Rudolf Tinneberg, Prof.",University of Giessen,,NCT04344171,hans-rudolf tinneberg,hans-rudolf,male,1.0,23,326,NCT04344171,CovidDB: The Covid-19 Inpatient Database,Recruiting,No Results Available,COVID-19,,"April 14, 2020","RoMed - Klinikum Bad Aibling, Bad Aibling, Germany|DONAUISAR Klinikum Deggendorf, Deggendorf, Germany|DONAUISAR Klinikum Dingolfing, Dingolfing, Germany|RoMed - Klinikum Prien am Chiemsee, Prien, Germany|RoMed - Klinikum Rosenheim, Rosenheim, Germany|Universitätsklinikum Ulm, Ulm, Germany|RoMed - Klinikum Wasserburg Am Inn, Wasserburg Am Inn, Germany|Klinikum Altmühlfranken, Weißenburg, Germany|Timiş County Emergency Clinical Hospital, Timisoara, Romania",https://ClinicalTrials.gov/show/NCT04344171
Study Chair,"Julia Upton, MD, MPH",The Hospital for Sick Children,,NCT04377568,julia upton,julia,female,0.97,106666,1029,NCT04377568,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,Not yet recruiting,No Results Available,Hospitalized Children|Covid-19 Infection,Biological: Convalescent plasma (CP),"May 6, 2020","Alberta Children's Hospital, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|Winnipeg Children's Hospital, Winnipeg, Manitoba, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada|McGill Univ Health Ctr - Montreal Children's Hospital, Montréal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04377568
Study Director,Kathy Brodeur-Robb,C17 Council (regulatory sponsor),,NCT04377568,kathy brodeur-robb,kathy,female,0.98,11449,1029,NCT04377568,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,Not yet recruiting,No Results Available,Hospitalized Children|Covid-19 Infection,Biological: Convalescent plasma (CP),"May 6, 2020","Alberta Children's Hospital, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|Winnipeg Children's Hospital, Winnipeg, Manitoba, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada|McGill Univ Health Ctr - Montreal Children's Hospital, Montréal, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan, Canada",https://ClinicalTrials.gov/show/NCT04377568
Study Chair,"Rosa Polo, MD,PhD",Plan Nacional sobre el Sida (PNS),,NCT04334928,rosa polo,rosa,female,0.98,77424,1729,NCT04334928,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Recruiting,No Results Available,Coronavirus Infection,Drug: Emtricitabine/tenofovir disoproxil|Drug: Hydroxychloroquine|Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo|Drug: Placebo: Hydroxychloroquine,"April 6, 2020","Hospital Universitario de Ferrol, Ferrol, A Coruña, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, A Coruña, Spain|Hospital General de Elche, Elche, Alicante, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Sant Joan de Deu de Esplugues, Esplugues De Llobregat, Barcelona, Spain|Parc Sanitari Sant Joan de Déu de Sant Boi, Sant Boi De Llobregat, Barcelona, Spain|Hospital Infanta Margarita, Cabra, Córdoba, Spain|Hospital Insular de Las Palmas, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Canarias, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital de Donostia, San Sebastián, Guipuzcoa, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital Fundación de Alcorcón, Alcorcón, Madrid, Spain|Hospital Colllado Villalba, Collado-Villalba, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Quirón Pozuelo, Pozuelo De Alarcón, Madrid, Spain|Hospital de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital Virgen del Castillo, Yecla, Murcia, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Arnau de Vilanova, Llíria, Valencia, Spain|Hospital de Araba, Alava, Vitoria, Spain|Hospital General Universitario de Albacete, Albacete, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Dexeus, Barcelona, Spain|Hospital Quirón Barcelona, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital Universitario Sagrat Cor, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Clínico San Cecilio, Granada, Spain|Hospital Universitario de León, León, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital La Princesa, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Reina Sofía, Murcia, Spain|Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Virgen de la Victoria, Málaga, Spain|Complejo Asistencial de Palencia, Palencia, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Virgen Macarena, Sevilla, Spain|Hospital Clinico Universitario, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital de Valladolid, Valladolid, Spain|Hospital Rio Hortega, Valladolid, Spain|Hospital Lozano Blesa, Zaragoza, Spain|Hospital Miguel Servet, Zaragoza, Spain|Hospital Nuestra Señora de Sonsoles, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04334928
Study Chair,"Miguel Hernán, MD,PhD",Harvard School of Public Health,,NCT04334928,miguel hernán,miguel,male,0.99,158479,1729,NCT04334928,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Recruiting,No Results Available,Coronavirus Infection,Drug: Emtricitabine/tenofovir disoproxil|Drug: Hydroxychloroquine|Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo|Drug: Placebo: Hydroxychloroquine,"April 6, 2020","Hospital Universitario de Ferrol, Ferrol, A Coruña, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, A Coruña, Spain|Hospital General de Elche, Elche, Alicante, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Sant Joan de Deu de Esplugues, Esplugues De Llobregat, Barcelona, Spain|Parc Sanitari Sant Joan de Déu de Sant Boi, Sant Boi De Llobregat, Barcelona, Spain|Hospital Infanta Margarita, Cabra, Córdoba, Spain|Hospital Insular de Las Palmas, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Canarias, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital de Donostia, San Sebastián, Guipuzcoa, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital Fundación de Alcorcón, Alcorcón, Madrid, Spain|Hospital Colllado Villalba, Collado-Villalba, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Quirón Pozuelo, Pozuelo De Alarcón, Madrid, Spain|Hospital de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital Virgen del Castillo, Yecla, Murcia, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Arnau de Vilanova, Llíria, Valencia, Spain|Hospital de Araba, Alava, Vitoria, Spain|Hospital General Universitario de Albacete, Albacete, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Dexeus, Barcelona, Spain|Hospital Quirón Barcelona, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital Universitario Sagrat Cor, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Clínico San Cecilio, Granada, Spain|Hospital Universitario de León, León, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital La Princesa, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Reina Sofía, Murcia, Spain|Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Virgen de la Victoria, Málaga, Spain|Complejo Asistencial de Palencia, Palencia, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Virgen Macarena, Sevilla, Spain|Hospital Clinico Universitario, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital de Valladolid, Valladolid, Spain|Hospital Rio Hortega, Valladolid, Spain|Hospital Lozano Blesa, Zaragoza, Spain|Hospital Miguel Servet, Zaragoza, Spain|Hospital Nuestra Señora de Sonsoles, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04334928
Principal Investigator,"Steven Deeks, MD","University of California, San Francisco",,NCT04362150,steven deeks,steven,male,0.99,61542,168,NCT04362150,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Recruiting,No Results Available,COVID,,"April 24, 2020","Zuckerberg San Francisco General Hospital (ZSFG), San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04362150
Principal Investigator,"Steven M Holland, M.D.",National Institute of Allergy and Infectious Diseases (NIAID),,NCT04383444,steven m holland,steven,male,0.99,61542,853,NCT04383444,Surveillance of Individuals Following SARS-CoV-2 Exposure,Recruiting,No Results Available,COVID-19,,"May 12, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04383444
Study Chair,"Steven K. Libutti, MD, FACS",Rutgers Cancer Institute of New Jersey,,NCT04336332,steven k. libutti,steven,male,0.99,61542,944,NCT04336332,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Combination Product: Hydroxychloroquine Sulfate + Azithromycin|Drug: Hydroxychloroquine Sulfate,"April 7, 2020","Saint Barnabas Medical Center, Livingston, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Robert Wood Johnson University Hopsital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04336332
Principal Investigator,"Sabiha Hussain, MD","Rutgers, The State University of New Jersey",,NCT04336332,sabiha hussain,sabiha,female,0.97,980,944,NCT04336332,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Combination Product: Hydroxychloroquine Sulfate + Azithromycin|Drug: Hydroxychloroquine Sulfate,"April 7, 2020","Saint Barnabas Medical Center, Livingston, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Robert Wood Johnson University Hopsital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey, United States|Overlook Hospital, Summit, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04336332
Principal Investigator,"Steven Chan, M.D.",Princess Margaret Cancer Centre,,NCT04331665,steven chan,steven,male,0.99,61542,1165,NCT04331665,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19|Pneumonia,Drug: Ruxolitinib,"April 2, 2020","Princess Margaret Cancer Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04331665
Principal Investigator,"Vikas Gupta, M.D.",Princess Margaret Cancer Centre,,NCT04331665,vikas gupta,vikas,male,0.99,2499,1165,NCT04331665,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19|Pneumonia,Drug: Ruxolitinib,"April 2, 2020","Princess Margaret Cancer Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04331665
Principal Investigator,"Steven Keller, MD, PhD","Brigham & Women's Hospital, Boston, MA",,NCT04389671,steven keller,steven,male,0.99,61542,1174,NCT04389671,The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19,Not yet recruiting,No Results Available,COVID-19|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),Drug: Lucinactant,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04389671
Principal Investigator,Steven Shaw,Chang Gung University,,NCT04377412,steven shaw,steven,male,0.99,61542,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Study Chair,"Anna Kajdy, MD, PhD",Centre of Postgraduate Medical Education,,NCT04377412,anna kajdy,anna,female,0.98,383713,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,Karine Stiberg Birkelund,The Arctic University of Norway,,NCT04377412,karine stiberg birkelund,karine,female,0.99,56339,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Maria del Mar Gil Mira, MD, PhD","Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna""",,NCT04377412,maria del mar gil mira,maria,female,0.98,334287,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Sonia Hassan, MD",Wayne State University,,NCT04377412,sonia hassan,sonia,female,0.98,114177,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Stefan Verlohren, MD, Professor","Charite University, Berlin, Germany",,NCT04377412,stefan verlohren,stefan,male,0.98,83987,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Sebastian Kwiatkowski, MD, PhD",Pomeranian Medical University Szczecin,,NCT04377412,sebastian kwiatkowski,sebastian,male,0.99,81792,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Federico Prefumo, MD, PhD",Università degli Studi di Brescia,,NCT04377412,federico prefumo,federico,male,0.99,43663,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Barbara Baranowska, PhD, RM",Centre of Postgraduate Medical Education,,NCT04377412,barbara baranowska,barbara,female,0.98,94709,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Jon Hayett, Professor","Royal Prince Alfred Hospital, Sydney",,NCT04377412,jon hayett,jon,male,0.98,29554,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Simone Schwank, PhD M.S. M.A. Msc. Clinical Ps",Karolinska Institutet,,NCT04377412,simone schwank,simone,male,0.75,86110,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Jan Modzelewski, MD",Centre of Postgraduate Medical Education,,NCT04377412,jan modzelewski,jan,male,0.95,142869,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Dorota Sys, PhD",Centre of Postgraduate Medical Education,,NCT04377412,dorota sys,dorota,female,0.98,34684,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Roksana Lewandowska, MD",Pomeranian Medical University Szczecin,,NCT04377412,roksana lewandowska,roksana,female,0.98,4500,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Dariusz Borowski, MD, PhD","Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz",,NCT04377412,dariusz borowski,dariusz,male,1.0,18670,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Artur Pokropek, PhD, Professor",Institute of Philosophy and Sociology of the Polish Academy of Sciences,,NCT04377412,artur pokropek,artur,male,1.0,43424,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Urszula Ajdacka, MD",Central Clinical Hospital of Ministry of Internal Affairs and Administration,,NCT04377412,urszula ajdacka,urszula,female,0.98,8001,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Stepan Feduniw, MD",Żelazna Medical Centre; Medical Faculty od Lazarski University,,NCT04377412,stepan feduniw,stepan,male,0.98,1517,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Ksenia Olisova, MD, MPH","Taiji Clinic, Taipei",,NCT04377412,ksenia olisova,ksenia,female,0.98,5202,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Jade Harris, MD",Wayne State University,,NCT04377412,jade harris,jade,female,0.91,13455,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Orion Gliozheni, MD","University of Medicine, Tirana",,NCT04377412,orion gliozheni,orion,male,0.91,915,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Pavel Calda, MD, MSc, Professor",Charles University,,NCT04377412,pavel calda,pavel,male,0.98,62180,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Laurent J Salomon, MD, PhD, Professor",Université de Paris,,NCT04377412,laurent j salomon,laurent,male,0.99,84979,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Liona C Poon, MBBS, MRCOG, Professor",Chinese University of Hong Kong,,NCT04377412,liona c poon,liona,female,0.96,956,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Tal Biron-Shental, MD",Meir Medical Center,,NCT04377412,tal biron-shental,tal,male,0.68,1045,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Maya Ben-Zion, MD",Meir Medical Center,,NCT04377412,maya ben-zion,maya,female,0.95,22722,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Gihad Chalouhi, MD, PhD",American University of Beirut Medical Center,,NCT04377412,gihad chalouhi,gihad,male,0.89,95,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Ganesh Acharya, MD, PhD, FRCOG, Professor",Karolinska Institutet,,NCT04377412,ganesh acharya,ganesh,male,0.98,1900,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Heidi Tiller, MD, PhD",The Arctic University of Norway,,NCT04377412,heidi tiller,heidi,female,0.97,15937,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,Solrun Rasmussen,The Arctic University of Norway,,NCT04377412,solrun rasmussen,solrun,female,1.0,10,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Ewa Andersson, RNM, PhD",Karolinska Institutet,,NCT04377412,ewa andersson,ewa,female,0.98,57904,1976,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety|Depression|Pregnancy Related,Other: Pandemic control measures,"May 6, 2020","Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei, Taiwan",https://ClinicalTrials.gov/show/NCT04377412
Principal Investigator,"Steven Lo, FRCS Plast",NHS Greater Glasgow and Clyde Clinical Research and Development Central Office,,NCT04359225,steven lo,steven,male,0.99,61542,2031,NCT04359225,A Comparison of 3D and 2D Telemedicine During Covid 19,Not yet recruiting,No Results Available,Telehealth,Other: 3D Telemedicine|Other: 2D Telemedicine,"April 24, 2020","Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04359225
Principal Investigator,"Sujeet Jha, MRCP (U.K)",Max Healthcare,,NCT04339608,sujeet jha,sujeet,male,0.99,151,169,NCT04339608,Max COVID19- Study,Recruiting,No Results Available,COVID-19,,"April 9, 2020","Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04339608
Principal Investigator,"Sujeet Jha, MRCP (U.K)",Max Healthcare Institute Ltd.,,NCT04368884,sujeet jha,sujeet,male,0.99,151,348,NCT04368884,Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients,Recruiting,No Results Available,Covid-19,,"April 30, 2020","Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04368884
Principal Investigator,"Paul E Wischmeyer, MD, EDIC, FASPEN, FCCM",Duke University,,NCT04350073,paul e wischmeyer,paul,male,0.99,148099,173,NCT04350073,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Recruiting,No Results Available,COVID-19,Device: Q-NRG Metobolic Cart Device|Device: MuscleSound Ultrasound|Device: Multifrequency Bioimpedance Spectroscopy,"April 16, 2020","Duke University Medial Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04350073
Principal Investigator,"Paul Mathew, MD",Tufts Medical Center,,NCT04425538,paul mathew,paul,male,0.99,148099,182,NCT04425538,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Recruiting,No Results Available,COVID-19,Drug: Infliximab,"June 11, 2020","Tufts Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04425538
Study Chair,"Paul Little, MD PhD",University of Southampton,,NCT04381962,paul little,paul,male,0.99,148099,286,NCT04381962,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Recruiting,No Results Available,COVID-19,Drug: Azithromycin Capsule,"May 11, 2020","Horton General Hospital, Banbury, Oxfordshire, United Kingdom|John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Birmingham City Hospital, Birmingham, United Kingdom|Sandwell General Hospital, West Bromwich, United Kingdom",https://ClinicalTrials.gov/show/NCT04381962
Principal Investigator,"Paul BILLOIR, pharmacist",Rouen University Hospital,,NCT04367662,paul billoir,paul,male,0.99,148099,690,NCT04367662,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Completed,No Results Available,COVID-19,Procedure: blood sampling,"April 29, 2020","Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04367662
Principal Investigator,Paul,Rambam MC,,NCT04323631,paul,paul,male,0.99,148099,757,NCT04323631,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Other: The control group will not receive hydroxychloroquine,"March 26, 2020",,https://ClinicalTrials.gov/show/NCT04323631
Principal Investigator,"Paul C Cremer, M. D.",The Cleveland Clinic,,NCT04399980,paul c cremer,paul,male,0.99,148099,1062,NCT04399980,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Recruiting,No Results Available,COVID 19|SARS-CoV 2|Pneumonia,Drug: Mavrilimumab|Drug: Placebos,"May 22, 2020","Cleveland Clinic Health System, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04399980
Principal Investigator,"Paul C Cremer, M. D.",The Cleveland Clinic,,NCT04365153,paul c cremer,paul,male,0.99,148099,1423,NCT04365153,Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19,Recruiting,No Results Available,COVID-19|SARS-CoV 2,Drug: Canakinumab Injection 600mg|Drug: Canakinumab Injection 300mg|Drug: Placebos,"April 28, 2020","Cleveland Clinic, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04365153
Principal Investigator,"Paul G. Thomas, PhD",St. Jude Children's Research Hospital,,NCT04362995,paul g. thomas,paul,male,0.99,148099,1515,NCT04362995,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Coronavirus|SARS-CoV-2,,"April 27, 2020","St. Jude Children's Research Hospital, Memphis, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04362995
Principal Investigator,"Nitin V Kolhe, MD",University Hospitals of Derby and Burton,,NCT04407156,nitin v kolhe,nitin,male,1.0,2710,174,NCT04407156,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,Not yet recruiting,No Results Available,COVID|AKI,Other: acute kidney injury,"May 29, 2020","Derby Hospital NHS Foundation Trust, Derby, Derbyshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04407156
Principal Investigator,"Nathalie Ganne-Carrié, MD-PhD","AP-HP, Jean Verdier Hospital",,NCT04375670,nathalie ganne-carrié,nathalie,female,0.98,94304,175,NCT04375670,COVID19-FOIE National Observatory,Recruiting,No Results Available,Liver Diseases|COVID19,,"May 5, 2020","Ganne, Bondy, France",https://ClinicalTrials.gov/show/NCT04375670
Principal Investigator,"Ivan FN Hung, MD FRCP",The University of Hong Kong,,NCT04350281,ivan fn hung,ivan,male,0.99,117756,176,NCT04350281,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Recruiting,No Results Available,COVID,Drug: Interferon Beta-1B|Drug: Hydroxychloroquine,"April 17, 2020","The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04350281
Principal Investigator,"Ivan Tancevski, Doz. Dr.","Medical University Innsbruck, Department Internal Medicine II",,NCT04416100,ivan tancevski,ivan,male,0.99,117756,1333,NCT04416100,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),Recruiting,No Results Available,Covid-19|Pulmonary Fibrosis,Diagnostic Test: Pulmonary function tests|Diagnostic Test: Imaging|Biological: Blood sampling,"June 4, 2020","Medical University of Innsbruck, Innsbruck, Austria",https://ClinicalTrials.gov/show/NCT04416100
Principal Investigator,"Ivan FN Hung, MD FRCP",The University of Hong Kong,,NCT04276688,ivan fn hung,ivan,male,0.99,117756,2320,NCT04276688,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Completed,No Results Available,Novel Coronavirus Infection,Drug: Lopinavir/ritonavir|Drug: Ribavirin|Drug: Interferon Beta-1B,"February 19, 2020","University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04276688
Principal Investigator,"Simon Bessis, MD","Infectious diseases department, Raymond Poincaré Hospital, APHP",,NCT04364698,simon bessis,simon,male,0.98,71276,177,NCT04364698,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Recruiting,No Results Available,COVID-19,,"April 28, 2020","Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches, France",https://ClinicalTrials.gov/show/NCT04364698
Study Director,"Aurelien Dinh, MD","Infectious diseases department, Raymond Poincaré Hospital, APHP",,NCT04364698,aurelien dinh,aurelien,male,0.99,12821,177,NCT04364698,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Recruiting,No Results Available,COVID-19,,"April 28, 2020","Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches, France",https://ClinicalTrials.gov/show/NCT04364698
Principal Investigator,"Marcus Schultz, MD, PhD","Department of Intensive Care, Academic Medical Center, University of Amsterdam",,NCT04346342,marcus schultz,marcus,male,0.99,28005,178,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Recruiting,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,"April 15, 2020","Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre hospitals, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|Reinier de Graaf Groep, Delft, Netherlands|Haga Hospital, Den Haag, Netherlands|Medical Center Haaglanden, Den Haag, Netherlands|Gelderse Vallei Hospital, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Medical Centre Leeuwarden, Leeuwarden, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
Study Chair,"Frederique Paulus, PhD","Department of Intensive Care, Academic Medical Center, University of Amsterdam",,NCT04346342,frederique paulus,frederique,female,0.9,4471,178,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Recruiting,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,"April 15, 2020","Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre hospitals, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|Reinier de Graaf Groep, Delft, Netherlands|Haga Hospital, Den Haag, Netherlands|Medical Center Haaglanden, Den Haag, Netherlands|Gelderse Vallei Hospital, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Medical Centre Leeuwarden, Leeuwarden, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
Study Chair,"Ary Serpa Neto, MD, PhD","Department of Intensive Care, Academic Medical Center, University of Amsterdam",,NCT04346342,ary serpa neto,ary,female,0.63,3631,178,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Recruiting,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,"April 15, 2020","Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre hospitals, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|Reinier de Graaf Groep, Delft, Netherlands|Haga Hospital, Den Haag, Netherlands|Medical Center Haaglanden, Den Haag, Netherlands|Gelderse Vallei Hospital, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Medical Centre Leeuwarden, Leeuwarden, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
Study Director,"Anna Geke Algera, MD","Department of Intensive Care, Academic Medical Center, University of Amsterdam",,NCT04346342,anna geke algera,anna,female,0.98,383713,178,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Recruiting,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,"April 15, 2020","Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre hospitals, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|Reinier de Graaf Groep, Delft, Netherlands|Haga Hospital, Den Haag, Netherlands|Medical Center Haaglanden, Den Haag, Netherlands|Gelderse Vallei Hospital, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Medical Centre Leeuwarden, Leeuwarden, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
Study Director,"Anissa Tsonas, MD","Department of Intensive Care, Academic Medical Center, University of Amsterdam",,NCT04346342,anissa tsonas,anissa,female,0.98,5859,178,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Recruiting,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,"April 15, 2020","Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre hospitals, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|Reinier de Graaf Groep, Delft, Netherlands|Haga Hospital, Den Haag, Netherlands|Medical Center Haaglanden, Den Haag, Netherlands|Gelderse Vallei Hospital, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Medical Centre Leeuwarden, Leeuwarden, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
Study Director,"Michela Botta, MD","Department of Intensive Care, Academic Medical Center, University of Amsterdam",,NCT04346342,michela botta,michela,female,0.99,24959,178,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Recruiting,No Results Available,COVID|Mechanical Ventilation|Acute Respiratory Failure,,"April 15, 2020","Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre hospitals, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|Reinier de Graaf Groep, Delft, Netherlands|Haga Hospital, Den Haag, Netherlands|Medical Center Haaglanden, Den Haag, Netherlands|Gelderse Vallei Hospital, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Medical Centre Leeuwarden, Leeuwarden, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medical Centre, Sittard, Netherlands|UMC Utrecht, Utrecht, Netherlands",https://ClinicalTrials.gov/show/NCT04346342
Principal Investigator,"Marcus Lance, MD, PhD",HMC,,NCT04445935,marcus lance,marcus,male,0.99,28005,590,NCT04445935,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,Recruiting,No Results Available,Anticoagulation in COVID-19 ARDS,Drug: Bivalirudin Injection|Drug: Standard treatment,"June 24, 2020","Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04445935
Principal Investigator,"Marcus Lance, MD, PhD","Hamad Medical Corporation, Weill-Cornell-Medicine Qatar, Qatar University",,NCT04399317,marcus lance,marcus,male,0.99,28005,593,NCT04399317,Flow Controlled Ventilation in ARDS Associated With COVID-19,Recruiting,No Results Available,ARDS Associated With COVID-19,Device: Flow controlled ventilation (Evone-ventilator),"May 22, 2020","Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04399317
Principal Investigator,"Anna Puigdellívol-Sánchez, Ph D",Consorci Sanitari de Terrassa,,NCT04367883,anna puigdellívol-sánchez,anna,female,0.98,383713,1505,NCT04367883,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",Recruiting,No Results Available,COVID19|Influenza Vaccination|ACE Inhibitors|ARB,Drug: ACE inhibitor|Drug: ARB,"April 29, 2020","Hospital de Terrassa, Terrassa, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04367883
Study Director,"houssam ho masoud, MD",COVID sceintific comittee ministry of health and population,,NCT04425707,houssam ho masoud,houssam,male,0.98,3352,179,NCT04425707,Ivermectin In Treatment of COVID 19 Patients,Recruiting,No Results Available,Covid19,Drug: Ivermectin,"June 11, 2020","isolation and referal hospitals for COVID 19 patients, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04425707
Principal Investigator,"Harry P Selker, MD",Tufts Medical Center,,NCT04399356,harry p selker,harry,male,0.98,24264,185,NCT04399356,Niclosamide for Mild to Moderate COVID-19,Not yet recruiting,No Results Available,COVID (SARS-CoV-2),Drug: Niclosamide|Drug: Placebo|Other: Telehealth monitoring,"May 22, 2020",,https://ClinicalTrials.gov/show/NCT04399356
Study Chair,"Jeffery S Kuo, MD",Ochsner Health System,,NCT04343183,jeffery s kuo,jeffery,male,0.99,2273,187,NCT04343183,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Not yet recruiting,No Results Available,COVID-19,Device: Hyperbaric Oxygen Therapy,"April 13, 2020","Ochsner Medical Center, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04343183
Study Chair,"DOMENICO GIRELLI, MD-PhD",Universita di Verona,,NCT04412382,domenico girelli,domenico,male,0.99,40956,189,NCT04412382,Covid-19: Possible Role of Neutrophil Extracellular Traps,Not yet recruiting,No Results Available,Covid-19,Diagnostic Test: NETosis markers,"June 2, 2020",,https://ClinicalTrials.gov/show/NCT04412382
Principal Investigator,"Asser Ghoneim, phD","Professor in Pharmacology, Faculty of pharmacy, Damanhour University",,NCT04374513,asser ghoneim,asser,male,0.98,191,190,NCT04374513,Community Pharmacists Behaviour During Covid-19,Recruiting,No Results Available,Covid19,,"May 5, 2020","Damanhour university, Beheira, Damanhour, Egypt|Damanhour universty, Alexandria, Egypt",https://ClinicalTrials.gov/show/NCT04374513
Principal Investigator,"Ercument Ovalı, MD",Acıbadem Labcell Cellular Therapy Laboratories,,NCT04432987,ercument ovalı,ercument,male,0.98,334,191,NCT04432987,Dornase Alpha for the Treatment of COVID-19,Recruiting,No Results Available,COVID-19,Drug: Pulmozyme,"June 16, 2020","Acıbadem Altunizade Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04432987
Study Director,"Yadollah Shakiba, MD, PhD","Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran",,NCT04333550,yadollah shakiba,yadollah,male,1.0,18,192,NCT04333550,Application of Desferal to Treat COVID-19,Recruiting,No Results Available,COVID-19,Drug: Deferoxamine,"April 3, 2020","Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04333550
Principal Investigator,"Amir Kiani, PhD","Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran",,NCT04333550,amir kiani,amir,male,0.98,31516,192,NCT04333550,Application of Desferal to Treat COVID-19,Recruiting,No Results Available,COVID-19,Drug: Deferoxamine,"April 3, 2020","Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04333550
Principal Investigator,"Amir Hadanny, MD",Shamir Medical Center,,NCT04358926,amir hadanny,amir,male,0.98,31516,1132,NCT04358926,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Recruiting,No Results Available,COVID-19|Desaturation of Blood,Device: Hyperbaric oxygen therapy|Device: Normobaric oxygen therapy,"April 24, 2020","Amir Hadanny, Zerifin, Israel",https://ClinicalTrials.gov/show/NCT04358926
Principal Investigator,"Guillaume Lemaire, MD",Cliniques universitaires Saint-Luc,,NCT04375774,guillaume lemaire,guillaume,male,0.99,58261,193,NCT04375774,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Recruiting,No Results Available,COVID,Device: FFP2|Device: Facial mask|Device: MFS,"May 5, 2020","Cliniques Universitaires Saint-Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04375774
Principal Investigator,"Guillaume MARTIN-BLONDEL, MD PhD","University Hospital, Toulouse",,NCT04385108,guillaume martin-blondel,guillaume,male,0.99,58261,384,NCT04385108,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Not yet recruiting,No Results Available,COVID-19,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,"May 12, 2020","Purpan University Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04385108
Study Director,"Guillaume BONNET, MD",Hopital Européen Georges Pompidou,,NCT04344327,guillaume bonnet,guillaume,male,0.99,58261,1280,NCT04344327,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Completed,No Results Available,"Infection Viral|Infection, Hospital|COVID",,"April 14, 2020","CHU d'Amiens, Amiens, France|CHU Annecy, Annecy, France|CHU de Bordeaux, Bordeaux, France|CHU de Caen, Caen, France|Cotentin hospital, Cherbourg, France|CHU Dijon, Dijon, France|Elbeuf Louviers Val de Reuil, Elbeuf, France|CHU de Fréjus / Saint-Raphael, Fréjus, France|Lille Catholic Institute Hospital Group, Lille, Lille, France|CHU de Lyon, Lyon, France|APHM, Marseille, France|Jacques Cartier Private Hospital, Massy, Massy, France|CHR d'Orléans, Orléans, France|Bichat (APHP), Paris, France|Georges Pompidou European Hospital (AP-HP), Paris, France|Institut Mutualiste Montsouris, Paris, Paris, France|CHU de Reims, Reims, France|CHU de Rouen, Rouen, France|CHU Saint Etienne, Saint-Étienne, France|CHU de Strasbourg, Strasbourg, France|CHU de Toulouse, Toulouse, France|Saint Gatien hospital, Tours, France|CHU de Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04344327
Principal Investigator,"Orianne WEIZMAN, MD",CHU de Nancy,,NCT04344327,orianne weizman,orianne,female,0.96,579,1280,NCT04344327,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Completed,No Results Available,"Infection Viral|Infection, Hospital|COVID",,"April 14, 2020","CHU d'Amiens, Amiens, France|CHU Annecy, Annecy, France|CHU de Bordeaux, Bordeaux, France|CHU de Caen, Caen, France|Cotentin hospital, Cherbourg, France|CHU Dijon, Dijon, France|Elbeuf Louviers Val de Reuil, Elbeuf, France|CHU de Fréjus / Saint-Raphael, Fréjus, France|Lille Catholic Institute Hospital Group, Lille, Lille, France|CHU de Lyon, Lyon, France|APHM, Marseille, France|Jacques Cartier Private Hospital, Massy, Massy, France|CHR d'Orléans, Orléans, France|Bichat (APHP), Paris, France|Georges Pompidou European Hospital (AP-HP), Paris, France|Institut Mutualiste Montsouris, Paris, Paris, France|CHU de Reims, Reims, France|CHU de Rouen, Rouen, France|CHU Saint Etienne, Saint-Étienne, France|CHU de Strasbourg, Strasbourg, France|CHU de Toulouse, Toulouse, France|Saint Gatien hospital, Tours, France|CHU de Nancy, Vandœuvre-lès-Nancy, France",https://ClinicalTrials.gov/show/NCT04344327
Principal Investigator,"Guillaume DEBELLEMANIERE, MD",Fondation Adolphe de Rothschild,,NCT04345159,guillaume debellemaniere,guillaume,male,0.99,58261,1810,NCT04345159,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,"Active, not recruiting",No Results Available,SARS-CoV-2|Systemic Lupus Erythematosus|Rheumatoid Arthritis|Sjogren's Syndrome|Psoriatic Arthritis,Other: Questionnaire by phone call,"April 14, 2020","Fondation Adolphe de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04345159
Study Director,"Guillaume CAYLA, MD",Hôpital Universitaire Carémeau,,NCT04357314,guillaume cayla,guillaume,male,0.99,58261,2069,NCT04357314,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Not yet recruiting,No Results Available,Myocardial Infarction,,"April 22, 2020",,https://ClinicalTrials.gov/show/NCT04357314
Principal Investigator,"Guillaume BONNET, MD",Inserm 970,,NCT04357314,guillaume bonnet,guillaume,male,0.99,58261,2069,NCT04357314,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Not yet recruiting,No Results Available,Myocardial Infarction,,"April 22, 2020",,https://ClinicalTrials.gov/show/NCT04357314
Study Director,Novartis pharmaceuticals,Novartis Pharmaceuticals,,NCT04382053,novartis pharmaceuticals,novartis,male,1.0,4,195,NCT04382053,Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Recruiting,No Results Available,"COVID 19 Pneumonia, Impaired Respiratory Function",Drug: DFV890|Drug: Standard of Care (SoC),"May 11, 2020","Novartis Investigative Site, Copenhagen, Denmark|Novartis Investigative Site, Hvidovre, Denmark|Novartis Investigative Site, Heidelberg, Baden-Württemberg, Germany|Novartis Investigative Site, Regensburg, Bavaria, Germany|Novartis Investigative Site, Bonn, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Wuerzburg, Germany|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Budapest, Hungary",https://ClinicalTrials.gov/show/NCT04382053
Study Director,Novartis Pharmaceuticals,Novartis Pharmaceuticals,,NCT04362137,novartis pharmaceuticals,novartis,male,1.0,4,831,NCT04362137,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",Recruiting,No Results Available,Cytokine Storm (Covid-19),Drug: Ruxolitinib|Drug: Placebo,"April 24, 2020","Novartis Investigative Site, Aurora, Colorado, United States|Novartis Investigative Site, Stamford, Connecticut, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Ann Arbor, Michigan, United States|Novartis Investigative Site, Newark, New Jersey, United States|Novartis Investigative Site, New York, New York, United States|Novartis Investigative Site, Seattle, Washington, United States|Novartis Investigative Site, Madison, Wisconsin, United States|Novartis Investigative Site, Aachen, Germany|Novartis Investigative Site, Lubeck, Germany|Novartis Investigative Site, Muenchen, Germany|Novartis Investigative Site, Nuernberg, Germany|Novartis Investigative Site, Bologna, BO, Italy|Novartis Investigative Site, Firenze, FI, Italy|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Rozzano, MI, Italy|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Blackpool, United Kingdom|Novartis Investigative Site, Harrow, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04362137
Study Director,Novartis Pharmaceuticals,Novartis Pharmaceuticals,,NCT04337359,novartis pharmaceuticals,novartis,male,1.0,4,875,NCT04337359,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Available,No Results Available,Severe/Very Severe COVID-19 Illness,Drug: Ruxolitinib,"April 7, 2020",,https://ClinicalTrials.gov/show/NCT04337359
Study Director,Novartis Pharmaceuticals,Novartis Pharmaceuticals,,NCT04382651,novartis pharmaceuticals,novartis,male,1.0,4,893,NCT04382651,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,Recruiting,No Results Available,"COVID-19 Pneumonia, Impaired Respiratory Function",Drug: MAS825|Drug: Matching placebo,"May 11, 2020","Novartis Investigative Site, Chula Vista, California, United States|Novartis Investigative Site, La Mesa, California, United States|Novartis Investigative Site, Mission Hills, California, United States|Novartis Investigative Site, Santa Monica, California, United States|Novartis Investigative Site, Torrance, California, United States|Novartis Investigative Site, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04382651
Principal Investigator,"Eric J Lenze, MD",Washington University School of Medicine,,NCT04342663,eric j lenze,eric,male,0.99,135071,196,NCT04342663,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Recruiting,No Results Available,COVID 19|Coronavirus,Drug: Fluvoxamine|Drug: Placebo,"April 13, 2020","BJC, Belleville, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04342663
Principal Investigator,"Eric CUA, MD",Centre Hospitalier Universitaire de Nice,,NCT04393038,eric cua,eric,male,0.99,135071,272,NCT04393038,ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,Recruiting,No Results Available,COVID-19,Drug: ABX464|Drug: Placebo,"May 19, 2020","Centre Hospitalier Universitaire de Nice, Nice, France",https://ClinicalTrials.gov/show/NCT04393038
Principal Investigator,Eric Adehossi,Hôpital Général de Référence de Niamey,,NCT04409483,eric adehossi,eric,male,0.99,135071,628,NCT04409483,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Not yet recruiting,No Results Available,Covid-19,Drug: Lopinavir-Ritonavir Drug Combination|Combination Product: Standard Care,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409483
Study Director,Rebecca F Grais,Epicentre,,NCT04409483,rebecca f grais,rebecca,female,0.98,36835,628,NCT04409483,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Not yet recruiting,No Results Available,Covid-19,Drug: Lopinavir-Ritonavir Drug Combination|Combination Product: Standard Care,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409483
Study Director,"Eric L Sievers, MD",Chief Medical Officer,,NCT04334980,eric l sievers,eric,male,0.99,135071,778,NCT04334980,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",Not yet recruiting,No Results Available,COVID-19,Biological: bacTRL-Spike|Other: Placebo,"April 6, 2020","Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia., Vancouver, British Columbia, Canada|Canadian Center for Vaccinology Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada",https://ClinicalTrials.gov/show/NCT04334980
Principal Investigator,"Joanne Langley, MD, FRCPSC",Principal Investigator,,NCT04334980,joanne langley,joanne,female,0.98,12034,778,NCT04334980,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",Not yet recruiting,No Results Available,COVID-19,Biological: bacTRL-Spike|Other: Placebo,"April 6, 2020","Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia., Vancouver, British Columbia, Canada|Canadian Center for Vaccinology Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada",https://ClinicalTrials.gov/show/NCT04334980
Study Chair,"Manish Sadarangani, MRCPCH, DPHIL",Principal Investigator,,NCT04334980,manish sadarangani,manish,male,0.99,3879,778,NCT04334980,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",Not yet recruiting,No Results Available,COVID-19,Biological: bacTRL-Spike|Other: Placebo,"April 6, 2020","Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia., Vancouver, British Columbia, Canada|Canadian Center for Vaccinology Dalhousie University, IWK Health Centre, Halifax, Nova Scotia, Canada",https://ClinicalTrials.gov/show/NCT04334980
Principal Investigator,"Eric Raymond, MD",Groupe Hospitalier Paris Saint Joseph,,NCT04437719,eric raymond,eric,male,0.99,135071,1267,NCT04437719,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Not yet recruiting,No Results Available,Oncology|COVID-19,Other: Obvio-19 app,"June 18, 2020","Groupe Hospitalier Paris Saint-Joseph, Paris, France",https://ClinicalTrials.gov/show/NCT04437719
Principal Investigator,"Eric Hachulla, MD,PhD","University Hospital, Lille",,NCT04353609,eric hachulla,eric,male,0.99,135071,1497,NCT04353609,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",Recruiting,No Results Available,Sars-CoV2|Chronic Inflammatory Rheumatism|Autoimmune Diseases,,"April 20, 2020","Hôpital Huriez, Lille, France",https://ClinicalTrials.gov/show/NCT04353609
Principal Investigator,"Eric LACHASSINNE, MD",Assistance Publique - Hôpitaux de Paris,,NCT04413968,eric lachassinne,eric,male,0.99,135071,1605,NCT04413968,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Not yet recruiting,No Results Available,Coronavirus|Coronavirus Infection|Covid19|Sars-CoV2,Diagnostic Test: Rapid detection test|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Stool collection,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04413968
Principal Investigator,"Eric Delaporte, MD, PhD","IRD, Inserm, University of Montpellier",,NCT04371835,eric delaporte,eric,male,0.99,135071,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Principal Investigator,"Alexandra Calmy, MD, PhD","University Hospital, Geneva",,NCT04371835,alexandra calmy,alexandra,female,0.98,122985,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Study Chair,"Mark Polizzotto, MD, PhD",Kirby Institute,,NCT04371835,mark polizzotto,mark,male,0.99,119313,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Principal Investigator,"Francois WD Venter, MD",Wits Reproductive Health and HIV Institute,,NCT04371835,francois wd venter,francois,male,0.98,26836,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Principal Investigator,"Saye Khoo, MD, PhD",University of Liverpool,,NCT04371835,saye khoo,saye,female,0.7,194,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Principal Investigator,"Emmanuelle Papot, MD",Kirby Institute,,NCT04371835,emmanuelle papot,emmanuelle,female,0.97,14356,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Principal Investigator,"Joana Woods, MD",Wits Reproductive Health and HIV Institute,,NCT04371835,joana woods,joana,female,0.97,29349,1827,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Not yet recruiting,No Results Available,HIV-infection/Aids|Coronavirus Infection,,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371835
Principal Investigator,"Manaf Al Qahtani, Dr.",Royal College of Surgeons in Ireland - Bahrain,,NCT04356534,manaf al qahtani,manaf,male,0.95,304,198,NCT04356534,Convalescent Plasma Trial in COVID -19 Patients,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Other: plasma therapy using convalescent plasma with antibody against SARS-CoV-2|Other: Routine care for COVID-19 patients,"April 22, 2020","Royal College of Surgeons in Ireland - Bahrain, Manama, Bahrain",https://ClinicalTrials.gov/show/NCT04356534
Principal Investigator,"Manaf Al Qahtani, Dr.",Royal College of Surgeons in Ireland - Bahrain,,NCT04387760,manaf al qahtani,manaf,male,0.95,304,237,NCT04387760,Favipiravir vs Hydroxychloroquine in COVID -19,Not yet recruiting,No Results Available,SARS-CoV 2|COVID-19,Drug: Hydroxychloroquine|Drug: Favipiravir|Other: Routine care for COVID-19 patients,"May 14, 2020","Royal College of Surgeons in Ireland - Bahrain, Manama, Bahrain",https://ClinicalTrials.gov/show/NCT04387760
Principal Investigator,"Giuliano Rizzardini, Md",ASST Fatebenefratelli Sacco,,NCT04336904,giuliano rizzardini,giuliano,male,0.99,8715,199,NCT04336904,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir|Other: Placebo,"April 7, 2020","Asst Fatebenefratelli Sacco, Milano, Italy",https://ClinicalTrials.gov/show/NCT04336904
Principal Investigator,"Karine LACOMBE, PU-PH",Assistance Publique - Hôpitaux de Paris,,NCT04345991,karine lacombe,karine,female,0.99,56339,200,NCT04345991,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",Recruiting,No Results Available,Covid19,Drug: Transfusion of COVID-19 convalescent plasma,"April 15, 2020","SMIT, Saint Antoine hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04345991
Principal Investigator,"Karine Faure, MD,PhD","University Hospital, Lille",,NCT04372082,karine faure,karine,female,0.99,56339,1251,NCT04372082,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Not yet recruiting,No Results Available,Sars-CoV2,Other: Standard of care (SOC)|Drug: Hydroxychloroquine|Drug: Association of diltiazem and niclosamide,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04372082
Principal Investigator,Jose Antonio Pérez Molina,Hospital Universitario Ramón y Cajal,,NCT04445272,jose antonio pérez molina,jose,male,0.98,451671,201,NCT04445272,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Recruiting,No Results Available,COVID-19,Drug: Tocilizumab,"June 24, 2020","Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Universitario Central Asturias, Oviedo, Asturias, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Sant Joan de Déu de Manresa, Manresa, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Hospital Universitario Marqués Valdecilla, Santander, Cantabria, Spain|Hospital Público General del Tomelloso, Tomelloso, Ciudad Real, Spain|Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Toledo, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, Spain|Hospital Infanta Cristina, Badajoz, Spain|Hospital Clínic i Provincial Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital General Universitario de Ciudad Real, Ciudad Real, Spain|Hospital San Pedro Alcántara, Cáceres, Spain|Hospital Universitario Dr. Josep Trueta, Gerona, Spain|Hospital Universitario Clínico San Cecilio, Granada, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Complexo Hospitalario Universitario de Ourense, Orense, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitario Virgen de la Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Poliectenic La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04445272
Principal Investigator,"Jose Ramón Arribas, MD",H. Univ. La Paz,,NCT04355871,jose ramón arribas,jose,male,0.98,451671,264,NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Completed,No Results Available,Covid19,,"April 21, 2020","Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04355871
Principal Investigator,"Juan Berenguer, MD",H. Univ. Gregorio Marañón,,NCT04355871,juan berenguer,juan,male,0.98,274814,264,NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Completed,No Results Available,Covid19,,"April 21, 2020","Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04355871
Principal Investigator,"Pablo Ryan, MD",H. Univ. Infanta Leonor,,NCT04355871,pablo ryan,pablo,male,0.99,76709,264,NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Completed,No Results Available,Covid19,,"April 21, 2020","Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04355871
Principal Investigator,"Jordi Carratala, MD",H. Univ. de Bellvitge,,NCT04355871,jordi carratala,jordi,male,0.99,31600,264,NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Completed,No Results Available,Covid19,,"April 21, 2020","Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04355871
Principal Investigator,"Jerónimo Pachón, MD",H. Univ. VIrgen del Rocio,,NCT04355871,jerónimo pachón,jerónimo,male,0.99,75,264,NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Completed,No Results Available,Covid19,,"April 21, 2020","Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila, Spain",https://ClinicalTrials.gov/show/NCT04355871
Principal Investigator,"Jose Muñoz Gutiérrez, MD, PhD",Barcelona Institute for Global Health,,NCT04331834,jose muñoz gutiérrez,jose,male,0.98,451671,760,NCT04331834,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebos,"April 2, 2020","ISGlobal, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04331834
Principal Investigator,"Jose L Diaz-Miron, MD",University of Colorado/Children's Hospital Colorado,,NCT04340479,jose l diaz-miron,jose,male,0.98,451671,917,NCT04340479,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Not yet recruiting,No Results Available,COVID|Trauma|Ultrasound,Diagnostic Test: Ultrasound lung imaging as part of FAST+ evaluation,"April 9, 2020","Children's Hospital Colorado, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04340479
Principal Investigator,"Jose L Casado, MD, PhD",Ramon y Cajal Physician,,NCT04402827,jose l casado,jose,male,0.98,451671,2176,NCT04402827,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,Recruiting,No Results Available,"Health Care Worker Patient Transmission|Receptor Site Alteration|Susceptibility, Disease|Immune Response",Diagnostic Test: Susceptibility to infection,"May 27, 2020","Hospital Ramon y Cajal, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04402827
Principal Investigator,"Hernando Gaitán, MD",Universidad Nacional de Colombia,,NCT04359095,hernando gaitán,hernando,male,0.98,555,202,NCT04359095,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir Pill|Drug: Azithromycin|Other: Standard treatment,"April 24, 2020","Hospital Universitario de Neiva, Neiva, Huila, Colombia|Clínica Reina Sofía, Bogotá, Colombia|Fundacion Cardio Infantil, Bogotá, Colombia|Hospital Universitario San Ignacio, Bogotá, Colombia|Clinica Universitaria Colombia, Bogotá, Colombia|Hospital Universitario Nacional de Colombia, Bogotá, Colombia",https://ClinicalTrials.gov/show/NCT04359095
Principal Investigator,Mary Beth Graham,Medical College of Wisconsin,,NCT04354831,mary beth graham,mary,female,0.99,142684,203,NCT04354831,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,Recruiting,No Results Available,COVID-19,Biological: anti-SARS-CoV-2 convalescent plasma,"April 21, 2020","Froedtert Hospital, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04354831
Principal Investigator,"Mary Cushman, MD","University of Vermont Medical Center, Vermont",,NCT04362085,mary cushman,mary,female,0.99,142684,393,NCT04362085,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Recruiting,No Results Available,COVID-19,Drug: Therapeutic Anticoagulation,"April 24, 2020","St. Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04362085
Principal Investigator,"Michelle Sholzberg, MD, FRCPC","St. Michael's Hospital, Toronto",,NCT04362085,michelle sholzberg,michelle,female,0.98,66334,393,NCT04362085,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Recruiting,No Results Available,COVID-19,Drug: Therapeutic Anticoagulation,"April 24, 2020","St. Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04362085
Principal Investigator,"Peter Jüni, MD, FESC","St. Michael's Hospital, Toronto",,NCT04362085,peter jüni,peter,male,0.99,165452,393,NCT04362085,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Recruiting,No Results Available,COVID-19,Drug: Therapeutic Anticoagulation,"April 24, 2020","St. Michael's Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04362085
Principal Investigator,Mary DAVAL,Hopital Fondation A de Rothschild,,NCT04361474,mary daval,mary,female,0.99,142684,1709,NCT04361474,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Recruiting,No Results Available,Budesonide|Olfaction Disorders|SARS-CoV-2|Anosmia,Drug: Budesonide Nasal|Other: Physiological serum,"April 24, 2020","Amélie YAvchitz, Paris, France",https://ClinicalTrials.gov/show/NCT04361474
Principal Investigator,"Vivek Reddy, MD",Icahn School of Medicine at Mount Sinai,,NCT04358029,vivek reddy,vivek,male,0.99,3051,204,NCT04358029,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Recruiting,No Results Available,COVID 19 Cardiac|COVID 16 Arrhythmia|COVID 19 Death,,"April 22, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04358029
Principal Investigator,"Martin Goldman, MD",Icahn School of Medicine at Mount Sinai,,NCT04358029,martin goldman,martin,male,0.98,180687,204,NCT04358029,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Recruiting,No Results Available,COVID 19 Cardiac|COVID 16 Arrhythmia|COVID 19 Death,,"April 22, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04358029
Principal Investigator,"Vivek Y Reddy, MD",Icahn School of Medicine at Mount Sinai,,NCT04350476,vivek y reddy,vivek,male,0.99,3051,895,NCT04350476,COVID-19 Remote Monitoring,Not yet recruiting,No Results Available,COVID-19|Cardiac Arrhythmias,Diagnostic Test: VitalConnect Vital Sign Patch,"April 17, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04350476
Principal Investigator,"Martin Goldman, MD",Icahn School of Medicine at Mount Sinai,,NCT04350476,martin goldman,martin,male,0.98,180687,895,NCT04350476,COVID-19 Remote Monitoring,Not yet recruiting,No Results Available,COVID-19|Cardiac Arrhythmias,Diagnostic Test: VitalConnect Vital Sign Patch,"April 17, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04350476
Principal Investigator,"Jean Michel DEVYS, MD",Fondation Adolphe de Rothschild,,NCT04385810,jean michel devys,jean,male,0.95,196185,304,NCT04385810,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,Recruiting,No Results Available,Covid19|Sars-CoV2,Procedure: Ophthalmologic exam,"May 13, 2020","Fondation Adolphe de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04385810
Principal Investigator,"Jean François TIMSIT, Pr",Assistance Publique - Hôpitaux de Paris,,NCT04344730,jean françois timsit,jean,male,0.95,196185,858,NCT04344730,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Recruiting,No Results Available,Acute Hypoxemic Respiratory Failure|COVID-19,Drug: Dexamethasone injection|Drug: placebo|Procedure: conventional oxygen|Procedure: CPAP|Procedure: HFNO|Procedure: mechanical ventilation,"April 14, 2020","Hopital Bichat - Aphp, Paris, France",https://ClinicalTrials.gov/show/NCT04344730
Principal Investigator,"Jean Ma Treluyer, MD PhD",Assitance publique - Hôpitaux de Paris.,,NCT04344379,jean ma treluyer,jean,male,0.95,196185,1422,NCT04344379,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,Suspended,No Results Available,SARS-CoV-2 Infection,Drug: hydroxychloroquine|Drug: azithromycin|Drug: hydroxychloroquine placebo,"April 14, 2020","Hopial Avicenne, Bobigny, France|Hôpital GHU Paris Saclay, Le Kremlin-Bicêtre, France|Hôpital Saint Antoine, Paris, France|Hôpital Broca, Paris, France|Hôpital La Pitié-Salpétrière, Paris, France|Hôpital Cochin, Paris, France|Hôpital européen Georges Pompidou, Paris, France|Hôpital Necker, Paris, France",https://ClinicalTrials.gov/show/NCT04344379
Principal Investigator,"Jean Liu, PhD",Yale-NUS College,,NCT04367363,jean liu,jean,male,0.95,196185,1778,NCT04367363,Social Media and COVID-19,Recruiting,No Results Available,Coronavirus|Depression|Anxiety|Stress,Behavioral: Social media & news consumption,"April 29, 2020","Yale-NUS College, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04367363
Principal Investigator,"Jean Marie JOUANNIC, PU-PH",Assistance Publique - Hôpitaux de Paris,,NCT04366817,jean marie jouannic,jean,male,0.95,196185,1856,NCT04366817,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Not yet recruiting,No Results Available,Post Partum Depression,Behavioral: psychological assessment,"April 29, 2020","Service médecine foetale-Hôpital Trousseau, Paris, France",https://ClinicalTrials.gov/show/NCT04366817
Principal Investigator,"Jean Liu, PhD",Yale-NUS College,,NCT04305574,jean liu,jean,male,0.95,196185,2247,NCT04305574,Social Media Use During COVID-19,Recruiting,No Results Available,Coronavirus|Depression|Anxiety|Stress,Behavioral: Use of social media during COVID-19,"March 12, 2020","Yale-NUS College, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04305574
Principal Investigator,"Julie Sanders, PhD",St. Bartholomew's Hospital,,NCT04366167,julie sanders,julie,female,0.98,116926,231,NCT04366167,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Recruiting,No Results Available,Cardiac Surgery|COVID,Other: Cardiac surgery,"April 28, 2020","St Bartholomew's Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04366167
Principal Investigator,"Julie CHASTANG, Dr",Department of General Medicine,,NCT04371406,julie chastang,julie,female,0.98,116926,251,NCT04371406,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Not yet recruiting,No Results Available,Covid-19,Drug: Hydroxychloroquine and Azithromycin|Dietary Supplement: Azinc,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371406
Principal Investigator,Julie HELMS,CHU de Strasbourg,,NCT04385121,julie helms,julie,female,0.98,116926,1465,NCT04385121,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,Not yet recruiting,No Results Available,"Covid-19|Stress Disorders, Post-Traumatic|Anxiety|Depression",Other: Questionnary,"May 12, 2020","Les Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04385121
Principal Investigator,"Patrick R. Lawler, MD, MPH",Peter Munk Cardiac Centre/University Health Network,,NCT04372589,patrick r. lawler,patrick,male,0.99,153288,1142,NCT04372589,Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Recruiting,No Results Available,COVID-19|Pneumonia,Drug: Heparin,"May 4, 2020","University of Chicago, Chicago, Illinois, United States|Ochsner Clinic, Jefferson, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States|Deborah Heart and Lung Center, Browns Mills, New Jersey, United States|Albany Medical College, Albany, New York, United States|Mount Sinai Health System, New York, New York, United States|Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of São Paulo, São Paulo, Brazil|Victoria General Hospital, Victoria, British Columbia, Canada|Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|CHU de Quebec-University Laval, Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Unidad de Investigación en Epidemiología Clínica, Instituto Mexicano del Seguro Social, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04372589
Principal Investigator,"Ewan C. Goligher, MD, PhD","University Health Network, Toronto",,NCT04372589,ewan c. goligher,ewan,male,0.97,862,1142,NCT04372589,Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Recruiting,No Results Available,COVID-19|Pneumonia,Drug: Heparin,"May 4, 2020","University of Chicago, Chicago, Illinois, United States|Ochsner Clinic, Jefferson, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States|Deborah Heart and Lung Center, Browns Mills, New Jersey, United States|Albany Medical College, Albany, New York, United States|Mount Sinai Health System, New York, New York, United States|Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of São Paulo, São Paulo, Brazil|Victoria General Hospital, Victoria, British Columbia, Canada|Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|CHU de Quebec-University Laval, Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Unidad de Investigación en Epidemiología Clínica, Instituto Mexicano del Seguro Social, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04372589
Principal Investigator,"Ryan Zarychanski, MD, MSc",University of Manitoba,,NCT04372589,ryan zarychanski,ryan,male,0.99,45164,1142,NCT04372589,Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Recruiting,No Results Available,COVID-19|Pneumonia,Drug: Heparin,"May 4, 2020","University of Chicago, Chicago, Illinois, United States|Ochsner Clinic, Jefferson, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States|Deborah Heart and Lung Center, Browns Mills, New Jersey, United States|Albany Medical College, Albany, New York, United States|Mount Sinai Health System, New York, New York, United States|Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of São Paulo, São Paulo, Brazil|Victoria General Hospital, Victoria, British Columbia, Canada|Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|CHU de Quebec-University Laval, Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Unidad de Investigación en Epidemiología Clínica, Instituto Mexicano del Seguro Social, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04372589
Study Chair,"yohanny andrade, researcher",Genesis Foundation,,NCT04343742,yohanny andrade,yohanny,female,0.87,106,209,NCT04343742,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Recruiting,No Results Available,COVID-19,Drug: chlorine dioxide 3000 ppm,"April 13, 2020","Hospital Fhsj, Bogota, Cundinamarca, Colombia|San Carlos Hospital, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04343742
Study Chair,"oswaldo leyva, researcher",Genesis Foundation,,NCT04343742,oswaldo leyva,oswaldo,male,0.98,1643,209,NCT04343742,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Recruiting,No Results Available,COVID-19,Drug: chlorine dioxide 3000 ppm,"April 13, 2020","Hospital Fhsj, Bogota, Cundinamarca, Colombia|San Carlos Hospital, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04343742
Study Chair,"Anil Avhad, MBBS",Cadila Pharmaceuticals Limited,,NCT04347174,anil avhad,anil,male,0.97,6560,213,NCT04347174,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Recruiting,No Results Available,COVID-19,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Standard therapy of COVID-19,"April 15, 2020","All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Postgraduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04347174
Study Chair,"Nomita Bhandari, MD",Cadila Pharmaceuticals Limited,,NCT04347174,nomita bhandari,nomita,female,1.0,9,213,NCT04347174,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Recruiting,No Results Available,COVID-19,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Standard therapy of COVID-19,"April 15, 2020","All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Postgraduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04347174
Principal Investigator,"Ishtiaq Ahmed, DPT",Government College University,,NCT04445376,ishtiaq ahmed,ishtiaq,male,0.99,233,216,NCT04445376,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Not yet recruiting,No Results Available,Covid19,Other: Physical Exercises,"June 24, 2020",,https://ClinicalTrials.gov/show/NCT04445376
Principal Investigator,"Marion Plaze, MD, PHD",Service Hospitalo-Universitaire - GHU PARIS Psychiatrie & Neurosciences,,NCT04366739,marion plaze,marion,female,0.96,46455,218,NCT04366739,Repurposing of Chlorpromazine in Covid-19 Treatment,Not yet recruiting,No Results Available,COVID-19,Drug: CHLORPROMAZINE (CPZ)|Combination Product: Standard of Care (SOC),"April 29, 2020","Centre Hospitalier Sainte-Anne, Paris, France",https://ClinicalTrials.gov/show/NCT04366739
Principal Investigator,Marion Grimaud,Assistance Publique - Hôpitaux de Paris,,NCT04420468,marion grimaud,marion,female,0.96,46455,311,NCT04420468,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,Not yet recruiting,No Results Available,COVID-19,,"June 9, 2020","Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Armand Trousseau, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Robert Debré, Paris, France",https://ClinicalTrials.gov/show/NCT04420468
Study Director,"Sylvain Renolleau, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04420468,sylvain renolleau,sylvain,male,0.99,37051,311,NCT04420468,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,Not yet recruiting,No Results Available,COVID-19,,"June 9, 2020","Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Armand Trousseau, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Robert Debré, Paris, France",https://ClinicalTrials.gov/show/NCT04420468
Principal Investigator,"Marion LEBOYER, PHD",Assistance Publique des Hopitaux de Paris,,NCT04381845,marion leboyer,marion,female,0.96,46455,584,NCT04381845,Immunity and Infections in the Psychiatric Population,Not yet recruiting,No Results Available,COVID|Psychiatric Disorders,Diagnostic Test: COVID19 immunization testing,"May 11, 2020",,https://ClinicalTrials.gov/show/NCT04381845
Study Chair,"ORLANDO CARILLO-TORRES, PHD",Hospital General de Mexico Dr Eduardo Liceaga,,NCT04405310,orlando carillo-torres,orlando,male,0.98,9898,219,NCT04405310,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,Recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma of patients with COVID-19|Other: placebo (hartmann plus albumine),"May 28, 2020","Hospital Nava de Alta Especialidad, Mexico City, Mexico|Hospital General de Mexico Dr Eduardo Liceaga, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04405310
Principal Investigator,"Orlando R Perez Nieto, MD",Hospital General San Juan del Rio,,NCT04407468,orlando r perez nieto,orlando,male,0.98,9898,900,NCT04407468,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,Recruiting,No Results Available,COVID|ARDS|Pneumonia,Procedure: Prone position,"May 29, 2020","Hospital Materno Celaya, Celaya, Guanajuato, Mexico|Hospital Santo Tomas, Querétaro City, Queretaro, Mexico|Hospital General San Juan del Rio, Querétaro City, Queretaro, Mexico|ISSSTE Hospital Regional Merida, Mérida, Yucatan, Mexico|Hospital General de Zona 48 San PEDRO Xalpa IMSS, Estado De México, Mexico|Hospital Fernando Quiroz Gutierrez, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04407468
Principal Investigator,"Pedro Póvoa, PhD",Hospital São Francisco Xavier,,NCT04355741,pedro póvoa,pedro,male,0.99,165413,222,NCT04355741,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"April 21, 2020","Hospital CUF Infante Santo, S.A., Lisbon, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04355741
Principal Investigator,"Cristina Granja, PhD",Centro Hospitalar Universitário São João,,NCT04355741,cristina granja,cristina,female,0.99,140931,222,NCT04355741,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"April 21, 2020","Hospital CUF Infante Santo, S.A., Lisbon, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04355741
Principal Investigator,"Maria JR Sousa, PhD","Centro de Medicina Laboratorial Germano de Sousa, S.A.",,NCT04355741,maria jr sousa,maria,female,0.98,334287,222,NCT04355741,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"April 21, 2020","Hospital CUF Infante Santo, S.A., Lisbon, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04355741
Study Chair,"José Leal, PhD","Centro de Medicina Laboratorial Germano de Sousa, S.A.",,NCT04355741,josé leal,josé,male,0.97,2086,222,NCT04355741,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Not yet recruiting,No Results Available,COVID-19,Other: Exposure,"April 21, 2020","Hospital CUF Infante Santo, S.A., Lisbon, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário São João, Oporto, Portugal",https://ClinicalTrials.gov/show/NCT04355741
Principal Investigator,"Pedro Abizanda Soler, MD,PhD",Head Geriatrics Department,,NCT04362943,pedro abizanda soler,pedro,male,0.99,165413,485,NCT04362943,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Recruiting,No Results Available,COVID-19,Drug: Baricitinib or Anakinra,"April 27, 2020","Complejo Hospitalario Universitario de Albacete, Albacete, Spain",https://ClinicalTrials.gov/show/NCT04362943
Principal Investigator,"Pedro Exman, MD",Instituto do Cancer do Estado de São Paulo,,NCT04447235,pedro exman,pedro,male,0.99,165413,1072,NCT04447235,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Not yet recruiting,No Results Available,Cancer|COVID|Coronavirus Infection,Drug: Placebo|Drug: Ivermectin|Drug: Losartan,"June 25, 2020",,https://ClinicalTrials.gov/show/NCT04447235
Study Director,"Maria del Pilar Diz, MD, PhD",Instituto do Cancer do Estado de São Paulo,,NCT04447235,maria del pilar diz,maria,female,0.98,334287,1072,NCT04447235,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Not yet recruiting,No Results Available,Cancer|COVID|Coronavirus Infection,Drug: Placebo|Drug: Ivermectin|Drug: Losartan,"June 25, 2020",,https://ClinicalTrials.gov/show/NCT04447235
Principal Investigator,"PEDRO B FROTA, MD",Hospital Sao Domingos,,NCT04377503,pedro b frota,pedro,male,0.99,165413,1136,NCT04377503,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Not yet recruiting,No Results Available,Cytokine Release Syndrome|Covid-19,Drug: Tocilizumab 180 MG/ML|Drug: Methylprednisolone Sodium Succinate,"May 6, 2020",,https://ClinicalTrials.gov/show/NCT04377503
Study Chair,"Cristina MD Avendaño Solá, MD",Hospital Puerta de Hierro de Majadahonda de Madrid,,NCT04344002,cristina md avendaño solá,cristina,female,0.99,140931,586,NCT04344002,LunG canceR pAtients coVId19 Disease (GRAVID),Recruiting,No Results Available,Covid-19|Lung Cancer,,"April 14, 2020","Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain|H. Clínica Benidorm, Benidorm, Alicante, Spain|Hospital de Elche, Elche, Alicante, Spain|Hospital General Universitario de Elda, Elda, Alicante, Spain|Hospital de Torrevieja, Torrevieja, Alicante, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Cetir Centre Mèdic, Esplugues De Llobregat, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Complejo Hospitalario de la Coruña, La Coruña, Coruña, Spain|H. Insular de Gran Canarias, Las Palmas De Gran Canaria, Gran Canarias, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario de Móstoles, Móstoles, Madrid, Spain|Hospital de Manacor, Manacor, Mallorca, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Instituto Onkologikoa, San Sebastián, País Vasco, Spain|Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|H. Universitario de Canarias, La Laguna, Tenerife, Spain|Hospital Universitario de La Ribera, Alzira, Valencia, Spain|Hospital de Manises, Manises, Valencia, Spain|Hospital de Cruces, Baracaldo, Vizcaya, Spain|Hospital de Basurto, Bilbao, Vizcaya, Spain|H. Gen. Universitario Alicante, Alicante, Spain|H. Universitario Quirón Dexeus, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|H. Duran i Reynals-ICO, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital La Mancha Centro, Ciudad Real, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Universitario de Puerto Real, Cádiz, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital San Millan Y San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|MD Anderson, Madrid, Spain|H.U. Puerta de Hierro, Madrid, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Santa María Naí, Ourense, Spain|Hospital Son Espases, Palma de Mallorca, Spain|H. Son Llàtzer, Palma de Mallorca, Spain|Hospital Clinico de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital universitario Nuestra Señora Candelaria, Tenerife, Spain|H. General U. de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital Politècnic i Universitari La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|H. Miguel Servet, Zaragoza, Spain|Hospital Ntra. Sra. Sónsoles, Ávila, Spain|Hospital Universitario de Áraba, Vitoria, Áraba, Spain",https://ClinicalTrials.gov/show/NCT04344002
Study Chair,"María MD González-Cao, MD",Hospital Universitario Dexeus de Barcelona.,,NCT04344002,maría md gonzález-cao,maría,female,0.99,232436,586,NCT04344002,LunG canceR pAtients coVId19 Disease (GRAVID),Recruiting,No Results Available,Covid-19|Lung Cancer,,"April 14, 2020","Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain|H. Clínica Benidorm, Benidorm, Alicante, Spain|Hospital de Elche, Elche, Alicante, Spain|Hospital General Universitario de Elda, Elda, Alicante, Spain|Hospital de Torrevieja, Torrevieja, Alicante, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Cetir Centre Mèdic, Esplugues De Llobregat, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Complejo Hospitalario de la Coruña, La Coruña, Coruña, Spain|H. Insular de Gran Canarias, Las Palmas De Gran Canaria, Gran Canarias, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario de Móstoles, Móstoles, Madrid, Spain|Hospital de Manacor, Manacor, Mallorca, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Instituto Onkologikoa, San Sebastián, País Vasco, Spain|Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|H. Universitario de Canarias, La Laguna, Tenerife, Spain|Hospital Universitario de La Ribera, Alzira, Valencia, Spain|Hospital de Manises, Manises, Valencia, Spain|Hospital de Cruces, Baracaldo, Vizcaya, Spain|Hospital de Basurto, Bilbao, Vizcaya, Spain|H. Gen. Universitario Alicante, Alicante, Spain|H. Universitario Quirón Dexeus, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|H. Duran i Reynals-ICO, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital La Mancha Centro, Ciudad Real, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Universitario de Puerto Real, Cádiz, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital San Millan Y San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|MD Anderson, Madrid, Spain|H.U. Puerta de Hierro, Madrid, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Santa María Naí, Ourense, Spain|Hospital Son Espases, Palma de Mallorca, Spain|H. Son Llàtzer, Palma de Mallorca, Spain|Hospital Clinico de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital universitario Nuestra Señora Candelaria, Tenerife, Spain|H. General U. de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital Politècnic i Universitari La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|H. Miguel Servet, Zaragoza, Spain|Hospital Ntra. Sra. Sónsoles, Ávila, Spain|Hospital Universitario de Áraba, Vitoria, Áraba, Spain",https://ClinicalTrials.gov/show/NCT04344002
Study Chair,"Mariano MD Provencio, MD",Hospital Puerta de Hierro de Majadahonda de Madrid,,NCT04344002,mariano md provencio,mariano,male,0.98,14862,586,NCT04344002,LunG canceR pAtients coVId19 Disease (GRAVID),Recruiting,No Results Available,Covid-19|Lung Cancer,,"April 14, 2020","Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain|H. Clínica Benidorm, Benidorm, Alicante, Spain|Hospital de Elche, Elche, Alicante, Spain|Hospital General Universitario de Elda, Elda, Alicante, Spain|Hospital de Torrevieja, Torrevieja, Alicante, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Cetir Centre Mèdic, Esplugues De Llobregat, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Complejo Hospitalario de la Coruña, La Coruña, Coruña, Spain|H. Insular de Gran Canarias, Las Palmas De Gran Canaria, Gran Canarias, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario de Móstoles, Móstoles, Madrid, Spain|Hospital de Manacor, Manacor, Mallorca, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Instituto Onkologikoa, San Sebastián, País Vasco, Spain|Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|H. Universitario de Canarias, La Laguna, Tenerife, Spain|Hospital Universitario de La Ribera, Alzira, Valencia, Spain|Hospital de Manises, Manises, Valencia, Spain|Hospital de Cruces, Baracaldo, Vizcaya, Spain|Hospital de Basurto, Bilbao, Vizcaya, Spain|H. Gen. Universitario Alicante, Alicante, Spain|H. Universitario Quirón Dexeus, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|H. Duran i Reynals-ICO, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital La Mancha Centro, Ciudad Real, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Universitario de Puerto Real, Cádiz, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital San Millan Y San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|MD Anderson, Madrid, Spain|H.U. Puerta de Hierro, Madrid, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Santa María Naí, Ourense, Spain|Hospital Son Espases, Palma de Mallorca, Spain|H. Son Llàtzer, Palma de Mallorca, Spain|Hospital Clinico de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital universitario Nuestra Señora Candelaria, Tenerife, Spain|H. General U. de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital Politècnic i Universitari La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|H. Miguel Servet, Zaragoza, Spain|Hospital Ntra. Sra. Sónsoles, Ávila, Spain|Hospital Universitario de Áraba, Vitoria, Áraba, Spain",https://ClinicalTrials.gov/show/NCT04344002
Study Director,"Cristina Plesoianu, PhD",Medical Sciences Academy from Romania,,NCT04325867,cristina plesoianu,cristina,female,0.99,140931,1861,NCT04325867,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Recruiting,No Results Available,"Angina Pectoris|Acute Coronary Syndrome|Coronary Syndrome|Coronary Artery Disease|Angioplasty|Stent Restenosis|Hypertension|Heart Failure, Systolic|Depression, Anxiety|Covid-19|Isolation, Social",Other: Tele-medicine platform,"March 30, 2020","Medical Sciences Academy, Bucharest, Romania|University of Medicine and Pharmacy Gr T Popa, Iasi, Romania",https://ClinicalTrials.gov/show/NCT04325867
Principal Investigator,"Alexandru Burlacu, MD, PhD","University of Medicine and Pharmacy ""Gr. T. Popa"" Iasi, Romania",,NCT04325867,alexandru burlacu,alexandru,male,0.97,11274,1861,NCT04325867,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Recruiting,No Results Available,"Angina Pectoris|Acute Coronary Syndrome|Coronary Syndrome|Coronary Artery Disease|Angioplasty|Stent Restenosis|Hypertension|Heart Failure, Systolic|Depression, Anxiety|Covid-19|Isolation, Social",Other: Tele-medicine platform,"March 30, 2020","Medical Sciences Academy, Bucharest, Romania|University of Medicine and Pharmacy Gr T Popa, Iasi, Romania",https://ClinicalTrials.gov/show/NCT04325867
Study Director,"Cristina Bárbara, PhD",University of Lisbon,,NCT04388579,cristina bárbara,cristina,female,0.99,140931,2138,NCT04388579,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,Completed,No Results Available,Respiratory Disease,Other: Pulmonary Rehabilitation,"May 14, 2020","Nippon Gases Portugal Unipessoal Lda, Maia, Porto, Portugal|Universidade de Lisboa, Faculdade de Medicina, Instituto de Saúde Ambiental (ISAMB), Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória, Lisboa, Portugal",https://ClinicalTrials.gov/show/NCT04388579
Principal Investigator,"Catarina D Santos, MSc",University of Lisbon,,NCT04388579,catarina d santos,catarina,female,0.97,13836,2138,NCT04388579,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,Completed,No Results Available,Respiratory Disease,Other: Pulmonary Rehabilitation,"May 14, 2020","Nippon Gases Portugal Unipessoal Lda, Maia, Porto, Portugal|Universidade de Lisboa, Faculdade de Medicina, Instituto de Saúde Ambiental (ISAMB), Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória, Lisboa, Portugal",https://ClinicalTrials.gov/show/NCT04388579
Study Director,"Cristina Bravo Navarro, PhD",Department Nursing and Physiotherapy,,NCT04396314,cristina bravo navarro,cristina,female,0.99,140931,2164,NCT04396314,Effectiveness of Basic Body Awareness Therapy in Survivors of Covid-19 and Health Workers Regarding Post-traumatic Stress Disorders,Not yet recruiting,No Results Available,PostTraumatic Stress Disorder,Behavioral: Basic Body Awareness Therapy|Behavioral: Psychological treatment,"May 20, 2020",,https://ClinicalTrials.gov/show/NCT04396314
Principal Investigator,"Cristina S Albott, MD",University of Minnesota,,NCT04396600,cristina s albott,cristina,female,0.99,140931,2282,NCT04396600,The Professional Peer Resilience Initiative,Recruiting,No Results Available,"Stress|Stress Disorder|Stress, Psychological|Trauma, Psychological|Anxiety|Anxiety State|Post Traumatic Stress Disorder|Secondary Traumatic Stress|Professional Quality of Life|Stress Related Disorder|Stress Reaction|Stress Risk|Mental Resilience|Emotional Resilience",Behavioral: MinnRAP Peer Support Program,"May 20, 2020","University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04396600
Principal Investigator,"Maria T DeSancho, MD, MSc",Weill Medical College of Cornell University,,NCT04406389,maria t desancho,maria,female,0.98,334287,249,NCT04406389,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Not yet recruiting,No Results Available,COVID-19,Drug: Enoxaparin sodium|Drug: Unfractionated heparin|Drug: Fondapariniux|Drug: Argatroban,"May 28, 2020","Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04406389
Study Director,"Maria C Jimenez-Martínez, MD PhD",Universidad Nacional Autonoma de Mexico,,NCT04379479,maria c jimenez-martínez,maria,female,0.98,334287,472,NCT04379479,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral,"May 7, 2020","Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04379479
Study Director,"Sonia Mayra Pérez-Tapia, PhD",Instituto Politecnico Nacional,,NCT04379479,sonia mayra pérez-tapia,sonia,female,0.98,114177,472,NCT04379479,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral,"May 7, 2020","Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04379479
Principal Investigator,"Toni A Homberg von Thaden, MD","National Polytechnic Institute, Mexico",,NCT04379479,toni a homberg von thaden,toni,male,0.94,64776,472,NCT04379479,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral,"May 7, 2020","Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04379479
Principal Investigator,"Maria Elvira Balcells, MD",ebalcells@uc.cl,,NCT04375098,maria elvira balcells,maria,female,0.98,334287,1027,NCT04375098,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Biological: COVID-19 convalescent plasma,"May 5, 2020","Hospital Clínico Universidad Católica, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04375098
Principal Investigator,"Maria Goossens, MD, PhD",Sciensano,,NCT04356586,maria goossens,maria,female,0.98,334287,1127,NCT04356586,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Enrolling by invitation,No Results Available,COVID-19|Serology,,"April 22, 2020","Sciensano, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04356586
Principal Investigator,"Maria Cronhjort, PhD","Karolinska Institutet, Department of Clinical Science and Education",,NCT04412304,maria cronhjort,maria,female,0.98,334287,1470,NCT04412304,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,Completed,No Results Available,Covid-19|Thromboembolic Events|Bleeding,Drug: Dose of Tinzaparin or Dalteparin,"June 2, 2020","South General Hospital, Stockholm, Stockholms Län, Sweden",https://ClinicalTrials.gov/show/NCT04412304
Principal Investigator,"Maria Lucia Madariaga, MD",University of Chicago Biological Sciences Division Department of Surgery,,NCT04340050,maria lucia madariaga,maria,female,0.98,334287,1572,NCT04340050,COVID-19 Convalescent Plasma,"Active, not recruiting",No Results Available,Coronavirus,Biological: anti-SARS-CoV-2 convalescent plasma,"April 9, 2020","University of Chicago Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04340050
Principal Investigator,"Maria Ines Mitrani, MD, PhD","Chief Science Officer at Organicell Regenerative Medicine, Inc",,NCT04384445,maria ines mitrani,maria,female,0.98,334287,1610,NCT04384445,Organicell Flow for Patients With COVID-19,Not yet recruiting,No Results Available,Corona Virus Infection|COVID-19|SARS|Acute Respiratory Distress Syndrome,Biological: Organicell Flow|Other: Placebo,"May 12, 2020","Landmark Hospital, Naples, Florida, United States|Landmark Hospital, Athens, Georgia, United States",https://ClinicalTrials.gov/show/NCT04384445
Principal Investigator,"William Kapp, MD, FAAOS",Co-Investigator,,NCT04384445,william kapp,william,male,0.99,64097,1610,NCT04384445,Organicell Flow for Patients With COVID-19,Not yet recruiting,No Results Available,Corona Virus Infection|COVID-19|SARS|Acute Respiratory Distress Syndrome,Biological: Organicell Flow|Other: Placebo,"May 12, 2020","Landmark Hospital, Naples, Florida, United States|Landmark Hospital, Athens, Georgia, United States",https://ClinicalTrials.gov/show/NCT04384445
Principal Investigator,"George C Shapiro, MD, FACC","Chief Medical Officer at Organicell Regenerative Medicine, Inc",,NCT04384445,george c shapiro,george,male,0.98,65488,1610,NCT04384445,Organicell Flow for Patients With COVID-19,Not yet recruiting,No Results Available,Corona Virus Infection|COVID-19|SARS|Acute Respiratory Distress Syndrome,Biological: Organicell Flow|Other: Placebo,"May 12, 2020","Landmark Hospital, Naples, Florida, United States|Landmark Hospital, Athens, Georgia, United States",https://ClinicalTrials.gov/show/NCT04384445
Principal Investigator,"Maria Donatella Barbagallo, MD","Yoga Experience Association,Cervia (Ra), Italy",,NCT04413747,maria donatella barbagallo,maria,female,0.98,334287,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Study Director,Maria Luisa Vitobello,"EJTN GEIE, Brussellese, Belgium",,NCT04413747,maria luisa vitobello,maria,female,0.98,334287,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Principal Investigator,"Enrico Ricci, MD","Yoga Experience Association,Cervia (Ra), Italy",,NCT04413747,enrico ricci,enrico,male,0.99,35298,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Principal Investigator,"Nagarathna Raghuram, MD","Vivekananda Yoga Anusandhana Samsthana, Bengaluru, India",,NCT04413747,nagarathna raghuram,nagarathna,female,0.67,3,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Study Chair,"HR Nagendra., Eng","Vivekananda Yoga Anusandhana Samsthana, Bengaluru, India",,NCT04413747,hr nagendra.,hr,male,0.63,521,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Principal Investigator,"Morena Gaddoni, MD","Casa di Riposo Giardino St Lucia, Massa Lombarda (Ra) Italy",,NCT04413747,morena gaddoni,morena,female,0.98,14411,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Study Director,"Luca Ghetti, Eng.",Halnet Srl,,NCT04413747,luca ghetti,luca,male,0.96,185452,1612,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID -19,Not yet recruiting,No Results Available,Coronavirus Infection|Cytokine Storm|Mental Disorder,Behavioral: morning pranayama|Behavioral: pre_lunch pranayama|Behavioral: pre_dinner pranayama,"June 4, 2020","Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna, Italy",https://ClinicalTrials.gov/show/NCT04413747
Principal Investigator,"José Barberán, MD",HOSPITAL UNIVERSITARIO HM MONTEPRÍNCIPE,,NCT04382066,josé barberán,josé,male,0.97,2086,351,NCT04382066,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Recruiting,No Results Available,COVID-19,Drug: Plitidepsin 1.5 mg/day|Drug: Plitidepsin 2.0 mg/day|Drug: Plitidepsin 2.5 mg/day,"May 11, 2020","Hospital Universitario Hm Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Ciudad Real, Ciudad Real, Spain|Hospital La Princesa, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04382066
Principal Investigator,"Vicente Estrada, MD",Hospital Clínico San Carlos,,NCT04382066,vicente estrada,vicente,male,0.98,20107,351,NCT04382066,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Recruiting,No Results Available,COVID-19,Drug: Plitidepsin 1.5 mg/day|Drug: Plitidepsin 2.0 mg/day|Drug: Plitidepsin 2.5 mg/day,"May 11, 2020","Hospital Universitario Hm Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Ciudad Real, Ciudad Real, Spain|Hospital La Princesa, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04382066
Principal Investigator,"José Fe Castilleja-Leal, MD.",Hospital San José,,NCT04333355,josé fe castilleja-leal,josé,male,0.97,2086,427,NCT04333355,Safety in Convalescent Plasma Transfusion to COVID-19,Recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma,"April 3, 2020","Hospital San José, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04333355
Principal Investigator,"José J Torres-Ruiz, MD, MSc",Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,NCT04367168,josé j torres-ruiz,josé,male,0.97,2086,801,NCT04367168,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,Recruiting,No Results Available,COVID,Drug: Colchicine|Drug: Placebo oral tablet,"April 29, 2020","Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico",https://ClinicalTrials.gov/show/NCT04367168
Principal Investigator,"José M Morales-Asencio, PhD","University of Malaga; Malaga, Spain.",,NCT04400019,josé m morales-asencio,josé,male,0.97,2086,1469,NCT04400019,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),Not yet recruiting,No Results Available,Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine,Drug: Hydroxychloroquine Only Product in Oral Dose Form,"May 22, 2020",,https://ClinicalTrials.gov/show/NCT04400019
Principal Investigator,"Juan C Morilla-Herrera, PhD",Distrito de Atención Primaria Málaga-Valle del Guadalhorce,,NCT04400019,juan c morilla-herrera,juan,male,0.98,274814,1469,NCT04400019,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),Not yet recruiting,No Results Available,Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine,Drug: Hydroxychloroquine Only Product in Oral Dose Form,"May 22, 2020",,https://ClinicalTrials.gov/show/NCT04400019
Principal Investigator,"Ricardo Gómez-Huelgas, PhD",Hospital Regional Universitario de Málaga,,NCT04400019,ricardo gómez-huelgas,ricardo,male,0.99,75750,1469,NCT04400019,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),Not yet recruiting,No Results Available,Sars-CoV2|Coronavirus Infection|Prevention & Control|Nursing Home|Hydroxychloroquine,Drug: Hydroxychloroquine Only Product in Oral Dose Form,"May 22, 2020",,https://ClinicalTrials.gov/show/NCT04400019
Principal Investigator,"José López Miranda, MD",Hospital Universitario Reina Sofía,,NCT04366908,josé lópez miranda,josé,male,0.97,2086,1567,NCT04366908,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Not yet recruiting,No Results Available,SARS-CoV 2|COVID19|SARS (Severe Acute Respiratory Syndrome)|Cytokine Release Syndrome|Cytokine Storm,Drug: BAT + Calcifediol|Drug: BAT,"April 29, 2020",,https://ClinicalTrials.gov/show/NCT04366908
Principal Investigator,"José Meneses Calderón, MD.",Research Unit,,NCT04406246,josé meneses calderón,josé,male,0.97,2086,2067,NCT04406246,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Recruiting,No Results Available,Coronavirus Infection,Drug: Nitazoxanide 500Mg Oral Tablet,"May 28, 2020","Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico",https://ClinicalTrials.gov/show/NCT04406246
Principal Investigator,"José Meneses Calderón, MD","Hospital Materno-Perinatal ""Mónica Pretelini Sáenz""",,NCT04341493,josé meneses calderón,josé,male,0.97,2086,2084,NCT04341493,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Recruiting,No Results Available,Coronavirus Infection,Drug: Nitazoxanide 500 MG|Drug: Hydroxychloroquine,"April 10, 2020","Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico",https://ClinicalTrials.gov/show/NCT04341493
Principal Investigator,"Srivatsan Padmanabhan, MD, PhD",St. Joseph Medical Center,,NCT04341493,srivatsan padmanabhan,srivatsan,male,1.0,23,2084,NCT04341493,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Recruiting,No Results Available,Coronavirus Infection,Drug: Nitazoxanide 500 MG|Drug: Hydroxychloroquine,"April 10, 2020","Materno-Perinatal Hospital ""Mónica Pretelini"", Toluca, Mexico",https://ClinicalTrials.gov/show/NCT04341493
Principal Investigator,"José R Galindo-Donaire, MD",Universidad Nacional Autonoma de Honduras,,NCT04394455,josé r galindo-donaire,josé,male,0.97,2086,2305,NCT04394455,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Not yet recruiting,No Results Available,Anxiety|Depressive Symptoms|Post Traumatic Stress Symptoms|Perceived Stress,Behavioral: Brief cognitive behavioral therapy|Behavioral: Crisis intervention therapy,"May 19, 2020","Universidad Nacional Autónoma de Honduras, Tegucigalpa, Francisco Morazán, Honduras",https://ClinicalTrials.gov/show/NCT04394455
Principal Investigator,"Elena N Reyes-Flores, MD",Universidad Nacional Autonoma de Honduras,,NCT04394455,elena n reyes-flores,elena,female,0.99,149871,2305,NCT04394455,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Not yet recruiting,No Results Available,Anxiety|Depressive Symptoms|Post Traumatic Stress Symptoms|Perceived Stress,Behavioral: Brief cognitive behavioral therapy|Behavioral: Crisis intervention therapy,"May 19, 2020","Universidad Nacional Autónoma de Honduras, Tegucigalpa, Francisco Morazán, Honduras",https://ClinicalTrials.gov/show/NCT04394455
Principal Investigator,"Marvin Konstam, MD",Tufts Medical Center,,NCT04388683,marvin konstam,marvin,male,0.99,17482,224,NCT04388683,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Recruiting,No Results Available,COVID-19,Drug: Nitric Oxide,"May 14, 2020","Tufts Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04388683
Principal Investigator,Marvin R McCreary,Mount Carmel Health System,,NCT04400890,marvin r mccreary,marvin,male,0.99,17482,471,NCT04400890,Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol for COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Resveratrol|Dietary Supplement: Vitamin D3,"May 26, 2020",,https://ClinicalTrials.gov/show/NCT04400890
Principal Investigator,"Marie-Anne RAMEIX-WELTI, MD, PhD","Laboratoire de Microbiologie Hygiène hospitalière, Hôpital Ambroise paré, APHP",,NCT04377763,marie-anne rameix-welti,marie-anne,female,0.98,1045,229,NCT04377763,Developement and Evaluation of Serological Assays for COVID-19,Not yet recruiting,No Results Available,COVID-19,,"May 6, 2020","Laboratory of microbiology of hospital hygiene, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France",https://ClinicalTrials.gov/show/NCT04377763
Principal Investigator,"Woo-Joo Kim, M.D.,Ph.D.",Korea University Guro Hospital,,NCT04347915,woo-joo kim,woo-joo,female,1.0,1,232,NCT04347915,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Recruiting,No Results Available,COVID-19,Drug: Clevudine|Drug: Hydroxychloroquine,"April 15, 2020","Korea University Guro Hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04347915
Principal Investigator,"Derek W Guillory, MD.",Root Causes Medicine,,NCT04428801,derek w guillory,derek,male,0.99,11770,233,NCT04428801,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: autologous adipose-derived stem cells,"June 11, 2020",,https://ClinicalTrials.gov/show/NCT04428801
Study Director,Hervé FOEHRENBACH,Direction Centrale du Service de Santé des Armées (DCSSA),,NCT04372979,hervé foehrenbach,hervé,male,1.0,13,235,NCT04372979,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,Not yet recruiting,No Results Available,COVID-19,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,"May 4, 2020","HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04372979
Study Director,Catherine VERRET,Service de Santé des Armées-Direction de la Formation de la Recherche et de l'Innovation,,NCT04372979,catherine verret,catherine,female,0.98,50312,235,NCT04372979,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,Not yet recruiting,No Results Available,COVID-19,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,"May 4, 2020","HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04372979
Principal Investigator,Christophe MARTINAUD,Centre de Transfusion Sanguine des Armées,,NCT04372979,christophe martinaud,christophe,male,0.99,90978,235,NCT04372979,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,Not yet recruiting,No Results Available,COVID-19,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,"May 4, 2020","HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04372979
Principal Investigator,Jean-Luc BOSSON,Statistical and methodological investigator - Laboratoire TIMC UMR 5525 CNRS Equipe Themas,,NCT04372979,jean-luc bosson,jean-luc,male,0.99,9755,235,NCT04372979,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,Not yet recruiting,No Results Available,COVID-19,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,"May 4, 2020","HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon, France",https://ClinicalTrials.gov/show/NCT04372979
Principal Investigator,"Catherine H Marshall, MD/MPH",Johns Hopkins University,,NCT04374279,catherine h marshall,catherine,female,0.98,50312,406,NCT04374279,Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2,Drug: Bicalutamide 150 Mg Oral Tablet|Drug: Ivermectin 3Mg Tab,"May 5, 2020","Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04374279
Principal Investigator,"Catherine Oldenburg, ScD, MPH","University of California, San Francisco",,NCT04332107,catherine oldenburg,catherine,female,0.98,50312,860,NCT04332107,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Azithromycin|Drug: Placebos,"April 2, 2020","University of California San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04332107
Principal Investigator,"Thuy Doan, MD, PhD","University of California, San Francisco",,NCT04332107,thuy doan,thuy,female,0.9,909,860,NCT04332107,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Azithromycin|Drug: Placebos,"April 2, 2020","University of California San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04332107
Principal Investigator,"Christophe LENCLUD, MD","Hospital of Mantes-la-Jolie, France",,NCT04384731,christophe lenclud,christophe,male,0.99,90978,1186,NCT04384731,Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Not yet recruiting,No Results Available,"COVID-19|ARDS, Human",Drug: poractant alfa,"May 12, 2020",,https://ClinicalTrials.gov/show/NCT04384731
Principal Investigator,"Christophe PARIS, MD",CHU RENNES,,NCT04416308,christophe paris,christophe,male,0.99,90978,1496,NCT04416308,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Recruiting,No Results Available,Coronavirus,Diagnostic Test: NG test|Diagnostic Test: Blood test|Behavioral: Self-questionnary,"June 4, 2020","Chu Rennes, Rennes, France",https://ClinicalTrials.gov/show/NCT04416308
Principal Investigator,"Jean-Luc PERROT, MD PhD",CHU SAINT-ETIENNE,,NCT04427176,jean-luc perrot,jean-luc,male,0.99,9755,1898,NCT04427176,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Recruiting,No Results Available,Nurse,Device: ARFC mask,"June 11, 2020","CHU Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04427176
Principal Investigator,"Prapa Kanagaratnam, FRCP, PhD",Imperial College Healthcare NHS Trust,,NCT04333407,prapa kanagaratnam,prapa,female,0.77,31,236,NCT04333407,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Recruiting,No Results Available,COVID-19,Drug: Aspirin 75mg|Drug: Clopidogrel 75mg|Drug: Rivaroxaban 2.5 MG|Drug: Atorvastatin 40mg|Drug: Omeprazole 20mg,"April 3, 2020","Charing Cross Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04333407
Principal Investigator,"Cesare Perotti, MD",Foundation IRCCS San Matteo Hospital,,NCT04321421,cesare perotti,cesare,male,0.99,6731,238,NCT04321421,Hyperimmune Plasma for Critical Patients With COVID-19,Completed,No Results Available,COVID-19,Other: hyperimmune plasma,"March 25, 2020","Catherine Klersy, Pavia, PV, Italy|Ospedale Asst Carlo Poma Mantova, Mantova, Italy",https://ClinicalTrials.gov/show/NCT04321421
Principal Investigator,"Daryoush Hamidi Alamdari, Ph.D","Mashhad University of Medical Sciences, Mashhad, Iran",,NCT04370288,daryoush hamidi alamdari,daryoush,male,0.99,83,239,NCT04370288,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Recruiting,No Results Available,Covid-19,"Drug: MCN (Methylene blue, vitamin C, N-acetyl cysteine)","April 30, 2020","Imam Reza Hospital, Mashhad, Razavi Khorasan, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04370288
Study Chair,"Ahmad Ameri, Prof.",Shahid Beheshti University of Medical Sciences,,NCT04390412,ahmad ameri,ahmad,male,0.97,46229,243,NCT04390412,Low Dose Radiotherapy in COVID-19 Pneumonia,Recruiting,No Results Available,COVID|SARS (Severe Acute Respiratory Syndrome),Radiation: Low Dose Radiotherapy,"May 15, 2020","Imam Hossein Hospital, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04390412
Principal Investigator,"Nazanin Rahnama, M.D.",Shahid Beheshti University of Medical Sciences,,NCT04390412,nazanin rahnama,nazanin,female,0.98,1302,243,NCT04390412,Low Dose Radiotherapy in COVID-19 Pneumonia,Recruiting,No Results Available,COVID|SARS (Severe Acute Respiratory Syndrome),Radiation: Low Dose Radiotherapy,"May 15, 2020","Imam Hossein Hospital, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04390412
Study Director,Ahmad Alaskar,KAIMRC,,NCT04392973,ahmad alaskar,ahmad,male,0.97,46229,244,NCT04392973,FAvipiravir and HydroxyChloroquine Combination Therapy,Recruiting,No Results Available,COVID19,Combination Product: Favipiravir and Hydroxychloroquine,"May 19, 2020","King Abdulaziz Hospital, Hasa, Eastern Region, Saudi Arabia|AlMadina General Hospital, Al Madīnah, Saudi Arabia|King Abdulaziz Medical City, Jeddah, Saudi Arabia|King Abdulaziz Hospital, Mecca, Saudi Arabia|King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia|Imam Abdulrahman Alfaisal Hospital, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04392973
Study Director,"AHMAD AALIBRAHIM, M.D",Princess Nourah Bint Abdulrahman University,,NCT04388618,ahmad aalibrahim,ahmad,male,0.97,46229,1503,NCT04388618,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Not yet recruiting,No Results Available,Anosmia|Ageusia|Covid19|Corona Virus Infection,Other: NHANES smell and taste tests,"May 14, 2020","Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04388618
Principal Investigator,"OSAMA KENTAB, M.D",Princess Nourah Bint Abdulrahman University,,NCT04388618,osama kentab,osama,male,0.98,8125,1503,NCT04388618,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Not yet recruiting,No Results Available,Anosmia|Ageusia|Covid19|Corona Virus Infection,Other: NHANES smell and taste tests,"May 14, 2020","Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04388618
Principal Investigator,"Scott Sigman, MD",Lowell General Hospital,,NCT04391712,scott sigman,scott,male,0.99,31815,245,NCT04391712,Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Recruiting,No Results Available,COVID-19,Device: MLS Laser|Other: Regular Inpatient Medical Care,"May 18, 2020","Lowell General Hospital, Lowell, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04391712
Principal Investigator,"Scott Rickert, MD",NYU Langone Health,,NCT04344236,scott rickert,scott,male,0.99,31815,743,NCT04344236,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Recruiting,No Results Available,COVID-19,Drug: Saline oral/nasal rinse|Drug: 0.5% Povidone/Iodine oral/nasal rinse|Drug: 0.12% Chlorhexidine oral/nasal rinse,"April 14, 2020","NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04344236
Principal Investigator,"Scott A Halperin, MD",Canadian Center for Vaccinology,,NCT04398147,scott a halperin,scott,male,0.99,31815,1673,NCT04398147,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,Not yet recruiting,No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,"May 21, 2020","Canadian Center for Vaccinology, Halifax, Canada",https://ClinicalTrials.gov/show/NCT04398147
Principal Investigator,"Joanne M Langley, MD",Canadian Center for Vaccinology,,NCT04398147,joanne m langley,joanne,female,0.98,12034,1673,NCT04398147,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,Not yet recruiting,No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,"May 21, 2020","Canadian Center for Vaccinology, Halifax, Canada",https://ClinicalTrials.gov/show/NCT04398147
Principal Investigator,"Gailen D Marshall, Jr., MD, PhD",University of Mississippi Medical Center,,NCT04412486,gailen d marshall,gailen,male,0.75,8,248,NCT04412486,COVID-19 Convalescent Plasma (CCP) Transfusion,Recruiting,No Results Available,COVID-19,Biological: COVID Convalescent Plasma,"June 2, 2020","University of Mississippi Medical Center, Jackson, Mississippi, United States",https://ClinicalTrials.gov/show/NCT04412486
Principal Investigator,"Jérémie ZERBIT, PharmaD",Assistance Publique - Hôpitaux de Paris,,NCT04365725,jérémie zerbit,jérémie,male,1.0,5,252,NCT04365725,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Recruiting,No Results Available,COVID-19,Drug: Remdesivir,"April 28, 2020","Hôpital Cochin, Paris, France",https://ClinicalTrials.gov/show/NCT04365725
Principal Investigator,"Jérémie Rouger-Gaudichon, MD, PhD",University Hospital of Caen,,NCT04433871,jérémie rouger-gaudichon,jérémie,male,1.0,5,1109,NCT04433871,COVID-19 in Pediatric Oncology and Hematology Centers in France,Recruiting,No Results Available,Covid-19|Cancer,"Other: No intervention, observational","June 16, 2020","Jérémie Rouger-Gaudichon, Caen, France",https://ClinicalTrials.gov/show/NCT04433871
Study Director,"Janssen Pharmaceutica N.V., Belgium Clinical Trial","Janssen Pharmaceutica N.V., Belgium",,NCT04380961,janssen pharmaceutica n.v.,janssen,male,0.8,171,253,NCT04380961,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Recruiting,No Results Available,Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug: Sirukumab|Drug: Placebo|Other: Standard of Care (SOC),"May 8, 2020","Loyola University Medical Center, Maywood, Illinois, United States|University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States|Kentuckiana Pulmonary Associates, Louisville, Kentucky, United States|Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States|Wayne State University/Detroit Medical Center, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Beaumont Health Systems, Royal Oak, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Saint Michael's Medical Center - Infectious Disease, Newark, New Jersey, United States|SUNY Upstate Medical University, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04380961
Principal Investigator,"HATEM ELALFY, MD",PROFESSOR OF ENDEMIC MEDICINE DEPARTMENT,,NCT04392427,hatem elalfy,hatem,male,0.98,6060,255,NCT04392427,New Antiviral Drugs for Treatment of COVID-19,Not yet recruiting,No Results Available,COVID|Drug Effect,"Drug: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :","May 18, 2020","Mansoura University, Mansoura, Select A State Or Province, Egypt",https://ClinicalTrials.gov/show/NCT04392427
Principal Investigator,"HATEM ELALFY, MD",Mansoura University,,NCT04392427,hatem elalfy,hatem,male,0.98,6060,255,NCT04392427,New Antiviral Drugs for Treatment of COVID-19,Not yet recruiting,No Results Available,COVID|Drug Effect,"Drug: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :","May 18, 2020","Mansoura University, Mansoura, Select A State Or Province, Egypt",https://ClinicalTrials.gov/show/NCT04392427
Principal Investigator,"Andrew Ip, MD",Hackensack Meridian Health,,NCT04347993,andrew ip,andrew,male,0.99,60301,258,NCT04347993,"A Prospective ""Universal"" Observational Database for COVID-19",Recruiting,No Results Available,COVID-19,,"April 15, 2020","Hackensack Meridian Health - John Theurer Cancer Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04347993
Study Director,"Andrew Badley, MD",Mayo Clinic,,NCT04410354,andrew badley,andrew,male,0.99,60301,405,NCT04410354,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,Recruiting,No Results Available,COVID-19,Drug: Merimepodib|Drug: Matching Placebo|Drug: Remdesivir,"June 1, 2020","Mayo Clinic in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Atlantic Health System / Overlook Medical Center, Summit, New Jersey, United States|St. David's South Austin Medical Center, Austin, Texas, United States",https://ClinicalTrials.gov/show/NCT04410354
Principal Investigator,"Andrew Pollard, Prof",University of Oxford,,NCT04324606,andrew pollard,andrew,male,0.99,60301,1696,NCT04324606,A Study of a Candidate COVID-19 Vaccine (COV001),"Active, not recruiting",No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19|Biological: MenACWY|Biological: ChAdOx1 nCoV-19 boost|Drug: Paracetamol,"March 27, 2020","University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04324606
Principal Investigator,"Andrew McCaskie, FRCS",University of Cambridge & Cambridge University Hospitals NHS Foundation Trust,,NCT04397471,andrew mccaskie,andrew,male,0.99,60301,1733,NCT04397471,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,Not yet recruiting,No Results Available,Healthy Volunteers for Bone Marrow Donation,Procedure: Bone Marrow Harvest,"May 21, 2020","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04397471
Principal Investigator,"Andrew Pollard, Prof",University of Oxford,,NCT04400838,andrew pollard,andrew,male,0.99,60301,1826,NCT04400838,Investigating a Vaccine Against COVID-19,Not yet recruiting,No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19|Biological: MenACWY vaccine|Biological: ChAdOx1 nCoV-19 + boost|Biological: MenACWY vaccine + boost|Biological: ChAdox1 n-CoV vaccine low dose,"May 26, 2020","University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, Tooting, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|NIHR Cambridge Clinical Research Facility, Cambridge, United Kingdom|Public Health Wales, Cardiff, United Kingdom|Castle Hill Hospital, Cottingham, United Kingdom|NHS Lothian, Western General Hospital, Edinburgh, United Kingdom|Glasgow University and NHS Greater Glasgow & Clyde, New Lister Building, Glasgow Royal Infirmary & Queen Elizabeth University Hospital, Glasgow, United Kingdom|Liverpool School of Tropical Medicine (LSTM), Accelerator Research Clinic. Clinical Sciences Accelerator, LIverpool, United Kingdom|London North West University Healthcare Trust (LNWUH), Northwick Park Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, Department of Infection, St Thomas Hospital, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom|University of Nottingham Health Service, Cripps Health Centre, University Park, Nottingham, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04400838
Principal Investigator,"Andrew DiNardo, MD",Baylor College of Medicine,,NCT04348370,andrew dinardo,andrew,male,0.99,60301,1858,NCT04348370,BCG Vaccine for Health Care Workers as Defense Against COVID 19,Recruiting,No Results Available,Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere,Biological: BCG Vaccine|Biological: Placebo Vaccine,"April 16, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04348370
Principal Investigator,"Jeffrey D Cirillo, PhD",Texas A&M University,,NCT04348370,jeffrey d cirillo,jeffrey,male,0.99,22034,1858,NCT04348370,BCG Vaccine for Health Care Workers as Defense Against COVID 19,Recruiting,No Results Available,Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere,Biological: BCG Vaccine|Biological: Placebo Vaccine,"April 16, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04348370
Principal Investigator,"Ashish M Kamat, MD",M.D. Anderson Cancer Center,,NCT04348370,ashish m kamat,ashish,male,0.99,3872,1858,NCT04348370,BCG Vaccine for Health Care Workers as Defense Against COVID 19,Recruiting,No Results Available,Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere,Biological: BCG Vaccine|Biological: Placebo Vaccine,"April 16, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04348370
Principal Investigator,"Moshe Arditi, MD",Cedars-Sinai Medical Center,,NCT04348370,moshe arditi,moshe,male,0.98,833,1858,NCT04348370,BCG Vaccine for Health Care Workers as Defense Against COVID 19,Recruiting,No Results Available,Coronavirus|Coronavirus Infection|Coronavirus as the Cause of Diseases Classified Elsewhere,Biological: BCG Vaccine|Biological: Placebo Vaccine,"April 16, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04348370
Principal Investigator,Tim D Spector,King's College London,,NCT04331509,tim d spector,tim,male,0.99,47038,259,NCT04331509,COVID-19 Symptom Tracker,Recruiting,No Results Available,COVID-19,Other: No Intervention,"April 2, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States|King's College London, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04331509
Principal Investigator,"Rafael Diaz, MD",ECLA- ICR,,NCT04328480,rafael diaz,rafael,male,0.99,45829,1366,NCT04328480,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Recruiting,No Results Available,COVID-19,Drug: Colchicine|Other: Local standard of care,"March 31, 2020","Sanatorio Parque, Rosario, Santa Fe, Argentina",https://ClinicalTrials.gov/show/NCT04328480
Principal Investigator,"Mackenzie Cervenka, MD",Johns Hopkins University,,NCT04358835,mackenzie cervenka,mackenzie,male,0.53,247,262,NCT04358835,Keto-diet for Intubated Critical Care COVID-19,Not yet recruiting,No Results Available,COVID-19,Dietary Supplement: Ketogenic diet|Other: standard of care,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04358835
Principal Investigator,"Juan C cataño, MD.MI.ID",infectious medicine doctor,,NCT04362124,juan c cataño,juan,male,0.98,274814,912,NCT04362124,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection,Not yet recruiting,No Results Available,COVID-19,Biological: vaccine BCG|Other: Placebo,"April 24, 2020","Program for Research and Control in Tropical Diseases - PECET, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04362124
Principal Investigator,"Juan J Vila, PhD",Tertiary referral hospital: Complejo Hospitalario de Navarra. Pamplona.Spain,,NCT04371354,juan j vila,juan,male,0.98,274814,1012,NCT04371354,Outcomes of Covid-19 Protective Measures in Endoscopy,Recruiting,No Results Available,Covid-19 Disease|Endoscopy Unit,,"May 1, 2020","Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04371354
Principal Investigator,"Juan M Anaya Cabrera, MD, PhD",Universidad del Rosario,,NCT04332380,juan m anaya cabrera,juan,male,0.98,274814,1735,NCT04332380,Convalescent Plasma for Patients With COVID-19: A Pilot Study,Not yet recruiting,No Results Available,Coronavirus|Coronavirus Infection,Drug: Plasma,"April 2, 2020","Universidad del Rosario, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04332380
Study Director,"Juan M Anaya Cabrera, MD, PhD",Universidad del Rosario,,NCT04332835,juan m anaya cabrera,juan,male,0.98,274814,1764,NCT04332835,"Convalescent Plasma for Patients With COVID-19: A Randomized, Open Label, Parallel, Controlled Clinical Study",Not yet recruiting,No Results Available,Coronavirus|Coronavirus Infection,Drug: Plasma|Drug: Hydroxychloroquine,"April 3, 2020","Universidad del Rosario, Bogota, Cundinamarca, Colombia",https://ClinicalTrials.gov/show/NCT04332835
Principal Investigator,"Juan Felix, M.D.",Medical College of Wisconsin,,NCT04447495,juan felix,juan,male,0.98,274814,1991,NCT04447495,Self-sampling for the Study of COVID-19,Not yet recruiting,No Results Available,Coronavirus,Diagnostic Test: iAMP test,"June 25, 2020",,https://ClinicalTrials.gov/show/NCT04447495
Principal Investigator,Jordi Colmenero,Sociedad Española de Trasplante Hepático,,NCT04361591,jordi colmenero,jordi,male,0.99,31600,1180,NCT04361591,COVID-19 in Liver Transplant Recipients,Recruiting,No Results Available,Liver Transplant; Complications|COVID19|Respiratory Failure,Other: Observational only,"April 24, 2020","SETH-affiliated Liver Transplant Programs in Spain, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04361591
Principal Investigator,"Joanne Kurtzberg, MD",Duke Health,,NCT04399889,joanne kurtzberg,joanne,female,0.98,12034,265,NCT04399889,hCT-MSCs for COVID19 ARDS,Recruiting,No Results Available,COVID|Corona Virus Infection|COVID19,Biological: human cord tissue mesenchymal stromal cells,"May 22, 2020","Duke Hospital, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04399889
Principal Investigator,"Bryan Frank, MD",Duke Health,,NCT04399889,bryan frank,bryan,male,0.99,22678,265,NCT04399889,hCT-MSCs for COVID19 ARDS,Recruiting,No Results Available,COVID|Corona Virus Infection|COVID19,Biological: human cord tissue mesenchymal stromal cells,"May 22, 2020","Duke Hospital, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04399889
Principal Investigator,"Chetan Bettegowda, MD/PhD",Johns Hopkins University,,NCT04365257,chetan bettegowda,chetan,male,0.98,1297,266,NCT04365257,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Recruiting,No Results Available,COVID-19,Drug: Prazosin|Other: Standard of care,"April 28, 2020","Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04365257
Principal Investigator,"Elena Pavlikova, MD,PhD,Prof",Moscow State University n.a. M.V. Lomonosov,,NCT04434248,elena pavlikova,elena,female,0.99,149871,268,NCT04434248,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir|Drug: Standard of Care,"June 16, 2020","Republican Clinical Hospital, Makhachkala, Russian Federation|""K+31"" Clinic, Moscow, Russian Federation|""Khaven"" Llc, Moscow, Russian Federation|Central Clinical Hospital with Polyclinic, Moscow, Russian Federation|Central Research Institute of Epidemiology, Moscow, Russian Federation|City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital named after S.S. Yudin, Moscow, Russian Federation|City Clinical Hospital No. 24, Moscow, Russian Federation|City Clinical Hospital No. 51, Moscow, Russian Federation|First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation|Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation|National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russian Federation|City Hospital № 33 of the Leninsky region of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Infectious clinical hospital No.2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Ryazan State Medical University named after I.P. Pavlov, Ryazan, Russian Federation|Military Medical Academy named after S.M. Kirova, Saint Petersburg, Russian Federation|Saratov State Medical University named after V.I. Razumovsky, Saratov, Russian Federation|Clinical hospital No.1, Smolensk, Russian Federation|Regional Clinic Hospital, Tver, Russian Federation|Bashkir State Medical University, Ufa, Russian Federation|Yakutsk City Clinical Hospital, Yakutsk, Russian Federation|Yaroslavl Regional Clinical Hospital for War Veterans, Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04434248
Principal Investigator,"Nikita Lomakin, MD,PhD",Central Clinical Hospital with Polyclinic,,NCT04434248,nikita lomakin,nikita,female,0.52,10326,268,NCT04434248,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,"Active, not recruiting",No Results Available,COVID-19,Drug: Favipiravir|Drug: Standard of Care,"June 16, 2020","Republican Clinical Hospital, Makhachkala, Russian Federation|""K+31"" Clinic, Moscow, Russian Federation|""Khaven"" Llc, Moscow, Russian Federation|Central Clinical Hospital with Polyclinic, Moscow, Russian Federation|Central Research Institute of Epidemiology, Moscow, Russian Federation|City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital named after S.S. Yudin, Moscow, Russian Federation|City Clinical Hospital No. 24, Moscow, Russian Federation|City Clinical Hospital No. 51, Moscow, Russian Federation|First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation|Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation|National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russian Federation|City Hospital № 33 of the Leninsky region of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Infectious clinical hospital No.2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Ryazan State Medical University named after I.P. Pavlov, Ryazan, Russian Federation|Military Medical Academy named after S.M. Kirova, Saint Petersburg, Russian Federation|Saratov State Medical University named after V.I. Razumovsky, Saratov, Russian Federation|Clinical hospital No.1, Smolensk, Russian Federation|Regional Clinic Hospital, Tver, Russian Federation|Bashkir State Medical University, Ufa, Russian Federation|Yakutsk City Clinical Hospital, Yakutsk, Russian Federation|Yaroslavl Regional Clinical Hospital for War Veterans, Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04434248
Study Chair,"Elena Arbelo, MD, PhD, MSc",Hospital Clinic of Barcelona,,NCT04437901,elena arbelo,elena,female,0.99,149871,1723,NCT04437901,COVIDAR - Arrhythmias in COVID-19,Not yet recruiting,No Results Available,"COVID|Arrhythmia|Torsades de Pointe Caused by Drug|Qt Interval, Variation in|Atrioventricular Block|Atrial Fibrillation|Bradyarrhythmia|Ventricular Arrythmia",,"June 18, 2020","Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04437901
Study Director,"Arthur A Wilde, MD, PhD",Amsterdam UMC,,NCT04437901,arthur a wilde,arthur,male,0.99,20587,1723,NCT04437901,COVIDAR - Arrhythmias in COVID-19,Not yet recruiting,No Results Available,"COVID|Arrhythmia|Torsades de Pointe Caused by Drug|Qt Interval, Variation in|Atrioventricular Block|Atrial Fibrillation|Bradyarrhythmia|Ventricular Arrythmia",,"June 18, 2020","Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04437901
Study Director,"Lia Crotti, MD, PhD","Istituto Auxologico Italiano, IRCCS",,NCT04437901,lia crotti,lia,female,0.97,12635,1723,NCT04437901,COVIDAR - Arrhythmias in COVID-19,Not yet recruiting,No Results Available,"COVID|Arrhythmia|Torsades de Pointe Caused by Drug|Qt Interval, Variation in|Atrioventricular Block|Atrial Fibrillation|Bradyarrhythmia|Ventricular Arrythmia",,"June 18, 2020","Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04437901
Study Director,"Elijah Behr, MD, PhD",St George's University Hospitals NHS Foundation Trust,,NCT04437901,elijah behr,elijah,male,0.95,1647,1723,NCT04437901,COVIDAR - Arrhythmias in COVID-19,Not yet recruiting,No Results Available,"COVID|Arrhythmia|Torsades de Pointe Caused by Drug|Qt Interval, Variation in|Atrioventricular Block|Atrial Fibrillation|Bradyarrhythmia|Ventricular Arrythmia",,"June 18, 2020","Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04437901
Study Director,"Hein Heidbuchel, MD, PhD","University Hospital, Antwerp",,NCT04437901,hein heidbuchel,hein,male,0.95,1269,1723,NCT04437901,COVIDAR - Arrhythmias in COVID-19,Not yet recruiting,No Results Available,"COVID|Arrhythmia|Torsades de Pointe Caused by Drug|Qt Interval, Variation in|Atrioventricular Block|Atrial Fibrillation|Bradyarrhythmia|Ventricular Arrythmia",,"June 18, 2020","Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04437901
Study Director,"Xavier Corbella, MD, PhD",Hospital Universitari de Bellvige,,NCT04341038,xavier corbella,xavier,male,0.99,36056,1197,NCT04341038,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Recruiting,No Results Available,COVID-19|Lung Injury,Drug: Tacrolimus|Drug: Methylprednisolone,"April 10, 2020","Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04341038
Principal Investigator,"Xavier ELHARRAR, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,xavier elharrar,xavier,male,0.99,36056,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Chair,"Marie Bernardi, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,marie bernardi,marie,female,0.98,229433,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Chair,"Camille begne, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,camille begne,camille,female,0.9,51457,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Chair,"Laurence Maulin, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,laurence maulin,laurence,female,0.96,53900,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Chair,"Stephanie Martinez, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,stephanie martinez,stephanie,female,0.98,68107,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Chair,"Laurent Lefebvre, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,laurent lefebvre,laurent,male,0.99,84979,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Director,"Youssef Trigui, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,youssef trigui,youssef,male,0.97,38065,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Study Chair,"Thibaut Helbert, MD","Centre Hospitalier Intercommunal Aix-Pertuis (CHIAP), France",,NCT04344106,thibaut helbert,thibaut,male,0.99,6926,2099,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Recruiting,No Results Available,Coronavirus Infection|Oxygen Deficiency,Procedure: Prone positioning,"April 14, 2020","CHI Aix-Pertuis, Aix-en-Provence, France",https://ClinicalTrials.gov/show/NCT04344106
Principal Investigator,"Xavier DUVAL, MD","Institut National de la Santé Et de la Recherche Médicale, France",,NCT04322279,xavier duval,xavier,male,0.99,36056,2101,NCT04322279,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,Recruiting,No Results Available,Coronavirus,Diagnostic Test: Serology|Genetic: Sequencing,"March 26, 2020","Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon, Besançon, France|Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, Bordeaux, France|Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand, Clermont Ferrand, France|Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne, Dijon, France|Centre d'investigation clinique 1406 CHU Grenoble, Grenoble, France|Centre d'Investigation Clinique 1403 -CHU Lille, Lille, France|Centre d'investigation clinique Infectiologie Hôtel-Dieu CHU Nantes, Nantes, France|Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France|Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard, Paris, France|Hôpital Cochin CIC 1417 Bâtiment Lavoisier, Paris, France|Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou, Rennes, France|Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord, Saint Denis, France|Département maladie infectieux CHU Saint Etienne, Saint Etienne, France|Centre d'Investigation Clinique Ile de la Réunion CHU sud, Saint-Pierre, France|Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau, Tours, France|Centre Investigation Clinique 1433 CHRU de NANCY, Vandœuvre-lès-Nancy, France|Service de Maladies infectieuses et tropicales Centre hospitalier, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04322279
Principal Investigator,"Xavier Mariette, MD, PhD","Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris",,NCT04341584,xavier mariette,xavier,male,0.99,36056,2200,NCT04341584,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Not yet recruiting,No Results Available,Corona Virus Infection,Drug: Anakinra,"April 10, 2020",,https://ClinicalTrials.gov/show/NCT04341584
Principal Investigator,"Xavier Duval, MD","Institut National de la Santé Et de la Recherche Médicale, France",,NCT04259892,xavier duval,xavier,male,0.99,36056,2208,NCT04259892,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,Recruiting,No Results Available,Coronavirus,Biological: 2019-nCoV PCR,"February 7, 2020","Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon, Besançon, France|Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, Bordeaux, France|Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand, Clermont-Ferrand, France|Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne, Dijon, France|Centre d'investigation clinique 1406 CHU Grenoble, Grenoble, France|Centre d'Investigation Clinique 1403 -CHU Lille, Lille, France|Centre Investigation Clinique 1433 CHRU de NANCY, Nancy, France|Centre d'investigation clinique Infectiologie Hôtel-Dieu CHU Nantes, Nantes, France|Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France|Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard, Paris, France|Centre Investigation Clinique 1417 Hôpital Cochin Bâtiment Lavoisier, Paris, France|Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou, Rennes, France|Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord, Saint Denis, France|Centre d'Investigation Clinique Ile de la Réunion CHU sud, Saint-Pierre, France|Département maladie infectieux CHU Saint Etienne, Saint-Étienne, France|Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau, Tours, France|Service de Maladies infectieuses et tropicales Centre hospitalier, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04259892
Principal Investigator,"Helen Sambatakou, MD","Athens General Hospital ""Hippokrateio"", 2nd department of Pathology",,NCT04344951,helen sambatakou,helen,female,0.98,32058,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Nikolaos Koulouris, MD","Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic",,NCT04344951,nikolaos koulouris,nikolaos,male,0.99,1396,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Garyfallia Poulakou, MD","Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic",,NCT04344951,garyfallia poulakou,garyfallia,female,0.88,16,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Malvina Lada, MD","General Hospital of Athens ""Sismanoglio"", 2nd Department of Pathology",,NCT04344951,malvina lada,malvina,female,0.98,1602,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Ioannis Baraboutis, MD","Divine Providence Hospital ""Pammakaristos"", Pathology Department",,NCT04344951,ioannis baraboutis,ioannis,male,0.99,2807,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Symeon Metallidis, MD","University General Hospital of Thessaloniki AHEPA, 1st University Pathology Clinic",,NCT04344951,symeon metallidis,symeon,male,0.97,59,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Haralambos Milionis, MD","University General Hospital of Ioannina, 1st University Pathology Clinic",,NCT04344951,haralambos milionis,haralambos,male,1.0,32,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,"Ilias Papanikolaou, MD","Corfu General Hospital Agia Irini, Pulmonary Clinic",,NCT04344951,ilias papanikolaou,ilias,male,0.99,5642,992,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Recruiting,No Results Available,"Pneumonia, Viral|Covid-19",Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,"April 14, 2020","Divine Providence Hospital ""Pammakaristos"", Athens, Greece|Athens General Hospital ""Hippokrateio"", Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases ""SOTIRIA"", 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens ""Sismanoglio"", Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04344951
Principal Investigator,Premal Lulla,Baylor College of Medicine,,NCT04401410,premal lulla,premal,male,0.9,30,278,NCT04401410,Anti-SARS Cov-2 T Cell Infusions for COVID 19,Not yet recruiting,No Results Available,SARS-CoV 2|Viral Infection|COVID 19,Biological: Partially HLA-matched Virus Specific T cells (VSTs),"May 26, 2020","Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04401410
Principal Investigator,"Dr.Joshua Rhein, MD","Department of Medicine, University of Minnesota",,NCT04363346,joshua rhein,joshua,male,0.99,20919,279,NCT04363346,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Recruiting,No Results Available,COVID-19,Drug: FT516,"April 27, 2020","University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04363346
Principal Investigator,"Stefania Fugazzaro, MD",Azienda USL - IRCCS of Reggio Emilia (Italy),,NCT04438239,stefania fugazzaro,stefania,female,0.99,39842,281,NCT04438239,Rehabilitation Needs After COVID-19 Hospital Treatment,Not yet recruiting,No Results Available,Covid-19,"Other: none, this study is observational","June 18, 2020",,https://ClinicalTrials.gov/show/NCT04438239
Principal Investigator,"Sherry Mansour, MD, MS",Yale University,,NCT04342689,sherry mansour,sherry,female,0.9,3544,282,NCT04342689,The Role of Resistant Starch in COVID-19 Infection,Recruiting,No Results Available,COVID-19,Drug: Dietary Supplement containing resistant starch|Dietary Supplement: Placebo Starch,"April 13, 2020","Yale University, New Haven, Connecticut, United States|University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04342689
Principal Investigator,"Paolo Fiorina, MD, PhD",ASST FBF Sacco,,NCT04382794,paolo fiorina,paolo,male,0.99,102713,283,NCT04382794,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,Completed,No Results Available,Covid19,Drug: Retrospective case-control analysis,"May 11, 2020","ASST FBF-Sacco P.O. Sacco, Milan, MI, Italy|Papa Giovanni XXIII Hospital, Bergamo, Italy|Ospedale dell'Angelo, Venezia-Mestre, Mestre, Italy|Humanitas Hospital, Milan, Italy|University of Pavia, Pavia, Italy|IRCCS Policlinico S. Matteo, Pavia, Italy",https://ClinicalTrials.gov/show/NCT04382794
Principal Investigator,"Paolo Simioni, Prof.","Department of Medicine, University of Padua (I)",,NCT04393805,paolo simioni,paolo,male,0.99,102713,977,NCT04393805,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,Not yet recruiting,No Results Available,COVID-19|Hypercoagulability,Drug: Low Molecular Weight Heparin,"May 19, 2020",,https://ClinicalTrials.gov/show/NCT04393805
Principal Investigator,"Paolo Simioni, MD","Department of Medicine, University of Padua (I)",,NCT04359212,paolo simioni,paolo,male,0.99,102713,1071,NCT04359212,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Not yet recruiting,No Results Available,"COVID-19 Disease|Thromboembolism, Venous",Drug: thromboprophylaxis with low-molecular-weight heparin or fondaparinux,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359212
Principal Investigator,"Paolo Fiorina, MD, PhD",University of Milan,,NCT04365517,paolo fiorina,paolo,male,0.99,102713,1440,NCT04365517,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Not yet recruiting,No Results Available,"Covid19|Diabetes Mellitus, Type 2|CKD",Drug: Sitagliptin,"April 28, 2020","ASST FBF Sacco, Milan, Italy",https://ClinicalTrials.gov/show/NCT04365517
Principal Investigator,"Michele L Donato, MD",Hackensack Meridian Health,,NCT04343755,michele l donato,michele,male,0.86,88388,287,NCT04343755,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,Recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma,"April 13, 2020","Hackensack University Medical Center, Hackensack, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04343755
Principal Investigator,"Ali Mostafaie, PhD","Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.",,NCT04392141,ali mostafaie,ali,male,0.95,319583,292,NCT04392141,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,Recruiting,No Results Available,COVID-19,Drug: Standard Treatment|Drug: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions,"May 18, 2020","Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04392141
Principal Investigator,"Ali R Rezai, MD",West Virginia University,,NCT04402840,ali r rezai,ali,male,0.95,319583,999,NCT04402840,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Procedure: Stellate Ganglion Block,"May 27, 2020","West Virginia University Rockefeller Neuroscience Institute, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04402840
Principal Investigator,"Ali Asan, MD",Bursa Yuksek Ihtisas Training and Research Hospital,,NCT04383483,ali asan,ali,male,0.95,319583,2265,NCT04383483,"CoV-ICU Score, Intensive Care Unit, SARS-CoV-2",Recruiting,No Results Available,Coronavirus as the Cause of Diseases Classified Elsewhere,Other: COVICU,"May 12, 2020","Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Yildirim, Turkey",https://ClinicalTrials.gov/show/NCT04383483
Principal Investigator,Marlies Ostermann,"Department of Critical Care, Guy's & St Thomas' Hospital",,NCT04408326,marlies ostermann,marlies,female,0.98,2218,294,NCT04408326,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,Recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome,Drug: Angiotensin II|Drug: Interleukin-1 receptor antagonist,"May 29, 2020","Guy's & St Thomas' Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408326
Principal Investigator,"Marlies Ostermann, MD, PhD",Guy's and St Thomas' NHS Foundation Trust,,NCT04408248,marlies ostermann,marlies,female,0.98,2218,981,NCT04408248,AKI Biomarkers in Coronavirus(COVID)-19,Not yet recruiting,No Results Available,COVID|Acute Respiratory Failure|Acute Kidney Injury,,"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04408248
Study Director,"Guido Bertolini, MD",Istituto di Ricerche Farmacologiche Mario Negri IRCCS,,NCT04323878,guido bertolini,guido,male,0.99,15568,295,NCT04323878,Early CPAP in COVID Patients With Respiratory Failure. A Prospective Cohort Study.,Not yet recruiting,No Results Available,Early CPAP Ventilation in COVID-19 Patients,,"March 27, 2020",,https://ClinicalTrials.gov/show/NCT04323878
Principal Investigator,"Guido Bertolini, MD",Mario Negri Institute for Pharmacological Research,,NCT04361916,guido bertolini,guido,male,0.99,15568,389,NCT04361916,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Recruiting,No Results Available,COVID-19,Other: home care monitoring,"April 24, 2020","Asl Alessandria, Casale Monferrato, Alessandria, Italy",https://ClinicalTrials.gov/show/NCT04361916
Principal Investigator,"Guido Beldi, Prof. Dr.","University Hospital Inselspital, Berne",,NCT04333862,guido beldi,guido,male,0.99,15568,834,NCT04333862,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Recruiting,No Results Available,SARS-CoV-2,,"April 3, 2020","Guido Beldi, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04333862
Principal Investigator,"Guido Bertolini, MD",Istituto di Ricerche Farmacologiche Mario Negri IRCCS,,NCT04326075,guido bertolini,guido,male,0.99,15568,1091,NCT04326075,Early CPAP in COVID Patients With Respiratory Failure.,Not yet recruiting,No Results Available,CPAP Ventilation|COVID-19|Emergency Departments,Device: CPAP treatment,"March 30, 2020",,https://ClinicalTrials.gov/show/NCT04326075
Principal Investigator,"Hani Al-Hashmi, MD",King Fahad Specialist Hospital,,NCT04347681,hani al-hashmi,hani,male,0.84,8274,297,NCT04347681,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,Recruiting,No Results Available,Convalescent Plasma for COVID 19,Other: convalescent plasma from recovered COVID 19 donor,"April 15, 2020","John Hopkins Aramco Healthcare, Dhahran, Eastern Provence, Saudi Arabia|Dammam Medical Complex, Dammam, Saudi Arabia|Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia|king Fahad specialist hospital, Dammam, Saudi Arabia|DHahran Military Medical Complex, Dhahran, Saudi Arabia|International Medical Center, Jeddah, Saudi Arabia|Madinah General Hospital, Medina, Saudi Arabia|Ohud Hospital, Medina, Saudi Arabia|Taibah University, Medina, Saudi Arabia|Qatif Central Hospital, Qatif, Saudi Arabia|King Abdulaziz Medical City, Riyadh, Saudi Arabia|King Fahad Medical City, Riyadh, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia|King Khalid University Hospital, Riyadh, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04347681
Principal Investigator,"Allison J McGeer, MD",MOUNT SINAI HOSPITAL,,NCT04448119,allison j mcgeer,allison,female,0.93,4385,298,NCT04448119,Control of COVID-19 Outbreaks in Long Term Care,Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Favipiravir|Drug: Favipiravir Placebo,"June 25, 2020",,https://ClinicalTrials.gov/show/NCT04448119
Study Director,"Todd Zimmerman, MD",BeiGene,,NCT04382586,todd zimmerman,todd,male,0.99,6598,299,NCT04382586,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,Recruiting,No Results Available,COVID-19 Pulmonary Complications|COVID-19,Drug: Zanubrutinib|Drug: Supportive Care|Drug: Placebo,"May 11, 2020","MedStar Heath Research Institute/ MedStar Washington Hospital Center, Washington, District of Columbia, United States|Loyola University Medical Center, Maywood, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham And Women's Hospital, Boston, Massachusetts, United States|Atlantic Health System Inc. / Morristown Medical Center, Morristown, New Jersey, United States|Rutgers University Hospital, Newark, New Jersey, United States|Overlook Medical Center, Summit, New Jersey, United States|Covenant Health System, Lubbock, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04382586
Principal Investigator,"Todd W Rice, MD, MSc",Vanderbilt University Medical Center,,NCT04359797,todd w rice,todd,male,0.99,6598,548,NCT04359797,COVID-19 Patient Positioning Pragmatic Trial,Enrolling by invitation,No Results Available,COVID-19,Other: Prone|Other: Usual Care,"April 24, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04359797
Principal Investigator,"Todd Rice, MD",Vanderbilt University Medical Center,,NCT04372628,todd rice,todd,male,0.99,6598,656,NCT04372628,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir/ritonavir 400 mg/100 mg|Other: Placebo,"May 4, 2020","University of Colorado School of Medicine, Aurora, Colorado, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04372628
Principal Investigator,"Todd Seto, MD",The Queen's Medical Center,,NCT04412772,todd seto,todd,male,0.99,6598,681,NCT04412772,A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS,Recruiting,No Results Available,COVID-19,Drug: Tocilizumab|Drug: Placebo,"June 2, 2020","Queen's Medical Center, Honolulu, Hawaii, United States",https://ClinicalTrials.gov/show/NCT04412772
Principal Investigator,"Todd Seto, MD",Queen's Medical Centre,,NCT04345692,todd seto,todd,male,0.99,6598,747,NCT04345692,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine,"April 14, 2020","Queen's Medical Center, Honolulu, Hawaii, United States",https://ClinicalTrials.gov/show/NCT04345692
Principal Investigator,"Todd Rice, MD",Vanderbilt University Medical Center,,NCT04362176,todd rice,todd,male,0.99,6598,995,NCT04362176,Passive Immunity Trial of Nashville II for COVID-19,Recruiting,No Results Available,COVID-19|Coronavirus|SARS-CoV-2,Biological: pathogen reduced SARS-CoV-2 convalescent plasma|Biological: Placebo,"April 24, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04362176
Principal Investigator,"Todd C Lee, MD MPH FIDSA",Research Institute of the McGill University Health Centre,,NCT04421664,todd c lee,todd,male,0.99,6598,1823,NCT04421664,Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),Recruiting,No Results Available,Corona Virus Infection|SARS-CoV Infection|Coronavirus,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"June 9, 2020","University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of British Columbia, Vancouver, British Columbia, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Eastern Health, Saint John's, Newfoundland and Labrador, Canada|McMaster University, Hamilton, Ontario, Canada|Lawson Health Research Institute, London, Ontario, Canada|Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04421664
Principal Investigator,"Joseph Conigliaro, MD",Northwell Health,,NCT04370262,joseph conigliaro,joseph,male,0.99,60259,300,NCT04370262,Multi-site Adaptive Trials for COVID-19,Recruiting,No Results Available,COVID-19,Drug: SOC + Intravenous Famotidine|Drug: SOC + Placebo,"April 30, 2020","Southside Hospital, Bay Shore, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Northern Westchester Hospital, Mount Kisco, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States",https://ClinicalTrials.gov/show/NCT04370262
Principal Investigator,"Joseph Cheriyan, MBCHB, FRCP",Cambridge University Hospitals NHS Foundation Trust,,NCT04352933,joseph cheriyan,joseph,male,0.99,60259,337,NCT04352933,PROLIFIC ChemoprophylaxisTrial (COVID-19),Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine - Daily dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Matched Placebo Hydroxychloroquine,"April 20, 2020","Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04352933
Principal Investigator,"Joseph Vinetz, M.D.","Professor, Section of Infectious Diseases: Department of Internal Medicine",,NCT04353284,joseph vinetz,joseph,male,0.99,60259,601,NCT04353284,Camostat Mesylate in COVID-19 Outpatients,Recruiting,No Results Available,COVID-19,Drug: Camostat Mesilate|Other: Placebo,"April 20, 2020","Yale University, New Haven, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04353284
Principal Investigator,"Joseph Cheriyan, MBChB MA FRCP",Cambridge University Hospitals NHS Foundation Trust,,NCT04393246,joseph cheriyan,joseph,male,0.99,60259,718,NCT04393246,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Not yet recruiting,No Results Available,COVID-19,Drug: EDP1815|Drug: Dapagliflozin|Drug: Ambrisentan|Other: Standard of care,"May 19, 2020","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04393246
Principal Investigator,"Joseph Walline, MD",Chinese University of Hong Kong,,NCT04377464,joseph walline,joseph,male,0.99,60259,824,NCT04377464,COVID-19 - Quality of Life After Infection,Not yet recruiting,No Results Available,COVID-19|Quality of Life,"Other: SF12, EQ-5D-5L and work status standardized quantitative assessments","May 6, 2020",,https://ClinicalTrials.gov/show/NCT04377464
Principal Investigator,"Joseph Woo, MD",Stanford University,,NCT04381013,joseph woo,joseph,male,0.99,60259,1332,NCT04381013,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Not yet recruiting,No Results Available,COVID-19,Device: Emergency Ventilator Splitter,"May 8, 2020","Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04381013
Study Director,"Robert W Körner, Dr.",Children's University Hospital Cologne,,NCT04341168,robert w körner,robert,male,0.99,177418,301,NCT04341168,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Other: this study is non- interventional,"April 10, 2020","University Hospital Cologne, Cologne, NRW, Germany",https://ClinicalTrials.gov/show/NCT04341168
Study Director,"Miguel A Alejandre Alcazar, Prof. Dr. Dr.",Children's University Hospital Cologne,,NCT04341168,miguel a alejandre alcazar,miguel,male,0.99,158479,301,NCT04341168,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Other: this study is non- interventional,"April 10, 2020","University Hospital Cologne, Cologne, NRW, Germany",https://ClinicalTrials.gov/show/NCT04341168
Principal Investigator,"Robert CAIAZZO, MD,PhD","University Hospital, Lille",,NCT04395599,robert caiazzo,robert,male,0.99,177418,340,NCT04395599,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,Not yet recruiting,No Results Available,Sars-CoV2|Surgery|COVID,"Other: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.","May 20, 2020",,https://ClinicalTrials.gov/show/NCT04395599
Principal Investigator,"Robert J Kreitman, M.D.",National Cancer Institute (NCI),,NCT04362865,robert j kreitman,robert,male,0.99,177418,396,NCT04362865,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,Recruiting,No Results Available,COVID-19,,"April 27, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04362865
Study Chair,"Robert O Dillman, MD",AIVITA Biomedical,,NCT04386252,robert o dillman,robert,male,0.99,177418,766,NCT04386252,Phase Ib-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,Not yet recruiting,No Results Available,COVID-19,Biological: AV-COVID-19,"May 13, 2020","Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States",https://ClinicalTrials.gov/show/NCT04386252
Study Director,"Robert Gordon, MD",CTI Clinical Trial & Consulting Services,,NCT04447404,robert gordon,robert,male,0.99,177418,1501,NCT04447404,DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury,Recruiting,No Results Available,SARS-CoV 2,Drug: DUR-928|Drug: Placebo,"June 25, 2020","Site 02, Chicago, Illinois, United States|Site 01, Detroit, Michigan, United States|Site 03, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04447404
Principal Investigator,"Robert Frithiof, MD. PhD",Uppsala University Hospital,,NCT04316884,robert frithiof,robert,male,0.99,177418,1760,NCT04316884,Mechanisms for Organ Dysfunction in Covid-19,Recruiting,No Results Available,"COVID-19|Organ Dysfunction Syndrome Sepsis|Organ Dysfunction Syndrome, Multiple|Septic Shock|Acute Kidney Injury|Acute Respiratory Distress Syndrome",,"March 20, 2020","Uppsala University Hospital, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04316884
Principal Investigator,"Robert P Lennon, MD, JD",Penn State College of Medicine,,NCT04377581,robert p lennon,robert,male,0.99,177418,1790,NCT04377581,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Recruiting,No Results Available,Public Health|Demography|Pandemics|Corona Virus Infection|News|Global Health|Perception,,"May 6, 2020","Penn State College of Medicine, Hershey, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04377581
Principal Investigator,Robert G Maunder,Sinai Health,,NCT04373382,robert g maunder,robert,male,0.99,177418,1918,NCT04373382,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Burnout,Behavioral: Peer Resilience Champion|Behavioral: Enriched Survey Feedback,"May 4, 2020","Sinai Health, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04373382
Study Chair,"Robert W Alexander, MD",Global Alliance Regenerative Medicine,,NCT04326036,robert w alexander,robert,male,0.99,177418,2168,NCT04326036,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,Enrolling by invitation,No Results Available,Pulmonary Alveolar Proteinosis|COPD|Idiopathic Pulmonary Fibrosis|Viral Pneumonia|Coronavirus Infection|Interstitial Lung Disease,Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)|Device: Centricyte 1000|Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution|Drug: Liberase Enzyme (Roche)|Drug: Sterile Normal Saline for Intravenous Use,"March 30, 2020","Robert W. Alexander, MD, FICS, LLC, Stevensville, Montana, United States",https://ClinicalTrials.gov/show/NCT04326036
Principal Investigator,"Miguel Sánchez García, MD",Hospital Clínico San Carlos,,NCT04393324,miguel sánchez garcía,miguel,male,0.99,158479,1135,NCT04393324,The Critical Care Response to the COVID-19 Pandemic in Madrid,Recruiting,No Results Available,"COVID-19|ARDS, Human",,"May 19, 2020","Hospital Clinico San Carlos, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04393324
Study Chair,"Faida Ajili, MD",Military Hospital of Tunis,,NCT04377646,faida ajili,faida,female,0.9,107,303,NCT04377646,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Not yet recruiting,No Results Available,Sars-CoV2|COVID19,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine (placebo)|Drug: Zinc|Drug: Zinc (Placebo),"May 6, 2020","Military Hospital of Tunis, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04377646
Study Director,"Nejla Mrabet, PhD",Military Hospital of Tunis,,NCT04377646,nejla mrabet,nejla,female,0.97,2024,303,NCT04377646,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Not yet recruiting,No Results Available,Sars-CoV2|COVID19,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine (placebo)|Drug: Zinc|Drug: Zinc (Placebo),"May 6, 2020","Military Hospital of Tunis, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04377646
Principal Investigator,"nejla uzun, MSc, Pt",Istanbul University-Cerrahpasa,,NCT04403438,nejla uzun,nejla,female,0.97,2024,1269,NCT04403438,Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic,Enrolling by invitation,No Results Available,Behcet Disease|COVID|FMF,"Other: ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF.","May 27, 2020","IstanbulU, Istanbul, Bakırköy, Turkey",https://ClinicalTrials.gov/show/NCT04403438
Principal Investigator,Matthias Salathe,University of Kansas Medical Center,,NCT04335123,matthias salathe,matthias,male,1.0,26402,305,NCT04335123,Study of Open Label Losartan in COVID-19,Recruiting,No Results Available,COVID-19,Drug: Losartan,"April 6, 2020","University of Kansas Medical Center, Kansas City, Kansas, United States",https://ClinicalTrials.gov/show/NCT04335123
Principal Investigator,"Matthias Jörg, MD","Emergency Department, University Hospital Linköping, Sweden",,NCT04400877,matthias jörg,matthias,male,1.0,26402,1638,NCT04400877,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Recruiting,No Results Available,COVID-19|Venous Thromboembolism|Pulmonary Embolism|Deep Vein Thrombosis|SARS-CoV 2,Diagnostic Test: Diagnostic examination for venous thromboembolism,"May 26, 2020","University Hospital Linköping, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04400877
Principal Investigator,"Jens Wretborn, MD","Emergency Department, University Hospital Linköping, Sweden",,NCT04400877,jens wretborn,jens,male,0.99,23807,1638,NCT04400877,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Recruiting,No Results Available,COVID-19|Venous Thromboembolism|Pulmonary Embolism|Deep Vein Thrombosis|SARS-CoV 2,Diagnostic Test: Diagnostic examination for venous thromboembolism,"May 26, 2020","University Hospital Linköping, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04400877
Principal Investigator,"Patrik Benjaminsson Nyberg, PhD","Emergency Department, University Hospital Linköping, Sweden",,NCT04400877,patrik benjaminsson nyberg,patrik,male,0.99,19252,1638,NCT04400877,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Recruiting,No Results Available,COVID-19|Venous Thromboembolism|Pulmonary Embolism|Deep Vein Thrombosis|SARS-CoV 2,Diagnostic Test: Diagnostic examination for venous thromboembolism,"May 26, 2020","University Hospital Linköping, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04400877
Principal Investigator,Wing Hang Leung,"KK Hospital, SingHealth, Duke-NUS",,NCT04351659,wing hang leung,wing,male,0.59,1284,306,NCT04351659,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,Recruiting,No Results Available,COVID-19,Other: Blood donation from convalescent donor,"April 17, 2020","National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04351659
Principal Investigator,"Riham H Raafat, MD",Ainshams university,,NCT04403581,riham h raafat,riham,female,0.97,977,307,NCT04403581,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",Not yet recruiting,No Results Available,Covid-19,Other: Questionnaire,"May 27, 2020",,https://ClinicalTrials.gov/show/NCT04403581
Study Director,"Johanne SILVAIN, MD PhD","Sorbonne University, ACTION Group, AP-HP Pitié-Salpêtrière Hospital Paris France",,NCT04344912,johanne silvain,johanne,female,0.93,1655,308,NCT04344912,Impact of COVID19 Outbreak in Cardiac Acute Care,Recruiting,No Results Available,Acute Coronary Syndrome|Heart Failure|COVID,Other: Data collection,"April 14, 2020","Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04344912
Study Chair,"Gilles MONTALESCOT, MD PhD","Sorbonne University, ACTION Group, AP-HP Pitié-Salpêtrière Hospital Paris France",,NCT04344912,gilles montalescot,gilles,male,0.99,26205,308,NCT04344912,Impact of COVID19 Outbreak in Cardiac Acute Care,Recruiting,No Results Available,Acute Coronary Syndrome|Heart Failure|COVID,Other: Data collection,"April 14, 2020","Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP, Paris, France",https://ClinicalTrials.gov/show/NCT04344912
Principal Investigator,"Gilles MONTALESCOT, MD, PhD",Institut Cardiologie - Pitié Salpêtrière(APHP) / ACTION Study Group / Univ. Paris 6 (UPMC) - INSERM UMRS 1166,,NCT04329195,gilles montalescot,gilles,male,0.99,26205,1536,NCT04329195,ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic,Recruiting,No Results Available,History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection,Drug: 1: discontinuation of RAS blocker therapy|Drug: 2: continuation of RAS blocker therapy,"April 1, 2020","Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04329195
Study Director,"Sylvie BASTUJI-GARIN, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04386759,sylvie bastuji-garin,sylvie,female,0.98,65175,313,NCT04386759,COVID-19 Infection in Healthcare Workers,Not yet recruiting,No Results Available,COVID-19,Other: Cohort,"May 13, 2020","Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil, France",https://ClinicalTrials.gov/show/NCT04386759
Principal Investigator,Mohamed M Moussa,Ain Shams University,,NCT04376788,mohamed m moussa,mohamed,male,0.98,175927,315,NCT04376788,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,Not yet recruiting,No Results Available,COVID-19,Biological: exchange blood transfusion from normal donor|Biological: plasma from convalescent patients with COVID-19|Drug: Methylene Blue 5 MG/ML,"May 6, 2020","Ain Shams University, Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04376788
Principal Investigator,"Mohamed F. Mostafa, MD",membership/educator,,NCT04413045,mohamed f. mostafa,mohamed,male,0.98,175927,547,NCT04413045,"Novel COVID-19, A National Analysis",Recruiting,No Results Available,COVID-19,Other: Prevalence of COVID-19,"June 2, 2020","Assiut University Hospitals, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04413045
Principal Investigator,"Mohamed El Darouti, Professor",Cairo University,,NCT04383717,mohamed el darouti,mohamed,male,0.98,175927,1530,NCT04383717,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,Not yet recruiting,No Results Available,Respiratory Tract Infections,Drug: Levamisole and isoprinosine|Drug: Azithromycin and hydroxychloroquine,"May 12, 2020",,https://ClinicalTrials.gov/show/NCT04383717
Principal Investigator,"Janneke Cox, MD, PhD",Jessa Hospital,,NCT04366882,janneke cox,janneke,female,0.98,1429,316,NCT04366882,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Recruiting,No Results Available,COVID-19,Procedure: CT-scan with minimal invasive autopsy,"April 29, 2020","Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04366882
Principal Investigator,"Kamal Okasha, Md, PhD",Tanta University,,NCT04360356,kamal okasha,kamal,male,0.97,23590,317,NCT04360356,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Not yet recruiting,No Results Available,COVID-19,Combination Product: Ivermectin plus Nitazoxanide|Other: Standard Care,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04360356
Principal Investigator,"Kamal Okasha, MD, PhD",Tanta University,,NCT04361318,kamal okasha,kamal,male,0.97,23590,325,NCT04361318,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Not yet recruiting,No Results Available,COVID-19,Combination Product: Hydroxychloroquine plus Nitazoxanide|Other: Standard care,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04361318
Study Director,"Edouard TUAILLON, MD; PhD",UH MONTPELLIER,,NCT04347850,edouard tuaillon,edouard,male,0.98,6348,321,NCT04347850,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Recruiting,No Results Available,SARS-CoV-2|COVID-19,Other: blood sample,"April 15, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04347850
Study Chair,"Mikhail Kosiborod, MD",Saint Luke's Mid America Heart Institute,,NCT04350593,mikhail kosiborod,mikhail,male,0.99,3514,322,NCT04350593,Dapagliflozin in Respiratory Failure in Patients With COVID-19,Recruiting,No Results Available,COVID-19,Drug: Dapagliflozin 10 MG|Drug: Placebo,"April 17, 2020","NorthShore University HealthSystem, Evanston, Illinois, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Luke's Mid America Heart Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Jacobi Medical Center, Bronx, New York, United States|St. Francis Hospital, Roslyn, New York, United States|Sentara Healthcare, Norfolk, Virginia, United States",https://ClinicalTrials.gov/show/NCT04350593
Study Director,Mikhail Samsonov,"Chief Medical Officer, R-Pharm",,NCT04380519,mikhail samsonov,mikhail,male,0.99,3514,544,NCT04380519,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Recruiting,No Results Available,COVID-19,Biological: RPH-104 80 mg|Drug: Olokizumab 64 mg|Drug: Placebo,"May 8, 2020","Federal State Budget Institution ""National Medical Surgery Center named after N.I. Pirogov"" of Ministry of Health of Russian Federation, Moscow, Russian Federation|State Budget Healthcare Institution ""City Clinical Hospital № 15 named after O.M. Filatov"" of Moscow City Healthcare Department, Moscow, Russian Federation|Federal State Budgetary Institution ""Federal Center for Cerebrovascular Pathology and Stroke"" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation|Federal State Autonomous Education Insitution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of Russian Federation (Sechenov University), Moscow, Russian Federation|Federal State Budget Institution ""National Medicine Research Center on Cardiology"" By Ministry of Healthcare of Russian Federation, Moscow, Russian Federation|State Budget Institution of Healthcare ""City Clinical Hospital #52"", Moscow City Healthcare Department, Moscow, Russian Federation|Moscow State Budget Institution of Healthcare ""Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare"", Moscow, Russian Federation|State Budget Healthcare Institution ""City Clinical Hospital #40"", Moscow City Healthcare Department, ""Communarca"" Division, Moscow, Russian Federation|АО ""State Company ""Medsi"" based on Clinical Hospital №1"", Moscow, Russian Federation|Saint Petersburg State Budget Institution of Healthcare ""Clinical infectious diseases hospital named after S.P. Botkin"", Saint Petersburg, Russian Federation|Saint-Petersburg State Budget Institution of Healthcare ""City Hospital №40"", Saint Petersburg, Russian Federation",https://ClinicalTrials.gov/show/NCT04380519
Principal Investigator,"Yimin Li, PhD, MD",The First Affiliated Hospital of Guangzhou Medical University,,NCT04287686,yimin li,yimin,male,0.85,52,324,NCT04287686,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Withdrawn,No Results Available,COVID-19,Drug: Recombinant human angiotensin-converting enzyme 2 (rhACE2),"February 27, 2020","GCP Office of The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04287686
Principal Investigator,"LOUIS BERNARD, MD, PhD",CHRU DE TOURS,,NCT04359511,louis bernard,louis,male,0.97,26805,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"JOUNEAU STEPHANE, MD, PhD",Rennes University Hospital,,NCT04359511,jouneau stephane,jouneau,male,1.0,2,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"MAILLOT FRANCOIS, MD",CHRU DE TOURS,,NCT04359511,maillot francois,maillot,male,0.59,148,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"LIOGER BERTRAND, MD",CH DE BLOIS,,NCT04359511,lioger bertrand,lioger,male,1.0,3,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"GOUPIL FRANCOIS, MD",CH Le Mans,,NCT04359511,goupil francois,goupil,male,0.76,99,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"RABUT Thi- Tuyet Hong, MD",CH DE CHARTRES,,NCT04359511,rabut thi- tuyet hong,rabut,male,0.75,4,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"POPA Mihai, MD",CH DE RDREUX,,NCT04359511,popa mihai,popa,male,0.55,3950,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"MOREL HUGUES, MD",CHR ORLEANS,,NCT04359511,morel hugues,morel,male,0.68,886,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"GUY TIPHAINE, MD",CH DE VANNES,,NCT04359511,guy tiphaine,guy,male,0.98,26733,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"LEMMENS BRUNO, MD",CH AMBOISE,,NCT04359511,lemmens bruno,lemmens,male,0.58,62,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"BAZIN YANN, MD",CH SAINT MALO,,NCT04359511,bazin yann,bazin,male,0.61,122,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"ROY XAVIER, MD",CH DE CHATEAUROUX,,NCT04359511,roy xavier,roy,male,0.98,21602,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"PECQUERIAUX OLIVIER, MD",CH DE BOURGES,,NCT04359511,pecqueriaux olivier,pecqueriaux,male,0.75,4,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"MARCHAND ADAM Sylvain, MD, PhD",CHRU DE TOURS,,NCT04359511,marchand adam sylvain,marchand,male,0.53,372,711,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Prednisone|Drug: Hydrocortisone,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359511
Principal Investigator,"Louis Grandjean, Dr",Great Ormond Street Hospital NHS Foundation Trust,,NCT04380896,louis grandjean,louis,male,0.97,26805,1212,NCT04380896,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Recruiting,No Results Available,SARS-CoV-2 Infection,Other: Blood test|Other: Standardised questionnaires,"May 8, 2020","Great Ormond Street Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04380896
Principal Investigator,"Nicolas Batlle, MD",,,NCT04363814,nicolas batlle,nicolas,male,0.99,116713,746,NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Biological: Bactek-R,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363814
Study Director,Guillermo Ángeles,,,NCT04363814,guillermo ángeles,guillermo,male,0.99,15173,746,NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Biological: Bactek-R,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363814
Principal Investigator,"Martín Martín, MD",,,NCT04363814,martín martín,martín,male,1.0,31,746,NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Biological: Bactek-R,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363814
Principal Investigator,Raymundo Hernández,,,NCT04363814,raymundo hernández,raymundo,male,0.99,395,746,NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Biological: Bactek-R,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363814
Principal Investigator,Natalia García,,,NCT04363814,natalia garcía,natalia,female,0.98,102542,746,NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19,Biological: Bactek-R,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363814
Principal Investigator,"Nicolas Nesseler, doctor",Rennes University Hospital,,NCT04397588,nicolas nesseler,nicolas,male,0.99,116713,1345,NCT04397588,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,Recruiting,No Results Available,ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2|Acute Refractory Heart Failure Related to SARS-CoV 2,,"May 21, 2020","Angers University Hospital, Angers, France|Besançon Hospital, Besançon, France|Brest university Hospital, Brest, France|Caen University Hospital, Caen, France|Clermont ferrand University hospital, Clermont-Ferrand, France|APHP Henri Mondor Paris University Hospital, Créteil, France|Dijon University Hospital, Dijon, France|Vendée Hospital, La Roche-sur-Yon, France|Grenoble University Hospital, La Tronche, France|APHP Kremli Bicetre Paris University Hospital, Le Kremlin-Bicêtre, France|Marie Lannelongue Hospital, Le Plessis-Robinson, France|Lens Hospital, Lens, France|Lille University Hospital, Lille, France|Limoges University Hospital, Limoges, France|Clinique de la Sauvegarde, Lyon, France|Lyon University Hospital, Lyon, France|Marseille Européen Hospital, Marseille, France|APHM la Timone- Marseille University Hospital, Marseille, France|Metz University Hospital, Metz, France|Montpellier University Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy University Hospital, Nancy, France|Nantes University Hospital, Nantes, France|Ambroise Paré Hospital, Neuilly-sur-Seine, France|Nimes University Hospital, Nimes, France|Institut Mutualiste Montsouris, Paris, France|APHP Hopital Européen Georges Pompidou - Paris University Hospital, Paris, France|APHP necker Paris University Hospital, Paris, France|APHP Bichat - Paris University Hospital, Paris, France|Bordeaux University Hospital, Pessac, France|Poitiers University hospital, Poitiers, France|Reims University hospital, Reims, France|Rennes University hospital, Rennes, France|Rouen University Hospital, Rouen, France|Saint brieuc Hospital, Saint brieuc, France|La Réunion University Hospital, Saint-Denis, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg University Hospital, Strasbourg, France|Toulouse University Hospital - Rangueil Hospital, Toulouse, France|Tours University Hospital, Tours, France|Bretagne Atlantique Hospital, Vannes, France",https://ClinicalTrials.gov/show/NCT04397588
Principal Investigator,"André Vincentelli, professor",Lille University Hospital,,NCT04397588,andré vincentelli,andré,male,1.0,3,1345,NCT04397588,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,Recruiting,No Results Available,ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2|Acute Refractory Heart Failure Related to SARS-CoV 2,,"May 21, 2020","Angers University Hospital, Angers, France|Besançon Hospital, Besançon, France|Brest university Hospital, Brest, France|Caen University Hospital, Caen, France|Clermont ferrand University hospital, Clermont-Ferrand, France|APHP Henri Mondor Paris University Hospital, Créteil, France|Dijon University Hospital, Dijon, France|Vendée Hospital, La Roche-sur-Yon, France|Grenoble University Hospital, La Tronche, France|APHP Kremli Bicetre Paris University Hospital, Le Kremlin-Bicêtre, France|Marie Lannelongue Hospital, Le Plessis-Robinson, France|Lens Hospital, Lens, France|Lille University Hospital, Lille, France|Limoges University Hospital, Limoges, France|Clinique de la Sauvegarde, Lyon, France|Lyon University Hospital, Lyon, France|Marseille Européen Hospital, Marseille, France|APHM la Timone- Marseille University Hospital, Marseille, France|Metz University Hospital, Metz, France|Montpellier University Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy University Hospital, Nancy, France|Nantes University Hospital, Nantes, France|Ambroise Paré Hospital, Neuilly-sur-Seine, France|Nimes University Hospital, Nimes, France|Institut Mutualiste Montsouris, Paris, France|APHP Hopital Européen Georges Pompidou - Paris University Hospital, Paris, France|APHP necker Paris University Hospital, Paris, France|APHP Bichat - Paris University Hospital, Paris, France|Bordeaux University Hospital, Pessac, France|Poitiers University hospital, Poitiers, France|Reims University hospital, Reims, France|Rennes University hospital, Rennes, France|Rouen University Hospital, Rouen, France|Saint brieuc Hospital, Saint brieuc, France|La Réunion University Hospital, Saint-Denis, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg University Hospital, Strasbourg, France|Toulouse University Hospital - Rangueil Hospital, Toulouse, France|Tours University Hospital, Tours, France|Bretagne Atlantique Hospital, Vannes, France",https://ClinicalTrials.gov/show/NCT04397588
Principal Investigator,Benjamin Lallemant,CHU Nimes,,NCT04354857,benjamin lallemant,benjamin,male,0.99,62465,328,NCT04354857,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Recruiting,No Results Available,COVID-19,Other: olfactory and gustatory tests,"April 21, 2020","CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04354857
Principal Investigator,"Benjamin Meder, Prof. Dr.",University Hospital Heidelberg,,NCT04376853,benjamin meder,benjamin,male,0.99,62465,487,NCT04376853,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,Recruiting,No Results Available,COVID-19,Device: Apple Watch Series 5,"May 6, 2020","Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany",https://ClinicalTrials.gov/show/NCT04376853
Principal Investigator,"Benjamin Mordmüller, Prof.",University Hospital Tübingen,,NCT04342221,benjamin mordmüller,benjamin,male,0.99,62465,887,NCT04342221,Hydroxychloroquine for COVID-19,Recruiting,No Results Available,"COVID-19, Hydroxychloroquine Sulfate",Drug: Hydroxychloroquine Sulfate|Drug: Placebo,"April 10, 2020","Institute for Tropical Medicine, Tübingen, Germany",https://ClinicalTrials.gov/show/NCT04342221
Principal Investigator,Benjamin Lallemant,CHU Nimes,,NCT04408391,benjamin lallemant,benjamin,male,0.99,62465,1164,NCT04408391,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,Not yet recruiting,No Results Available,Covid-19|Anosmia,Other: Brain MRI scan,"May 29, 2020","CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04408391
Study Chair,"Alexander R Precioso, MD, PhD",Instituto butantan,,NCT04408014,alexander r precioso,alexander,male,0.99,66065,370,NCT04408014,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo,Not yet recruiting,No Results Available,COVID|SARS-CoV 2,Diagnostic Test: Serological test|Diagnostic Test: Nasopharyngeal Swab|Diagnostic Test: Oropharyngeal Swab,"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04408014
Principal Investigator,"Alexander V Averyanov, MD, PhD","Federal Pulmonology Scientific and Research Institute, FMBA of Russia",,NCT04392414,alexander v averyanov,alexander,male,0.99,66065,697,NCT04392414,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,Recruiting,No Results Available,COVID-19,Biological: COVID-19 convalescent hyperimmune plasma|Biological: Non-convalescent fresh frozen plasma (Standard plasma),"May 18, 2020","Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04392414
Study Director,"Vladimir P Baklaushev, MD, PhD","Federal Research Clinical Center, FMBA of Russia",,NCT04392414,vladimir p baklaushev,vladimir,male,0.99,24429,697,NCT04392414,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,Recruiting,No Results Available,COVID-19,Biological: COVID-19 convalescent hyperimmune plasma|Biological: Non-convalescent fresh frozen plasma (Standard plasma),"May 18, 2020","Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04392414
Principal Investigator,"Alexander Supady, MD, MPH",University Clinic Freiburg,,NCT04405973,alexander supady,alexander,male,0.99,66065,1371,NCT04405973,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Extracorporeal Membrane Oxygenation|ARDS,Device: vv-ECMO,"May 28, 2020","University Clinic Freiburg, Freiburg, Germany",https://ClinicalTrials.gov/show/NCT04405973
Study Chair,"Alexander Zarbock, MD","University Hospital Muenster, Dept. of Anesthesiology, Intensive Care Medicine and Pain Therapy",,NCT04406688,alexander zarbock,alexander,male,0.99,66065,1456,NCT04406688,Prediction of Acute Kidney Injury in Patients With COVID-19,Not yet recruiting,No Results Available,Acute Kidney Injury|COVID-19|ARDS,,"May 28, 2020","University Hospital Münster, Münster, Germany",https://ClinicalTrials.gov/show/NCT04406688
Principal Investigator,"Alexander Supady, Dr., MPH",University Clinic Freiburg,,NCT04385771,alexander supady,alexander,male,0.99,66065,1571,NCT04385771,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Not yet recruiting,No Results Available,Coronavirus Infection|COVID|SARS-CoV 2|Respiratory Failure|Cytokine Storm|Extracorporeal Membrane Oxygenation,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),"May 13, 2020","University Clinic Freiburg, Freiburg, Germany",https://ClinicalTrials.gov/show/NCT04385771
Principal Investigator,"Alexander Supady, Dr., MPH",University Clinic Freiburg,,NCT04324528,alexander supady,alexander,male,0.99,66065,1689,NCT04324528,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Recruiting,No Results Available,Coronavirus|COVID-19|SARS-CoV Infection|Respiratory Failure|Cytokine Storm,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),"March 27, 2020","University Clinic Freiburg, Freiburg, Germany",https://ClinicalTrials.gov/show/NCT04324528
Principal Investigator,"Sreekanth Vemulapallli, MD",Duke University,,NCT04336774,sreekanth vemulapallli,sreekanth,male,0.99,148,330,NCT04336774,CAPTION AI to Minimize Risk of COVID Exposure,Recruiting,No Results Available,COVID-19,Device: Caption AI,"April 7, 2020","Duke Health, Durham, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04336774
Principal Investigator,"Alexandra Calmy, Prof",Hôpitaux Universitaires de Genève,,NCT04364022,alexandra calmy,alexandra,female,0.98,122985,336,NCT04364022,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Recruiting,No Results Available,Prevention of COVID-19,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|Drug: Lopinavir/ritonavir,"April 27, 2020","Universitätsspital Basel and SwissTPH, Basel, Switzerland|Hôpitaux Universitaires de Genève, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04364022
Principal Investigator,"Niklaus Labhardt, Prof",Universitätsspital Basel,,NCT04364022,niklaus labhardt,niklaus,male,0.98,113,336,NCT04364022,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Recruiting,No Results Available,Prevention of COVID-19,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|Drug: Lopinavir/ritonavir,"April 27, 2020","Universitätsspital Basel and SwissTPH, Basel, Switzerland|Hôpitaux Universitaires de Genève, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04364022
Principal Investigator,"Alexandra E Kejner, MD",Univesity of Kentucky,,NCT04364802,alexandra e kejner,alexandra,female,0.98,122985,828,NCT04364802,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Recruiting,No Results Available,COVID-19|SARS-CoV 2,Drug: Povidone-Iodine Nasal Spray and Gargle,"April 28, 2020","University of Kentucky, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04364802
Study Director,"Alexandra AUDEMARD-VERGER, MD-PhD",University Hospital of Tours,,NCT04364009,alexandra audemard-verger,alexandra,female,0.98,122985,1460,NCT04364009,Anakinra for COVID-19 Respiratory Symptoms,Recruiting,No Results Available,COVID-19 Infection|ANAKINRA Treatment|Optimized Standard of Care (oSOC),Drug: Anakinra plus oSOC|Drug: oSOC,"April 27, 2020","CHRU de TOURS, Tours, France",https://ClinicalTrials.gov/show/NCT04364009
Principal Investigator,"Amira Al Balakosy, M.D",Ain Shams University,,NCT04445610,amira al balakosy,amira,female,0.97,11084,343,NCT04445610,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,Not yet recruiting,No Results Available,Coronavirus (COVID-19),,"June 24, 2020","Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04445610
Study Chair,Hasan Haciosman,"academic staff, MD",,NCT04379310,hasan haciosman,hasan,male,0.97,100395,344,NCT04379310,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Completed,No Results Available,Covid-19,Drug: ACE Inhibitors and Calcium Channel Blockers,"May 7, 2020","Vital Hospital, Bahcelievler, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04379310
Principal Investigator,"Pierluigi Viale, MD","Infectious Diseases Unit, Dep. Med. and Surg. Science University of Bologna",,NCT04427098,pierluigi viale,pierluigi,male,0.99,4714,349,NCT04427098,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Recruiting,No Results Available,COVID-19,Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution|Drug: Enoxaparin,"June 11, 2020","Policlinico S. Orsola Malpighi Dipartimento Malattie Infettive, Bologna, Emilia Romagna, Italy|Azienda Ospedaliero-Universitaria di Parma Anestesia e Rianimazione Dipartimento di Medicina e Chirurgia, Parma, Emilia Romagna, Italy|I.R.C.C.S. ""Casa Sollievo della Sofferenza"", San Giovanni Rotondo (FG) UOVD Emostasi e trombosi- Poliambulatorio Giovanni Paolo II Viale Padre Pio n.7 San Giovanni Rotondo (FG), San Giovanni Rotondo, Foggia, Italy|Fondazione Poliambulanza Chirurgia Vascolare, Brescia, Italy|Piazzale Spedali Civili, 1, 25123 Brescia BS Medicina Interna UniBS 2° Medicina ASST Spedali Civili, Brescia, Italy|Azienda Ospedaliero-Universitaria ""Policlinico - V. Emanuele"", Catania Anestesia e Rianimazione UO Malattie Infettive, Catania, Italy|ASST Cremona Unità Operativa di Chirurgia Vascolare Dipartimento di Medicina di Laboratorio e di Radiologia- Centro Emostasi e Trombosi, Cremona, Italy|Ospedale Morgagni Pierantoni U.O.C. Malattie Infettive, Forlì, Italy|Ospedale Carlo Poma di Mantova MALATTIE INFETTIVE Padiglione 37 Str. Lago Paiolo, 10, 46100 Mantova, Mantova, Italy|AZIENDA OSPEDALIERA Regionale S CARLO POTENZA Struttura Complessa Interaziendale ""Malattie Infettive"", Matera, Italy|Ospedale San Raffaele Unità Funzionale dell'Unità Operativa di Malattie Infettive Osp. San Raffaele, Milano, Italy|Ospedale Amedeo di Savoia Torino Università di Torino Malattie Infettive, Torino, Italy|Azienda Ospedaliera Universitaria Integrata Verona UOC Malattie Infettive e Tropicali, Verona, Italy",https://ClinicalTrials.gov/show/NCT04427098
Study Chair,"Pierluigi Viale, Prof.",Univeristy of Bologna,,NCT04363827,pierluigi viale,pierluigi,male,0.99,4714,1538,NCT04363827,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Recruiting,No Results Available,COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2,Drug: Hydroxychloroquine,"April 27, 2020","Irst Irccs, Meldola, FC, Italy",https://ClinicalTrials.gov/show/NCT04363827
Study Chair,"Giovanni Martinelli, Prof.","Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS , Meldola Italy",,NCT04363827,giovanni martinelli,giovanni,male,0.99,104824,1538,NCT04363827,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Recruiting,No Results Available,COVID19|Hydroxychloroquine|Prophylaxis|Treatment|SARS-CoV-2,Drug: Hydroxychloroquine,"April 27, 2020","Irst Irccs, Meldola, FC, Italy",https://ClinicalTrials.gov/show/NCT04363827
Principal Investigator,Vicente Navarro,"Hospital universitario del Vinalopo, Elche, Spain",,NCT04390477,vicente navarro,vicente,male,0.98,20107,1145,NCT04390477,Study to Evaluate the Effect of a Probiotic in COVID-19,Recruiting,No Results Available,COVID-19|Coronavirus Infection,Dietary Supplement: Probiotic,"May 15, 2020","Hospital Universitario del Vinalopó, Elche, Alicante, Spain|Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain",https://ClinicalTrials.gov/show/NCT04390477
Principal Investigator,"Deba P Dhibar, MD","PGIMER, Chandigarh, India",,NCT04408456,deba p dhibar,deba,male,0.72,123,352,NCT04408456,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Recruiting,No Results Available,CoVID-19,Drug: HCQ|Other: Standard therapy,"May 29, 2020","Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India",https://ClinicalTrials.gov/show/NCT04408456
Principal Investigator,"Johan Ursing, MD, PhD",Danderyd Hospital,,NCT04390178,johan ursing,johan,male,0.99,41501,355,NCT04390178,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),"Active, not recruiting",No Results Available,COVID-19,Biological: SARS-CoV-2 convalescent plasma,"May 15, 2020","Danderyd Hospital, Danderyd, Sweden",https://ClinicalTrials.gov/show/NCT04390178
Principal Investigator,"Johan Ursing, MD, PhD",Danderyd Hospital,,NCT04384497,johan ursing,johan,male,0.99,41501,402,NCT04384497,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,Recruiting,No Results Available,COVID-19,Biological: SARS-CoV-2 convalescent plasma,"May 12, 2020","Danderyd Hospital, Danderyd, Stockholm, Sweden|Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04384497
Principal Investigator,"Francisco Moreno, MD","ABC Medical Center Internal Medicine Department. Mexico City, Mexico",,NCT04432103,francisco moreno,francisco,male,0.99,98797,356,NCT04432103,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,Not yet recruiting,No Results Available,Covid-19,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,"June 16, 2020",,https://ClinicalTrials.gov/show/NCT04432103
Principal Investigator,"Irma Hoyo, MD PHD","ABC Medical Center Internal Medicine Department. Mexico City, Mexico",,NCT04432103,irma hoyo,irma,female,0.98,7296,356,NCT04432103,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,Not yet recruiting,No Results Available,Covid-19,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,"June 16, 2020",,https://ClinicalTrials.gov/show/NCT04432103
Principal Investigator,"Benjamín Valente, MD MSc DTMH","ABC Medical Center Internal Medicine Department. Mexico City, Mexico",,NCT04432103,benjamín valente,benjamín,male,1.0,7,356,NCT04432103,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,Not yet recruiting,No Results Available,Covid-19,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,"June 16, 2020",,https://ClinicalTrials.gov/show/NCT04432103
Study Chair,"Francisco Azzato, MD","Department of Internal Medicine, Hospital de Clínicas 'José de San Martín', Facultad de Medicina, Universidad de Buenos Aires",,NCT04355936,francisco azzato,francisco,male,0.99,98797,433,NCT04355936,Telmisartan for Treatment of COVID-19 Patients,Recruiting,No Results Available,COVID-19 Drug Treatment,Drug: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.,"April 21, 2020","Hospital de Clínicas 'José de San Martín', Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ciudad De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04355936
Principal Investigator,"Mariano Duarte, MD","Hospital de Clínicas 'José de San Martín', Universidad de Buenos Aires",,NCT04355936,mariano duarte,mariano,male,0.98,14862,433,NCT04355936,Telmisartan for Treatment of COVID-19 Patients,Recruiting,No Results Available,COVID-19 Drug Treatment,Drug: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.,"April 21, 2020","Hospital de Clínicas 'José de San Martín', Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ciudad De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04355936
Principal Investigator,"Jessica Lin, MD, MSCR",UNC-Chapel Hill,,NCT04445233,jessica lin,jessica,female,0.98,144795,359,NCT04445233,COVID-19 Household Transmission Study,Recruiting,No Results Available,COVID-19,,"June 24, 2020","University of North Carolina Health Care, Chapel Hill, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04445233
Principal Investigator,"Jessica Justman, MD",Columbia University,,NCT04390503,jessica justman,jessica,female,0.98,144795,377,NCT04390503,Convalescent Plasma for COVID-19 Close Contacts,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Control (albumin 5%),"May 15, 2020","Columbia University Irving Medical Center/NYP, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04390503
Principal Investigator,"Jessica Manson, Dr",University College London Hospital,,NCT04385069,jessica manson,jessica,female,0.98,144795,1239,NCT04385069,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,Recruiting,No Results Available,COV-HI|COVID-19|COVID-19 (COV) Hyperinflammatory (HI) Syndrome,,"May 12, 2020","The Leeds Teaching Hospitals NHS Trust, St James University Hospital, Leeds, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle Upon Tyne, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Sheffield, United Kingdom",https://ClinicalTrials.gov/show/NCT04385069
Principal Investigator,"Esper G Kallás, PhD, MD",University of Sao Paulo General Hospital,,NCT04415086,esper g kallás,esper,male,0.57,54,360,NCT04415086,Treatment of Patients With COVID-19 With Convalescent Plasma,Recruiting,No Results Available,COVID-19,Biological: convalescent plasma,"June 4, 2020","University of Sao Paulo - General Hospital, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04415086
Principal Investigator,"Aldar Bourinbayar, MD/PhD",Immunitor LLC,,NCT04380532,aldar bourinbayar,aldar,male,0.98,54,361,NCT04380532,Tableted COVID-19 Therapeutic Vaccine,"Active, not recruiting",No Results Available,Covid19,Biological: V-SARS,"May 8, 2020","Immunitor Inc, Vancouver, BC - British Columbia, Canada|Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo, Mongolia",https://ClinicalTrials.gov/show/NCT04380532
Principal Investigator,Arnab Chakravarti,"James Cancer Hospital, Department of Radiation Oncology",,NCT04427566,arnab chakravarti,arnab,male,1.0,235,362,NCT04427566,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Recruiting,No Results Available,COVID-19,Radiation: Radiation therapy,"June 11, 2020","Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04427566
Study Chair,"Hao Li, Professor",Xiyuan Hospital of China Academy of Chinese Medical Sciences,,NCT04323332,hao li,hao,male,0.89,1289,365,NCT04323332,Traditional Chinese Medicine for Severe COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Traditional Chinese Medicine Prescription,"March 26, 2020","Hao Li, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04323332
Principal Investigator,"Rosario Garcia de Vicuña, MD PhD",Fundación de Investigación Biomédica - Hospital Universitario de La Princesa,,NCT04357808,rosario garcia de vicuña,rosario,male,0.69,23533,369,NCT04357808,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Recruiting,No Results Available,Covid-19,Drug: Sarilumab|Other: Standar of care,"April 22, 2020","Hospital Universitario de la Princesa, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04357808
Principal Investigator,Anatole HARROIS,Assistance Publique - Hôpitaux de Paris,,NCT04366856,anatole harrois,anatole,male,0.96,604,373,NCT04366856,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Not yet recruiting,No Results Available,COVID|ARDS,Behavioral: 1: Prone positioning|Behavioral: 2: No instruction regarding positioning,"April 29, 2020","Département d'Anesthésie Réanimation - Kremlin Bicêtre, Le Kremlin-Bicêtre, France",https://ClinicalTrials.gov/show/NCT04366856
Principal Investigator,"Omid Ebrahimi, Cand Psychol",University of Oslo and Modum Bad,,NCT04444115,omid ebrahimi,omid,male,0.99,3882,378,NCT04444115,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,Not yet recruiting,No Results Available,Loneliness During COVID-19,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444115
Principal Investigator,"Asle Hoffart, PhD",Modum Bad and University of Oslo,,NCT04444115,asle hoffart,asle,male,0.66,119,378,NCT04444115,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,Not yet recruiting,No Results Available,Loneliness During COVID-19,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444115
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo and Modum Bad,,NCT04444115,sverre urnes johnson,sverre,male,0.98,196,378,NCT04444115,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,Not yet recruiting,No Results Available,Loneliness During COVID-19,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444115
Principal Investigator,"Omid V. E. Ebrahimi, Cand Psychol",University of Oslo and Modum Bad,,NCT04365881,omid v. e. ebrahimi,omid,male,0.99,3882,1745,NCT04365881,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Completed,No Results Available,"Loneliness, Worry, Rumination, Health Anxiety, Depression, Anxiety",Other: Cross-sectional observational study,"April 28, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04365881
Principal Investigator,"Asle Hoffart, PhD",Modum Bad and University of Oslo,,NCT04365881,asle hoffart,asle,male,0.66,119,1745,NCT04365881,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Completed,No Results Available,"Loneliness, Worry, Rumination, Health Anxiety, Depression, Anxiety",Other: Cross-sectional observational study,"April 28, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04365881
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo and Modum Bad,,NCT04365881,sverre urnes johnson,sverre,male,0.98,196,1745,NCT04365881,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Completed,No Results Available,"Loneliness, Worry, Rumination, Health Anxiety, Depression, Anxiety",Other: Cross-sectional observational study,"April 28, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04365881
Principal Investigator,"Omid Ebrahimi, Mr",University of Oslo & Modum Bad,,NCT04443361,omid ebrahimi,omid,male,0.99,3882,1954,NCT04443361,Insomnia After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Insomnia|Metacognitive Beliefs|Anxiety|Depression|Sleep,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443361
Principal Investigator,"Asle Hoffart, PhD",University of Oslo & Modum Bad,,NCT04443361,asle hoffart,asle,male,0.66,119,1954,NCT04443361,Insomnia After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Insomnia|Metacognitive Beliefs|Anxiety|Depression|Sleep,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443361
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo & Modum Bad,,NCT04443361,sverre urnes johnson,sverre,male,0.98,196,1954,NCT04443361,Insomnia After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Insomnia|Metacognitive Beliefs|Anxiety|Depression|Sleep,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443361
Principal Investigator,Omid Ebrahimi,University of Oslo & Modum Bad,,NCT04374097,omid ebrahimi,omid,male,0.99,3882,1961,NCT04374097,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Completed,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,"May 5, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04374097
Principal Investigator,"Asle Hoffart, PhD",Modum Bad & University of Oslo,,NCT04374097,asle hoffart,asle,male,0.66,119,1961,NCT04374097,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Completed,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,"May 5, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04374097
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo & Modum Bad,,NCT04374097,sverre urnes johnson,sverre,male,0.98,196,1961,NCT04374097,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Completed,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,"May 5, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04374097
Principal Investigator,Omid Ebrahimi,University of Oslo & Modum Bad,,NCT04377074,omid ebrahimi,omid,male,0.99,3882,1962,NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Completed,No Results Available,Parental Stress|Depression|Anxiety,,"May 6, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04377074
Principal Investigator,"Asle Hoffart, PhD",Modum Bad & University of Oslo,,NCT04377074,asle hoffart,asle,male,0.66,119,1962,NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Completed,No Results Available,Parental Stress|Depression|Anxiety,,"May 6, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04377074
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo & Modum Bad,,NCT04377074,sverre urnes johnson,sverre,male,0.98,196,1962,NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Completed,No Results Available,Parental Stress|Depression|Anxiety,,"May 6, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04377074
Principal Investigator,Nora Paulsen Skjerdingstad,University of Bergen,,NCT04377074,nora paulsen skjerdingstad,nora,female,0.97,21072,1962,NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Completed,No Results Available,Parental Stress|Depression|Anxiety,,"May 6, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04377074
Principal Investigator,"Miriam Sinkerud Johnson, PhD",Oslo Metropolitan University,,NCT04377074,miriam sinkerud johnson,miriam,female,0.98,47010,1962,NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Completed,No Results Available,Parental Stress|Depression|Anxiety,,"May 6, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04377074
Principal Investigator,"Omid V. E Ebrahimi, Double PhD Candidate",University of Oslo,,NCT04356365,omid v. e ebrahimi,omid,male,0.99,3882,1994,NCT04356365,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Completed,No Results Available,Depression|Generalized Anxiety|Adherence to Non-pharmacological Epidemiological Interventions (NPIs),Other: Cross-sectional study investigating the association of NPIs with mental health,"April 22, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04356365
Principal Investigator,"Asle Hoffart, PhD",Professor at University of Oslo,,NCT04356365,asle hoffart,asle,male,0.66,119,1994,NCT04356365,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Completed,No Results Available,Depression|Generalized Anxiety|Adherence to Non-pharmacological Epidemiological Interventions (NPIs),Other: Cross-sectional study investigating the association of NPIs with mental health,"April 22, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04356365
Principal Investigator,"Sverre Urnes Johnson, PhD",Associate Professor at University of Oslo,,NCT04356365,sverre urnes johnson,sverre,male,0.98,196,1994,NCT04356365,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Completed,No Results Available,Depression|Generalized Anxiety|Adherence to Non-pharmacological Epidemiological Interventions (NPIs),Other: Cross-sectional study investigating the association of NPIs with mental health,"April 22, 2020","University of Oslo, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04356365
Principal Investigator,Omid Ebrahimi,University of Oslo & Modum Bad,,NCT04442308,omid ebrahimi,omid,male,0.99,3882,2001,NCT04442308,Parental Stress After the Covid-19 Pandemic,Not yet recruiting,No Results Available,Parenting|Anxiety|Depression|Anger,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442308
Principal Investigator,"Asle Hoffart, PhD",University of Oslo & Modum Bad,,NCT04442308,asle hoffart,asle,male,0.66,119,2001,NCT04442308,Parental Stress After the Covid-19 Pandemic,Not yet recruiting,No Results Available,Parenting|Anxiety|Depression|Anger,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442308
Principal Investigator,Nora Paulsen Skjerdingstad,University of Bergen,,NCT04442308,nora paulsen skjerdingstad,nora,female,0.97,21072,2001,NCT04442308,Parental Stress After the Covid-19 Pandemic,Not yet recruiting,No Results Available,Parenting|Anxiety|Depression|Anger,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442308
Principal Investigator,"Miriam S Johnson, PhD",Oslo Metropolitan University,,NCT04442308,miriam s johnson,miriam,female,0.98,47010,2001,NCT04442308,Parental Stress After the Covid-19 Pandemic,Not yet recruiting,No Results Available,Parenting|Anxiety|Depression|Anger,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442308
Principal Investigator,"Omid Ebrahimi, Double PhD Candidate",University of Oslo,,NCT04443699,omid ebrahimi,omid,male,0.99,3882,2028,NCT04443699,Predictors of Mental Well-being During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Mental Well-being,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443699
Principal Investigator,"Sverre Urnes Sverre Urnes, PhD",University of Oslo,,NCT04443699,sverre urnes sverre urnes,sverre,male,0.98,196,2028,NCT04443699,Predictors of Mental Well-being During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Mental Well-being,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443699
Principal Investigator,"Sara Ebling, Cand.psychol. stud.",University of Bergen,,NCT04443699,sara ebling,sara,female,0.98,244324,2028,NCT04443699,Predictors of Mental Well-being During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Mental Well-being,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443699
Principal Investigator,"Hoffart Hoffart, PhD",Modum Bad,,NCT04443699,hoffart hoffart,hoffart,male,1.0,1,2028,NCT04443699,Predictors of Mental Well-being During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Mental Well-being,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443699
Principal Investigator,"Omid V. Ebrahimi, Double PhD Candidate",University of Oslo,,NCT04442386,omid v. ebrahimi,omid,male,0.99,3882,2035,NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Not yet recruiting,No Results Available,Parental Burnout,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442386
Principal Investigator,"Asle Hoffart, PhD",Modum Bad,,NCT04442386,asle hoffart,asle,male,0.66,119,2035,NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Not yet recruiting,No Results Available,Parental Burnout,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442386
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo,,NCT04442386,sverre urnes johnson,sverre,male,0.98,196,2035,NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Not yet recruiting,No Results Available,Parental Burnout,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442386
Principal Investigator,"Nora Paulsen Skjerdingstad, Cand.psychol. stud",University of Oslo,,NCT04442386,nora paulsen skjerdingstad,nora,female,0.97,21072,2035,NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Not yet recruiting,No Results Available,Parental Burnout,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442386
Principal Investigator,"Miriam Sinkerud Johnson, PhD",Oslo Metropolitan University,,NCT04442386,miriam sinkerud johnson,miriam,female,0.98,47010,2035,NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Not yet recruiting,No Results Available,Parental Burnout,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442386
Principal Investigator,"Omid V. Ebrahimi, PhD",University of Oslo,,NCT04442360,omid v. ebrahimi,omid,male,0.99,3882,2065,NCT04442360,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Generalized Anxiety|Health Anxiety,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442360
Principal Investigator,"Asle Hoffart, PhD",Modum Bad,,NCT04442360,asle hoffart,asle,male,0.66,119,2065,NCT04442360,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Generalized Anxiety|Health Anxiety,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442360
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo,,NCT04442360,sverre urnes johnson,sverre,male,0.98,196,2065,NCT04442360,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Generalized Anxiety|Health Anxiety,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442360
Principal Investigator,"Ole Myklebust Amundsen, Cand.Psychol Student",University of Bergen,,NCT04442360,ole myklebust amundsen,ole,male,0.95,5205,2065,NCT04442360,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Generalized Anxiety|Health Anxiety,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442360
Principal Investigator,"Omid Ebrahimi, Double PhD Candidate",University of Oslo,,NCT04442204,omid ebrahimi,omid,male,0.99,3882,2068,NCT04442204,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Anxiety,Other: Prospective study across two time-points examining the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442204
Principal Investigator,"Asle Hoffart, PhD",Modum Bad Psychiatric Hospital,,NCT04442204,asle hoffart,asle,male,0.66,119,2068,NCT04442204,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Anxiety,Other: Prospective study across two time-points examining the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442204
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo,,NCT04442204,sverre urnes johnson,sverre,male,0.98,196,2068,NCT04442204,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Depression|Anxiety,Other: Prospective study across two time-points examining the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442204
Principal Investigator,"Omid Ebrahimi, Mr",University of Oslo & Modum Bad,,NCT04443764,omid ebrahimi,omid,male,0.99,3882,2115,NCT04443764,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Migrants|Anxiety|Depression,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443764
Principal Investigator,"Asle Hoffart, PhD",Modum Bad & University of Oslo,,NCT04443764,asle hoffart,asle,male,0.66,119,2115,NCT04443764,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Migrants|Anxiety|Depression,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443764
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo & Modum Bad,,NCT04443764,sverre urnes johnson,sverre,male,0.98,196,2115,NCT04443764,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Migrants|Anxiety|Depression,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443764
Principal Investigator,"KariAnne Vrabel, PhD",Modum Bad,,NCT04443764,karianne vrabel,karianne,female,1.0,88,2115,NCT04443764,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Migrants|Anxiety|Depression,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443764
Principal Investigator,"Omid Ebrahimi, Mr",University of Oslo & Modum Bad,,NCT04442243,omid ebrahimi,omid,male,0.99,3882,2131,NCT04442243,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,Not yet recruiting,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442243
Principal Investigator,"Asle Hoffart, PhD",University of Oslo & Modum Bad,,NCT04442243,asle hoffart,asle,male,0.66,119,2131,NCT04442243,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,Not yet recruiting,No Results Available,Post Traumatic Stress Disorder|Anxiety|Depression,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442243
Principal Investigator,"Omid Ebrahimi, Mr",University of Oslo & Modum Bad,,NCT04442282,omid ebrahimi,omid,male,0.99,3882,2149,NCT04442282,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Anxiety|Depression|Interpersonal Problem|Emotion Regulation,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442282
Principal Investigator,"Asle Hoffart, PhD",University of Oslo & Modum Bad,,NCT04442282,asle hoffart,asle,male,0.66,119,2149,NCT04442282,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Anxiety|Depression|Interpersonal Problem|Emotion Regulation,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442282
Principal Investigator,"Jon Monsen, PhD",University of Oslo,,NCT04442282,jon monsen,jon,male,0.98,29554,2149,NCT04442282,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Anxiety|Depression|Interpersonal Problem|Emotion Regulation,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442282
Principal Investigator,"Ole Andrè Solbakken, PhD",University of Oslo,,NCT04442282,ole andrè solbakken,ole,male,0.95,5205,2149,NCT04442282,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Not yet recruiting,No Results Available,Anxiety|Depression|Interpersonal Problem|Emotion Regulation,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442282
Principal Investigator,"Omid V. Ebrahimi, Double PhD Candidate",University of Oslo,,NCT04442217,omid v. ebrahimi,omid,male,0.99,3882,2151,NCT04442217,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Adherence to WHO-advised Hygiene-related Behavior|Adherence to Viral Mitigation Protocols,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442217
Principal Investigator,"Asle Hoffart, PhD",Modum Bad,,NCT04442217,asle hoffart,asle,male,0.66,119,2151,NCT04442217,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Adherence to WHO-advised Hygiene-related Behavior|Adherence to Viral Mitigation Protocols,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442217
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo,,NCT04442217,sverre urnes johnson,sverre,male,0.98,196,2151,NCT04442217,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Not yet recruiting,No Results Available,Adherence to WHO-advised Hygiene-related Behavior|Adherence to Viral Mitigation Protocols,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442217
Principal Investigator,"Omid Ebrahimi, Double PhD Candidate",University of Oslo,,NCT04444336,omid ebrahimi,omid,male,0.99,3882,2153,NCT04444336,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Not yet recruiting,No Results Available,Depression|Anxiety,Behavioral: Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444336
Principal Investigator,"Asle Hoffart, PhD",Modum Bad,,NCT04444336,asle hoffart,asle,male,0.66,119,2153,NCT04444336,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Not yet recruiting,No Results Available,Depression|Anxiety,Behavioral: Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444336
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo,,NCT04444336,sverre urnes johnson,sverre,male,0.98,196,2153,NCT04444336,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Not yet recruiting,No Results Available,Depression|Anxiety,Behavioral: Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444336
Principal Investigator,"Omid Ebrahimi, CandPsychol",Modum Bad and University of Oslo,,NCT04444713,omid ebrahimi,omid,male,0.99,3882,2308,NCT04444713,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,Not yet recruiting,No Results Available,Depressive Symptoms|Metacognitive Variables,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444713
Principal Investigator,"Asle Hoffart, PhD",University of Oslo and Modum Bad,,NCT04444713,asle hoffart,asle,male,0.66,119,2308,NCT04444713,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,Not yet recruiting,No Results Available,Depressive Symptoms|Metacognitive Variables,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444713
Principal Investigator,"Sverre Urnes Johnson, PhD",University of Oslo and Modum Bad,,NCT04444713,sverre urnes johnson,sverre,male,0.98,196,2308,NCT04444713,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,Not yet recruiting,No Results Available,Depressive Symptoms|Metacognitive Variables,,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444713
Principal Investigator,"Christian F Clarenbach, MD",University of Zurich,,NCT04365595,christian f clarenbach,christian,male,0.99,156233,379,NCT04365595,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),Recruiting,No Results Available,SARS-CoV 2|COVID,"Other: Questionnaires, spirometry","April 28, 2020","University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04365595
Study Director,"Christian JORGENSEN, Resident","University Hospital, Montpellier",,NCT04355702,christian jorgensen,christian,male,0.99,156233,1076,NCT04355702,Covid-19 in Lupus Patients,Recruiting,No Results Available,Systemic Lupus Erythematosus|Covid-19,,"April 21, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04355702
Principal Investigator,"Christian Hengstenberg, Univ.-Prof.",Medical University of Vienna,,NCT04407429,christian hengstenberg,christian,male,0.99,156233,1095,NCT04407429,Vienna Versus SARS-CoV-2 Virus Study,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Diagnostic Test: Laboratory Analyses,"May 29, 2020","Medical University of Vienna, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04407429
Principal Investigator,Christian Rabaud,Nancy University Hospital,,NCT04429815,christian rabaud,christian,male,0.99,156233,2056,NCT04429815,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,Not yet recruiting,No Results Available,Smoking Behaviors,Diagnostic Test: Serological test for COVID-19.,"June 12, 2020",,https://ClinicalTrials.gov/show/NCT04429815
Principal Investigator,"Joaquin Espinosa, PhD","University of Colorado, Denver",,NCT04348071,joaquin espinosa,joaquin,male,0.99,14675,380,NCT04348071,Safety and Efficacy of Ruxolitinib for COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Ruxolitinib,"April 15, 2020",,https://ClinicalTrials.gov/show/NCT04348071
Principal Investigator,"Joaquin Espinosa, PhD","University of Colorado, Denver",,NCT04340232,joaquin espinosa,joaquin,male,0.99,14675,382,NCT04340232,Safety and Efficacy of Baricitinib for COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Baricitinib,"April 9, 2020","University of Colorado, Denver, Aurora, Colorado, United States",https://ClinicalTrials.gov/show/NCT04340232
Study Chair,"Joaquin De Haro, MD",Hospital Universitario Getafe. Red de Investigacion Vascular,,NCT04361981,joaquin de haro,joaquin,male,0.99,14675,627,NCT04361981,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Not yet recruiting,No Results Available,COVID-19,Other: Deep Venous Disease Diagnostic,"April 24, 2020","Red de Investigacion Vascular (SEACV), Madrid, Spain",https://ClinicalTrials.gov/show/NCT04361981
Study Chair,"Joaquin De Haro, MD",Hospital Universitario Getafe,,NCT04361643,joaquin de haro,joaquin,male,0.99,14675,650,NCT04361643,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Not yet recruiting,No Results Available,COVID-19,"Drug: Lenalidomide as a 5 mg capsule PO daily, days 1, 3, and 5.|Drug: Placebo","April 24, 2020","Hospital Universitario de Getafe, Getafe, Spain",https://ClinicalTrials.gov/show/NCT04361643
Principal Investigator,"Ricardo Palacios, MD, PhD",Butantan Institute,,NCT04355338,ricardo palacios,ricardo,male,0.99,75750,381,NCT04355338,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),Not yet recruiting,No Results Available,COVID-19,,"April 21, 2020",,https://ClinicalTrials.gov/show/NCT04355338
Principal Investigator,"Alexia VERROKEN, MD, PhD",Cliniques universitaires St-Luc,,NCT04382092,alexia verroken,alexia,female,0.97,26590,383,NCT04382092,Co-infection Management in COVID-19 Critically Ill,Completed,No Results Available,COVID-19,Diagnostic Test: FilmArray Pneumonia,"May 11, 2020","Cliniques Universitaires Saint-Luc, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04382092
Principal Investigator,"Samuel M Brown, MD MS","Intermountain Health Care, Inc.",,NCT04329832,samuel m brown,samuel,male,0.99,59464,386,NCT04329832,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 1, 2020","Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04329832
Principal Investigator,"Dong Yang, Master",First Hospital of Jilin University,,NCT04346602,dong yang,dong,male,0.92,3611,387,NCT04346602,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,Recruiting,No Results Available,COVID-2019,Other: all treatment about COVID-2019,"April 15, 2020","the First Hospital of Jilin University, Chang chun, Jilin, China",https://ClinicalTrials.gov/show/NCT04346602
Principal Investigator,"Dong Shang, M.D.",Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University,,NCT04310865,dong shang,dong,male,0.92,3611,1450,NCT04310865,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Suspended,No Results Available,COVID-19|Severe Pneumonia|Chinese Medicine,Drug: Yinhu Qingwen Granula|Drug: Yin Hu Qing Wen Granula(low does)|Other: standard medical treatment,"March 17, 2020","Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04310865
Principal Investigator,"Xiao-Dong Li, M.D.",Hubei Hospital of Traditional Chinese Medicine,,NCT04310865,xiao-dong li,xiao-dong,male,1.0,1,1450,NCT04310865,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Suspended,No Results Available,COVID-19|Severe Pneumonia|Chinese Medicine,Drug: Yinhu Qingwen Granula|Drug: Yin Hu Qing Wen Granula(low does)|Other: standard medical treatment,"March 17, 2020","Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04310865
Study Director,"Zhong Wang, M.D.",China Academy of Chinese Medical Sciences,,NCT04310865,zhong wang,zhong,male,0.79,365,1450,NCT04310865,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Suspended,No Results Available,COVID-19|Severe Pneumonia|Chinese Medicine,Drug: Yinhu Qingwen Granula|Drug: Yin Hu Qing Wen Granula(low does)|Other: standard medical treatment,"March 17, 2020","Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04310865
Principal Investigator,"Priya Nori, MD",Montefiore Medical Center,,NCT04350450,priya nori,priya,female,0.95,2322,390,NCT04350450,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Withdrawn,No Results Available,COVID|Coronavirus|COVID-19,Drug: Hydroxychloroquine,"April 17, 2020","Montefiore Medical Center, Bronx, New York, United States",https://ClinicalTrials.gov/show/NCT04350450
Principal Investigator,"Joanna Porter, MD PhD","University College, London",,NCT04359654,joanna porter,joanna,female,0.98,72381,392,NCT04359654,Nebulised Dornase Alfa for Treatment of COVID-19,Not yet recruiting,No Results Available,COVID19|Hypoxia,Drug: Dornase Alfa Inhalation Solution [Pulmozyme],"April 24, 2020","University College London Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04359654
Principal Investigator,"Peter A McCullough, MD, MPH",Baylor Health Care System,,NCT04333225,peter a mccullough,peter,male,0.99,165452,715,NCT04333225,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine,"April 3, 2020","Baylor University Medical Center, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04333225
Study Director,"Peter Nelson, MD",CytoSorbents Corporation,,NCT04391920,peter nelson,peter,male,0.99,165452,737,NCT04391920,Registry of CytoSorb Therapy in COVID-19 ICU Patients,Not yet recruiting,No Results Available,COVID-19,Device: CytoSorb 300 mL device,"May 18, 2020",,https://ClinicalTrials.gov/show/NCT04391920
Principal Investigator,"Peter G. Kaufmann, PhD",Villanova University,,NCT04370821,peter g. kaufmann,peter,male,0.99,165452,864,NCT04370821,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Recruiting,No Results Available,Occupational Exposure to SARS-CoV-2|COVID-19,,"May 1, 2020","Villanova University, Villanova, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04370821
Principal Investigator,"Donna Havens, PhD,RN,FAAN",Villanova University,,NCT04370821,donna havens,donna,female,0.98,22910,864,NCT04370821,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Recruiting,No Results Available,Occupational Exposure to SARS-CoV-2|COVID-19,,"May 1, 2020","Villanova University, Villanova, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04370821
Principal Investigator,"Janell Mensinger, PhD,FAED",Villanova University,,NCT04370821,janell mensinger,janell,female,0.9,104,864,NCT04370821,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Recruiting,No Results Available,Occupational Exposure to SARS-CoV-2|COVID-19,,"May 1, 2020","Villanova University, Villanova, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04370821
Study Chair,"Peter M. Villiger, Prof. Dr. med.",University Hospital Bern (Inselspital),,NCT04335071,peter m. villiger,peter,male,0.99,165452,1052,NCT04335071,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Tocilizumab (TCZ)|Drug: Placebo,"April 6, 2020","University Hospital Bern (Inselspital), Bern, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano (EOC), Viganello, Switzerland|University Hospital Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04335071
Principal Investigator,"Peter Rosenberger, Prof.",+4970712986622,,NCT04341285,peter rosenberger,peter,male,0.99,165452,1160,NCT04341285,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Not yet recruiting,No Results Available,"ARDS, Human|COVID-19",Procedure: ECMO Implantation,"April 10, 2020","University Hospital Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04341285
Principal Investigator,"Peter L. Kristensen, MD, ph.D",Nordsjællands Hospital,,NCT04430608,peter l. kristensen,peter,male,0.99,165452,1484,NCT04430608,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Recruiting,No Results Available,Diabetes|Covid-19|Infection,Device: Dexcom G6,"June 12, 2020","Nordsjællands Hospital, Hillerød, Denmark",https://ClinicalTrials.gov/show/NCT04430608
Study Chair,"Peter Kelleher, MD PhD",Imperial College London,,NCT04444609,peter kelleher,peter,male,0.99,165452,1508,NCT04444609,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,Not yet recruiting,No Results Available,"COVID-19|SARS-CoV 2|ARDS, Human|Immune System Disorder","Other: Blood tests sputum, nasal lavage and brushing","June 23, 2020",,https://ClinicalTrials.gov/show/NCT04444609
Principal Investigator,"Peter Juni, MD, FESC","St Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto",,NCT04444700,peter juni,peter,male,0.99,165452,1635,NCT04444700,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic,Recruiting,No Results Available,"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders",Drug: Therapeutic anticoagulation,"June 23, 2020","Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04444700
Principal Investigator,"Elnara M Negri, MD, PhD",Laboratório de Investigação Médica da FMUSP,,NCT04444700,elnara m negri,elnara,female,0.96,344,1635,NCT04444700,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic,Recruiting,No Results Available,"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders",Drug: Therapeutic anticoagulation,"June 23, 2020","Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04444700
Principal Investigator,"Heraldo P de Souza, MD, PhD","Disciplina de Emergências Clínicas, Hospital das Clínicas da FMUSP",,NCT04444700,heraldo p de souza,heraldo,male,0.99,98,1635,NCT04444700,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic,Recruiting,No Results Available,"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders",Drug: Therapeutic anticoagulation,"June 23, 2020","Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04444700
Principal Investigator,"Hassan Rahhal, MD","Disciplina de Emergências Clínicas, Hospital das Clínicas da FMUSP",,NCT04444700,hassan rahhal,hassan,male,0.97,49197,1635,NCT04444700,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to COVID-19 Pandemic,Recruiting,No Results Available,"COVID|Coronavirus Infection|Severe Acute Respiratory Syndrome|Thromboembolism, Venous|Anticoagulants and Bleeding Disorders",Drug: Therapeutic anticoagulation,"June 23, 2020","Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04444700
Study Chair,"Peter Lindholm, MD, PhD",Karolinska Institutet,,NCT04327505,peter lindholm,peter,male,0.99,165452,1637,NCT04327505,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Recruiting,No Results Available,"SARS (Severe Acute Respiratory Syndrome)|Cytokine Storm|ARDS, Human|COVID-19|Sars-CoV2|Acute Respiratory Failure",Drug: Hyperbaric oxygen,"March 31, 2020","Bergmannsheil und Kinderklinik Buer GmbH, Gelsenkirchen, Germany|Krankenhaus St. Joesf, Regensburg, Germany|Blekingesjukhuset, Karlskrona, Blekinge, Sweden",https://ClinicalTrials.gov/show/NCT04327505
Principal Investigator,"Anders Kjellberg, MD",Karolinska Institutet,,NCT04327505,anders kjellberg,anders,male,0.99,12623,1637,NCT04327505,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Recruiting,No Results Available,"SARS (Severe Acute Respiratory Syndrome)|Cytokine Storm|ARDS, Human|COVID-19|Sars-CoV2|Acute Respiratory Failure",Drug: Hyperbaric oxygen,"March 31, 2020","Bergmannsheil und Kinderklinik Buer GmbH, Gelsenkirchen, Germany|Krankenhaus St. Joesf, Regensburg, Germany|Blekingesjukhuset, Karlskrona, Blekinge, Sweden",https://ClinicalTrials.gov/show/NCT04327505
Study Chair,"Kenny Rodriguez-Wallberg, MD, PhD",Karolinska Institutet,,NCT04327505,kenny rodriguez-wallberg,kenny,male,0.94,15791,1637,NCT04327505,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Recruiting,No Results Available,"SARS (Severe Acute Respiratory Syndrome)|Cytokine Storm|ARDS, Human|COVID-19|Sars-CoV2|Acute Respiratory Failure",Drug: Hyperbaric oxygen,"March 31, 2020","Bergmannsheil und Kinderklinik Buer GmbH, Gelsenkirchen, Germany|Krankenhaus St. Joesf, Regensburg, Germany|Blekingesjukhuset, Karlskrona, Blekinge, Sweden",https://ClinicalTrials.gov/show/NCT04327505
Principal Investigator,Peter W Horby,University of Oxford,,NCT04381936,peter w horby,peter,male,0.99,165452,1781,NCT04381936,Randomised Evaluation of COVID-19 Therapy,Recruiting,No Results Available,Severe Acute Respiratory Syndrome,Drug: Lopinavir-Ritonavir|Drug: Corticosteroid|Drug: Hydroxychloroquine|Drug: Azithromycin|Biological: Convalescent plasma|Drug: Tocilizumab,"May 11, 2020","Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04381936
Principal Investigator,"Julien Tiete, PhD",Université Libre de Bruxelles,,NCT04344145,julien tiete,julien,male,0.99,114975,395,NCT04344145,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Completed,No Results Available,COVID-19,,"April 14, 2020","Hôpital de Warquignies, Boussu, Hainaut, Belgium|Hôpital de Jolimont, Haine-Saint-Paul, Hainaut, Belgium|Hôpital de Lobbes, Lobbes, Hainaut, Belgium|Hôpital de Mons, Mons, Hainaut, Belgium|Erasme Hospital CUB, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04344145
Principal Investigator,Julien Frandon,CHU Nimes,,NCT04418245,julien frandon,julien,male,0.99,114975,691,NCT04418245,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,"Active, not recruiting",No Results Available,Covid-19,Diagnostic Test: Imaging by thoracic scanner,"June 5, 2020","CHU la Timone, Marseille, France|CHU Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France|CHU Poitiers, Poitiers, France|CHU Strasbourg, Strasbourg, France|CHU Martinique, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04418245
Principal Investigator,"Julien Poissy, MD,PhD","University Hospital, Lille",,NCT04327180,julien poissy,julien,male,0.99,114975,2014,NCT04327180,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Recruiting,No Results Available,Infection Viral|Coronavirus|ARDS|Pneumonia,,"March 30, 2020","Hôpital Roger Salengro, ICU, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04327180
Principal Investigator,"Carlo Martinenghi, MD",IRCCS Ospedale San Raffaele,,NCT04394026,carlo martinenghi,carlo,male,0.99,55640,399,NCT04394026,Imaging Feature of SARS-CoV2 Infection,Recruiting,No Results Available,Viral Pneumonia|COVID,,"May 19, 2020","Deaprtment of Radiology, IRCCS Ospedale San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04394026
Study Director,"Sandra Hansen, MD",Hvidovre University Hospital,,NCT04345289,sandra hansen,sandra,female,0.98,266121,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Study Director,"Karen Brorup Heje Pedersen, MD",Hvidovre University Hospital,,NCT04345289,karen brorup heje pedersen,karen,female,0.95,48557,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Study Director,"Simone Bastrup Israelsen, MD",Hvidovre University Hospital,,NCT04345289,simone bastrup israelsen,simone,male,0.75,86110,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Study Director,"Louise Thorlacius-Ussing, MD",Hvidovre University Hospital,,NCT04345289,louise thorlacius-ussing,louise,female,0.97,23447,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Study Director,"Clara Clausen, MD",Hvidovre University Hospital,,NCT04345289,clara clausen,clara,female,0.98,42811,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Study Director,"Michaela Tinggaard, MD",Hvidovre University Hospital,,NCT04345289,michaela tinggaard,michaela,female,0.99,44698,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Study Director,"Nichlas Hovmand, MD",Hvidovre University Hospital,,NCT04345289,nichlas hovmand,nichlas,male,0.99,167,1286,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Recruiting,No Results Available,COVID|Corona Virus Infection|Viral Pneumonia,Biological: Convalescent anti-SARS-CoV-2 plasma|Drug: Sarilumab|Drug: Baricitinib|Drug: Hydroxychloroquine|Other: Injective placebo|Other: Oral placebo,"April 14, 2020","Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle, Denmark",https://ClinicalTrials.gov/show/NCT04345289
Principal Investigator,"Eduardo Oliveira, MD",AdventHealth,,NCT04374370,eduardo oliveira,eduardo,male,0.99,43964,821,NCT04374370,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),Available,No Results Available,COVID|SARSCoV2 Convalescent Plasma,Biological: SARSCoV2 Convalescent Plasma,"May 5, 2020","AdventHealth Orlando, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04374370
Study Chair,"Eduardo Gotuzzo, MD",Universidad Peruana Cayetano Heredia,,NCT04414241,eduardo gotuzzo,eduardo,male,0.99,43964,1326,NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Hydroxychloroquine,"June 4, 2020","Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04414241
Principal Investigator,"Alejandro Llanos, MD, PhD",Universidad Peruana Cayetano Heredia,,NCT04414241,alejandro llanos,alejandro,male,0.99,56977,1326,NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Hydroxychloroquine,"June 4, 2020","Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04414241
Study Chair,"Patricia García, MD, MPH, PhD",Universidad Peruana Cayetano Heredia,,NCT04414241,patricia garcía,patricia,female,0.98,132232,1326,NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Hydroxychloroquine,"June 4, 2020","Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04414241
Study Chair,"Manuel Espinoza, MD",Instituto de Nacional de Salud,,NCT04414241,manuel espinoza,manuel,male,0.99,166605,1326,NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Hydroxychloroquine,"June 4, 2020","Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04414241
Study Chair,"Max Grogl, PhD",U.S. Naval Medical Research Unit Six,,NCT04414241,max grogl,max,male,0.98,106688,1326,NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,Not yet recruiting,No Results Available,SARS-CoV-2,Drug: Hydroxychloroquine,"June 4, 2020","Centro Médico Naval ""Cirujano Mayor Santiago Távara"", Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima, Peru",https://ClinicalTrials.gov/show/NCT04414241
Study Chair,"Eduardo Rivero-Sigarroa, MD",Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,NCT04336345,eduardo rivero-sigarroa,eduardo,male,0.99,43964,1454,NCT04336345,Outcomes of Patients With COVID-19 in the Intensive Care Unit,"Active, not recruiting",No Results Available,Coronavirus Infections|COVID-19|Viral Pneumonia Human Coronavirus,,"April 7, 2020","Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico|All centres from Mexico willing to contribute are Welcome., Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04336345
Study Director,"Guillermo Dominguez-Cherit, MD",Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,NCT04336345,guillermo dominguez-cherit,guillermo,male,0.99,15173,1454,NCT04336345,Outcomes of Patients With COVID-19 in the Intensive Care Unit,"Active, not recruiting",No Results Available,Coronavirus Infections|COVID-19|Viral Pneumonia Human Coronavirus,,"April 7, 2020","Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico|All centres from Mexico willing to contribute are Welcome., Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04336345
Principal Investigator,"Silvio A. Ñamendys-Silva, MD, MSc",Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,NCT04336345,silvio a. ñamendys-silva,silvio,male,0.99,14558,1454,NCT04336345,Outcomes of Patients With COVID-19 in the Intensive Care Unit,"Active, not recruiting",No Results Available,Coronavirus Infections|COVID-19|Viral Pneumonia Human Coronavirus,,"April 7, 2020","Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico|All centres from Mexico willing to contribute are Welcome., Mexico, Mexico",https://ClinicalTrials.gov/show/NCT04336345
Study Chair,"Joel Vasquez-Pérez, MD",National Institute of Respiratory Diseases - México,,NCT04315896,joel vasquez-pérez,joel,male,0.98,42048,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Principal Investigator,"Carmen Hernandez-Cárdenas, MD. MSc.",National Institute of Respiratory Diseases - México,,NCT04315896,carmen hernandez-cárdenas,carmen,female,0.98,103801,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Study Director,"Luis-Felipe Jurado-Camacho, MD",National Institute of Respiratory Diseases - México,,NCT04315896,luis-felipe jurado-camacho,luis-felipe,male,1.0,2,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Study Chair,"Ireri Thirion-Romero, MD. MSc",National Institute of Respiratory Diseases - México,,NCT04315896,ireri thirion-romero,ireri,female,0.6,15,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Study Chair,"Sebastian Rodriguez-Llamazares, MD.MPH",National Institute of Respiratory Diseases - México,,NCT04315896,sebastian rodriguez-llamazares,sebastian,male,0.99,81792,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Study Director,"Rogelio Perez-Padilla, MD. PhD",National Institute of Respiratory Diseases - México,,NCT04315896,rogelio perez-padilla,rogelio,male,0.99,2159,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Study Chair,"Cristobal Guadarrama, MD MSc",National Institute of Respiratory Diseases - México,,NCT04315896,cristobal guadarrama,cristobal,male,0.98,4849,836,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 20, 2020","Instituto Nacional de Enfermedades Respiratorias, ""Ismael Cosío Villegas"", Mexico, City, Mexico",https://ClinicalTrials.gov/show/NCT04315896
Study Director,"Jennifer Ho, MD, PhD","Ansun Biopharma, Inc.",,NCT04354389,jennifer ho,jennifer,female,0.98,90255,404,NCT04354389,DAS181 for STOP COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: DAS181|Drug: Placebo,"April 21, 2020","Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy|A.O.U Policlinico Di Modena, Modena, Italy",https://ClinicalTrials.gov/show/NCT04354389
Study Director,"Jennifer Ho, MD, PhD","Ansun Biopharma, Inc.",,NCT04298060,jennifer ho,jennifer,female,0.98,90255,1705,NCT04298060,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Not yet recruiting,No Results Available,Influenza Infection|SAD-RV Infection and COVID-19,Drug: DAS181|Drug: Placebo,"March 6, 2020","Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China",https://ClinicalTrials.gov/show/NCT04298060
Principal Investigator,"Jennifer A Woyach, MD",Ohio State University Comprehensive Cancer Center,,NCT04439006,jennifer a woyach,jennifer,female,0.98,90255,1866,NCT04439006,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Not yet recruiting,No Results Available,Aplastic Anemia|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Monoclonal B-Cell Lymphocytosis|Monoclonal Gammopathy of Undetermined Significance|Myelodysplastic Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,Other: Best Practice|Drug: Ibrutinib,"June 19, 2020","Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States",https://ClinicalTrials.gov/show/NCT04439006
Principal Investigator,"Min Liu, A.B",Chongqing Public Health Center,,NCT04324996,min liu,min,male,0.57,7493,408,NCT04324996,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,Recruiting,No Results Available,COVID-19,"Biological: NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells","March 27, 2020","Chongqing Public Health Medical Center, Chongqing, China",https://ClinicalTrials.gov/show/NCT04324996
Principal Investigator,Yan Zhao,Nanyang Technological University,,NCT04433013,yan zhao,yan,male,0.75,10113,411,NCT04433013,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Lianhua Qingwen|Drug: Placebo,"June 16, 2020",,https://ClinicalTrials.gov/show/NCT04433013
Principal Investigator,Yan Liu,The Fifth Medical Center of Chinese PLA General Hospital,,NCT04281693,yan liu,yan,male,0.75,10113,2249,NCT04281693,A New Screening Strategy for 2019 Novel Coronavirus Infection,Not yet recruiting,No Results Available,Novel Coronavirus Infection Pneumonia,Diagnostic Test: Standard screening strategy|Diagnostic Test: New screening strategy,"February 24, 2020","the Fifth Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04281693
Principal Investigator,Fanny BOUNES,"University Hospital, Toulouse",,NCT04397822,fanny bounes,fanny,female,0.97,33073,415,NCT04397822,COVID-19: Study of INFLAmmasome and PLAtelets Functions,Recruiting,No Results Available,COVID-19,Biological: Blood samples,"May 21, 2020","CHU Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04397822
Principal Investigator,"Priscilla Hsue, MD","University of California, San Francisco",,NCT04421404,priscilla hsue,priscilla,female,0.98,11744,420,NCT04421404,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,Recruiting,No Results Available,COVID-19|Sars-CoV2,Biological: COVID-19 Convalescent Plasma (CCP)|Biological: Placebo,"June 9, 2020","San Francisco General Hospital, San Francisco, California, United States|UCSF Medical Center at Mount Zion, San Francisco, California, United States|University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04421404
Principal Investigator,"Annie Leutkemeyer, MD","University of California, San Francisco",,NCT04421404,annie leutkemeyer,annie,female,0.98,28150,420,NCT04421404,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,Recruiting,No Results Available,COVID-19|Sars-CoV2,Biological: COVID-19 Convalescent Plasma (CCP)|Biological: Placebo,"June 9, 2020","San Francisco General Hospital, San Francisco, California, United States|UCSF Medical Center at Mount Zion, San Francisco, California, United States|University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04421404
Principal Investigator,"Annie SOBASZEK, MD","University Hospital, Lille",,NCT04371692,annie sobaszek,annie,female,0.98,28150,1352,NCT04371692,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Not yet recruiting,No Results Available,Sars-CoV2,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371692
Principal Investigator,"Annie SOBASZEK, MD","University Hospital, Lille",,NCT04362267,annie sobaszek,annie,female,0.98,28150,1359,NCT04362267,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Not yet recruiting,No Results Available,Sars-CoV2,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04362267
Principal Investigator,"Geraldine Blanchard-Rohner, MD-PhD","University Hospital, Geneva",,NCT04352582,geraldine blanchard-rohner,geraldine,female,0.98,9148,421,NCT04352582,COVID-19 and Vaccination Attitudes,Recruiting,No Results Available,COVID-19,Other: Survey,"April 20, 2020","Survey, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04352582
Principal Investigator,"Daniel Freilich, MD",Bassett Medical Center,,NCT04328012,daniel freilich,daniel,male,0.99,317409,426,NCT04328012,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Recruiting,No Results Available,SARS-CoV-2 Infection,Drug: lopinavir/ritonavir|Drug: Hydroxychloroquine Sulfate|Drug: Losartan|Drug: Placebos,"March 31, 2020","Bassett Medical Center, Cooperstown, New York, United States",https://ClinicalTrials.gov/show/NCT04328012
Study Director,"Daniel Monti, M.D.",Thomas Jefferson University,,NCT04363216,daniel monti,daniel,male,0.99,317409,674,NCT04363216,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Not yet recruiting,No Results Available,COVID-19,Drug: Ascorbic Acid,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363216
Principal Investigator,"Dagan Coppock, M.D.",Thomas Jefferson University,,NCT04363216,dagan coppock,dagan,female,0.51,97,674,NCT04363216,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Not yet recruiting,No Results Available,COVID-19,Drug: Ascorbic Acid,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363216
Principal Investigator,"Daniel I McIsaac, MD",The Ottawa Hospital Research Institute,,NCT04392115,daniel i mcisaac,daniel,male,0.99,317409,1595,NCT04392115,The PREPARE for COVID Trial,Not yet recruiting,No Results Available,Comorbidities and Coexisting Conditions|Social Isolation,Behavioral: The PREPARE program,"May 18, 2020",,https://ClinicalTrials.gov/show/NCT04392115
Principal Investigator,"Daniel P Andersson, MD, PhD",Karolinska University Hospital,,NCT04381364,daniel p andersson,daniel,male,0.99,317409,1693,NCT04381364,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Not yet recruiting,No Results Available,"Covid-19|Pneumonia, Viral|ARDS|ARDS, Human|Sars-CoV2|Coronavirus Infection|Corona Virus Infection",Drug: Ciclesonide Inhalation Aerosol,"May 8, 2020","Danderyd Hospital, Danderyd, Entrévägen 2, Sweden|Capio S:t Görans Hospital, Stockholm, Sankt Göransplan 1, Sweden|Västmanland County Hospital Västerås, Västerås, Sigtunagatan, Sweden|Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04381364
Principal Investigator,"Ola Blennow, MD, PhD",Capio S:t Görans Hospital and Karolinska University Hospital,,NCT04381364,ola blennow,ola,female,0.83,39815,1693,NCT04381364,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Not yet recruiting,No Results Available,"Covid-19|Pneumonia, Viral|ARDS|ARDS, Human|Sars-CoV2|Coronavirus Infection|Corona Virus Infection",Drug: Ciclesonide Inhalation Aerosol,"May 8, 2020","Danderyd Hospital, Danderyd, Entrévägen 2, Sweden|Capio S:t Görans Hospital, Stockholm, Sankt Göransplan 1, Sweden|Västmanland County Hospital Västerås, Västerås, Sigtunagatan, Sweden|Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04381364
Principal Investigator,"Daniel Blumberger, MD",CAMH,,NCT04384965,daniel blumberger,daniel,male,0.99,317409,2116,NCT04384965,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,Recruiting,No Results Available,Major Depressive Disorder,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil","May 12, 2020","CAMH, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04384965
Principal Investigator,"Daniel Blumberger, MD",CAMH,,NCT04427137,daniel blumberger,daniel,male,0.99,317409,2121,NCT04427137,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,Recruiting,No Results Available,Bipolar Depression,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil","June 11, 2020","CAMH, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04427137
Study Chair,"Mohammad Shahbaz, MBBS, MCPS","Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar",,NCT04434144,mohammad shahbaz,mohammad,male,0.98,31501,637,NCT04434144,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,Completed,No Results Available,Ivermectin|Hydroxychloroquine|COVID19,Drug: Ivermectin + Doxycycline|Drug: Hydroxychloroquine + Azithromycin,"June 16, 2020","Chakoria Upazilla Health Complex, Cox's Bazar, Bangladesh",https://ClinicalTrials.gov/show/NCT04434144
Study Director,"Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD",First Affiliated Hospital Xi'an Jiaotong University,,NCT04434144,abu taiub mohammed mohiuddin chowdhury,abu,male,0.96,6557,637,NCT04434144,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,Completed,No Results Available,Ivermectin|Hydroxychloroquine|COVID19,Drug: Ivermectin + Doxycycline|Drug: Hydroxychloroquine + Azithromycin,"June 16, 2020","Chakoria Upazilla Health Complex, Cox's Bazar, Bangladesh",https://ClinicalTrials.gov/show/NCT04434144
Study Chair,"Mohammad S Rahman, MPhil; FCPS","Professor and Chairman of Pharmacology, BSMMU",,NCT04403477,mohammad s rahman,mohammad,male,0.98,31501,1146,NCT04403477,Convalescent Plasma Therapy in Severe COVID-19 Infection,Recruiting,No Results Available,Covid19|Convalescence,Biological: Convalescent plasma,"May 27, 2020","Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04403477
Principal Investigator,"Mohammad K Khan, MD, PhD",Emory University Hospital/Winship Cancer Institute,,NCT04433949,mohammad k khan,mohammad,male,0.98,31501,1480,NCT04433949,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Recruiting,No Results Available,Pneumonia|Severe Acute Respiratory Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,Other: Best Practice|Radiation: Low Dose Radiation Therapy,"June 16, 2020","Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04433949
Principal Investigator,"Mohammad K Khan, MD, PhD",Emory University Hospital/Winship Cancer Institute,,NCT04366791,mohammad k khan,mohammad,male,0.98,31501,1542,NCT04366791,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Recruiting,No Results Available,Pneumonia|Coronavirus Infection in 2019 (COVID-19)|Severe Acute Respiratory Syndrome (SARS) Pneumonia,Radiation: Low Dose Radiation Therapy,"April 29, 2020","Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04366791
Principal Investigator,"Clayton B Hess, MD, MPH",Emory University Hospital/Winship Cancer Institute,,NCT04366791,clayton b hess,clayton,male,0.99,1874,1542,NCT04366791,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Recruiting,No Results Available,Pneumonia|Coronavirus Infection in 2019 (COVID-19)|Severe Acute Respiratory Syndrome (SARS) Pneumonia,Radiation: Low Dose Radiation Therapy,"April 29, 2020","Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04366791
Principal Investigator,"Mohammad Javaherian, Ph.D. cand.",Tehran University of Medical Sciences,,NCT04357340,mohammad javaherian,mohammad,male,0.98,31501,1671,NCT04357340,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Completed,No Results Available,Covid-19|Pneumonia|SARS Pneumonia,Other: Pulmonary Physiotherapy Techniques,"April 22, 2020","Imam Khomeini Hospital Complex, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04357340
Study Director,"Mohammad Y Jalaludin, MBBS MPaeds",University of Malaya Medical Center,,NCT04447209,mohammad y jalaludin,mohammad,male,0.98,31501,2072,NCT04447209,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,Recruiting,No Results Available,Dietary Diversity,"Other: Dietary counselling on Food Groups according to IYC Feeding practices, WHO","June 25, 2020","University of Malaya Medical Center, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04447209
Principal Investigator,"Seyed Sina Naghibi Irvani, MD, MPH, MBA",Shahid Beheshti University of Medical Sciences,,NCT04343768,seyed sina naghibi irvani,seyed,male,0.98,521,438,NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,"April 13, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04343768
Study Chair,"Ilad Alavi Darazam, MD",Shahid Beheshti University of Medical Sciences,,NCT04343768,ilad alavi darazam,ilad,male,0.85,20,438,NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,"April 13, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04343768
Study Director,"Shervin Shokouhi, MD",Shahid Beheshti University of Medical Sciences,,NCT04343768,shervin shokouhi,shervin,male,0.94,554,438,NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,"April 13, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04343768
Principal Investigator,"Minoosh Shabani, MD",Shahid Beheshti University of Medical Sciences,,NCT04343768,minoosh shabani,minoosh,female,0.91,11,438,NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,"April 13, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04343768
Principal Investigator,"Mohammadreza Haji Esmaelie, MD",Shahid Beheshti University of Medical Sciences,,NCT04343768,mohammadreza haji esmaelie,mohammadreza,male,0.99,686,438,NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Completed,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,"April 13, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04343768
Principal Investigator,"Seyed Sina Naghibi Irvani, MD, MPH, MBA",Shahid Beheshti University of Medical Sciences,,NCT04350671,seyed sina naghibi irvani,seyed,male,0.98,521,467,NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350671
Study Chair,"Ilad Alavi Darazam, MD",Shahid Beheshti University of Medical Sciences,,NCT04350671,ilad alavi darazam,ilad,male,0.85,20,467,NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350671
Study Director,"Shervin Shokouhi, MD",Shahid Beheshti University of Medical Sciences,,NCT04350671,shervin shokouhi,shervin,male,0.94,554,467,NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350671
Principal Investigator,"Minoosh Shabani, MD",Shahid Beheshti University of Medical Sciences,,NCT04350671,minoosh shabani,minoosh,female,0.91,11,467,NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350671
Principal Investigator,"Mohammadreza Haji Esmaelie, MD",Shahid Beheshti University of Medical Sciences,,NCT04350671,mohammadreza haji esmaelie,mohammadreza,male,0.99,686,467,NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350671
Principal Investigator,"Seyed Sina Naghibi Irvani, MD, MPH, MBA",Shahid Beheshti University of Medical Sciences,,NCT04350684,seyed sina naghibi irvani,seyed,male,0.98,521,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Study Director,"Ilad Alavi Darazam, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,ilad alavi darazam,ilad,male,0.85,20,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Study Chair,"Shervin Shokouhi, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,shervin shokouhi,shervin,male,0.94,554,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Principal Investigator,"Minoosh Shabani, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,minoosh shabani,minoosh,female,0.91,11,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Principal Investigator,"Mohammadreza Haji Esmaelie, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,mohammadreza haji esmaelie,mohammadreza,male,0.99,686,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Principal Investigator,"Latif Gachkar, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,latif gachkar,latif,male,0.96,3339,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Principal Investigator,"Mahdi Amirdosara, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,mahdi amirdosara,mahdi,male,0.97,9917,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Principal Investigator,"Masoud Mardani, MD",Shahid Beheshti University of Medical Sciences,,NCT04350684,masoud mardani,masoud,male,0.99,2822,493,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,Enrolling by invitation,No Results Available,COVID-19,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,"April 17, 2020","Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04350684
Study Director,"Olaf Rieß, Prof. Dr.",University Hospital Tübingen,,NCT04364828,olaf rieß,olaf,male,0.99,6421,431,NCT04364828,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Not yet recruiting,No Results Available,COVID-19,Genetic: Whole Genome Analysis|Genetic: T-cell receptor (TCR) repertoire|Genetic: SARS-CoV-2 viral composition,"April 28, 2020",,https://ClinicalTrials.gov/show/NCT04364828
Principal Investigator,"Belen L Dofitas, MD",Philippine General Hospital,,NCT04364815,belen l dofitas,belen,female,0.99,13681,432,NCT04364815,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine plus standard preventive measures|Drug: Placebo plus standard preventive measures,"April 28, 2020",,https://ClinicalTrials.gov/show/NCT04364815
Principal Investigator,"Mariano Provencio, MD",Hospital Puerta de Hierro de Majadahonda de Madrid,,NCT04407143,mariano provencio,mariano,male,0.98,14862,1044,NCT04407143,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,Recruiting,No Results Available,Lung Cancer|COVID|Corona Virus Infection,Diagnostic Test: IgG test,"May 29, 2020","Hospital General Universitario de Elche, Elche, Alicante, Spain|ICO Hospitalet, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Insular de Gran canaria, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Torrejón, Torrejón, Madrid, Spain|Hospital Universitario Son Llàtzer, Palma De Mallorca, Mallorca, Spain|Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain|Complejo Hospitalario de A Coruña, A Coruña, Spain|Hospital La Esperanza, A Coruña, Spain|Hospital Universitario de Ferrol, A Coruña, Spain|Hospital Virgen de los Lirios, Alicante, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Dexeus, Barcelona, Spain|Hospital Universitario Cruces, Bilbao, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Universitario Puerto Real, Cadiz, Spain|Hospital General La Mancha Centro, Ciudad Real, Spain|Hospital Universitario San Pedro de Alcántara, Cáceres, Spain|Hospital Universitario Puerta del Mar, Cádiz, Spain|Hospital Universitario Reina Sofía, Córdoba, Spain|Hospital Universitario de Vinalopó, Elche, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Complejo Hospitalario de Jaén, Jaén, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital universitari Arnau de Vilanova, Lleida, Spain|Hospital San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Puerta de Hierro, Madrid, Spain|Clínica Universidad de Navarra, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Severo Ochoa, Madrid, Spain|Hospital Universitario de Móstoles, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Fundación Alcorcón, Madrid, Spain|Hospital Universitario Infanta Cristina, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Madrid, Spain|Hospital General Universitario de Málaga, Málaga, Spain|Hospital Costa del Sol, Málaga, Spain|Complejo Hospitalario Universitario de Ourense Santa María Nai, Ourense, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Clínica Universidad de Navarra, Pamplona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Sant Joan de Reus, Reus, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain|Hospital Universitari i Politécnic La Fe, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital de Manises, Valencia, Spain|Hospital General Universitario de Valencia, Valencia, Spain|Hospital Lluís Alcanyís, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Río Ortega, Valladolid, Spain|Complejo Hospitalario Zamora, Zamora, Spain",https://ClinicalTrials.gov/show/NCT04407143
Principal Investigator,"Donald M Arnold, MD",McMaster University,,NCT04348656,donald m arnold,donald,male,0.98,12059,446,NCT04348656,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,"April 16, 2020","Brooklyn Hospital, Brooklyn, New York, United States|Lower Manhattan Hospital, New York, New York, United States|Weill Cornell Medical Center, New York, New York, United States|Hamilton General Hospital, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|Trillium Health Partners, Mississauga, Ontario, Canada|Trillium Health Partners - Credit Valley, Mississauga, Ontario, Canada|Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Scarborough Health Network - Centenary Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - General Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - Birchmount Hospital, Scarborough, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Unity Health St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Windsor Regional Hospital - Metropolitan Campus, Windsor, Ontario, Canada|Windsor Regional Hospital - Ouellette Campus, Windsor, Ontario, Canada|Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada|Hotel Dieu Hospital of Lévis, Lévis, Quebec, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Centre hospitalier universitaire Sainte-Justine, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hôpital du Sacré-Coeur de Montreal, Montréal, Quebec, Canada|Ciussse De L'Estrie CHUS, Sherbrooke, Quebec, Canada|Centre hospitalier affilié universitaire régional de Trois-Rivières, Trois-Rivières, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04348656
Principal Investigator,"Donald Cooper, Ph.D.",Neuroganics LLC,,NCT04348864,donald cooper,donald,male,0.98,12059,1667,NCT04348864,COVID-19 Antibody Self-testing Using Virtual Point-of-care,Recruiting,No Results Available,Communicable Disease|COVID-19|Sars-CoV2|Infectious Disease|Coronavirus|Virus Diseases,"Diagnostic Test: COVID-19 IgM/IgG Rapid Testing, mobile device image capture and telemedicine support|Other: Telemedicine","April 16, 2020","Neuroganics, Northglenn, Colorado, United States",https://ClinicalTrials.gov/show/NCT04348864
Principal Investigator,"Iñigo Les Bujanda, PhD",Complejo Hospitalario de Navarra,,NCT04438980,iñigo les bujanda,iñigo,male,1.0,32,447,NCT04438980,Glucocorticoids in COVID-19 (CORTIVID),Recruiting,No Results Available,Covid-19 Pneumonia,Drug: Methylprednisolone|Other: Placebo,"June 19, 2020","Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain",https://ClinicalTrials.gov/show/NCT04438980
Study Chair,CTC CLINICAL TRIAL CENTER,Clinical Trials Center - Ospedale Papa Giovanni XXIII Bergamo,,NCT04367792,ctc clinical trial center,ctc,male,0.78,23,449,NCT04367792,Cardiac Injury in COVID-19: a Pathology Study,Recruiting,No Results Available,COVID-19,,"April 29, 2020","ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy",https://ClinicalTrials.gov/show/NCT04367792
Principal Investigator,"Renaud Tamisier, MD, PhD, MBA",University Hospital Grenoble Aples,,NCT04406324,renaud tamisier,renaud,male,0.98,7267,451,NCT04406324,COVID-19: Respiratory and Sleep Follow-up,Not yet recruiting,No Results Available,COVID-19,Other: No intervention,"May 28, 2020","Hôpital Avicenne, Bobigny, France|Centre Hospitalier Henri Mondor, APHP, Créteil, France|CHU Grenoble Alpes, Grenoble, France|CHRU Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04406324
Study Director,"Fabrice DENIS, MD",Jean Bernard Center - LE MANS,,NCT04331171,fabrice denis,fabrice,male,0.99,38300,455,NCT04331171,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Recruiting,No Results Available,COVID-19,Device: Web application users,"April 2, 2020","All French Emergency services, Le Mans, France",https://ClinicalTrials.gov/show/NCT04331171
Principal Investigator,"Fabrice Carrat, MD",Inserm - Sorbonne Université,,NCT04392388,fabrice carrat,fabrice,male,0.99,38300,1154,NCT04392388,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",Recruiting,No Results Available,SARS-CoV 2,Biological: Non applicable,"May 18, 2020","Inserm, Paris, France",https://ClinicalTrials.gov/show/NCT04392388
Principal Investigator,"Michail S Lionakis, M.D.",National Institute of Allergy and Infectious Diseases (NIAID),,NCT04394884,michail s lionakis,michail,male,0.99,972,463,NCT04394884,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),Recruiting,No Results Available,COVID-19,,"May 20, 2020","Johns Hopkins Hospital, Baltimore, Maryland, United States|Walter Reed National Medical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04394884
Study Director,"Sonia Shah, DO",Swedish Hospital,,NCT04373161,sonia shah,sonia,female,0.98,114177,466,NCT04373161,Home Pulse Oximeter Use in Patients With COVID-19,Completed,No Results Available,Sars-CoV2|COVID-19|COVID,Device: Home Pulse Oximetry Monitoring,"May 4, 2020","Swedish Hospital, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04373161
Study Director,"Sonia Hernandez-Diaz, MD, DrPh","Department of Epidemiology, Harvard T.H. Chan School of Public Health",,NCT04385238,sonia hernandez-diaz,sonia,female,0.98,114177,1811,NCT04385238,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Completed,No Results Available,COVID-19|Pregnancy Complications|Mental Health Wellness 1|Anxiety|Depression|Ptsd|Coronavirus,Other: This is an online survey with no intervention.,"May 12, 2020","Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04385238
Study Director,"Diego Wyszynski, MD, MHS, PhD",Pregistry,,NCT04385238,diego wyszynski,diego,male,0.99,85672,1811,NCT04385238,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Completed,No Results Available,COVID-19|Pregnancy Complications|Mental Health Wellness 1|Anxiety|Depression|Ptsd|Coronavirus,Other: This is an online survey with no intervention.,"May 12, 2020","Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04385238
Principal Investigator,"Karestan Koenen, PhD","Department of Epidemiology, Harvard T.H. Chan School of Public Health",,NCT04385238,karestan koenen,karestan,male,1.0,1,1811,NCT04385238,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Completed,No Results Available,COVID-19|Pregnancy Complications|Mental Health Wellness 1|Anxiety|Depression|Ptsd|Coronavirus,Other: This is an online survey with no intervention.,"May 12, 2020","Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04385238
Principal Investigator,Judith Ju Ming Wong,KK Women's and Children's Hospital,,NCT04395781,judith ju ming wong,judith,female,0.98,19741,469,NCT04395781,Pediatric Acute and Critical Care COVID-19 Registry of Asia,Not yet recruiting,No Results Available,COVID|Pediatric Disorder,,"May 20, 2020",,https://ClinicalTrials.gov/show/NCT04395781
Principal Investigator,"Judith Breuer, MD","University College, London",,NCT04405934,judith breuer,judith,female,0.98,19741,1516,NCT04405934,COG-UK Project Hospital-Onset COVID-19 Infections Study,Not yet recruiting,No Results Available,Covid-19|Nosocomial Infection|Coronavirus|Coronavirus Infection|SARS-CoV 2,Other: Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures,"May 28, 2020",,https://ClinicalTrials.gov/show/NCT04405934
Principal Investigator,Mayur Ramesh,Henry Ford Health System,,NCT04374071,mayur ramesh,mayur,male,0.99,885,470,NCT04374071,Early Short Course Corticosteroids in COVID-19,Completed,No Results Available,"COVID|Pneumonia, Viral",Drug: Methylprednisolone,"May 5, 2020","Henry Ford Hospital, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04374071
Principal Investigator,"Robin A Weir, MD",NHS Lanarkshire,,NCT04438993,robin a weir,robin,male,0.93,34003,478,NCT04438993,The COVID-19 Disease and CARdiac Events Study,Recruiting,No Results Available,COVID|Coronavirus,,"June 19, 2020","University Hospital Hairmyres, Glasgow, Scotland, United Kingdom",https://ClinicalTrials.gov/show/NCT04438993
Principal Investigator,"Jonas Tverring, MD",Lund University,,NCT04395807,jonas tverring,jonas,male,0.99,25038,479,NCT04395807,Helmet CPAP Versus HFNC in COVID-19,Recruiting,No Results Available,COVID|Acute Hypoxemic Respiratory Failure,Device: Helmet CPAP|Device: HFNC,"May 20, 2020","Helsingborg's Hospital, Helsingborg, Region Skane, Sweden",https://ClinicalTrials.gov/show/NCT04395807
Principal Investigator,"Stefano Fontana, M.D.","Servizio Trasfusionale, Lugano",,NCT04365439,stefano fontana,stefano,male,0.99,95107,482,NCT04365439,Convalescent Plasma for COVID-19,Not yet recruiting,No Results Available,Blood Plasma Therapy|COVID,Biological: Blood plasma,"April 28, 2020",,https://ClinicalTrials.gov/show/NCT04365439
Principal Investigator,"Stefano M Magrini, Prof",Brescia University - ASST Spedali Civili Hospital,,NCT04377477,stefano m magrini,stefano,male,0.99,95107,570,NCT04377477,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Recruiting,No Results Available,COVID-19,Radiation: Single fraction whole lung radiotherapy,"May 6, 2020","Radiation Oncology Department, ASST SpedaliCivili, Brescia, Brescia, Italy",https://ClinicalTrials.gov/show/NCT04377477
Principal Investigator,"Leonardo Mastropasqua, Professor","Ophtalmology Clinic, G. d'Annunzio University",,NCT04346160,leonardo mastropasqua,leonardo,male,0.99,31322,483,NCT04346160,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Not yet recruiting,No Results Available,COVID|Conjunctivitis,Diagnostic Test: Schirmer Test I,"April 15, 2020","Ophtalmology Clinic, G.d'Annunzio University, Chieti, Italy",https://ClinicalTrials.gov/show/NCT04346160
Principal Investigator,"Leonardo O Reis, MD, PhD","UroScience, University of Campinas",,NCT04369794,leonardo o reis,leonardo,male,0.99,31322,1574,NCT04369794,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",Not yet recruiting,No Results Available,COVID-19|Therapeutic Vaccine|BCG|SARS-CoV 2|Transmission,Biological: BCG|Biological: Placebo,"April 30, 2020","Hospital das Clínicas Unicamp, Campinas, SP, Brazil",https://ClinicalTrials.gov/show/NCT04369794
Study Director,"Leonardo A. Peyré-Tartaruga, PhD",Federal University of Rio Grande do Sul,,NCT04422353,leonardo a. peyré-tartaruga,leonardo,male,0.99,31322,2150,NCT04422353,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,Recruiting,No Results Available,Parkinson Disease|Parkinson Disease 10,Other: Video Dance classes|Other: Unsupervised physical activities,"June 9, 2020","Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04422353
Principal Investigator,"Elisabeth Botelho-Nevers, MD, PhD",CHU de Saint-Etienne,,NCT04328285,elisabeth botelho-nevers,elisabeth,female,0.98,27551,484,NCT04328285,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir|Drug: Placebo of LPV/r Tablets,"March 31, 2020","CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|CHU de Clermont-Ferrand, Clermont-ferrand, France|CHU de Montpellier, Montpellier, France|CHU de Nancy, Nancy, France|CHU de Nantes, Nantes, France|AP-HP - Hôpital Bichat, Paris, France|CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04328285
Study Director,"Bruno Hoen, MD, PhD",Institut Pasteur,,NCT04328285,bruno hoen,bruno,male,0.99,103169,484,NCT04328285,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,"Active, not recruiting",No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir|Drug: Placebo of LPV/r Tablets,"March 31, 2020","CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|CHU de Clermont-Ferrand, Clermont-ferrand, France|CHU de Montpellier, Montpellier, France|CHU de Nancy, Nancy, France|CHU de Nantes, Nantes, France|AP-HP - Hôpital Bichat, Paris, France|CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de Saint-Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04328285
Principal Investigator,"Elisabeth Bendstrup, MD, PhD",Aarhus University Hospital,,NCT04401163,elisabeth bendstrup,elisabeth,female,0.98,27551,1241,NCT04401163,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,Not yet recruiting,No Results Available,Sars-CoV2|Covid19,Diagnostic Test: Imaging of the lungs,"May 26, 2020","Aarhus University Hospital, Aarhus, Denmark",https://ClinicalTrials.gov/show/NCT04401163
Study Chair,"Bruno François, MD","University Hospital, Limoges",,NCT04407689,bruno françois,bruno,male,0.99,103169,1204,NCT04407689,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,Recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: Interleukin-7|Drug: Placebo,"May 29, 2020","University Hospital of Limoges, Limoges, France|Hôpital Edouard Herriot, Lyon, France",https://ClinicalTrials.gov/show/NCT04407689
Principal Investigator,"Bruno HOEN, Pr",Institut Pasteur,,NCT04325646,bruno hoen,bruno,male,0.99,103169,1347,NCT04325646,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome)|COVID-19,Other: Human Biological samples,"March 27, 2020","CHU Amiens-Picardie, Amiens, France|CHU François Mitterand, Dijon, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|CHU Limoges, Limoges, France|Hôpital de la Croix Rousse, Lyon, France|CHRU de Nancy, Nancy, France|Hôpitaux de Brabois, Nancy, France|CHR Orléans, Orléans, France|Institut Pasteur, Paris, France|Hôpital la Pitié Salpetrière, Paris, France|CHU Poitiers, Poitiers, France|Hôpital Pontchaillou, Rennes, France|CHU Saint-Etienne, Saint-Étienne, France|CHRU de Strasbourg, Strasbourg, France|CH de Tourcoing, Tourcoing, France|Hôpital Bretonneau, Tours, France",https://ClinicalTrials.gov/show/NCT04325646
Principal Investigator,Bruno Gualano,HC FMUSP,,NCT04425005,bruno gualano,bruno,male,0.99,103169,2097,NCT04425005,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Recruiting,No Results Available,Bariatric Surgery|Obesity,Other: Home-based exercise,"June 11, 2020","Univsersity of Sao Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04425005
Principal Investigator,"Moussa Seydi, MD","Fann Hospital, Senegal",,NCT04390594,moussa seydi,moussa,male,0.98,17629,486,NCT04390594,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + Azithromycin,"May 15, 2020","Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal|Diamniadio Children Hospital, Diamniadio, Senegal|Dalal Jamm Hospital, Guédiawaye, Senegal",https://ClinicalTrials.gov/show/NCT04390594
Study Director,"Amadou A. Sall, PhD","Institut Pasteur de Dakar, Senegal",,NCT04390594,amadou a. sall,amadou,male,0.98,9765,486,NCT04390594,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + Azithromycin,"May 15, 2020","Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal|Diamniadio Children Hospital, Diamniadio, Senegal|Dalal Jamm Hospital, Guédiawaye, Senegal",https://ClinicalTrials.gov/show/NCT04390594
Principal Investigator,"Fabien Taieb, MD, PhD","Institut Pasteur de Dakar, Senegal",,NCT04390594,fabien taieb,fabien,male,0.99,33928,486,NCT04390594,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + Azithromycin,"May 15, 2020","Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal|Diamniadio Children Hospital, Diamniadio, Senegal|Dalal Jamm Hospital, Guédiawaye, Senegal",https://ClinicalTrials.gov/show/NCT04390594
Principal Investigator,"Ulf Teichgräber, Prof. Dr.","Department of Radiology, Jena University Hospital, Germany",,NCT04357938,ulf teichgräber,ulf,male,0.98,3044,1535,NCT04357938,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Device: CT-imaging,"April 22, 2020","Jena University Hospital, Jena, Thuringia, Germany",https://ClinicalTrials.gov/show/NCT04357938
Principal Investigator,"Filip K Knop, MD, PhD","Center for Clinical Metabolic Research, Gentofte Hospital",,NCT04351581,filip k knop,filip,male,0.98,23771,494,NCT04351581,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Recruiting,No Results Available,Covid-19,Other: Discontinuation of ACEi/ARB|Other: Continuation of ACEi/ARB,"April 17, 2020","Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Capital Region Of Denmark, Denmark|Department of Medicine, Herlev Hospital, University of Copenhagen, Herlev, Capital Region Of Denmark, Denmark",https://ClinicalTrials.gov/show/NCT04351581
Principal Investigator,"Marshall Glesby, MD",Weill Cornell Medicine,,NCT04418518,marshall glesby,marshall,male,0.96,1693,497,NCT04418518,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,Not yet recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,"June 5, 2020","Weill Cornell Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04418518
Principal Investigator,"Dinesh Saralaya, MBBS, MD, MRCP, FRCP",Bradford Royal Infirmary,,NCT04363372,dinesh saralaya,dinesh,male,0.99,3252,498,NCT04363372,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: MRx-4DP0004|Drug: Placebo,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363372
Principal Investigator,"Luu Pham, MD",Johns Hopkins University,,NCT04344561,luu pham,luu,female,0.65,610,500,NCT04344561,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Recruiting,No Results Available,COVID|Hypoxic Respiratory Failure,Other: Postural Positioning,"April 14, 2020","Johns Hopkins Bayview Hospital, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04344561
Study Chair,"Tiziano Barbui, Prof",Fondazione per la Ricerca Ospedale di Bergamo,,NCT04385160,tiziano barbui,tiziano,male,0.99,6561,501,NCT04385160,Myeloproliferative Neoplasms (MPN) and COVID-19,Recruiting,No Results Available,Myeloproliferative Neoplasm|COVID,,"May 12, 2020","Mount Sinai Health System, New York, New York, United States|New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States|Zealand University Hospital, Køge, Denmark|Hopital Saint-Louis, Paris, France|University Medical Center RWTH, Aachen, Germany|University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, Germany|Ospedale San Gerardo di Monza, Monza, Monza Brianza, Italy|A.S.O. SS. Antonio e Biagio e C.Arrigo di Alessandria, Alessandria, Italy|Asl AT - Ospedale ""Cardinal Massaia"" di Asti, Asti, Italy|ASST-Papa Giovanni XXIII, Bergamo, Italy|Policlinico S.Orsola-Malpighi, Bologna, Italy|ASST-Spedali Civili, Brescia, Italy|AOU Ospedale Careggi, Firenze, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Policlinico Universitario Fondazione Agostino Gemelli, Roma, Italy|A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy|Ospedale Policlinico ""G.B. Rossi"" Borgo Roma, Verona, Italy|Ospedale San Bortolo, Vicenza, Italy|Hospital Clínic De Barcelona, Barcelona, Barcellona, Spain|Hospital del Mar, Barcelona, Barcellona, Spain|Institut Català d' Oncologia - Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|ICO L'Hospitalet - Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital General de La Palma, Breña Alta, Santa Cruz De Tenerife, Spain|Servicio de Hematología Hospital General Universitario de Albacete, Albacete, Spain|Hospital General de Elche, Alicante, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|ICO Girona Hospital Josep Trueta Servei d'hematologia, Girona, Spain|FEA Hematología Hospital Universitario de Móstoles, Madrid, Spain|Hospital 12 de octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Moncloa, Madrid, Spain|Hospital Ramón y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario, Valencia, Spain|Guy's and St. Thomas' NHS Foundation Trust., London, United Kingdom",https://ClinicalTrials.gov/show/NCT04385160
Principal Investigator,"Nuttha Lumlertgul, MD, PhD",Guy's & St Thomas' Hospital,,NCT04408365,nuttha lumlertgul,nuttha,female,0.73,15,503,NCT04408365,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",Not yet recruiting,No Results Available,COVID|Shock,,"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04408365
Principal Investigator,"Nuttha Lumlertgul, MD, PhD",Guy's & St Thomas' Hospital,,NCT04445259,nuttha lumlertgul,nuttha,female,0.73,15,1246,NCT04445259,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,Recruiting,No Results Available,COVID|Acute Kidney Injury|Critical Illness,,"June 24, 2020","Guy's & St Thomas' Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04445259
Principal Investigator,"Katja Weisel, MD",University Medical Center of Hamburg-Eppendorf,,NCT04408339,katja weisel,katja,female,0.97,17879,504,NCT04408339,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,Recruiting,No Results Available,Cancer|COVID,Other: No Intervention,"May 29, 2020","University Hospital Hamburg Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04408339
Study Chair,"Juli Benbenisty, MPH",Hadassah Medical Center,,NCT04377750,juli benbenisty,juli,female,0.66,6954,505,NCT04377750,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Recruiting,No Results Available,Covid19 Pneumonia,Drug: Tocilizumab,"May 6, 2020","Hadassah Medical Orginisation, Jerusalem, Please Select:, Israel|Barzilai Medical Center, Ashkelon, Israel|Wolfson Medical Center, H̱olon, Israel|Sheba Medical Center, Ramat Gan, Israel",https://ClinicalTrials.gov/show/NCT04377750
Principal Investigator,"Jayakar V. Nayak, MD, PhD",Stanford University,,NCT04347954,jayakar v. nayak,jayakar,male,1.0,4,507,NCT04347954,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Recruiting,No Results Available,COVID-19,Drug: Povidone-Iodine 2%|Drug: Povidone-Iodine 0.5%|Drug: Isotonic saline 0.9%,"April 15, 2020","Stanford Health Care, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04347954
Principal Investigator,"Javed Akram, FRCP",University of Health Sciences Lahore,,NCT04338698,javed akram,javed,male,0.98,1727,511,NCT04338698,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Not yet recruiting,No Results Available,COVID 19,Drug: Hydroxychloroquine|Drug: Oseltamivir|Drug: Azithromycin,"April 8, 2020",,https://ClinicalTrials.gov/show/NCT04338698
Principal Investigator,Chunxue Bai,Shanghai Respiratory Research Institution,,NCT04275947,chunxue bai,chunxue,female,0.56,9,515,NCT04275947,The COVID-19 Mobile Health Study (CMHS),Recruiting,No Results Available,COVID-19,"Other: nCapp, a cell phone-based auto-diagnosis system","February 19, 2020","Renmin Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04275947
Principal Investigator,"Marcel Curlin, MD",Oregon Health and Science University,,NCT04363866,marcel curlin,marcel,male,0.99,63607,517,NCT04363866,A Pilot Study to Assess Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Not yet recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Hydroxychloroquine|Drug: Placebo,"April 27, 2020","Oregon Health and Science University, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04363866
Principal Investigator,"Marcel van den Brink, MD, PhD",Memorial Sloan Kettering Cancer Center,,NCT04426201,marcel van den brink,marcel,male,0.99,63607,1235,NCT04426201,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-O ),Not yet recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: CYT107|Drug: Placebo,"June 11, 2020",,https://ClinicalTrials.gov/show/NCT04426201
Principal Investigator,"Steve Pastores, MD",Memorial Sloan Kettering Cancer Center,,NCT04426201,steve pastores,steve,male,0.99,72719,1235,NCT04426201,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-O ),Not yet recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: CYT107|Drug: Placebo,"June 11, 2020",,https://ClinicalTrials.gov/show/NCT04426201
Principal Investigator,"Sean Wasserman, MBChB","CIDRI-Africa, University of Cape Town",,NCT04360759,sean wasserman,sean,male,0.99,25765,1167,NCT04360759,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Not yet recruiting,No Results Available,Covid-19|HIV,Drug: Chloroquine or hydroxychloroquine,"April 24, 2020","Khayelitsha Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04360759
Principal Investigator,"Graeme Meintjes, PhD","CIDRI-Africa, University of Cape Town",,NCT04360759,graeme meintjes,graeme,male,0.99,2375,1167,NCT04360759,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Not yet recruiting,No Results Available,Covid-19|HIV,Drug: Chloroquine or hydroxychloroquine,"April 24, 2020","Khayelitsha Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04360759
Principal Investigator,"Matthieu Koszutski, MD","CHRU de NANCY, Médecine Intensive et Réanimation Brabois",,NCT04386369,matthieu koszutski,matthieu,male,0.99,18665,520,NCT04386369,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,Completed,No Results Available,ARDS|COVID19,Other: Airway pressure release ventilation,"May 13, 2020","Centre Hospitalier Régional Universitaire de Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04386369
Study Chair,Matthieu Jabaudon,"University Hospital, Clermont-Ferrand",,NCT04383730,matthieu jabaudon,matthieu,male,0.99,18665,1955,NCT04383730,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),Not yet recruiting,No Results Available,Critically Illness|Sedation|Invasive Mechanical Ventilation|Acute Respiratory Distress Syndrome,Drug: Intravenous sedation|Drug: Inhaled sedation,"May 12, 2020","CHU, Clermont-Ferrand, France|Centre Hospitalier, Dunkerque, France|Pitié-Salpêtrière Hospital - APHP, Paris, France|CH Privé de la Loire, Saint-Étienne, France|University Medical Center Schleswig-Holstein, Kiel, Germany|Hospital Clínico Universitario de Valencia, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04383730
Principal Investigator,"Charles J Lowenstein, MD",Johns Hopkins University,,NCT04435184,charles j lowenstein,charles,male,0.99,49331,522,NCT04435184,Crizanlizumab for Treating COVID-19 Vasculopathy,Not yet recruiting,No Results Available,COVID-19,Drug: Crizanlizumab|Other: 0.9% saline,"June 17, 2020","Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04435184
Principal Investigator,Charles Grégoire,Hôpital Fondation A de Rothschild,,NCT04355364,charles grégoire,charles,male,0.99,49331,827,NCT04355364,Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE),Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome,Drug: Dornase Alfa Inhalation Solution [Pulmozyme]|Procedure: standard procedure,"April 21, 2020","Hôpital Fondation A. de Rotschhild, Paris, France",https://ClinicalTrials.gov/show/NCT04355364
Principal Investigator,Alexandre Loupy,Paris Translational Research Center for Organ Transplantation,,NCT04416256,alexandre loupy,alexandre,male,0.99,61354,523,NCT04416256,COVID-19 Pandemic and Worldwide Organ Procurement,Recruiting,No Results Available,COVID-19,,"June 4, 2020","Paris Transplant Group, Paris, France",https://ClinicalTrials.gov/show/NCT04416256
Principal Investigator,"Alexandre R Zlotta, MD PhD","University Health Network, Toronto",,NCT04439045,alexandre r zlotta,alexandre,male,0.99,61354,1310,NCT04439045,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,Not yet recruiting,No Results Available,SARS-CoV-2 Infection,Biological: VPM1002|Other: Placebo,"June 19, 2020",,https://ClinicalTrials.gov/show/NCT04439045
Study Chair,"Alexandre Biasi, PhD",Hospital do Coração,,NCT04322123,alexandre biasi,alexandre,male,0.99,61354,2147,NCT04322123,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),"Active, not recruiting",No Results Available,Coronavirus Infections,Drug: Hydroxychloroquine Oral Product|Drug: Hydroxychloroquine + azithromycin,"March 26, 2020","Hospital Geral Clériston Andrade, Feira De Santana, BA, Brazil|Hospital Ana Nery - HAN/SESAB, Salvador, BA, Brazil|HHospital SAMUR, Vitória Da Conquista, BA, Brazil|Hospital Geral de Vitória da Conquista, Vitória Da Conquista, BA, Brazil|Hospital de Brasília, Brasilia, DF, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, DF, Brazil|Hospital Maternidade São José - UNESC - Fundação Social Rural de Colatina, Colatina, ES, Brazil|Hospital Vila da Serra, Nova Lima, MG, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, MG, Brazil|Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina, Londrina, PR, Brazil|Instituto Estadual do Cérebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil|Hospital Geral de Caxias do Sul, Caxias do Sul, RS, Brazil|Hospital Santa Rita - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São Francisco - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São José, Criciuma, SC, Brazil|Hospital Baía Sul - Baía Sul Medical Center, Florianópolis, SC, Brazil|Hospital Nereu Ramos, Florianópolis, Sc, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital de Amor - Unidade Barretos (Fundação PIO XII), Barretos, SP, Brazil|Casa de Saúde Santa Marcelina, São Paulo, SP, Brazil|Hospital Albert Einstein, São Paulo, SP, Brazil|Hospital Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, SP, Brazil|Hospital BP Mirante - Real e Benemérita, São Paulo, SP, Brazil|Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil|Hospital do Servidor Público Estadual - HSPE - IAMSPE, São Paulo, SP, Brazil|Hospital São Paulo - UNIFESP, São Paulo, SP, Brazil|Hospital Sírio-Libanês, São Paulo, SP, Brazil|Hospital SEPACO, São Paulo, S, Brazil",https://ClinicalTrials.gov/show/NCT04322123
Principal Investigator,Otavio Berwanger,Hospital Israelita Albert Einstein,,NCT04322123,otavio berwanger,otavio,male,0.99,209,2147,NCT04322123,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),"Active, not recruiting",No Results Available,Coronavirus Infections,Drug: Hydroxychloroquine Oral Product|Drug: Hydroxychloroquine + azithromycin,"March 26, 2020","Hospital Geral Clériston Andrade, Feira De Santana, BA, Brazil|Hospital Ana Nery - HAN/SESAB, Salvador, BA, Brazil|HHospital SAMUR, Vitória Da Conquista, BA, Brazil|Hospital Geral de Vitória da Conquista, Vitória Da Conquista, BA, Brazil|Hospital de Brasília, Brasilia, DF, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, DF, Brazil|Hospital Maternidade São José - UNESC - Fundação Social Rural de Colatina, Colatina, ES, Brazil|Hospital Vila da Serra, Nova Lima, MG, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, MG, Brazil|Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina, Londrina, PR, Brazil|Instituto Estadual do Cérebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil|Hospital Geral de Caxias do Sul, Caxias do Sul, RS, Brazil|Hospital Santa Rita - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São Francisco - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São José, Criciuma, SC, Brazil|Hospital Baía Sul - Baía Sul Medical Center, Florianópolis, SC, Brazil|Hospital Nereu Ramos, Florianópolis, Sc, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital de Amor - Unidade Barretos (Fundação PIO XII), Barretos, SP, Brazil|Casa de Saúde Santa Marcelina, São Paulo, SP, Brazil|Hospital Albert Einstein, São Paulo, SP, Brazil|Hospital Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, SP, Brazil|Hospital BP Mirante - Real e Benemérita, São Paulo, SP, Brazil|Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil|Hospital do Servidor Público Estadual - HSPE - IAMSPE, São Paulo, SP, Brazil|Hospital São Paulo - UNIFESP, São Paulo, SP, Brazil|Hospital Sírio-Libanês, São Paulo, SP, Brazil|Hospital SEPACO, São Paulo, S, Brazil",https://ClinicalTrials.gov/show/NCT04322123
Principal Investigator,"Bart Lambrecht, MD, PhD","University Hospital, Ghent",,NCT04330638,bart lambrecht,bart,male,0.99,16580,524,NCT04330638,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Recruiting,No Results Available,COVID-19,Other: Usual Care|Drug: Anakinra|Drug: Siltuximab|Drug: Tocilizumab,"April 1, 2020","AZ Sint-Jan Brugge, Brugge, Belgium|University Hospital Saint-Pierre, Brussels, Belgium|Erasmus University Hospital, Brussels, Belgium|University Hospital Saint-Luc, Brussels, Belgium|University Hospital Antwerp, Edegem, Belgium|Ziekenhuis Oost-Limurg, Genk, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jessa ZH, Hasselt, Belgium|University Hospital Brussels, Jette, Belgium|CHU Tivoli, La Louvière, Belgium|CHR de la Citadelle, Liège, Belgium|University Hospital Liège, Liège, Belgium|Cliniques Saint-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium|AZ Delta, Roeselare, Belgium",https://ClinicalTrials.gov/show/NCT04330638
Principal Investigator,Bart Lambrecht,"University Hospital, Ghent",,NCT04326920,bart lambrecht,bart,male,0.99,16580,561,NCT04326920,Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Recruiting,No Results Available,COVID-19,Drug: Sargramostim|Other: Control,"March 30, 2020","AZ Sint Jan Brugge, Brugge, Belgium|University Hospital Ghent, Gent, Belgium|UZ Brussel, Jette, Belgium|AZ Delta Roeselare, Roeselare, Belgium",https://ClinicalTrials.gov/show/NCT04326920
Principal Investigator,"Bart Rijnders, MD, PhD",Erasmus Medical Center,,NCT04342182,bart rijnders,bart,male,0.99,16580,688,NCT04342182,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),Recruiting,No Results Available,COVID-19,Biological: Convalescent plasma,"April 10, 2020","Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|NoordWest Ziekenhuisgroep, Alkmaar, Netherlands|Onze Lieve Vrouwen Gasthuis, Amsterdam, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Reinier de Graaf Gasthuis, Delft, Netherlands|Haaglanden Medisch Centrum, Den Haag, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Groene Hart Ziekenhuis, Gouda, Netherlands|Martini Hospital, Groningen, Netherlands|Spaarna Gasthuis, Haarlem, Netherlands|Alrijne Ziekenhuis, Leiderdorp, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Netherlands|Canisius-Wilhelmina Hospital, Nijmegen, Netherlands|Maasstad Ziekenhuis, Rotterdam, Netherlands|ZorgSaam Hospital, Terneuzen, Netherlands|Bernhoven Hospital, Uden, Netherlands|VieCuri, Venlo, Netherlands",https://ClinicalTrials.gov/show/NCT04342182
Principal Investigator,"Jean-Eric BLATTEAU, MD, PhD",Sainte-Anne military hospital,,NCT04344431,jean-eric blatteau,jean-eric,male,1.0,95,527,NCT04344431,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Recruiting,No Results Available,Covid-19,Combination Product: Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),"April 14, 2020","Sainte Anne Military Teaching Hospital, Toulon, France",https://ClinicalTrials.gov/show/NCT04344431
Principal Investigator,"Jorg Taubel, MD",Richmond Pharmacology Limited,,NCT04404062,jorg taubel,jorg,male,0.98,641,528,NCT04404062,Validation of COVID-19 Tests,"Active, not recruiting",No Results Available,COVID-19,Diagnostic Test: Covid-19 Rapid Test Kit (RAPG-COV-019)|Diagnostic Test: Quantitative IgG Test,"May 27, 2020","Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04404062
Study Director,"Syed MR Kazmi, FCPS",Aga Khan University,,NCT04341688,syed mr kazmi,syed,male,0.98,8166,533,NCT04341688,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Not yet recruiting,No Results Available,Covid-19,Drug: Gargle/Mouthwash,"April 10, 2020",,https://ClinicalTrials.gov/show/NCT04341688
Principal Investigator,Samer Elkhodair,University College London Hospitals,,NCT04408066,samer elkhodair,samer,male,0.96,7512,534,NCT04408066,COVID-19: A POC Test Under Research & Evaluation,Recruiting,No Results Available,COVID-19,Diagnostic Test: Sample Collection/Performance Evaluation (A)|Diagnostic Test: Sample Collection/Performance Evaluation (B),"May 29, 2020","Barts Health NHS Trust, London, United Kingdom|Homerton University Hospital NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04408066
Study Chair,Meg Jardine,The George Institute,,NCT04394117,meg jardine,meg,female,0.93,3088,536,NCT04394117,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Recruiting,No Results Available,SARS-Cov-2|COVID-19,Drug: Angiotensin Receptor Blockers,"May 19, 2020","Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Canterbury Hospital, Campsie, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia",https://ClinicalTrials.gov/show/NCT04394117
Principal Investigator,"Richard Kaufman, MD",Brigham and Women's Hospital,,NCT04361253,richard kaufman,richard,male,0.99,101928,538,NCT04361253,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,Recruiting,No Results Available,COVID|Infectious Disease,Biological: High-Titer COVID-19 Convalescent Plasma (HT-CCP)|Biological: Standard Plasma (FFP),"April 24, 2020","Brigham and Women's Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04361253
Study Chair,"Richard M Fleming, PhD, MD, JD",FHHI-OI-Camelot;QME,,NCT04349410,richard m fleming,richard,male,0.99,101928,814,NCT04349410,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Enrolling by invitation,No Results Available,CoVid 19 Positive,"Drug: Hydroxychloroquine, Azithromycin|Drug: Hydroxychloroquine, Doxycycline|Drug: Hydroxychloroquine, Clindamycin|Drug: Hydroxychloroquine, Clindamycin, Primaquine - low dose.|Drug: Hydroxychloroquine, Clindamycin, Primaquine - high dose.|Drug: Remdesivir|Drug: Tocilizumab|Drug: Methylprednisolone|Drug: Interferon-Alpha2B|Drug: Losartan|Drug: Convalescent Serum","April 16, 2020","FHHI-OI-Camelot; QME, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04349410
Principal Investigator,"Richard Greil, MD","IIIrd Medical Department, Private Medical University Hospital Salzburg",,NCT04351529,richard greil,richard,male,0.99,101928,1040,NCT04351529,Austrian COVID-19 Registry,Recruiting,No Results Available,Infectious Disease|COVID-19,,"April 17, 2020","IIIrd Medical Department, Private Medical University Hospital Salzburg, Salzburg, Austria",https://ClinicalTrials.gov/show/NCT04351529
Principal Investigator,Richard S Nicholas,Clinical Lead,,NCT04354519,richard s nicholas,richard,male,0.99,101928,1138,NCT04354519,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Recruiting,No Results Available,Multiple Sclerosis|COVID-19,,"April 21, 2020","Swansea Univeristy, Swansea, United Kingdom",https://ClinicalTrials.gov/show/NCT04354519
Principal Investigator,Nikos Evangelou,Co-PI,,NCT04354519,nikos evangelou,nikos,male,0.99,23105,1138,NCT04354519,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Recruiting,No Results Available,Multiple Sclerosis|COVID-19,,"April 21, 2020","Swansea Univeristy, Swansea, United Kingdom",https://ClinicalTrials.gov/show/NCT04354519
Study Director,Richard Body,Manchester University NHS Foundation Trust,,NCT04408170,richard body,richard,male,0.99,101928,1190,NCT04408170,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),Not yet recruiting,No Results Available,Coronavirus Infection|COVID-19,Diagnostic Test: Point-of-care test for SARS-CoV-2,"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04408170
Principal Investigator,"Richard Hotchkiss, MD PhD",Washington University School of Medicine,,NCT04442178,richard hotchkiss,richard,male,0.99,101928,1234,NCT04442178,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),Not yet recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: CYT107|Drug: Placebo,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442178
Principal Investigator,Richard F Little,National Cancer Institute (NCI),,NCT04370834,richard f little,richard,male,0.99,101928,1813,NCT04370834,Tocilizumab for Patients With Cancer and COVID-19 Disease,Recruiting,No Results Available,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed,Biological: Tocilizumab,"May 1, 2020","National Cancer Institute, Rockville, Maryland, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04370834
Principal Investigator,"Richard Beale, MD",Guy's and St Thomas' NHS Foundation Trust,,NCT04334629,richard beale,richard,male,0.99,101928,1993,NCT04334629,LIBERATE Trial in COVID-19,Recruiting,No Results Available,Coronavirus|Respiratory Distress Syndrome|SARS-CoV Infection,Drug: Ibuprofen,"April 6, 2020","Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04334629
Principal Investigator,"Thierry FREBOURG, Pr",Rouen University Hospital,,NCT04367545,thierry frebourg,thierry,male,0.99,62474,539,NCT04367545,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Recruiting,No Results Available,COVID|RT-ddPCR Multiplex,Diagnostic Test: Saliva collection,"April 29, 2020","Rouen University Hospital, Rouen, France",https://ClinicalTrials.gov/show/NCT04367545
Principal Investigator,"Mark Mulligan, MD, FIDSA",NYU Langone Health,,NCT04369742,mark mulligan,mark,male,0.99,119313,540,NCT04369742,Treating COVID-19 With Hydroxychloroquine (TEACH),Suspended,No Results Available,COVID-19,Drug: Hydroxychloroquine (HCQ)|Other: Pacebo: Calcium citrate,"April 30, 2020","State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York, United States|NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04369742
Principal Investigator,"Mark Wurfel, MD, PhD",University of Washington,,NCT04391309,mark wurfel,mark,male,0.99,119313,825,NCT04391309,IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19),Not yet recruiting,No Results Available,SARS-CoV2,Biological: IC14|Other: Placebo,"May 18, 2020","University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04391309
Study Director,"Mark Wingertzahn, PhD",Kaleido Biosciences,,NCT04414124,mark wingertzahn,mark,male,0.99,119313,953,NCT04414124,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Recruiting,No Results Available,Mild-to-moderate COVID-19,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,"June 4, 2020","Medical Center for Clinical Research, San Diego, California, United States|Mount Vernon Clinical Research, Atlanta, Georgia, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Carolina Institute For Clinical Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|ClinSearch LLC, Chattanooga, Tennessee, United States|Global Medical Research, DeSoto, Texas, United States",https://ClinicalTrials.gov/show/NCT04414124
Principal Investigator,"Mark Sulkowski, MD",Johns Hopkins University,,NCT04344600,mark sulkowski,mark,male,0.99,119313,1097,NCT04344600,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Recruiting,No Results Available,Sars-CoV2,Drug: Peginterferon lambda alfa-1a subcutaneous injection|Other: Saline,"April 14, 2020","Johns Hopkins Hospital, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04344600
Principal Investigator,"Mark Parkulo, MD",Mayo Clinic,,NCT04383587,mark parkulo,mark,male,0.99,119313,1240,NCT04383587,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Enrolling by invitation,No Results Available,SARS-CoV 2|COVID-19,Other: Serologic testing,"May 12, 2020","Mayo Clinic in Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04383587
Principal Investigator,"Mark Polizzotto, MD",Kirby Institute UNSW,,NCT04354818,mark polizzotto,mark,male,0.99,119313,1715,NCT04354818,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),Recruiting,No Results Available,HIV-1-infection|Cancer|Primary Immune Deficiency Disorder|Immunosuppression Disorders|COVID-19,,"April 21, 2020","St Vincent's Hospital, Darlinghurst, New South Wales, Australia|East Sydney Doctors, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Blacktown Hospital, Sydney, New South Wales, Australia|Liverpool Hospital, Sydney, New South Wales, Australia|St George Hospital, Sydney, New South Wales, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, Australia|Melanoma Institute Australia, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales, Australia",https://ClinicalTrials.gov/show/NCT04354818
Principal Investigator,Mark Shapiro,xCures,,NCT04321811,mark shapiro,mark,male,0.99,119313,1779,NCT04321811,"Behavior, Environment And Treatments for Covid-19",Recruiting,No Results Available,Coronavirus,"Other: Observation of patients with known, suspected, or at risk for COVID-19 infection","March 25, 2020","BEAT19.org, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04321811
Study Director,"Mark La Meir, Phd, MD",Universitair Ziekenhuis Brussel,,NCT04406181,mark la meir,mark,male,0.99,119313,1893,NCT04406181,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety and Fear|Anxiety Depression|Anxiety Postoperative|Psychological Stress,Behavioral: HADS|Behavioral: a survey,"May 28, 2020","universitair Ziekenhuis Brussel, Jette, Vlaams Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04406181
Principal Investigator,"Jan Nijs, MD",Universitair Ziekenhuis Brussel,,NCT04406181,jan nijs,jan,male,0.95,142869,1893,NCT04406181,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety and Fear|Anxiety Depression|Anxiety Postoperative|Psychological Stress,Behavioral: HADS|Behavioral: a survey,"May 28, 2020","universitair Ziekenhuis Brussel, Jette, Vlaams Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04406181
Study Chair,"Ashley Welch, MD",Universitair Ziekenhuis Brussel,,NCT04406181,ashley welch,ashley,female,0.61,13738,1893,NCT04406181,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Recruiting,No Results Available,Anxiety and Fear|Anxiety Depression|Anxiety Postoperative|Psychological Stress,Behavioral: HADS|Behavioral: a survey,"May 28, 2020","universitair Ziekenhuis Brussel, Jette, Vlaams Brabant, Belgium",https://ClinicalTrials.gov/show/NCT04406181
Principal Investigator,"Mark R Beauchamp, PhD",University of British Columbia,,NCT04412343,mark r beauchamp,mark,male,0.99,119313,1981,NCT04412343,The Seniors COvid-19 Pandemic and Exercise Study,Recruiting,No Results Available,Well-Being (Psychological Flourishing)|Depression|Quality of Life|Loneliness|Physical Activity|Social Identification|Physical Health,Behavioral: Virtual Group Intervention|Behavioral: Personal Exercise Intervention,"June 2, 2020","University of British Columbia, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04412343
Principal Investigator,Mark B Loeb,McMaster University,,NCT04296643,mark b loeb,mark,male,0.99,119313,2059,NCT04296643,Medical Masks vs N95 Respirators for COVID-19,Not yet recruiting,No Results Available,Coronavirus|N95|Medical Mask,Device: Medical Mask|Device: N95 respirator,"March 5, 2020",,https://ClinicalTrials.gov/show/NCT04296643
Study Director,"Mark L Levitt, MD, PhD",RedHill Biopharma Ltd.,,NCT04414618,mark l levitt,mark,male,0.99,119313,2306,NCT04414618,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,Recruiting,No Results Available,Coronavirus Infections,Drug: Opaganib|Drug: Placebo,"June 4, 2020","Oregon Health & Science University, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04414618
Principal Investigator,"Chris Woods, MD",Duke University,,NCT04368234,chris woods,chris,male,0.9,156083,541,NCT04368234,Duke COVID-19 Shared Data and Specimen Repository,Recruiting,No Results Available,COVID-19,,"April 29, 2020","Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04368234
Principal Investigator,"Oleg I Vinogradov, MD, PhD",N.I. Pirogov National Medical and Surgical Center,,NCT04405544,oleg i vinogradov,oleg,male,1.0,14108,545,NCT04405544,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Recruiting,No Results Available,Encephalopathy|COVID,Diagnostic Test: CT-scan|Diagnostic Test: EEG|Diagnostic Test: EP|Diagnostic Test: Pulse oximetry|Diagnostic Test: Blood tests,"May 28, 2020","N.I. Pirogov National Medical and Surgical Center, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04405544
Study Chair,"Andri MT Lubis, MD, PhD",Faculty of Medicine Universitas Indonesia - Dr Cipto Mangunkusumo Hospital,,NCT04380935,andri mt lubis,andri,male,0.78,2861,554,NCT04380935,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,Not yet recruiting,No Results Available,COVID|Acute Respiratory Distress Syndrome,Biological: Convalescent plasma|Drug: Standard of care,"May 8, 2020","Dr. Cipto Mangunkusumo General Hospital, Jakarta, DKI Jakarta, Indonesia|St. Carolus Hospital, Jakarta, DKI Jakarta, Indonesia|PELNI Hospital, Jakarta, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04380935
Principal Investigator,"Machelle Wilchesky, PhD",Lady Davis Institute and McGill University,,NCT04389411,machelle wilchesky,machelle,female,0.92,51,555,NCT04389411,The COvid-19 Symptom MOntelukast Trial,Not yet recruiting,No Results Available,COVID-19,Drug: Montelukast 10mg,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04389411
Principal Investigator,"Geoffrey Tranmer, PhD",University of Manitoba,,NCT04389411,geoffrey tranmer,geoffrey,male,0.99,14049,555,NCT04389411,The COvid-19 Symptom MOntelukast Trial,Not yet recruiting,No Results Available,COVID-19,Drug: Montelukast 10mg,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04389411
Principal Investigator,"Roland Grad, MDCM MSc FCFP",Herzl Family Practice Centre and McGill University,,NCT04389411,roland grad,roland,male,0.99,30706,555,NCT04389411,The COvid-19 Symptom MOntelukast Trial,Not yet recruiting,No Results Available,COVID-19,Drug: Montelukast 10mg,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04389411
Principal Investigator,"Elisa Mazzini, MD",Azienda USL - IRCCS di Reggio Emilia,,NCT04423978,elisa mazzini,elisa,female,0.99,80935,558,NCT04423978,Implications of Covid-19 on the Lifestyle Changes,Recruiting,No Results Available,COVID-19,,"June 9, 2020","Elisa Mazzini, Reggio Emilia, Italy",https://ClinicalTrials.gov/show/NCT04423978
Study Chair,"Elisa Cordero-Matía, MD-PhD",University Hospital Virgen del Rocío,,NCT04319172,elisa cordero-matía,elisa,female,0.99,80935,1763,NCT04319172,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Not yet recruiting,No Results Available,"Transplant Recipient|Infections, Coronavirus",,"March 24, 2020",,https://ClinicalTrials.gov/show/NCT04319172
Principal Investigator,"William O Richards, MD",University of South Alabama College of Medicine,,NCT04353271,william o richards,william,male,0.99,64097,905,NCT04353271,Trial of Hydroxychloroquine In Covid-19 Kinetics,"Active, not recruiting",No Results Available,Covid 19|Corona Virus Infection,Drug: Hydroxychloroquine|Other: Placebo,"April 20, 2020","University of South Alabama, Mobile, Alabama, United States",https://ClinicalTrials.gov/show/NCT04353271
Study Director,"William Marks, MD",Verily Life Sciences,,NCT04388813,william marks,william,male,0.99,64097,1103,NCT04388813,Predictors of Severe COVID-19 Outcomes,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,,"May 14, 2020","University of Illinois at Chicago, Chicago, Illinois, United States|Inova Health Care Services, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04388813
Study Director,"Charlie Kim, PhD",Verily Life Sciences,,NCT04388813,charlie kim,charlie,male,0.81,17826,1103,NCT04388813,Predictors of Severe COVID-19 Outcomes,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,,"May 14, 2020","University of Illinois at Chicago, Chicago, Illinois, United States|Inova Health Care Services, Falls Church, Virginia, United States",https://ClinicalTrials.gov/show/NCT04388813
Principal Investigator,"William Schilling, MD",Mahidol Oxford Tropical Medicine Research Unit,,NCT04303507,william schilling,william,male,0.99,64097,1290,NCT04303507,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,"Active, not recruiting",No Results Available,COVID19|Coronavirus|Acute Respiratory Illnesses,Drug: Chloroquine or Hydroxychloroquine|Drug: Placebo,"March 11, 2020","Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand|Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom|Oxford University Hospital NHS Foundation Trust, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04303507
Principal Investigator,"William W O'Neill, MD",Henry Ford Health System,,NCT04341441,william w o'neill,william,male,0.99,64097,1432,NCT04341441,Will Hydroxychloroquine Impede or Prevent COVID-19,Recruiting,No Results Available,COVID-19|Coronavirus|Coronavirus Infections|SARS-CoV 2,Drug: Hydroxychloroquine - Daily Dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Placebo oral tablet|Diagnostic Test: Monitoring Visit - Baseline|Diagnostic Test: Monitoring Visit - Week 4|Diagnostic Test: Monitoring Visit - Week 8|Other: Weekly Assessment,"April 10, 2020","Henry Ford Hospital, Detroit, Michigan, United States|Detroit Department of Transportation (DDOT), Detroit, Michigan, United States|Detroit Fire Department & Detroit EMS, Detroit, Michigan, United States|Detroit Police Department, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04341441
Study Director,"Dee Dee Wang, MD",Henry Ford Health System,,NCT04341441,dee dee wang,dee,female,0.56,7611,1432,NCT04341441,Will Hydroxychloroquine Impede or Prevent COVID-19,Recruiting,No Results Available,COVID-19|Coronavirus|Coronavirus Infections|SARS-CoV 2,Drug: Hydroxychloroquine - Daily Dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Placebo oral tablet|Diagnostic Test: Monitoring Visit - Baseline|Diagnostic Test: Monitoring Visit - Week 4|Diagnostic Test: Monitoring Visit - Week 8|Other: Weekly Assessment,"April 10, 2020","Henry Ford Hospital, Detroit, Michigan, United States|Detroit Department of Transportation (DDOT), Detroit, Michigan, United States|Detroit Fire Department & Detroit EMS, Detroit, Michigan, United States|Detroit Police Department, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04341441
Principal Investigator,"Patricia Fanlo Mateo, PhD",Complejo Hospitalario de Navarra,,NCT04443881,patricia fanlo mateo,patricia,female,0.98,132232,572,NCT04443881,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Recruiting,No Results Available,COVID-19 Pnemonia,Drug: Anakinra 149 MG/ML Prefilled Syringe [Kineret],"June 23, 2020","Hospital Clinic, Barcelona, Cataluña, Spain|Hospital Universitario Vall d´Hebron, Barcelona, Cataluña, Spain|Complexo Hospitalario Universitario de Santiago, Santiago De Compostela, Galicia, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Mallorca, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario y Politecnico La Fe, Valencia, Spain|Complejo Hospitalario Universitario de Vigo, Vigo, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain",https://ClinicalTrials.gov/show/NCT04443881
Principal Investigator,"Kaushal Madan, DM",Max healthcare,,NCT04422379,kaushal madan,kaushal,male,0.99,296,573,NCT04422379,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,Not yet recruiting,No Results Available,COVID-19,,"June 9, 2020","Max Super Speciality Hospital, Saket (A Unit Of Devki Devi Foundation), New Delhi, Dlelhi, India",https://ClinicalTrials.gov/show/NCT04422379
Study Director,"Allan J Walkey, MD",Boston University,,NCT04344587,allan j walkey,allan,male,0.99,15455,578,NCT04344587,Awake Prone Position for Early Hypoxemia in COVID-19,Enrolling by invitation,No Results Available,COVID-19,Other: Self-prone position recommendation|Other: Usual care,"April 14, 2020","MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Piedmont Atlanta, Atlanta, Georgia, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Boston Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Creighton University, Omaha, Nebraska, United States",https://ClinicalTrials.gov/show/NCT04344587
Principal Investigator,"Fernando Cabanillas, MD",Hospital Español Auxilio Mutuo,,NCT04355247,fernando cabanillas,fernando,male,0.99,88476,579,NCT04355247,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Recruiting,No Results Available,Covid-19,Drug: MethylPREDNISolone 80 Mg/mL Injectable Suspension,"April 21, 2020","San Juan City Hospital / Puerto Rico Medical Center, San Juan, Puerto Rico|Hospital Auxilio Mutuo Cancer Center, San Juan, Puerto Rico",https://ClinicalTrials.gov/show/NCT04355247
Principal Investigator,"Fernando Riera, MD",Sanatorio Allende (Córdoba),,NCT04405271,fernando riera,fernando,male,0.99,88476,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Study Chair,"Waldo H Belloso, MD",Hospital Italiano de Buenos Aires,,NCT04405271,waldo h belloso,waldo,male,0.98,794,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Ventura Simonovich, MD",HIBA,,NCT04405271,ventura simonovich,ventura,male,0.87,781,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Esteban Nannini, MD",Sanatorio Britanico,,NCT04405271,esteban nannini,esteban,male,0.99,13148,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Wanda Cornistein, MD",Hospital Austral,,NCT04405271,wanda cornistein,wanda,female,0.95,5056,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Marcelo Figueiras, MD",Richmond Laboratorio,,NCT04405271,marcelo figueiras,marcelo,male,0.99,17962,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Elvira Zini, MD",Richmond Laboratorio,,NCT04405271,elvira zini,elvira,female,0.98,13934,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Omar Sued, MD",HUESPED,,NCT04405271,omar sued,omar,male,0.98,68333,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Santiago Ramirez Borga, MD",Hospital Italiano de La Plata,,NCT04405271,santiago ramirez borga,santiago,male,0.98,16342,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Gustavo Costilla Campero, MD",Hospital Padilla (Tucumán),,NCT04405271,gustavo costilla campero,gustavo,male,0.98,18273,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Gustavo D Lopardo, MD",Hospital Bernardo Houssay,,NCT04405271,gustavo d lopardo,gustavo,male,0.98,18273,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Gonzalo Corral, MD",Hospital Alende (Mar del Plata),,NCT04405271,gonzalo corral,gonzalo,male,0.99,14183,982,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Not yet recruiting,No Results Available,Healthcare Workers|COVID-19|SARS-CoV 2,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,"May 28, 2020","Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal, Argentina",https://ClinicalTrials.gov/show/NCT04405271
Principal Investigator,"Cheryl Maier, MD, PhD",Emory University,,NCT04441996,cheryl maier,cheryl,female,0.98,6582,581,NCT04441996,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,Not yet recruiting,No Results Available,COVID-19,Biological: Therapeutic plasma exchange (TPE)|Other: Standard of care,"June 22, 2020","Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04441996
Study Director,"Roberto Martinez-Alejos, MD, PhD","University Hospital, Montpellier",,NCT04347070,roberto martinez-alejos,roberto,male,0.99,151858,585,NCT04347070,Implementation of Physiotherapy on COVID-19 Patients in ICU,Recruiting,No Results Available,Sars-CoV2|COVID-19,Other: Phsyiotherapy,"April 15, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04347070
Principal Investigator,"Roberto Copetti, MD, Director",Ospedale di Latisana,,NCT04370275,roberto copetti,roberto,male,0.99,151858,936,NCT04370275,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral",,"April 30, 2020","SC Pronto Soccorso e Medicina d'Urgenza, Latisana, Udine, Italy",https://ClinicalTrials.gov/show/NCT04370275
Principal Investigator,"Ashwin D Dhanda, MRCP PhD",University Hospitals Plymouth NHS Trust,,NCT04436484,ashwin d dhanda,ashwin,male,0.99,1100,587,NCT04436484,Immune Biomarkers of Outcome From COVID-19,Recruiting,No Results Available,COVID-19,Diagnostic Test: Peripheral blood sampling,"June 18, 2020","University Hospitals Plymouth NHS Trust, Plymouth, Devon, United Kingdom",https://ClinicalTrials.gov/show/NCT04436484
Principal Investigator,"Raffaele Antonelli Incalzi, M.D.",Policlinico Campus Bio-Medico,,NCT04379440,raffaele antonelli incalzi,raffaele,male,0.99,27499,589,NCT04379440,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),Recruiting,No Results Available,COVID-19,,"May 7, 2020","RSA La Quiete, Castiglione Cosentino, Calabria, Italy|ASP Catanzaro, Catanzaro Lido, Calabria, Italy|AOU Ferrara, Ferrara, Emilia Romagna, Italy|Policlinico Campus Bio-Medico, Rome, Roma, Italy|AOU Careggi, Firenze, Toscana, Italy|AOU Pisana Geriatria, Pisa, Toscana, Italy|Ospedale di Comunita' ULSS 6 Euganea- COVID Center, Camposampiero, Veneto, Italy",https://ClinicalTrials.gov/show/NCT04379440
Study Chair,"Raffaele Bruno, Prof","Infectious Diseases; IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy",,NCT04399798,raffaele bruno,raffaele,male,0.99,27499,2098,NCT04399798,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Not yet recruiting,No Results Available,Corona Virus Infection,Drug: Baricitinib,"May 22, 2020",,https://ClinicalTrials.gov/show/NCT04399798
Principal Investigator,"Stuart Katz, MD",NYU Langone Health,,NCT04365699,stuart katz,stuart,male,0.99,10695,592,NCT04365699,Cardiovascular Effects of COVID-19,Recruiting,No Results Available,COVID-19,Drug: AT-001,"April 28, 2020","NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04365699
Principal Investigator,"Stuart A Gansky, DrPH",Professor and Lee Hysan Chair of Oral Epidemiology,,NCT04409873,stuart a gansky,stuart,male,0.99,10695,1681,NCT04409873,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2|Severe Acute Respiratory Syndrome Coronavirus 2|Virus Disease|Coronavirus Infections|Pharyngeal Diseases,Drug: Oral-B Mouth Sore mouthwash|Drug: Crest Pro-Health Multi-Protection mouthwash|Drug: CloSYS mouthwash|Drug: Distilled water,"June 1, 2020","University Of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04409873
Principal Investigator,"Jeffrey Berger, MD",NYU Langone Health,,NCT04359277,jeffrey berger,jeffrey,male,0.99,22034,595,NCT04359277,A Randomized Trial of Anticoagulation Strategies in COVID-19,Recruiting,No Results Available,COVID-19,Drug: Enoxaparin Higher Dose|Drug: Lower-dose prophylactic anticoagulation,"April 24, 2020","NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04359277
Principal Investigator,"Jeffrey Miller, MD",Emory University,,NCT04331366,jeffrey miller,jeffrey,male,0.99,22034,704,NCT04331366,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Recruiting,No Results Available,COVID-19,Device: GO2 PEEP MOUTHPIECE,"April 2, 2020","Emory University Hospital, Atlanta, Georgia, United States|Emory St. Joseph's Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04331366
Principal Investigator,"Jeffrey L Carson, MD","Rutgers, The State University of New Jersey",,NCT04374552,jeffrey l carson,jeffrey,male,0.99,22034,1233,NCT04374552,Asymptomatic COVID-19 Trial,Not yet recruiting,No Results Available,SARS-CoV-2 Infection,Drug: Hydroxychloroquine sulfate &Azithromycin|Drug: Placebo,"May 5, 2020","Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04374552
Principal Investigator,"Jeffrey L Carson, MD",Rutgers Biomedical Health Sciences,,NCT04336215,jeffrey l carson,jeffrey,male,0.99,22034,1510,NCT04336215,Rutgers COVID-19 Cohort Study,Recruiting,No Results Available,Coronavirus|SARS-CoV-2,Other: Non-Interventional,"April 7, 2020","Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower -, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Clinical Research Unit Rutgers New Jersey Medical School, Newark, New Jersey, United States|Rutgers School of Dental Medicine, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States|Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, United States|RUCDR Infinite Biologics, Piscataway, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04336215
Principal Investigator,"Reynold A Panettieri, MD",Rutgers Institute for Translational Medicine and Science,,NCT04336215,reynold a panettieri,reynold,male,1.0,301,1510,NCT04336215,Rutgers COVID-19 Cohort Study,Recruiting,No Results Available,Coronavirus|SARS-CoV-2,Other: Non-Interventional,"April 7, 2020","Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower -, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Clinical Research Unit Rutgers New Jersey Medical School, Newark, New Jersey, United States|Rutgers School of Dental Medicine, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States|Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, United States|RUCDR Infinite Biologics, Piscataway, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04336215
Principal Investigator,"Jeffrey Zahn, MD",Icahn School of Medicine at Mount Sinai,,NCT04431297,jeffrey zahn,jeffrey,male,0.99,22034,2054,NCT04431297,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Not yet recruiting,No Results Available,Chronic Stress,Other: Mindfulness Rounds,"June 16, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04431297
Principal Investigator,"Claire Falandry, MD",Hospices Civils de Lyon,,NCT04422340,claire falandry,claire,female,0.97,42044,600,NCT04422340,Senior-COVID-Rea Multicentric Survey,Recruiting,No Results Available,"COVID-19 Disease, Severe Form",Other: Group1,"June 9, 2020","Resuscitation unit at Hospital Emile Roux, Le Puy-en-Velay, France|- Resuscitation unit of the Groupement Hospitalier Nord - Hospices Civils de Lyon, Lyon, France|- Resuscitation unit of the Groupement Hospitalier Sud - Hospices Civils de Lyon, Lyon, France|Resuscitation unit of the Groupement Hospitalier Centre - Hospices Civils de Lyon, Lyon, France|Resuscitation unit of the Groupement Hospitalier Sud - Hospices Civils de Lyon, Lyon, France|Service de Réanimation de l'Hôpital Nord Ouest, Villefranche-sur-Saône, France|Medipole Resuscitation unit, Villeurbanne, France",https://ClinicalTrials.gov/show/NCT04422340
Study Director,"Claire Xu, MD, PhD",I-Mab Biopharma US Limited,,NCT04341116,claire xu,claire,female,0.97,42044,1007,NCT04341116,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Recruiting,No Results Available,Coronavirus Disease 2019 COVID-19,Drug: TJ003234|Drug: Placebo,"April 10, 2020","The GW Medical Faculty Associates, Washington, District of Columbia, United States|OSF Healthcare Saint Francis Medical Center, Peoria, Illinois, United States|Indiana University Health, Indianapolis, Indiana, United States|Medpharmics, LLC, Metairie, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple Univeristy Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04341116
Principal Investigator,CLAIRE ROGER,Nimes University Hospital,,NCT04340466,claire roger,claire,female,0.97,42044,1788,NCT04340466,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Recruiting,No Results Available,"Pneumonia, Viral|Critically Ill|Corona Virus Infection",Other: No intervention,"April 9, 2020","CHU Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04340466
Principal Investigator,"Lin H Chen, MD",Mount Auburn Hospital,,NCT04380402,lin h chen,lin,female,0.63,6642,602,NCT04380402,Atorvastatin as Adjunctive Therapy in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Atorvastatin,"May 8, 2020",,https://ClinicalTrials.gov/show/NCT04380402
Principal Investigator,"Katharine J. Bar, MD",University of Pennsylvania,,NCT04388527,katharine j. bar,katharine,female,0.96,340,603,NCT04388527,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,Recruiting,No Results Available,Covid-19,Biological: COVID-19 Convalescent Plasma,"May 14, 2020","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04388527
Principal Investigator,Katharine J. Bar,University of Pennsylvania,,NCT04397757,katharine j. bar,katharine,female,0.96,340,649,NCT04397757,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,Recruiting,No Results Available,COVID-19,Biological: COVID-19 Convalescent Plasma,"May 21, 2020","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04397757
Principal Investigator,"Tor Biering-Sørensen, MD, PhD, MPH",Research Director,,NCT04377035,tor biering-sørensen,tor,male,0.95,2123,606,NCT04377035,The Role of Ultrasound in COVID-19,Recruiting,No Results Available,COVID-19,,"May 6, 2020","Cardiovascular Non-Invasive Imaging Research Laboratory, department of Cardiology, Herlev & Gentofte Hospital, Hellerup, Denmark",https://ClinicalTrials.gov/show/NCT04377035
Principal Investigator,"Shai Efrati, MD",Head of Research and Development Unit,,NCT04348422,shai efrati,shai,male,0.7,571,608,NCT04348422,Evaluating the Immune Response for COVID-19,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: COVID-19 Serology|Other: Symptoms questionnare,"April 16, 2020",,https://ClinicalTrials.gov/show/NCT04348422
Principal Investigator,"Morten H Bestle, MD, PhD","Nordsjællands Hospital, University of Copenhagen",,NCT04384900,morten h bestle,morten,male,0.99,4878,610,NCT04384900,Accelerated Prone Position Ventilation of Patients With COVID-19,Recruiting,No Results Available,COVID-19,Procedure: Prone position ventilation,"May 12, 2020","Nordsjællands Hospital, Hillerød, Region Hovedstanden, Denmark",https://ClinicalTrials.gov/show/NCT04384900
Principal Investigator,"Rajarshi Banerjee, MSc, DPhil","Honorary Consultant Physician, Oxford University NHS Foundation Trust",,NCT04369807,rajarshi banerjee,rajarshi,male,1.0,42,611,NCT04369807,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Recruiting,No Results Available,COVID-19,Diagnostic Test: Outpatient MRI,"April 30, 2020","Mayo Clinic Healthcare, London, United Kingdom|Gemini, Oxford, United Kingdom",https://ClinicalTrials.gov/show/NCT04369807
Principal Investigator,"Raj Makkar, MD","Cedars-Sinai Medical Center, Los Angeles, CA 90048",,NCT04338347,raj makkar,raj,male,0.97,10726,616,NCT04338347,CAP-1002 in Severe COVID-19 Disease,Available,No Results Available,COVID-19,Biological: CAP-1002 Allogeneic Cardiosphere-Derived Cells,"April 8, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04338347
Principal Investigator,"Hyung Chun, MD",Yale School of Medicine,,NCT04415151,hyung chun,hyung,male,0.95,821,619,NCT04415151,Tofacitinib for Treatment of Moderate COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Tofacitinib 10 mg|Drug: Placebo,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04415151
Study Chair,Amarjeet S Bhamra,All Party Parliamentary Group - Indian Traditional Sciences,,NCT04395976,amarjeet s bhamra,amarjeet,male,0.9,138,622,NCT04395976,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Not yet recruiting,No Results Available,Covid-19,Other: Ayurveda,"May 20, 2020","British Ayurvedic Medical Council, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04395976
Study Director,Neha Sharma,British Ayurvedic Medical Council,,NCT04395976,neha sharma,neha,female,0.97,2082,622,NCT04395976,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Not yet recruiting,No Results Available,Covid-19,Other: Ayurveda,"May 20, 2020","British Ayurvedic Medical Council, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04395976
Study Chair,Neha Sharma,British Ayurvedic Medical Council (UK),,NCT04387643,neha sharma,neha,female,0.97,2082,633,NCT04387643,Protecting Health Care Workers During the COVID-19 Outbreak,Completed,No Results Available,Covid-19,Dietary Supplement: Ayurvedic Kadha,"May 14, 2020","Samta Ayurveda Prakoshtha, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04387643
Study Director,Jaydeep Joshi,Aarogyam UK,,NCT04387643,jaydeep joshi,jaydeep,male,0.98,152,633,NCT04387643,Protecting Health Care Workers During the COVID-19 Outbreak,Completed,No Results Available,Covid-19,Dietary Supplement: Ayurvedic Kadha,"May 14, 2020","Samta Ayurveda Prakoshtha, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04387643
Study Director,Parashar Sharma,"Samta Ayurveda Prakoshtha, India",,NCT04387643,parashar sharma,parashar,male,0.93,14,633,NCT04387643,Protecting Health Care Workers During the COVID-19 Outbreak,Completed,No Results Available,Covid-19,Dietary Supplement: Ayurvedic Kadha,"May 14, 2020","Samta Ayurveda Prakoshtha, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04387643
Principal Investigator,Sahil Singhal,"Samta Ayurveda Prakoshtha, India",,NCT04387643,sahil singhal,sahil,male,0.96,3434,633,NCT04387643,Protecting Health Care Workers During the COVID-19 Outbreak,Completed,No Results Available,Covid-19,Dietary Supplement: Ayurvedic Kadha,"May 14, 2020","Samta Ayurveda Prakoshtha, Jaipur, Rajasthan, India",https://ClinicalTrials.gov/show/NCT04387643
Principal Investigator,"Neha Sharma, PhD",Aarogyam UK,,NCT04351542,neha sharma,neha,female,0.97,2082,2057,NCT04351542,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Completed,No Results Available,Flu Like Illness,Dietary Supplement: Ayurveda|Other: Usual Care,"April 17, 2020","Aarogyam, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04351542
Study Director,"Jaydeep Joshi, BAMS",Aarogyam UK,,NCT04351542,jaydeep joshi,jaydeep,male,0.98,152,2057,NCT04351542,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Completed,No Results Available,Flu Like Illness,Dietary Supplement: Ayurveda|Other: Usual Care,"April 17, 2020","Aarogyam, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04351542
Principal Investigator,Neha Sharma,Aarogyam UK,,NCT04345549,neha sharma,neha,female,0.97,2082,2112,NCT04345549,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Completed,No Results Available,Flu Like Symptom|Flu Like Illness,Other: Individualised Ayurveda,"April 14, 2020","Aarogyam, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04345549
Study Director,Jaydeep Joshi,Aarogyam UK,,NCT04345549,jaydeep joshi,jaydeep,male,0.98,152,2112,NCT04345549,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Completed,No Results Available,Flu Like Symptom|Flu Like Illness,Other: Individualised Ayurveda,"April 14, 2020","Aarogyam, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04345549
Principal Investigator,Søren H Skaarup,Aarhus Universitets Hospital,,NCT04327674,søren h skaarup,søren,male,1.0,360,624,NCT04327674,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Recruiting,No Results Available,COVID-19,,"March 31, 2020","Lungemedicinsk Forskningsafdeling. Aarhus University Hospital, Aarhus, Denmark|Regionshospitalet Horsens., Horsens, Denmark",https://ClinicalTrials.gov/show/NCT04327674
Principal Investigator,"Emily Blumberg, MD",University of Pennsylvania,,NCT04412785,emily blumberg,emily,female,0.98,16379,625,NCT04412785,Cyclosporine in Patients With Moderate COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Cyclosporine,"June 2, 2020","University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04412785
Principal Investigator,"Emily O'Brien, PhD",Duke University,,NCT04342806,emily o'brien,emily,female,0.98,16379,1616,NCT04342806,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Recruiting,No Results Available,Health Care Worker (HCW)|COVID-19,,"April 13, 2020","Duke Clinical Research Institute, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04342806
Principal Investigator,"Jason M Tarkin, MBBS, PhD",University of Cambridge,,NCT04412369,jason m tarkin,jason,male,0.99,63418,626,NCT04412369,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,Not yet recruiting,No Results Available,COVID19|Cardiovascular Diseases,Diagnostic Test: Non-invasive cardiac imaging,"June 2, 2020","Cambridge Univeristy Hospitals NHS Foundation Trust, Cambridge, United Kingdom",https://ClinicalTrials.gov/show/NCT04412369
Principal Investigator,"Jason Stout, MD",Duke University Hospital,,NCT04335552,jason stout,jason,male,0.99,63418,1191,NCT04335552,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Recruiting,No Results Available,SARS-CoV-2,Other: Standard of care|Drug: Hydroxychloroquine|Drug: Azithromycin,"April 6, 2020","Duke Regional Hospital, Durham, North Carolina, United States|Duke University Hospital, Durham, North Carolina, United States|Durham VA Medical Center, Durham, North Carolina, United States|Duke Raleigh Hospital, Raleigh, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04335552
Principal Investigator,"Jason Weatherald, MD",University of Calgary,,NCT04402879,jason weatherald,jason,male,0.99,63418,1644,NCT04402879,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19|Acute Respiratory Distress Syndrome|ARDS|Hypoxemic Respiratory Failure,Procedure: Prone Positioning (PP),"May 27, 2020","Peter Lougheed Centre (PLC), Calgary, Alberta, Canada|Foothills Hospital Intensive Care Unit, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04402879
Principal Investigator,"Ken Parhar, MD, MSc",University of Calgary,,NCT04402879,ken parhar,ken,male,0.98,20992,1644,NCT04402879,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|COVID-19|Acute Respiratory Distress Syndrome|ARDS|Hypoxemic Respiratory Failure,Procedure: Prone Positioning (PP),"May 27, 2020","Peter Lougheed Centre (PLC), Calgary, Alberta, Canada|Foothills Hospital Intensive Care Unit, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04402879
Study Chair,Rebecca A Auer,Ottawa Hospital Research Institute,,NCT04442048,rebecca a auer,rebecca,female,0.98,36835,1282,NCT04442048,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Not yet recruiting,No Results Available,Cancer|Covid-19,Biological: IMM-101|Other: Observation,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442048
Principal Investigator,"Rebecca E Wells, MD, MPH",Wake Forest University Health Sciences,,NCT04319445,rebecca e wells,rebecca,female,0.98,36835,1633,NCT04319445,Mindfulness During COVID-19,Recruiting,No Results Available,Migraine Disorders|Stress|Anxiety,Behavioral: Mindfulness session(s),"March 24, 2020","Wake Forest Health Sciences, Winston-Salem, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04319445
Principal Investigator,"Shukri David, MD","Ascension Providence Hospital, Southfield Campus",,NCT04411602,shukri david,shukri,male,0.82,331,629,NCT04411602,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,Recruiting,No Results Available,Severe Acute Respiratory Syndrome|COVID,Drug: SARS-CoV-2 plasma,"June 2, 2020","Ascension Providence Hospital, Novi Campus, Novi, Michigan, United States|Ascension Providence Hospital, Southfield Campus, Southfield, Michigan, United States|Ascension Macomb-Oakland Hospital, Warren Campus, Warren, Michigan, United States",https://ClinicalTrials.gov/show/NCT04411602
Principal Investigator,"Debra J Levan, DO","Ascension Macomb-Oakland Hospital, Warren Campus",,NCT04411602,debra j levan,debra,female,0.97,3324,629,NCT04411602,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,Recruiting,No Results Available,Severe Acute Respiratory Syndrome|COVID,Drug: SARS-CoV-2 plasma,"June 2, 2020","Ascension Providence Hospital, Novi Campus, Novi, Michigan, United States|Ascension Providence Hospital, Southfield Campus, Southfield, Michigan, United States|Ascension Macomb-Oakland Hospital, Warren Campus, Warren, Michigan, United States",https://ClinicalTrials.gov/show/NCT04411602
Principal Investigator,Lucie Uncapher,University of Colorado Health,,NCT04424797,lucie uncapher,lucie,female,0.99,85580,632,NCT04424797,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Recruiting,No Results Available,COVID-19,Other: Prone Positioning|Other: Supine Positioning,"June 11, 2020","UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|UCHealth Medical Center of the Rockies, Loveland, Colorado, United States",https://ClinicalTrials.gov/show/NCT04424797
Principal Investigator,"Nancy Dreyer, PhD, MPH",Iqvia Pty Ltd,,NCT04368065,nancy dreyer,nancy,female,0.98,42623,634,NCT04368065,Registry to Study Factors That May Impact COVID-19 Occurrence and Severity,Recruiting,No Results Available,COVID-19,,"April 29, 2020","IQVIA, Cambridge, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04368065
Principal Investigator,"Nancy Lee, MD",Memorial Sloan Kettering Cancer Center,,NCT04381988,nancy lee,nancy,female,0.98,42623,1004,NCT04381988,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,Recruiting,No Results Available,COVID-19|Cancer,Drug: Hydroxychloroquine|Other: Placebo|Radiation: Radiation therapy,"May 11, 2020","Memoral Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States|Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (All protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States",https://ClinicalTrials.gov/show/NCT04381988
Principal Investigator,Zeno Bisoffi,IRCCS Sacro Cuore Don Calabria hospital,,NCT04438850,zeno bisoffi,zeno,male,0.95,750,635,NCT04438850,COVidIVERmectin: Ivermectin for Treatment of Covid-19,Not yet recruiting,No Results Available,Covid19,Drug: Ivermectin|Other: Placebo,"June 19, 2020","IRCCS Sacro Cuore Don Calabria hospital, Negrar, Verona, Italy|Policlinico S. Orsola, Bologna, Italy|Ospedale Luigi Sacco, Milan, Italy|Ospedale di Rovereto, Rovereto, Italy|Ospedale Amedeo di Savoia, Turin, Italy|Hospital Clinic/ISGlobal, Barcelona, Spain|Hospital La Paz-Carlos III, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04438850
Principal Investigator,"Nishant Gupta, MD",University of Cincinnati,,NCT04341675,nishant gupta,nishant,male,0.99,948,639,NCT04341675,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Recruiting,No Results Available,COVID-19,Drug: Sirolimus|Drug: Placebo,"April 10, 2020","Loyola University Medical Center, Chicago, Illinois, United States|University of Cincinnati, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04341675
Principal Investigator,"James B Adams, PhD",Arizona State University,,NCT04407286,james b adams,james,male,0.99,117309,641,NCT04407286,Vitamin D Testing and Treatment for COVID 19,Recruiting,No Results Available,Covid 19|Vitamin D Deficiency,Dietary Supplement: Vitamin D3,"May 29, 2020","Arizona State University, Tempe, Arizona, United States",https://ClinicalTrials.gov/show/NCT04407286
Principal Investigator,"Sarah Trahan, NMD",Southwest College of Naturopathic Medicine,,NCT04407286,sarah trahan,sarah,female,0.98,174584,641,NCT04407286,Vitamin D Testing and Treatment for COVID 19,Recruiting,No Results Available,Covid 19|Vitamin D Deficiency,Dietary Supplement: Vitamin D3,"May 29, 2020","Arizona State University, Tempe, Arizona, United States",https://ClinicalTrials.gov/show/NCT04407286
Principal Investigator,"James Welker, MD",Anne Arundel Medical Center,,NCT04317040,james welker,james,male,0.99,117309,1028,NCT04317040,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,Recruiting,No Results Available,Severe Coronavirus Disease (COVID-19),Drug: CD24Fc|Drug: Placebo,"March 20, 2020","Baptist Health Research Institute, Jacksonville, Florida, United States|Martin Army Community Hospital, Fort Benning, Georgia, United States|Anne Anundel Medical Center, Annapolis, Maryland, United States|Institute of Human Virology, University of Maryland Baltimore, Baltimore, Maryland, United States|Shady Grove Medical Center, Rockville, Maryland, United States|White Oak Medical Center, Silver Spring, Maryland, United States|Henry Ford Health System, Detroit, Michigan, United States|Cooper University Hospital, Camden, New Jersey, United States|Atlantic Health System, Morristown, New Jersey, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|The Ohio State University Medical Center, Columbus, Ohio, United States|Thomas Jefferson University Medical Center, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04317040
Principal Investigator,"James Veltmeyer, MD",Therapeutic Solutions International,,NCT04421391,james veltmeyer,james,male,0.99,117309,1293,NCT04421391,QuadraMune(TM) for Prevention of COVID-19,Recruiting,No Results Available,Covid19|Coronavirus|SARS-CoV 2,Dietary Supplement: QuadraMune(TM),"June 9, 2020","Therapeutic Solutions International, Oceanside, California, United States",https://ClinicalTrials.gov/show/NCT04421391
Principal Investigator,"James Neaton, PhD",University of Minnesota,,NCT04385251,james neaton,james,male,0.99,117309,1380,NCT04385251,International SARS-CoV-2 (COVID-19) Infection Observational Study,Not yet recruiting,No Results Available,COVID|COVID19|SARS-CoV 2|Dyspnea,Other: Data Collection,"May 12, 2020","Denver Public Health, Denver, Colorado, United States|Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos, Buenos Aires, Argentina|CHIP Department of Infectious Diseases, Copenhagen, Denmark|University College London Medical School Centre for Sexual Health and HIV Research, London, England, United Kingdom",https://ClinicalTrials.gov/show/NCT04385251
Principal Investigator,"Ravi Amaravadi, MD",University of Pennsylvania,,NCT04329923,ravi amaravadi,ravi,male,0.98,6167,645,NCT04329923,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate 400 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg once a day|Drug: Placebo oral tablet,"April 1, 2020","University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04329923
Principal Investigator,"Santosha Vardhana, MD, PhD",Memorial Sloan Kettering Cancer Center,,NCT04374461,santosha vardhana,santosha,male,0.58,12,647,NCT04374461,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Recruiting,No Results Available,Covid-19,Drug: N-acetylcysteine|Other: Peripheral Blood,"May 5, 2020","Memorial Sloan Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04374461
Principal Investigator,"Augusto Di Castelnuovo, MSc, PhD",IRCCS Neuromed,,NCT04318418,augusto di castelnuovo,augusto,male,0.99,7715,651,NCT04318418,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Not yet recruiting,No Results Available,COVID-19,,"March 24, 2020","IRCCS Neuromed, Department of Epidemiology and Prevention, Pozzilli, Italy",https://ClinicalTrials.gov/show/NCT04318418
Principal Investigator,"Lee Goldstein, MD","HaEmek Medical Center, Israel",,NCT04333628,lee goldstein,lee,male,0.8,38767,653,NCT04333628,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: chloroquine|Other: standard care,"April 3, 2020",,https://ClinicalTrials.gov/show/NCT04333628
Study Chair,"Lee Hullender Rubin, DOAM","University of California, San Francisco",,NCT04380870,lee hullender rubin,lee,male,0.8,38767,1988,NCT04380870,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Recruiting,No Results Available,Coronavirus Infection,Dietary Supplement: Chinese Herbal Medicine,"May 8, 2020","Seattle Intstitute of East Asian Medicine, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04380870
Study Chair,"Lisa Taylor-Swanson, PhD",University of Utah,,NCT04380870,lisa taylor-swanson,lisa,female,0.98,102796,1988,NCT04380870,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Recruiting,No Results Available,Coronavirus Infection,Dietary Supplement: Chinese Herbal Medicine,"May 8, 2020","Seattle Intstitute of East Asian Medicine, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04380870
Principal Investigator,"Amit Singla, MD",Rutgers University,,NCT04410328,amit singla,amit,male,0.99,8292,658,NCT04410328,Aggrenox To Treat Acute Covid-19,Not yet recruiting,No Results Available,Covid19,Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally|Other: Standard of care,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04410328
Principal Investigator,LEROY Sylvie,"CHU de Nice, pneumologie",,NCT04418206,leroy sylvie,leroy,male,0.87,3347,659,NCT04418206,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Not yet recruiting,No Results Available,Covid 19,Other: patients COVID 19,"June 5, 2020","CH Antibes, Antibes, Alpes Maritimes, France|Ch Cannes, Pneumologie, Cannes, Alpes Maritimes, France|Ch Grasse, Grasse, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes, France",https://ClinicalTrials.gov/show/NCT04418206
Study Chair,Manuel Monreal,Germans Trias i Pujol Hospital,,NCT04380792,manuel monreal,manuel,male,0.99,166605,664,NCT04380792,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,Recruiting,No Results Available,COVID-19,,"May 8, 2020","Manuel Monreal, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04380792
Study Chair,Manuel Monreal,Germans Trias i Pujol Hospital,,NCT04380779,manuel monreal,manuel,male,0.99,166605,726,NCT04380779,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,Recruiting,No Results Available,COVID-19,,"May 8, 2020","Manuel Monreal, Badalona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04380779
Principal Investigator,"Manuel Castellà, MD PhD",Hospital Clínic de Barcelona,,NCT04361526,manuel castellà,manuel,male,0.99,166605,928,NCT04361526,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Recruiting,No Results Available,Coronavirus Infection|Acute Respiratory Distress Syndrome|COVID,Device: Cytokine Adsorption,"April 24, 2020","Hospital Clínic de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04361526
Principal Investigator,"Manuel J Castillo, MD, PhD",Universidad de Granada,,NCT04334005,manuel j castillo,manuel,male,0.99,166605,968,NCT04334005,Vitamin D on Prevention and Treatment of COVID-19,Not yet recruiting,No Results Available,Patients Infected With COVID-19,Dietary Supplement: Vitamin D,"April 3, 2020","Universidad de Granada, Granada, Andalucia, Spain|Medicine Faculty, Granada, Spain",https://ClinicalTrials.gov/show/NCT04334005
Principal Investigator,"Reza Ardehali, MD, PhD","University of California, Los Angeles",,NCT04355143,reza ardehali,reza,male,0.97,11963,666,NCT04355143,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Recruiting,No Results Available,COVID-19,Drug: Colchicine Tablets|Other: Current care per UCLA treating physicians,"April 21, 2020","UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|UCLA Santa Monica Hospital, Santa Monica, California, United States",https://ClinicalTrials.gov/show/NCT04355143
Principal Investigator,"Dirk-Jan Slebos, MD PhD","UMCG, Department of pulmonology",,NCT04359459,dirk-jan slebos,dirk-jan,male,1.0,84,668,NCT04359459,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Not yet recruiting,No Results Available,COVID-19,,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359459
Principal Investigator,"Janesh Pillay, MD PhD","UMCG, Intensive Care Medicine",,NCT04359459,janesh pillay,janesh,male,0.88,16,668,NCT04359459,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Not yet recruiting,No Results Available,COVID-19,,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359459
Principal Investigator,Reem Jan,University of Chicago,,NCT04351620,reem jan,reem,female,0.95,4278,670,NCT04351620,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine,"April 17, 2020","University of Chicago, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04351620
Principal Investigator,Aliae Mohamed-Hussein,Assiut University,,NCT04319315,aliae mohamed-hussein,aliae,female,0.95,19,672,NCT04319315,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Recruiting,No Results Available,COVID-19,Other: survey,"March 24, 2020","Assiut University Hospitals, Assiut, Egypt",https://ClinicalTrials.gov/show/NCT04319315
Principal Investigator,"Kamille A West, M.D.",National Institutes of Health Clinical Center (CC),,NCT04360278,kamille a west,kamille,female,0.89,469,673,NCT04360278,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,Recruiting,No Results Available,COVID-19,,"April 24, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04360278
Principal Investigator,"Raimundo Gazitua, MD",Fundacion Arturo Lopez Perez,,NCT04384588,raimundo gazitua,raimundo,male,0.98,1054,675,NCT04384588,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),Recruiting,No Results Available,COVID-19 Infection|Cancer Patients|General Population,Biological: Convalescent Plasma from COVID-19 donors,"May 12, 2020","Fundacion Arturo Lopez Perez, Providencia, Santiago, Chile",https://ClinicalTrials.gov/show/NCT04384588
Principal Investigator,"Stavros Garantziotis, M.D.",National Institute of Environmental Health Sciences (NIEHS),,NCT04403386,stavros garantziotis,stavros,male,0.99,3069,679,NCT04403386,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",Recruiting,No Results Available,COVID-19,,"May 27, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States|NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04403386
Principal Investigator,"Brandon Webb, MD","Intermountain Health Care, Inc.",,NCT04334382,brandon webb,brandon,male,0.99,14697,682,NCT04334382,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 6, 2020","Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04334382
Study Chair,"Tina V. Hartert, MD, MPH","Vanderbilt University School of Medicine, Dept. of Medicine",,NCT04375761,tina v. hartert,tina,female,0.98,56487,683,NCT04375761,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Enrolling by invitation,No Results Available,Coronavirus Disease 2019 (COVID-19)|SARS-CoV-2,Procedure: Collection of Biological Samples|Procedure: Symptom and Exposure Surveys,"May 5, 2020","Children's Hospital Colorado: Inner City Asthma Consortium (ICAC) Site, Aurora, Colorado, United States|Children's Hospital Colorado: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site, Aurora, Colorado, United States|Children's National Medical Center: Inner City Asthma Consortium (ICAC) Site, Washington, District of Columbia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago: Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD) and Improving Technology-Assisted Recording of Asthma Control in Children (iTRACC) Site, Chicago, Illinois, United States|Massachusetts General Hospital:Childhood Microbiome (CHIME) and Wheezing Index (WIND) Site, Boston, Massachusetts, United States|Boston Children's Hospital: School Inner-City Asthma Study (SICAS-2), Environmental Assessment of Sleep in Youth (EASY), Severe Asthma Research Program (SARP) and Preventing Asthma in High Risk Kids (PARK) Site, Boston, Massachusetts, United States|Boston Medical Center: Inner City Asthma Consortium (ICAC) Site, Boston, Massachusetts, United States|Henry Ford Health System: Childhood Allergy Study (CAS) Site, Detroit, Michigan, United States|Henry Ford Health System: Inner City Asthma Consortium (ICAC) Site, Detroit, Michigan, United States|Henry Ford Health System: Microbes, Asthma, Allergy and Pets (MAAP) and Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study (WHEALS) Site, Detroit, Michigan, United States|St. Louis Children's Hospital: Inner City Asthma Consortium (ICAC) Site, Saint Louis, Missouri, United States|Columbia University Medical Center: Inner City Asthma Consortium (ICAC) Site, New York, New York, United States|Cincinnati Children's Hospital Medical Center: Greater Cincinnati Pediatric Clinic Repository (GCPCR) and Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center: Inner City Asthma Consortium (ICAC) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center:Cincinnati Childhood Allergy & Air Pollution Study (CCAAPS) Site, Cincinnati, Ohio, United States|Vanderbilt University Medical Center: Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE) Site, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center: Inner City Asthma Consortium (ICAC) Site, Dallas, Texas, United States|University of Wisconsin Hospital and Clinics: Childhood Origins of Asthma (COAST) Site, Madison, Wisconsin, United States|University of Wisconsin Hospital and Clinics: Wisconsin Infant Study Cohort (WISC) Site, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04375761
Study Director,"Kristian Tonby, MD",Oslo University Hospital,,NCT04345536,kristian tonby,kristian,male,0.99,8752,685,NCT04345536,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Recruiting,No Results Available,COVID-19,,"April 14, 2020","Oslo University Hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04345536
Study Chair,Haleema Shakur-Still,London School of Hygiene and Tropical Medicine,,NCT04343001,haleema shakur-still,haleema,female,0.95,108,689,NCT04343001,Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Not yet recruiting,No Results Available,Covid-19,Drug: Aspirin|Drug: Losartan|Drug: Simvastatin,"April 13, 2020","University College Hospital, Ibadan, Oyo, Nigeria|Shifa Tameer-e-Millat University, Rawalpindi, Pakistan",https://ClinicalTrials.gov/show/NCT04343001
Study Chair,Ian Roberts,London School of Hygiene and Tropical Medicine,,NCT04343001,ian roberts,ian,male,0.99,27117,689,NCT04343001,Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Not yet recruiting,No Results Available,Covid-19,Drug: Aspirin|Drug: Losartan|Drug: Simvastatin,"April 13, 2020","University College Hospital, Ibadan, Oyo, Nigeria|Shifa Tameer-e-Millat University, Rawalpindi, Pakistan",https://ClinicalTrials.gov/show/NCT04343001
Principal Investigator,NURUL A MOHAMED,Universiti Sains Islam Malaysia,,NCT04410159,nurul a mohamed,nurul,female,0.94,7757,692,NCT04410159,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Recruiting,No Results Available,COVID-19,Drug: Povidone-Iodine|Drug: Essential oils|Other: Tap water,"June 1, 2020","Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur, Malaysia",https://ClinicalTrials.gov/show/NCT04410159
Principal Investigator,"Kevin V Grimes, MD",Stanford University,,NCT04393311,kevin v grimes,kevin,male,0.99,157365,696,NCT04393311,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Ulinastatin|Drug: Placebo,"May 19, 2020","Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04393311
Principal Investigator,"Kevin Kain, MD","University Health Network, Toronto",,NCT04374942,kevin kain,kevin,male,0.99,157365,2075,NCT04374942,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Enrolling by invitation,No Results Available,Pre-Exposure Prophylaxis|Coronavirus|SARS-CoV 2,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"May 5, 2020","University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04374942
Principal Investigator,"Megan Landes, MD","University Health Network, Toronto",,NCT04374942,megan landes,megan,female,0.96,5933,2075,NCT04374942,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Enrolling by invitation,No Results Available,Pre-Exposure Prophylaxis|Coronavirus|SARS-CoV 2,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"May 5, 2020","University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04374942
Principal Investigator,"Anahi Perlas, MD,FRCPC","Toronto Western Hospital , UHN",,NCT04373096,anahi perlas,anahi,female,0.99,829,700,NCT04373096,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Not yet recruiting,No Results Available,Covid19,Device: current IPAC-UHN PPE|Device: modified IPAC-UHN PPE,"May 4, 2020",,https://ClinicalTrials.gov/show/NCT04373096
Principal Investigator,"Shaul Lev, MD",Rabin Medical Center,,NCT04389645,shaul lev,shaul,male,0.99,100,706,NCT04389645,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,Completed,No Results Available,COVID-19,Diagnostic Test: IP-10 in CDS protocol,"May 15, 2020","Rabin Medical Center, Petach Tikva, Israel",https://ClinicalTrials.gov/show/NCT04389645
Principal Investigator,"Lieven Herbots, MD, PhD",Hartcentrum Hasselt,,NCT04371679,lieven herbots,lieven,male,0.98,595,707,NCT04371679,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Recruiting,No Results Available,Covid-19,Other: No interventions planned,"May 1, 2020","Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04371679
Principal Investigator,"Rajiv Thakur, MD",Advanced Diagnostics Healthcare,,NCT04362189,rajiv thakur,rajiv,male,0.99,1467,708,NCT04362189,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: HB-adMSC|Drug: Placebo,"April 24, 2020","River Oaks Hospital and Clinics, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04362189
Study Director,Vaseeharan Sathiyamoorthy,World Health Organization,,NCT04330690,vaseeharan sathiyamoorthy,vaseeharan,female,1.0,1,709,NCT04330690,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,Recruiting,No Results Available,COVID-19,Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: remdesivir,"April 1, 2020","Peter Lougheed Centre, Calgary, Alberta, Canada|Foothills Medical Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|University of Alberta Hopsital, Edmonton, Alberta, Canada|Vancouver General Hospital, Vancouver Coastal Health, Univeristy of British Columbia, Vancouver, British Columbia, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Island Health - Royal Jubilee Hospital, Victoria, British Columbia, Canada|Island Health - Victoria General Hospital, Victoria, British Columbia, Canada|William Osler Health System - Brampton Civic Hospital, Brampton, Ontario, Canada|William Osler Health System - Etobicoke General Hospital, Etobicoke, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St.Joseph's Health Care, London, Ontario, Canada|University Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Trillium Health Partners -Mississauga Site, Mississauga, Ontario, Canada|Trillium Health Partners-Credit Valley Hospital, Mississauga, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Queensway Carleton Hospital, Ottawa, Ontario, Canada|Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada|McGill University Health Centre-Glen Site Royal Victoria Hospital, Montréal, Quebec, Canada|CHU de Québec - Université Laval, Québec, Quebec, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Québec- Université Laval, Québec, Quebec, Canada|Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04330690
Principal Investigator,"Guy Thwaites, PhD. MD","University of Oxford, UK",,NCT04328493,guy thwaites,guy,male,0.98,26733,790,NCT04328493,The Vietnam Chloroquine Treatment on COVID-19,Recruiting,No Results Available,SARS-CoV-2 Infection|COVID-19,Drug: Chloroquine phosphate,"March 31, 2020","National Hospital for Tropical Diseases, Hanoi, Vietnam|Can Gio COVID Hospital, Ho Chi Minh City, Vietnam|Cho Ray Hospital, Ho Chi Minh City, Vietnam|Cu Chi COVID Hospital, Ho Chi Minh City, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam",https://ClinicalTrials.gov/show/NCT04328493
Principal Investigator,"Pankti Reid, MD, MPH","University of Chicago, Department of Medicine, Section of Rheumatology",,NCT04331795,pankti reid,pankti,female,0.83,6,712,NCT04331795,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Completed,No Results Available,COVID-19,Drug: Tocilizumab,"April 2, 2020","University of Chicago Medicine, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04331795
Principal Investigator,"Bernd Jilma, MD",Medical University of Vienna,,NCT04351724,bernd jilma,bernd,male,0.99,12170,717,NCT04351724,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Recruiting,No Results Available,COVID-19,Drug: Chloroquine or Hydroxychloroquine|Drug: Lopinavir/Ritonavir|Other: Best standard of care|Drug: Rivaroxaban|Drug: Thromboprophylaxis|Drug: Candesartan|Drug: non-RAS blocking antihypertensives|Drug: Clazakizumab|Drug: placebo for clazakizumab,"April 17, 2020","Medical University of Innsbruck, Innsbruck, Tirol, Austria|Medical University of Vienna, Vienna, Austria|Wilhelminenspital, Vienna, Austria|SMZ Süd Kaiser Franz Josef Spital, Vienna, Austria|KH Hietzing, Vienna, Austria|SMZ Baumgartner Höhe Otto Wagner Spital, Vienna, Austria|SMZ Ost Donauspital, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04351724
Principal Investigator,"Meredith Clement, MD",LSUHSC/UMCNO,,NCT04344444,meredith clement,meredith,female,0.96,701,719,NCT04344444,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin,"April 14, 2020","University Medical Center New Orleans, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04344444
Principal Investigator,"Stefan Kluge, MD","University Hospital Hamburg-Eppendorf, Department of Intensive Care Medicine",,NCT04344080,stefan kluge,stefan,male,0.98,83987,722,NCT04344080,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Recruiting,No Results Available,COVID-19,Device: CytoSorb-Therapy,"April 14, 2020","University Medical Center Hamburg-Eppendorf, Hamburg, Germany",https://ClinicalTrials.gov/show/NCT04344080
Principal Investigator,"Stefan S Jeppesen, MD, PhD","Odense University Hospital, Denmark",,NCT04389996,stefan s jeppesen,stefan,male,0.98,83987,1765,NCT04389996,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,Recruiting,No Results Available,Cancer,Other: No intervention,"May 15, 2020","Department of Haemotology, Odense University Hospital, Odense, Region Of Southern Denmark, Denmark|Department of Oncology, Odense University Hospital, Odense C, Denmark",https://ClinicalTrials.gov/show/NCT04389996
Principal Investigator,"Boglarka Gyurkocza, MD",Memorial Sloan Kettering Cancer Center,,NCT04377659,boglarka gyurkocza,boglarka,female,0.99,83,723,NCT04377659,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Recruiting,No Results Available,COVID-19,Drug: Tocilizumab,"May 6, 2020","Memorial Sloan Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04377659
Principal Investigator,"Dr. Tahir Shamsi, FRCP MRCPath",National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD),,NCT04352751,tahir shamsi,tahir,male,0.97,7688,727,NCT04352751,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,Recruiting,No Results Available,Covid-19,Other: convalescent plasma,"April 20, 2020","National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD), Karachi, Sindh, Pakistan",https://ClinicalTrials.gov/show/NCT04352751
Principal Investigator,Reginaldo Raimundo Fujita,Federal University of São Paulo,,NCT04435314,reginaldo raimundo fujita,reginaldo,male,0.99,710,728,NCT04435314,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,Not yet recruiting,No Results Available,covid19,Drug: Nitazoxanide|Drug: Placebo,"June 17, 2020",,https://ClinicalTrials.gov/show/NCT04435314
Principal Investigator,"Marie-France VAILLANT, PhD",Centre Hospitalier Universitaire Grenoble Alpes,,NCT04365816,marie-france vaillant,marie-france,female,0.99,2819,730,NCT04365816,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Not yet recruiting,No Results Available,COVID-19,Other: Interview,"April 28, 2020",,https://ClinicalTrials.gov/show/NCT04365816
Principal Investigator,"Matthew B. Rettig, MD","VA Greater Los Angeles Healthcare System, West Los Angeles, CA",,NCT04397718,matthew b. rettig,matthew,male,1.0,35521,732,NCT04397718,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,Not yet recruiting,No Results Available,CoVID19,Drug: Degarelix|Other: Saline,"May 21, 2020","VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States|Brooklyn Campus of the VA NY Harbor Healthcare System, Brooklyn, NY, Brooklyn, New York, United States|Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, New York, United States|VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04397718
Principal Investigator,"Matthew Sims, MD PhD",Beaumont Health,,NCT04432272,matthew sims,matthew,male,1.0,35521,979,NCT04432272,ANTIBODY-LEVEL BASED ANALYSIS OF COVID CONVALESCENT SERUM (ABACCuS),Not yet recruiting,No Results Available,COVID-19|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections,Biological: COVID-19 convalescent plasma,"June 16, 2020","William Beaumont Hospital, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04432272
Principal Investigator,"Matthew Sims, MD, PhD",William Beaumont Hospitals,,NCT04349202,matthew sims,matthew,male,1.0,35521,1065,NCT04349202,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Recruiting,No Results Available,COVID-19|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2,Diagnostic Test: EUROIMMUN assay,"April 16, 2020","Beaumont Health System, Royal Oak, Michigan, United States|Beaumont Health, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04349202
Principal Investigator,"Matthew Yocum, MD",University of Minnesota,,NCT04339998,matthew yocum,matthew,male,1.0,35521,1338,NCT04339998,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Recruiting,No Results Available,Coronavirus Infection|COVID|Covid-19|SARS-CoV-2,Diagnostic Test: Point-of-Care Ultrasonography (POCUS),"April 9, 2020","University of Minnesota Medical Center (UMMC), Minneapolis, Minnesota, United States|M Health Fairview Bethesda Hospital, Saint Paul, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04339998
Principal Investigator,"Matthew J Memoli, M.D.",National Institute of Allergy and Infectious Diseases (NIAID),,NCT04334954,matthew j memoli,matthew,male,1.0,35521,1390,NCT04334954,SARS-COV2 Pandemic Serosurvey and Blood Sampling,Recruiting,No Results Available,SARS-COV2 Virus,,"April 6, 2020","University of Alabama, Birmingham, Alabama, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04334954
Principal Investigator,"Matthew Dallos, MD",Columbia University Irving Medical Center,,NCT04347226,matthew dallos,matthew,male,1.0,35521,1418,NCT04347226,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Recruiting,No Results Available,Solid Tumor|Sars-CoV2|Hematological Malignancy,Drug: BMS-986253,"April 15, 2020","Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04347226
Principal Investigator,"Matthew Sims, MD PhD",Beaumont Health,,NCT04365985,matthew sims,matthew,male,1.0,35521,1584,NCT04365985,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Severe Acute Respiratory Syndrome (SARS)|Coronavirus Infections,Drug: Naltrexone|Drug: Ketamine|Other: Placebo,"April 28, 2020","William Beaumont Hospital, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04365985
Principal Investigator,"Lola Morozova, Md",I.M. Sechenov First Moscow State Medical University,,NCT04437875,lola morozova,lola,female,0.97,55346,738,NCT04437875,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",Recruiting,No Results Available,Preventive Immunization COVID-19,Biological: Gam-COVID-Vac Lyo,"June 18, 2020","Sechenov First Moscow State Medical University, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04437875
Study Chair,"Meifang Han, Professor",Tongji Hospital,,NCT04365634,meifang han,meifang,female,0.9,20,740,NCT04365634,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,Completed,No Results Available,COVID-19,,"April 28, 2020","Tongji Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04365634
Principal Investigator,"Natalia G Antonevich, Dr.",Head of the Lab of Institute of Biophysics and Cell Engineering of NAS,,NCT04382547,natalia g antonevich,natalia,female,0.98,102542,1506,NCT04382547,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Enrolling by invitation,No Results Available,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Other: Standard treatment according to the Clinical protocols,"May 11, 2020","Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",https://ClinicalTrials.gov/show/NCT04382547
Study Director,"Andrei Y Hancharou, Dr.","Director, the Institute of Biophysics and Cell Engineering of NAS of Belarus",,NCT04382547,andrei y hancharou,andrei,male,0.97,21506,1506,NCT04382547,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Enrolling by invitation,No Results Available,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Other: Standard treatment according to the Clinical protocols,"May 11, 2020","Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",https://ClinicalTrials.gov/show/NCT04382547
Study Director,"Eduard A Dotsenko, Dr., prof.","Head of the chair, Belarusian State Medical University",,NCT04382547,eduard a dotsenko,eduard,male,0.99,10188,1506,NCT04382547,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Enrolling by invitation,No Results Available,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Other: Standard treatment according to the Clinical protocols,"May 11, 2020","Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk, Belarus",https://ClinicalTrials.gov/show/NCT04382547
Principal Investigator,"Hubert Schrezenmeier, Prof.Dr.",IKT Ulm,,NCT04433910,hubert schrezenmeier,hubert,male,0.98,15039,750,NCT04433910,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,Recruiting,No Results Available,COVID-19,Drug: Convalesscent Plasma,"June 16, 2020","University Hospital Ulm, Ulm, Baden-Württmberg, Germany|University Hopsital Frankfurt, Frankfurt, Hessia, Germany|Saarland University Hospital, Homburg, Saarland, Germany",https://ClinicalTrials.gov/show/NCT04433910
Study Director,"Erhard Seifried, Prof.Dr.Dr.",German Red Cross Blood Service,,NCT04433910,erhard seifried,erhard,male,0.98,389,750,NCT04433910,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,Recruiting,No Results Available,COVID-19,Drug: Convalesscent Plasma,"June 16, 2020","University Hospital Ulm, Ulm, Baden-Württmberg, Germany|University Hopsital Frankfurt, Frankfurt, Hessia, Germany|Saarland University Hospital, Homburg, Saarland, Germany",https://ClinicalTrials.gov/show/NCT04433910
Principal Investigator,Upinder Singh,Professor (Medicine -Infectious Diseases),,NCT04331899,upinder singh,upinder,male,0.89,9,751,NCT04331899,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Recruiting,No Results Available,COVID-19,Drug: Peginterferon Lambda-1a|Other: Placebo,"April 2, 2020","Stanford University School of Medicine, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04331899
Principal Investigator,"Edimilson Migowski, MD",NEPS SEMUS Mesquita,,NCT04441398,edimilson migowski,edimilson,male,0.98,43,755,NCT04441398,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,Not yet recruiting,No Results Available,covid19,Drug: Nitazoxanide|Drug: Placebo,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04441398
Principal Investigator,"Agnès Hamzaoui, Pr",Hopital Abderrahmane Mami,,NCT04384614,agnès hamzaoui,agnès,female,0.98,934,756,NCT04384614,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,Not yet recruiting,No Results Available,Covid 19|BCG Vaccination,Diagnostic Test: Test PCR|Genetic: TDR|Other: Clinical Examination,"May 12, 2020","Eshmoun Clinical Research Centre, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04384614
Principal Investigator,Siamack Afazeli,Fasa University of Medical Sciences,,NCT04331470,siamack afazeli,siamack,male,1.0,20,761,NCT04331470,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Recruiting,No Results Available,COVID-19,Drug: Levamisole Pill + Budesonide+Formoterol inhaler|Drug: Lopinavir/Ritonavir + hydoxychloroquine,"April 2, 2020","Vali-Asr Hospital, Fasa, Fars, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04331470
Principal Investigator,"Andrea Natale, MD",St. David`s Medical Center,,NCT04371926,andrea natale,andrea,male,0.62,302977,763,NCT04371926,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Withdrawn,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate,"May 1, 2020",,https://ClinicalTrials.gov/show/NCT04371926
Principal Investigator,"Andrea Goldstein-Piekarski, PhD",Stanford University,,NCT04409743,andrea goldstein-piekarski,andrea,male,0.62,302977,1888,NCT04409743,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Recruiting,No Results Available,Sleep Disturbance|Insomnia,Behavioral: Remote Cognitive Behavioral Therapy for Insomnia,"June 1, 2020","Stanford University, Palo Alto, California, United States",https://ClinicalTrials.gov/show/NCT04409743
Principal Investigator,"Andrea Smargiassi, MD, PhD","Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italy",,NCT04322487,andrea smargiassi,andrea,male,0.62,302977,1934,NCT04322487,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Recruiting,No Results Available,"Coronavirus|Epidemic Disease|Pneumonia, Viral",Diagnostic Test: Lung ultrasound,"March 26, 2020","Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera, Italy",https://ClinicalTrials.gov/show/NCT04322487
Principal Investigator,"Riccardo Inchingolo, MD, PhD","Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italy",,NCT04322487,riccardo inchingolo,riccardo,male,0.99,36394,1934,NCT04322487,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Recruiting,No Results Available,"Coronavirus|Epidemic Disease|Pneumonia, Viral",Diagnostic Test: Lung ultrasound,"March 26, 2020","Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera, Italy",https://ClinicalTrials.gov/show/NCT04322487
Principal Investigator,"Libertario Demi, PhD","Dept. of Information Engineering and Computer Science, University of Trento, Italy",,NCT04322487,libertario demi,libertario,male,0.93,14,1934,NCT04322487,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Recruiting,No Results Available,"Coronavirus|Epidemic Disease|Pneumonia, Viral",Diagnostic Test: Lung ultrasound,"March 26, 2020","Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera, Italy",https://ClinicalTrials.gov/show/NCT04322487
Study Director,"Gino Soldati, MD","Diagnostic and Interventional Ultrasound Unit, Valle del Serchio Hospital, Lucca, Italy",,NCT04322487,gino soldati,gino,male,0.98,21115,1934,NCT04322487,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Recruiting,No Results Available,"Coronavirus|Epidemic Disease|Pneumonia, Viral",Diagnostic Test: Lung ultrasound,"March 26, 2020","Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera, Italy",https://ClinicalTrials.gov/show/NCT04322487
Study Chair,"Prof. Qingsong Ye, PhD,DDS","Center for Regenerative Medicine, Renmin Hospital of Wuhan University",,NCT04336254,qingsong ye,qingsong,male,1.0,30,769,NCT04336254,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,Recruiting,No Results Available,COVID-19,Biological: allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Other: Intravenous saline injection (Placebo),"April 7, 2020","Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04336254
Principal Investigator,"Blaise Genton, MD-PhD",Unisanté,,NCT04385264,blaise genton,blaise,male,0.97,3382,775,NCT04385264,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Mannitol,"May 12, 2020","Unisanté, Lausanne, Vaud, Switzerland",https://ClinicalTrials.gov/show/NCT04385264
Principal Investigator,"Mary-Anne Hartley, MD, PhD MPH",Unisanté,,NCT04385264,mary-anne hartley,mary-anne,female,1.0,123,775,NCT04385264,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,Not yet recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Mannitol,"May 12, 2020","Unisanté, Lausanne, Vaud, Switzerland",https://ClinicalTrials.gov/show/NCT04385264
Principal Investigator,"Avni Thakore, MD",Saint Francis Memorial Hospital,,NCT04370782,avni thakore,avni,male,0.95,2086,776,NCT04370782,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Drug: Doxycycline,"May 1, 2020","St Francis Hospital, Roslyn, New York, United States",https://ClinicalTrials.gov/show/NCT04370782
Principal Investigator,"Cecilia M Shikuma, MD",University of Hawaii at Manoa John A Burns School of Medicine,,NCT04360551,cecilia m shikuma,cecilia,female,0.99,21692,785,NCT04360551,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19,Drug: Telmisartan 40mg|Drug: Placebo,"April 24, 2020","University of Hawaii - Manoa, John A Burns School of Medicine UH Clinics at Kakaako, Honolulu, Hawaii, United States",https://ClinicalTrials.gov/show/NCT04360551
Principal Investigator,"Bonnie Lonze, MD",NYU Langone Health,,NCT04343989,bonnie lonze,bonnie,female,0.9,3712,786,NCT04343989,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Recruiting,No Results Available,COVID-19,Drug: Clazakizumab 25 mg|Drug: Clazakizumab 12.5 mg|Other: Placebo,"April 14, 2020","New York University School of Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04343989
Principal Investigator,"Thanh Cheng, MD",Hope Biosciences Stem Cell Research Foundation,,NCT04348435,thanh cheng,thanh,male,0.7,2100,791,NCT04348435,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",Enrolling by invitation,No Results Available,COVID-19,Drug: HB-adMSCs|Drug: Placebos,"April 16, 2020","Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04348435
Principal Investigator,"Thanh Cheng, MD",Hope Biosciences Stem Cell Research Foundation,,NCT04349631,thanh cheng,thanh,male,0.7,2100,1351,NCT04349631,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,Enrolling by invitation,No Results Available,COVID-19,Drug: HB-adMSCs,"April 16, 2020","Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States",https://ClinicalTrials.gov/show/NCT04349631
Study Director,Luciana Ferrara,Azidus Brasil,,NCT04329572,luciana ferrara,luciana,female,0.98,10121,792,NCT04329572,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Suspended,No Results Available,COVID-19,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets,"April 1, 2020","Prevent Senior Private Operadora de Saúde LTDA., São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04329572
Principal Investigator,"Jean-Claude Tardif, MD",Montreal Heart Institute,,NCT04322682,jean-claude tardif,jean-claude,male,0.99,9062,2245,NCT04322682,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Recruiting,No Results Available,Corona Virus Infection,Drug: Colchicine|Drug: Placebo oral tablet,"March 26, 2020","University of California, San Francisco - San Francisco General Hospital, San Francisco, California, United States|New York University School of Medecine, New York, New York, United States|Montreal Heart Institute, Montreal, Quebec, Canada|Hospital Universitario La Paz, IdiPaz, La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04322682
Study Director,"Zohar Bassevitch, B.SC.",Montreal Health Innovations Coordinating Center,,NCT04322682,zohar bassevitch,zohar,male,0.79,127,2245,NCT04322682,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Recruiting,No Results Available,Corona Virus Infection,Drug: Colchicine|Drug: Placebo oral tablet,"March 26, 2020","University of California, San Francisco - San Francisco General Hospital, San Francisco, California, United States|New York University School of Medecine, New York, New York, United States|Montreal Heart Institute, Montreal, Quebec, Canada|Hospital Universitario La Paz, IdiPaz, La Paz, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04322682
Principal Investigator,"Gaetan GAVAZZI, Pr","University Hospital, Grenoble",,NCT04381312,gaetan gavazzi,gaetan,male,0.99,11785,798,NCT04381312,Direct and Indirect Impact of COVID-19 In Older Populations,Recruiting,No Results Available,Risk Factors for COVID-19 Outcomes in Elderly Populations,,"May 8, 2020","Chu Grenoble Alpes, Grenoble Cedex 9, Grenoble, France",https://ClinicalTrials.gov/show/NCT04381312
Study Chair,"Aristomenis Extradaktylos, Prof. MD",University Hospital Bern - Department of Emergency Medicine,,NCT04357834,aristomenis extradaktylos,aristomenis,male,1.0,20,803,NCT04357834,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Not yet recruiting,No Results Available,COVID|COVID 19|SARS-CoV 2,Other: Equipment with smartwatch throughout hospital stay on the general ward,"April 22, 2020","Emergency Department, University Hospital Bern, Inselspital, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04357834
Principal Investigator,Shaji Sebastian,Hull University Teaching Hospitals,,NCT04411784,shaji sebastian,shaji,male,0.95,219,807,NCT04411784,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis","Active, not recruiting",No Results Available,Inflammatory Bowel Diseases|COVID,,"June 2, 2020","Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",https://ClinicalTrials.gov/show/NCT04411784
Principal Investigator,Shaji Sebastian,Hull and East Yorkshire NHS Trust,,NCT04410484,shaji sebastian,shaji,male,0.95,219,2205,NCT04410484,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,"Active, not recruiting",No Results Available,Inflammatory Bowel Diseases|Coronavirus Infection,,"June 1, 2020","Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull, United Kingdom",https://ClinicalTrials.gov/show/NCT04410484
Study Chair,"Péter Hegyi, MD, PhD, DSc","Insitute for Translational Medicine, University of Pécs, HU",,NCT04422626,péter hegyi,péter,male,0.95,88,812,NCT04422626,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,Not yet recruiting,No Results Available,SARS-CoV-2|COVID-19,,"June 9, 2020",,https://ClinicalTrials.gov/show/NCT04422626
Study Chair,"Péter Hegyi, MD, PhD, DSc","Insitute for Translational Medicine, University of Pécs, HU",,NCT04321928,péter hegyi,péter,male,0.95,88,1619,NCT04321928,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Recruiting,No Results Available,SARS-CoV-2|Coronavirus|COVID-19|2019-nCoV|2019nCoV,Behavioral: Personalized health education|Behavioral: General health education,"March 25, 2020","Institute for Translational Medicine, University of Pécs, Pécs, Hungary",https://ClinicalTrials.gov/show/NCT04321928
Principal Investigator,"Adrian Camacho Ortiz, MD","Hospital Universitario ""Dr. Jose Eleuterio Gonzalez"", UANL",,NCT04428268,adrian camacho ortiz,adrian,male,0.99,90344,813,NCT04428268,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Chloroquine Phosphate Tablets,"June 11, 2020","Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04428268
Principal Investigator,"Adrian Egli, Prof. Dr. med.","Division of Clinical Bacteriology & Mycology, University Hospital Basel",,NCT04351503,adrian egli,adrian,male,0.99,90344,1188,NCT04351503,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Recruiting,No Results Available,SARS Coronavirus (SARS-CoV-2) Infection,Other: Study A|Other: Study B|Other: Study C|Other: Study D,"April 17, 2020","Viollier AG, Allschwil, Switzerland|University Hospital Basel, Basel, Switzerland|Biozentrum University of Basel, Basel, Switzerland|sciCore University of Basel, Basel, Switzerland|Department of Biosystems Science and Engineering ETH Zurich, Basel, Switzerland|Swiss Institute of Bioinformatics, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04351503
Principal Investigator,"Adrian Hernandez, MD",Duke University,,NCT04334148,adrian hernandez,adrian,male,0.99,90344,1750,NCT04334148,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"April 6, 2020","University of Florida, Gainesville, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|University of South Florida, Tampa, Florida, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Johns Hopkins, Baltimore, Maryland, United States|Mayo Clinic Hospital Rochester, Rochester, Minnesota, United States|University of Missouri-Columbia, Columbia, Missouri, United States|Hospital for Special Surgery, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor Scott & White Medical Center-Temple, Temple, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Marshfield Clinic Health System, Marshfield, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04334148
Principal Investigator,"Adrian I Espiritu, MD",University of the Philippines,,NCT04386083,adrian i espiritu,adrian,male,0.99,90344,1816,NCT04386083,Neurologic Manifestations of COVID-19,Not yet recruiting,No Results Available,Coronavirus Disease 2019,,"May 13, 2020",,https://ClinicalTrials.gov/show/NCT04386083
Principal Investigator,"Adrian Camacho-Ortiz, MD","Hospital Universitario ""Dr. Jose Eleuterio Gonzalez, UANL",,NCT04393142,adrian camacho-ortiz,adrian,male,0.99,90344,1876,NCT04393142,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,Recruiting,No Results Available,Coronavirus Infection,,"May 19, 2020","Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04393142
Principal Investigator,"Adrian Camacho-Ortiz, MD","Hospital Universitario ""Dr. Jose Eleuterio Gonzalez, UANL",,NCT04358783,adrian camacho-ortiz,adrian,male,0.99,90344,1963,NCT04358783,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,Recruiting,No Results Available,Coronavirus Infection,Biological: Plasma|Other: Best Available Therapy,"April 24, 2020","Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon, Mexico",https://ClinicalTrials.gov/show/NCT04358783
Principal Investigator,"Geneva Tatem, MD",Henry Ford Health System,,NCT04385199,geneva tatem,geneva,female,0.89,229,820,NCT04385199,Convalescent Plasma for Patients With COVID-19,Recruiting,No Results Available,Coronavirus Infection|Coronavirus|COVID,Biological: Convalescent plasma,"May 12, 2020","Henry Ford Hospital, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04385199
Principal Investigator,"Isabelle SERMET-GAUDELUS, MD, PhD",Assistance Publique-Hôpitaux de Pars,,NCT04355533,isabelle sermet-gaudelus,isabelle,female,0.99,89728,832,NCT04355533,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Not yet recruiting,No Results Available,COVID-19 Infection,Biological: serology test|Diagnostic Test: NG Biotech|Biological: nasopharyngeal swab|Biological: rectal swab|Biological: saliva sample,"April 21, 2020","Hôpital necker Enfants-Malades, ¨Paris, France",https://ClinicalTrials.gov/show/NCT04355533
Principal Investigator,"Isabelle LAFFONT, Professor","University Hospital, Montpellier",,NCT04384406,isabelle laffont,isabelle,female,0.99,89728,1575,NCT04384406,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,Completed,No Results Available,Chronic Disabling|COVID-19,,"May 12, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04384406
Principal Investigator,Meletios Athanasios Dimopoulos,National and Kapodistrian University of Athens,,NCT04408209,meletios athanasios dimopoulos,meletios,male,1.0,10,837,NCT04408209,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,Recruiting,No Results Available,COVID-19 Infection,Procedure: Convalescent Plasma,"May 29, 2020","""Evangelismos"" General Hospital, Athens, Attiki, Greece|""Agios Savas"" Oncology Hospital, Athens, Attiki, Greece|""Alexandra"" General Hospital, Athens, Attiki, Greece|""Sotiria"" General Hospital, Athens, Attiki, Greece|Attikon"" University General Hospital, Athens, Chaidari, Greece|University General Hospital of Patras, Patra, Rio, Greece",https://ClinicalTrials.gov/show/NCT04408209
Principal Investigator,"Danilo C Berton, Dr",Universidade Federal do Rio Grande do Sul/Hospital de Clínicas de Porto Alegre,,NCT04410107,danilo c berton,danilo,male,0.99,24662,841,NCT04410107,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",Recruiting,No Results Available,COVID-19|SARS-CoV-2 Infection,"Diagnostic Test: Lung Function tests|Diagnostic Test: Exercise capacity|Diagnostic Test: Exercise physiology|Diagnostic Test: Health-related quality of life|Diagnostic Test: Respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening","June 1, 2020","Universidade de Passo Fundo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital de Clínicas de Porto Alegre/Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, Brazil|Univesidade de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande Do Sul, Brazil",https://ClinicalTrials.gov/show/NCT04410107
Principal Investigator,"Neomi Shah, MD, MPH, MS",Icahn School of Medicine at Mount Sinai,,NCT04390191,neomi shah,neomi,female,0.91,58,842,NCT04390191,Early CPAP in COVID-19 Confirmed or Suspected Patients,Recruiting,No Results Available,COVID-19|COVID|Coronavirus,Device: Continuous Positive Airway Pressure,"May 15, 2020","Icahn School of Medicine at Mount Sinai, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04390191
Principal Investigator,"Yihai Cao, Dr","Qilu Hospital of Shandong University, Karolinska Institutet",,NCT04305106,yihai cao,yihai,male,1.0,4,845,NCT04305106,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Bevacizumab,"March 12, 2020","Qilu Hospital of Shandong University, Jinan, Shandong, China",https://ClinicalTrials.gov/show/NCT04305106
Principal Investigator,"Yuguo Chen, Dr",Qilu Hospital of Shandong University,,NCT04305106,yuguo chen,yuguo,male,0.86,7,845,NCT04305106,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Recruiting,No Results Available,COVID-19 Pneumonia,Drug: Bevacizumab,"March 12, 2020","Qilu Hospital of Shandong University, Jinan, Shandong, China",https://ClinicalTrials.gov/show/NCT04305106
Principal Investigator,"Yuguo Chen, Dr",Qilu Hospital of Shandong University,,NCT04275414,yuguo chen,yuguo,male,0.86,7,1814,NCT04275414,Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Recruiting,No Results Available,Coronavirus Infections,Drug: Bevacizumab Injection,"February 19, 2020","Renmin Hospital of Wuhan University, Wuhan, Hubei, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Moriggia-Pelascini Gravedona Hospital, Gravedona, Italy",https://ClinicalTrials.gov/show/NCT04275414
Study Chair,"Nadine Rouphael, M.D.",Emory University,,NCT04378777,nadine rouphael,nadine,female,0.98,55786,847,NCT04378777,Immunophenotyping Assessment in a COVID-19 Cohort,Enrolling by invitation,No Results Available,Coronavirus Disease 2019 (COVID-19)|SARS-CoV-2,Procedure: Biological sample collection|Procedure: Data Collection: Clinical Care Assessments,"May 7, 2020","University of California, Los Angeles: Department of Medicine, Los Angeles, California, United States|University of California San Francisco School of Medicine, San Francisco, California, United States|Stanford Medicine: Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, United States|Yale School of Medicine, New Haven, Connecticut, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|Drexel University College of Medicine, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04378777
Principal Investigator,"Jean-Philippe Lanoix, Pr",CHU Amiens,,NCT04371107,jean-philippe lanoix,jean-philippe,male,0.99,4945,848,NCT04371107,Proactive Care of Ambulatory COVID19 Patients,Not yet recruiting,No Results Available,Covid19|Azithromycin|Ambulatory,Other: consultation|Drug: Azithromycin,"May 1, 2020","CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04371107
Principal Investigator,"Rok Civljak, MD, PhD","University Hospital for Infectious Diseases ""Dr Fran Mihaljevic""",,NCT04359667,rok civljak,rok,male,0.96,1374,849,NCT04359667,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Not yet recruiting,No Results Available,COVID-19|Severe Pneumonia,Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA],"April 24, 2020","University Hospital for Infectious Diseases ""Dr Fran Mihaljevic"", Zagreb, Croatia",https://ClinicalTrials.gov/show/NCT04359667
Principal Investigator,"Stacy A Johnson, MD",University of Utah,,NCT04368000,stacy a johnson,stacy,female,0.9,4493,850,NCT04368000,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Recruiting,No Results Available,Respiratory Failure|COVID-19,Behavioral: Intermittent prone positioning instructions|Behavioral: Usual care positioning with no instructions,"April 29, 2020","University of Utah Health Sciences Center, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04368000
Principal Investigator,"Karen M Frank, M.D.",National Institutes of Health Clinical Center (CC),,NCT04424446,karen m frank,karen,female,0.95,48557,854,NCT04424446,Saliva/Nares as Source of Detection for SARS-CoV-2 at NIH,Recruiting,No Results Available,COVID-19,,"June 11, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04424446
Principal Investigator,"Karen Sepucha, PhD",Massachusetts General Hospital,,NCT04432870,karen sepucha,karen,female,0.95,48557,1890,NCT04432870,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,Enrolling by invitation,No Results Available,Colon Cancer,,"June 16, 2020","Massachusetts General Hospital, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04432870
Principal Investigator,"Wasif Ali Khan, MBBS, MHS","International Centre for Diarrhoeal Disease Research, Bangladesh",,NCT04407130,wasif ali khan,wasif,male,0.99,313,861,NCT04407130,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,Enrolling by invitation,No Results Available,COVID-19 Patients,Drug: Ivermectin + Doxycycline + Placebo|Drug: Ivermectin + Placebo|Drug: Placebo,"May 29, 2020","Icddr,B, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04407130
Principal Investigator,"Renato D. Lopes, MD, PhD",D'Or Institute for Research and Education,,NCT04364893,renato d. lopes,renato,male,0.99,17487,868,NCT04364893,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Recruiting,No Results Available,Corona Virus Infection|COVID-19,Other: Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors,"April 28, 2020","Idor, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04364893
Study Chair,"Renato D. Lopes, MD, PhD",BCRI,,NCT04394377,renato d. lopes,renato,male,0.99,17487,1853,NCT04394377,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Recruiting,No Results Available,Coronavirus Infection,Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed|Drug: Group 2: control group with enoxaparin 40mg/d,"May 19, 2020","Núcleo de Ciências de Saúde - Unidade de Pesquisa - Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04394377
Principal Investigator,Sara Hassan,Ain Shams University,,NCT04346056,sara hassan,sara,female,0.98,244324,869,NCT04346056,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Recruiting,No Results Available,Coronavirus Disease (COVID-19)|COVID-19,,"April 15, 2020","Faculty of Medicine Ain Shams University, Cairo, Non-US, Egypt|Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04346056
Principal Investigator,"Sara Ghandehari, MD",Cedars-Sinai Medical Center,,NCT04365127,sara ghandehari,sara,female,0.98,244324,885,NCT04365127,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Recruiting,No Results Available,COVID-19|Sars-CoV2,Drug: Progesterone 100 MG,"April 28, 2020","Cedars Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04365127
Principal Investigator,"Sara P Myers, MD, PhD",University of Pittsburgh,,NCT04370938,sara p myers,sara,female,0.98,244324,1970,NCT04370938,Provider Burnout During COVID-19,Recruiting,No Results Available,"Perceived Organizational Support, Anxiety, Burnout",Behavioral: Coping strategies video,"May 1, 2020","UPMC, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04370938
Study Chair,"Inge J Knudsen, MD","Rigshospitalet, Department of Microbiology",,NCT04356560,inge j knudsen,inge,female,0.94,7763,870,NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Enrolling by invitation,No Results Available,COVID-19,"Diagnostic Test: COVID-19 test, polymerase chain reaction for SARS-CoV-2","April 22, 2020","Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04356560
Study Chair,"Nikolai S Kirkeby, MSc","Rigshospitalet, Department of Microbiology",,NCT04356560,nikolai s kirkeby,nikolai,male,0.99,2511,870,NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Enrolling by invitation,No Results Available,COVID-19,"Diagnostic Test: COVID-19 test, polymerase chain reaction for SARS-CoV-2","April 22, 2020","Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04356560
Principal Investigator,"Ramon G Jensen, MD","Rigshospitalet, Dep. of ORL, Head and neck & Audiology",,NCT04356560,ramon g jensen,ramon,male,0.98,27550,870,NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Enrolling by invitation,No Results Available,COVID-19,"Diagnostic Test: COVID-19 test, polymerase chain reaction for SARS-CoV-2","April 22, 2020","Rigshospitalet University Hospital of Copenhagen, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04356560
Principal Investigator,Fatma Ebeid,Excuitive Director of MARSI-CRC,,NCT04404244,fatma ebeid,fatma,female,0.97,34628,871,NCT04404244,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,Recruiting,No Results Available,Coronavirus COVID-19,,"May 27, 2020","Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04404244
Principal Investigator,"Annika von Heymann, PhD","Department of Oncology, Rigshospitalet, Denmark",,NCT04409821,annika von heymann,annika,female,0.97,11182,874,NCT04409821,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Not yet recruiting,No Results Available,Posttraumatic Stress Disorder|Prolonged Grief Disorder|COVID,Behavioral: Tele-delivered psychological intervention,"June 1, 2020",,https://ClinicalTrials.gov/show/NCT04409821
Principal Investigator,"Ramy Saleh, MD",McGill University Health Centre/Research Institute of the McGill University Health Centre,,NCT04417257,ramy saleh,ramy,male,0.91,5875,876,NCT04417257,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,Not yet recruiting,No Results Available,COVID-19 Disease,Drug: LAU-7b|Drug: Placebo oral capsule,"June 4, 2020","St-Paul's Hospital, Vancouver, British Columbia, Canada|Centre d'études cliniques CIUSS SLJ, Hôpital Chicoutimi, Chicoutimi, Quebec, Canada|CIUSSSS de l'Est-de-l'Ile-de-Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|CISSS Ds Laurentides, Saint-Jérôme, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04417257
Principal Investigator,"Jinglin Xia, MD",First Affiliated Hospital of Wenzhou Medical University,,NCT04273529,jinglin xia,jinglin,male,0.56,16,877,NCT04273529,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Not yet recruiting,No Results Available,COVID-19 Thalidomide,Drug: thalidomide|Drug: placebo,"February 18, 2020",,https://ClinicalTrials.gov/show/NCT04273529
Principal Investigator,"Jinglin Xia, MD",First Affiliated Hospital of Wenzhou Medical University,,NCT04273581,jinglin xia,jinglin,male,0.56,16,878,NCT04273581,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Not yet recruiting,No Results Available,COVID-19 Thalidomide,Drug: placebo|Drug: Thalidomide,"February 18, 2020",,https://ClinicalTrials.gov/show/NCT04273581
Principal Investigator,"Erich Huang, MD, PhD",Duke University,,NCT04437706,erich huang,erich,male,0.98,3025,880,NCT04437706,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2,,"June 18, 2020","Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04437706
Principal Investigator,"Professor J Kurinczuk, MBChB,MSc,MD",University of Oxford,,NCT04386109,professor j kurinczuk,professor,male,0.98,222,884,NCT04386109,Neonatal Complications of Coronavirus Disease (COVID-19),Recruiting,No Results Available,Neonatal COVID-19 Disease,Other: No intervention - exposure is to COVID-19,"May 13, 2020","Imperial College, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04386109
Study Chair,"Yuksel Peker, MD, PhD",Koc University School of Medicine,,NCT04363333,yuksel peker,yuksel,male,0.9,2042,888,NCT04363333,Obstructive Sleep Apnea & Covid-19 Outcomes,Recruiting,No Results Available,COVID|Obstructive Sleep Apnea|Pneumonia,Diagnostic Test: Polysomnography,"April 27, 2020","Koc University, Istanbul, Turkey|Koc Healthcare Istanbul American Hospital, İstanbul, Turkey|Marmara University Pendik Education and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04363333
Principal Investigator,"Jenny Low, MBBS",Singapore General Hospital,,NCT04400929,jenny low,jenny,female,0.98,74278,892,NCT04400929,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,Not yet recruiting,No Results Available,"COVID|Sars-CoV2|ARDS, Human",Drug: Sargramostim|Other: Normal Saline 0.9%,"May 26, 2020",,https://ClinicalTrials.gov/show/NCT04400929
Principal Investigator,"Jenny Low, MBBS",SingHealth Investigational Medicine Unit,,NCT04429529,jenny low,jenny,female,0.98,74278,1443,NCT04429529,"Safety of TY027, a Treatment for COVID-19, in Humans",Recruiting,No Results Available,Coronavirus Disease-2019 (COVID-19),Biological: TY027|Other: 0.9% Saline,"June 12, 2020","SingHealth Investigational Medicine Unit, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04429529
Study Chair,"Susan Hoover, MD",Sanford Health,,NCT04372017,susan hoover,susan,female,0.98,32184,896,NCT04372017,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV 2,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin D,"May 1, 2020","Sanford Health, Sioux Falls, South Dakota, United States",https://ClinicalTrials.gov/show/NCT04372017
Principal Investigator,"Anne-Sophie Brazeau, PhD",McGill University,,NCT04384471,anne-sophie brazeau,anne-sophie,female,0.97,4583,898,NCT04384471,Covid-19 Pandemic: Patients' Experience in T1D,Enrolling by invitation,No Results Available,Type1diabetes|Covid19,Other: Online survey,"May 12, 2020","Institut de Recherches Cliniques de Montréal, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04384471
Principal Investigator,"Emanuele Bosi, Professor",IRCCS Ospedale San Raffaele,,NCT04449380,emanuele bosi,emanuele,male,0.99,30449,899,NCT04449380,Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19 Virus Infection,Drug: Interferon-ß-1a|Combination Product: Standard of Care (SOC),"June 26, 2020","IRCCS Ospedale San Raffaele, Milano, Italy",https://ClinicalTrials.gov/show/NCT04449380
Principal Investigator,"Emanuele Nicastri, MD",Direttore Dipartimento di Malattie Infettive,,NCT04324021,emanuele nicastri,emanuele,male,0.99,30449,1397,NCT04324021,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Recruiting,No Results Available,SARS-CoV-2,Biological: Emapalumab|Biological: Anakinra,"March 27, 2020","ASST Spedali Civili di Brescia Dipartimento di Reumatologia e Immunologia Clinica, Brescia, Italy|Ospedale Maggiore Policlinico, Dipartimento di Anestesia-Rianimazione e Medicina di Urgenza, Milano, Italy|Azienda Ospedaliero-Universitaria di Parma, Dipartimento di Malattie infettive ed epatologia, Parma, Italy|Ospedale Lazzaro Spallanzani, Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose,Ospedale Lazzaro Spallanzani, Roma, Italy",https://ClinicalTrials.gov/show/NCT04324021
Principal Investigator,"Salomeh Keyhani, MD MPH","San Francisco VA/University of California, San Francisco",,NCT04363203,salomeh keyhani,salomeh,female,1.0,19,901,NCT04363203,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Suspended,No Results Available,SARS-CoV-2|COVID-19,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Placebo oral tablet,"April 27, 2020","San Francisco VA, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04363203
Principal Investigator,"Daya Nand Sharma, MD","AIIMS, New Delhi",,NCT04394793,daya nand sharma,daya,female,0.7,625,902,NCT04394793,Low Dose Radiation Therapy for Covid-19 Pneumonia,Recruiting,No Results Available,COVID-19|Pneumonia,Radiation: Low dose radiation therapy,"May 19, 2020","All India Institute of Medical Sciences, New Delhi, New Delhi, Delhi, India",https://ClinicalTrials.gov/show/NCT04394793
Principal Investigator,"Cédric Annweiler, M.D., Ph.D.","University Hospital, Angers",,NCT04343781,cédric annweiler,cédric,male,1.0,4,903,NCT04343781,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Completed,No Results Available,SARS-CoV-2|COVID-19,Other: observation,"April 13, 2020","Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04343781
Principal Investigator,"Cédric ANNWEILER, MD, PhD","University Hospital, Angers",,NCT04435119,cédric annweiler,cédric,male,1.0,4,1922,NCT04435119,Covid-19 and Vitamin D in Nursing-home,Completed,No Results Available,Coronavirus,,"June 17, 2020","Angers University Hospital, Angers, France",https://ClinicalTrials.gov/show/NCT04435119
Principal Investigator,"Arun Jayaraman, PhD",Shirley Ryan AbilityLab,,NCT04393558,arun jayaraman,arun,male,0.98,4661,904,NCT04393558,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,Recruiting,No Results Available,COVID-19|Healthy Control,Device: ADAM Sensor,"May 19, 2020","Shirley Ryan AbilityLab, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04393558
Principal Investigator,"Blake M Warner, D.D.S.",National Institute of Dental and Craniofacial Research (NIDCR),,NCT04348240,blake m warner,blake,male,0.96,2426,913,NCT04348240,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Recruiting,No Results Available,COVID-19,,"April 16, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04348240
Principal Investigator,"Craig Selzman, MD",University of Utah,,NCT04319731,craig selzman,craig,male,0.99,19490,915,NCT04319731,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,Recruiting,No Results Available,SARS CoV-2 Infection,Biological: Human Amniotic Fluid,"March 24, 2020","University of Utah Health, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04319731
Study Chair,"Mingkai Chen, MD",Renmin Hospital of Wuhan University,,NCT04329559,mingkai chen,mingkai,male,1.0,9,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Study Chair,"Xiaolong Qi, MD",LanZhou University,,NCT04329559,xiaolong qi,xiaolong,male,0.96,114,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Fengmei Wang, MD",Tianjin Second People's Hospital,,NCT04329559,fengmei wang,fengmei,female,0.92,13,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Ye Gu, MD",Sixth People’s Hospital of Shenyang,,NCT04329559,ye gu,ye,male,0.54,1419,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Zicheng Jiang, MD",Ankang Central Hospital,,NCT04329559,zicheng jiang,zicheng,male,1.0,11,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Guo Zhang, MD",Guangxi Zhuang Autonomous Region,,NCT04329559,guo zhang,guo,male,0.7,648,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Yong Zhang, MD",Dalian Sixth People’s Hospital,,NCT04329559,yong zhang,yong,male,0.88,4622,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Qing He, MD",Shenzhen Third People's Hospital,,NCT04329559,qing he,qing,female,0.55,749,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Hua Yang, MD",Minda Hospital Affiliated to Hubei University for Nationalities,,NCT04329559,hua yang,hua,male,0.56,935,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Zhengyan Wang, MD","Suizhou Hospital, Hubei University of Medicine",,NCT04329559,zhengyan wang,zhengyan,male,0.6,10,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Bin Xiong, MD","Wuhan Union Hospital, China",,NCT04329559,bin xiong,bin,male,0.91,3575,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Xiaodan Li, MD",The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture,,NCT04329559,xiaodan li,xiaodan,female,0.85,34,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Hongguang Zhang, MD",The Affiliated Third Hospital of Jiangsu University,,NCT04329559,hongguang zhang,hongguang,male,1.0,14,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Chuxiao Shao, MD",The Central Hospital of Lishui City,,NCT04329559,chuxiao shao,chuxiao,male,1.0,2,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Hongmei Yue, MD",LanZhou University,,NCT04329559,hongmei yue,hongmei,female,0.98,89,918,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Recruiting,No Results Available,COVID-19|Liver Cirrhosis,,"April 1, 2020","Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang, China",https://ClinicalTrials.gov/show/NCT04329559
Principal Investigator,"Yong Goo Song, Professor",Gangnam Severance Hospital,,NCT04330144,yong goo song,yong,male,0.88,4622,1171,NCT04330144,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Not yet recruiting,No Results Available,Contact Person From COVID-19 Confirmed Patient,Drug: Hydroxychloroquine as post exposure prophylaxis|Other: Others(No intervention),"April 1, 2020",,https://ClinicalTrials.gov/show/NCT04330144
Principal Investigator,Bin Lu,First Affiliated Hospital of Zhejiang Chinese Medical University,,NCT04399005,bin lu,bin,male,0.91,3575,2289,NCT04399005,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Completed,No Results Available,Daily Room Disinfection|After-each-case Room Disinfection,Other: after-each-case room disinfection|Other: daily room disinfection,"May 22, 2020","First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04399005
Study Director,"Elard S Koch, PhD",MELISA Institute Genomics & Proteomics Research SpA,,NCT04446065,elard s koch,elard,male,1.0,33,921,NCT04446065,Protection of Health Workers Against COVID-19,Not yet recruiting,No Results Available,COVID-19|SARS-CoV2,Drug: Previfenon®|Drug: Placebo,"June 24, 2020",,https://ClinicalTrials.gov/show/NCT04446065
Principal Investigator,"Melphine Harriott, PhD","Ascension St. John Hospital, Detroit, Michigan",,NCT04403035,melphine harriott,melphine,female,1.0,1,923,NCT04403035,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,Recruiting,No Results Available,Covid-19,Diagnostic Test: ID NOW vs. Accula,"May 27, 2020","Ascension St. John Hospital, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04403035
Study Chair,"Davey Smith, MD","University of California, San Diego",,NCT04358068,davey smith,davey,male,0.98,1094,926,NCT04358068,Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,"Active, not recruiting",No Results Available,COVID-19|SARS-CoV 2,Drug: Hydroxychloroquine (HCQ)|Drug: Azithromycin (Azithro)|Drug: Placebo for Hydroxychloroquine|Drug: Placebo for Azithromycin,"April 22, 2020","Alabama CRS, Birmingham, Alabama, United States|UCSD Antiviral Research Center CRS, San Diego, California, United States|Harbor-UCLA CRS, Torrance, California, United States|Whitman-Walker Health CRS, Washington, District of Columbia, United States|Northwestern University CRS, Chicago, Illinois, United States|Rush University CRS, Chicago, Illinois, United States|Greensboro CRS, Greensboro, North Carolina, United States|Cincinnati Clinical Research Site, Cincinnati, Ohio, United States|University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States|Trinity Health and Wellness Center CRS, Dallas, Texas, United States|University of Washington AIDS CRS, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04358068
Principal Investigator,"Werner Z`Graggen, MD",Universitätsklinik für Neurochirurgie und Neurologie,,NCT04397172,werner z`graggen,werner,male,0.99,9378,927,NCT04397172,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,Recruiting,No Results Available,COVID|Corona Virus Infection|Sars-CoV2,Procedure: Study Arm,"May 21, 2020","Inselspital Bern, Bern, Switzerland",https://ClinicalTrials.gov/show/NCT04397172
Study Director,"Werner Seeger, MD","University Hospital Giessen and Marburg, Giessen",,NCT04353583,werner seeger,werner,male,0.99,9378,2012,NCT04353583,Renal Outcome in Patients With COVID-19,Recruiting,No Results Available,Acute Kidney Injury|Corona Virus Infection,,"April 20, 2020","University Hospital Giessen and Marburg, Giessen, Giessen, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04353583
Study Director,"Werner Seeger, MD","University Hospital Giessen and Marburg, Giessen",,NCT04351906,werner seeger,werner,male,0.99,9378,2166,NCT04351906,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Recruiting,No Results Available,ARDS|Hypercapnic Respiratory Failure|AKI,Device: ECCO2R,"April 17, 2020","University Hospital Giessen and Marburg, Giessen, Giessen, Hessen, Germany",https://ClinicalTrials.gov/show/NCT04351906
Principal Investigator,"Fadi Haddad, MD",Sharp HealthCare,,NCT04402814,fadi haddad,fadi,male,0.95,9510,931,NCT04402814,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With Nasopharyngeal PCR Testing.,Recruiting,No Results Available,SARS-CoV 2,Diagnostic Test: Clungene rapid test cassette,"May 27, 2020","Fadi A. Haddad MD Inc., La Mesa, California, United States|Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hosptial, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04402814
Principal Investigator,Xiaopin Wang,Guang'anmen Hospital of China Academy of Chinese Medical Sciences,,NCT04374084,xiaopin wang,xiaopin,male,1.0,1,932,NCT04374084,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Recruiting,No Results Available,COVID-19|Convalescence,Other: Moxibustion plus Cupping,"May 5, 2020","Hubei Province Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04374084
Principal Investigator,Zhongyu Zhou,Hubei Hospital of Traditional Chinese Medicine,,NCT04374084,zhongyu zhou,zhongyu,male,0.8,10,932,NCT04374084,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Recruiting,No Results Available,COVID-19|Convalescence,Other: Moxibustion plus Cupping,"May 5, 2020","Hubei Province Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04374084
Principal Investigator,"Giovanni Martinelli, Prof.",IRST IRCCS,,NCT04345315,giovanni martinelli,giovanni,male,0.99,104824,933,NCT04345315,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Recruiting,No Results Available,COVID-19|SARS-CoV-2,Other: serological test|Other: Rapid molecular test|Genetic: Next generation Sequencing (NGS) analysis|Other: serum chemistry analysis,"April 14, 2020","UO Microbiologia,Centro Servizi Pievesestina, AUSL Romagna, Cesena, FC, Italy|Irst Irccs, Meldola, FC, Italy",https://ClinicalTrials.gov/show/NCT04345315
Principal Investigator,"Jordan Feld, MD","University Health Network, Toronto",,NCT04354259,jordan feld,jordan,male,0.97,30440,934,NCT04354259,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,Recruiting,No Results Available,Sars-CoV2|Covid-19,Drug: Peginterferon Lambda-1A|Other: placebo,"April 21, 2020","Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04354259
Principal Investigator,Qin Yu,"West China Second University Hospital, Sichuan University",,NCT04412538,qin yu,qin,female,0.65,478,935,NCT04412538,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,Recruiting,No Results Available,COVID-19,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Placebo on a 0- and 28-day schedule|Biological: Placebo on a 0- and 14-day schedule,"June 2, 2020","West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan, China",https://ClinicalTrials.gov/show/NCT04412538
Principal Investigator,Xiaoqiang Liu,Yunnan Center for Disease Control and Prevention,,NCT04412538,xiaoqiang liu,xiaoqiang,male,0.98,53,935,NCT04412538,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,Recruiting,No Results Available,COVID-19,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Placebo on a 0- and 28-day schedule|Biological: Placebo on a 0- and 14-day schedule,"June 2, 2020","West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan, China",https://ClinicalTrials.gov/show/NCT04412538
Principal Investigator,"Leslie G Biesecker, M.D.",National Human Genome Research Institute (NHGRI),,NCT04371432,leslie g biesecker,leslie,female,0.77,12112,938,NCT04371432,Genetics of COVID-19 Susceptibility and Manifestations,Recruiting,No Results Available,COVID-19|Coronavirus 2019,,"May 1, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04371432
Principal Investigator,"Ramin Séverin, MD","University Hospital, Montpellier",,NCT04381286,ramin séverin,ramin,male,0.98,3436,940,NCT04381286,Transpulmonary Driving Pressure in ARDS COVID19 Patients,Recruiting,No Results Available,Mechanical Ventilation|SARS-CoV-2|COVID-19,,"May 8, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04381286
Principal Investigator,"Duncan J Stewart, MD",Ottawa Hospital Research Institute,,NCT04400032,duncan j stewart,duncan,male,0.99,3407,942,NCT04400032,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard,Not yet recruiting,No Results Available,Acute Respiratory Distress Syndrome|Covid19,Biological: Mesenchymal Stromal Cells,"May 22, 2020","The Ottawa Hospital, Ottawa, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04400032
Principal Investigator,"Fengcai Zhu, Doctor",Jiangsu Provincial Center for Disease Control and Prevention,,NCT04352608,fengcai zhu,fengcai,female,0.67,3,945,NCT04352608,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),Recruiting,No Results Available,COVID-19,Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of placebo at the emergency vaccination schedule|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of placebo at the routine vaccination schedule,"April 20, 2020","Suining County Center for Disease Control and Prevention, Xuzhou, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04352608
Principal Investigator,"Fengcai Zhu, MD",Jiangsu Province Centers of Disease Control and Prevention,,NCT04341389,fengcai zhu,fengcai,female,0.67,3,1050,NCT04341389,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),"Active, not recruiting",No Results Available,COVID-19,Biological: Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)|Other: Placebo,"April 10, 2020","Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04341389
Principal Investigator,"Yuliang Zhao, Master",Hubei Provincial Center for Disease Control and Prevention,,NCT04383574,yuliang zhao,yuliang,male,0.93,27,946,NCT04383574,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),Not yet recruiting,No Results Available,COVID-19,"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28","May 12, 2020","Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei, China",https://ClinicalTrials.gov/show/NCT04383574
Principal Investigator,"Teresa Gaither, NP",Athena Medical Group,,NCT04344457,teresa gaither,teresa,female,0.98,51700,950,NCT04344457,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Indomethacin|Drug: Zithromax Oral Product,"April 14, 2020","Perseverance Research Center, Scottsdale, Arizona, United States|Covidcraz 19, Llc, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04344457
Study Director,"Nicole C. Hank, PhD, MCR, MHSM",Perseverance Research Center,,NCT04344457,nicole c. hank,nicole,female,0.98,102075,950,NCT04344457,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Recruiting,No Results Available,COVID-19,Drug: Hydroxychloroquine|Drug: Indomethacin|Drug: Zithromax Oral Product,"April 14, 2020","Perseverance Research Center, Scottsdale, Arizona, United States|Covidcraz 19, Llc, New Orleans, Louisiana, United States",https://ClinicalTrials.gov/show/NCT04344457
Principal Investigator,"Federico Cagnazzo, MD PhD",UH Montpellier,,NCT04406090,federico cagnazzo,federico,male,0.99,43663,954,NCT04406090,Endovascular Thrombectomy in COVID-19 Infected Patients,Recruiting,No Results Available,Ischemic Stroke|Covid 19,Other: Mechanical Trombectomy,"May 28, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04406090
Principal Investigator,"Anders Perner, MD, PhD","Copenhagen University Hospital, Intensive care Unit 4131",,NCT04420741,anders perner,anders,male,0.99,12623,955,NCT04420741,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Recruiting,No Results Available,COVID-19|Respiratory Failure,Drug: Iloprost|Drug: Isotonic saline,"June 9, 2020","Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital Herlev, Herlev, Denmark|Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital, Hillerød, Denmark|Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital, Hvidovre, Denmark",https://ClinicalTrials.gov/show/NCT04420741
Study Director,"Pär I Johansson, MD, DMSc","Copenhagen University Hospital, Capital Blood Bank 2034",,NCT04420741,pär i johansson,pär,male,1.0,1,955,NCT04420741,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Recruiting,No Results Available,COVID-19|Respiratory Failure,Drug: Iloprost|Drug: Isotonic saline,"June 9, 2020","Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital Herlev, Herlev, Denmark|Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital, Hillerød, Denmark|Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital, Hvidovre, Denmark",https://ClinicalTrials.gov/show/NCT04420741
Study Chair,"Anders Perner, MD, PhD","Rigshospitalet, Denmark",,NCT04348305,anders perner,anders,male,0.99,12623,961,NCT04348305,Hydrocortisone for COVID-19 and Severe Hypoxia,"Active, not recruiting",No Results Available,Covid-19|Hypoxia,Drug: Hydrocortisone|Drug: Sodium Chloride 9mg/mL,"April 16, 2020","Aarhus University Hospital - Dept of Intensive care, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Dept of Infectious diseases, Rigshospitalet, Copenhagen, Denmark|Herlev Hospital - Dept. of Intensive Care, Herlev, Denmark|North Zealand Hospital, Hillerød, Denmark|Hvidovre Hospital - Dept of Infectious diseases, Hvidovre, Denmark|Hvidovre Hospital - Dept of Intensive Care, Hvidovre, Denmark|Hvidovre Hospital - Dept of Pulmonary Medicine, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Køge Hospital, Køge, Denmark|Dept of Intensive Care, Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Slagelse Hospital, Slagelse, Denmark|Viborg Hospital, Viborg, Denmark",https://ClinicalTrials.gov/show/NCT04348305
Study Director,"Cameron Durrant, MD","Humanigen, Inc.",,NCT04351152,cameron durrant,cameron,male,0.92,3334,956,NCT04351152,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19) Pneumonia,Biological: Lenzilumab|Drug: Standard of Care,"April 17, 2020","Mayo Clinic, Phoenix, Arizona, United States|Mayo Clinic, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|Mayo Clinic, Rochester, Minnesota, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Atrium Health, Charlotte, North Carolina, United States|Texas Health, Dallas, Texas, United States",https://ClinicalTrials.gov/show/NCT04351152
Principal Investigator,"Cameron G Estrich, MPH, PhD",American Dental Association Science and Research Institute,,NCT04423770,cameron g estrich,cameron,male,0.92,3334,1060,NCT04423770,COVID-19 Related Health and Infection Control Practices Among Dentists,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Other: No intervention,"June 9, 2020","American Dental Association, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04423770
Principal Investigator,"Jim Lewis, MD",Lawson Health Research Institute,,NCT04375735,jim lewis,jim,male,0.98,26900,957,NCT04375735,London's Exogenous Surfactant Study for COVID19,Not yet recruiting,No Results Available,"ARDS, Human|COVID-19",Drug: Bovine Lipid Extract Surfactant,"May 5, 2020",,https://ClinicalTrials.gov/show/NCT04375735
Principal Investigator,Bertrand Glize,bertrand.glize@chu-bordeaux.fr,,NCT04405986,bertrand glize,bertrand,male,0.97,14197,960,NCT04405986,Exploring Brain Damages After COVID-19 Infection,Recruiting,No Results Available,SARS-CoV 2,Procedure: Auditory Evoked Potentials (AEP)|Procedure: Blink and Masseter Inhibitory Reflex,"May 28, 2020","CHU de Bordeaux, Bordeaux, France",https://ClinicalTrials.gov/show/NCT04405986
Study Director,Medical Monitor,Theravance Biopharma,,NCT04402866,medical monitor,medical,male,0.66,35,962,NCT04402866,TD-0903 for ALI Associated With COVID-19,Recruiting,No Results Available,Acute Lung Injury (ALI) Associated With COVID-19|Lung Inflammation Associated With COVID-19,Drug: TD-0903|Drug: Placebo,"May 27, 2020","Theravance Biopharma Investigational Site, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04402866
Study Director,Medical Monitor,Theravance Biopharma,,NCT04350736,medical monitor,medical,male,0.66,35,994,NCT04350736,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Recruiting,No Results Available,Acute Lung Injury (ALI) Associated With COVID-19|Inflammatory Lung Conditions Associated With COVID-19,Drug: TD-0903|Drug: Placebo,"April 17, 2020","Theravance Biopharma Investigational Site, Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04350736
Study Director,Medical Responsible,"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",,NCT04448756,medical responsible,medical,male,0.66,35,1720,NCT04448756,M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia,Not yet recruiting,No Results Available,Coronavirus Disease 2019,Drug: M5049|Drug: Placebo,"June 26, 2020","University of Alabama-Birmingham Hospital, Birmingham, Alabama, United States|Sharp Medical Center/Healthcare, San Diego, California, United States|Henry Ford Medical Center, Detroit, Michigan, United States",https://ClinicalTrials.gov/show/NCT04448756
Principal Investigator,"Hany ASSAAD, MD, PhD",University of Alexandria,,NCT04422678,hany assaad,hany,male,0.91,5871,964,NCT04422678,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Not yet recruiting,No Results Available,COVID-19,Drug: Imatinib Mesylate|Drug: Standard of Care,"June 9, 2020",,https://ClinicalTrials.gov/show/NCT04422678
Principal Investigator,Hany Dabbous,Ain Shams University,,NCT04349241,hany dabbous,hany,male,0.91,5871,972,NCT04349241,Efficacy and Safety of Favipiravir in Management of COVID-19,Completed,No Results Available,Coronavirus Disease (COVID-19),Drug: favipiravir|Drug: Standard of care therapy,"April 16, 2020","Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04349241
Principal Investigator,"Gabriella d'Ettorre, MD, PhD",University of Rome Sapienza - Policlinico Umberto I Rome (Italy),,NCT04368351,gabriella d'ettorre,gabriella,female,0.99,18306,965,NCT04368351,Bacteriotherapy in the Treatment of COVID-19,"Active, not recruiting",No Results Available,COVID|Pneumonia|Diarrhea,Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine,"April 29, 2020","Department of Public Heath and Infectious Diseases. University of Rome ""Sapienza"" (Italy), Rome, Italy",https://ClinicalTrials.gov/show/NCT04368351
Principal Investigator,Jean-François MORNEX,Hospices Civils de Lyon,,NCT04344288,jean-françois mornex,jean-françois,male,0.99,1826,966,NCT04344288,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Recruiting,No Results Available,Viral Pneumonia Human Coronavirus|COVID-19,Drug: Prednisone|Other: Control group,"April 14, 2020","Hôpital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France|Groupement Hospitalier Nord, Lyon, France|Groupement Hospitalier Nord, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital St Joseph Saint Luc, Lyon, France|Hôpital St Joseph, Marseille, France|Centre hospitalier Lyon Sud, Pierre-Bénite, France|Centre hospitalier Lyon Sud, Pierre-Bénite, France|CHU St Etienne, Saint-Étienne, France|Clinique Charcot, Sainte-Foy-lès-Lyon, France|CHG Vienne, Vienne, France|Médipôle, Villeurbanne, France|Clinique des Portes du Sud, Vénissieux, France|CH Annecy-Genevois, Épagny, France",https://ClinicalTrials.gov/show/NCT04344288
Principal Investigator,"sicard antoine, ph","Néphrologie, CHU de Nice",,NCT04371510,sicard antoine,sicard,female,0.63,48,969,NCT04371510,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Recruiting,No Results Available,COVID-19 by SARS-CoV-2 Infection,Other: blood sample,"May 1, 2020","CHU de nice, Nice, Alpes-Maritimes, France",https://ClinicalTrials.gov/show/NCT04371510
Principal Investigator,"Marc Klapholz, MD, MBA",Rutgers New Jersey Medical School; University Hospital,,NCT04420988,marc klapholz,marc,male,0.99,116213,971,NCT04420988,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,Available,No Results Available,COVID-19|SARS-CoV 2|SARS-CoV Infection,Biological: COVID-19 Convalescent Plasma,"June 9, 2020","Rutgers New Jersey Medical School, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04420988
Principal Investigator,"Rada Grubovic Rastvorceva, MD MSci PhD",Institute for Transfusion Medicine of RNM,,NCT04397523,rada grubovic rastvorceva,rada,female,0.8,1941,973,NCT04397523,Efficacy and Safety of COVID-19 Convalescent Plasma,Recruiting,No Results Available,Convalescent Plasma|COVID-19|SARS-CoV 2,Biological: anti-SARS-CoV-2 convalescent plasma,"May 21, 2020","Institute for Transfusion Medicine of RNM, Skopje, North Macedonia",https://ClinicalTrials.gov/show/NCT04397523
Principal Investigator,"Sedulla Useini, MD",Institute for Transfusion Medicine of RNM,,NCT04397523,sedulla useini,sedulla,female,0.5,2,973,NCT04397523,Efficacy and Safety of COVID-19 Convalescent Plasma,Recruiting,No Results Available,Convalescent Plasma|COVID-19|SARS-CoV 2,Biological: anti-SARS-CoV-2 convalescent plasma,"May 21, 2020","Institute for Transfusion Medicine of RNM, Skopje, North Macedonia",https://ClinicalTrials.gov/show/NCT04397523
Study Director,"Samira FAFI-KREMER, PharmD, PhD",Laboratoire de Virologie Plateau Technique de Microbiologie,,NCT04405726,samira fafi-kremer,samira,female,0.98,22495,975,NCT04405726,Prognostic Factors of COVID19,Recruiting,No Results Available,SARS-CoV-2,,"May 28, 2020","Service de Virologie - Hôpital Civil, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04405726
Principal Investigator,"Jun Pu, M.D","Renji Hospital, School of Medicine, Shanghai Jiaotong University",,NCT04352842,jun pu,jun,male,0.9,8911,980,NCT04352842,Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）,Completed,No Results Available,Covid19|Echocardiography,Other: Echocardiography,"April 20, 2020","Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04352842
Principal Investigator,"Esteban Nannini, MD","Sanatorio Britanico Rosario, pcia Santa Fe",,NCT04383535,esteban nannini,esteban,male,0.99,13148,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Wanda Cornistein, MD","Austral University, Argentina",,NCT04383535,wanda cornistein,wanda,female,0.95,5056,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Nora A Fuentes, MD",Hospital Privado de la Comunidad de Mar del Plata,,NCT04383535,nora a fuentes,nora,female,0.97,21072,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Florencia Otermin, MD",Hospital Italiano de la Plata,,NCT04383535,florencia otermin,florencia,female,0.99,2042,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Karina Rainiero, MD",Suiza Argentina,,NCT04383535,karina rainiero,karina,female,0.98,29586,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Erica Miyazaki, MD",Clinica Zabala,,NCT04383535,erica miyazaki,erica,female,0.99,22048,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Gabriela Diviella, MD",Sanatorio Agote,,NCT04383535,gabriela diviella,gabriela,female,0.98,36660,1122,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,Recruiting,No Results Available,SARS Virus|SARS-CoV-2|COVID-19,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,"May 12, 2020","Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04383535
Principal Investigator,"Esteban L Siga, MD",Dialisis Madariaga,,NCT04374058,esteban l siga,esteban,male,0.99,13148,2263,NCT04374058,Less Frequency Hemodialysis and COVID-19,"Active, not recruiting",No Results Available,End Stage Renal Disease,Other: less-frequency hemodialysis,"May 5, 2020","Dialisis Madariaga, General Juan Madariaga, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04374058
Principal Investigator,"Marcelo R Santos, PhD",University of Sao Paulo Medical School,,NCT04396353,marcelo r santos,marcelo,male,0.99,17962,1624,NCT04396353,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Corona Virus Infection|Sedentary Behavior,Other: Electronic questionnaire,"May 20, 2020","Marcelo Rodrigues dos Santos, São Paulo, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04396353
Principal Investigator,"Marcelo O Silva, MD",Austral University,,NCT04358380,marcelo o silva,marcelo,male,0.99,17962,1736,NCT04358380,Liver Injury in Patients With COVID-19,Enrolling by invitation,No Results Available,Liver Injury,Other: Liver injury,"April 24, 2020","Universidad Austral, Pilar, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04358380
Principal Investigator,"Marie Reine LOSSER, MD, PhD","Central Hospital, Nancy, France",,NCT04380727,marie reine losser,marie,female,0.98,229433,985,NCT04380727,Almitrine and COVID-19 Related Hypoxemia,Completed,No Results Available,COVID-19|Hypoxic Respiratory Failure,,"May 8, 2020","Centre Hospitalier Universitaire NANCY, Vandoeuvre-les-Nancy, France",https://ClinicalTrials.gov/show/NCT04380727
Principal Investigator,"Marie Bistoquet, MD","University Hospital, Montpellier",,NCT04376944,marie bistoquet,marie,female,0.98,229433,1202,NCT04376944,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,Recruiting,No Results Available,Caregivers|COVID-19,Other: Survey,"May 6, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04376944
Study Director,"Marie de BOUTRAY, PH",UH MONTPELLIER,,NCT04355442,marie de boutray,marie,female,0.98,229433,1331,NCT04355442,Evolution of Facial Trauma During COVID Containment Measures,"Active, not recruiting",No Results Available,Maxillofacial Injuries|Skull Fractures|COVID-19,Procedure: Facial fractures reduction or osteosynthesis,"April 21, 2020","Uh Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04355442
Principal Investigator,"MARIE REINE LOSSER, MD, PhD","Central Hospital, Nancy, France",,NCT04386395,marie reine losser,marie,female,0.98,229433,1425,NCT04386395,Immune Changes in Severe COVID-19 Pulmonary Infections,"Active, not recruiting",No Results Available,SARS-CoV-2|Immune System Disorder,,"May 13, 2020","Centre Hospitalier Universitaire NANCY, Vandoeuvre-les-Nancy, France",https://ClinicalTrials.gov/show/NCT04386395
Principal Investigator,"Yonathan FREUND, PU-PH",Assistance Publique - Hôpitaux de Paris,,NCT04357457,yonathan freund,yonathan,male,0.99,893,989,NCT04357457,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Not yet recruiting,No Results Available,Covid 19|Hypoxemic Respiratory Failure,Drug: Almitrine|Drug: Placebo,"April 22, 2020","Hospital Pitié-Salpêtrière, Paris, France",https://ClinicalTrials.gov/show/NCT04357457
Study Director,Margaret Cooper,Tameside and Glossop Integrated Care NHS Foundation Trust,,NCT04386044,margaret cooper,margaret,female,0.99,17172,990,NCT04386044,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,Not yet recruiting,No Results Available,COVID-19|Vitamin D Deficiency,,"May 13, 2020","Tameside Hospital NHS Foundation Trust, Ashton-under-Lyne, Greater Manchester, United Kingdom",https://ClinicalTrials.gov/show/NCT04386044
Principal Investigator,Tom Wilkinson,Study Principal Investigator,,NCT04385095,tom wilkinson,tom,male,0.99,126230,991,NCT04385095,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,Recruiting,No Results Available,SARS-CoV-2,Drug: Interferon beta 1a|Drug: Placebo,"May 12, 2020","Belfast City Hospital, Belfast, United Kingdom|Queen Elizabeth Hospital,, Birmingham, United Kingdom|Bradford Royal Infirmary, Bradford, United Kingdom|Hull and East Yorkshire NHS Trust, Castle Hill Hospital,, Hull, United Kingdom|Glenfield Hospital,, Leicester, United Kingdom|Wythenshawe Hospital, Manchester, United Kingdom|City Campus of Nottingham University, Nottingham, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|University Hospital Southampton Nhs Foundation Trust, Southampton, United Kingdom",https://ClinicalTrials.gov/show/NCT04385095
Principal Investigator,"Garyfallia Poulakou, MD, PhD","National Kapodistrian University of Athens, Medical School",,NCT04398004,garyfallia poulakou,garyfallia,female,0.88,16,1313,NCT04398004,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Recruiting,No Results Available,COVID-19|Virus Diseases|Corona Virus Infection,Drug: Clarithromycin,"May 21, 2020","COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Nikaia, Piraeus, Attica, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|1st University Department of Internal Medicine, LAIKO General Hospital of Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus ""Tzaneio"", Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04398004
Principal Investigator,"Heinz-Josef Lenz, MD",University of Southern California,,NCT04373044,heinz-josef lenz,heinz-josef,male,1.0,33,1008,NCT04373044,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",Recruiting,No Results Available,Symptomatic COVID-19 Infection Laboratory-Confirmed,Drug: Baricitinib|Drug: Hydroxychloroquine|Drug: Placebo Administration,"May 4, 2020","Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04373044
Principal Investigator,"Christine Johnston, MD, MPH",University of Washington,,NCT04354428,christine johnston,christine,female,0.99,91004,1014,NCT04354428,Treatment for COVID-19 in High-Risk Adult Outpatients,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Ascorbic Acid|Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Folic Acid,"April 21, 2020","Ruth M. Rothstein CORE Center - Cook County Health, Chicago, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Boston University, Boston, Massachusetts, United States|NYU Langone Health, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04354428
Principal Investigator,"Christine Katlama, MD",Pitie-Salpetriere Hospital,,NCT04402905,christine katlama,christine,female,0.99,91004,1941,NCT04402905,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",Not yet recruiting,No Results Available,Coronavirus Infection,,"May 27, 2020","Yasmine Dudoit, Paris, France",https://ClinicalTrials.gov/show/NCT04402905
Study Director,"Vincent DEGOS, Pr",Assistance Publique - Hôpitaux de Paris,,NCT04413864,vincent degos,vincent,male,0.99,79107,1017,NCT04413864,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Recruiting,No Results Available,SARS-CoV 2,Other: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,"June 4, 2020","Intensive Care Unit and Respiratory division ; Groupe hospitalier Pitie-Salpetriere and Universite Pierre et Marie Curie Paris 6, Paris, France",https://ClinicalTrials.gov/show/NCT04413864
Principal Investigator,"Vincent MINVILLE, PU-PH","University Hospital, Toulouse",,NCT04358952,vincent minville,vincent,male,0.99,79107,1894,NCT04358952,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,Recruiting,No Results Available,Cardiomyopathies,Diagnostic Test: Global Longitudinal Strain,"April 24, 2020","UHToulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04358952
Principal Investigator,"George Sakoulas, MD",Sharp HealthCare,,NCT04411667,george sakoulas,george,male,0.98,65488,1021,NCT04411667,Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection,Recruiting,No Results Available,Sars-CoV2,Drug: Octagam,"June 2, 2020","Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hospital, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04411667
Study Director,"George Sakoulas, MD",Sharp HealthCare,,NCT04340557,george sakoulas,george,male,0.98,65488,2222,NCT04340557,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,Recruiting,No Results Available,SARS-CoV Infection,Drug: Losartan,"April 9, 2020","Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Sharp Coronado Hospital, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States",https://ClinicalTrials.gov/show/NCT04340557
Principal Investigator,"Georgia Kostopanagiotou, MD",ATTIKON University General Hospital,,NCT04348513,georgia kostopanagiotou,georgia,female,0.98,6130,1022,NCT04348513,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Recruiting,No Results Available,Pulmonary Infection|Covid-19,Drug: T3 solution for injection|Drug: Placebo,"April 16, 2020","Attikon University General Hospital, Haidari/Athens, Greece",https://ClinicalTrials.gov/show/NCT04348513
Principal Investigator,"Georgia Micha, Dr","Elena Venizelou General and Maternity Hospital of Athens, Greece",,NCT04432948,georgia micha,georgia,female,0.98,6130,1341,NCT04432948,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,Recruiting,No Results Available,Covid-19|Maternal Psychological Distress|Anesthesia,Other: PHQ-9 Depression Scale|Other: GAD-7 General anxiety disorder scale|Other: 38-questions questionnaire,"June 16, 2020","""Elena Venizelou"" General and Maternity Hospital of Athens, Athens, Attica, Greece",https://ClinicalTrials.gov/show/NCT04432948
Principal Investigator,"Georgia Micha, PhD","Elena Venizelou General and Maternity Hospital of Athens, Greece",,NCT04437342,georgia micha,georgia,female,0.98,6130,1809,NCT04437342,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,Not yet recruiting,No Results Available,Postpartum Depression|Psychological Stress|Maternal Distress,Other: PHQ-9 (Patient Health Questionnaire) Depression Scale|Other: GAD-7 (General Anxiety Disorder) scale|Other: 38 questions questionnaire|Other: EPDS (Edinburgh Postnatal Depression Scale),"June 18, 2020","""Elena Venizelou"" General and Maternity Hospital of Athens, Athens, Attica, Greece|Aretaieio University Hospital, Athens, Attica, Greece|Alexandra Genaral Hospital Athens, Athens, Greece|University of Ioannina Health Science, Ioannina, Greece|University of Ioannina, Medical School, Ioannina, Greece|University of Thessaly Medical School, Larisa, Greece",https://ClinicalTrials.gov/show/NCT04437342
Principal Investigator,Aya Mostafa,Ain Shams University,,NCT04348214,aya mostafa,aya,female,0.95,12830,1025,NCT04348214,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Recruiting,No Results Available,Coronavirus Disease (COVID-19),,"April 16, 2020","Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US, Egypt",https://ClinicalTrials.gov/show/NCT04348214
Principal Investigator,"Kirill A Zykov, Prof","Federal State Budgetary Institution, Pulmonology Scientific Research Institute",,NCT04380376,kirill a zykov,kirill,male,1.0,4979,1026,NCT04380376,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Recruiting,No Results Available,COVID-19|Viral Pneumonia,Drug: Melphalan|Other: Standard of care,"May 8, 2020","Kirill Zykov, Moscow, Russian Federation|Clinical hospital, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04380376
Study Chair,Larry Corey,"HIV Vaccine Trials Network, Fred Hutch",,NCT04403880,larry corey,larry,male,0.97,11821,1033,NCT04403880,Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Other: Sample collection,"May 27, 2020","Alabama Vaccine CRS, Birmingham, Alabama, United States|UCLA CARE Center CRS, Los Angeles, California, United States|Bridge HIV CRS, San Francisco, California, United States|George Washington University CRS, Washington, District of Columbia, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|Adolescent & Young Adult Research at The CORE Center (AYAR at CORE), Chicago, Illinois, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health Clinical Research Site CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Bronx Prevention Research Center CRS, Bronx, New York, United States|Harlem Prevention Center CRS, New York, New York, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Case CRS, Cleveland, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Vanderbilt Vaccine CRS, Nashville, Tennessee, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Malawi CRS, Lilongwe, Malawi|Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS, Maputo, Mozambique|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Callao, Peru|San Miguel CRS, San Miguel, Lima, Peru|Asociacion Civil Selva Amazonica (ACSA) CRS, Iquitos, Maynas, Peru|Via Libra CRS, Lima, Peru|Barranco CRS, Lima, Peru|Josha Research CRS, Bloemfontein, South Africa|Emavundleni CRS, Cape Town, South Africa|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Synexus Stanza Clinical Research Centre CRS, Pretoria, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CRS, Tembisa, South Africa|The Aurum Institute Tembisa Clinical Research Centre CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS, Mbeya, Tanzania|Matero Reference Clinic CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Lusaka CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Ndola CRS, Ndola, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Zengeza CRS, Chitungwiza, Zimbabwe|Seke South CRS, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04403880
Study Chair,Shelly Karuna,"HIV Vaccine Trials Network, Fred Hutch",,NCT04403880,shelly karuna,shelly,female,0.96,2748,1033,NCT04403880,Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Other: Sample collection,"May 27, 2020","Alabama Vaccine CRS, Birmingham, Alabama, United States|UCLA CARE Center CRS, Los Angeles, California, United States|Bridge HIV CRS, San Francisco, California, United States|George Washington University CRS, Washington, District of Columbia, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|Adolescent & Young Adult Research at The CORE Center (AYAR at CORE), Chicago, Illinois, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health Clinical Research Site CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Bronx Prevention Research Center CRS, Bronx, New York, United States|Harlem Prevention Center CRS, New York, New York, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Case CRS, Cleveland, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Vanderbilt Vaccine CRS, Nashville, Tennessee, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Malawi CRS, Lilongwe, Malawi|Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS, Maputo, Mozambique|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Callao, Peru|San Miguel CRS, San Miguel, Lima, Peru|Asociacion Civil Selva Amazonica (ACSA) CRS, Iquitos, Maynas, Peru|Via Libra CRS, Lima, Peru|Barranco CRS, Lima, Peru|Josha Research CRS, Bloemfontein, South Africa|Emavundleni CRS, Cape Town, South Africa|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Synexus Stanza Clinical Research Centre CRS, Pretoria, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CRS, Tembisa, South Africa|The Aurum Institute Tembisa Clinical Research Centre CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS, Mbeya, Tanzania|Matero Reference Clinic CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Lusaka CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Ndola CRS, Ndola, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Zengeza CRS, Chitungwiza, Zimbabwe|Seke South CRS, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04403880
Study Director,"Jean-Olivier ARNAUD, Director",Assistance Publique Hôpitaux de Marseille,,NCT04432805,jean-olivier arnaud,jean-olivier,male,0.99,67,1034,NCT04432805,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Recruiting,No Results Available,Pregnant Women Suspected of COVID-19,Device: Performing of lung ultrasound,"June 16, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, France",https://ClinicalTrials.gov/show/NCT04432805
Study Director,"Jean-Olivier ARNAUD, Director",Assistance Publique Hôpitaux de Marseille,,NCT04408131,jean-olivier arnaud,jean-olivier,male,0.99,67,2023,NCT04408131,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Recruiting,No Results Available,Homeless,Biological: Blood sample,"May 29, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France",https://ClinicalTrials.gov/show/NCT04408131
Study Director,"Jean-Olivier ARNAUD, Director",Assistance Publique Hôpitaux de Marseille,,NCT04369859,jean-olivier arnaud,jean-olivier,male,0.99,67,2043,NCT04369859,Obstetric and Perinatal Outcomes of Women With COVID-19,Recruiting,No Results Available,Pregnant Women,Behavioral: Examine the impact of COVID-19 during pregnancy,"April 30, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France",https://ClinicalTrials.gov/show/NCT04369859
Study Director,"Jean-Olivier ARBAUD, Director",Assistance Publique Hôpitaux de Marseille,,NCT04420338,jean-olivier arbaud,jean-olivier,male,0.99,67,2231,NCT04420338,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Recruiting,No Results Available,Chronic Hemodialysis Patients|Caregivers of Chronic Hemodialysis Patients,Biological: Blood sample|Biological: Serum tube collection,"June 9, 2020","Assistance Publique Hôpitaux de Marseille, Marseille, Paca, France",https://ClinicalTrials.gov/show/NCT04420338
Study Director,"Yonatan PEREZ, MD","University Hospital, Tours",,NCT04358939,yonatan perez,yonatan,male,0.98,733,1035,NCT04358939,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Other: Prone decubitus,"April 24, 2020","Intensive Care Unit, Hospital, Argenteuil, Argenteuil, France|Medical Intensive Care Unit, University Hospital, Brest, Brest, France|Intensive Care Unit, Louis Mourier-APHP, Colombes, France|Intensive Care Unit, Hospital, Le Mans, Le Mans, France|Intensive Care Unit, University Hospital, Lille, Lille, France|Medical Intensive Care Unit, University Hospital, Nantes, Nantes, France|Medical Intensive Care Unit, University Hospital, Nice, NIce, France|Medical Intensive Care Unit, Hospital, Orléans, Orléans, France|Medical Intensive Care Unit, Tenon-APHP, Paris, France|Medical Intensive Care Unit, University Hospital, Poitiers, Poitiers, France|Medical Intensive Care Unit, University Hospital, Tours, Tours, France|Surgical Intensive Care Unit, University Hospital, Tours, Tours, France|Intensive Care Unit, Hospital, Vannes, Vannes, France",https://ClinicalTrials.gov/show/NCT04358939
Study Director,"Mahboob Rahman, MD","Mesoblast, Inc.",,NCT04366830,mahboob rahman,mahboob,male,0.85,200,1037,NCT04366830,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",No longer available,No Results Available,Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19,Drug: Remestemcel-L,"April 29, 2020","Mount Sinai Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04366830
Principal Investigator,"Ernesto Molmenti, MD, PhD, MBA",Northwell Health,,NCT04392323,ernesto molmenti,ernesto,male,0.99,15976,1039,NCT04392323,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: COVID-19 PCR and Serology,"May 18, 2020","North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States",https://ClinicalTrials.gov/show/NCT04392323
Principal Investigator,"Aaron Nizam, MD",Northwell Health,,NCT04392323,aaron nizam,aaron,male,0.99,24633,1039,NCT04392323,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: COVID-19 PCR and Serology,"May 18, 2020","North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States",https://ClinicalTrials.gov/show/NCT04392323
Principal Investigator,"Bruce Liang, MD",UConn Health,,NCT04424901,bruce liang,bruce,male,0.98,10698,1047,NCT04424901,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Recruiting,No Results Available,COVID-19 Pneumonia|Vascular Complications,Drug: Dipyridamole,"June 11, 2020","UConn Health, Farmington, Connecticut, United States",https://ClinicalTrials.gov/show/NCT04424901
Principal Investigator,Bruce Biccard,University of Cape Town,,NCT04367207,bruce biccard,bruce,male,0.98,10698,1273,NCT04367207,African Covid-19 Critical Care Outcomes Study,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,,"April 29, 2020",,https://ClinicalTrials.gov/show/NCT04367207
Principal Investigator,Aneel Bhangu,University of Birmingham,,NCT04386070,aneel bhangu,aneel,male,0.97,124,1048,NCT04386070,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Not yet recruiting,No Results Available,Pulmonary Complications in Surgical Patients|COVID|Severe Acute Respiratory Syndrome,Drug: Lopinavir-Ritonavir|Drug: Hydroxychloroquine,"May 13, 2020",,https://ClinicalTrials.gov/show/NCT04386070
Principal Investigator,Aneel Bhangu,University of Birmingham,,NCT04384926,aneel bhangu,aneel,male,0.97,124,1606,NCT04384926,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,Recruiting,No Results Available,COVID-19|Coronavirus|Cancer|Surgery,Procedure: Elective Cancer Surgery,"May 12, 2020","Hospital del Henares, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04384926
Principal Investigator,Ronghua Jin,Beijing YouAn Hospital,,NCT04286503,ronghua jin,ronghua,male,0.64,22,1053,NCT04286503,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Not yet recruiting,No Results Available,Novel Coronavirus Infectious Disease (COVID-19),Drug: Carrimycin|Drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate|Drug: basic treatment,"February 27, 2020",,https://ClinicalTrials.gov/show/NCT04286503
Principal Investigator,"Jeremy Warner, MD",Vanderbilt-Ingram Cancer Center,,NCT04354701,jeremy warner,jeremy,male,0.99,48233,1054,NCT04354701,COVID-19 and Cancer Consortium Registry,Recruiting,No Results Available,COVID-19|Invasive Malignancy (Any Type),Other: Web-based REDCap survey,"April 21, 2020","Vanderbilt University Medical Center, Nashville, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04354701
Principal Investigator,"Jeremy Road, MD",SaNOtize Medical Advisor,,NCT04443868,jeremy road,jeremy,male,0.99,48233,2162,NCT04443868,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,Not yet recruiting,No Results Available,SARS-CoV Infection,Drug: Nitric Oxide-Releasing Drug,"June 23, 2020",,https://ClinicalTrials.gov/show/NCT04443868
Principal Investigator,"Jeremy Road, MD",Private Practice,,NCT04337918,jeremy road,jeremy,male,0.99,48233,2167,NCT04337918,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Recruiting,No Results Available,Corona Virus Infection,Drug: NORS (Nitric Oxide Releasing Solution),"April 8, 2020","BC Diabetes, Vancouver, British Columbia, Canada|LMC Manna, Pointe-Claire, Quebec, Canada|Diex Recherche Québec, Québec, Quebec, Canada|Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada|Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04337918
Study Director,"ELENI KORTIANOU, PhD, PT",Clinical Exercise Physiology and Rehabilitation Research Laboratory,,NCT04368845,eleni kortianou,eleni,female,0.98,7342,1057,NCT04368845,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Recruiting,No Results Available,COVID-19|Comorbidities and Coexisting Conditions,Device: Telerehabilitation,"April 30, 2020","Clinical exercise Physiology and rehabilitation research laboratory, Lamia, Greece",https://ClinicalTrials.gov/show/NCT04368845
Study Chair,"ELENI KAPRELI, PhD, PT",Clinical Exercise Physiology and Rehabilitation Research Laboratory,,NCT04368845,eleni kapreli,eleni,female,0.98,7342,1057,NCT04368845,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Recruiting,No Results Available,COVID-19|Comorbidities and Coexisting Conditions,Device: Telerehabilitation,"April 30, 2020","Clinical exercise Physiology and rehabilitation research laboratory, Lamia, Greece",https://ClinicalTrials.gov/show/NCT04368845
Study Chair,"Eleni V Kapreli, MSc,PhD","Clinical Exercise Physiology & Rehabilitation Laboratory,University of Thessaly",,NCT04381000,eleni v kapreli,eleni,female,0.98,7342,1966,NCT04381000,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Recruiting,No Results Available,Chronic Pain,Other: Exercise Group,"May 8, 2020","Clinical Exercise Physiology and Rehabilitation Laboratory, Lamia, Sterea Ellada, Greece",https://ClinicalTrials.gov/show/NCT04381000
Principal Investigator,"Georgios Tsatsakos, PhD",TherapyLab,,NCT04381000,georgios tsatsakos,georgios,male,0.99,2379,1966,NCT04381000,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Recruiting,No Results Available,Chronic Pain,Other: Exercise Group,"May 8, 2020","Clinical Exercise Physiology and Rehabilitation Laboratory, Lamia, Sterea Ellada, Greece",https://ClinicalTrials.gov/show/NCT04381000
Study Chair,"Fu-Sheng Wang, MD, PhD",The fifth medical center of PLA general hospital,,NCT04288102,fu-sheng wang,fu-sheng,female,1.0,1,1058,NCT04288102,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),"Active, not recruiting",No Results Available,Corona Virus Disease 2019(COVID-19),Biological: UC-MSCs|Biological: Saline containing 1% Human serum albumin（solution without UC-MSCs）,"February 28, 2020","General Hospital of Central Theater Command, Wuhan, Hubei, China|Maternal and Child Hospital of Hubei Province, Wuhan, Hubei, China|Wuhan Huoshenshan Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04288102
Principal Investigator,"Camille TAILLE, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04331054,camille taille,camille,female,0.9,51457,1067,NCT04331054,Protective Role of Inhaled Steroids for Covid-19 Infection,Recruiting,No Results Available,Covid-19 Infection|Hospitalization in Respiratory Disease Department,Drug: 2: Usual practice + SYMBICORT RAPIHALER|Other: 1: Usual practice,"April 2, 2020","Hôpital Bichat - Service de Pneumologie, Paris, France",https://ClinicalTrials.gov/show/NCT04331054
Study Director,"Camille LOCHT, Professor",Institut Pasteur de Lille,,NCT04384549,camille locht,camille,female,0.9,51457,1741,NCT04384549,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,Not yet recruiting,No Results Available,"Infection|Viral, Agent as Cause of Disease Classified Elsewhere",Biological: BCG GROUP|Other: PLACEBO GROUP,"May 12, 2020","I-REIVAC/CIC 1417 Cochin Hospital, APHP, Paris, France",https://ClinicalTrials.gov/show/NCT04384549
Principal Investigator,"Odile LAUNAY, Professor",Assitance Publique-Hôpitaux de Paris,,NCT04384549,odile launay,odile,female,0.98,6093,1741,NCT04384549,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,Not yet recruiting,No Results Available,"Infection|Viral, Agent as Cause of Disease Classified Elsewhere",Biological: BCG GROUP|Other: PLACEBO GROUP,"May 12, 2020","I-REIVAC/CIC 1417 Cochin Hospital, APHP, Paris, France",https://ClinicalTrials.gov/show/NCT04384549
Principal Investigator,"Marc-Alain Widdowson, Dr",Institute of Tropical Medicine,,NCT04442165,marc-alain widdowson,marc-alain,male,1.0,22,1073,NCT04442165,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,Not yet recruiting,No Results Available,COVID-19,,"June 22, 2020",,https://ClinicalTrials.gov/show/NCT04442165
Principal Investigator,"Francois STEPHAN, MD, PhD",Centre Chirurgical Marie Lannelongue,,NCT04347980,francois stephan,francois,male,0.98,26836,1074,NCT04347980,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult|COVID-19",Drug: Dexamethasone and Hydroxychloroquine|Drug: Hydroxychloroquine,"April 15, 2020","Reanimation adulte. Hopital Marie Lannelongue, Le Plessis-Robinson, France",https://ClinicalTrials.gov/show/NCT04347980
Study Director,"Francois Pattou, MD",Centre Hospitalier Régional & Universitaire de Lille (CHRU),,NCT04391738,francois pattou,francois,male,0.98,26836,1360,NCT04391738,Association Between BMI and COVID-19,"Active, not recruiting",No Results Available,SARS-CoV 2,Other: Patients admitted to Intensive Care Unit with SARS-CoV2,"May 18, 2020","Centre Hospitalier Régional & Universitaire de Lille (CHRU), Lille, France",https://ClinicalTrials.gov/show/NCT04391738
Principal Investigator,Francois Lellouche,IUCPQ-UL,,NCT04320056,francois lellouche,francois,male,0.98,26836,1968,NCT04320056,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Recruiting,No Results Available,Coronavirus|Pneumonia|Oxygen Toxicity,Other: Standard administration of oxygen flow|Device: Automated oxygen administration - FreeO2,"March 24, 2020","Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04320056
Principal Investigator,"Enrico Dr Capochiani, hematologist",Azienda USL Toscana Nord Ovest,,NCT04361903,enrico dr capochiani,enrico,male,0.99,35298,1081,NCT04361903,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2,Drug: Ruxolitinib Oral Tablet,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04361903
Principal Investigator,"Tiziana Meschi, MD,PhD",Azienda Ospedaliero-Universitaria di Parma,,NCT04386447,tiziana meschi,tiziana,female,0.99,16318,1083,NCT04386447,Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,Not yet recruiting,No Results Available,Covid-19|Corona Virus Infection|SARS-CoV 2,Drug: Oxytocin|Drug: Standard of Care,"May 13, 2020","CNRS, Lyon, France|Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy|Ospedale San Francesco, Nuoro, Italy",https://ClinicalTrials.gov/show/NCT04386447
Principal Investigator,"Odysseas Androutsos, M.Med.Sci., Ph.D.",University of Thessaly,,NCT04437121,odysseas androutsos,odysseas,male,1.0,311,1084,NCT04437121,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,Completed,No Results Available,Eating Behavior|COVID-19,Other: Online Survey about Dietary and Lifestyle Habits,"June 18, 2020","Department of Nutrition-Dietetics, Tríkala, Thessaly, Greece",https://ClinicalTrials.gov/show/NCT04437121
Principal Investigator,"Leticia Peroni, MD",HIBA,,NCT04387890,leticia peroni,leticia,female,0.98,10868,1086,NCT04387890,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2|Health Personnel,Diagnostic Test: Serologic SARS-CoV-2 screening,"May 14, 2020",,https://ClinicalTrials.gov/show/NCT04387890
Principal Investigator,"Vanina Stanek, MD",HIBA,,NCT04387890,vanina stanek,vanina,female,0.98,1593,1086,NCT04387890,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2|Health Personnel,Diagnostic Test: Serologic SARS-CoV-2 screening,"May 14, 2020",,https://ClinicalTrials.gov/show/NCT04387890
Principal Investigator,"Diego Sanchez Thomas, MD",HIBA,,NCT04387890,diego sanchez thomas,diego,male,0.99,85672,1086,NCT04387890,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Not yet recruiting,No Results Available,COVID-19|SARS-CoV 2|Health Personnel,Diagnostic Test: Serologic SARS-CoV-2 screening,"May 14, 2020",,https://ClinicalTrials.gov/show/NCT04387890
Principal Investigator,"Diego Wyszynski, MD, MHS, PhD",CEO Pregistry,,NCT04366986,diego wyszynski,diego,male,0.99,85672,1329,NCT04366986,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Recruiting,No Results Available,Covid-19,Other: Tested for SARS-CoV-2 (regardless of the result)|Other: Clinical diagnosis of COVID-19 by a health care professional,"April 29, 2020","Pregistry, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04366986
Principal Investigator,"Diego Hijano, MD",St. Jude Children's Research Hospital,,NCT04371315,diego hijano,diego,male,0.99,85672,2141,NCT04371315,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Recruiting,No Results Available,Corona Virus Infection|Pediatric Cancer|Adult Children|Cancer,,"May 1, 2020","St. Jude Children's Research Hospital, Memphis, Tennessee, United States",https://ClinicalTrials.gov/show/NCT04371315
Principal Investigator,"Zahid Hassan, MBBS, PhD",Bangladesh University of Health Sciences,,NCT04403672,zahid hassan,zahid,male,0.98,2328,1088,NCT04403672,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,Recruiting,No Results Available,High Sensitivity and Specificity (With 95% Confidence Interval) of RealDetect™ COVID-19 RT-PCR Kit,Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection,"May 27, 2020","Institute of Epidemiology, Disease Control and Research (IEDCR), Mohakhali, Dhaka (For sample collection & sample storage), Institute for Developing Science & Health Initiatives (ideSHi); Mohakhali, Dhaka (For sample analysis, data collection, data analys, Dhaka, Bangladesh",https://ClinicalTrials.gov/show/NCT04403672
Study Director,"Yahong Chen, MD","Ascletis Pharmaceuticals Co., Ltd.",,NCT04345276,yahong chen,yahong,female,0.86,7,1089,NCT04345276,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Completed,No Results Available,COVID-19,Drug: Danoprevir+Ritonavir,"April 14, 2020","Huoshenshan Hostipal, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04345276
Study Director,"Yahong Chen, MD","Ascletis Pharmaceuticals Co., Ltd.",,NCT04291729,yahong chen,yahong,female,0.86,7,1090,NCT04291729,Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Completed,No Results Available,COVID-19,Drug: Ganovo+ritonavir+/-Interferon nebulization,"March 2, 2020","The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China",https://ClinicalTrials.gov/show/NCT04291729
Principal Investigator,"Barbara von Ingersleben, Dr.",Miltenyi Biotec B.V. & Co. KG,,NCT04405466,barbara von ingersleben,barbara,female,0.98,94709,1093,NCT04405466,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,Recruiting,No Results Available,COVID-19,Procedure: Blood sampling|Procedure: Throat swab,"May 28, 2020","Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, NRW, Germany",https://ClinicalTrials.gov/show/NCT04405466
Principal Investigator,"Andre D Kumar, MD, MEd",Stanford University,,NCT04384055,andre d kumar,andre,male,0.95,64369,1096,NCT04384055,Predicting Outcomes for Covid-19 Using Sonography,Enrolling by invitation,No Results Available,"COVID-19|Pneumonia, Viral",Diagnostic Test: Lung Ultrasound,"May 12, 2020","University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04384055
Principal Investigator,"Kavita Gandhi, MD","University of California, San Francisco",,NCT04384055,kavita gandhi,kavita,female,0.98,505,1096,NCT04384055,Predicting Outcomes for Covid-19 Using Sonography,Enrolling by invitation,No Results Available,"COVID-19|Pneumonia, Viral",Diagnostic Test: Lung Ultrasound,"May 12, 2020","University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04384055
Principal Investigator,"Andre Lopes, MD",Instituto Brasileiro de Controle do Cancer,,NCT04434261,andre lopes,andre,male,0.95,64369,1485,NCT04434261,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,Recruiting,No Results Available,SARS-CoV-2|Oncology|Surgery,Diagnostic Test: PT-PCR test for SARS-CoV-2,"June 16, 2020","Instituto Brasileiro de Controle do Cancer - IBCC, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04434261
Principal Investigator,"Muriel FARTOUKH, PU-PH MD PHD",Assistance Publique - Hôpitaux de Paris,,NCT04334850,muriel fartoukh,muriel,female,0.98,14732,1098,NCT04334850,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Recruiting,No Results Available,Covid19|Pneumonia,Procedure: Combined use of a respiratory broad panel multiplex PCR and procalcitonin|Other: Usual antibiotic treatment,"April 6, 2020","Intensive care department-Hospital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04334850
Principal Investigator,"Miklos Lipcsey, PhD",Uppsala University,,NCT04390074,miklos lipcsey,miklos,male,0.88,351,1101,NCT04390074,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,Not yet recruiting,No Results Available,COVID-19|Critical Illness,Other: COVID-19 and Intensive Care,"May 15, 2020",,https://ClinicalTrials.gov/show/NCT04390074
Principal Investigator,"Rosanna FERREIRA, MD",UH Montpellier,,NCT04407559,rosanna ferreira,rosanna,female,0.99,8924,1106,NCT04407559,COVID-SErology in Rheumatoid Arthritis (COVID-19),"Active, not recruiting",No Results Available,COVID-19|Rheumatoid Arthritis,Other: Serological analyses to be lead on a pre-existing biobank,"May 29, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04407559
Study Chair,"Tarek Sharshar, MD, PHD",Centre Hospitalier Sainte Anne,,NCT04350580,tarek sharshar,tarek,male,0.98,17364,1108,NCT04350580,Polyvalent Immunoglobulin in COVID-19 Related ARds,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Drug: Human immunoglobulin|Drug: Placebo,"April 17, 2020","Centre Hospitalier Sainte-Anne, Paris, France",https://ClinicalTrials.gov/show/NCT04350580
Principal Investigator,"Aurélien Mazeraud, MD, PHD",Centre Hospitalier Sainte Anne,,NCT04350580,aurélien mazeraud,aurélien,male,1.0,90,1108,NCT04350580,Polyvalent Immunoglobulin in COVID-19 Related ARds,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Drug: Human immunoglobulin|Drug: Placebo,"April 17, 2020","Centre Hospitalier Sainte-Anne, Paris, France",https://ClinicalTrials.gov/show/NCT04350580
Principal Investigator,"Otto C Burghuber, Prof.MD",Ludwig Boltzmann Institute for Lung Health,,NCT04346264,otto c burghuber,otto,male,0.97,5152,1110,NCT04346264,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Enrolling by invitation,No Results Available,Virus Diseases|COVID-19,Diagnostic Test: NO intervention planned due to the observational study design only a diagnostic testing,"April 15, 2020","The LEAD Study Center, Vienna, Austria",https://ClinicalTrials.gov/show/NCT04346264
Study Director,Zivit Harpaz,Can-Fite BioPharma Ltd,,NCT04333472,zivit harpaz,zivit,female,0.67,3,1111,NCT04333472,Piclidenoson for Treatment of COVID-19,Not yet recruiting,No Results Available,COVID-19|Coronavirus Infection,Drug: Piclidenoson,"April 3, 2020","Rabin Medical Center, Petah tikva, Israel",https://ClinicalTrials.gov/show/NCT04333472
Principal Investigator,"Esra Pehlivan, PhD",Saglik Bilimleri Universitesi,,NCT04402983,esra pehlivan,esra,female,0.96,34071,1114,NCT04402983,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Recruiting,No Results Available,Covid19|Telerehabilitation|Physical Therapy,Other: Physiotherapy,"May 27, 2020","University of Health Sciences Turkey, İstanbul, Turkey",https://ClinicalTrials.gov/show/NCT04402983
Principal Investigator,"Jonghun Lee, M.D., ph.D.",Daegu Catholic University Medical Center,,NCT04395872,jonghun lee,jonghun,male,0.97,69,1115,NCT04395872,Psychiatric Consultation for COVID-19 Patients,Not yet recruiting,No Results Available,"Covid19|Psychiatric Problem|Isolation, Social",Behavioral: Psychiatric counseling,"May 20, 2020",,https://ClinicalTrials.gov/show/NCT04395872
Study Chair,"Ajay Kirtane, MD",Columbia University,,NCT04367831,ajay kirtane,ajay,male,0.99,4648,1117,NCT04367831,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Recruiting,No Results Available,COVID-19|Venous Thromboses|Arterial Thrombosis,Drug: Enoxaparin Prophylactic Dose|Drug: Heparin Infusion|Drug: Heparin SC|Drug: Enoxaparin/Lovenox Intermediate Dose,"April 29, 2020","Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04367831
Principal Investigator,"Ajay Gupta, MD, PhD",Queen Mary University London,,NCT04433260,ajay gupta,ajay,male,0.99,4648,1657,NCT04433260,COVID19 and Physical and Emotional Wellbeing of HCP,Not yet recruiting,No Results Available,Mental Health,"Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index|Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.|Other: Informed consent","June 16, 2020",,https://ClinicalTrials.gov/show/NCT04433260
Principal Investigator,Ajay K Nooka,Emory University Hospital/Winship Cancer Institute,,NCT04361552,ajay k nooka,ajay,male,0.99,4648,2227,NCT04361552,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Withdrawn,No Results Available,Cerebrovascular Accident|Chronic Obstructive Pulmonary Disease|Chronic Renal Failure|Coronary Artery Disease|Diabetes Mellitus|Malignant Neoplasm|SARS Coronavirus 2 Infection,Other: Best Practice|Biological: Tocilizumab,"April 24, 2020","Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04361552
Principal Investigator,"GUYGUY KABUNDI TSHIMA, MD",University of Kinshasa,,NCT04424940,guyguy kabundi tshima,guyguy,male,0.75,248,1118,NCT04424940,COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach,Not yet recruiting,No Results Available,COVID-19,,"June 11, 2020","Cliniques Universitaires de Kinshasa, Kinshasa, Congo, The Democratic Republic of the",https://ClinicalTrials.gov/show/NCT04424940
Study Chair,"Jörg Goldhahn, MD",ETH Zurich,,NCT04377724,jörg goldhahn,jörg,male,0.99,628,1119,NCT04377724,Spread and Course of COVID-19 Infections,"Active, not recruiting",No Results Available,Covid-19|Virus Disease,,"May 6, 2020","ETH, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04377724
Principal Investigator,"Christopher W McIntyre, MD",Western University,,NCT04353674,christopher w mcintyre,christopher,male,0.99,53539,1120,NCT04353674,Modulation of Hyperinflammation in COVID-19,Recruiting,No Results Available,COVID-19|SARS,Device: Control group|Device: SLEDD with a L-MOD,"April 20, 2020","University Hospital, London, Ontario, Canada|Victoria Hospital - Critical Care Trauma Centre, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04353674
Principal Investigator,"Dmitry Enikeev, M.D., Ph.D.",Sechenov University,,NCT04386564,dmitry enikeev,dmitry,male,1.0,8624,1121,NCT04386564,Kidney Injury Severity and COVID-19,Not yet recruiting,No Results Available,COVID-19|Kidney Injury,Diagnostic Test: mRNA in urine test,"May 13, 2020","Sechenov University., Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04386564
Principal Investigator,"Gabriela Kuster Pfister, MD","Department of Cardiology, University Hospital Basel",,NCT04366765,gabriela kuster pfister,gabriela,female,0.98,36660,1384,NCT04366765,COVID-19 Survival - The COVIVA Study,Recruiting,No Results Available,COVID-19|SARS-CoV 2,,"April 29, 2020","University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04366765
Principal Investigator,"Raphael Twerenbold, MD",Department of Cardiology and Cardiodiovascular Research Institute Basel (CRIB),,NCT04366765,raphael twerenbold,raphael,male,0.99,10284,1384,NCT04366765,COVID-19 Survival - The COVIVA Study,Recruiting,No Results Available,COVID-19|SARS-CoV 2,,"April 29, 2020","University Hospital Basel, Basel, Switzerland",https://ClinicalTrials.gov/show/NCT04366765
Principal Investigator,"Marie-Pierre REVEL, MD,PhD",Assistance Publique - Hôpitaux de Paris,,NCT04355507,marie-pierre revel,marie-pierre,female,0.98,1894,1124,NCT04355507,Computed Tomography for COVID-19 Diagnosis,Not yet recruiting,No Results Available,COVID-19,Diagnostic Test: Chest computed tomography (CT)|Diagnostic Test: Reverse-transcription polymerase chain reaction (RT-PCR),"April 21, 2020","Cochin Hospital, Paris, France",https://ClinicalTrials.gov/show/NCT04355507
Principal Investigator,Lorenzo Azzi,Università degli Studi dell'Insubria,,NCT04357327,lorenzo azzi,lorenzo,male,0.99,55168,1125,NCT04357327,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Recruiting,No Results Available,COVID-19|SARS-CoV 2|Corona Virus Infection,Diagnostic Test: rapid salivary test,"April 22, 2020","ASST dei Sette Laghi, Varese, VA, Italy",https://ClinicalTrials.gov/show/NCT04357327
Principal Investigator,Lorenzo Cohen,M.D. Anderson Cancer Center,,NCT04447222,lorenzo cohen,lorenzo,male,0.99,55168,1224,NCT04447222,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,Recruiting,No Results Available,COVID-19 Infection|Malignant Solid Neoplasm,Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Survey Administration,"June 25, 2020","M D Anderson Cancer Center, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04447222
Principal Investigator,"Lorenzo Dagna, MD",Ospedale San Raffaele,,NCT04397497,lorenzo dagna,lorenzo,male,0.99,55168,1573,NCT04397497,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),Not yet recruiting,No Results Available,"Covid-19|Acute Respiratory Failure|ARDS, Human|Sars-CoV2|Viral Pneumonia",Drug: Mavrilimumab|Drug: Placebo,"May 21, 2020","IRCCS Policlinico San Donato, San Donato, MI, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|IRCCS Istituto Ortopedico Galeazzi, Milano, Italy",https://ClinicalTrials.gov/show/NCT04397497
Principal Investigator,"Lorenzo Berra, MD",Massachusetts General Hospital,,NCT04290858,lorenzo berra,lorenzo,male,0.99,55168,1636,NCT04290858,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,Withdrawn,No Results Available,"Coronavirus Infections|Pneumonia, Viral|Dyspnea",Drug: Nitric Oxide,"March 2, 2020",,https://ClinicalTrials.gov/show/NCT04290858
Principal Investigator,"Lei Chong, MD, PhD",Xijing Hospital,,NCT04290858,lei chong,lei,female,0.51,2362,1636,NCT04290858,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,Withdrawn,No Results Available,"Coronavirus Infections|Pneumonia, Viral|Dyspnea",Drug: Nitric Oxide,"March 2, 2020",,https://ClinicalTrials.gov/show/NCT04290858
Principal Investigator,"Lorenzo Berra, MD",Massachusetts General Hospital,,NCT04290871,lorenzo berra,lorenzo,male,0.99,55168,2079,NCT04290871,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Withdrawn,No Results Available,Coronavirus|SARS (Severe Acute Respiratory Syndrome),Drug: Nitric Oxide Gas,"March 2, 2020",,https://ClinicalTrials.gov/show/NCT04290871
Principal Investigator,"Chong Lei, MD, PhD",Fourth Military Medical University,,NCT04290871,chong lei,chong,male,0.71,2092,2079,NCT04290871,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Withdrawn,No Results Available,Coronavirus|SARS (Severe Acute Respiratory Syndrome),Drug: Nitric Oxide Gas,"March 2, 2020",,https://ClinicalTrials.gov/show/NCT04290871
Study Director,"Lorenzo Berra, MD",Massachusetts General Hospital,,NCT04306393,lorenzo berra,lorenzo,male,0.99,55168,2225,NCT04306393,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Recruiting,No Results Available,SARS (Severe Acute Respiratory Syndrome)|Coronavirus,Drug: Nitric Oxide Gas,"March 12, 2020","University of Alabama, Birmingham, Alabama, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States",https://ClinicalTrials.gov/show/NCT04306393
Principal Investigator,"Pere Clavé, MD, PhD",Hospital de Mataró,,NCT04425759,pere clavé,pere,male,0.97,3882,1147,NCT04425759,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),Recruiting,No Results Available,Covid19|Corona Virus Infection|SARS-CoV 2|COVID,Diagnostic Test: Blood sample,"June 11, 2020","Hospital de Mataró, Mataró, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04425759
Principal Investigator,"Pere Clavé, MD, PhD",Hospital de Mataró,,NCT04346212,pere clavé,pere,male,0.97,3882,1518,NCT04346212,Oropharyngeal Dysphagia in Patients With COVID-19,Recruiting,No Results Available,Oropharyngeal Dysphagia|COVID-19|Sars-CoV2|Nutrition,Diagnostic Test: Swallowing evaluation with the EAT-10 and the volume-viscosity swallowing test (V-VST),"April 15, 2020","Consorci Sanitari del Maresme (Hospital de Mataró), Mataró, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04346212
Study Chair,"Mical Paul, MD",Rambam,,NCT04438837,mical paul,mical,male,0.7,117,1152,NCT04438837,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Not yet recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19)|Post-Exposure Prophylaxis,Drug: Hydroxychloroquine,"June 19, 2020","Rambam Health Care Campus, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04438837
Principal Investigator,"Yacine TANDJAOUI-LAMBIOTTE, Dr",Assistance Publique - Hôpitaux de Paris,,NCT04355481,yacine tandjaoui-lambiotte,yacine,male,0.93,14535,1153,NCT04355481,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,Recruiting,No Results Available,Covid-19|Viral Infection,,"April 21, 2020","Service de réanimation Hôpital Avicenne, Bobigny, France|Service de réanimation Hôpital Bichat, Paris, France|Service de réanimation Hôpital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04355481
Principal Investigator,"Yacine TANDJAOUI-LAMBIOTTE, MD",Assistance Publique - Hôpitaux de Paris,,NCT04355429,yacine tandjaoui-lambiotte,yacine,male,0.93,14535,1495,NCT04355429,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Not yet recruiting,No Results Available,Pneumonia|Coronavirus Infection|COVID-19,Drug: captopril 25mg,"April 21, 2020","CH Victor Dupuy- Argenteuil, Argenteuil, France|Hôpital Avicenne,, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Antoine Béclère, Clamart, France|CH de Compiègne-Noyon, Compiègne, France|Groupe hospitalier Sud Ile de France, Melun, France|Hôpital de la Pitié- Salpêtrière, Paris, France|Hôpital Tenon, Paris, France|CHRU de Tours, Hôpital Bretonneau, Tours, France|Hôpital de Tours, Tours, France",https://ClinicalTrials.gov/show/NCT04355429
Study Chair,"Dr Deepa Jayakody Arachchillage, FRCPath, MD",Imperial College London,,NCT04405232,deepa jayakody arachchillage,deepa,female,0.93,592,1155,NCT04405232,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,Recruiting,No Results Available,COVID|Thrombosis|Bleeding|Anticoagulation,Other: Non-interventional,"May 28, 2020","Imperial College Healthcare NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04405232
Principal Investigator,Betsy J Barnes,Feinstein Institute for Medical Research,,NCT04387786,betsy j barnes,betsy,female,0.97,1109,1156,NCT04387786,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),"Active, not recruiting",No Results Available,COVID-19|Mechanical Ventilation,Drug: Dornase Alfa,"May 14, 2020","Feinstein Insitute for Medical Research at Northwell Health, Manhasset, New York, United States",https://ClinicalTrials.gov/show/NCT04387786
Principal Investigator,"Milind Desai, M. D.",The Cleveland Clinic,,NCT04342728,milind desai,milind,male,0.99,374,1157,NCT04342728,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Enrolling by invitation,No Results Available,COVID|Corona Virus Infection,Dietary Supplement: Ascorbic Acid|Dietary Supplement: Zinc Gluconate|Dietary Supplement: Ascorbic Acid and Zinc Gluconate|Other: Standard of Care,"April 13, 2020","Cleveland Clinic, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04342728
Principal Investigator,Suma Thomas,The Cleveland Clinic,,NCT04342728,suma thomas,suma,female,0.7,342,1157,NCT04342728,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Enrolling by invitation,No Results Available,COVID|Corona Virus Infection,Dietary Supplement: Ascorbic Acid|Dietary Supplement: Zinc Gluconate|Dietary Supplement: Ascorbic Acid and Zinc Gluconate|Other: Standard of Care,"April 13, 2020","Cleveland Clinic, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04342728
Principal Investigator,"Viviane C Veiga, MD",Beneficência Portuguesa de Sao Paulo,,NCT04403685,viviane c veiga,viviane,female,0.98,9913,1161,NCT04403685,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,Recruiting,No Results Available,COVID|SARS Pneumonia|Cytokine Release Syndrome,Drug: Tocilizumab,"May 27, 2020","UNIFESP, São Paulo, Sao Paulo, Brazil|HCOR -Hospital do Coracao, Sao Paulo, SP, Brazil|HAOC - Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil|Beneficência Portuguesa de Sao Paulo, Sao Paulo, Brazil|HAOC - Hospital Alemao Oswaldo Cruz - unidade Vergueiro, Sao Paulo, Brazil|HIAE - Hospital Israelita Albert Einstein, Sao Paulo, Brazil|HSL - Hospital Sírio Libanês, Sao Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04403685
Principal Investigator,"Ronni R Plovsing, MD, PhD","Dept. of Intensive Care, University Hospital Hvidovre, Denmark",,NCT04354584,ronni r plovsing,ronni,male,0.93,762,1162,NCT04354584,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,Recruiting,No Results Available,COVID-19|Respiratory Failure,,"April 21, 2020","Dept. of Intensive Care 542, University Hospital Hvidovre, Hvidovre, Copenhagen, Denmark",https://ClinicalTrials.gov/show/NCT04354584
Principal Investigator,Wei Zhang,Jingzhou Hospital of Traditional Chinese Medicine,,NCT04278963,wei zhang,wei,male,0.72,5779,1172,NCT04278963,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Suspended,No Results Available,CoVID-19|Chinese Medicine,Drug: YinHu QingWen Decoction|Drug: YinHu QingWen Decoction(low dose)|Other: Chinese medicine treatment|Other: standard western medicine treatment,"February 20, 2020","Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China|Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, China",https://ClinicalTrials.gov/show/NCT04278963
Principal Investigator,"Xiao-Dong Li, M.D.",Hubei Hospital of Traditional Chinese Medicine,,NCT04278963,xiao-dong li,xiao-dong,male,1.0,1,1172,NCT04278963,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Suspended,No Results Available,CoVID-19|Chinese Medicine,Drug: YinHu QingWen Decoction|Drug: YinHu QingWen Decoction(low dose)|Other: Chinese medicine treatment|Other: standard western medicine treatment,"February 20, 2020","Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China|Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei, China",https://ClinicalTrials.gov/show/NCT04278963
Principal Investigator,"Jon T. Giles, MD",Columbia University Irving Medical Center,,NCT04318444,jon t. giles,jon,male,0.98,29554,1175,NCT04318444,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Recruiting,No Results Available,COVID-19|Corona Virus Infection,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"March 24, 2020","Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04318444
Principal Investigator,"Jon Irazusta, PhD","Basque Country University (UPV-EHU), Leioa, Bizkaia, 48940, Spain",,NCT04361019,jon irazusta,jon,male,0.98,29554,1965,NCT04361019,Physical Activity in University Students Around COVID-19 Confinement,Recruiting,No Results Available,Physical Activity,Other: On-Line Survey,"April 24, 2020","Basque Country University (UPV-EHU),, Bilbao, Bizkaia, Spain",https://ClinicalTrials.gov/show/NCT04361019
Principal Investigator,"Bernard Cortet, MD,PhD","University Hospital, Lille",,NCT04351633,bernard cortet,bernard,male,0.98,38897,1177,NCT04351633,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Completed,No Results Available,Sars-CoV2|Osteoporosis,Other: questionnaire assesment,"April 17, 2020","Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04351633
Principal Investigator,Claire-Marie RANGON,Fondation Adolphe de Rothschild,,NCT04341415,claire-marie rangon,claire-marie,female,0.94,109,1178,NCT04341415,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Recruiting,No Results Available,Covid19|SARS-CoV Infection,Procedure: Auricular neuromodulation|Procedure: Control,"April 10, 2020","Fondation Adolphe de Rothschild, Paris, France",https://ClinicalTrials.gov/show/NCT04341415
Principal Investigator,"Manisha Palta, MD",Duke University Health System,,NCT04357574,manisha palta,manisha,female,0.97,643,1181,NCT04357574,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,Enrolling by invitation,No Results Available,COVID-19|Cancer,Other: Telehealth,"April 22, 2020","Duke Cancer Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04357574
Principal Investigator,"Erland Östberg, M.D., Ph.D.",Region Västmanland,,NCT04382417,erland östberg,erland,male,0.98,188,1183,NCT04382417,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,Recruiting,No Results Available,Covid-19|Critical Illness,Other: Observational study,"May 11, 2020","Intensive Care Unit, Västerås Hospital, Västerås, Västmanland, Sweden",https://ClinicalTrials.gov/show/NCT04382417
Principal Investigator,"Giacomo Grasselli, MD","Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",,NCT04388670,giacomo grasselli,giacomo,male,0.99,25600,1184,NCT04388670,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,Recruiting,No Results Available,COVID-19|Critical Illness,,"May 14, 2020","Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico, Milan, Italy",https://ClinicalTrials.gov/show/NCT04388670
Principal Investigator,Larissa A Korde,National Cancer Institute (NCI),,NCT04387656,larissa a korde,larissa,female,0.98,10179,1185,NCT04387656,"NCI COVID-19 in Cancer Patients, NCCAPS Study",Recruiting,No Results Available,Asymptomatic COVID-19 Infection Laboratory-Confirmed|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,Procedure: Biospecimen Collection|Other: Data Collection,"May 14, 2020","Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States|NEA Baptist Memorial Hospital, Jonesboro, Arkansas, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Enloe Medical Center, Chico, California, United States|Kaiser Permanente Dublin, Dublin, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Veterans Affairs Loma Linda Healthcare System, Loma Linda, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Kaiser Permanente Downtown Commons, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser San Rafael-Gallinas, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Cancer Center of Colorado at Sloan's Lake, Denver, Colorado, United States|National Jewish Health-Main Campus, Denver, Colorado, United States|The Women's Imaging Center, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Western Surgical Care, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Littleton Adventist Hospital, Littleton, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|Longmont United Hospital, Longmont, Colorado, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|Parker Adventist Hospital, Parker, Colorado, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, United States|National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven, Connecticut, United States|Beebe Medical Center, Lewes, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|Nanticoke Memorial Hospital, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|Broward Health North, Deerfield Beach, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Northeast Georgia Medical Center Braselton, Braselton, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, United States|Kootenai Cancer Center, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Mountain States Tumor Institute-Twin Falls, Twin Falls, Idaho, United States|Rush - Copley Medical Center, Aurora, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Carle on Vermilion, Danville, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Illinois CancerCare-Dixon, Dixon, Illinois, United States|Carle Physician Group-Effingham, Effingham, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Ingalls Memorial Hospital, Harvey, Illinois, United States|Edward Hines Jr VA Hospital, Hines, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, United States|Carle Cancer Center, Urbana, Illinois, United States|The Carle Foundation Hospital, Urbana, Illinois, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, United States|IU Health North Hospital, Carmel, Indiana, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States|Sidney and Lois Eskenazi Hospital, Indianapolis, Indiana, United States|Reid Health, Richmond, Indiana, United States|Memorial Hospital of South Bend, South Bend, Indiana, United States|Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States|Greater Regional Medical Center, Creston, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Laurel, Des Moines, Iowa, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, United States|University of Kansas Clinical Research Center, Fairway, Kansas, United States|HaysMed University of Kansas Health System, Hays, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Olathe Health Cancer Center, Olathe, Kansas, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States|University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, United States|Salina Regional Health Center, Salina, Kansas, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Flaget Memorial Hospital, Bardstown, Kentucky, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, United States|Saint Joseph Hospital East, Lexington, Kentucky, United States|Saint Joseph London, London, Kentucky, United States|Jewish Hospital, Louisville, Kentucky, United States|The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, United States|Jewish Hospital Medical Center Northeast, Louisville, Kentucky, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, United States|LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States|Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, United States|Our Lady of the Lake Physicians Group - Medical Oncology, Baton Rouge, Louisiana, United States|Woman's Hospital, Baton Rouge, Louisiana, United States|Mary Bird Perkins Cancer Center - Covington, Covington, Louisiana, United States|Northshore Oncology Associates-Covington, Covington, Louisiana, United States|Women's Cancer Care-Covington, Covington, Louisiana, United States|Mary Bird Perkins Cancer Center - Houma, Houma, Louisiana, United States|Terrebonne General Medical Center, Houma, Louisiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana, United States|Ochsner LSU Health Monroe Medical Center, Monroe, Louisiana, United States|Louisiana State University Health Science Center, New Orleans, Louisiana, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Mercy Medical Center, Baltimore, Maryland, United States|Greater Baltimore Medical Center, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|FMH James M Stockman Cancer Institute, Frederick, Maryland, United States|Beverly Hospital, Beverly, Massachusetts, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Addison Gilbert Hospital, Gloucester, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|Mercy Medical Center, Springfield, Massachusetts, United States|Winchester Hospital, Winchester, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, United States|Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Beaumont Hospital - Farmington Hills, Farmington Hills, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States|Ascension Providence Hospitals - Novi, Novi, Michigan, United States|Henry Ford Medical Center-Columbus, Novi, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Henry Ford Macomb Health Center - Shelby Township, Shelby, Michigan, United States|Ascension Providence Hospitals - Southfield, Southfield, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|William Beaumont Hospital - Troy, Troy, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Cambridge Medical Center, Cambridge, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, United States|Baptist Cancer Center-Grenada, Grenada, Mississippi, United States|Gulfport Memorial Hospital, Gulfport, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, United States|Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Cox Cancer Center Branson, Branson, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Parkland Health Center - Farmington, Farmington, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Truman Medical Centers, Kansas City, Missouri, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Saint Vincent Frontier Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|CHI Health Saint Francis, Grand Island, Nebraska, United States|CHI Health Good Samaritan, Kearney, Nebraska, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Midlands Community Hospital, Papillion, Nebraska, United States|Holy Name Hospital, Teaneck, New Jersey, United States|Inspira Medical Center Woodbury, Woodbury, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Rochester General Hospital, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Hematology Oncology Associates of Central New York-Onondaga Hill, Syracuse, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|CaroMont Regional Medical Center, Gastonia, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Nash General Hospital, Rocky Mount, North Carolina, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States|Trinity Cancer Care Center, Minot, North Dakota, United States|Summa Health System - Akron Campus, Akron, Ohio, United States|Indu and Raj Soin Medical Center, Beavercreek, Ohio, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, United States|Saint Elizabeth Boardman Hospital, Boardman, Ohio, United States|Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, United States|Miami Valley Hospital South, Centerville, Ohio, United States|Adena Regional Medical Center, Chillicothe, Ohio, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, United States|Mount Carmel East Hospital, Columbus, Ohio, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States|Riverside Methodist Hospital, Columbus, Ohio, United States|Grant Medical Center, Columbus, Ohio, United States|The Mark H Zangmeister Center, Columbus, Ohio, United States|Mount Carmel Health Center West, Columbus, Ohio, United States|Doctors Hospital, Columbus, Ohio, United States|Miami Valley Hospital, Dayton, Ohio, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States|Grady Memorial Hospital, Delaware, Ohio, United States|Dublin Methodist Hospital, Dublin, Ohio, United States|Armes Family Cancer Center, Findlay, Ohio, United States|Blanchard Valley Hospital, Findlay, Ohio, United States|Orion Cancer Care, Findlay, Ohio, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States|Dayton Physicians LLC-Atrium, Franklin, Ohio, United States|Central Ohio Breast and Endocrine Surgery, Gahanna, Ohio, United States|Dayton Physicians LLC-Wayne, Greenville, Ohio, United States|Wayne Hospital, Greenville, Ohio, United States|Mount Carmel Grove City Hospital, Grove City, Ohio, United States|Greater Dayton Cancer Center, Kettering, Ohio, United States|First Dayton Cancer Care, Kettering, Ohio, United States|Kettering Medical Center, Kettering, Ohio, United States|Fairfield Medical Center, Lancaster, Ohio, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, United States|Marietta Memorial Hospital, Marietta, Ohio, United States|OhioHealth Marion General Hospital, Marion, Ohio, United States|Knox Community Hospital, Mount Vernon, Ohio, United States|Licking Memorial Hospital, Newark, Ohio, United States|Newark Radiation Oncology, Newark, Ohio, United States|Southern Ohio Medical Center, Portsmouth, Ohio, United States|Springfield Regional Cancer Center, Springfield, Ohio, United States|Springfield Regional Medical Center, Springfield, Ohio, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, United States|Dayton Physicians LLC-Upper Valley, Troy, Ohio, United States|Upper Valley Medical Center, Troy, Ohio, United States|Saint Joseph Warren Hospital, Warren, Ohio, United States|University Pointe, West Chester, Ohio, United States|Saint Ann's Hospital, Westerville, Ohio, United States|Saint Elizabeth Youngstown Hospital, Youngstown, Ohio, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|Ephrata Cancer Center, Ephrata, Pennsylvania, United States|Adams Cancer Center, Gettysburg, Pennsylvania, United States|Cherry Tree Cancer Center, Hanover, Pennsylvania, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States|Sechler Family Cancer Center, Lebanon, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|Pottstown Hospital, Pottstown, Pennsylvania, United States|WellSpan Health-York Cancer Center, York, Pennsylvania, United States|Women and Infants Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Baptist Hospital, Columbia, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Prisma Health Cancer Institute - Spartanburg, Spartanburg, South Carolina, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, United States|Thompson Cancer Survival Center, Knoxville, Tennessee, United States|Thompson Cancer Survival Center - West, Knoxville, Tennessee, United States|Thompson Oncology Group-Lenoir City, Lenoir City, Tennessee, United States|Thompson Oncology Group-Maryville, Maryville, Tennessee, United States|Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, United States|Baptist Memorial Hospital for Women, Memphis, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Thompson Oncology Group-Oak Ridge, Oak Ridge, Tennessee, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, United States|Farmington Health Center, Farmington, Utah, United States|University of Utah Sugarhouse Health Center, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, United States|Harrison Medical Center, Bremerton, Washington, United States|Highline Medical Center-Main Campus, Burien, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Saint Elizabeth Hospital, Enumclaw, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Saint Francis Hospital, Federal Way, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|Saint Clare Hospital, Lakewood, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Jefferson Healthcare, Port Townsend, Washington, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States|Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States|Aurora Medical Center in Summit, Summit, Wisconsin, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States|Cheyenne Regional Medical Center-West, Cheyenne, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States",https://ClinicalTrials.gov/show/NCT04387656
Principal Investigator,"IN-GYU BAE, MD",Gyeongsang National University Hospital,,NCT04418128,in-gyu bae,in-gyu,male,1.0,6,1187,NCT04418128,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Not yet recruiting,No Results Available,Corona Virus Infection|COVID-19,Drug: Nafamostat Mesylate,"June 5, 2020",,https://ClinicalTrials.gov/show/NCT04418128
Study Director,"Gianfranco Parati, MD, PhD",Istituto Auxologico Italiano,,NCT04371289,gianfranco parati,gianfranco,male,0.99,10710,1192,NCT04371289,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,Not yet recruiting,No Results Available,COVID-19|Cardiovascular Risk Factor,,"May 1, 2020","Istituto Auxologico Italiano, Milan, Italy",https://ClinicalTrials.gov/show/NCT04371289
Principal Investigator,"Subodh Verma, MD, PhD",Canadian Medical and Surgical Knowledge Translation Research Group,,NCT04412018,subodh verma,subodh,male,0.98,228,1193,NCT04412018,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Recruiting,No Results Available,COVID-19|Inflammatory Response,Drug: Icosapent ethyl,"June 2, 2020","North York Diagnostic and Cardiology Clinic, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04412018
Principal Investigator,"Faming Zhang, MD; PHD",The Second Hospital of Nanjing Medical University,,NCT04251767,faming zhang,faming,male,1.0,6,1195,NCT04251767,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,Withdrawn,No Results Available,COVID-19 Complicated With Refractory Intestinal Infections,Other: washed microbiota transplantation|Other: placebo,"February 5, 2020","Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04251767
Principal Investigator,"Tessa Goetghebuer, MD PhD",Centre Hospitalier Universitaire Saint Pierre,,NCT04432779,tessa goetghebuer,tessa,female,0.98,4864,1198,NCT04432779,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,Not yet recruiting,No Results Available,Pregnancy|Covid-19,Other: no intervention,"June 16, 2020","CHU SAINT Pierre, Brussels, Belgium",https://ClinicalTrials.gov/show/NCT04432779
Principal Investigator,"Soeren Haghstroem, M.D, PhD","Aalborg University Hospital, Aalborg University",,NCT04375410,soeren haghstroem,soeren,male,0.99,340,1199,NCT04375410,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,Enrolling by invitation,No Results Available,Hand Eczema|Hand Dermatitis|Covid19,,"May 5, 2020","Tine Caroc Warner, Hjørring, Nordjylland, Denmark",https://ClinicalTrials.gov/show/NCT04375410
Principal Investigator,"Luise Borch, M.D, PhD","Regional Hospital West Jutland, Herning",,NCT04375410,luise borch,luise,female,0.91,1438,1199,NCT04375410,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,Enrolling by invitation,No Results Available,Hand Eczema|Hand Dermatitis|Covid19,,"May 5, 2020","Tine Caroc Warner, Hjørring, Nordjylland, Denmark",https://ClinicalTrials.gov/show/NCT04375410
Principal Investigator,"Michiel Thomeer, MD,PhD",Ziekenhuis Oost-Limburg,,NCT04338568,michiel thomeer,michiel,male,0.99,2434,1201,NCT04338568,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Recruiting,No Results Available,COVID-19 Pneumonia|Lung Ultrasound,Diagnostic Test: Lung ultrasound,"April 8, 2020","Ziekenhuis Oost Limburg, Genk, Limburg, Belgium",https://ClinicalTrials.gov/show/NCT04338568
Principal Investigator,"Manu Shankar-Hari, MD PhD",Guy's and St Thomas' NHS Foundation Trust,,NCT04379076,manu shankar-hari,manu,male,0.84,71796,1205,NCT04379076,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Recruiting,No Results Available,COVID-19|Lymphocytopenia,Drug: Interleukin-7|Drug: Placebos,"May 7, 2020","Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04379076
Principal Investigator,"Mazen Albaghdadi, MD",Massachusetts General Hospital,,NCT04377997,mazen albaghdadi,mazen,male,0.98,3947,1206,NCT04377997,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Not yet recruiting,No Results Available,Cardiovascular Diseases|COVID-19,Drug: Enoxaparin,"May 7, 2020",,https://ClinicalTrials.gov/show/NCT04377997
Principal Investigator,"Nicola Fazio, M.D., Ph.D.","European Institute of Oncology, IEO, IRCCS",,NCT04444401,nicola fazio,nicola,male,0.85,60815,1208,NCT04444401,Registry on NEN Patients and COVID-19,Recruiting,No Results Available,Neuroendocrine Tumors|COVID-19,,"June 23, 2020","European Institute of Oncology, IEO, IRCCS, Milan, MI, Italy",https://ClinicalTrials.gov/show/NCT04444401
Principal Investigator,"Aurélie Mieuset, PhD",University Hospitals of Montpellier,,NCT04380714,aurélie mieuset,aurélie,female,0.98,366,1209,NCT04380714,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,Recruiting,No Results Available,People Incarcerated|COVID-19,,"May 8, 2020","UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04380714
Principal Investigator,"Enagnon Kazali ALIDJINOU, MD","University Hospital, Lille",,NCT04367142,enagnon kazali alidjinou,enagnon,male,0.89,18,1213,NCT04367142,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Not yet recruiting,No Results Available,Sars-CoV2,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,"April 29, 2020",,https://ClinicalTrials.gov/show/NCT04367142
Study Chair,"Sergio I Valdés-Ferrer, MD, PhD",Instituto Nacional De Ciencias Médicas y Nutrición,,NCT04343963,sergio i valdés-ferrer,sergio,male,0.99,131922,1220,NCT04343963,Pyridostigmine in Severe SARS-CoV-2 Infection,Recruiting,No Results Available,COVID-19|SARS-CoV-2,Drug: Pyridostigmine Bromide|Drug: Placebo,"April 14, 2020","Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Tlalpan, Mexico",https://ClinicalTrials.gov/show/NCT04343963
Study Director,"Sergio Serni, Prof",University of Florence,,NCT04446169,sergio serni,sergio,male,0.99,131922,1654,NCT04446169,COVID-19 (SARS-CoV-2) in Urine and Semen,Recruiting,No Results Available,SARS-CoV 2|Sexual Function and Fertility Disorders|Urinary Function Disorders|Urine|Semen,Diagnostic Test: SARS-CoV 2 RNA PCR Urine|Diagnostic Test: SARS-CoV 2 RNA PCR Semen|Diagnostic Test: Semen Qualitative Analysis|Diagnostic Test: IIEF-5 questionnaire|Diagnostic Test: Male Sexual Health Questionnaire (MSHQ)|Diagnostic Test: IPSS questionnaire|Diagnostic Test: SECRET questionnaire|Diagnostic Test: Interleukin assessment in semen,"June 24, 2020","AOU Careggi, Florence, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04446169
Principal Investigator,"Mauro Gacci, MD",Careggi University Hospital,,NCT04446169,mauro gacci,mauro,male,0.99,48289,1654,NCT04446169,COVID-19 (SARS-CoV-2) in Urine and Semen,Recruiting,No Results Available,SARS-CoV 2|Sexual Function and Fertility Disorders|Urinary Function Disorders|Urine|Semen,Diagnostic Test: SARS-CoV 2 RNA PCR Urine|Diagnostic Test: SARS-CoV 2 RNA PCR Semen|Diagnostic Test: Semen Qualitative Analysis|Diagnostic Test: IIEF-5 questionnaire|Diagnostic Test: Male Sexual Health Questionnaire (MSHQ)|Diagnostic Test: IPSS questionnaire|Diagnostic Test: SECRET questionnaire|Diagnostic Test: Interleukin assessment in semen,"June 24, 2020","AOU Careggi, Florence, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04446169
Principal Investigator,"Osama Kentab, MD",Princess Nourah Bint Abdulrahman University,,NCT04387240,osama kentab,osama,male,0.98,8125,1226,NCT04387240,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,Not yet recruiting,No Results Available,Covid 19 Positive|Corona Virus Infection,Drug: Artemisinin / Artesunate|Other: placebo,"May 13, 2020","Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia",https://ClinicalTrials.gov/show/NCT04387240
Principal Investigator,"Osama Abou Arab, MD",CHU Amiens,,NCT04354558,osama abou arab,osama,male,0.98,8125,1582,NCT04354558,French Single Centre Experience of Critically Ill Patients With Covid 19,Not yet recruiting,No Results Available,Epidemiology|Sars-CoV2|COVID 19|Critical Care|Prognostic|Survival,,"April 21, 2020","CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04354558
Principal Investigator,"Mehdi BENCHOUFI, MD",Assistance Publique - Hôpitaux de Paris,,NCT04335019,mehdi benchoufi,mehdi,male,0.98,48418,1232,NCT04335019,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Not yet recruiting,No Results Available,2019-nCoV (COVID-19)|Interstitial Pneumonia,Other: Pulmonary ultrasound,"April 6, 2020",,https://ClinicalTrials.gov/show/NCT04335019
Principal Investigator,"Oliver Perilla Suarez, Hematologist",Hospital San Vicente Fundación,,NCT04391101,oliver perilla suarez,oliver,male,0.99,32776,1243,NCT04391101,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),Not yet recruiting,No Results Available,SARS-Cov-2,Drug: Convalescent plasma,"May 18, 2020","Hospital San Vicente Fundacion, Medellín, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04391101
Principal Investigator,"Jamil Azzi, MD, PhD",Birgham and Women's Hospital,,NCT04420364,jamil azzi,jamil,male,0.97,3042,1247,NCT04420364,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,Not yet recruiting,No Results Available,COVID|Kidney Transplant; Complications|Immunosuppression,Other: Maintenance or reduction of immunosuppression,"June 9, 2020",,https://ClinicalTrials.gov/show/NCT04420364
Study Chair,Abdol Hossein Shahverdi,Royan Institute,,NCT04366063,abdol hossein shahverdi,abdol,male,0.97,520,1253,NCT04366063,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,Recruiting,No Results Available,Covid-19,Biological: Cell therapy protocol 1|Biological: Cell therapy protocol 2,"April 28, 2020","Royan Institute, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04366063
Principal Investigator,"Hossein Baharvand, Professor","Department of Stem Cells Biology and Technology, Cell Science Research Center, Royan Institute for Stem Cells Biology & Technology, Iran",,NCT04366063,hossein baharvand,hossein,male,0.99,3576,1253,NCT04366063,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,Recruiting,No Results Available,Covid-19,Biological: Cell therapy protocol 1|Biological: Cell therapy protocol 2,"April 28, 2020","Royan Institute, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04366063
Principal Investigator,"Dr. Eman Elmekaty, PharmD",Hamad Medical Corporation,,NCT04425382,eman elmekaty,eman,female,0.78,2638,1256,NCT04425382,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,Recruiting,No Results Available,Coronavirus|COVID|Pneumonia,Drug: Darunavir/Cobicistat|Drug: Lopinavir/Ritonavir,"June 11, 2020","Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04425382
Principal Investigator,"Stéphane Bar, MD",CHU Amiens,,NCT04368338,stéphane bar,stéphane,male,0.99,761,1257,NCT04368338,Lung Ultrasound to Diagnose COVID-19,Recruiting,No Results Available,Covid-19|Lung Ultrasound|Respiratory Complication,Diagnostic Test: COVID-19 RT-PCR|Procedure: lung ultrasound,"April 29, 2020","BAR, Amiens, France",https://ClinicalTrials.gov/show/NCT04368338
Principal Investigator,"Stéphane Zuily, MD, PhD",Nancy Academic Hospital,,NCT04373707,stéphane zuily,stéphane,male,0.99,761,1447,NCT04373707,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Recruiting,No Results Available,COVID|Thrombosis|Pulmonary Embolism|Deep Vein Thrombosis,Drug: Enoxaparin,"May 4, 2020","Amiens Academic Hospital, Amiens, France|Besançon Academic Hospital, Besançon, France|Brest Academic Hospital, Brest, France|Civil Hospital, Colmar, France|Dijon Academic Hospital, Dijon, France|Marseille Academic Hospital, Marseille, France|Metz-Thionville Regional Hospital, Metz, France|Montpellier Academic Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy Academic Hospital, Nancy, France|George Pompidou European Hospital, Paris, France|St Etienne Academic Hospital, Saint-Étienne, France|Strasbourg Academic Hospital, Strasbourg, France|Toulouse Academic Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04373707
Study Director,El Mehdi Siaghy,"Research and Innovation Department, Nancy University Hospital",,NCT04373707,el mehdi siaghy,el,male,0.91,46947,1447,NCT04373707,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Recruiting,No Results Available,COVID|Thrombosis|Pulmonary Embolism|Deep Vein Thrombosis,Drug: Enoxaparin,"May 4, 2020","Amiens Academic Hospital, Amiens, France|Besançon Academic Hospital, Besançon, France|Brest Academic Hospital, Brest, France|Civil Hospital, Colmar, France|Dijon Academic Hospital, Dijon, France|Marseille Academic Hospital, Marseille, France|Metz-Thionville Regional Hospital, Metz, France|Montpellier Academic Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy Academic Hospital, Nancy, France|George Pompidou European Hospital, Paris, France|St Etienne Academic Hospital, Saint-Étienne, France|Strasbourg Academic Hospital, Strasbourg, France|Toulouse Academic Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04373707
Principal Investigator,"Stéphane Raffard, PhD",University Hospitals of Montpellier,,NCT04356885,stéphane raffard,stéphane,male,0.99,761,1990,NCT04356885,COVID-19 and Psychotic Symptoms in France,Recruiting,No Results Available,Mental Disorder,,"April 22, 2020","UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04356885
Principal Investigator,"Stéphane Raffard, PhD",University Hospitals of Montpellier,,NCT04384419,stéphane raffard,stéphane,male,0.99,761,2158,NCT04384419,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",Not yet recruiting,No Results Available,Mental Disorder|General Population,,"May 12, 2020","UH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04384419
Study Chair,"Stéphane Cook, MD",University of Freiburg,,NCT04379986,stéphane cook,stéphane,male,0.99,761,2327,NCT04379986,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device,Not yet recruiting,No Results Available,Blood Pressure,Device: Sensbiosys,"May 8, 2020","University and hospital Fribourg, Fribourg, Switzerland",https://ClinicalTrials.gov/show/NCT04379986
Study Chair,"Ting Yang, Doctor",China-Japan Friendship Hospital,,NCT04368793,ting yang,ting,female,0.65,1837,1258,NCT04368793,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,Recruiting,No Results Available,COVID-2019 Pneumonia|Pulmonary Rehabilitation,Behavioral: pulmonary rehabilitation,"April 30, 2020","Wuhan Lung Hospital, Wuhan, Hubei, China|Wuhan Central Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04368793
Principal Investigator,"Susi Kriemler, Prof.",University of Zurich,,NCT04448717,susi kriemler,susi,female,0.97,11474,1270,NCT04448717,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,Recruiting,No Results Available,SARS-CoV 2|COVID-19,Diagnostic Test: COVID-19 Antibody testing,"June 26, 2020","Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04448717
Principal Investigator,Zhu Fengcai,Jiangsu Province Centers for Disease Control and Prevention,,NCT04313127,zhu fengcai,zhu,male,0.58,635,1272,NCT04313127,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,"Active, not recruiting",No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),"March 18, 2020","Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04313127
Principal Investigator,Guan Xuhua,Hubei Provincial Center for Disease Control and Prevention,,NCT04313127,guan xuhua,guan,male,0.81,424,1272,NCT04313127,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,"Active, not recruiting",No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),"March 18, 2020","Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04313127
Principal Investigator,Wang Wei,Tongji Hospital,,NCT04313127,wang wei,wang,male,0.64,3532,1272,NCT04313127,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,"Active, not recruiting",No Results Available,COVID-19,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),"March 18, 2020","Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04313127
Principal Investigator,"Jalila Ben Khelil, Pr",Hopital Abderrahmane Mami,,NCT04349228,jalila ben khelil,jalila,female,0.98,855,1275,NCT04349228,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,Recruiting,No Results Available,COVID19|Sars-CoV2|Hydroxychloroquine|Prophylaxis|Healthcare Worker,Drug: Hydroxychloroquine (HCQ)|Drug: Placebo oral tablet,"April 16, 2020","Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Tunis, Tunisia",https://ClinicalTrials.gov/show/NCT04349228
Study Chair,"Constantino López Macías, PhD","UIMIQ Hospital de especialidades, CMN S.XXI",,NCT04423640,constantino lópez macías,constantino,male,0.98,917,1276,NCT04423640,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,Recruiting,No Results Available,SARS-CoV-2,Other: Active COVID-19 disease,"June 9, 2020","UMAE Hospital de Especialidades del Centro Médico Nacional Siglo XXI, IMSS., México, Ciudad De México, Mexico",https://ClinicalTrials.gov/show/NCT04423640
Study Director,"JungWon Woo, Ph.D.","Genexine, Inc.",,NCT04445389,jungwon woo,jungwon,female,0.53,142,1279,NCT04445389,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",Recruiting,No Results Available,SARS-CoV-2,Drug: GX-19|Drug: Saline,"June 24, 2020","Severance hospital, Seoul, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04445389
Principal Investigator,"Ugo Pastorino, MD","Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",,NCT04441814,ugo pastorino,ugo,male,0.97,7537,1283,NCT04441814,FOUND - Ancillary Study to Smile Protocol NCT03654105,Enrolling by invitation,No Results Available,COVID 19|Inflammatory Status,,"June 22, 2020","Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",https://ClinicalTrials.gov/show/NCT04441814
Principal Investigator,"Simone Donati, Professor","University of Insubria, Varese",,NCT04402853,simone donati,simone,male,0.75,86110,1413,NCT04402853,SARS Cov-2 in Conjunctival Secretion,Completed,No Results Available,Sars-CoV2|Tear,Diagnostic Test: Tears swab,"May 27, 2020","ASST Sette Laghi, Varese, Italy",https://ClinicalTrials.gov/show/NCT04402853
Principal Investigator,"Roger A Alvarez, D.O.",University of Miami,,NCT04398290,roger a alvarez,roger,male,0.98,38190,1295,NCT04398290,iNOPulse for COVID-19,Not yet recruiting,No Results Available,COVID-19|Hypoxemia|Hypoxemic Respiratory Failure,Drug: Inhaled nitric oxide (iNO)|Drug: Nitrogen gas|Drug: Oxygen gas,"May 21, 2020","University of Miami Hospitals & Clinics, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04398290
Principal Investigator,Jordon Thornes,"Laboratory for Personalized Molecular Medicine,",,NCT04391400,jordon thornes,jordon,male,0.94,323,1296,NCT04391400,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",Not yet recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: nasal pharyngeal (NP) swab samples|Diagnostic Test: peripheral blood draw,"May 18, 2020",,https://ClinicalTrials.gov/show/NCT04391400
Principal Investigator,"Wei-jie Guan, PhD",Guangzhou Institute of Respiratory Disease,,NCT04378712,wei-jie guan,wei-jie,male,1.0,1,1299,NCT04378712,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Completed,No Results Available,Covid-19|Hydrogen/Oxygen Mixed Gas|Dyspnea,Device: Hydrogen Oxygen Generator with Nebulizer|Other: Standard-of-care,"May 7, 2020","First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04378712
Principal Investigator,"Anton Chau, MD",University of British Columbia,,NCT04366141,anton chau,anton,male,0.97,25344,1302,NCT04366141,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Recruiting,No Results Available,COVID-19,Device: COVID-19 barrier box,"April 28, 2020","Providence Health Care, Vancouver, British Columbia, Canada",https://ClinicalTrials.gov/show/NCT04366141
Principal Investigator,"Girish B Nair, MD",William Beaumont Hospitals,,NCT04320511,girish b nair,girish,male,0.99,951,1308,NCT04320511,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Recruiting,No Results Available,SARS-COV2|Severe Acute Respiratory Syndrome|COVID-19,Device: CT-V,"March 25, 2020","Beaumont Health, Royal Oak, Michigan, United States",https://ClinicalTrials.gov/show/NCT04320511
Principal Investigator,"Claire-Anne Siegrist, MD",Professor of vaccinology,,NCT04329546,claire-anne siegrist,claire-anne,female,1.0,20,1314,NCT04329546,Understanding COVID-19,Recruiting,No Results Available,SARS-CoV-2 Viral Kinetics and Host Immune Responses,Other: NA (no intervention),"April 1, 2020","University Hospitals of Geneva, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04329546
Study Director,Chun C Pan,"Zhongda hospital, Southeast University, Jiangsu, China",,NCT04359251,chun c pan,chun,male,0.84,1985,1315,NCT04359251,Different PEEP Settings of COVID-19 Induced ARDS,Completed,No Results Available,COVID-19|Mechanical Ventilation Pressure High|Acute Respiratory Distress Syndrome,Other: Gas exchanges at different PEEP|Other: lung mechanics at different PEEP|Other: Hemodynamics changes at different PEEP,"April 24, 2020","Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China",https://ClinicalTrials.gov/show/NCT04359251
Principal Investigator,"Thibault Duburcq, MD","University Hospital, Lille",,NCT04347928,thibault duburcq,thibault,male,0.99,8562,1316,NCT04347928,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Recruiting,No Results Available,COVID-19|ARDS|Sars-CoV2,,"April 15, 2020","Hopital Roger Salengro, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04347928
Principal Investigator,"Yogendra Kanthi, MD",University of Michigan,,NCT04391179,yogendra kanthi,yogendra,male,1.0,186,1320,NCT04391179,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Recruiting,No Results Available,COVID|Corona Virus Infection|Covid-19|SARS-CoV-2 Infection,Drug: Dipyridamole 100 Milligram(mg)|Drug: Placebo oral tablet,"May 18, 2020","University of Michigan, Ann Arbor, Michigan, United States",https://ClinicalTrials.gov/show/NCT04391179
Study Chair,"Claudio Yaryour, MD","Hospital de Clínicas José de San Martín, UBA",,NCT04398043,claudio yaryour,claudio,male,0.99,67759,1892,NCT04398043,SARS-CoV 2 in Personal Protective Equipment,Not yet recruiting,No Results Available,rt PCR|COVID|Personal Protective Equipment PPE|SARS-CoV 2|Health Personnel Attitude|Virus Diseases,,"May 21, 2020",,https://ClinicalTrials.gov/show/NCT04398043
Principal Investigator,"Eu Suk Kim, MD",Seoul National University Bundang Hospital,,NCT04447781,eu suk kim,eu,male,0.64,2913,1325,NCT04447781,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",Not yet recruiting,No Results Available,Coronavirus Infection|SARS-CoV 2,Biological: INO-4800|Device: CELLECTRA® 2000|Other: Saline-sodium citrate (SSC) buffer,"June 25, 2020",,https://ClinicalTrials.gov/show/NCT04447781
Principal Investigator,"Max O'Donnell, MD",Columbia University,,NCT04359810,max o'donnell,max,male,0.98,106688,1784,NCT04359810,Plasma Therapy of COVID-19 in Critically Ill Patients,Recruiting,No Results Available,SARS-CoV Infection,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Non-convalescent Plasma (control plasma),"April 24, 2020","Columbia University Irving Medical Center/NYP, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04359810
Principal Investigator,"Resul Karakus, MD",Zeynep Kamil Maternity and Childrens Hospital Training and Research Hospital,,NCT04443140,resul karakus,resul,male,0.97,6253,1330,NCT04443140,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,Recruiting,No Results Available,Covid-19|Preeclampsia|Pregnancy Related,"Diagnostic Test: PCR, lung ultrasound","June 23, 2020","Zeynep Kamil Maternity and Childrens Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04443140
Principal Investigator,"Souhail ALOUINI, M.D., Ph.D.",CHR ORLEANS,,NCT04395924,souhail alouini,souhail,male,0.97,1622,1339,NCT04395924,Maternal-foetal Transmission of SARS-Cov-2,Recruiting,No Results Available,Maternal Fetal Infection Transmission|COVID-19|SARS-CoV 2,"Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta","May 20, 2020","CHR Orléans, Orléans, France",https://ClinicalTrials.gov/show/NCT04395924
Principal Investigator,"Michel Slama, Pr",CHU Amiens,,NCT04377490,michel slama,michel,male,0.97,93795,1340,NCT04377490,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,Recruiting,No Results Available,COVID-19|Hemostasis|Coagulation,Other: venous ultrasound|Biological: blood sample,"May 6, 2020","CHU Amiens, Amiens, France",https://ClinicalTrials.gov/show/NCT04377490
Principal Investigator,"Romaric Larcher, MD, PharmD, MSc",UH Montpellier,,NCT04393428,romaric larcher,romaric,male,0.99,2422,1342,NCT04393428,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),Recruiting,No Results Available,COVID-19|Renal Replacement Therapy|Acute Kidney Injury,Other: [TIMP-2]*[IGFBP-7],"May 19, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04393428
Study Chair,"Antoni Torres, MD, PhD",Hospital Clínic de Barcelona,,NCT04390139,antoni torres,antoni,male,0.97,5088,1343,NCT04390139,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,Recruiting,No Results Available,COVID-19|SARS-CoV 2|Adult Respiratory Distress Syndrome,Drug: XCEL-UMC-BETA|Other: Placebo,"May 15, 2020","Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Mútua de Terrassa, Terrassa, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04390139
Study Chair,"Niels van Royen, MD PhD",Radboud University,,NCT04335786,niels van royen,niels,male,0.99,7479,1344,NCT04335786,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Recruiting,No Results Available,Acute Respiratory Distress Syndrome|SARS-CoV-2|COVID|COVID-19|Severe Acute Respiratory Syndrome,Drug: Valsartan (Diovan)|Drug: Placebo oral tablet,"April 6, 2020","Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands|Rijnstate, Arnhem, Netherlands|Radboudumc, Nijmegen, Netherlands|Laurentius Ziekenhuis, Roermond, Netherlands|Erasmus MC, Rotterdam, Netherlands|Franciscus Gasthuis, Rotterdam, Netherlands|Ikazia Ziekenhuis, Rotterdam, Netherlands",https://ClinicalTrials.gov/show/NCT04335786
Principal Investigator,"Ammar Sarwar, MD",Beth Israel Deaconess Medical Center,,NCT04351191,ammar sarwar,ammar,male,0.97,6181,1346,NCT04351191,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Recruiting,No Results Available,Sars-CoV2|Symptomatic Condition|Covid-19,Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo,"April 17, 2020","Expo Covid Isolation Center / Mayo Hospital Field Hospital, Lahore, Punjab, Pakistan|Mayo Hospital / King Edward Medical University, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan|Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04351191
Principal Investigator,"Kunling Shen, MD,PhD","Beijing Children's Hospital of Capital Medical University, China",,NCT04270383,kunling shen,kunling,female,1.0,4,1354,NCT04270383,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Not yet recruiting,No Results Available,2019-nCoV,,"February 17, 2020","Beijing Children's Hospital,, Beijing, China",https://ClinicalTrials.gov/show/NCT04270383
Principal Investigator,"Tianyou Wang, MD,PhD","Beijing Children's Hospital of Capital Medical University, China",,NCT04270383,tianyou wang,tianyou,male,0.92,12,1354,NCT04270383,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Not yet recruiting,No Results Available,2019-nCoV,,"February 17, 2020","Beijing Children's Hospital,, Beijing, China",https://ClinicalTrials.gov/show/NCT04270383
Principal Investigator,"Baoping Xu, MD,PhD","Beijing Children's Hospital of Capital Medical University, China",,NCT04270383,baoping xu,baoping,male,0.9,10,1354,NCT04270383,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Not yet recruiting,No Results Available,2019-nCoV,,"February 17, 2020","Beijing Children's Hospital,, Beijing, China",https://ClinicalTrials.gov/show/NCT04270383
Principal Investigator,"Valbona Mirakaj, Prof.",University hospital Tübingen,,NCT04377334,valbona mirakaj,valbona,female,0.97,572,1355,NCT04377334,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),Not yet recruiting,No Results Available,ARDS|COVID-19,Biological: MSC,"May 6, 2020","University Hospital Tuebingen, Tuebingen, Germany",https://ClinicalTrials.gov/show/NCT04377334
Principal Investigator,"Saad Nseir, MD,PhD","University Hospital, Lille",,NCT04359693,saad nseir,saad,male,0.97,15627,1357,NCT04359693,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,Recruiting,No Results Available,SARS-CoV 2,,"April 24, 2020","Hôpital Roger Salengro, ICU, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04359693
Principal Investigator,"Saad Nseir, MD,PhD","University Hospital, Lille",,NCT04359706,saad nseir,saad,male,0.97,15627,1369,NCT04359706,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,Not yet recruiting,No Results Available,Sars-CoV2,,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04359706
Principal Investigator,"Saad Nseir, MD,PhD","University Hospital, Lille",,NCT04378842,saad nseir,saad,male,0.97,15627,1417,NCT04378842,COVID-19 and ICU-acquired MDR Bacteria,Recruiting,No Results Available,Sars-CoV2|Critical Illness,,"May 7, 2020","Hôpital Roger Salengro, ICU, CHU Lille, Lille, France",https://ClinicalTrials.gov/show/NCT04378842
Principal Investigator,"Genovefa Papanicolaou, MD",Memorial Sloan Kettering Cancer Center,,NCT04379492,genovefa papanicolaou,genovefa,female,1.0,27,1358,NCT04379492,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,Recruiting,No Results Available,COVID-19|COVID19|Sars-CoV2|SARS-Cov-2,Drug: Hydroxychloroquine|Other: Placebo,"May 7, 2020","Memorial Sloan - Kettering Cancer Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04379492
Principal Investigator,"Delphine Garrigue, MD","University Hospital, Lille",,NCT04341792,delphine garrigue,delphine,female,0.98,34395,1362,NCT04341792,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Not yet recruiting,No Results Available,Infection Viral|Coronavirus|COVID-19,,"April 10, 2020",,https://ClinicalTrials.gov/show/NCT04341792
Principal Investigator,Delphine DOUILLET,"University Hospital, Angers",,NCT04338841,delphine douillet,delphine,female,0.98,34395,2235,NCT04338841,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,Recruiting,No Results Available,Coronavirus Infection,Other: HOME-CoV rule implementation,"April 8, 2020","Clinique Universitaire Saint-Luc, Bruxelles, Belgium|CHU de Liège, Liege, Belgium|Ch Argenteuil, Argenteuil, France|CHU Brest, Brest, France|CH Cholet, Cholet, France|CHU Clermont Ferrand, Clermont Ferrand, France|Ch Colmar, Colmar, France|CH Alpes Lemant, Contamine-sur-Arve, France|CHU Dijon, Dijon, France|CH Le Mans, Le Mans, France|CH Libourne, Libourne, France|CH Limoges, Limoges, France|Ch Longjumeau, Longjumeau, France|Hospices Civils de Lyon (University Hospital of Lyon), Lyon, France|Chu Montpellier, Montpellier, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|CH Niort, Niort, France|Hopital Paris Saint Joseph, Paris, France|Hopital Saint Antoine, Paris, France|Hôpital Bichat, Paris, France|Hôpital Lariboisière, Paris, France|CHU de Poitiers, Poitiers, France|CH Reims, Reims, France|Ch Remiremont, Remiremont, France|Chu Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de St Etienne, Saint Etienne, France|CH de Saint-Brieuc, Saint-Brieuc, France|Ch Troyes, Troyes, France|CH VICHY, Vichy, France|CH Princesse Grace, Monaco, Monaco",https://ClinicalTrials.gov/show/NCT04338841
Principal Investigator,Delphine Douillet,UH Angers,,NCT04349163,delphine douillet,delphine,female,0.98,34395,2237,NCT04349163,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.,Recruiting,No Results Available,Psychological,Other: Questionnaire,"April 16, 2020","CHU, Angers, France",https://ClinicalTrials.gov/show/NCT04349163
Principal Investigator,"Annapoorna Kini, MD",Icahn School of Medicine at Mount Sinai,,NCT04397939,annapoorna kini,annapoorna,female,1.0,5,1363,NCT04397939,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,Recruiting,No Results Available,COVID-19|Myocardial Reperfusion Injury|Cardiovascular Diseases,,"May 21, 2020","Mount Sinai Hospital, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04397939
Principal Investigator,"Alessandra Del Felice, MD, PhD",University of Padova,,NCT04381338,alessandra del felice,alessandra,female,0.99,47882,1365,NCT04381338,Rehabilitation for People With COVID-19 in ICU,Not yet recruiting,No Results Available,Corona Virus Disease 19 (COVID-19)|COVID|Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)|Critical Illness,Other: Pulmonary and Motor Rehabilitation,"May 8, 2020","Teaching Hospital, University of Padova, Padova, Italy|Teaching Hospital, University of Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04381338
Study Director,"Lauren Vitalie, BA",Soniphi LLC,,NCT04418544,lauren vitalie,lauren,female,0.9,8924,1368,NCT04418544,Vocal Feature Analysis Algorithm,Recruiting,No Results Available,COVID-19,Device: Device used to record voice for screening,"June 5, 2020","Soniphi, Sebastopol, California, United States",https://ClinicalTrials.gov/show/NCT04418544
Principal Investigator,"Lauren E Wisk, PhD","Division of General Internal Medicine & Health Services Research, UCLA",,NCT04373135,lauren e wisk,lauren,female,0.9,8924,1792,NCT04373135,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Recruiting,No Results Available,Covid-19|Critical Illness|Attitude of Health Personnel|Attitude to Health|Health Behavior|Health Care Utilization,Behavioral: Brief educational video,"May 4, 2020","University of California, Los Angeles, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04373135
Principal Investigator,"Russell G Buhr, MD, PhD","Division of Pulmonary & Critical Care Medicine, UCLA",,NCT04373135,russell g buhr,russell,male,0.98,5609,1792,NCT04373135,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Recruiting,No Results Available,Covid-19|Critical Illness|Attitude of Health Personnel|Attitude to Health|Health Behavior|Health Care Utilization,Behavioral: Brief educational video,"May 4, 2020","University of California, Los Angeles, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04373135
Principal Investigator,"Gerry Gin Wai Kwok, MBBS","Queen Mary Hospital, Hong Kong",,NCT04356508,gerry gin wai kwok,gerry,male,0.93,8208,1372,NCT04356508,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Not yet recruiting,No Results Available,"COVID-19|SARS-CoV-2|2019-nCoV|Pneumonia, Viral",Drug: Nivolumab,"April 22, 2020",,https://ClinicalTrials.gov/show/NCT04356508
Principal Investigator,"Katalin Burián, MD","University of Szeged, Institute of Clinical Microbilogy",,NCT04429620,katalin burián,katalin,female,0.98,12213,1375,NCT04429620,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,Recruiting,No Results Available,Sars-CoV2,Diagnostic Test: Immunfluorescence,"June 12, 2020","University of Szeged, Albert Szent-Györgyi Health Center, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04429620
Study Director,"Shoaib Ashraf, PhD","Massachusetts General Hospital, Harvard Medical School, USA",,NCT04347382,shoaib ashraf,shoaib,male,0.99,1484,1378,NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,Recruiting,No Results Available,Coronavirus Infection|Sars-CoV2,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,"April 15, 2020","Kingedward Medical University, Mayo Hospital, Lahore, Punjab, Pakistan|Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04347382
Study Chair,"Muhammad Ashraf, DVM, PhD","University Of Veterinary & Animal Sciences, Lahore",,NCT04347382,muhammad ashraf,muhammad,male,0.99,32597,1378,NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,Recruiting,No Results Available,Coronavirus Infection|Sars-CoV2,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,"April 15, 2020","Kingedward Medical University, Mayo Hospital, Lahore, Punjab, Pakistan|Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04347382
Principal Investigator,"Muhammad Ahmad Imran, MBBS","Shaikh Zayed Hospital, Lahore",,NCT04347382,muhammad ahmad imran,muhammad,male,0.99,32597,1378,NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,Recruiting,No Results Available,Coronavirus Infection|Sars-CoV2,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,"April 15, 2020","Kingedward Medical University, Mayo Hospital, Lahore, Punjab, Pakistan|Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04347382
Principal Investigator,"Sohaib Ashraf, MBBS","Federal Post-Graduate Medical Institute, Lahore",,NCT04347382,sohaib ashraf,sohaib,male,0.99,913,1378,NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,Recruiting,No Results Available,Coronavirus Infection|Sars-CoV2,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,"April 15, 2020","Kingedward Medical University, Mayo Hospital, Lahore, Punjab, Pakistan|Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04347382
Principal Investigator,"Ayesha Hamayun, MBBS, PhD","Shaikh Khalifa Bin Zayed Al-Nahyan Medical & Dental College, Lahore",,NCT04347382,ayesha hamayun,ayesha,female,0.97,1619,1378,NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,Recruiting,No Results Available,Coronavirus Infection|Sars-CoV2,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,"April 15, 2020","Kingedward Medical University, Mayo Hospital, Lahore, Punjab, Pakistan|Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04347382
Study Director,"Hunter Gilles, MD",Bellerophon Pulse Technologies,,NCT04421508,hunter gilles,hunter,male,0.96,2375,1381,NCT04421508,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,Not yet recruiting,No Results Available,COVID-19|Coronavirus|Coronavirus Infection,Combination Product: INOpulse|Combination Product: Placebo,"June 9, 2020","Houston Methodist, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04421508
Study Director,"Hunter Gilles, MD",Acting Chief Medical Officer,,NCT04358588,hunter gilles,hunter,male,0.96,2375,1386,NCT04358588,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,No longer available,No Results Available,"Coronavirus Infection|COVID-19|Pneumonia, Viral",Drug: iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System,"April 24, 2020",,https://ClinicalTrials.gov/show/NCT04358588
Principal Investigator,"Hunter Hoffman, Ph.D.",University of Washington,,NCT04360850,hunter hoffman,hunter,male,0.96,2375,2100,NCT04360850,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Recruiting,No Results Available,Online Therapy,Behavioral: online survey,"April 24, 2020","University of Washington, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04360850
Study Director,"Geert Meyfroidt, MD, PhD",UZ Leuven,,NCT04429854,geert meyfroidt,geert,male,0.99,5138,1382,NCT04429854,Donated Antibodies Working Against nCoV,Recruiting,No Results Available,COVID-19,Biological: Convalescent Plasma|Drug: Standard of care,"June 12, 2020","ZNA, Antwerpen, Belgium|Institut Bordet, Brussel, Belgium|UMC Sint-Pieter, Brussel, Belgium|CHU Brugmann, Brussel, Belgium|Erasmus Ziekenhuis, Brussel, Belgium|UZ Brussel, Brussel, Belgium|Cliniques Universitaires St Luc, Brussel, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven, Leuven, Belgium|CHC Liège Mont Légia, Liège, Belgium|CHR Citadelle Liège, Liège, Belgium|CHU Liège Sart-Tilman, Liège, Belgium|CHR Jolimont Mons-Hainaut, Mons, Belgium|AZ Delta, Roeselare, Belgium",https://ClinicalTrials.gov/show/NCT04429854
Principal Investigator,Béatrice RIU-POULENC,"University Hospital, Toulouse",,NCT04372680,béatrice riu-poulenc,béatrice,female,0.98,80,1385,NCT04372680,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Recruiting,No Results Available,"COVID-19|ARDS, Human|Mechanical Ventilation",Diagnostic Test: CTUS examination,"May 4, 2020","CHU de LIMOGES, Limoges, France|CHU de TOULOUSE, Toulouse, France",https://ClinicalTrials.gov/show/NCT04372680
Principal Investigator,"Manel Algara, MD, PhD",Hospital del Mar,,NCT04380818,manel algara,manel,male,0.61,10628,1776,NCT04380818,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Recruiting,No Results Available,"Pneumonia, Viral",Radiation: Low-dose radiotherapy|Drug: Hydroxychloroquine Sulfate|Drug: Ritonavir/lopinavir|Drug: Tocilizumab Injection [Actemra]|Drug: Azithromycin|Drug: Corticosteroid|Drug: Low molecular weight heparin|Device: Oxygen supply,"May 8, 2020","Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04380818
Principal Investigator,"Angel Montero, MD, PhD",Hospital Universitario Madrid Sanchinarro,,NCT04380818,angel montero,angel,male,0.68,105060,1776,NCT04380818,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Recruiting,No Results Available,"Pneumonia, Viral",Radiation: Low-dose radiotherapy|Drug: Hydroxychloroquine Sulfate|Drug: Ritonavir/lopinavir|Drug: Tocilizumab Injection [Actemra]|Drug: Azithromycin|Drug: Corticosteroid|Drug: Low molecular weight heparin|Device: Oxygen supply,"May 8, 2020","Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04380818
Principal Investigator,"Aymeric LE NEINDRE, PT, PhD",Hôpital Forcilles,,NCT04373811,aymeric le neindre,aymeric,male,0.99,3762,1396,NCT04373811,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,Recruiting,No Results Available,COVID-19|ICU Acquired Weakness|Weaning Failure,Diagnostic Test: Lung ultrasound|Diagnostic Test: Muscle ultrasound,"May 4, 2020","Centre Hospitalier de Béthune, Beuvry, Hauts-de-France, France|APHP - Hôpital Universitaire Pitié-Salpétrière, Paris, Ile De France, France|Hôpital Forcilles, Férolles-Attilly, Ile-de-France, France",https://ClinicalTrials.gov/show/NCT04373811
Study Director,Hope Pharmaceuticals Medical Director,Hope Pharmaceuticals,,NCT04401527,hope pharmaceuticals medical director,hope,female,0.69,3238,1398,NCT04401527,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,Not yet recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Acute Respiratory Failure,Drug: Sodium Nitrite|Drug: Normal Saline,"May 26, 2020",,https://ClinicalTrials.gov/show/NCT04401527
Principal Investigator,Veronique Michaud,Tabula Rasa HealthCare,,NCT04378881,veronique michaud,veronique,female,0.99,25006,1402,NCT04378881,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,Not yet recruiting,No Results Available,COVID|Drug Effect|Drug Interaction|Adverse Drug Event,,"May 7, 2020",,https://ClinicalTrials.gov/show/NCT04378881
Principal Investigator,"Veronique Michaud, PhD",Tabula Rasa HealthCare,,NCT04339634,veronique michaud,veronique,female,0.99,25006,1451,NCT04339634,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,"Active, not recruiting",No Results Available,COVID|Drug Effect|Drug Interaction|Adverse Drug Event,Other: Simulation of Repurposed Drugs for COVID-19,"April 9, 2020","Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida, United States",https://ClinicalTrials.gov/show/NCT04339634
Principal Investigator,Veronique Michaud,Tabula Rasa HealthCare,,NCT04432350,veronique michaud,veronique,female,0.99,25006,1555,NCT04432350,Assessment of Mortality Rates in SARS-CoV-2 Infected Populations Treated With Repurposed Medications,Not yet recruiting,No Results Available,COVID|Drug Effect|Drug Interaction|Risk Reduction,,"June 16, 2020",,https://ClinicalTrials.gov/show/NCT04432350
Principal Investigator,"Yupin Suputtamongkol, MD","Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University",,NCT04435587,yupin suputtamongkol,yupin,female,0.96,136,1403,NCT04435587,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Not yet recruiting,No Results Available,Asymptomatic Infections|SARS-CoV2 Infection,Drug: Ivermectin Pill|Drug: Combined ART/hydroxychloroquine,"June 17, 2020","Siriraj Hospital, Bangkok Noi, Bangkok, Thailand",https://ClinicalTrials.gov/show/NCT04435587
Principal Investigator,"Andrzej Januszewicz, MD, PhD",National Institute of Cardiology,,NCT04374110,andrzej januszewicz,andrzej,male,0.99,40041,1415,NCT04374110,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Recruiting,No Results Available,COVID|Hypertension|Cardiovascular Diseases|Cardiovascular Risk Factor,Other: Clinical data,"May 5, 2020","National Institute of Cardiology, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04374110
Principal Investigator,"Tomasz Hryniewiecki, MD, PhD",National Institute of Cardiology,,NCT04374110,tomasz hryniewiecki,tomasz,male,1.0,61026,1415,NCT04374110,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Recruiting,No Results Available,COVID|Hypertension|Cardiovascular Diseases|Cardiovascular Risk Factor,Other: Clinical data,"May 5, 2020","National Institute of Cardiology, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04374110
Principal Investigator,"Rafal Dabrowski, MD, PhD",National Institute of Cardiology,,NCT04374110,rafal dabrowski,rafal,male,0.99,10767,1415,NCT04374110,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Recruiting,No Results Available,COVID|Hypertension|Cardiovascular Diseases|Cardiovascular Risk Factor,Other: Clinical data,"May 5, 2020","National Institute of Cardiology, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04374110
Study Chair,Will Hahn,Fred Hutch,,NCT04431414,will hahn,will,male,0.97,15251,1426,NCT04431414,A Study of Immune Responses to the Virus That Causes COVID-19,Recruiting,No Results Available,SARS-CoV-2|COVID-19,Other: Sample collection,"June 16, 2020","Alabama CRS, Birmingham, Alabama, United States|Bridge HIV CRS, San Francisco, California, United States|University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS, Miami, Florida, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health (FH) CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Cincinnati Clinical Research Site, Cincinnati, Ohio, United States|Case CRS, Cleveland, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Vanderbilt Vaccine (VV) CRS, Nashville, Tennessee, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Fundacion Huesped CRS, Buenos Aires, Argentina|Hospital General de Agudos JM Ramos Mejía CRS, Buenos Aires, Argentina|Caici Crs, Rosario, Argentina|Gaborone CRS, Gaborone, Botswana|SOM Federal University Minas Gerais Brazil NICHD CRS, Belo Horizonte, Brazil|Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil|Kisumu Crs, Kisumu, Kenya|Malawi CRS, Lilongwe, Malawi|Merida CoVPN CRS, Merida, Mexico|Mexico City CoVPN CRS, Mexico City, Mexico|Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS, Maputo, Mozambique|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Peru|Asociacion Civil Selva Amazonica (ASCA) CRS, Iquitos, Peru|Barranco CRS, Lima, Peru|San Miguel CRS, Lima, Peru|Via Libre CRS, Lima, Peru|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Ndlovu Research Centre CoVPN CRS, Elandsdoorn, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|MeCRU CRS, Medunsa, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CoVPN CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS, Mbeya, Tanzania|Matero Reference Clinic CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Lusaka CoVPN CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Ndola CoVPN CRS, Ndola, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Milton Park CRS, Harare, Zimbabwe|Seke South CRS, Harare, Zimbabwe",https://ClinicalTrials.gov/show/NCT04431414
Principal Investigator,Denis DOYEN,CHU de NICE - Archet 1,,NCT04335162,denis doyen,denis,male,0.96,57303,1737,NCT04335162,Cardiovascular Complications and COVID-19 (CovCardioVasc),Recruiting,No Results Available,COVID|Acute Coronary Syndrome|Myocardial Infarction|Myocarditis|Venous Thromboembolism|Deep Vein Thrombosis|Pulmonary Embolism,,"April 6, 2020","Centre Hospitalier de Cannes, Cannes, France|Centre Hospitalier de Draguignan, Draguignan, France|Centre Hospitalier de Grasse, Grasse, France|CHU de Nice, Nice, France|Hôpitaux Universitaires Paris Centre - Hôpital Cochin, Paris, France",https://ClinicalTrials.gov/show/NCT04335162
Study Director,"Sophie CAILLARD, MD, PhD",Service de Néphrologie et Transplantation,,NCT04360707,sophie caillard,sophie,female,0.98,87796,1430,NCT04360707,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,Recruiting,No Results Available,SARS-CoV-2,,"April 24, 2020","Service de Néphrologie et Transplantation, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04360707
Study Director,"Mehmet K Kanburoglu, M.D.","Head of Pediatrics and Neonatology, Associate Professor",,NCT04401540,mehmet k kanburoglu,mehmet,male,0.97,228228,1434,NCT04401540,Characteristics of Neonatal Covid-19 in Turkey,Recruiting,No Results Available,COVID-19|Neonatal Disease|Healthy,,"May 26, 2020","Recep Tayyip Erdogan University Medical School, Rize, Turkey",https://ClinicalTrials.gov/show/NCT04401540
Principal Investigator,"Nadir Kharma, MD",Hamad Medical Corporation,,NCT04445246,nadir kharma,nadir,male,0.96,9370,1435,NCT04445246,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Recruiting,No Results Available,"COVID-19|ARDS, Human|Hypoxemic Respiratory Failure",Drug: Inhaled ILOPROST,"June 24, 2020","Hamad Medical Corporation, Doha, Qatar",https://ClinicalTrials.gov/show/NCT04445246
Principal Investigator,"Camillo Ricordi, MD",University of Miami,,NCT04355728,camillo ricordi,camillo,male,0.99,1790,1448,NCT04355728,Use of UC-MSCs for COVID-19 Patients,Recruiting,No Results Available,"Corona Virus Infection|ARDS|ARDS, Human|Acute Respiratory Distress Syndrome|COVID-19",Biological: Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Other: Vehicle + Heparin along with best supportive care,"April 21, 2020","Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04355728
Principal Investigator,"Victoria Leavitt, PhD",Columbia University,,NCT04379661,victoria leavitt,victoria,female,0.98,35658,1452,NCT04379661,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Recruiting,No Results Available,MS (Multiple Sclerosis)|COVID-19|Support Groups,Behavioral: Online support Group,"May 7, 2020","Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04379661
Principal Investigator,"Yoojin Lee, M.D.",Keimyung University Dongsan Medical Center,,NCT04387279,yoojin lee,yoojin,female,0.86,166,1453,NCT04387279,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,Recruiting,No Results Available,"COVID-19|Perception, Self|Facilities and Services Utilization",Other: Interview,"May 13, 2020","KeimyungUniversity, Daegu, Jung-gu, Korea, Republic of",https://ClinicalTrials.gov/show/NCT04387279
Principal Investigator,"Silvio Brugger, SB",USZ,,NCT04410263,silvio brugger,silvio,male,0.99,14558,1700,NCT04410263,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,Recruiting,No Results Available,Corona Virus Infection|ARDS|Coinfection,"Diagnostic Test: Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)","June 1, 2020","University Hospital Zurich, Zürich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04410263
Study Chair,"Philipp K Buehler, PB",USZ,,NCT04410263,philipp k buehler,philipp,male,1.0,18479,1700,NCT04410263,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,Recruiting,No Results Available,Corona Virus Infection|ARDS|Coinfection,"Diagnostic Test: Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)","June 1, 2020","University Hospital Zurich, Zürich, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04410263
Principal Investigator,"Alma M Perez, MD",Centro de Investigación Farmacéutica Especializada de Occidente S.C.,,NCT04407507,alma m perez,alma,female,0.95,9312,1461,NCT04407507,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Not yet recruiting,No Results Available,COVID-19,Drug: Ivermectin|Drug: Placebo,"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04407507
Principal Investigator,"Mila B Ortigoza, MD, PhD",NYU Langone Health,,NCT04364737,mila b ortigoza,mila,female,0.95,12989,1463,NCT04364737,Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,Recruiting,No Results Available,COVID-19|Coronavirus|Coronavirus Infection,Biological: Convalescent Plasma|Other: Saline solution,"April 28, 2020","Yale University School of Medicine, New Haven, Connecticut, United States|Montefiore Medical Center, Bronx, New York, United States|NYU Langone Health, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04364737
Study Director,"Quintus Ngumah, OD, PhD",PTC Therapeutics,,NCT04439071,quintus ngumah,quintus,male,0.96,121,1467,NCT04439071,A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),Not yet recruiting,No Results Available,Pneumonia|COVID-19|Coronavirus,Drug: PTC299|Other: SOC|Drug: Placebo,"June 19, 2020","Augusta University, Augusta, Georgia, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04439071
Principal Investigator,"András Lovas, MD PhD",SZTE AITI,,NCT04360837,andrás lovas,andrás,male,0.99,965,1468,NCT04360837,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Recruiting,No Results Available,COVID-19|Virus; Pneumonia|Atelectasis,Procedure: alveolar recruitment,"April 24, 2020","University of Szeged, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04360837
Principal Investigator,"Saira Burney, FRCP (Edin)",SIMS,,NCT04370015,saira burney,saira,female,0.98,862,1471,NCT04370015,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Not yet recruiting,No Results Available,SARS-CoV-2|Healthcare Workers,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"April 30, 2020",,https://ClinicalTrials.gov/show/NCT04370015
Principal Investigator,"Gwenaelle Jacq, RN",CH Versailles,,NCT04402229,gwenaelle jacq,gwenaelle,female,0.98,2961,1473,NCT04402229,Psychological Impact of the Covid-19 Pandemic on Student Nurses,Recruiting,No Results Available,Nurse|Student|Post Traumatic Stress Disorder|COVID-19,,"May 26, 2020","Versailles hospital, Le Chesnay, France|Toulouse University Hospital, Toulouse, France",https://ClinicalTrials.gov/show/NCT04402229
Principal Investigator,"Gwenaelle GRAVIS, MD",Institut Paoli-Calmettes,,NCT04401046,gwenaelle gravis,gwenaelle,female,0.98,2961,1883,NCT04401046,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Not yet recruiting,No Results Available,Cancer,Other: Survey to assess Post traumatic stress and anxiety at inclusion and 6 months later,"May 26, 2020",,https://ClinicalTrials.gov/show/NCT04401046
Principal Investigator,"Frank H Lau, MD",LSUHSC-NO,,NCT04363840,frank h lau,frank,male,0.99,82391,1474,NCT04363840,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Not yet recruiting,No Results Available,COVID|Vitamin D Deficiency|Coagulopathy|Disseminated Intravascular Coagulation,Drug: Aspirin 81 mg|Dietary Supplement: Vitamin D,"April 27, 2020",,https://ClinicalTrials.gov/show/NCT04363840
Study Director,"Moustapha DRAME, PHD",Unversity hospital of Martinique,,NCT04414319,moustapha drame,moustapha,male,0.98,5556,1475,NCT04414319,Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly,Recruiting,No Results Available,SARS-CoV 2,,"June 4, 2020","University hospital of Rennes, Rennes, France|Va de Lys-Ramsay Gds group Clinic, Tourcoing, France|Hopsital of Valenciennes, Valenciennes, France|University hospital of Guadeloupe, Les Abymes, Guadeloupe|University hospital of Martinique, Fort-de-France, Martinique",https://ClinicalTrials.gov/show/NCT04414319
Study Chair,Amato De Monte,"Presidio Ospedaliero Universitario ""Santa Maria della Misericordia"", Udine - Italy",,NCT04388514,amato de monte,amato,male,0.79,363,1476,NCT04388514,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure,Recruiting,No Results Available,SARS-CoV-2 Respiratory Failure,Procedure: Medical Ozone procedure,"May 14, 2020","Dott. Amato De Monte, Udine, Italy",https://ClinicalTrials.gov/show/NCT04388514
Principal Investigator,"Courtney Rowan, MD",Indiana University,,NCT04334876,courtney rowan,courtney,female,0.79,1805,1479,NCT04334876,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,Not yet recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: SARS-CoV-2 IgG Antibody Testing Kit,"April 6, 2020",,https://ClinicalTrials.gov/show/NCT04334876
Principal Investigator,"Arya Mani, MD",Yale University,,NCT04435015,arya mani,arya,male,0.74,1629,1481,NCT04435015,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,Not yet recruiting,No Results Available,Coagulopathy|Cardiovascular Complication|COVID-19,"Drug: Camostat Mesylate|Drug: Microcrystalline Cellulose, NF","June 17, 2020",,https://ClinicalTrials.gov/show/NCT04435015
Study Chair,"XIAN SHEN, phd",The 2nd Affiliated Hospital of Wenzhou Medical University,,NCT04273763,xian shen,xian,male,0.67,507,1487,NCT04273763,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),"Active, not recruiting",No Results Available,Novel Coronavirus Pneumonia|2019-nCoV,Drug: Bromhexine Hydrochloride Tablets|Drug: Arbidol Hydrochloride Granules|Drug: Recombinant Human Interferon α2b Spray,"February 18, 2020","The Second AffIliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04273763
Principal Investigator,"REYNES Jacques, PU PH",Montpellier Hospital,,NCT04337424,reynes jacques,reynes,male,0.67,12,1489,NCT04337424,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2,Recruiting,No Results Available,SARS-CoV-2,Diagnostic Test: Sampling salivary,"April 7, 2020","UCH Montpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04337424
Principal Investigator,"Ane Fisker, MD, PhD",Bandim Health Project,,NCT04445428,ane fisker,ane,female,0.86,2916,1492,NCT04445428,OPV as Potential Protection Against COVID,Not yet recruiting,No Results Available,"Poliovirus Vaccine, Oral|COVID|Mortality|Morbidity|Non-Specific Effects of Vaccines",Biological: oral polio vaccine + information|Behavioral: Information,"June 24, 2020","Bandim Health Project, Bissau, Guinea-Bissau",https://ClinicalTrials.gov/show/NCT04445428
Principal Investigator,"Karsten Becker, Prof.Dr.",University Medicine Greifswald,,NCT04370119,karsten becker,karsten,male,0.99,5789,1493,NCT04370119,Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,Recruiting,No Results Available,SARS-Cov-2,Diagnostic Test: Nasal swab|Diagnostic Test: Serum testing,"April 30, 2020","Greifswald University Medicine, Greifswald, Germany",https://ClinicalTrials.gov/show/NCT04370119
Principal Investigator,"Frauke Vanden Meerschaut, MD","University Hospital, Ghent",,NCT04396210,frauke vanden meerschaut,frauke,female,0.96,1141,1500,NCT04396210,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,Recruiting,No Results Available,Coronavirus|COVID|ART|Fertility Issues,Other: Questionnaire,"May 20, 2020","Ghent University Hospital, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04396210
Principal Investigator,"Sant P Chawla, MD",Mission Community Hospital,,NCT04378244,sant p chawla,sant,male,0.88,326,1502,NCT04378244,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Not yet recruiting,No Results Available,COVID-19|Cytokine Storm|Acute Respiratory Distress Syndrome,Drug: DeltaRex-G,"May 7, 2020",,https://ClinicalTrials.gov/show/NCT04378244
Principal Investigator,"Ingrid Oakley-Girvan, PhD",Medable Inc.,,NCT04363268,ingrid oakley-girvan,ingrid,female,0.98,26843,1507,NCT04363268,ACCESS A Master Digital Surveillance Protocol for COVID-19,Recruiting,No Results Available,Coronavirus|COVID|COVID-19|COVID19|Corona Virus Infection|Coronavirus Infection,,"April 27, 2020","Medable Inc., Palo Alto, California, United States",https://ClinicalTrials.gov/show/NCT04363268
Study Director,Rubi Zomer,MGC Pharmaceuticals,,NCT04382040,rubi zomer,rubi,female,0.84,2599,1509,NCT04382040,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Recruiting,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV 2|Coronavirus|Coronavirus Infection,Drug: ArtemiC|Drug: Placebo,"May 11, 2020","Hillel Yaffe Medical Center, Hadera, Haifa, Israel|Nazareth Hospital EMMS, Nazareth, North, Israel|Rambam Health Care Campus, Haifa, Israel",https://ClinicalTrials.gov/show/NCT04382040
Principal Investigator,Prof Nigel Curtis,Murdoch Children's Research Institute,,NCT04327206,nigel curtis,nigel,male,0.99,5537,1511,NCT04327206,BCG Vaccination to Protect Healthcare Workers Against COVID-19,Recruiting,No Results Available,Coronavirus Disease 2019 (COVID-19)|Respiratory Illness|Corona Virus Infection|COVID-19,Drug: BCG Vaccine|Drug: 0.9%NaCl,"March 31, 2020","St Vincent's Hospital, Sydney, Sydney, New South Wales, Australia|Prince of Wales Hospital, Sydney, New South Wales, Australia|Sydney Children's Hospital, Randwick, Sydney, New South Wales, Australia|The Children's Hospital at Westmead, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia|Women's and Children's Hospital, North Adelaide, South Australia, Australia|Epworth Victoria Parade, Melbourne, Victoria, Australia|Royal Children's Hospital, Melbourne, Victoria, Australia|Epworth Richmond, Melbourne, Victoria, Australia|Epworth Eastern, Melbourne, Victoria, Australia|Monash Health- Monash Medical Centre, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia",https://ClinicalTrials.gov/show/NCT04327206
Principal Investigator,"Sabine Hazan, MD",ProgenaBiome,,NCT04334512,sabine hazan,sabine,female,0.98,43397,1512,NCT04334512,A Study of Quintuple Therapy to Treat COVID-19 Infection,Not yet recruiting,No Results Available,COVID-19|Corona Virus Infection|Coronavirus-19|Sars-CoV2,Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,"April 6, 2020","ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04334512
Principal Investigator,"Sabine Hazan, MD",ProgenaBiome,,NCT04359836,sabine hazan,sabine,female,0.98,43397,1569,NCT04359836,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Recruiting,No Results Available,Gut Microbiome|Gastrointestinal Microbiome|COVID|COVID-19|Corona Virus Infection|Coronavirus|Coronaviridae Infections|Coronavirus 19|Coronavirus-19|COVID 19,Other: There is no intervention in this study,"April 24, 2020","ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04359836
Principal Investigator,"Sabine Hazan, MD",ProgenaBiome,,NCT04395716,sabine hazan,sabine,female,0.98,43397,1655,NCT04395716,A Study of ResCure™ to Treat COVID-19 Infection,Not yet recruiting,No Results Available,COVID|Covid-19|Corona Virus Infection|Sars-CoV2|Coronavirus-19|SARS Pneumonia|SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Biological: ResCure™,"May 20, 2020","ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04395716
Principal Investigator,"Sabine Hazan, MD",ProgenaBiome,,NCT04335084,sabine hazan,sabine,female,0.98,43397,1687,NCT04335084,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Not yet recruiting,No Results Available,COVID-19|Coronavirus Infection|Sars-CoV2|Corona Virus Infection|COVID|Coronavirus|Coronavirus-19|Coronavirus 19,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,"April 6, 2020","ProgenaBiome, Ventura, California, United States",https://ClinicalTrials.gov/show/NCT04335084
Principal Investigator,"Ruanne V. Barnabas, MBChB, DPhil",University of Washington,,NCT04328961,ruanne v. barnabas,ruanne,female,1.0,3,1517,NCT04328961,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),Recruiting,No Results Available,COVID-19|Corona Virus Infection|SARS (Severe Acute Respiratory Syndrome)|SARS-CoV-2,Drug: Hydroxychloroquine Sulfate|Drug: Ascorbic Acid,"April 1, 2020","University of California Los Angeles, Los Angeles, California, United States|Tulane, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Baltimore, Maryland, United States|Boston University, Boston, Massachusetts, United States|NYU Langone Health, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington, Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04328961
Principal Investigator,"Apostolos Armaganidis, MD, PhD","National Kapodistrian University of Athens, Medical School",,NCT04339712,apostolos armaganidis,apostolos,male,0.99,1017,1521,NCT04339712,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Recruiting,No Results Available,COVID-19|Virus Diseases|Macrophage Activation Syndrome|Corona Virus Infection,Drug: Anakinra|Drug: Tocilizumab,"April 9, 2020","2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece|Intensive Care Unit, Ioannina University Hospital, Ioánnina, Ioannina, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Rion, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece|Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens, Greece|4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece|Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens, Greece|Intensive Care Unit, ""Latsio"", Thriasio Elefsis General Hospital, Elefsína, Greece|Intensive Care Unit, ""Koutlimbaneio & Triantafylleio"" Larissa General Hospital, Larissa, Greece|Department of Internal Medicine, Larissa University Hospital, Larissa, Greece|Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, General Hospital of Thessaloniki IPPOKRATEIO, Thessaloniki, Greece|Department of Anesthesiology and Intensive Care Medicine, University General Hospital of Thessaloniki AHEPA, Thessaloniki, Greece",https://ClinicalTrials.gov/show/NCT04339712
Principal Investigator,Reinoud Cartuyvels,"Jessa Hospital, Hasselt, Belgium",,NCT04361448,reinoud cartuyvels,reinoud,male,1.0,62,1522,NCT04361448,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Not yet recruiting,No Results Available,Covid-19|SARS-CoV-2|Diagnosis|Polymerase Chain Reaction,Other: samling of oropharynx and nasopharynx,"April 24, 2020","Jessa Hospital, Hasselt, Belgium",https://ClinicalTrials.gov/show/NCT04361448
Principal Investigator,"Magdalena Sobieszczyk, MD, MPH",Columbia University Irving Medical Center,,NCT04367857,magdalena sobieszczyk,magdalena,female,0.98,74013,1526,NCT04367857,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Recruiting,No Results Available,Covid-19|Coronavirus Infection|Coronavirus,Other: COVID-19 Serology|Behavioral: Health Care Worker Survey,"April 29, 2020","NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04367857
Principal Investigator,"Magdalena Salcedo, MD PhD",Liver Transplantation Unit,,NCT04410471,magdalena salcedo,magdalena,female,0.98,74013,1643,NCT04410471,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,Recruiting,No Results Available,Liver Transplant Infection|Covid19|Mortality|Immune Response,Diagnostic Test: CLIA of IgG and IgM against SARS-Cov-2,"June 1, 2020","Victor Fernandez Alonso, Madrid, Spain|Victor Fernández Alonso, Madrid, Spain",https://ClinicalTrials.gov/show/NCT04410471
Principal Investigator,"Gianluca Iacobellis, MD PhD",University of Miami,,NCT04341935,gianluca iacobellis,gianluca,male,0.99,41833,1808,NCT04341935,Effects of DPP4 Inhibition on COVID-19,Not yet recruiting,No Results Available,Coronavirus Infection|Type 2 Diabetes,Drug: Linagliptin|Drug: Insulin regimen,"April 10, 2020","University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04341935
Principal Investigator,"Bjorn Meijers, MD, PhD",UZ Leuven,,NCT04378686,bjorn meijers,bjorn,male,0.99,5027,1532,NCT04378686,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,Recruiting,No Results Available,SARS-CoV 2|End Stage Renal Failure on Dialysis,Other: dialysis,"May 7, 2020","Jessa Ziekenhuis, Hasselt, Limburg, Belgium|University Hospitals Leuven, Leuven, Belgium",https://ClinicalTrials.gov/show/NCT04378686
Study Director,"Françoise LAZARINI, PhD",Institut Pasteur,,NCT04366934,françoise lazarini,françoise,female,0.98,1015,1539,NCT04366934,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Recruiting,No Results Available,Coronavirus Infection|Severe Acute Respiratory Syndrome|Sars-CoV2,Other: Nasal swab|Other: Taste and olfactory function evaluation,"April 29, 2020","Hôpital Lariboisière, Policlinique, Paris, France|Hôpital Lariboisière, Service ORL, Paris, France",https://ClinicalTrials.gov/show/NCT04366934
Principal Investigator,"Stephane LEGRIEL, MD, PhD",Ictal Group,,NCT04320472,stephane legriel,stephane,male,0.99,59726,1541,NCT04320472,Acute Encephalopathy in Critically Ill Patients With COVID-19,Recruiting,No Results Available,COVID-19|Encephalopathy|Critically Ill,Other: Follow up,"March 25, 2020","Jackson Memorial Health System; University of Miami, Miller School of Medicine, Miami, Florida, United States|Wellstar Atlanta Medical Center, Atlanta, Georgia, United States|Universidade Federal de São Paulo, São Paulo, Brazil|Fundación Valle del Lili, University Hospital, Cali, Colombia|Centre Hospitalier d'Argenteuil, Argenteuil, France|Centre Hospitalier de Beauvais, Beauvais, France|Centre Hospitalier Universitaire Ambroise Paré, Boulogne, France|Centre Hospitalier de Bourg en Bresse, Bourg-en-Bresse, France|Centre Hospitalier Régional Universitaire de Brest, Brest, France|Centre Hospitalier de Brives, Brive-la-Gaillarde, France|Centre Hospitalier Universitaire Beaujon, Clichy, France|Centre Hospitalier Universitaire Louis Mourier, Colombes, France|Centre Hospitalier Universitaire Henri Mondor, Créteil, France|Centre hospitalier de Dieppe, Dieppe, France|Centre Hospitalier Universitaire de Dijon, Dijon, France|Centre Hospitalier d'Etampes, Etampes, France|Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée, Jossigny, France|Centre Hospitalier de la Roche-sur-Yon, La Roche-sur-Yon, France|Centre Hospitalier de La Rochelle, La Rochelle, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Universitaire de Lille, Lille, France|Centre Hospitalier Universitaire Hôpital Edouard Herriot, Lyon, France|Hôpital privé Jacques Cartier, Massy, France|Groupe Hospitalier Sud Ile-de-France, Melun, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|Centre Hospitalier Régional d'Orléans, Orléans, France|Centre Hospitalier Universitaire Cochin, Paris, France|Groupe hospitalier Paris Saint-Joseph, Paris, France|Hôpital Fondation Adolphe de Rothschild, Paris, France|Hopital Privé Claude Galien, Quincy-sous-Sénart, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Centre Hospitalier de Roanne, Roanne, France|Hopital Foch, Suresnes, France|Centre Hospitalier de Toulon, Toulon, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Tours, Tours, France|Gustave-Roussy, Villejuif, France|Hospital Clinic Universitari, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04320472
Principal Investigator,"Cris Vilaplana, MD, PhD",Fundació Institut Germans Trias i Pujol,,NCT04378452,cris vilaplana,cris,female,0.68,32965,1544,NCT04378452,Assessment of the Psycho-social Impact of COVID-19 Outbreak,Recruiting,No Results Available,SARS-CoV 2|COVID-19|Quality of Life|Mental Health Wellness 1|Social Distance|SARS (Disease)|Psychological,Behavioral: COM-COVID anonimous survey,"May 7, 2020","Fundació Institut Germans Trias i Pujol, Badalona, Catalonia, Spain|Fundació Lluita contra la Sida (FLS, Fight AIDS Foundation), Badalona, Catalonia, Spain|Anaxomics biotech, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04378452
Study Chair,"Siti Sabzah Mohd Hashim, MD MS",Hospital Sultanah Bahiyah,,NCT04384042,siti sabzah mohd hashim,siti,female,0.99,12114,1546,NCT04384042,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,Not yet recruiting,No Results Available,SARS-CoV Infection|COVID-19|Anosmia|Dysgeusia,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,"May 12, 2020","Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia|Hospital Sultan Ismail, Johor Bahru, Johor, Malaysia|Hospital Permai, Johor Bahru, Johor, Malaysia|Hospital Enche' Besar Hajjah Khalsom, Kluang, Johor, Malaysia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia|Hospital Sultanah Maliha, Langkawi, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia|Penang Hospital, George Town, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Tuanku Fauziah, Kangar, Perlis, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia|Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia|Hospital Melaka, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04384042
Study Chair,"Siti Sabzah Mohd Hashim, MD MS",Hospital Sultanah Bahiyah,,NCT04390165,siti sabzah mohd hashim,siti,female,0.99,12114,1547,NCT04390165,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,Not yet recruiting,No Results Available,SARS-CoV Infection|COVID-19|Anosmia|Dysgeusia,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,"May 15, 2020","Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia|Hospital Sultan Ismail, Johor Bahru, Johor, Malaysia|Hospital Permai, Johor Bahru, Johor, Malaysia|Hospital Enche' Besar Hajjah Khalsom, Kluang, Johor, Malaysia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia|Hospital Sultanah Maliha, Langkawi, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia|Penang Hospital, George Town, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Tuanku Fauziah, Kangar, Perlis, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia|Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia|Hospital Melaka, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04390165
Principal Investigator,"Simeon Metallidis, MD, PhD","Aristotle University of Thessaloniki, Medical School",,NCT04357366,simeon metallidis,simeon,male,0.97,1572,1548,NCT04357366,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Recruiting,No Results Available,COVID-19|Virus Diseases|Corona Virus Infection|Lower Respiratory Tract Infection Viral,Drug: Anakinra|Drug: trimethoprim/sulfamethoxazole,"April 22, 2020","COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens, Greece|Department of Infectious Diseases, General Hospital of Kerkira, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, University General Hospital of Larissa, Larissa, Greece|Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Patra, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece",https://ClinicalTrials.gov/show/NCT04357366
Principal Investigator,Fabienne VENET,Hospices Civils de Lyon,,NCT04392401,fabienne venet,fabienne,female,0.98,21920,1553,NCT04392401,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,Recruiting,No Results Available,Intensive Care Unit|SARS-Cov-2,Biological: Collection of blood samples in order to create a biocollection,"May 18, 2020","Hôpital Pierre Wertheimer, Bron, France|Hôpital Gabriel Montpied, Clermont-Ferrand, France|Centre hospitalier universitaire de Grenoble Alpes, Grenoble, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpial de la Croix Rousse, Lyon, France|Hôpital Lyon Sud, Pierre-Bénite, France|CH de St Etienne, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04392401
Principal Investigator,"Gokhan T Adas, Prof.Dr.",SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi,,NCT04392778,gokhan t adas,gokhan,male,0.97,11372,1559,NCT04392778,Clinical Use of Stem Cells for the Treatment of Covid-19,Recruiting,No Results Available,Covid19|Pneumonia|Multiple Organ Failure|Corona Virus Infection,Biological: MSC Treatment|Biological: Saline Control,"May 19, 2020","Istinye University, Istanbul, Turkey|SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04392778
Principal Investigator,"Erdal Karaoz, Prof.Dr.",Istinye University,,NCT04392778,erdal karaoz,erdal,male,0.97,20895,1559,NCT04392778,Clinical Use of Stem Cells for the Treatment of Covid-19,Recruiting,No Results Available,Covid19|Pneumonia|Multiple Organ Failure|Corona Virus Infection,Biological: MSC Treatment|Biological: Saline Control,"May 19, 2020","Istinye University, Istanbul, Turkey|SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04392778
Study Director,"Gokhan T. Adas, Prof",Bakirkoy Dr. Sadi Konuk Research and Training Hospital,,NCT04411563,gokhan t. adas,gokhan,male,0.97,11372,1817,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,"June 2, 2020","Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
Principal Investigator,"Asuman Gedikbasi, Assoc.Prof.",Bakirkoy Dr. Sadi Konuk Research and Training Hospital,,NCT04411563,asuman gedikbasi,asuman,female,0.96,2175,1817,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,"June 2, 2020","Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
Principal Investigator,"Kadriye Yaşar, Prof.",Bakirkoy Dr. Sadi Konuk Research and Training Hospital,,NCT04411563,kadriye yaşar,kadriye,female,0.97,3010,1817,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,"June 2, 2020","Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
Principal Investigator,"Zafer Çukurova, Assoc.Prof.",Bakirkoy Dr. Sadi Konuk Research and Training Hospital,,NCT04411563,zafer çukurova,zafer,male,0.97,18679,1817,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,"June 2, 2020","Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
Principal Investigator,"Oya G. Hergünsel, MD, Intensivist",Bakirkoy Dr. Sadi Konuk Research and Training Hospital,,NCT04411563,oya g. hergünsel,oya,female,0.94,2291,1817,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,"June 2, 2020","Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
Principal Investigator,"Sacide Pehlivan, Prof.",Istanbul University,,NCT04411563,sacide pehlivan,sacide,female,0.98,184,1817,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,Recruiting,No Results Available,Prognosis,Other: Taking biological samples,"June 2, 2020","Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04411563
Study Chair,"Mai-Anh NAY, Dr",CHR Orléans,,NCT04363463,mai-anh nay,mai-anh,female,1.0,4,1563,NCT04363463,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Not yet recruiting,No Results Available,COVID19|Oxygen Therapy|Prone Position|Spontaneous Ventilation|Respiratory Distress Syndrome,Other: prone position,"April 27, 2020","CH de DAX, Dax, France|CHD de VENDEE, La Roche sur Yon, France|CH de LA ROCHELLE, La Rochelle, France|CHR d'Orléans - Service Pneumologie, Orléans, France|CHR d'Orleans - Service Maladies Infectieuses, Orléans, France|HOPITAL LARIBOISIERE - Service diabétologie, endocrinologie, nutrition, Paris, France|Hopital Lariboisiere - Medecine Interne, Paris, France|Hopital Lariboisiere, Paris, France|CH de PERPIGNAN - Service Maladies infectieuses, Perpignan, France|CH de Perpignan - pneumologie, Perpignan, France|Centre Hospitalier Intercommunal de Cornouaille - Quimper Concarneau, Quimper, France|CHRU de Tours - Service Médecine interne et immunologie Clinique, Tours, France|CHRU de Tours - Service Pneumologie, Tours, France|CHRU DE TOURS - Service Médecine interne et maladies infectieuses, Tours, France",https://ClinicalTrials.gov/show/NCT04363463
Study Director,"Kada KLOUCHE, MD PhD",UH Montpellier,,NCT04376905,kada klouche,kada,male,0.91,1084,1564,NCT04376905,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),Recruiting,No Results Available,COVID-19|Pneumonia|Acute Respiratory Distress Syndrome,,"May 6, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04376905
Principal Investigator,"Brian C Davis, MD","Staff Physician, GI Division",,NCT04357782,brian c davis,brian,male,0.99,51483,1565,NCT04357782,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Recruiting,No Results Available,COVID-19|Hypoxia,Drug: L-ascorbic acid,"April 22, 2020","Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04357782
Study Director,"Brian Davis, MD","Hunter Holmes McGuire VA Medical Center - Richmond, VA",,NCT04344184,brian davis,brian,male,0.99,51483,1600,NCT04344184,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Not yet recruiting,No Results Available,"COVID-19|Lung Injury, Acute",Drug: L-ascorbic acid|Other: Placebo,"April 14, 2020","Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04344184
Principal Investigator,"Markos G Kashiouris, MD MPH",Virginia Commonwealth University,,NCT04344184,markos g kashiouris,markos,male,0.98,2718,1600,NCT04344184,Early Infusion of Vitamin C for Treatment of Novel COVID-19 Acute Lung Injury (EVICT-CORONA-ALI),Not yet recruiting,No Results Available,"COVID-19|Lung Injury, Acute",Drug: L-ascorbic acid|Other: Placebo,"April 14, 2020","Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States",https://ClinicalTrials.gov/show/NCT04344184
Principal Investigator,"Brian Kendal, MD",Providence Medical Group Infectious Disease,,NCT04334967,brian kendal,brian,male,0.99,51483,1620,NCT04334967,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Suspended,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C,"April 6, 2020","Portland Providence Medical Center, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04334967
Study Director,"Trista Johnson, PhD, MPH",Providence Ambulatory Quality and Clinical Services,,NCT04334967,trista johnson,trista,female,0.94,190,1620,NCT04334967,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Suspended,No Results Available,COVID-19|Corona Virus Infection|SARS-CoV-2|2019-nCoV|2019 Novel Coronavirus,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C,"April 6, 2020","Portland Providence Medical Center, Portland, Oregon, United States",https://ClinicalTrials.gov/show/NCT04334967
Principal Investigator,"Brian Peppers, DO, PhD",WVU Medicine Children's,,NCT04376034,brian peppers,brian,male,0.99,51483,1906,NCT04376034,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,Recruiting,No Results Available,COVID19|Coronavirus Infection|Coronavirus|Virus Diseases|RNA Virus Infections,Biological: Convalescent Plasma 1 Unit|Biological: Convalescent Plasma 2 Units|Other: Standard of Care,"May 6, 2020","WVU Medicine, Morgantown, West Virginia, United States",https://ClinicalTrials.gov/show/NCT04376034
Principal Investigator,"Brian A Fallon, MD",Columbia University Irving Medical Center,,NCT04386291,brian a fallon,brian,male,0.99,51483,2044,NCT04386291,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Recruiting,No Results Available,Generalized Anxiety|Health Anxiety,Behavioral: Anxiety Reduction Training|Behavioral: Kundalini Yoga and Anxiety Reduction Training|Behavioral: Meditation and Anxiety Reduction Training,"May 13, 2020","ProofPilot (Virtual Study: https://proofpilot.com/covid-anxiety/), New York, New York, United States|Columbia University Department of Psychiatry, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04386291
Principal Investigator,"Jean-Guillaume Letarouilly, MD","University Hospital, Lille",,NCT04426279,jean-guillaume letarouilly,jean-guillaume,male,1.0,69,1566,NCT04426279,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,Not yet recruiting,No Results Available,Sars-CoV2|Rheumatoid Arthritis|Rheumatic Diseases,Other: questionnaire assesment,"June 11, 2020",,https://ClinicalTrials.gov/show/NCT04426279
Principal Investigator,"Antonios Papadopoulos, MD, PhD","National Kapodistrian University of Athens, Medical School",,NCT04414267,antonios papadopoulos,antonios,male,0.99,626,1568,NCT04414267,Bacillus Calmette-guérin Vaccination to Prevent COVID-19,Recruiting,No Results Available,COVID-19|Virus Diseases|Corona Virus Infection|Coronary Heart Disease|Chronic Obstructive Pulmonary Disease,Biological: BCG vaccine|Biological: Placebo,"June 4, 2020","General Hospital of Argolida - Nafplion Unit, Náfplio, Argos, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|4th Department of Internal Medicine, ""Attikon"" University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|General Hospital of Korinthos, Kórinthos, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Greece|General Hospital of Ptolemaida MPODOSAKEIO, Ptolemaḯda, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece|General Hospital of Imathia - Veria Unit, Véria, Greece",https://ClinicalTrials.gov/show/NCT04414267
Principal Investigator,"Irene Lie, PhD",Oslo University Hospital,,NCT04372056,irene lie,irene,female,0.99,50462,1570,NCT04372056,The COVID-ICU Healthcare Professional Study,Recruiting,No Results Available,COVID-19|Critical Care|Intensive Care Units|Health Personnel,Behavioral: Views and experiences of health care professionals working in intensive care units during the COVID-19 pandemic,"May 1, 2020","Oslo university hospital, Oslo, Norway",https://ClinicalTrials.gov/show/NCT04372056
Principal Investigator,"Irene Aprile, MD, PhD",IRCCS Fondazione Don Carlo Gnocchi,,NCT04392453,irene aprile,irene,female,0.99,50462,2157,NCT04392453,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Not yet recruiting,No Results Available,Stroke,Device: Robotic therapy,"May 18, 2020",,https://ClinicalTrials.gov/show/NCT04392453
Principal Investigator,"Irene APRILE, MD,PHD",IRCCS Fondazione Don Carlo Gnocchi,,NCT04408196,irene aprile,irene,female,0.99,50462,2279,NCT04408196,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,Not yet recruiting,No Results Available,Rehabilitation,,"May 29, 2020",,https://ClinicalTrials.gov/show/NCT04408196
Principal Investigator,"Anthony F Suffredini, M.D.",National Institutes of Health Clinical Center (CC),,NCT04401449,anthony f suffredini,anthony,male,0.99,98251,1576,NCT04401449,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,Enrolling by invitation,No Results Available,Acute and Long Term Effects of COVID-19:on Systemic Inflammation|Acute and Long Term Effects of COVID-19 on Lung Function|Acute and Long Term Effects of COVID-19 on Mrain Function|Acute and Long Term Effects of COVID-19 on Cardiac Function|Acute and Long Term Effects of COVID-19 on Kidney Function,,"May 26, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04401449
Principal Investigator,"Anthony Sung, MD",Duke University,,NCT04399252,anthony sung,anthony,male,0.99,98251,1757,NCT04399252,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Not yet recruiting,No Results Available,Microbiome,Dietary Supplement: Lactobaciltus rhamnosus GG|Dietary Supplement: Lactobaciltus rhamnosus GG Placebo,"May 22, 2020","Duke University, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04399252
Study Director,"Anthony Ting, PhD","Athersys, Inc",,NCT04367077,anthony ting,anthony,male,0.99,98251,1771,NCT04367077,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),Recruiting,No Results Available,ARDS,Biological: MultiStem|Biological: Placebo,"April 29, 2020","Athersys Investigational Site 101, Cleveland, Ohio, United States|Athersys Investigational Site 102, Cleveland, Ohio, United States",https://ClinicalTrials.gov/show/NCT04367077
Principal Investigator,"Stephanie Lheureux, M.D.",Princess Margaret Cancer Centre,,NCT04373005,stephanie lheureux,stephanie,female,0.98,68107,1583,NCT04373005,Screening of Cancer Patients to Assess Impact of COVID-19,Not yet recruiting,No Results Available,Covid-19|Cancer,Diagnostic Test: Nasopharyngeal (NP) swab,"May 4, 2020","Princess Margaret Cancer Centre, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04373005
Principal Investigator,"Ozden Ozyemisci Taskiran, Prof",Koc University School of Medicine,,NCT04435080,ozden ozyemisci taskiran,ozden,male,0.51,258,1588,NCT04435080,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,Completed,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Rehabilitation|Intensive Care Unit Acquired Weakness|Critical Illness Polyneuromyopathy,,"June 17, 2020","Koc University School of Medicine, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04435080
Principal Investigator,"Nils Kucher, Prof.",University of Zurich,,NCT04400799,nils kucher,nils,male,0.99,9603,1590,NCT04400799,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Not yet recruiting,No Results Available,"COVID-19|Pulmonary Embolism, Deep Vein Thrombosis",Drug: Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml,"May 26, 2020",,https://ClinicalTrials.gov/show/NCT04400799
Principal Investigator,"Clemence ISAAC, PhD",CH Ville Evrard,,NCT04357418,clemence isaac,clemence,female,0.94,3178,1593,NCT04357418,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,"Active, not recruiting",No Results Available,"Anxiety State|COVID-19|Isolation, Social|Health Personnel Attitude",Other: it is a survey,"April 22, 2020","URC Ville Evrard, Neuilly-sur-Marne, France",https://ClinicalTrials.gov/show/NCT04357418
Study Director,"Dominique JANUEL, Pr",CH Ville Evrard,,NCT04357418,dominique januel,dominique,male,0.57,51398,1593,NCT04357418,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,"Active, not recruiting",No Results Available,"Anxiety State|COVID-19|Isolation, Social|Health Personnel Attitude",Other: it is a survey,"April 22, 2020","URC Ville Evrard, Neuilly-sur-Marne, France",https://ClinicalTrials.gov/show/NCT04357418
Principal Investigator,"Sezen Karakus, MD",Wilmer Eye Institute at Johns Hopkins University,,NCT04374656,sezen karakus,sezen,female,0.93,2475,1596,NCT04374656,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,Recruiting,No Results Available,"Conjunctivitis|SARS-CoV-2|COVID-19|Ocular Infection, Viral|Ocular Inflammation",,"May 5, 2020","Wilmer Eye Institute, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04374656
Principal Investigator,"Prakash Satwani, MD",Columbia University Irving Medical Center,,NCT04445402,prakash satwani,prakash,male,0.99,2377,1598,NCT04445402,Pediatrics HOT COVID-19 Database in NY Tristate,Recruiting,No Results Available,Pediatric Cancer|Immune System Disorder|COVID-19|Hemoglobinopathies,,"June 24, 2020","Connecticut Children's Hospital, Hartford, Connecticut, United States|Yale New Haven Children's Hospital, New Haven, Connecticut, United States|Hackensack Meridian Health, Hackensack, New Jersey, United States|Steven Halpern, Morristown, New Jersey, United States|Archana Sharma, New Brunswick, New Jersey, United States|Mount Sinai Beth Israel, Newark, New Jersey, United States|St. Joseph's Regional Medical Center, New Jersey, Paterson, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Maimondes Medical Center, Brooklyn, New York, United States|Mount Sinai, New York, New York, United States|NYU Langone Health, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Stephen Roberts, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Cohen Children's Northwell Health, Queens, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Westchester Medical Center, Valhalla, New York, United States",https://ClinicalTrials.gov/show/NCT04445402
Principal Investigator,"Lorusso, Prof. Dr.",Maastricht University Hospital,,NCT04366921,lorusso,lorusso,male,0.77,52,1599,NCT04366921,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,Recruiting,No Results Available,"COVID|SARS-CoV-2|ARDS, Human|Refractory Hypoxemia|Cardiogenic Shock|Septic Shock|Extracorporeal Membrane Oxygenation",,"April 29, 2020","Universitätskliniken Innsbruck, Innsbruck, Austria|Landesklinikum Sankt Polten, St.Pölten, Austria|Medical University of Vienna, Vienna, Austria|Onze Lieve Vrouwziekenhuis Aalst, Aalst, Belgium|University Hospital, Antwerp, Antwerp, Belgium|Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium|Chirec, Brussels, Belgium|Erasme University Hospital, Brussel, Belgium|Universitair Ziekenhuis Brussel, Brussel, Belgium|Hôpital Civil Marie Curie de Charleroi, Charleroi, Belgium|University Hospital, Ghent, Ghent, Belgium|La Louvière Hopital, La Louvière, Belgium|Universitaire Ziekenhuizen Leuven, Leuven, Belgium|CHU de Liege, Liège, Belgium|Charles University, Czech Republic, Praha, Czechia|General University Hospital, Prague, Praha, Czechia|Copenhagen University Hospital at Herlev, Copenhagen, Denmark|University Hospital, Bordeaux, Bourdeaux, France|Hospices Civils de Lyon, Lyon, France|University Hospital, Montpellier, Montpellier, France|Henri Mondor University Hospital, Paris, France|Paris South University Hospitals, Paris, France|Pitié-Salpêtrière Hospital, Paris, France|Rennes University Hospital, Rennes, France|University Hospital, Aachen, Aachen, Germany|German Heart Center, Berlin, Germany|Universitätsklinikum Düsseldorf, Düsseldorf, Germany|Children's Medical Hospital, University of Essen, Essen, Germany, Essen, Germany|University Hospital, Essen, Essen, Germany|University Heart Center Freiburg - Bad Krozingen, Freiburg, Germany|Hannover Medical School, Hannover, Germany|Klinikum Kassel, Kassel, Germany|Universitätsklinikum Köln, Köln, Germany|Heart Center Leipzig - University Hospital, Leipzig, Germany|Klinikum Nürnberg, Nürnberg, Germany|University Hospital Regensburg, Regensburg, Germany|University Hospital Tuebingen, Tuebingen, Germany|University Hospital, Alexandroupolis, Alexandroupolis, Greece|Heim Pal Children's Hospital, Budapest, Hungary|ECMO Centers Israel, Jerusalem, Israel|San Giorgio Clinic, Alessandria, Italy|Ospedali Riuniti Ancona, Ancona, Italy|Papa Giovanni XXIII Hospital, Bergamo, Italy|St. Orsola Hospital, Bologna, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy|Ospedale Maurizio Bufalini, Cesena, Italy|Gaslini Children's Hospital, Genua, Italy|G. Pasquinucci Heart Hospital, Massa, Massa, Italy|Policlinico Hospital Milan, Milano, Italy|Niguarda Hospital, Milan, Italy|Ospedale San Donato, Milan, Italy|San Raffaele University Hospital, Italy, Milan, Italy|San Gerardo Hospital, Monza, Italy|IRCCS Policlinico S. Matteo, Pavia, Italy|GVM Care & Research, Puglia, Italy|Bambino Gesù Hospital and Research Institute, Roma, Italy|San Camillo Hospital, Rome, Roma, Italy|A.O.U. Città della Salute e della Scienza - Molinette Hospital, Turin, Italy|Mauriziano Umberto I Hospital, Turin, Italy|Ospedale S. Giovanni Bosco, Turin, Italy|University Hospital, Udine, Italy, Udine, Italy|Ospedale dell'Angelo, Venezia-Mestre, Venice, Italy|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|University of Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|UMC Utrecht, Utrecht, Netherlands|Medical University of Warsaw, Warsaw, Poland|Hospital Sao Joao, Porto, Portugal|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation|City Hospital No 41, Ekaterinburg, Russia, Ekaterinburg, Russian Federation|Kemerovo Regional Clinical Cardiological Center named after academician L.S. Barbarash, Kemerovo, Russian Federation|Krasnodar Regional Hospital no 1, Krasnodar, Russian Federation|City Clinical Hospital No. 67, Moscow, Russia, Moscow, Russian Federation|Novosibirsk City Hospital #2, Novosibirsk, Russian Federation|City Hospital No 40, Saint Petersburg, Russia, Saint Petersburg, Russian Federation|Hospital Sant Joan de Deu, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Miguel Servet, Zaragoza, Spain|Lund University Hospital, Lund, Sweden|Karolinska University Hospital, Stockholm, Sweden|University Hospital, Basel, Switzerland, Basel, Switzerland|University of Bern, Bern, Switzerland|University Hospital, Geneva, Geneva, Switzerland|University of Lausanne Hospitals, Lausanne, Switzerland|Cardiocentro Ticino, Lugano, Switzerland|Klinik Hirslanden, Zurich, Zürich, Switzerland|University of Zurich, Zürich, Switzerland|Royal Brompton & Harefield NHS Foundation Trust, Brompton, United Kingdom|Paediatric Intensive Care Glasgow, Glasgow, United Kingdom|Leicester Children's Hospital, Leicester, United Kingdom|Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom",https://ClinicalTrials.gov/show/NCT04366921
Principal Investigator,"Bradley A Connor, MD",Dr. Bradley A. Connor,,NCT04352946,bradley a connor,bradley,male,0.99,5098,1604,NCT04352946,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Not yet recruiting,No Results Available,Prophylaxis|COVID-19|Health Care Worker|Hydroxychloroquine,Drug: Hydroxychloroquine Pre-Exposure Prophylaxis|Drug: Placebo oral tablet,"April 20, 2020","The New York Center for Travel and Tropical Medicine, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04352946
Principal Investigator,"Oscar Peñuelas, P.h.D",Fundación de Investigación del Hospital Universitario de Getafe,,NCT04379258,oscar peñuelas,oscar,male,0.99,69174,1608,NCT04379258,Analysis of Mortality of Critically Ill Patients With COVID-19,Not yet recruiting,No Results Available,"COVID-19|Critical Illness|Effectiveness|Outcome, Fatal",,"May 7, 2020",,https://ClinicalTrials.gov/show/NCT04379258
Principal Investigator,"Oscar Simonsson, MD, PhD",Uppsala University,,NCT04447833,oscar simonsson,oscar,male,0.99,69174,1718,NCT04447833,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,Recruiting,No Results Available,"ARDS, Human|COVID",Drug: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205,"June 25, 2020","Uppsala University Hospital, Uppsala, Sweden",https://ClinicalTrials.gov/show/NCT04447833
Principal Investigator,"Oscar Len, MD, PhD",Vall d'Hebron Hospital Universitari,,NCT04423289,oscar len,oscar,male,0.99,69174,1848,NCT04423289,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Completed,No Results Available,Face-to-face Reconsultation to Emergency Room,Other: Farmalarm,"June 9, 2020","Vall d'Hebron Hospital Universitari, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04423289
Principal Investigator,"Maxwell Weinmann, MD",Emory University,,NCT04369599,maxwell weinmann,maxwell,male,0.98,3503,1614,NCT04369599,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19,Enrolling by invitation,No Results Available,Acute Respiratory Distress Syndrome|COVID-19,Device: V/Q Vest,"April 30, 2020","Emory University Hospital, Atlanta, Georgia, United States",https://ClinicalTrials.gov/show/NCT04369599
Principal Investigator,"Zhou Qi, Doctor","Institute of zoology, Chinese Academy of Sciences",,NCT04331613,zhou qi,zhou,male,0.66,803,1618,NCT04331613,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,Recruiting,No Results Available,COVID-19|Acute Respiratory Distress Syndrome|Virus; Pneumonia|Acute Lung Injury,Biological: CAStem,"April 2, 2020","Beijing YouAn Hospital, Capital Medical University, Beijing, Beijing, China, China",https://ClinicalTrials.gov/show/NCT04331613
Principal Investigator,"Kirby P Mayer, PhD",University of Kentucky,,NCT04412330,kirby p mayer,kirby,male,0.68,523,1622,NCT04412330,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Recruiting,No Results Available,Covid-19|Critical Illness|Post Intensive Care Unit Syndrome|Muscle Weakness,Other: ICU Recovery + Physical Therapy,"June 2, 2020","University of Kentucky, Lexington, Kentucky, United States",https://ClinicalTrials.gov/show/NCT04412330
Principal Investigator,"Nina Weis, MD, PhD","Copenhagen University Hospital, Hvidovre",,NCT04351789,nina weis,nina,female,0.98,80011,1623,NCT04351789,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Not yet recruiting,No Results Available,COVID-19|Mental Health|Psychoeducation|Anxiety,Other: Psychoeducational intervention,"April 17, 2020",,https://ClinicalTrials.gov/show/NCT04351789
Principal Investigator,"Verena Sengpiel, MD, PhD","Sahlgrenska University Hospital, Sweden",,NCT04433364,verena sengpiel,verena,female,0.97,9158,1626,NCT04433364,COPE - COVID-19 in Pregnancy and Early Childhood,Recruiting,No Results Available,Sars-CoV2|Covid-19|Pregnancy Complications|Pregnancy Preterm|Pregnancy in Diabetic|Neonatal Infection,"Other: biological samples, questionnaires and interviews","June 16, 2020","Falu Hospital, Falun, Dalarna, Sweden|Halmstad lasarett, Halmstad, Halland, Sweden|Varbergs sjukhus, Varberg, Halland, Sweden|Helsingborgs lasarett, Helsingborg, Skåne, Sweden|Skåne Universitetssjukhus, Lund, Skåne, Sweden|Eskiltuna hospital, Eskilstuna, Södermanland, Sweden|Boras hospital, Boras, VGR, Sweden|Sahlgrenska Univeristy Hospital, Gothenburg, VGR, Sweden|Ryhovs sjukhus, Jönköping, Sweden|Kalmar Lasarett, Kalmar, Sweden|Karlstad lasarett, Karlstad, Sweden|Kristiandstad länssjukhus, Kristianstad, Sweden|Skaraborgs sjukhus Skövde, Skövde, Sweden|BB Stockholm, Stockholm, Sweden|Danderyd, Stockholm, Sweden|Karolinska University Hospital Solna, Stockholm, Sweden|Karolinska University Hospital- Huddinge, Stockholm, Sweden|Södersjukhuset, Stockholm, Sweden|Södertälje, Stockholm, Sweden|Sundsvall, Sundsvall, Sweden|Umeå University Hospital, Umeå, Sweden|Uppsala University Hospital, Uppsala, Sweden|Västerås, Västerås, Sweden|Ystad, Ystad, Sweden|Örebro University Hospital, Örebro, Sweden|Linköping University Hospital, Linköping, Östergötland, Sweden|Vrinnevisjukhuset, Norrköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04433364
Principal Investigator,"Rahul Kashya, MBBS",Mayo Clinic,,NCT04323787,rahul kashya,rahul,male,0.99,9912,1630,NCT04323787,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Recruiting,No Results Available,Coronavirus,Other: observational,"March 27, 2020","Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Society of Critical Care Medicine (150+ sites), Chicago, Illinois, United States|Rahul Kashyap, Rochester, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04323787
Principal Investigator,"Arndt Rolfs, Prof.",Centogene AG Rostock,,NCT04357496,arndt rolfs,arndt,male,0.98,275,1632,NCT04357496,COVID-19 Epidemic Response Study,Not yet recruiting,No Results Available,Fever|Pneumonia|Cough,,"April 22, 2020",,https://ClinicalTrials.gov/show/NCT04357496
Principal Investigator,"Zachary M Holliday, MD",University of Missouri-Columbia,,NCT04402970,zachary m holliday,zachary,male,0.99,2836,1639,NCT04402970,Dornase Alfa for ARDS in Patients With SARS-CoV-2,Recruiting,No Results Available,SARS-CoV 2|ARDS,Drug: Dornase Alfa Inhalation Solution,"May 27, 2020","University of Missouri Hospital and Clinics, Columbia, Missouri, United States",https://ClinicalTrials.gov/show/NCT04402970
Study Director,"Adam Schrum, PhD",University of Missouri-Columbia,,NCT04402970,adam schrum,adam,male,0.98,116396,1639,NCT04402970,Dornase Alfa for ARDS in Patients With SARS-CoV-2,Recruiting,No Results Available,SARS-CoV 2|ARDS,Drug: Dornase Alfa Inhalation Solution,"May 27, 2020","University of Missouri Hospital and Clinics, Columbia, Missouri, United States",https://ClinicalTrials.gov/show/NCT04402970
Principal Investigator,"Adam Spivak, MD",University of Utah,,NCT04342169,adam spivak,adam,male,0.98,116396,1846,NCT04342169,University of Utah COVID-19 Hydrochloroquine Trial,Recruiting,No Results Available,Coronavirus Infection|Coronavirus|Infectious Disease,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"April 10, 2020","University of Utah, Salt Lake City, Utah, United States",https://ClinicalTrials.gov/show/NCT04342169
Principal Investigator,"Adam Nelson, MBBS, FRACP","Children's Hospital Medical Center, Cincinnati",,NCT04406064,adam nelson,adam,male,0.98,116396,2020,NCT04406064,Viral Specific T-cells for Treatment of COVID-19,Not yet recruiting,No Results Available,Viral Infection,Biological: Viral Specific T-cells (VSTs),"May 28, 2020","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",https://ClinicalTrials.gov/show/NCT04406064
Principal Investigator,Aziz Sheikh,University of Edinburgh,,NCT04382131,aziz sheikh,aziz,male,0.97,41366,1640,NCT04382131,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19,Not yet recruiting,No Results Available,Upper Respiratory Tract Infections|Virus|COVID|Virus Shedding|Virus Diseases,Other: NaCl Solution,"May 11, 2020","NHS Lothian, Edinburgh, United Kingdom",https://ClinicalTrials.gov/show/NCT04382131
Principal Investigator,"Tracy F Chang, Ph.D.",Rutgers University,,NCT04414371,tracy f chang,tracy,female,0.92,13353,1642,NCT04414371,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Recruiting,No Results Available,Stress|Anxiety|Depression|Resilience|Wellbeing|Mood,Other: Yoga,"June 4, 2020","Rutgers University, New Brunswick, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04414371
Study Chair,"Alfredo Secchi, M.D.","President Ethical Commitee, Hospital Eurnekian",,NCT04425863,alfredo secchi,alfredo,male,0.99,28805,1646,NCT04425863,IVERMECTIN Aspirin Dexametasone and Enoxaparin as Treatment of Covid 19,"Active, not recruiting",No Results Available,Severe Acute Respiratory Syndrome|Ventilation Pneumonitis,Drug: Ivermectin 5 MG/ML,"June 11, 2020","Hospital Eurnekian, Buenos Aires, Argentina",https://ClinicalTrials.gov/show/NCT04425863
Principal Investigator,"Alfredo Hernandez-Ruiz, MSc",Clinica Somer,,NCT04390152,alfredo hernandez-ruiz,alfredo,male,0.99,28805,1756,NCT04390152,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,Not yet recruiting,No Results Available,Acute Respiratory Distress Syndrome,"Drug: Wharton's jelly derived Mesenchymal stem cells.|Drug: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)","May 15, 2020","Clinical Somer, Rionegro, Antioquia, Colombia",https://ClinicalTrials.gov/show/NCT04390152
Principal Investigator,"Rima Styra, MD, MEd","University Health Network, Toronto",,NCT04397848,rima styra,rima,female,0.97,6166,1650,NCT04397848,Mental Health Outcomes in Healthcare Workers During COVID-19,Recruiting,No Results Available,Mental Health Wellness 1|PTSD|Anxiety|Stress|Depression|COVID-19|Healthcare Workers,,"May 21, 2020","University Health Network, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04397848
Principal Investigator,Tushar Patel,Mayo Clinic,,NCT04341012,tushar patel,tushar,male,0.99,1097,1661,NCT04341012,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Recruiting,No Results Available,Liver Diseases|Liver Cancer|COVID19,Diagnostic Test: Collection of breath sample,"April 10, 2020","Mayo Clinic Florida, Jacksonville, Florida, United States",https://ClinicalTrials.gov/show/NCT04341012
Study Director,"Rehab Hegazy, PhD",National Research Center,,NCT04412395,rehab hegazy,rehab,female,0.92,530,1663,NCT04412395,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,Not yet recruiting,No Results Available,Corona Virus Infection|Middle East Respiratory Syndrome (MERS)|Acute Respiratory Distress Syndrome|Coronavirus Infection|COVID-19|SARS-CoV 2,Dietary Supplement: Lactoferrin (Apolactoferrin)|Drug: Placebo of excipient(s) will be administered,"June 2, 2020","National Research Center, Egypt (Clinical and Molecular Pharmacology), Cairo, Giza, Egypt|Clinmax CRO (Clinical Research Organization), Cairo, Egypt|Clinical Trial Unit National Research Center, Cairo, Egypt|Egyptian Military Medical Services (Hospitals), Cairo, Egypt",https://ClinicalTrials.gov/show/NCT04412395
Principal Investigator,"Flavio A Cadegiani, MD",Corpometria Institute,,NCT04446429,flavio a cadegiani,flavio,male,0.99,15386,1665,NCT04446429,Anti-Androgen Treatment for COVID-19,Not yet recruiting,No Results Available,COVID-19|SARS-CoV2|Androgenetic Alopecia|Prostate Cancer|Benign Prostatic Hyperplasia|SARS (Severe Acute Respiratory Syndrome),Drug: Dutasteride|Drug: Ivermectin|Drug: Azithromycin,"June 24, 2020","Corpometria Institute, Brasilia, Brazil",https://ClinicalTrials.gov/show/NCT04446429
Study Director,"Andy Goren, MD","Applied Biology, Inc.",,NCT04446429,andy goren,andy,male,0.92,66103,1665,NCT04446429,Anti-Androgen Treatment for COVID-19,Not yet recruiting,No Results Available,COVID-19|SARS-CoV2|Androgenetic Alopecia|Prostate Cancer|Benign Prostatic Hyperplasia|SARS (Severe Acute Respiratory Syndrome),Drug: Dutasteride|Drug: Ivermectin|Drug: Azithromycin,"June 24, 2020","Corpometria Institute, Brasilia, Brazil",https://ClinicalTrials.gov/show/NCT04446429
Principal Investigator,"Filippo Annoni, MD",Erasme hospital,,NCT04332666,filippo annoni,filippo,male,0.99,27899,1669,NCT04332666,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Not yet recruiting,No Results Available,Coronavirus|Respiratory Failure|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|SARS-CoV-2,Drug: Angiotensin 1-7|Drug: Placebos,"April 3, 2020",,https://ClinicalTrials.gov/show/NCT04332666
Principal Investigator,"Robson AS Santos, MD,PhD",Minas Gerais University,,NCT04332666,robson as santos,robson,male,0.98,1527,1669,NCT04332666,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Not yet recruiting,No Results Available,Coronavirus|Respiratory Failure|Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere|SARS-CoV-2,Drug: Angiotensin 1-7|Drug: Placebos,"April 3, 2020",,https://ClinicalTrials.gov/show/NCT04332666
Principal Investigator,"Juliana C Ferreira, MD",University of Sao Paulo - hospital das Clínicas da faculdade de medicina da USP (HCFMUSP),,NCT04378582,juliana c ferreira,juliana,female,0.98,14372,1670,NCT04378582,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,Recruiting,No Results Available,"SARS-CoV 2|Respiratory Distress Syndrome, Adult|Corona Virus Infection|Critical Illness",Other: risk factors,"May 7, 2020","Hospital das Clínicas -HCFMUSP, Sao Paulo, SP, Brazil",https://ClinicalTrials.gov/show/NCT04378582
Principal Investigator,"Boyd Taylor Thompson, MD",Massachusetts General Hospital,,NCT04332991,boyd taylor thompson,boyd,male,0.97,465,1674,NCT04332991,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,"Active, not recruiting",No Results Available,Coronavirus|Acute Respiratory Infection|SARS-CoV Infection,Drug: Hydroxychloroquine|Drug: Placebo,"April 3, 2020","University of Arizona, Tucson, Arizona, United States|UCSF Fresno, Fresno, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University, Stanford, California, United States|Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Kentucky, Lexington, Kentucky, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|St. Vincent's Hospital, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center-Weiler, Bronx, New York, United States|Montefiore Medical Center-Moses, Bronx, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Health Science Center, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04332991
Principal Investigator,"Alba Dr Camacho-Cardenosa, Doctor",University of Extremadura,,NCT04352517,alba dr camacho-cardenosa,alba,female,0.97,30366,1678,NCT04352517,Influence Physical Activity Psychological Responses COVID-19 Pandemic,Recruiting,No Results Available,Sedentary Behavior|Mental Health Wellness 1,Other: Online Survey,"April 20, 2020","Universidade da Sao Paulo, Ribeirão Preto, Sao Paulo, Brazil|Universidad Autonoma de Chile, Santiago, Región Metropolitana, Chile|Universidad de la República, Rivera, Uruguay",https://ClinicalTrials.gov/show/NCT04352517
Study Director,"Ashik Tal, MD",Beyond Air,,NCT04397692,ashik tal,ashik,male,0.99,224,1680,NCT04397692,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Not yet recruiting,No Results Available,"Corona Virus Infection|COVID-19|SARS-CoV 2|Nitric Oxide|Respiratory Disease|Pneumonia, Viral|Inhaled Nitric Oxide",Device: Nitric Oxide delivered via LungFit™ system,"May 21, 2020","Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States",https://ClinicalTrials.gov/show/NCT04397692
Principal Investigator,"Arthur M Feldman, MD, PhD",Temple University,,NCT04433078,arthur m feldman,arthur,male,0.99,20587,1683,NCT04433078,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,Recruiting,No Results Available,Cytokine Storm|SARS-CoV-2,Drug: Doxycycline|Drug: Placebo,"June 16, 2020","Temple University Hospital, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04433078
Principal Investigator,"Johannes Ehler, MD",University of Rostock,,NCT04359914,johannes ehler,johannes,male,0.99,13733,1684,NCT04359914,Neurocognitive Impairment in Patients With COVID-19,Recruiting,No Results Available,Critical Illness|COVID-19|Central Nervous System Injury|Delirium|Encephalopathy,,"April 24, 2020","Department of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock, Rostock, Mecklenburg-Vorpommern, Germany",https://ClinicalTrials.gov/show/NCT04359914
Study Chair,"Shuiping Zhou, PhD","Tasly Pharmaceutical Group Co., Ltd",,NCT04285190,shuiping zhou,shuiping,female,0.5,6,1690,NCT04285190,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Withdrawn,No Results Available,Coronavirus Disease 2019|Novel Coronavirus Pneumonia,Drug: T89,"February 26, 2020",,https://ClinicalTrials.gov/show/NCT04285190
Principal Investigator,"Heather Huddleston, MD","University of California, San Francisco",,NCT04388605,heather huddleston,heather,female,0.98,6049,1692,NCT04388605,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,Recruiting,No Results Available,Corona Virus Infection|COVID|Pregnancy Related|Early Pregnancy,,"May 14, 2020","University of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04388605
Principal Investigator,"Mario H Vargas, MSc",Instituto Nacional de Enfermedades Respiratorias,,NCT04443673,mario h vargas,mario,male,0.99,168958,1695,NCT04443673,Glycine Supplement for Severe COVID-19,Recruiting,No Results Available,"COVID-19|SARS-CoV Infection|SARS (Severe Acute Respiratory Syndrome)|SARS Pneumonia|ARDS, Human|Pneumonia, Viral",Dietary Supplement: Glycine,"June 23, 2020","Instituto Nacional de Enfermedades Respiratorias, Mexico DF, Mexico",https://ClinicalTrials.gov/show/NCT04443673
Principal Investigator,"Zaher Azzam, Prof",Rambam Health Care Campus,,NCT04325048,zaher azzam,zaher,male,0.96,1067,1698,NCT04325048,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Not yet recruiting,No Results Available,Coronavirus Infection,Device: Cordio App,"March 27, 2020",,https://ClinicalTrials.gov/show/NCT04325048
Study Director,"SHAOXIAN HU, M.D",Tongji Hospital,,NCT04306705,shaoxian hu,shaoxian,male,0.75,4,1703,NCT04306705,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Recruiting,No Results Available,Covid-19|SARS|Cytokine Storm|Cytokine Release Syndrome|Tocilizumab,Drug: Tocilizumab|Other: Standard of care|Procedure: Continuous renal replacement therapy,"March 13, 2020","Tongji Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04306705
Principal Investigator,"Tariq Cheema, MD",Allegheny Health Network,,NCT04382391,tariq cheema,tariq,male,0.98,5296,1707,NCT04382391,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Recruiting,No Results Available,"COVID|Corona Virus Infection|Respiratory Failure|Respiratory Distress Syndrome, Adult|ARDS, Human|SARS (Severe Acute Respiratory Syndrome)",Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies,"May 11, 2020","AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04382391
Study Director,"Boyle Cheng, PhD",Allegheny Health Network,,NCT04382391,boyle cheng,boyle,male,0.97,33,1707,NCT04382391,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Recruiting,No Results Available,"COVID|Corona Virus Infection|Respiratory Failure|Respiratory Distress Syndrome, Adult|ARDS, Human|SARS (Severe Acute Respiratory Syndrome)",Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies,"May 11, 2020","AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04382391
Principal Investigator,"Jean-Francois Rossi, Professor",University of Montpellier (Faculté de Médecine) and Institute Sainte Catherine,,NCT04381377,jean-francois rossi,jean-francois,male,0.99,765,1708,NCT04381377,Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19,Recruiting,No Results Available,"Infections, Coronavirus",Drug: azoximer bromide|Other: Placebo,"May 8, 2020","Regional state budgetary institution of public health ""City hospital No. 5 of Barnaul"", Barnaul, Russian Federation|Central Research Institute of Epidemiology of Rospotrebnadzor, Moscow, Russian Federation|The state healthcare institution of the city of Moscow ""City Clinical Hospital No. 15 named after OM Filatov"" in ""Moscow City Department of Health"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""Infectious Clinical Hospital No. 1 of the Moscow Department of Healthcare"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital No. 24 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State budgetary institution ""Research Institute of Emergency Care named after N.V. Sklifosovsky in Department of Health of the city of Moscow"", Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution ""City Clinical Hospital No. 40 of the Moscow Department of Healthcare"", Moscow, Russian Federation|State budgetary institution of health care of the Nizhny Novgorod region ""Infectious clinical hospital No. 2 of Nizhny Novgorod"", Nizhny Novgorod, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""Orenburg State Medical University"" of the Ministry of Health of the Russian Federation, Orenburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education ""First St. Petersburg State Medical University named after Academician I.P. Pavlov, Saint Petersburg, Russian Federation|State budgetary health institution of the Vladimir region ""Regional Clinical Hospital"", Vladimir, Russian Federation|Yaroslavl State Medical University of Ministry of Health of the Russian Federation, Yaroslavl, Russian Federation",https://ClinicalTrials.gov/show/NCT04381377
Principal Investigator,"Jean-Francois Pelletier, PhD",Research Centre - Montreal Mental Health University Institute,,NCT04445324,jean-francois pelletier,jean-francois,male,0.99,765,2160,NCT04445324,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,Not yet recruiting,No Results Available,Psychotic Disorders|Anxiety Depression,"Behavioral: Transitional Online Peer Support Group (n=24)|Other: Control Group (pharmacotherapy and/or psychotherapy, n=24)","June 24, 2020","CR-IUSMM, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04445324
Principal Investigator,Jean-Christophe Gris,CHU Nimes,,NCT04356950,jean-christophe gris,jean-christophe,male,0.99,2984,1710,NCT04356950,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Not yet recruiting,No Results Available,Sepsis|Blood Coagulation Disorders|Thrombin|Disseminated Intravascular Coagulation|COVID-19,Other: Thrombin generation test assay|Other: Fibrin generation markers assays,"April 22, 2020","CHU de Bordeaux, Bordeaux, France|CHU de Limoges, Limoges, France|CHU de Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France",https://ClinicalTrials.gov/show/NCT04356950
Study Chair,"Beatrice Beck Schimmer, Prof",University of Zurich,,NCT04355962,beatrice beck schimmer,beatrice,female,0.98,24617,1711,NCT04355962,Sevoflurane in COVID-19 ARDS (SevCov),Recruiting,No Results Available,"ARDS, Human|Coronavirus",Drug: Sevoflurane|Drug: Intravenous drug,"April 21, 2020","University Hospital Zuirch, Zurich, Switzerland",https://ClinicalTrials.gov/show/NCT04355962
Principal Investigator,"Gilmar Reis, MD, PhD",Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA,,NCT04403100,gilmar reis,gilmar,male,0.97,484,1713,NCT04403100,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",Recruiting,No Results Available,COVID-19|Coronavirus Infection|Virus Disease|Acute Respiratory Infection|SARS-CoV Infection,Drug: Hydroxychloroquine Sulfate Tablets|Drug: Lopinavir/ Ritonavir Oral Tablet|Drug: Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets|Drug: Placebo,"May 27, 2020","CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil|Pontificia Universidade Catolica de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Fundo Municipal de Saúde de Betim, Betim, Minas Gerais, Brazil|Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil",https://ClinicalTrials.gov/show/NCT04403100
Principal Investigator,"Kate E Doyle, MA",Promundo-US,,NCT04442152,kate e doyle,kate,female,0.98,38791,1716,NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Enrolling by invitation,No Results Available,Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,"June 22, 2020","Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04442152
Principal Investigator,"Ruti G Levtov, PhD",Promundo-US,,NCT04442152,ruti g levtov,ruti,female,0.65,113,1716,NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Enrolling by invitation,No Results Available,Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,"June 22, 2020","Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04442152
Principal Investigator,"Felix Sayingoza, MD, MSc",Ministry of Health/Rwanda Biomedical Center,,NCT04442152,felix sayingoza,felix,male,0.98,35608,1716,NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Enrolling by invitation,No Results Available,Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,"June 22, 2020","Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04442152
Principal Investigator,"Fidele Rutayisire, MA",Rwanda Men's Resource Center,,NCT04442152,fidele rutayisire,fidele,male,0.75,1047,1716,NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Enrolling by invitation,No Results Available,Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,"June 22, 2020","Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04442152
Principal Investigator,"Shamsi Kazimbaya, MA",Promundo-US,,NCT04442152,shamsi kazimbaya,shamsi,male,0.62,76,1716,NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Enrolling by invitation,No Results Available,Gender Relations|Partner Communication|Division of Carework|Couple Conflict|Stress,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,"June 22, 2020","Rwanda Men's Resource Centre (Rwamrec), Kigali, Rwanda",https://ClinicalTrials.gov/show/NCT04442152
Principal Investigator,"Felix Yang, MD",Maimonides Medical Center,,NCT04363437,felix yang,felix,male,0.98,35608,2103,NCT04363437,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Recruiting,No Results Available,Coronavirus Infection,Drug: Colchicine|Drug: Usual Care,"April 27, 2020","Maimonides Medical Center, Brooklyn, New York, United States",https://ClinicalTrials.gov/show/NCT04363437
Study Director,Dayana Michel,Karyopharm Therapeutics Inc,,NCT04349098,dayana michel,dayana,female,0.99,4230,1719,NCT04349098,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Recruiting,No Results Available,Coronavirus Infection,Drug: Selinexor|Other: Placebo,"April 16, 2020","UCLA, Los Angeles, California, United States|Kaiser Permanente Oakland, Oakland, California, United States|UC Davis Health, Sacramento, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|Kaiser Permanente San Francisco, San Francisco, California, United States|Miami Cancer Institute at Baptist Health, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Norton Healthcare, Louisville, Kentucky, United States|Boston Medical Center, Boston, Massachusetts, United States|Karmanos, Detroit, Michigan, United States|Michigan Center of Medical Research, Farmington Hills, Michigan, United States|Michigan Center of Medical Research, Royal Oak, Michigan, United States|Columbia University, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Levine Cancer Institute-Atrium Health University City, Charlotte, North Carolina, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|Baylor Scott & White Dallas, Dallas, Texas, United States|MultiCare Institute for Research & Innovation (Puget Sound), Tacoma, Washington, United States|Hospital Hietzing, 2. Medical department - Center for Diagnosis and Therapy of Rheumatic Diseases, Vienna, Austria|CHU Bordeaux, Bordeaux, France|CHU Lyon, Lyon, France|CHU Nantes, Nantes, France|Hadassah MC, Jerusalem, Israel|Hasharon Medical Center, Petah Tiqva, Israel|Sheba Medical Center, Tel HaShomer, Israel|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Servicio de Medicina Interna, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain|Princess Royal University Hospital, Kent, United Kingdom|Kings College Hospital, London, United Kingdom|The Royal Marsden Hospital, London, United Kingdom|University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom",https://ClinicalTrials.gov/show/NCT04349098
Study Director,Dayana Michel,Karyopharm Therapeutics Inc,,NCT04355676,dayana michel,dayana,female,0.99,4230,1730,NCT04355676,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Not yet recruiting,No Results Available,Coronavirus Infection,Drug: Selinexor,"April 21, 2020",,https://ClinicalTrials.gov/show/NCT04355676
Principal Investigator,Anita CE Vreugdenhil,Maastricht University Medical Center,,NCT04411511,anita ce vreugdenhil,anita,female,0.98,66163,1727,NCT04411511,"COVID-19, Obesity and Lifestyle in Children",Recruiting,No Results Available,"Covid-19|Obesity, Childhood|Lifestyle|Lifestyle, Healthy|Overweight, Childhood|Children, Only|Family",Other: Exposure to the Dutch measures due to the Covid-19 pandemic.,"June 2, 2020","Maastricht University Medical Center, Maastricht, Limburg, Netherlands",https://ClinicalTrials.gov/show/NCT04411511
Principal Investigator,"Tjhin Wiguna, PhD",Dr Cipto Mangunkusumo General Hospital,,NCT04343664,tjhin wiguna,tjhin,male,0.64,14,1728,NCT04343664,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Not yet recruiting,No Results Available,Mental Stress|Mental Health Wellness 1|Depression|Anxiety|Behavior Problem|Emotional Problem,,"April 13, 2020","dr. Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04343664
Principal Investigator,"Tjhin Wiguna, PhD",Fakultas Kedokteran Univeristas Indonesia,,NCT04343664,tjhin wiguna,tjhin,male,0.64,14,1728,NCT04343664,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Not yet recruiting,No Results Available,Mental Stress|Mental Health Wellness 1|Depression|Anxiety|Behavior Problem|Emotional Problem,,"April 13, 2020","dr. Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia",https://ClinicalTrials.gov/show/NCT04343664
Principal Investigator,"Eliza M Gordon-Lipkin, M.D.",National Human Genome Research Institute (NHGRI),,NCT04419870,eliza m gordon-lipkin,eliza,female,0.99,21564,1731,NCT04419870,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",Recruiting,No Results Available,Mitochondrial Disease,,"June 9, 2020","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04419870
Principal Investigator,"Jill Ehrenreich-May, Ph.D.",University of Miami,,NCT04431856,jill ehrenreich-may,jill,female,0.93,5787,1734,NCT04431856,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Recruiting,No Results Available,Anxiety|Depression|Traumatic Stress Disorder,Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)|Behavioral: SHG,"June 16, 2020","University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04431856
Principal Investigator,"Mona Bafadhel, MBBS, PhD",University of Oxford,,NCT04416399,mona bafadhel,mona,female,0.97,20027,1738,NCT04416399,STerOids in COVID-19 Study,Not yet recruiting,No Results Available,Coronavirus Infection,Drug: Budesonide dry powder inhaler,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04416399
Principal Investigator,"Tatiana Astrelina, MD PhD,DSc.",Burnasyan FMBC SRC FMBA of Russia,,NCT04347031,tatiana astrelina,tatiana,female,0.98,38772,1739,NCT04347031,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,"Active, not recruiting",No Results Available,"Pneumonia, Viral|Respiratory Failure",Drug: Mefloquine|Drug: Hydroxychloroquine|Combination Product: Mefloquine + azithromycin + / - tocilizumab|Combination Product: Hydroxychloroquine + azithromycin + / - tocilizumab,"April 15, 2020","Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04347031
Principal Investigator,"Moazzam N Tarar, MBBS, FCPS","Jinnah Burn & Reconstructive Surgery Center, Lahore",,NCT04437823,moazzam n tarar,moazzam,male,1.0,172,1744,NCT04437823,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,Recruiting,No Results Available,Corona Virus Infection,Biological: Intravenous Infusions of Stem Cells,"June 18, 2020","Jinnah Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04437823
Principal Investigator,"Azra Mehmood, PhD","Centre of Excellence in Molecular Biology, Lahore",,NCT04437823,azra mehmood,azra,female,0.97,4912,1744,NCT04437823,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,Recruiting,No Results Available,Corona Virus Infection,Biological: Intravenous Infusions of Stem Cells,"June 18, 2020","Jinnah Hospital, Lahore, Punjab, Pakistan",https://ClinicalTrials.gov/show/NCT04437823
Principal Investigator,Guiqiang Wang,Peking University First Hospital,,NCT04334265,guiqiang wang,guiqiang,male,1.0,1,1749,NCT04334265,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Recruiting,No Results Available,COVID-19,Drug: Anluohuaxian,"April 6, 2020","The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China|West Hospital Union Hospital Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04334265
Principal Investigator,Guiqiang Wang,Peking University First Hospital,,NCT04333589,guiqiang wang,guiqiang,male,1.0,1,1751,NCT04333589,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Recruiting,No Results Available,COVID-19,Drug: Favipiravir,"April 3, 2020","The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Hospital of Traditional Chinese Medicine, Ezhou, Hubei, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang, China",https://ClinicalTrials.gov/show/NCT04333589
Principal Investigator,Guiqiang Wang,Peking University First Hospital,,NCT04310228,guiqiang wang,guiqiang,male,1.0,1,1753,NCT04310228,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Recruiting,No Results Available,COVID-19,Drug: Favipiravir Combined With Tocilizumab|Drug: Favipiravir|Drug: Tocilizumab,"March 17, 2020","Guiqiang Wang, Beijing, Beijing, China|Peking University First Hospital, Beijing, Beijing, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04310228
Study Director,"Liwei cheng, doctor",Research office of wuhan renmin university,,NCT04302519,liwei cheng,liwei,male,0.64,99,1754,NCT04302519,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,Not yet recruiting,No Results Available,COVID-19,Biological: Dental pulp mesenchymal stem cells,"March 10, 2020",,https://ClinicalTrials.gov/show/NCT04302519
Principal Investigator,"Kwame Dapaah-Afriyie, MD",The Miriam Hospital,,NCT04445506,kwame dapaah-afriyie,kwame,male,0.98,1546,1758,NCT04445506,Short Term Corticosteroids in SARS-CoV2 Patients,Completed,No Results Available,Corticosteroids|Covid19|SARS-CoV 2|Steroids|Dexamethasone,Drug: Dexamethasone,"June 24, 2020","The Miriam Hospital, Providence, Rhode Island, United States",https://ClinicalTrials.gov/show/NCT04445506
Study Director,Mike Foley,Director Department of Obstetrics and Gynecology BUMCP,,NCT04329533,mike foley,mike,male,0.99,109844,1761,NCT04329533,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Recruiting,No Results Available,Perceived Stress|Anxiety|Sleep Disturbance,"Other: ""Calm"" is a mindfulness meditation mobile app","April 1, 2020","Banner University Medicine Women's Institute, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04329533
Study Chair,"Mike Foley, MD",Chair - BUMCP,,NCT04374786,mike foley,mike,male,0.99,109844,1762,NCT04374786,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Enrolling by invitation,No Results Available,Perceived Stress|Anxiety|Sleep Disturbance|Burnout|PTSD,Device: Calm Meditation App,"May 5, 2020","Banner University Medical Center Phoenix, Phoenix, Arizona, United States",https://ClinicalTrials.gov/show/NCT04374786
Principal Investigator,"Sergi Bellmunt, MD,PhD",Hospital Vall d'Hebron,,NCT04374617,sergi bellmunt,sergi,male,0.99,8651,1766,NCT04374617,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Completed,No Results Available,"COVID-19|Critical Illness|Venous Thromboembolism|Venous Thromboses|Venous Thromboses, Deep|Venous Thrombosis Pulmonary|Pulmonary Embolism|Pulmonary Embolism and Thrombosis|Sars-CoV2|SARS-CoV Infection",Diagnostic Test: Duplex ultrasound and Computed Tomography Angiography,"May 5, 2020","Vall d´Hebron Research Institute VHIR, Barcelona, Catalunya, Spain|Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona, Badalona, Spain|Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona, Spain",https://ClinicalTrials.gov/show/NCT04374617
Principal Investigator,"Xiaoju Zhang, PhD",Henan Provincial People's Hospital,,NCT04312100,xiaoju zhang,xiaoju,female,1.0,2,1767,NCT04312100,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Recruiting,No Results Available,Coronavirus Disease-2019,Other: oxygen treatment,"March 18, 2020","Henan Provincial People's Hospital, Zhengzhou, Henan, China",https://ClinicalTrials.gov/show/NCT04312100
Principal Investigator,"Babar Kayani, MBBS",Barts & The London NHS Trust,,NCT04375501,babar kayani,babar,male,0.93,1418,1768,NCT04375501,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,Completed,No Results Available,Femoral Neck Fractures|SARS-CoV 2,"Other: Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail","May 5, 2020","Barts Health NHS Trust, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04375501
Principal Investigator,Pallav Shah,Chelsea and Westminster NHS Foundation Trust,,NCT04373733,pallav shah,pallav,male,1.0,58,1769,NCT04373733,Early Intervention in COVID-19: Favipiravir Verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe,Recruiting,No Results Available,Coronavirus Infection,Drug: Favipiravir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Other: Standard of care management,"May 4, 2020","Chelsea and Westminster Hospital, London, United Kingdom|West Middlesex University Hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04373733
Principal Investigator,"Sanja Jelic, MD",Columbia University,,NCT04408222,sanja jelic,sanja,female,0.95,8376,1770,NCT04408222,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,"Active, not recruiting",No Results Available,Oxygen Deficiency|Coronavirus Infection,Other: Awake proning,"May 29, 2020","Columbia University Medical Center, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04408222
Study Chair,"Florence Ader, MD",Hospices Civils de Lyon,,NCT04315948,florence ader,florence,female,0.98,31246,1774,NCT04315948,Trial of Treatments for COVID-19 in Hospitalized Adults,Recruiting,No Results Available,Corona Virus Infection,Drug: Remdesivir|Drug: Lopinavir/ritonavir|Drug: Interferon Beta-1A|Drug: Hydroxychloroquine|Other: Standard of care,"March 20, 2020","Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France|Centre Hospitalier Regional Metz-Thionville, Ars-Laquenexy, France|Centre Hospitalier Régional Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France|APHP - hôpital Henri-Mondor, Créteil, France|Centre Hospitalier Universitaire Dijon-Bourgogne, Dijon, France|Centre Hospitalier Universitaire de Martinique, Fort De France, France|AP-HP Hôpital Bicêtre, Kremlin-Bicêtre, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Centre Hospitalier Régional Universitaire de Lille, Lille, France|Hospices Civils de Lyon, Lyon, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, France|Groupe Hospitalier de la Région de Mulhouse Sud Alsace, Mulhouse, France|Centre Hospitalier Régional et Universitaire de Nancy, Nancy, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|Centre Hospitalo-Universitaire de Nice, Nice, France|APHP - Hôpital Saint Antoine, Paris, France|APHP - Hôpital Universitaire Pitié Salpêtrière, Paris, France|APHP - Hôpital Cochin, Paris, France|Hôpital Paris Saint-Joseph et Marie Lannelongue, Paris, France|APHP- Hôpital Européen Georges-Pompidou, Paris, France|APHP - Hôpital Bichat Claude Bernard, Paris, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Hopital DELAFONTAINE, Saint-Denis, France|Hôpital d'Instruction des Armées BEGIN, Saint-Mandé, France|Centre Hospitalier Universitaire de Saint Etienne, Saint-Étienne, France|Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier de Tourcoing, Tourcoing, France|Centre Hospitalier Universitaire de Tours, Tours, France|Centre Hospitalier Annecy Genevois, Épagny, France|Centre Hospitalier Luxembourg, Luxembourg, Luxembourg|Hôpitaux Robert Schuman, Luxembourg, Luxembourg",https://ClinicalTrials.gov/show/NCT04315948
Principal Investigator,"Alexandru Burlacu, Lecturer",University of Medicine and Pharmacy Gr T Popa - Iasi,,NCT04313946,alexandru burlacu,alexandru,male,0.97,11274,1780,NCT04313946,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral|Influenza With Pneumonia|Flu Symptom|Flu Like Illness|Pneumonia, Interstitial|Pneumonia, Ventilator-Associated|Pneumonia Atypical",Diagnostic Test: Scanning Chest X-rays and performing AI algorithms on images,"March 18, 2020","U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale; Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute Università degli Studi di Trieste, Cremona, Italy|University of Medicine and Pharmacy Gr T Popa, Iaşi, Romania|Department of Cardiology at Chelsea and Westminster NHS hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04313946
Principal Investigator,"Radu Dabija, Lecturer",University of Medicine and Pharmacy Gr T Popa - Iasi,,NCT04313946,radu dabija,radu,male,0.87,9612,1780,NCT04313946,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Recruiting,No Results Available,"COVID-19|Pneumonia, Viral|Influenza With Pneumonia|Flu Symptom|Flu Like Illness|Pneumonia, Interstitial|Pneumonia, Ventilator-Associated|Pneumonia Atypical",Diagnostic Test: Scanning Chest X-rays and performing AI algorithms on images,"March 18, 2020","U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale; Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute Università degli Studi di Trieste, Cremona, Italy|University of Medicine and Pharmacy Gr T Popa, Iaşi, Romania|Department of Cardiology at Chelsea and Westminster NHS hospital, London, United Kingdom",https://ClinicalTrials.gov/show/NCT04313946
Study Chair,Hongwei Li,Beijing Friendship Hospital,,NCT04427735,hongwei li,hongwei,male,0.92,78,1785,NCT04427735,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,Recruiting,No Results Available,STEMI,,"June 11, 2020","Beijing Friendship Hospital, Capital Medical University, Beijing, China",https://ClinicalTrials.gov/show/NCT04427735
Study Chair,Charline BERTHOLDT,Centre Hospitalier Régional Universitaire de Nancy,,NCT04348929,charline bertholdt,charline,female,0.97,6416,1789,NCT04348929,Birth Experience During COVID-19 Confinement,Recruiting,No Results Available,Postpartum Depression,Other: Self-administered questionnaires,"April 16, 2020","Centre Hospitalier Régional Universitaire de Nancy, Nancy, France",https://ClinicalTrials.gov/show/NCT04348929
Principal Investigator,"Joost Wauters, MD PhD",UZ Leuven,,NCT04327570,joost wauters,joost,male,0.99,3237,1793,NCT04327570,In-depth Immunological Investigation of COVID-19.,Recruiting,No Results Available,Coronavirus Infections,Other: Patient sampling,"March 31, 2020","UZ Leuven, Leuven, Belgium",https://ClinicalTrials.gov/show/NCT04327570
Principal Investigator,"Leigh Sowerby, MD, FRCSC",Western University,,NCT04374474,leigh sowerby,leigh,male,0.5,2515,1796,NCT04374474,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Not yet recruiting,No Results Available,Olfactory Disorder,Other: Olfactory retraining|Drug: corticosteroid nasal irrigation|Other: smell household Items|Other: Nasal Irrigation,"May 5, 2020","St. Joseph's Health Care, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04374474
Study Director,Gilbert Lemmens,"University Hospital, Ghent",,NCT04382196,gilbert lemmens,gilbert,male,0.98,11960,1799,NCT04382196,Impact of COVID-19 on Mental Health of Health Care Workers,"Active, not recruiting",No Results Available,Mental Health|Quality of Life,Other: Online survey,"May 11, 2020","Ghent University Hospital, Ghent, Belgium",https://ClinicalTrials.gov/show/NCT04382196
Principal Investigator,"Umberto Maggiore, MD",Azienda Ospedaliero-Universitaria di Parma,,NCT04322565,umberto maggiore,umberto,male,0.99,10383,1801,NCT04322565,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Recruiting,No Results Available,"Coronavirus Infections|Pneumonia, Viral",Drug: Colchicine,"March 26, 2020","Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy",https://ClinicalTrials.gov/show/NCT04322565
Principal Investigator,"Neil J Greening, PhD",University of Leicester,,NCT04407598,neil j greening,neil,male,0.99,15028,1803,NCT04407598,COPD in the Time of COVID-19,Not yet recruiting,No Results Available,COPD Exacerbation|COPD,,"May 29, 2020","NIHR Leicester Biomedical Research Centre (Respiratory), Glenfield Hospital, Leicester, United Kingdom",https://ClinicalTrials.gov/show/NCT04407598
Principal Investigator,"Corey Casper, MD MPH",IDRI,,NCT04365101,corey casper,corey,male,0.98,3457,1804,NCT04365101,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19),Recruiting,No Results Available,"Coronavirus|Coronavirus Infection|Severe Acute Respiratory Syndrome Coronavirus 2|Pneumonia|Pneumonia, Viral|Lung Diseases|Respiratory Tract Disease|Respiratory Tract Infections|Coronaviridae Infections|Nidovirales Infections|RNA Virus Infections|Virus Disease|Immunologic Disease|ARDS|Immunologic Factors|Physiological Effects of Drugs|Antiviral Agents|Anti-infective Agents|Analgesics|Antimetabolites, Antineoplastic",Biological: CYNK-001,"April 28, 2020","Hackensack University Medical Center, Hackensack, New Jersey, United States|Atlantic Health, Morristown, New Jersey, United States|Atlantic Health, Summit, New Jersey, United States|Multicare Health System, Tacoma, Washington, United States",https://ClinicalTrials.gov/show/NCT04365101
Principal Investigator,"Carla Wilhite, DOT",University of New Mexico,,NCT04409535,carla wilhite,carla,female,0.98,72540,1805,NCT04409535,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,"Active, not recruiting",No Results Available,Activities|Mental Health Issue|Life Style,Other: WHOQOL-BREF survey,"June 1, 2020","University of New Mexico Department of Pediatrics, Albuquerque, New Mexico, United States",https://ClinicalTrials.gov/show/NCT04409535
Principal Investigator,"Paul-Henri Auboiroux, MD",University Hospital of Toulouse,,NCT04422587,paul-henri auboiroux,paul-henri,male,0.99,98,1807,NCT04422587,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,"Active, not recruiting",No Results Available,Emergencies,Other: RECOP unit patient,"June 9, 2020","University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04422587
Principal Investigator,"Lajos Kemény, Prof. Dr.","University of Szeged, Department of Dermatology and Allergology",,NCT04426266,lajos kemény,lajos,male,0.99,5803,1812,NCT04426266,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,"Active, not recruiting",No Results Available,Questionnaire Designs|COVID-19 Pandemic|Psychological Stress|Coping Skills|Two-Item Generalised Anxiety Disorder Scale|Patient Health Questionnaire Anxiety and Depression Scale|Health Status Index|Subjective Health Complaint|Mood,,"June 11, 2020","University of Szeged Department of Dermatology and Allergology, Szeged, Hungary",https://ClinicalTrials.gov/show/NCT04426266
Study Director,"Claus A Bertelsen, PhD",Nordsjaellands Hospital,,NCT04407117,claus a bertelsen,claus,male,0.96,4383,1818,NCT04407117,Appendicitis During the National Lockdown During the COVID-19 Pandemic,Completed,No Results Available,Appendicitis,Behavioral: Lock-down and social distancing,"May 29, 2020","Nordsjaellands Hospital, Hillerød, Denmark",https://ClinicalTrials.gov/show/NCT04407117
Study Chair,"Jianming Tan Tan, M.D and Ph.D",Fuzhou General Hospital,,NCT04371601,jianming tan tan,jianming,male,1.0,53,1820,NCT04371601,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,"Active, not recruiting",No Results Available,COVID-19 Pneumonia,Drug: Oseltamivir|Drug: hormones|Device: oxygen therapy|Procedure: mesenchymal stem cells,"May 1, 2020","Fuzhou General Hospital, Fuzhou, Fujian, China",https://ClinicalTrials.gov/show/NCT04371601
Principal Investigator,"Vanessa Jacoby, MD, MAS","University of California, San Francisco",,NCT04323839,vanessa jacoby,vanessa,female,0.98,123396,1821,NCT04323839,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Recruiting,No Results Available,Pregnancy|Coronavirus|COVID-19,Other: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19|Other: Postpartum women under investigation for Coronavirus or diagnosed with COVID-19,"March 27, 2020","University of California, San Francisco, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04323839
Principal Investigator,"Man Ping Kelvin Wang, PhD",The University of Hong Kong,,NCT04399967,man ping kelvin wang,man,male,0.89,12432,1822,NCT04399967,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Recruiting,No Results Available,Smoking Cessation,Behavioral: Chat-based support|Behavioral: AWARD plus COVID-specific advice|Behavioral: AWARD advice|Behavioral: COVID-19 related health warning leaflet|Behavioral: Health warning leaflet|Behavioral: SMS-based support|Behavioral: Referral card|Behavioral: COSH Self-help smoking cessation booklet,"May 22, 2020","Hong Kong Council on Smoking and Health (COSH), Hong Kong, Hong Kong, China",https://ClinicalTrials.gov/show/NCT04399967
Principal Investigator,"Sheela Rao, MD FRCP",Royal Marsden NHS Foundation Trust,,NCT04427280,sheela rao,sheela,female,0.98,342,1832,NCT04427280,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),Recruiting,No Results Available,Infectious Disease|Cancer|Coronavirus Infection,,"June 11, 2020","The Royal Marden NHS Foundation Trust, Sutton, Surrey, United Kingdom",https://ClinicalTrials.gov/show/NCT04427280
Principal Investigator,"Natasha Belfor, PhD",Miro Health,,NCT04438967,natasha belfor,natasha,female,0.98,17678,1833,NCT04438967,Brain Health in the Time of COVID-19,Recruiting,No Results Available,Brain Health,,"June 19, 2020","Miro Health, San Francisco, California, United States",https://ClinicalTrials.gov/show/NCT04438967
Study Chair,"Majid Saeedi, Ph.D.","Vice-Chancellor for Research, Mazandaran University of Medical Sciences",,NCT04327349,majid saeedi,majid,male,0.98,9133,1837,NCT04327349,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,Enrolling by invitation,No Results Available,Coronavirus Infections,Biological: Convalescent Plasma,"March 31, 2020","Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04327349
Study Chair,"Ayman J Hammoudeh, MD, FACC",JCC Group,,NCT04368637,ayman j hammoudeh,ayman,male,0.97,11330,1838,NCT04368637,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,Recruiting,No Results Available,"Acute Myocardial Infarction|Ventricular Tachycardia|Sudden Cardiac Death|Stroke, Acute",,"April 30, 2020","Istishari Hospital, Amman, Jordan|Abdelhadi Hospital, Amman, Jordan|Farah Hospital, Amman, Jordan|Jordan Hospital, Amman, Jordan|Specialty Hospital, Amman, Jordan",https://ClinicalTrials.gov/show/NCT04368637
Principal Investigator,"Ernest E Moore, MD",Denver Health Medical Center (DHMC),,NCT04357730,ernest e moore,ernest,male,0.98,9066,1840,NCT04357730,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Recruiting,No Results Available,Severe Acute Respiratory Syndrome|Respiratory Failure|Acute Respiratory Distress Syndrome,Drug: Alteplase 50 MG [Activase]|Drug: Alteplase 100 MG [Activase],"April 22, 2020","Denver Health Medical Center, Denver, Colorado, United States",https://ClinicalTrials.gov/show/NCT04357730
Principal Investigator,"Claude Flamand, PhD","Institut Pasteur de la Guyane, Head of Epidemiology Unit",,NCT04328129,claude flamand,claude,male,0.89,34671,1841,NCT04328129,Household Transmission Investigation Study for COVID-19 in French Guiana,Recruiting,No Results Available,Coronavirus Infections|Severe Acute Respiratory Syndrome|SARS-CoV Infection,Procedure: Human biological samples,"March 31, 2020","Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana|Institut Pasteur de la Guyane, Cayenne, French Guiana",https://ClinicalTrials.gov/show/NCT04328129
Principal Investigator,"Erik M Andersson, PhD",Karolinska Institutet,,NCT04341922,erik m andersson,erik,male,0.99,36091,1843,NCT04341922,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Recruiting,No Results Available,Dysfunctional Worry,Behavioral: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic,"April 10, 2020","Karolinska Institutet, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04341922
Study Director,"Maurizio Cipolla, MD","Medical director of UCCP CATANZARO, Italy",,NCT04316728,maurizio cipolla,maurizio,male,0.99,40604,1845,NCT04316728,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Not yet recruiting,No Results Available,Coronavirus Infections,Device: VivaDiag™ COVID-19 lgM/IgG Rapid Test,"March 20, 2020","Unità' Complesse di cure primarie (UCCP), ASP Catanzaro, Catanzaro, Italy",https://ClinicalTrials.gov/show/NCT04316728
Principal Investigator,"VINCENZO BRONTE, MD",University and Hospital Trust of Verona,,NCT04438629,vincenzo bronte,vincenzo,male,0.99,61364,1849,NCT04438629,Evaluation of Immune Response in COVID-19 Patients,Recruiting,No Results Available,Allergy and Immunology|Infection Viral,Drug: COVID-19 treatment,"June 19, 2020","Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy",https://ClinicalTrials.gov/show/NCT04438629
Principal Investigator,"Irini Sereti, M.D.",National Institute of Allergy and Infectious Diseases (NIAID),,NCT04401436,irini sereti,irini,female,0.97,925,1850,NCT04401436,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO),Recruiting,No Results Available,Corona Virus Disease 2019,,"May 26, 2020","MedStar Georgetown University Hospital, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04401436
Principal Investigator,"Escarlata López Ramírez, MD, PhD",Fundacion GenesisCare,,NCT04394182,escarlata lópez ramírez,escarlata,female,0.99,200,1851,NCT04394182,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Recruiting,No Results Available,"Pneumonia, Viral|Cytokine Storm",Radiation: Ultra-Low-dose radiotherapy|Device: ventilatory support with oxygen therapy|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Piperacillin/tazobactam|Drug: Low molecular weight heparin|Drug: Corticosteroid injection|Drug: Tocilizumab,"May 19, 2020","Hospital La Milagrosa, GenesisCare, Madrid, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain",https://ClinicalTrials.gov/show/NCT04394182
Study Director,"Nana Sarnadi, Sp.OG",director of research and develpment,,NCT04407208,nana sarnadi,nana,female,0.82,32306,1852,NCT04407208,Convalescent Plasma Therapy in Patients With COVID-19,Recruiting,No Results Available,Convalescence|Corona Virus Infection|Plaque,Biological: Convalescent plasma,"May 29, 2020","Gatot Soebroto central army presidential hospital, Jakarta Pusat, Indonesia",https://ClinicalTrials.gov/show/NCT04407208
Principal Investigator,Christelle Vauloup Fellous,Assistance Publique - Hôpitaux de Paris,,NCT04355234,christelle vauloup fellous,christelle,female,0.98,47991,1857,NCT04355234,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Not yet recruiting,No Results Available,Pregnancy,Diagnostic Test: identify SARS-CoV-2 infection by serology|Biological: collection of biological samples,"April 21, 2020",,https://ClinicalTrials.gov/show/NCT04355234
Study Chair,"Kazuko Matsuda, MD PhD MPH",Medicinova Inc,,NCT04429555,kazuko matsuda,kazuko,female,0.98,181,1860,NCT04429555,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",Not yet recruiting,No Results Available,"Pneumonia, Viral",Drug: Ibudilast|Drug: Placebo,"June 12, 2020",,https://ClinicalTrials.gov/show/NCT04429555
Principal Investigator,"Ara Darzi, Prof",Institute of Global Health Innovation,,NCT04337489,ara darzi,ara,female,0.67,2754,1868,NCT04337489,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Not yet recruiting,No Results Available,Coronavirus,Device: SensiumVitals wearable sensor,"April 7, 2020",,https://ClinicalTrials.gov/show/NCT04337489
Principal Investigator,"Matteo Bertini, MD, PhD",s.anna university hospital,,NCT04367129,matteo bertini,matteo,male,0.99,69199,1869,NCT04367129,Electrocardiogram Analysis in COVID-19 Patients,Recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: ECG,"April 29, 2020","Arcispedale S. Anna, Ferrara, Italy",https://ClinicalTrials.gov/show/NCT04367129
Principal Investigator,"Jiahong Dong, M.D",Beijing Tsinghua Changgung Hospital,,NCT04256395,jiahong dong,jiahong,male,0.79,19,1871,NCT04256395,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Recruiting,No Results Available,Susceptibility to Viral and Mycobacterial Infection,Other: mobile internet survey on self-test,"February 5, 2020","Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04256395
Principal Investigator,"Vijay A Ramchandani, Ph.D.",National Institute on Alcohol Abuse and Alcoholism (NIAAA),,NCT04391816,vijay a ramchandani,vijay,male,0.99,4926,1881,NCT04391816,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,Recruiting,No Results Available,Alcohol Drinking|Alcohol-Related Disorders|Pandemic|Psychological Stress,,"May 18, 2020","NIAAA Section on Human Psychopharmacology, Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04391816
Principal Investigator,"Charlotte Dubucs, MD","University Hospital, Toulouse",,NCT04360811,charlotte dubucs,charlotte,female,0.97,37761,1920,NCT04360811,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Recruiting,No Results Available,Pregnancy,Diagnostic Test: COVID 19 diagnostic test by PCR,"April 24, 2020","University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04360811
Study Director,"Fabrizio Cantini, MD","Hospital of Prato, Italy",,NCT04320277,fabrizio cantini,fabrizio,male,0.99,34325,1887,NCT04320277,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Not yet recruiting,No Results Available,Pharmacological Action,Drug: Baricitinib,"March 24, 2020","Fabrizio Cantini, Prato, Tuscany, Italy",https://ClinicalTrials.gov/show/NCT04320277
Principal Investigator,"Rajesh Hosadurga, Ph.D","Melaka-Manipal Medical College, Melaka, Malaysia",,NCT04449081,rajesh hosadurga,rajesh,male,0.99,5461,1895,NCT04449081,"Knowledge, Attitude and Practice of Dental Students About COVID-19",Completed,No Results Available,Acute Respiratory Distress Syndrome|Corona Virus Infection|Acute Lung Injury|Fever|Myalgia|Cough|Dyspnea|Septic Shock|Bleeding,"Behavioral: Knowledge, Attitude, Practice, Awareness, Preference","June 26, 2020","Faculty of Dentistry, Melaka-Manipal Medical College, Melaka Tengah, Melaka, Malaysia",https://ClinicalTrials.gov/show/NCT04449081
Principal Investigator,"Grethe Andersen, MD",Aarhus University Hospital,,NCT04377425,grethe andersen,grethe,female,0.98,426,1896,NCT04377425,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Not yet recruiting,No Results Available,"Neurological Diseases or Conditions|Stroke, Acute|Seizure Disorder",Diagnostic Test: COVID-19 swap test PCR,"May 6, 2020","Aalborg University Hospital, Aalborg, DK, Denmark|Aarhus University Hospital, Aarhus, DK, Denmark|Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark|Regional Hospital Central Jutland, Viborg, Viborg, DK, Denmark",https://ClinicalTrials.gov/show/NCT04377425
Principal Investigator,"Rupesh Agrawal, MD",Tan Tock Seng Hospital,,NCT04342156,rupesh agrawal,rupesh,male,0.99,517,1897,NCT04342156,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Not yet recruiting,No Results Available,Coronavirus Infection|Hydroxychloroquine Adverse Reaction,Drug: Hydroxychloroquine Sulfate 200 milligram (mg) Tab,"April 10, 2020",,https://ClinicalTrials.gov/show/NCT04342156
Principal Investigator,"Luciano Cesar Pontes Azevedo, Ph.D",Teaching Director of Teaching & Research Institute Sírio-Libanês Hospital,,NCT04327401,luciano cesar pontes azevedo,luciano,male,0.99,23887,1900,NCT04327401,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Recruiting,No Results Available,"Coronavirus Infection|Pneumonia, Viral|Acute Respiratory Distress Syndrome",Drug: Dexamethasone,"March 31, 2020","Hospital Ana Nery, Salvador, Bahia, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, Distrito Federal, Brazil|Fundação Social Rural de Colatina, Colatina, Esoírito Santo, Brazil|Hospital Vera Cruz AS, Belo Horizonte, Minas Gerais, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Eurolatino Natal Pesquisas Médicas Ltda, Natal, Rio Grande Do Norte, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP - HCFMRP, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Prevent Senior Private Operadora de Saude Ltda, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP, São Paulo, Brazil|Santa Casa de Misericórdia, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo, Brazil",https://ClinicalTrials.gov/show/NCT04327401
Study Director,"INA I SHARIFFUDDIN, MAnaes",University of Malaya,,NCT04385576,ina i shariffuddin,ina,female,0.97,12215,1905,NCT04385576,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Recruiting,No Results Available,COVID-19|Airway,Device: Aerosol Box|Device: Intubation Box,"May 13, 2020","University Malaya Medical Centre, Kuala Lumpur, Selangor, Malaysia",https://ClinicalTrials.gov/show/NCT04385576
Principal Investigator,"Jacek Smereka, PhD",Wroclaw Medical University,,NCT04366297,jacek smereka,jacek,male,0.99,31243,1908,NCT04366297,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Completed,No Results Available,Cardiac Arrest|Emergencies,Device: Intravenous access|Device: Intraosseous access,"April 28, 2020","Lazarski Univeristy, Warsaw, Poland",https://ClinicalTrials.gov/show/NCT04366297
Principal Investigator,Nelson Trelles,Centre Hospitalier René Dubos,,NCT04361396,nelson trelles,nelson,male,0.98,24495,1909,NCT04361396,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Recruiting,No Results Available,Coronavirus Infection,Other: Collection of samples,"April 24, 2020","Department of General and Digestive Surgery, Hospital René Dubos, Pontoise, France|Department of Gynecology-Obstetrics, Hospital René Dubos, Pontoise, France",https://ClinicalTrials.gov/show/NCT04361396
Study Director,"Leander Grode, Dr rer nat",Vakzine Projekt Management GmbH,,NCT04387409,leander grode,leander,male,0.96,514,1911,NCT04387409,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,Recruiting,No Results Available,"Infection, Respiratory Tract",Biological: VPM1002|Biological: Placebo,"May 13, 2020","Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany",https://ClinicalTrials.gov/show/NCT04387409
Study Director,"Leander Grode, Dr. rer. nat.",Vakzine Projekt Management GmbH,,NCT04435379,leander grode,leander,male,0.96,514,2234,NCT04435379,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Recruiting,No Results Available,"Infection, Respiratory Tract",Biological: VPM1002|Biological: Placebo,"June 17, 2020","Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany|emovis GmbH, Berlin, Germany|Klinische Forschung Berlin GbR, Berlin, Germany",https://ClinicalTrials.gov/show/NCT04435379
Principal Investigator,"Joyce Y Chung, M.D.",National Institute of Mental Health (NIMH),,NCT04339790,joyce y chung,joyce,female,0.96,16082,1912,NCT04339790,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Recruiting,No Results Available,Healthy Volunteer|Mood Disorder|Anxiety Disorder|Preexisting Medical Condition,,"April 9, 2020","National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04339790
Principal Investigator,"Jacques REYNES, MD,PhD",Montpellier University Hospital,,NCT04345861,jacques reynes,jacques,male,0.98,29221,1913,NCT04345861,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Terminated,No Results Available,"Coronavirus Infection|Pneumonia, Viral",Drug: Hydroxychloroquine + placebo|Drug: hydroxychloroquine + azithromycin,"April 15, 2020","Montpellier University hospital, Montpellier, France",https://ClinicalTrials.gov/show/NCT04345861
Principal Investigator,"Elise Noël-Savina, MD",University Hospital of Toulouse,,NCT04422613,elise noël-savina,elise,female,0.96,14846,1917,NCT04422613,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Recruiting,No Results Available,"Pneumonia, Viral",Diagnostic Test: pulmonary anomalies 4 months after documented COVID-19 pneumonia,"June 9, 2020","University Hospital of Toulouse, Toulouse, France",https://ClinicalTrials.gov/show/NCT04422613
Principal Investigator,"Aleksandra Luszczynska, PhD",SWPS University of Social Sciences and Humanities,,NCT04367337,aleksandra luszczynska,aleksandra,female,0.98,49679,1919,NCT04367337,Health Behavior Change During COVID-19 Pandemic,Recruiting,No Results Available,Health Behavior,Other: No intervention,"April 29, 2020","the University of Melbourne, Melbourne, Australia|University of New Brunswick, Fredericton, Canada|Peking University, Beijing, China|University of Bordeaux, Bordeaux, France|London School of Hygiene and Tropical Medicine (in collaboration with MRC Unit The Gambia at LSHTM), Fajara, Gambia|Freie Universität Berlin, Berlin, Germany|Bar-Ilan University, Ramat Gan, Israel|University of Padova, Padova, Italy|Perdana University, Serdang, Malaysia|SWPS University of Social Sciences and Humanities, Wroclaw, Lower Silezia, Poland|University of Lisbon, Lisbon, Portugal|Babes-Bolyai Unversity, Cluj-Napoca, Romania|Nanyang Technological University, Singapore, Singapore|University of Zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04367337
Study Director,"Sudarshan Hebbar, MD","CalciMedica, Inc.",,NCT04345614,sudarshan hebbar,sudarshan,male,0.98,194,1923,NCT04345614,A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia,Recruiting,No Results Available,Pneumonia,Drug: CM4620-Injectable Emulsion,"April 14, 2020","Henry Ford Hospital, Detroit, Michigan, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04345614
Principal Investigator,"Ronny K Gunnarsson, MD PhD","Primary Health care, Regionhalsan, Region Vastra Gotaland, Sweden",,NCT04383457,ronny k gunnarsson,ronny,male,0.98,15356,1926,NCT04383457,Covid-19 Triage Using Camera-based AI,Recruiting,No Results Available,Coronavirus Infections,Device: RIA-device (Remote Investigation and Assessment),"May 12, 2020","Östra Sjukhuset, Gothenburg, Sweden",https://ClinicalTrials.gov/show/NCT04383457
Principal Investigator,"Giorgio Limerutti, M.D.",Radiology Unit A.O.U. Città della Salute e della Scienza,,NCT04419545,giorgio limerutti,giorgio,male,0.99,41494,1928,NCT04419545,Covid Radiographic Images Data-set for A.I,Recruiting,No Results Available,Radiology|Artificial Intelligence,Diagnostic Test: Neural network diagnosis algorithm,"June 5, 2020","Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Turin, Italy",https://ClinicalTrials.gov/show/NCT04419545
Principal Investigator,"Andrey I Yaroshetskiy, Dr.Med.Sc.",Sechenov University,,NCT04445961,andrey i yaroshetskiy,andrey,male,0.99,16822,1931,NCT04445961,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,Recruiting,No Results Available,SARS Pneumonia,Diagnostic Test: Respiratory mechanics measurement|Diagnostic Test: Gas exchange measurement,"June 24, 2020","Sechenov University Clinic #1, Moscow, Russian Federation|Sechenov University Clinic #3, Moscow, Russian Federation|Sechenov University Clinic #4, Moscow, Russian Federation",https://ClinicalTrials.gov/show/NCT04445961
Principal Investigator,Malika DELOBEL-AYOUB,"University Hospital, Toulouse",,NCT04416360,malika delobel-ayoub,malika,female,0.97,10253,1932,NCT04416360,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Recruiting,No Results Available,Autism Spectrum Disorder|Attention-deficit Hyperactivity Disorder,Other: Interview by psychologists,"June 4, 2020","University hospital of Toulouse, Toulouse, Occitanie, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Esquirol, Limoges, France|Hôpital Robert-Debré (AP-HP), Paris, France|Maison de Solenn (Hôpital Cochin AP-HP), Paris, France",https://ClinicalTrials.gov/show/NCT04416360
Principal Investigator,"Ravindra Prof. Gupta, BMBCh",University of Cambridge & Cambridge University Hospitals NHS Foundation Trust,,NCT04326387,ravindra prof. gupta,ravindra,male,0.99,662,1937,NCT04326387,Evaluation of Novel Diagnostic Tests for COVID-19,Recruiting,No Results Available,Acute Disease|Coronavirus|Respiratory Viral Infection,Diagnostic Test: SAMBA II (Diagnostic for the Real World)|Diagnostic Test: Public Health England Gold Standard|Diagnostic Test: Cambridge Validated Viral Detection Method|Diagnostic Test: Radiological Detection,"March 30, 2020","Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04326387
Principal Investigator,"Afroze Khan, MBBS MRCS",Hampshire Hospitals NHS Foundation Trust,,NCT04393792,afroze khan,afroze,male,0.69,13,1939,NCT04393792,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Recruiting,No Results Available,Coronavirus Infection,Drug: Povidone-Iodine|Drug: Normal saline,"May 19, 2020","Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04393792
Principal Investigator,"Houssein Youness, MD",University of Oklahoma HSC - OKC Veterans Affairs Medical Center,,NCT04416919,houssein youness,houssein,male,0.95,919,1940,NCT04416919,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Not yet recruiting,No Results Available,Coronavirus Infection|Disease Prevention,Other: Assembled mask,"June 4, 2020","Oklahoma City VA Health Care System, Oklahoma City, Oklahoma, United States",https://ClinicalTrials.gov/show/NCT04416919
Principal Investigator,"Darrell Tan, MD FRCPC PhD","St. Michael's Hospital, Toronto",,NCT04321174,darrell tan,darrell,male,0.98,1701,1950,NCT04321174,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Recruiting,No Results Available,Coronavirus Infections|Post-exposure Prophylaxis,Drug: Lopinavir/ritonavir,"March 25, 2020","St. Paul's Hospital, Vancouver, British Columbia, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04321174
Principal Investigator,Erwan VION,Centre Hospitalier René Dubos,,NCT04370210,erwan vion,erwan,male,0.99,6446,1957,NCT04370210,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Recruiting,No Results Available,Sleep Disturbance,Behavioral: Questionnaires,"April 30, 2020","Centre Hospitalier René Dubos, Pontoise, France",https://ClinicalTrials.gov/show/NCT04370210
Principal Investigator,"Emanuela Keller, Prof. Dr.","University Hospital, Zürich",,NCT04418609,emanuela keller,emanuela,female,0.99,16539,1959,NCT04418609,Neuro-COVID-19: Neurological Complications of COVID-19,Recruiting,No Results Available,Neurologic Complication,Other: further processing of health data,"June 5, 2020","University Hospital Zurich, Zürich, Switzerland",https://ClinicalTrials.gov/show/NCT04418609
Principal Investigator,"Salome Kristensen, MD, PhD","Department of Rheumatology, Aalborg University Hospital",,NCT04335747,salome kristensen,salome,female,0.97,3168,1967,NCT04335747,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Recruiting,No Results Available,Rheumatoid Arthritis|Psoriatic Arthritis|Axial Spondyloarthritis|Systemic Lupus Erythematosus|Giant Cell Arteritis,Other: COVID-19 infection,"April 6, 2020","Aalborg University Hospital, Aalborg, Denmark",https://ClinicalTrials.gov/show/NCT04335747
Principal Investigator,"Hannelore Denys, MD, PhD",Medical Oncologist,,NCT04340219,hannelore denys,hannelore,female,0.97,1463,1969,NCT04340219,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic","Active, not recruiting",No Results Available,Cancer,Other: Survey administration,"April 9, 2020","University Hospital Gent, Gent, Belgium",https://ClinicalTrials.gov/show/NCT04340219
Principal Investigator,"Geltrude Mingrone, MD",Fondazione Policlinico Universitario A. Gemelli IRCCS,,NCT04387799,geltrude mingrone,geltrude,female,0.87,165,1972,NCT04387799,Determinants of COVID-19 Pneumonia (MC-19),Completed,No Results Available,"Pneumonia, Viral|Pneumonia, Bacterial|Coronavirus Infection|Obstructive Lung Disease",Diagnostic Test: Serology for Covid-19,"May 14, 2020","Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy",https://ClinicalTrials.gov/show/NCT04387799
Principal Investigator,"Geltrude Mingrone, MD PhD",Fondazione Policlinico Universitario A. Gemelli IRCCS,,NCT04324684,geltrude mingrone,geltrude,female,0.87,165,2022,NCT04324684,Prognostic Factors Keeping Track for COVID-19 Pneumonia,Completed,No Results Available,"Pneumonia, Viral|Hypertension|Diabetes Mellitus|Obesity|Cardiovascular Diseases|Obstructive Lung Disease",,"March 27, 2020","Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy",https://ClinicalTrials.gov/show/NCT04324684
Principal Investigator,"Sanjay K Jain, MD",Johns Hopkins University,,NCT04377672,sanjay k jain,sanjay,male,0.99,4711,1975,NCT04377672,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),Recruiting,No Results Available,Corona Virus Infection,Biological: Anti-SARS-CoV-2 Human Convalescent Plasma,"May 6, 2020","Johns Hopkins Hospitals, Baltimore, Maryland, United States",https://ClinicalTrials.gov/show/NCT04377672
Principal Investigator,"Suneeta Monga, MD, FRCPC",The Hospital for Sick Children (SickKids),,NCT04408027,suneeta monga,suneeta,female,1.0,16,1978,NCT04408027,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Not yet recruiting,No Results Available,Anxiety Disorder of Childhood or Adolescence,Behavioral: Virtual-Care Cognitive Behavioural Therapy,"May 29, 2020","The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04408027
Study Director,Celine BAIS,"University Hospital, Montpellier",,NCT04448405,celine bais,celine,female,0.99,62291,1979,NCT04448405,Covid-19 Lockdown and Deviant Sexual Fantasies,Recruiting,No Results Available,Deviant Sexual Fantasies,Behavioral: Questionnaire for evaluation of confinement on deviant sexual fantasies,"June 25, 2020","Uhmontpellier, Montpellier, France",https://ClinicalTrials.gov/show/NCT04448405
Principal Investigator,"Zhuan Liao, MD",Changhai Hospital,,NCT04320953,zhuan liao,zhuan,male,0.62,13,1983,NCT04320953,Non-contact Endoscopy at Covid-19 Outbreak,Completed,No Results Available,Gastrointestinal Disease|Infectious Disease,Device: Non-contact MCE system,"March 25, 2020","Changhai Hospital, Shanghai, China",https://ClinicalTrials.gov/show/NCT04320953
Study Chair,"Zhuan Liao, MD","Department of Gastroenterology, Changhai Hospital, the Naval Medical University",,NCT04389333,zhuan liao,zhuan,male,0.62,13,2140,NCT04389333,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Recruiting,No Results Available,Gastrointestinal Disease|Infectious Disease|Capsule Endoscopy,Device: non-contact magnetically-controlled capsule endoscopy,"May 15, 2020","Changhai Hospital, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04389333
Study Director,Yalim Dikmen,Prof,,NCT04345887,yalim dikmen,yalim,male,0.96,27,1984,NCT04345887,Spironolactone in Covid-19 Induced ARDS,Not yet recruiting,No Results Available,"Respiratory Distress Syndrome, Adult",Drug: Spironolactone 100mg|Drug: Placebo oral tablet,"April 15, 2020","Istanbul University-Cerrahpaşa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04345887
Principal Investigator,Dr.Jassim Alsuwaidi Senior Consultant,HMC,,NCT04430374,jassim alsuwaidi senior consultant,jassim,male,0.98,1050,1985,NCT04430374,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,Recruiting,No Results Available,Cardiovascular Diseases,Other: No interverntion,"June 12, 2020","Hamad Medical Corporation, Doha, Unlisted (UL), Qatar",https://ClinicalTrials.gov/show/NCT04430374
Principal Investigator,"Malek Khemili, Resident","Department of anesthesia and intensive care, Fattouma Bourguiba Hospital",,NCT04348227,malek khemili,malek,male,0.88,6665,2004,NCT04348227,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,"Active, not recruiting",No Results Available,Ventilator Associated Pneumonia,Behavioral: Enhanced hygiene measures,"April 16, 2020","Department of anesthesia and intensive care, Fattouma Bourguiba Hospital, Monastir, Tunisia",https://ClinicalTrials.gov/show/NCT04348227
Study Chair,ayse su cinar,,,NCT04424836,ayse su cinar,ayse,female,0.96,16275,2006,NCT04424836,HFNC Treatment in COVID-19 Pneumonia,Recruiting,No Results Available,"Coronavirus Infection|Pneumonia, Viral|Acute Respiratory Failure",Device: high flow nasal cannula device,"June 11, 2020","Sisli Etfal Research and Training Hospital, Istanbul, Turkey|Sisli Etfal Research and Training Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04424836
Principal Investigator,"Brett D Thombs, PhD","Lady Davis Institute, Sir Mortimer B. Davis Jewish General Hospital, McGill University",,NCT04335279,brett d thombs,brett,male,0.99,5601,2007,NCT04335279,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Recruiting,No Results Available,"Scleroderma|Scleroderma, Systemic|Systemic Sclerosis",Other: SPIN-CHAT Program,"April 6, 2020","Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04335279
Principal Investigator,Cai Yue,the first affiliated hospital of the Air force medical university,,NCT04365309,cai yue,cai,male,0.61,620,2008,NCT04365309,Protective Effect of Aspirin on COVID-19 Patients,Enrolling by invitation,No Results Available,Novel Coronavirus Pneumonia|Aspirin|Treatment,Drug: Aspirin 100mg,"April 28, 2020","Cai Yue, Xi'an, Shaanxi, China",https://ClinicalTrials.gov/show/NCT04365309
Principal Investigator,"Teck Ho, PhD","National University, Singapore",,NCT04410692,teck ho,teck,male,0.95,475,2024,NCT04410692,Can the Prediction Market Improve Predictions of COVID-19?,Completed,No Results Available,"Health Knowledge, Attitudes, Practice",Other: Prediction Market,"June 1, 2020","National University of Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04410692
Study Director,"Dante M Beltramo, PhD",Centro de Excelencia en Productos y Procesos Córdoba,,NCT04382768,dante m beltramo,dante,male,0.98,5943,2025,NCT04382768,Inhaled Ibuprofen to Treat COVID-19,Recruiting,No Results Available,Coronavirus Infection|Respiratory Disease|SARS (Disease),Drug: Inhaled Hypertonic ibuprofen,"May 11, 2020","Centro de Excelencia en Productos y Procesos Córdoba, Córdoba, Argentina",https://ClinicalTrials.gov/show/NCT04382768
Principal Investigator,"Britt Burton-Freeman, Ph.D",Illinois Insititute of Technology,,NCT04357041,britt burton-freeman,britt,female,0.94,2220,2027,NCT04357041,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being","Active, not recruiting",No Results Available,"ALL, Adult",,"April 22, 2020","Clinical Nutrition Research Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04357041
Principal Investigator,"Yves Beguin, MD,PhD",CHU de Liège,,NCT04445454,yves beguin,yves,male,0.98,27837,2032,NCT04445454,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,Recruiting,No Results Available,Coronavirus Infection,Biological: Mesenchymal stromal cells,"June 24, 2020","CHU de Liège, Liège, Belgium",https://ClinicalTrials.gov/show/NCT04445454
Principal Investigator,Kardelen Gencer,Marmara University,,NCT04400006,kardelen gencer,kardelen,female,0.95,3426,2033,NCT04400006,Ozone Therapy in the Prevention of COVID-19 Infection,Completed,No Results Available,Corona Virus Infection,,"May 22, 2020","Kardelen Gencer Atalay, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04400006
Principal Investigator,"Agnes YK Lai, PhD","School of Nursing, The University of Hong Kong",,NCT04365361,agnes yk lai,agnes,female,0.98,15854,2034,NCT04365361,The Psychological Impact of the COVID-19 on Students.,Recruiting,No Results Available,Mental Health Wellness 1,,"April 28, 2020","LAI Agnes, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04365361
Principal Investigator,"Agnes YK Lai, PhD",The University of Hong Kong,,NCT04365348,agnes yk lai,agnes,female,0.98,15854,2081,NCT04365348,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,Recruiting,No Results Available,Mental Health Wellness 1,,"April 28, 2020","Agnes, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04365348
Principal Investigator,"Swati Mehta, PhD",Lawson Health Research Institute,,NCT04408287,swati mehta,swati,female,0.98,714,2045,NCT04408287,Improving Activity Engagement Among Persons With SCI During COVID-19,Not yet recruiting,No Results Available,Spinal Cord Injuries,Other: WebEx Physical Activity Program,"May 29, 2020","St. Josephs Parkwood Institute, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04408287
Principal Investigator,"Eldon Loh, PhD","Parkwood Institute, St. Joseph's Health Care London",,NCT04408287,eldon loh,eldon,male,0.99,206,2045,NCT04408287,Improving Activity Engagement Among Persons With SCI During COVID-19,Not yet recruiting,No Results Available,Spinal Cord Injuries,Other: WebEx Physical Activity Program,"May 29, 2020","St. Josephs Parkwood Institute, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04408287
Principal Investigator,"Eldon Loh, MD",St. Joseph's Health Care London,,NCT04426071,eldon loh,eldon,male,0.99,206,2267,NCT04426071,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,Not yet recruiting,No Results Available,Brain Injuries|Stroke|Spinal Cord Injuries,,"June 11, 2020","Lawson Health Research Institute, London, Ontario, Canada",https://ClinicalTrials.gov/show/NCT04426071
Principal Investigator,"Viviana E Horigian, MD",University of Miami,,NCT04440098,viviana e horigian,viviana,female,0.99,11961,2046,NCT04440098,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,Completed,No Results Available,Loneliness|Depression|Anxiety|Alcohol Abuse|Drug Abuse,,"June 19, 2020","University of Miami, Miami, Florida, United States",https://ClinicalTrials.gov/show/NCT04440098
Principal Investigator,Dalili,SBMU,,NCT04375137,dalili,dalili,female,0.55,11,2047,NCT04375137,Correlation Between Oxidative Stress Status and COVID-19 Severity,Recruiting,No Results Available,Oxidative Stress,Diagnostic Test: Oxidative Stress ELISA Kit,"May 5, 2020","Nooshin Dalili, Tehran, Iran, Islamic Republic of",https://ClinicalTrials.gov/show/NCT04375137
Principal Investigator,"Bodil Steen Rasmussen, MD, PhD","Aalborg University Hospital, Denmark",,NCT04425031,bodil steen rasmussen,bodil,female,0.98,653,2048,NCT04425031,Handling Oxygenation Targets in COVID-19,Not yet recruiting,No Results Available,Hypoxemic Respiratory Failure|Oxygen Toxicity,Drug: Oxygen,"June 11, 2020","Dept. of Intensive Care, Aalborg University Hospital, Aalborg, Denmark",https://ClinicalTrials.gov/show/NCT04425031
Study Chair,"Bodil Steen Rasmussen, MD, PhD","Aalborg University Hospital, Denmark",,NCT04425031,bodil steen rasmussen,bodil,female,0.98,653,2048,NCT04425031,Handling Oxygenation Targets in COVID-19,Not yet recruiting,No Results Available,Hypoxemic Respiratory Failure|Oxygen Toxicity,Drug: Oxygen,"June 11, 2020","Dept. of Intensive Care, Aalborg University Hospital, Aalborg, Denmark",https://ClinicalTrials.gov/show/NCT04425031
Principal Investigator,"Vence L Bonham, J.D.",National Human Genome Research Institute (NHGRI),,NCT04417673,vence l bonham,vence,male,0.9,40,2049,NCT04417673,Living With Sickle Cell Disease in the COVID-19 Pandemic,Not yet recruiting,No Results Available,Isolation|Anxiety|Health Care Utilization|Sickle Cell Disease|Pain,,"June 5, 2020","University of Wisconsin, Madison, Wisconsin, United States",https://ClinicalTrials.gov/show/NCT04417673
Principal Investigator,"Kari Nadeau, MD, PhD",Stanford University,,NCT04373148,kari nadeau,kari,female,0.5,5594,2051,NCT04373148,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Recruiting,No Results Available,Coronavirus,Other: There is no intervention,"May 4, 2020","Stanford University, Hospital, and Clinics, Stanford, California, United States",https://ClinicalTrials.gov/show/NCT04373148
Principal Investigator,"wolfgang Kemmler, PhD","Institute of Medical Physics, Friedrich-Alexander University Erlangen-Nürnberg",,NCT04444661,wolfgang kemmler,wolfgang,male,0.99,12915,2053,NCT04444661,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,"Active, not recruiting",No Results Available,Osteoporosis|Sarcopenia,,"June 23, 2020","Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Bavaria, Germany",https://ClinicalTrials.gov/show/NCT04444661
Study Director,"Björn Persson, MD PhD",Karolinska University,,NCT04424082,björn persson,björn,male,1.0,517,2058,NCT04424082,External Dead Space in Ventilated COVID-19 Patients,Recruiting,No Results Available,"Coronavirus|ARDS, Human",Other: Removal of dead space filter,"June 9, 2020","Karolinska University Hospital, Stockholm, Sweden",https://ClinicalTrials.gov/show/NCT04424082
Principal Investigator,"Qiong Gong, MD.",Renmin Hospital of Wuhan University,,NCT04302688,qiong gong,qiong,female,0.84,114,2063,NCT04302688,Accurate Classification System for Patients With COVID-19 Pneumonitis,Completed,No Results Available,Pneumonitis,,"March 10, 2020","Renmin Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04302688
Study Chair,"Lukasz Szarpak, PhD",Lazarski University,,NCT04366947,lukasz szarpak,lukasz,male,0.99,12943,2074,NCT04366947,Intravascular Access in Suspected/Confirmed COVID-19 Patient,"Active, not recruiting",No Results Available,Emergency Medicine|Cardiopulmonary Arrest|Shock,Device: NIO® (Intraosseous access)|Device: Standard of Care (Intravenous access),"April 29, 2020","Lazarsku University, Warsaw, Masovian, Poland",https://ClinicalTrials.gov/show/NCT04366947
Principal Investigator,"Monique Ernst, M.D.",National Institute of Mental Health (NIMH),,NCT04377100,monique ernst,monique,female,0.98,28808,2077,NCT04377100,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Not yet recruiting,No Results Available,Anxiety|Healthy Volunteers,Behavioral: Computer task questionnaires,"May 6, 2020","National Institute of Mental Health (NIMH), Bethesda, Maryland, United States",https://ClinicalTrials.gov/show/NCT04377100
Principal Investigator,"Renee Murray-Bachmann, Ed.D, MSN",Northwell Health,,NCT04417270,renee murray-bachmann,renee,female,0.89,3998,2090,NCT04417270,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Not yet recruiting,No Results Available,Diabetes Mellitus,Device: Freestyle Libre 14 day CGM system|Device: Accuchek Inform II platform,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04417270
Principal Investigator,"Jérome MOREL, MD PhD",CHU de Saint Etienne,,NCT04363606,jérome morel,jérome,male,1.0,5,2102,NCT04363606,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Recruiting,No Results Available,Chronic Fatigue Syndrome|Intensive Care Unit|Muscle,Other: Questionnaires|Biological: blood test|Other: Maximal effort test|Device: actigraphy|Device: Neuromuscular evaluation,"April 27, 2020","CHU de Grenoble, Grenoble, France|Clinique de la Sauvegarde - Lyon, Lyon, France|Hôpital Croix Rousse - HCL, Lyon, France|Chu Saint-Etienne, Saint Etienne, France|Clinique Mutualiste Saint Etienne, Saint Etienne, France|Hôpital privé de la Loire, Saint-Étienne, France",https://ClinicalTrials.gov/show/NCT04363606
Principal Investigator,Ethan Berke,UnitedHealth Group Research & Development,,NCT04327804,ethan berke,ethan,male,0.99,3521,2105,NCT04327804,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: Odd/Even birth year intervention groups,"March 31, 2020","Everett Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04327804
Principal Investigator,Yuan Tu,"OptumCare, Everett Clinic",,NCT04327804,yuan tu,yuan,male,0.56,1393,2105,NCT04327804,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Recruiting,No Results Available,SARS-CoV Infection,Diagnostic Test: Odd/Even birth year intervention groups,"March 31, 2020","Everett Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04327804
Principal Investigator,"Ethan Berke, MD",UnitedHealth Group,,NCT04321369,ethan berke,ethan,male,0.99,3521,2126,NCT04321369,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Completed,No Results Available,"Infections, Respiratory|Fever|Cough",Diagnostic Test: Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,"March 25, 2020","Everett Clinic, Seattle, Washington, United States",https://ClinicalTrials.gov/show/NCT04321369
Principal Investigator,"Zhongtao Zhang, M.D.",Beijing Friendship Hospital,,NCT04401124,zhongtao zhang,zhongtao,male,1.0,5,2106,NCT04401124,Status of Management of Surgery in Beijing During COVID-19,Not yet recruiting,No Results Available,Gastric Cancer|Colorectal Cancer|Gastrointestinal Disease,Other: no intervention,"May 26, 2020",,https://ClinicalTrials.gov/show/NCT04401124
Study Chair,"Jeanine El Helou, MD, MSc",USJ,,NCT04372043,jeanine el helou,jeanine,female,0.98,3423,2109,NCT04372043,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Not yet recruiting,No Results Available,Sleep Hygiene,Other: Questionnaire,"May 1, 2020","Saint Joseph University, Beirut, Lebanon",https://ClinicalTrials.gov/show/NCT04372043
Principal Investigator,"Jie Li, PhD",Rush University Medical Center,,NCT04325906,jie li,jie,male,0.57,1619,2110,NCT04325906,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Recruiting,No Results Available,Prone Positioning|High Flow Nasal Cannula|Acute Respiratory Distress Syndrome|Corona Virus Infection,Device: high flow nasal cannula (HFNC)|Procedure: Prone positioning (PP),"March 30, 2020","Rush University Medical Center, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04325906
Principal Investigator,Evelyne Schvoerer,CHRU Nancy,,NCT04448769,evelyne schvoerer,evelyne,female,0.98,13782,2113,NCT04448769,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Not yet recruiting,No Results Available,Coronavirus Infection|Prevalence,Biological: Anti-SARS-CoV-2 IgT seropositivity,"June 26, 2020",,https://ClinicalTrials.gov/show/NCT04448769
Principal Investigator,ILKE KUPELI,Dr.,,NCT04373213,ilke kupeli,ilke,female,0.72,634,2122,NCT04373213,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Not yet recruiting,No Results Available,Pleth Variability Index,Diagnostic Test: Pleth variability index,"May 4, 2020","Erzincan University, Erzincan, Turkey",https://ClinicalTrials.gov/show/NCT04373213
Principal Investigator,Brahm H Segal,Roswell Park Cancer Institute,,NCT04379518,brahm h segal,brahm,male,0.88,171,2123,NCT04379518,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Not yet recruiting,No Results Available,Malignant Neoplasm|SARS Coronavirus 2 Infection,Biological: Recombinant Interferon Alfa-2b|Drug: Rintatolimod,"May 7, 2020","Roswell Park Cancer Institute, Buffalo, New York, United States",https://ClinicalTrials.gov/show/NCT04379518
Principal Investigator,"Gérard Amarenco, PhD","Sorbonne Université, GRC 001, GREEN Groupe de Recherche en Neuro-Urologie, AP-HP, Hôpital Tenon, F-75020, Paris, France",,NCT04341714,gérard amarenco,gérard,male,1.0,94,2124,NCT04341714,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Recruiting,No Results Available,"Efficacy, Self|Satisfaction, Patient|Telemedicine",Other: Satisfaction evaluation,"April 10, 2020","Department of Neuro- Urology, Hôpital Tenon, Paris, France",https://ClinicalTrials.gov/show/NCT04341714
Principal Investigator,"jianheng zhang, MD",First Afiliated hospital of Guangzhou medical university,,NCT04403009,jianheng zhang,jianheng,male,0.86,7,2129,NCT04403009,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,Recruiting,No Results Available,Coronavirus Disease 2019|Character of the Severe Patients,Other: no intervention,"May 27, 2020","The First Affiliated Hospital of Guangzhou Medical University, Guanzhou, Guangdong, China|Hankou Hospital, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04403009
Principal Investigator,"Hongzhou Lu, Ph.D",Shanghai Public Health Clinical Center,,NCT04292340,hongzhou lu,hongzhou,male,1.0,8,2132,NCT04292340,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,Recruiting,No Results Available,Coronavirus,,"March 3, 2020","Shanghai Public Health Clinical Center, Shanghai, Shanghai, China",https://ClinicalTrials.gov/show/NCT04292340
Principal Investigator,"Diana Speelman, PhD",Lake Erie College of Osteopathic Medicine,,NCT04369378,diana speelman,diana,female,0.98,89820,2136,NCT04369378,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Not yet recruiting,No Results Available,Anxiety|Well-being,Behavioral: Meditation app usage,"April 30, 2020",,https://ClinicalTrials.gov/show/NCT04369378
Principal Investigator,"Rudi De Raedt, PhD",University Ghent,,NCT04367636,rudi de raedt,rudi,male,0.97,7816,2143,NCT04367636,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Not yet recruiting,No Results Available,Rumination|Anxiety|Stress|Depressive Symptoms,Behavioral: Behavioral: OCAT-sham|Behavioral: Behavioral: OCAT|Other: psycho-education video,"April 29, 2020","Ghent University, Gent, Oost-Vlaanderen, Belgium",https://ClinicalTrials.gov/show/NCT04367636
Principal Investigator,"Ernst Koster, PhD",University Ghent,,NCT04367636,ernst koster,ernst,male,0.98,2680,2143,NCT04367636,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Not yet recruiting,No Results Available,Rumination|Anxiety|Stress|Depressive Symptoms,Behavioral: Behavioral: OCAT-sham|Behavioral: Behavioral: OCAT|Other: psycho-education video,"April 29, 2020","Ghent University, Gent, Oost-Vlaanderen, Belgium",https://ClinicalTrials.gov/show/NCT04367636
Principal Investigator,"Jean-Damien Ricard, MD, PhD",Assistance Publique - Hôpitaux de Paris,,NCT04385823,jean-damien ricard,jean-damien,male,1.0,41,2154,NCT04385823,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,Completed,No Results Available,"Respiratory Syndrome, Acute, Severe|Hypoxic Respiratory Failure|Viral Pneumonia",Device: patients receiving nasal high flow,"May 13, 2020","Hôpital Louis Mourier, Assistance Publique - Hôpitaux de Paris, Colombes, France",https://ClinicalTrials.gov/show/NCT04385823
Principal Investigator,"Eva Reininghaus, Prof.",Medical University of Graz,,NCT04410835,eva reininghaus,eva,female,0.98,135031,2161,NCT04410835,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,Recruiting,No Results Available,Corona Virus Infection|Psychiatric Disorder|Psychological Distress,Diagnostic Test: Online Survey,"June 1, 2020","Medical University Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Styria, Austria",https://ClinicalTrials.gov/show/NCT04410835
Study Chair,"Wael Almahmeed, MD",Cleveland Clinic Abu Dhabi,,NCT04422418,wael almahmeed,wael,male,0.98,10490,2171,NCT04422418,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,Recruiting,No Results Available,Cardiovascular Risk Factor|Burnout|Immune Deficiency,,"June 9, 2020","Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates|Mediclinic, Abu Dhabi, United Arab Emirates|Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates|Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates",https://ClinicalTrials.gov/show/NCT04422418
Principal Investigator,Jean-Louis PEPIN,"University Hospital, Grenoble",,NCT04409197,jean-louis pepin,jean-louis,male,0.99,5131,2173,NCT04409197,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",Recruiting,No Results Available,Comorbidities|Confinement|Obesity,,"June 1, 2020","CHU Grenoble Alpes, Grenoble, France",https://ClinicalTrials.gov/show/NCT04409197
Principal Investigator,"Elie AZOULAY, MD PhD",APHP,,NCT04341519,elie azoulay,elie,male,0.93,9097,2179,NCT04341519,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Not yet recruiting,No Results Available,Corona Virus Infection|Post-traumatic Stress Disorder,Behavioral: PTSD|Behavioral: Burnout,"April 10, 2020","Saint-Louis Hospital, Paris, Ile De France, France",https://ClinicalTrials.gov/show/NCT04341519
Principal Investigator,"Walid Habre, MD, PhD",University of Geneva,,NCT04359407,walid habre,walid,male,0.98,29000,2186,NCT04359407,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,Recruiting,No Results Available,Severe Acute Respiratory Syndrome Coronavirus 2|Electric Impedance|Prone Positioning,Other: Prone positioning,"April 24, 2020","University Hospitals of Geneva, Geneva, Switzerland",https://ClinicalTrials.gov/show/NCT04359407
Principal Investigator,"Liang Peng, Doctor",Third Affiliated Hospital of Sun Yat-sen University,,NCT04279795,liang peng,liang,male,0.79,1211,2189,NCT04279795,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Recruiting,No Results Available,Coronavirus,,"February 21, 2020","The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04279795
Principal Investigator,"Liang Peng, Doctor",Third Affiliated Hospital of Sun Yat-sen University,,NCT04279782,liang peng,liang,male,0.79,1211,2192,NCT04279782,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Recruiting,No Results Available,Coronavirus,Other: Comprehensive treatment,"February 21, 2020","The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04279782
Study Director,"Pierre-Emmanuel FALCOZ, MD, PhD",Service de Chirurgie Thoracique Nouvel Hôpital Civl Hôpitaux Univesitaires de Strasbourg,,NCT04343404,pierre-emmanuel falcoz,pierre-emmanuel,male,1.0,262,2194,NCT04343404,PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2,Recruiting,No Results Available,Respiratory Distress Syndrome,,"April 13, 2020","Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg, Strasbourg, France",https://ClinicalTrials.gov/show/NCT04343404
Principal Investigator,"Deneen Vojta, MD",UnitedHealth Group,,NCT04353037,deneen vojta,deneen,female,1.0,16,2195,NCT04353037,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Recruiting,No Results Available,Coronavirus|Corona Virus Infection,Drug: Group A HCQ|Drug: Group B Control,"April 20, 2020","ProHealth New York, New York, New York, United States",https://ClinicalTrials.gov/show/NCT04353037
Study Chair,Yazdan YAZDANPANAH,"Institut National de la Santé Et de la Recherche Médicale, France",,NCT04262921,yazdan yazdanpanah,yazdan,male,0.94,80,2197,NCT04262921,French COVID Cohort,Recruiting,No Results Available,Coronavirus Infections,,"February 10, 2020","CHG Agen, Agen, France|Centre Hospitalier Du Pays D'aix, Aix-en-Provence, France|CHU Amiens, Amiens, France|CHU Angers, Angers, France|CH Annecy Genevois, Annecy, France|Hopital privé d'Antony, Antony, France|Hôpital de Mercy. CHR METZ-THIONVILLE, Ars-Laquenexy, France|Centre Hospitalier Henri Duffaut, Avignon, France|Chu Jean Minjoz, Besançon, France|Hôpital Avicenne AP-HP, Bobigny, France|CHU Pellegrin, Bordeaux, France|CHU Ambroise Paré, Boulogne-Billancourt, France|Ch Fleyriat, Bourg-en-Bresse, France|Chru Hopital Cavale Blanche, Brest, France|CHU Brest, Brest, France|Centre hospitalier de Béziers, Béziers, France|CH Cahors, Cahors, France|Chms Chambery Nh, Chambéry, France|Centre Hospitalier De Cholet, Cholet, France|CHU Gabriel Montpied, Clermont-Ferrand, France|CH Colmar - Hopital Pasteur, Colmar, France|Centre hospitalier Alpes Leman, Contamine-sur-Arve, France|Centre hospitalier Intercommunal de Créteil, Créteil, France|Hôpital Henri Mondor, Créteil, France|Centre Hospitalier Dax, Dax, France|CHU Dijon Bourgogne, Dijon, France|Hopital Raymond Poincare, Garches, France|CHU Grenoble, Grenoble, France|Grand Hopital de l'Est Francilien site Marne-la-Vallée, Jossigny, France|Chd Les Oudairies, La Roche-sur-Yon, France|Hôpital Universitaire Bicêtre, Le Kremlin-Bicêtre, France|Centre Hospitalier Emile Roux, Le Puy-en-Velay, France|Centre Hospitalier Universitaire de Lille, Lille, France|CHRU Lille, Hôpital Salengro, Lille, France|CHU de Lille, Lille, France|Hôpital de la Croix-Rousse, Lyon, France|Hôpital Louis Raffalli, Manosque, France|Assistance publique hopitaux de Marseille, hopital Nord, Marseille, France|Hôpital Conception, Marseille, France|Groupe Hospitalier Sud Ile De France, Melun, France|CH de Mont Marsan, Mont de Marsan, France|CHU Montpellier, Montpellier, France|CHU Nantes, Nantes, France|Hopital Américain de Paris, Neuilly-sur-Seine, France|CHU de Nice, Nice, France|CHU Caremeau, Nîmes, France|APHP Bichat, Paris, France|APHP Tenon, Paris, France|CH Lariboisière, Paris, France|Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France|Hopital Cochin-CIC1417, Paris, France|Hopital Européen Georges Pompidou, Paris, France|Hopital Saint Antoine, Paris, France|Hopital Saint Louis, Paris, France|La pitié salpetrière, Paris, France|Centre Hospitalier de Pau, Pau, France|CH de Perpignan, Perpignan, France|CHU de Poitiers, Poitiers, France|Centre Hospitalier de Périgueux, Périgueux, France|Ch Cornouaille, Quimper, France|Chu Reims, Reims, France|Hôpital Pontchaillou, Rennes, France|CHU Rouen Normandie, Rouen, France|Hopital d'instruction des armées Begin 69, Saint-Mandé, France|Centre hospitalier Louis Constant Fleming, Saint-Martin, France|CHU de Saint-Etienne, Saint-Étienne, France|CH de Saintonge, Saintes, France|Centre Hospitalier de Soissons, Soissons, France|N.H.C. - Nouvel Hopital Civil, Strasbourg, France|Hopital Foch, Suresnes, France|CHR Metz-Thionville -Hopital Bel Air, Thionville, France|Hopitaux du Leman, Thonon-les-Bains, France|Centre Hospitalier Universitaire de Rangueil, Toulouse, France|CHU de Toulouse, Toulouse, France|CHU Toulouse IUCT Institut Universitaire de Cancer de Toulouse, Toulouse, France|Hôpital Gustave Dron, Tourcoing, France|Centre Hospitalier Régional Universitaire de Tours, Tours, France|CHRU de Tours, Tours, France|CHU Nancy, Vandœuvre-lès-Nancy, France|Centre Hospitalier Intercommunal, Villeneuve Saint Georges, France|CH Annecy Genevois, Épagny, France",https://ClinicalTrials.gov/show/NCT04262921
Principal Investigator,"Stephen Freedman, MD",University of Calgary,,NCT04330261,stephen freedman,stephen,male,0.99,36980,2198,NCT04330261,Clinical Characteristics and Outcomes of Pediatric COVID-19,Recruiting,No Results Available,"COVID-19|SARS-CoV-2 Infection|Pediatric ALL|Pneumonia, Viral|Pandemic Response",Other: Exposure (not intervention) - SARS-CoV-2 infection,"April 1, 2020","University of Calgary/Alberta Children's Hospital, Calgary, Alberta, Canada",https://ClinicalTrials.gov/show/NCT04330261
Principal Investigator,Yun Long,Peking Union Medical College Hospit,,NCT04340414,yun long,yun,female,0.52,2421,2201,NCT04340414,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Recruiting,No Results Available,COVID-19|ECMO,Device: Low flow ECMO driving by CVVH machine,"April 9, 2020","Yun Long, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04340414
Principal Investigator,Xiuling Shang,Fujian Provincial Hospital,,NCT04292327,xiuling shang,xiuling,female,0.88,17,2204,NCT04292327,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,"Active, not recruiting",No Results Available,Pneumonia Caused by Human Coronavirus,,"March 3, 2020","Fujian Provincial Hospital, Fuzhou, Fujian, China",https://ClinicalTrials.gov/show/NCT04292327
Study Chair,"XingHuan Wang, professor",Wuhan University,,NCT04269525,xinghuan wang,xinghuan,male,1.0,1,2211,NCT04269525,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,Recruiting,No Results Available,"Pneumonia, Viral|Pneumonia, Ventilator-Associated",Biological: UC-MSCs,"February 13, 2020","Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04269525
Study Director,Gary Barnette,Veru Inc.,,NCT04388826,gary barnette,gary,male,0.99,29381,2213,NCT04388826,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,Recruiting,No Results Available,"Respiratory Distress Syndrome, Adult",Drug: Veru-111,"May 14, 2020","HonorHealth, Scottsdale, Arizona, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|WC-CRCN at North Vista Hospital, Las Vegas, Nevada, United States|Inspira Medical Center, Vineland, New Jersey, United States",https://ClinicalTrials.gov/show/NCT04388826
Principal Investigator,"Becky Smith, MD",Duke University,,NCT04320862,becky smith,becky,female,0.97,6413,2215,NCT04320862,COVID-19 Pandemic Response Network,Recruiting,No Results Available,COVID-19|SARS-CoV-2|Coronavirus|Influenza -Like Illness|Lower Resp Tract Infection|Upper Resp Tract Infection,,"March 25, 2020","Duke University Medical Center, Durham, North Carolina, United States",https://ClinicalTrials.gov/show/NCT04320862
Principal Investigator,"Shabir A Madhi, MD, PhD","University of Witwatersrand, South Africa",,NCT04444674,shabir a madhi,shabir,male,1.0,280,2216,NCT04444674,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,Not yet recruiting,No Results Available,Coronavirus,Biological: ChAdOx1 nCoV-19|Biological: Normal saline 0.9%,"June 23, 2020","PHRU Kliptown, Johannesburg, Gauteng, South Africa|Wits RHI Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Setshaba Research Centre (SRC), Soshanguve, Gauteng, South Africa|Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU, Soweto, Gauteng, South Africa|FAMCRU, Cape Town, Western Cape, South Africa|Groote Schuur hospital, Lung infection and immunity unit, UCT, Cape Town, Western Cape, South Africa",https://ClinicalTrials.gov/show/NCT04444674
Principal Investigator,"Grace Aldrovandi, M.D.",University of Califiornia at Los Angeles,,NCT04407546,grace aldrovandi,grace,female,0.97,20056,2219,NCT04407546,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,Recruiting,No Results Available,Immunosuppression,,"May 29, 2020","University of California at Los Angeles, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04407546
Principal Investigator,"Yunqing Qiu, Master",First Affiliated Hospital of Zhejiang University,,NCT04261907,yunqing qiu,yunqing,female,0.78,9,2220,NCT04261907,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Not yet recruiting,No Results Available,2019-nCoV,Drug: ASC09/ritonavir group|Drug: lopinavir/ritonavir group,"February 10, 2020",,https://ClinicalTrials.gov/show/NCT04261907
Study Director,"Heng Li, MD,PhD",Tianhe Stem Cell Biotechnologies Inc.,,NCT04299152,heng li,heng,male,0.82,795,2223,NCT04299152,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,Not yet recruiting,No Results Available,Severe Acute Respiratory Syndrome (SARS) Pneumonia,Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis,"March 6, 2020",,https://ClinicalTrials.gov/show/NCT04299152
Study Director,"ShuPing Yang, MD, PhD",Inovio Pharmaceuticals,,NCT04336410,shuping yang,shuping,female,0.59,27,2230,NCT04336410,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Recruiting,No Results Available,Coronavirus Infection,Drug: INO-4800|Device: CELLECTRA® 2000,"April 7, 2020","Central Kentucky Research Associates, Lexington, Kentucky, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States",https://ClinicalTrials.gov/show/NCT04336410
Principal Investigator,"Zhiyong Peng, professor",Wuhan University,,NCT04264533,zhiyong peng,zhiyong,male,0.97,76,2233,NCT04264533,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Recruiting,No Results Available,"Vitamin C|Pneumonia, Viral|Pneumonia, Ventilator-Associated",Drug: VC|Drug: Sterile Water for Injection,"February 11, 2020","Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04264533
Principal Investigator,"Nazima Pathan, FRCPCH PhD",Cambridge University Hospitals NHS Foundation Trust,,NCT04233268,nazima pathan,nazima,female,0.95,61,2236,NCT04233268,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,Recruiting,No Results Available,Lower Respiratory Tract Infection|Ventilator Associated Pneumonia|COVID19,Diagnostic Test: Rapid Pathogen Detection,"January 18, 2020","Addenbrooke's Hospital, Cambridge, Cambs, United Kingdom",https://ClinicalTrials.gov/show/NCT04233268
Principal Investigator,"Yao Xie, Doctor","Department of Hepatology, Division 2, Beijing Ditan Hospital",,NCT04245631,yao xie,yao,male,0.8,3353,2240,NCT04245631,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Recruiting,No Results Available,New Coronavirus,Diagnostic Test: Recombinase aided amplification (RAA) assay,"January 29, 2020","Department of Hepatology Division 2, Beijing Ditan Hospital, Beijing, Beijing, China",https://ClinicalTrials.gov/show/NCT04245631
Principal Investigator,"Shmuel Shoham, MD",Johns Hopkins University,,NCT04323800,shmuel shoham,shmuel,male,0.98,120,2242,NCT04323800,Convalescent Plasma to Stem Coronavirus (CSSC-001),Recruiting,No Results Available,Coronavirus|Convalescence,Biological: Anti- SARS-CoV-2 Plasma|Biological: SARS-CoV-2 non-immune Plasma,"March 27, 2020","University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California, San Diego, La Jolla, California, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Lee Memorial Health System, Fort Myers, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|JHSPH Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States",https://ClinicalTrials.gov/show/NCT04323800
Principal Investigator,"Jihong Liu, M.D","Departments of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",,NCT04388631,jihong liu,jihong,male,0.78,67,2251,NCT04388631,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,Recruiting,No Results Available,Coronavirus Disease 2019,Other: Coronavirus Disease 2019,"May 14, 2020","Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",https://ClinicalTrials.gov/show/NCT04388631
Principal Investigator,"Luqian Zhou, MD",The First Affiliated Hospital of Guangzhou Medical University,,NCT04280913,luqian zhou,luqian,male,1.0,1,2252,NCT04280913,Clinical Outcomes of Patients With COVID19,Withdrawn,No Results Available,Coronavirus Disease 2019,Other: retrospective analysis,"February 21, 2020","HuiZhou Municipal Central Hospital, Huizhou, Guangdong, China",https://ClinicalTrials.gov/show/NCT04280913
Principal Investigator,"Jane O'Halloran, MD PhD",Washington University School of Medicine (ID-CRU),,NCT04341727,jane o'halloran,jane,female,0.97,36653,2259,NCT04341727,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection",Suspended,No Results Available,Coronavirus Infection,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Chloroquine Sulfate,"April 10, 2020","Washington University School of Medicine Infectious Disease Clinical Research Unit, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04341727
Principal Investigator,"Jack Green, MD",Cedars-Sinai Medical Center,,NCT04441632,jack green,jack,male,0.98,63210,2264,NCT04441632,Effect of Positive Attitudes on Behavior and Wellness,Recruiting,No Results Available,"Burnout|Stress, Emotional",Behavioral: Positive feedback,"June 22, 2020","Cedars-Sinai Medical Center, Los Angeles, California, United States",https://ClinicalTrials.gov/show/NCT04441632
Principal Investigator,"Dhanunjaya Lakkireddy, MD",Kansas City Heart Rhythm Institute,,NCT04361838,dhanunjaya lakkireddy,dhanunjaya,male,1.0,4,2268,NCT04361838,The COVID-19 ICU PRAYER Study,Recruiting,No Results Available,Coronavirus Infection,Behavioral: prayer,"April 24, 2020","Research Medical Center, Kansas City, Missouri, United States",https://ClinicalTrials.gov/show/NCT04361838
Principal Investigator,"Jesper S Nielsen, MD","Zealand University Hospital, Køge",,NCT04370678,jesper s nielsen,jesper,male,0.99,6327,2272,NCT04370678,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Completed,No Results Available,Arthroscopy,Behavioral: Change in preference to surgery under COVID-19 pandemic.,"May 1, 2020","Zealand University Hospital, Køge, Zealand Region, Denmark",https://ClinicalTrials.gov/show/NCT04370678
Principal Investigator,"Halidou Tinto, PhD",IRSS - URCN,,NCT04445441,halidou tinto,halidou,male,0.95,142,2276,NCT04445441,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,Recruiting,No Results Available,Coronavirus Infection,,"June 24, 2020","Sourou Sanon University Hospital, Bobo-Dioulasso, Burkina Faso|Tingadogo University Hospital, Ouagadougou, Burkina Faso",https://ClinicalTrials.gov/show/NCT04445441
Principal Investigator,"June K Robinson, MD",Northwestern University Feinberg School of Medicine,,NCT04420273,june k robinson,june,female,0.76,5901,2280,NCT04420273,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,Not yet recruiting,No Results Available,Melanoma,Behavioral: SSE educational intervention|Other: Home sample collection of concerning mole with physician supervision|Behavioral: Active control:Healthy Living,"June 9, 2020","Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago, Illinois, United States",https://ClinicalTrials.gov/show/NCT04420273
Study Director,"Ipek Yeldan, PhD",Istanbul University-Cerrahpasa,,NCT04357886,ipek yeldan,ipek,female,0.96,4637,2283,NCT04357886,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,Not yet recruiting,No Results Available,Healthy,,"April 22, 2020","Istanbul University-Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04357886
Principal Investigator,"Dolores Sanchez-Rodriguez, MD PhD","Division of Public Health, University of Liège, Liège, Belgium",,NCT04413877,dolores sanchez-rodriguez,dolores,female,0.98,8341,2285,NCT04413877,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),Not yet recruiting,No Results Available,Frailty Syndrome|COVID-19|Healthy Aging|Old Age; Debility,,"June 4, 2020",,https://ClinicalTrials.gov/show/NCT04413877
Principal Investigator,"Ekaterina Ninova, Ph.D.",University of Miami,,NCT04378803,ekaterina ninova,ekaterina,female,0.98,11546,2286,NCT04378803,Mindfulness Training for Seniors,"Active, not recruiting",No Results Available,Well Aging,Behavioral: Mindfulness training (MT) Connect,"May 7, 2020","University of Miami, Coral Gables, Florida, United States",https://ClinicalTrials.gov/show/NCT04378803
Principal Investigator,"Kerri A Morgan, PhD",Washington University School of Medicine,,NCT04422769,kerri a morgan,kerri,female,0.95,819,2287,NCT04422769,Needs of Persons With Spinal Cord Injury (SCI),Recruiting,No Results Available,Spinal Cord Injuries,,"June 9, 2020","Washington University School of Medicine, Saint Louis, Missouri, United States",https://ClinicalTrials.gov/show/NCT04422769
Principal Investigator,"Begum Kara Kaya, MSc",Biruni University,,NCT04335851,begum kara kaya,begum,female,0.95,452,2288,NCT04335851,Video-Based Exercises and Well-Being During Social Isolation,Completed,No Results Available,Social Isolation|Physical Inactivity|Well-Being,Other: Video based aerobic exercise,"April 6, 2020","Biruni University, Istanbul, Turkey|Istanbul University Cerrahpasa, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04335851
Principal Investigator,"Salih SS Sevdi, Md",Istanbul Bagcılar Training and Research Hospital,,NCT04442958,salih ss sevdi,salih,male,0.97,23933,2290,NCT04442958,Effectiveness of Convalescent Immune Plasma Therapy,Completed,No Results Available,Acute Respiratory Distress Syndrome,Other: Convalescent Immune Plasma,"June 23, 2020","Istanbul Bagcılar Training and Research Hospital, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04442958
Principal Investigator,"Tzu Tsun Luk, PhD, RN",The University of Hong Kong,,NCT04409496,tzu tsun luk,tzu,male,0.6,133,2293,NCT04409496,Chat-based Support for Preveting Smoking Relapse,Recruiting,No Results Available,Smoking Cessation,Behavioral: Chat-based instant messaging support|Behavioral: SMS message support|Behavioral: Self-help booklet,"June 1, 2020","Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation, Hong Kong, Hong Kong",https://ClinicalTrials.gov/show/NCT04409496
Principal Investigator,"Keith A Marill, MD",Massachusetts General Hospital,,NCT04369274,keith a marill,keith,male,0.98,14549,2298,NCT04369274,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Not yet recruiting,No Results Available,Respiratory Failure,Device: Mechanical ventilation with the automated BVM compressor,"April 30, 2020",,https://ClinicalTrials.gov/show/NCT04369274
Principal Investigator,"Brigitte C Sabourin, PhD",University of Manitoba,,NCT04413006,brigitte c sabourin,brigitte,female,0.98,32701,2300,NCT04413006,Self-compassion for Chronic Pain Virtual Group Treatment Program,Recruiting,No Results Available,Chronic Pain,Behavioral: Self-Compassion for Chronic Pain Virtual Group Treatment Program,"June 2, 2020","University of Manitoba, Winnipeg, Manitoba, Canada",https://ClinicalTrials.gov/show/NCT04413006
Principal Investigator,"Radha Rajasingham, MD",University of Minnesota,,NCT04328467,radha rajasingham,radha,female,0.73,407,2309,NCT04328467,Pre-exposure Prophylaxis for SARS-Coronavirus-2,"Active, not recruiting",No Results Available,COVID-19|Corona Virus Infection|ARDS|Acute Respiratory Distress Syndrome,Drug: Hydroxychloroquine|Other: Placebo,"March 31, 2020","Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States",https://ClinicalTrials.gov/show/NCT04328467
Principal Investigator,"Hans de Graaf, MD",University Hospital Southampton NHS Foundation Trust,,NCT04382508,hans de graaf,hans,male,0.97,37182,2314,NCT04382508,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,Enrolling by invitation,No Results Available,"Immune Suppression|Immune Deficiency|Infection|COVID|Children, Adult",Other: Questionnaire,"May 11, 2020","University Hospital Southampton NHS FT, Southampton, Hampshire, United Kingdom",https://ClinicalTrials.gov/show/NCT04382508
Principal Investigator,"Olav Dalgard, MD PhD",Akerhus University Hospital,,NCT04316377,olav dalgard,olav,male,0.99,589,2319,NCT04316377,Norwegian Coronavirus Disease 2019 Study,"Active, not recruiting",No Results Available,Corona Virus Infection,Drug: Hydroxychloroquine Sulfate,"March 20, 2020","Akershus University Hospital, Lørenskog, Norway",https://ClinicalTrials.gov/show/NCT04316377
Study Chair,Berna Dinçer,Istanbul Medeniyet University,,NCT04393077,berna dinçer,berna,female,0.89,7352,2322,NCT04393077,Emotional Freedom Technique (EFT) Effect on Nurses,Recruiting,No Results Available,"Stress|Anxiety|Burnout, Caregiver",Behavioral: Emotional Freedom Technique,"May 19, 2020","Medeniyet University, Istanbul, Turkey",https://ClinicalTrials.gov/show/NCT04393077
Principal Investigator,Chi Hornik,Duke Clinical Research Institute,,NCT04278404,chi hornik,chi,male,0.6,3281,2330,NCT04278404,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",Recruiting,No Results Available,"Coronavirus Infection (COVID-19)|Pulmonary Arterial Hypertension|Urinary Tract Infections in Children|Hypertension|Pain|Hyperphosphatemia|Primary Hyperaldosteronism|Edema|Hypokalemia|Heart Failure|Hemophilia Prior to Tooth Extraction|Menorrhagia|Insomnia|Pneumonia|Skin Infection|Arrythmia|Asthma in Children|Bronchopulmonary Dysplasia|Adrenal Insufficiency|Hypertension, Resistant to Conventional Therapy|Fibrinolysis; Hemorrhage","Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:","February 20, 2020","Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States|Colorado University Denver, Aurora, Colorado, United States|Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States|University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida, United States|Kapiolani Womens and Childrens Medical Center, Honolulu, Hawaii, United States|Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|University of Louisville Norton Childrens Hospital, Louisville, Kentucky, United States|Tulane University Health Science Center, New Orleans, Louisiana, United States|Ochsner Baptist Clinical Trials Unit, New Orleans, Louisiana, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Childrens Mercy Hospital, Kansas City, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|University of New Mexico Health Science Center, Albuquerque, New Mexico, United States|Kravis Children's Hospital at Mt. Sinai, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Health System, Durham, North Carolina, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Board of Regents of the University of Oklahoma, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina Children's Hospital, Charleston, South Carolina, United States|University of South Carolina, Columbia, South Carolina, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|University Wisconsin, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada",https://ClinicalTrials.gov/show/NCT04278404
Study Director,"Nic Bedard, MD",University of Iowa Department of Orthopaedics,,NCT04329897,nic bedard,nic,male,0.71,5976,2331,NCT04329897,Acceptance and Commitment Therapy Delivered by Automated Software Messaging,Enrolling by invitation,No Results Available,Hip Osteoarthritis|Knee Osteoarthritis|Mental Stress|Coronavirus,Behavioral: Software Messaging,"April 1, 2020","University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States",https://ClinicalTrials.gov/show/NCT04329897
Principal Investigator,"Marilou Lamourette, MD",Centre Psychothérapique de Nancy,,NCT04387708,marilou lamourette,marilou,female,0.99,2345,2332,NCT04387708,Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID),Not yet recruiting,No Results Available,Anorexia Nervosa,,"May 14, 2020",,https://ClinicalTrials.gov/show/NCT04387708
Principal Investigator,"Muradiye Nacak, MD,PhD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04444986,muradiye nacak,muradiye,female,0.97,238,2334,NCT04444986,Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions,Completed,No Results Available,Bioequivalence,Drug: FAVIR 200 MG FT|Drug: AVIGAN 200 mg FT,"June 24, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04444986
Study Chair,"Taner Ezgi, MD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04444986,taner ezgi,taner,male,0.97,16719,2334,NCT04444986,Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions,Completed,No Results Available,Bioequivalence,Drug: FAVIR 200 MG FT|Drug: AVIGAN 200 mg FT,"June 24, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04444986
Principal Investigator,"Muradiye Nacak, MD,PhD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04406194,muradiye nacak,muradiye,female,0.97,238,2340,NCT04406194,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions","Active, not recruiting",No Results Available,Bioequivalence,Drug: Favipiravir 200 mg,"May 28, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04406194
Principal Investigator,"Muradiye Nacak, MD,PhD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04400682,muradiye nacak,muradiye,female,0.97,238,2341,NCT04400682,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions","Active, not recruiting",No Results Available,Bioequivalence,Drug: Test Drug 200 mg favipiravir|Drug: Reference Drug 200 mg favipiravir,"May 22, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04400682
Study Chair,"Taner Ezgi, MD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04400682,taner ezgi,taner,male,0.97,16719,2341,NCT04400682,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions","Active, not recruiting",No Results Available,Bioequivalence,Drug: Test Drug 200 mg favipiravir|Drug: Reference Drug 200 mg favipiravir,"May 22, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04400682
Principal Investigator,"Muradiye Nacak, MD,PhD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04407000,muradiye nacak,muradiye,female,0.97,238,2344,NCT04407000,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions",Not yet recruiting,No Results Available,Bioequivalence,Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug: Reference: Favipiravir 200 mg (Avigan),"May 29, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04407000
Principal Investigator,"Muradiye Nacak, MD,PhD",Farmagen Ar-Ge Biyot. Ltd. Sti,,NCT04386876,muradiye nacak,muradiye,female,0.97,238,2345,NCT04386876,"Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions","Active, not recruiting",No Results Available,Bioequivalence,Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Test|Drug: Lopinavir 200Mg/Ritonavir 50Mg FT Reference,"May 13, 2020","Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep, Turkey",https://ClinicalTrials.gov/show/NCT04386876
Principal Investigator,"Julian Lim, PhD","National University, Singapore",,NCT04417153,julian lim,julian,male,0.98,33459,2336,NCT04417153,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes,Recruiting,No Results Available,"Stress, Psychological|Sleep Initiation and Maintenance Disorders",Behavioral: Mindfulness Based Intervention,"June 4, 2020","National University Singapore, Singapore, Singapore",https://ClinicalTrials.gov/show/NCT04417153
Principal Investigator,"Gerhard Andersson, PhD",Linkoeping University,,NCT04424212,gerhard andersson,gerhard,male,0.99,6677,2338,NCT04424212,ICBT for Mental Health Problems Related to the Coronavirus Pandemic,Recruiting,No Results Available,Depression and Quality of Life Related to the Coronavirus Pandemic,Behavioral: Intervention group CoronaCope,"June 9, 2020","Linköping University, Linköping, Östergötland, Sweden",https://ClinicalTrials.gov/show/NCT04424212
Principal Investigator,Eliz Arter,Eastern Mediterranean University,,NCT04339842,eliz arter,eliz,female,0.95,799,2343,NCT04339842,Eating Habits of Adults During the Quarantine,Recruiting,No Results Available,Health Behavior|Eating Behavior,Other: Assessment of Dietary Changes in Adults in the Quarantine,"April 9, 2020","Online, Nicosia, Cyprus",https://ClinicalTrials.gov/show/NCT04339842
